0001104659-14-001779.txt : 20140113 0001104659-14-001779.hdr.sgml : 20140113 20140110183126 ACCESSION NUMBER: 0001104659-14-001779 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20131031 FILED AS OF DATE: 20140113 DATE AS OF CHANGE: 20140110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO REFERENCE LABORATORIES INC CENTRAL INDEX KEY: 0000792641 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 222405059 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-15266 FILM NUMBER: 14522874 BUSINESS ADDRESS: STREET 1: 481 EDWARD H ROSS DR CITY: ELMWOOD PARK STATE: NJ ZIP: 07407-3118 BUSINESS PHONE: 2017912186 MAIL ADDRESS: STREET 1: 481 EDWARD H ROSS DRIVE CITY: ELMWOOD PARK STATE: NJ ZIP: 07407-3118 FORMER COMPANY: FORMER CONFORMED NAME: MED MOBILE INC DATE OF NAME CHANGE: 19891115 10-K 1 a13-13310_110k.htm 10-K

Table of Contents

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 10-K

 

[Mark One]

 

x

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended October 31, 2013

 

OR

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                  to                 

 

Commission file number 0-15266

 

BIO-REFERENCE LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

 

New Jersey

 

22-2405059

(State of incorporation)

 

(I.R.S. Employer

 

 

Identification No.)

 

481 Edward H. Ross Drive, Elmwood Park, New Jersey

 

07407

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code 201-791-2600

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Name of each exchange on which registered

Common Stock, $.01 par value

 

NASDAQ Global Select Market

 

Securities registered pursuant to Section 12(g) of the Act:             None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes o No x.

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.  Yes o No x.

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x No o.

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x No o.

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or in any amendment to this Form 10-K.  o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer.” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer  o

 

Accelerated filer  x

 

Non-Accelerated filer  o

 

Smaller reporting company  o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o No x.

 

The aggregate market value of the voting stock of Bio-Reference Laboratories, Inc. (consisting of Common Stock, $.01 par value) held by non-affiliates of the registrant was approximately $623,072,381 based upon the last sale price for the Common Stock on April 30, 2013, the last trading date of the registrant’s most recently completed second quarter, as reported on the NASDAQ Global Market System.

 

On January 9, 2014, there were 27,695,213 shares of Common Stock issued and outstanding.

 

 

 


Table of Contents

 

PART I

 

Forward Looking Statements

 

Statements included in this Annual Report on Form 10-K (Annual Report) that are not historical in nature, are intended to be, and are hereby identified as “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “will” or words of similar meaning and include, but are not limited to, statements about the expected future business and financial performance of Bio-Reference Laboratories, Inc. and its subsidiaries. Such statements concern matters that involve known and unknown risks and uncertainties that may cause the Company’s actual results in future periods, performance or achievements, or industry results, to be materially different from any future results, performance or achievements described, implied or suggested herein. Although we believe our expectations are based upon reasonable assumptions, there can be no assurance that our financial goals will be realized.

 

Factors could cause actual results, performance or achievement to differ materially from those expressed or implied from these forward-looking statements include, but are not limited to, the factors discussed under “Risk Factors” as well as elsewhere herein, which may include:

 

Loss or suspension of a license or imposition of a fine or penalties under, or future changes in, the law or regulations of CLIA, or those of state laboratory licensing laws;

Failure to comply with HIPAA, which could negatively impact profitability and cash flows;

FDA regulation of Laboratory Developed Tests and clinical laboratories;

Failure to comply with federal and state anti-kickback laws;

Failure to maintain the security of patient-related information;

Failure to comply with the Federal Occupational Safety and Health Administration requirements and Needlestick Safety and Prevention Act;

Failure to comply with federal and state laws and regulations related to submission of claims for our services;

Changes in regulation and policies, including increasing downward pressure on health care reimbursement;

Changing relationships with payers, including the various state and multi-state Blues programs, suppliers and strategic partners; Efforts by third-party payors to reduce utilization and reimbursement for clinical testing services;

Failure to timely or accurately bill for our services;

Failure to integrate newly acquired businesses and the costs related to such integration;

Increased competition, including price competition;

Ability to attract and retain experienced and qualified personnel;

Failure to obtain and retain new clients and business partners, or a reduction in tests ordered or specimens submitted by existing clients;

Adverse litigation results; and

Failure to establish, and perform to, appropriate quality standards to assure that the highest level of quality is observed in the performance of our testing services.

 

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this filing.  We assume no obligation to update the forward-looking statements to reflect actual results or changes in the factors affecting such forward-looking statements.

 

Item. 1. — Business

 

Overview

 

We are a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units.  We believe that we are the fourth largest full-service laboratory in the United States and the largest independent regional laboratory in the Northeastern market. We offer a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.  We primarily focus on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health and correctional health care.

 

We currently process approximately 7.8 million laboratory test requisitions each year. A requisition form accompanies a patient specimen, indicating the tests to be performed and the party to be invoiced for the tests. We have a network of approximately 116 patient service centers located in the Northeast (primarily in New York metropolitan super-regional area) for collection of patient specimens.  We currently conduct business in most New York State counties, as well as in most of New Jersey and Maryland as well as some parts of Pennsylvania, Delaware and Connecticut. We primarily offer laboratory services to physician offices in these areas with an infrastructure that includes a comprehensive logistical department, extensive phlebotomy services and phlebotomy draw stations scattered around our geographic area.  In October 2012, we launched Laboratorio Buena Salud, the first national testing laboratory dedicated to serving Spanish-speaking populations in the United States.  All business will be conducted in Spanish, including patient and physician interactions.

 

In addition to our clinical testing operations, we operate a clinical knowledge management service through our PSIMedica business unit.  This system uses customer data from laboratory results, pharmaceutical data, claims data and other data sources to provide administrative and clinical decision support systems that enable our customers to provide quality and efficient healthcare to their populations.

 

We also operate a web-based connectivity portal solution for laboratories and physicians through our CareEvolve subsidiary. We use this portal ourselves to provide laboratory ordering and results as well as connectivity to our physician customers.  We also market and license this connectivity solution to other laboratories throughout the country.

 

We are a New Jersey corporation. We are the successor to Med-Mobile, Inc., a New Jersey corporation that was organized in 1981. Our executive offices are located at 481 Edward H. Ross Drive, Elmwood Park, NJ  07407, and our telephone number is 201-791-2600. In this Form 10-K, we may at times refer to ourselves and our subsidiaries as “we,” “us” or “the Company.”

 

The Clinical Laboratory Testing Market in the United States

 

We believe that the U.S. market for clinical laboratory testing generated approximately $68 billion in annual revenue in 2013.  Nearly all laboratory tests are performed by one of three types of laboratories: hospital laboratories, physician office laboratories or independent clinical laboratories. We believe approximately 60% of the clinical laboratory tests done in the United States are currently performed in a hospital laboratory, approximately 35% performed by an independent clinical laboratory and the balance in a physician office or other laboratory.

 

Commencing with the advent of managed care cost containment in the 1990s, the industry has been impacted by the rapid growth of managed care arrangements, increasingly stringent government regulation and escalating numbers of investigations into fraud and abuse. Among other things, these factors have led to revenue and profit declines for many smaller and mid-sized clinical laboratories, and industry consolidations. As a result, fewer but larger commercial clinical laboratories have emerged with greater economies of scale, more effective compliance with government billing regulations and other laws and a better approach to pricing their services.  These changes have resulted in improved profitability for these larger commercial laboratories.  In addition, new and emerging technologies continue to provide greater testing opportunities for clinical laboratories.

 

2


Table of Contents

 

We believe that the clinical laboratory testing industry will continue to experience growth in testing volume due to the following factors:

 

the aging of the population of the United States;

patient awareness of the value of laboratory tests;

a decrease in the cost of tests;

the development of sophisticated and specialized tests for early detection of disease and disease management;

the diagnosis and monitoring of infectious diseases, such as AIDS and Hepatitis C;

increased recognition of early detection and prevention as a means of reducing healthcare costs;

the emergence of employer-sponsored wellness programs; and

additional research and development in genomics.

 

In addition, new and emerging technologies continue to provide greater testing opportunities for clinical laboratories.  As the result of health insurance coverage to uninsured Americans under the Patient Protection and Affordable Care Act as amended by the Health Care and Education Reconciliation Act, each enacted in March 2010 (the “Health Care Reform Law”) the demand for our services may increase.

 

Business Strengths and Focus

 

We operate as a national oncology laboratory through our GenPath business unit.  Our expertise in cancer pathology and diagnostics as well as molecular diagnostics has enabled GenPath to grow as a national provider.

 

Our innovative technology platform for sexually transmitted infections has enabled us to expand from a regional service offering to a national offering with specimens coming from throughout the contiguous 48 states in the area of Women’s Health, through our GenPath business unit.

 

GeneDx, our wholly owned subsidiary, is our genetics laboratory and is typically recognized as the leading national laboratory for testing of rare and ultra-rare genetic diseases.

 

We have one of the largest regional marketing staffs of any laboratory in the country, with approximately 336 managers and sales and service representatives working for us. We have groups dedicated to the Metropolitan regional market, the Oncology market, the Women’s Health market, the Genetic testing market and the Correctional Health market.  We have also recently created a new marketing group that will cross over into the genetics and Women’s Health groups to market to physicians who offer pre-natal testing.

 

We believe that our large marketing staff and strong infrastructure within our designated area can be leveraged to bring new technologies to physicians and healthcare providers. Over the past year, our volume of testing in the area of molecular diagnostics has increased by approximately 35%.

 

We believe that laboratory data has great value in managing the healthcare of a population, but can only be properly utilized when combined with medical claims and pharmacy data. Our medical information unit, PSIMedica, as well as our connectivity solution, CareEvolve, seek to combine laboratory data with these other data elements in order to provide actionable analytics designed to help to improve the quality and efficiency of healthcare.

 

Strategy

 

We seek to continue our strong growth not only through our marketing organization, new technologies and superior service, but also by providing value-added analytics in conjunction with laboratory results.  Our mission is to be recognized by our clients as the best provider of clinical laboratory testing, information and related services. The principal components of our strategy to achieve our mission are as follows:

 

capitalize on our position within the clinical market;

lead in providing medical information;

provide the highest quality service; and

pursue strategic growth opportunities, both through development of new testing services and through acquisitions.

 

Our Testing Services

 

Our laboratory testing business consists of routine testing and esoteric testing. Routine testing generates approximately 40% and esoteric testing generates approximately 60% of our net revenues.

 

Routine Testing

 

Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid and other organs. Below is an abbreviated list of some commonly ordered routine tests:

 

Blood cell counts

Cholesterol levels

Pregnancy

Substance abuse

Urinalysis

 

We perform these tests at our main processing facility in Elmwood Park, New Jersey.  We operate 24 hours a day, 365 days a year. We perform and report most routine tests within 24 hours. Tests results are delivered via driver or electronically.

 

Esoteric Tests

 

                                          We also perform esoteric tests that require sophisticated equipment and materials, highly skilled personnel and professional attention.  These tests are ordered less frequently than routine tests.  They are also generally priced higher than routine tests. Esoteric tests are typically related to the following medical fields:

 

Endocrinology (the study of glands and their hormone secretions)

Genetics (the study of chromosomes, genes and their protein products)

Immunology (the study of the immune system)

Microbiology (the study of microscopic forms of life)

HIV-related tests

Molecular diagnostics (the study of genetic content for disease information)

Oncology (the study of abnormal cell growth)

Serology (the study of body fluids)

Toxicology (the study of chemicals and drugs and their effects on the body)

 

3


Table of Contents

 

We perform cancer cytogenetic testing at our leased facilities in at our main processing facility in Elmwood Park, Smithtown, NY, Clarksburg, MD and Milford, MA and genetic testing at our GeneDx leased facility in Gaithersburg, MD, as well as at our Elmwood Park facility.  We perform cytology testing in Frederick, MD, Milford, MA, Columbus, OH, Houston, TX, Melbourne, FL, and Campbell, CA, and at our Elmwood Park facility.

 

PSIMedica—Medical Information

 

Our PSIMedica business unit is based on a clinical knowledge management, or CKM, system that uses data derived from various disparate sources to provide both administrative and clinical analysis of a population. The source data consists of enrollment (demographic) data, claims data, pharmacy data, laboratory data and any other data that may be available. The system uses sophisticated algorithms to cleanse and configure the data to facilitate comprehensive and meaningful analysis. The data is maintained on multiple levels enabling review of data from the global level to the granular transactional detail.  The system includes a base set of queries that provide basic functionality and also provides on-line real-time ad hoc query capability enabling the user to customize analysis to the needs of the user’s organization. In addition to the basic queries provided by the system, PSIMedica Quality Indicators, or PQI, provide comprehensive, disease-state-oriented queries that disclose the quality and efficiency of the care and service. These indicators have been designed to provide the user with standards and outcome predictors on a medical standards basis.  We are using PSIMedica to market value-added clinical laboratory services to bulk purchasers of clinical laboratory solutions, as well as marketing our PSIMedica programs to businesses such as health plans, integrated delivery networks, disease management companies, insurers, clinical trial companies and other healthcare providers that benefit from the ability of the system to combine both clinical and administrative analysis.

 

CareEvolve—Connectivity Solutions

 

Through our CareEvolve subsidiary, we offer a physician-based connectivity solution.  This system provides a complex, sophisticated portal for ordering laboratory services and delivering laboratory results, along with ancillary connectivity services.  The system is designed to be physician-centric and to provide a highly flexible, scalable, comprehensive desktop solution for physicians to manage their day-to-day practice needs, as well as to handle their clinical laboratory ordering and reporting.  This product has been designed to work as a platform with plug and play capability that can easily be used by other laboratories that also need a web-based solution for their physician customers.

 

Payors and Clients

 

We provide laboratory services to a range of healthcare providers. A “payor” is the party who pays for the tests while the “client” is the party that refers the tests to us. An organization that has a contract with us, such as a clinic or governmental agency, may be both a payor and a client. Some states, such as New York and New Jersey, prohibit us from billing physician clients.  During fiscal year 2013, no single client accounted for more than 10% of our net revenues.

 

The following table reflects our estimate of the breakdown of net revenue by type of payor for the fiscal years ended October 31, 2011, 2012, and 2013.

 

 

 

Fiscal Year Ended October 31,

 

 

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

Direct Patient Billing

 

2

%

2

%

2

%

Commercial Insurance

 

64

%

62

%

61

%

Professional Billing

 

16

%

17

%

17

%

Medicare

 

17

%

18

%

19

%

Medicaid

 

1

%

1

%

1

%

 

 

100

%

100

%

100

%

 

Physicians who order clinical tests for their patients represent one of the primary sources of our testing volume. Fees invoiced to patients and third parties are based on our fee schedule, which may be subject to limitations imposed by third-party payors. Fees invoiced to federal health care programs such as Medicare and Medicaid, are based on fee schedules set by applicable governmental authorities, such as the Center for Medicare and Medicaid Services (“CMS”).

 

We provide laboratory services to governmental agencies and large employer groups. We believe that we are the largest regional laboratory providing laboratory testing services to correctional facilities in the United States. All of these clients are charged on a contractual basis.

 

Billing

 

Billing for laboratory services is extremely complicated. We must bill various payors, such as patients, the Medicare program and state Medicaid programs, insurance companies and employer groups, all of which have different billing requirements. Compliance with applicable laws and regulations as well as internal compliance procedures adds complexity to this process.

 

Our bad debt expense is not the result of credit-related issues, as is the case in most industries. Our bad debt expense is due primarily to missing or incorrect demographic and billing information on our requisitions.  We depend on the healthcare provider to supply us with this information. We perform the tests and report the test results as requested on the requisition regardless of whether the demographic and billing information is correct or even missing altogether. We then attempt to obtain missing and to correct incorrect information. This adds to the complexity, slows the invoicing process and generally increases the aging of our accounts receivable. In addition, we perform all tests requested by the healthcare provider even though all of the tests ordered by the healthcare provider may not be reimbursed by the payor; it is our obligation to provide all tests requested by the healthcare provider. When all issues are not resolved in a timely manner, the item is written-off to bad debt expense through the allowance for doubtful accounts. Other items such as pricing differences and payor disputes also complicate billing. Adjustments to receivables as a result of these types of matters are accounted for as revenue adjustments and are not written-off to bad debt expense.

 

Sales and Marketing

 

                                          We employ full and part-time sales and marketing representatives. With approximately 336 managers and sales and service representatives working for us, we have groups dedicated to the New York metropolitan regional market, the oncology market, the women’s health market, the genetic testing market and the correctional health market.  We are currently building a new marketing group that will cross over into the genetics and women’s health groups to market to physicians who offer pre-natal testing.

 

All of our sales and marketing personnel operate in a dual capacity, as both marketing and client support representatives. This ensures that all of our salespersons are intimately involved with the client. We believe that this is extremely helpful in client retention, since it provides a strong connection between our physician clients and us.

 

Client Service Coordinators

 

                                                We utilize the services of full and part-time client service coordinators at our Elmwood Park, Clarksburg and Gaithersburg facilities, all of whom are trained in medical and laboratory terminology. This staff is used as an interface with physicians and nurses and supplements the

 

4


Table of Contents

 

client support provided by our sales force. They also report highly abnormal and life threatening results to the ordering physician via telephone in order to assist speedy medical resolution of patient problems.

 

Logistical Support

 

We employ full and part-time couriers. Our couriers pick up patient specimens from and deliver printed reports to physician offices, nursing homes, clinics and correctional facilities.

 

Acquisitions

 

On December 21, 2012, the Company entered into an agreement with Meridian Clinical Laboratory Corporation, a Florida corporation having its place of business in Miami, Florida (“Meridian”), pursuant to which the Company purchased all issued and outstanding common stock of Meridian for approximately $1,848 of which $250 is deferred for one year.

 

On December 31, 2012, Bio-Reference Laboratories, Inc. (the “Company”) entered into an agreement with Florida Clinical Laboratory, Inc., a Florida corporation having its place of business in Melbourne, Florida (“FCL”), pursuant to which the Company purchased all issued and outstanding shares of capital stock of FCL for approximately $7,016, of which $1,000 is deferred for eighteen months assuming certain conditions are met.

 

On August 7, 2013 the Company purchased substantially all of the operating assets and certain of the operating liabilities of Hunter Laboratories, Inc., (“Hunter”) a California corporation having its principal place of business in Campbell, California.  The gross purchase price was $15,215 plus payroll adjustment of $111 totaling $15,326.  Of that amount $3,000 was deferred to cover anticipated pre closing liabilities.

 

On August 20, 2013 the Company through its subsidiary GeneDx, Inc.  purchased the entire membership interest in Edge BioServ, LLC, (“Edge Bio”) a Delaware limited liability company having its place of business in Gaithersburg, Maryland.  The gross purchase price was approximately $2,502.  Of that $375 was deferred to cover anticipated pre closing liabilities.

 

Competition

 

We compete with three types of providers in a highly fragmented and competitive industry: hospital laboratories, physician-office laboratories and other independent clinical laboratories. Our major competitors in the New York metropolitan area are two of the largest national laboratories, Quest Diagnostics (DGX) and Laboratory Corporation of America (LH). Although we are much smaller than these national laboratories, we believe that we compete successfully with them in our region due to our innovative testing services and our level of service.  We believe our responses to medical consultation are faster and more personalized than those of the national laboratories. Our client service staff deals only with basic technical questions and those that have medical or scientific significance are referred directly to our senior scientists and medical staff.

 

Quality Assurance

 

In order to provide accurate and precise clinical information to the physician, it is essential that we maintain a well structured and vigorous quality assurance program. We hold the required Federal and state licenses necessary for the operation of a clinical laboratory at our facilities in New Jersey, New York, Maryland, Massachusetts, Texas and Ohio. We submit to vigorous proficiency tests (or surveys) for all tests that we perform. We are also subject to unannounced inspections from the various state and federal licensing agencies.

 

Our laboratories are accredited by the College of American Pathologists, or CAP.  This accreditation includes on-site inspections and participation in the CAP (or equivalent) proficiency testing program. CAP is an independent organization of board certified pathologists approved by the Center for Medicare and Medicaid Services (CMS), to inspect clinical laboratories in order to determine compliance with the standards required by the Clinical Laboratory Improvement Amendments of 1988, or CLIA.

 

We have a Quality Assurance Committee, headed by a Quality Assurance Coordinator and composed of supervisors from all of our departments.  The Committee meets each day to assess and evaluate our laboratory quality.  Based on the information received from the Committee, recommendations are made to correct conditions that have led to errors.  Management, department supervisors and members of the Committee continually monitor laboratory quality.  Depending on the test, two or three levels of quality control materials are run in each analytical assay to enhance precision and accuracy.  Patient population statistics are evaluated each day. Testing of highly abnormal samples is repeated to maximize accuracy.

 

We believe that all of these procedures are necessary, not only in maintaining Federal and state licensing, but also in assuring a quality product.  We believe that our high standards of quality are an important factor in client retention.

 

Regulation of Our Clinical Laboratory Operations

 

The clinical laboratory industry is highly regulated and subjected to significant and changing Federal and state laws and regulations. These laws and regulations affect key aspects of our business, including licensure and operations, billing and payment for laboratory services, sales and marketing interactions with ordering physicians, security and confidentiality of health information, and environmental and occupational safety.  Oversight by government officials includes regular inspections and audits.  Failure to comply with applicable requirements, which are sometimes vague or indefinite, may result in substantial fines, criminal penalties, or other enforcement actions, such as suspension or revocation of a clinical laboratory’s license. Changes in regulations often increase the cost of testing or processing claims.  Also, these laws may be interpreted or applied by a prosecutorial, regulatory or judicial authority in a manner that could require us to make changes in our operations, including in our pricing, billing and/or marketing practices in a manner that could adversely affect operations.  We seek to and believe that we do conduct our business in compliance with all applicable laws and regulations.  Set forth below are highlights of the key regulatory areas applicable to our business.

 

Reimbursement for Laboratory Services

 

                                                We typically bill third party payors such as Medicare, Medicaid, Governmental programs and private insurers for our services.  Billing for clinical testing services is very complicated, and our payors often have different coverage, billing and reimbursement requirements, and change those requirements on an ongoing basis.  Also, submissions of our claims are particularly complex because we provide both anatomic pathology services and clinical laboratory tests, which generally are paid using different reimbursement principals.  The clinical laboratory tests are often paid under a clinical laboratory fee schedule, and the anatomic pathology services are often paid under a physician fee schedule. If ordering physician requisitions contain incorrect or incomplete information, we may also be unable to collect reimbursement from payors.  The increased use of electronic ordering reduces, but does not eliminate, the incidence of missing or incorrect information.

 

In addition, both government and private sector payors have engaged in ongoing efforts in recent years to contain or reduce health care costs, including reimbursement for clinical laboratory services.  The combination of complex billing requirements and ongoing pressure with respect to reimbursement levels, presents substantial challenges to the clinical laboratory business.  Through the Health Care Reform Law substantial changes are being made to the current system for paying for healthcare in the United States, including programs to extend medical benefits to millions of individuals who currently lack insurance coverage, coupled with measures to cut Medicare spending for most health care

 

5


Table of Contents

 

services, including clinical laboratories.  The changes contemplated by the Health Care Reform Law are subject to rule-making and implementation timelines that extend for several years, and this uncertainty limits our ability to forecast changes that may occur in the future.

 

The U.S. Congress has considered, at least yearly in conjunction with budgetary legislation, changes to one or both of the Medicare fee schedules under which we receive reimbursement, which include the physician fee schedule for anatomical pathology services, and the clinical laboratory fee schedule for our clinical laboratory services. For example, currently there is no copayment or coinsurance required for clinical laboratory services, although there is for our physician services. However, Congress has periodically considered imposing a 20 percent coinsurance on laboratory services. If enacted, this would require us to attempt to collect this amount from patients, although in many cases the costs of collection would exceed the amount actually received.

 

For most of the tests performed for Medicare or Medicaid beneficiaries, laboratories are required to bill Medicare or Medicaid directly, and to accept Medicare or Medicaid reimbursement as payment in full. Part B of the Medicare program contains fee schedule payment methodologies for clinical laboratory services, and the Medicare approach and reimbursement levels often serve as a benchmark for commercial payors.  Payment under Medicare is generally the lesser of billed charges, the local fee for a geographic area, and a national limitation amount that is set at a percent of the median of all local fee schedule amounts for each laboratory test code.  Each year, subject to federal legislation, fees may be updated for inflation based on the percentage change in the Consumer Price Index, or CPI.  From 2004 through 2008 the clinical laboratory fee schedule remained frozen, with no CPI increases.  Then, for the first time in five years, as of January 1, 2009 laboratories received a 4.5% across the board increase in reimbursements.  For 2010, the clinical laboratory fee schedule was decreased by 1.9 percent. For 2011, under the Health Care Reform Law, it was decreased by 1.75 percent, the first of a series of such annual reductions effective from 2011 to 2015, and in 2011, certain “productivity adjustments were instituted that have functioned to decrease rate increases under the CPI update. For 2012, the clinical laboratory fee schedule was increased by .65%, and in February 2012, Congress passed legislation that reduced payment rates under the clinical laboratory fee schedule by 2%, effective January 1, 2013 and an additional 2% reduction in Medicare rates is scheduled to take effect on March 1, 2013 under a “sequestration” mandate, unless Congress acts to prevent this reduction.

 

Under the CMS framework, the national limitation amount for clinical laboratory services had been reduced in a number of instances over the past several years to a present level equal to 74% of the national median of laboratory charges, and a number of proposals for legislation or regulation are under discussion which could have the effect of substantially reducing reimbursements to clinical laboratories through reduction of the present allowable percentage or through other means.  We are unable to predict the outcome of these discussions. Depending upon the nature of congressional and/or regulatory action, if any, which is taken and the content of legislation, if any, which is adopted, we could experience a significant decrease in revenues from CMS, which could have a material adverse effect on us.

 

Also, CMS and other payors have expressed some concern regarding “billed charges” reporting by large clinical laboratories, in light of the common practice, among major clinical laboratories, of providing discounted pricing to certain clients that order testing services on a “bulk” basis, such as certain physicians, hospitals, and other institutions, resulting in economies of scale and relatively low administrative costs, as compared with the higher fees charged to individual patients and third party payors, including Medicare, who generally require separate bills or claims for each patient encounter and which involve relatively high administrative costs).  If this issue were decided in a manner that required the downward adjustment of billed charges reporting, it could adversely affect the Company.

 

Clinical Laboratory Improvement Amendments of 1988 (“CLIA”)

 

CLIA extends Federal licensing requirements to all clinical laboratories (regardless of the location, size or type of laboratory), including those operated by physicians in their offices, based on the complexity of the tests they perform.  CLIA also establishes a stringent proficiency testing program for laboratories and includes substantial sanctions, such as suspension, revocation or limitation of a laboratory’s CLIA certificate (which is necessary to conduct business), cancellation or suspension of the laboratory’s approval to receive Medicare and Medicaid reimbursement, and significant fines and/or criminal penalties.

 

CLIA, and its implementing regulations, includes quality standards (establishing Federal quality standards for all clinical laboratories); application and user fee requirements; and enforcement procedures.  The quality standard regulations establish varying levels of regulatory scrutiny depending upon the complexity of testing performed.  Under these regulations, a laboratory that performs only one or more of routine “waived” tests may apply for a waiver from most requirements of CLIA.  We believe that most tests performed by physician office laboratories will fall into either the “waived” or the “moderately complex” category.  The latter category applies to simple or automated tests and generally permits existing personnel in physicians’ offices to continue to perform testing under the implementation of systems that insure the integrity and accurate reporting of results, establishment of quality control systems, proficiency testing by approved agencies, and biannual inspection.

 

Under CLIA, the company remains subject to state and local laboratory regulations.  CLIA provides that a state may adopt laboratory regulations that are more stringent than those under federal law, and some states require additional personnel qualifications, quality control, record maintenance and other requirements.

 

Our laboratory completed its first CLIA inspection under CLIA guidelines and received its certificate of compliance effective February 7, 1996. It has been reinspected since on a bi-annual basis and found to be in compliance.  We believe the Company is in compliance with all applicable federal and state laboratory requirements.

 

Compliance Program

 

The Office of Inspector General has published a Model Compliance Program for the clinical laboratory industry. This is a voluntary program for laboratories to demonstrate to the Federal government that they are responsible providers. In addition, certain states, such as New York, require that health care providers, such as clinical laboratories, that engage in substantial business under the state Medicaid program have a compliance program that general adheres to the standards set forth in the Model Compliance Program. Also, under the Health Care Reform Law, the U.S. Department of Health and Human Services, or HHS, will require suppliers, such as the Company, to adopt, as a condition of Medicare participation, compliance programs that meet a core set of requirements.  This mandate has not yet been implemented with respect to clinical laboratories, and HHS has not yet provided a time frame for implementation.  We have implemented a comprehensive voluntary compliance program adhering to the standards set forth in the Model Compliance Program.

 

Health Insurance Portability and Accountability Act of 1996, as amended (“HIPAA”)

 

                                                Both as a health care provider of clinical laboratory services, and in connection with the services we furnish to health plans and others as a business associate though medical information services, we are required to comply with federal and state laws that protect the privacy and security of certain healthcare and personal information.  These include HIPAA, which establishes comprehensive standards with respect to the privacy and security of medical information, including requirements for safeguarding electronic protected health information, and comprehensive standards regarding uses and disclosures of protected health information.  The HIPAA standards create a complex regulatory framework, including penalties for non-compliance, requirements to respond to patient requests to review and amend their medical records, certain limitations regarding the use of patient information, and notification obligations in the event of certain breaches of patient information.  In addition to HIPAA, we are required to abide by various state laws protecting healthcare information, that impose standards that are stricter than those of HIPAA, such as state laws governing sensitive health information regarding HIV status and genetic testing.

 

HIPAA provides for significant fines as well as substantial criminal penalties for violations of the Act.  The federal Health Information Technology for Economic and Clinical Health, or HITCH, Act, strengthened and expanded HIPAA, including to require certain breach notification obligations, to extend a number of HIPAA requirements directly to business associates, to heighten penalties and enforcement

 

6


Table of Contents

 

provisions (including requiring HHS to conduct periodic audits to confirm compliance), and to extend enforcement authority over HIPAA to state attorney generals.

 

In addition, the HITECH Act established a program of Medicare and Medicaid incentive payments available to certain health care providers including, among others, physicians and dentists, if they meaningfully use certified electronic health record technology (“EHR”).  Also, eligible providers that fail to adopt certified EHR systems may be subject to Medicare reimbursement reductions beginning in 2015.  Qualification for the incentive payments requires the use of EHRs that are certified as having certain capabilities for meaningful use pursuant to standards adopted by the Department of Health and Human Services.  Initial (“stage one”) standards addressed criteria for periods beginning in 2011.  CMS has also issued a final rule with “stage two” criteria, for periods beginning in 2014, which are more demanding, and new, incrementally more rigorous criteria are expected to be issued for stage three compliance, however final standards have not yet been issued and so these criteria are not yet certain.  Certain of our businesses involve the marketing and distribution of certified EHR products, and these products must maintain compliance with these evolving governmental criteria.

 

In addition, HIPAA requires health care providers, such as clinical laboratories, and other covered entities, to use certain transaction and code set rules for specified electronic transactions, such as transactions involving claims submissions.  The Company believes it is in compliance in all material respects with the current rules.  With respect to these rules, commencing July 1, 2012, CMS required that all HIPAA-covered entities, such as the Company, conduct electronic claim submissions and related electronic transactions under a new HIPAA transaction standard, called Version 5010.  CMS has required this upgrade in connection with another new requirement applicable to the industry, the implementation of new diagnostic code sets to be used in claims submission.  The new diagnostic code sets are called the ICD-10-CM, and are to be implemented on October 1, 2014.  The Company has been aware of these changes for some time, and believes it is prepared to timely adopt the new standards.  However, it is expected that these changes, in particular the adoption of new diagnostic codes — which must be provided to us accurately by referring physicians in order for us to receive payment from payors, such as Medicare — will result in a degree of disruption and confusion, which may adversely affect Company operations, including reimbursement rates.

 

Laboratory Developed Tests (LDTs)

 

The federal Food and Drug Administration, or FDA, has regulatory responsibility over, among other areas, instruments, test kits reagents and other medical devices used by clinical laboratories to perform diagnostic testing.  High complexity and CLIA-certified laboratories, such as ours, frequently develop internal testing procedures to provide diagnostic results to customers. These tests are referred to as laboratory developed tests, or LDTs.  LTD’s are subject to CMS oversight through its enforcement of CLIA.  The FDA has also claimed regulatory authority over all LDTs, but indicates that it has exercised enforcement discretion with regard to most LDTs offered by high complexity CLIA-certified laboratories, and has not subjected these tests to the panoply of FDA rules and regulations governing medical devices.  However, the FDA has stated that it has been considering changes in the way it believes that laboratories ought to be allowed to offer these LDTs, and during 2010 publicly announced that it would be exercising regulatory authority over LDTS, using a risk-based approach that will direct more resources to tests with the highest risk of injury.  The FDA has not announced a framework or timetable for implementing its announced approach and in its 2013 Work Plan, the U.S. Department of Health & Human Services Office of Inspector General announced that it would examine the oversight of the clinical effectiveness of LDTs given the current approaches by CMS and FDA with respect to LDTs.  Depending upon the manner in which the FDA’s new regulatory framework is implemented, there may be an adverse affect on Company operations.

 

Fraud and Abuse Regulations

 

Since we supply services that are reimbursed by federal health care programs such as Medicare and Medicaid, our activities are also subject to regulation by CMS and enforcement by the Office of Inspector General, or OIG, within the HHS. A provision of the U.S. Social Security Act known as the “Anti-Kickback Law” prohibits providers and others from directly or indirectly soliciting, receiving, offering or paying any remuneration with the intent of generating referrals or orders for services or items covered by a federal health care program. Many states have similar laws. Courts have interpreted this law very broadly, including holding that a violation has occurred if even one purpose of the remuneration is to generate referrals, even if there are other lawful purposes. There are statutory and regulatory exceptions (known as safe harbors) that outline arrangements that are deemed lawful. However, the fact that an arrangement does not fall within a safe harbor does not necessarily render the conduct illegal under the Anti-Kickback Law. In sum, even legitimate business arrangements between the Company and referral sources, such as physicians, could lead to scrutiny by government enforcement agencies, and require extensive company resources to respond to government investigations. Violations of the Anti-Kickback Law may be punished by civil and criminal penalties and/or exclusion from participation in federal health care programs, including Medicare and Medicaid. The Health Care Reform Law strengthened provisions of the Anti-Kickback Law.

 

The federal “Stark Law” or “self-referral” prohibition, subject to certain exceptions, prohibits payment under Medicare or Medicaid for certain designated health services, including, among others, clinical laboratory services, where the referring physician has a financial relationships with the entity that furnishes the clinical laboratory service.  The applicable exceptions permitting federal reimbursement generally require written agreements and fair market value payments that do not vary based upon the volume or value of referrals.  Many states have similar self-referral laws that regulate the financial relationships between referring physicians and clinical laboratories, which extend to all referrals, not only referrals for services reimbursed by Medicare or Medicaid.  Another federal law, known as the “Anti-Markup Rule,” and similar state laws, address the practice of an independent clinical laboratory performing and then billing to the ordering physician a component of a diagnostic test, such as diagnostic pathology services, where the ordering physician bills the test to Medicare.  In this circumstance, penalties may apply to the physician if Medicare or other payor is billed at a rate that exceeds the laboratory’s charges to the physician, and the laboratory could be at risk under false claims laws, described below, for causing the submission of a false claim, if it advised the physician to submit claims to payors in violation of these provisions.

 

The federal False Claims Act, or FCA, is violated by any entity that “presents or causes to be presented” knowingly false claims for payment to the federal government and many states have similar laws that apply to governmental and private payors. In addition, the Health Care Reform Law amended the FCA to create a cause of action against any person who knowingly makes a false statement material to an obligation to pay money to the government, or knowingly conceals or improperly decreases an obligation to pay or transmit money or property to the government. For the purposes of these recent amendments, an “obligation” includes an overpayment, which is defined broadly to include “any funds that a person receives or retains under Medicare and Medicaid to which the person, after applicable reconciliation, is not entitled . . . .”

 

                                                The FCA is commonly used to sue those who submit allegedly false Medicare or Medicaid claims, as well as those who induce or assist others to submit a false claim. Courts and government officials have found that “false claims” can result not only from noncompliance with the express requirements of applicable governmental reimbursement programs, such as Medicare and Medicaid, but also from noncompliance with other laws, such as provisions of the Food, Drug and Cosmetic Act, or laws that require quality care in service delivery. In addition, the Health Care Reform Law amended the FCA to specify that a claim to federal health care programs that includes items or services resulting from a violation of the Anti-Kickback Law constitutes a false claim under the FCA.  The qui tam or whistleblower provisions of the FCA allow private individuals to bring actions on behalf of the government alleging that the government was defrauded, with tremendous potential financial gain to private citizens in the event they prevail. When a private party brings a whistleblower action under the FCA, the defendant is not made aware of the lawsuit until the government starts its own investigation or makes a decision on whether it will intervene. Many states have enacted similar laws that also apply to claims submitted to commercial insurance companies. The bringing of any FCA action could require us to devote resources to investigate and defend the action. Violations of the FCA could result in enormous economic liability. The law provides that all damages are trebled, and each false claim submitted is subject to a penalty of up to $11,000.

 

Historically, the clinical laboratory industry has been the focus of major governmental enforcement initiatives, and within the past few years federal and state governments continue to strengthen their enforcement efforts, such as through new laws that increase funding, powers and remedies to pursue suspected cases of fraud and abuse.  We believe we operate lawfully within these statutes; however, we cannot predict if some of our practices may be interpreted as violating these statutes and regulations.

 

7


Table of Contents

 

Waste Management, Health and Safety

 

We are subject to federal and state laws and regulations regarding the protection of the environment, the health and safety of employees, and the handling, transportation and disposal of medical specimens, and infectious and hazardous wastes.  For example, federal regulations require licensure of interstate transporters of medical waste. In New Jersey, we are subject to the Comprehensive Medical Waste Management Act, or CMWMA, which requires us to register as a generator of special medical waste. All of our medical waste is disposed of by a licensed interstate hauler.  The hauler provides a manifest of the disposition of the waste products as well as a certificate of incineration which is retained by us. These records are audited by the State of New Jersey on a yearly basis. We are also subject to the Federal Hazardous Materials Transportation Law, 49 U.S.C. 5101 et seq., and the Hazardous Materials Regulations, or HMR, 49 CFR parts 171-180.  In addition, the federal Occupational Safety and Health Administration, or OSHA, has established extensive requirements relating specifically to workplace programs to protect workers from exposure to blood-borne pathogens, such as HIV and the hepatitis B virus, including work practice controls, protective clothing and equipment, training, vaccinations and other measures designed to minimize hazardous exposures.

 

Intellectual Property Rights

 

The Company relies on a combination of patents, trademarks, copyrights, trade secrets and nondisclosure and non-competition agreements to establish and protect its proprietary technology. The Company believes, however, that no single patent, technology, trademark, intellectual property asset or license is material to its business as a whole.

 

Insurance

 

We maintain professional liability insurance.  We believe that our present insurance coverage is sufficient to cover currently estimated exposures, but we cannot assure that we will not incur liabilities in excess of the policy limits.  In addition, although we believe that we will be able to continue to obtain adequate insurance coverage, we cannot assure that we will be able to do so at acceptable cost.

 

Employees

 

At October 31, 2013, we had 3,338 full-time and 1,089 part-time employees serving in executive positions, as technicians and technologists (including physicians, pathologists and PhDs), in marketing, in logistics and in bookkeeping, clerical and administrative positions. None of our employees are represented by a labor union. We regard relations with our employees as satisfactory.

 

Available Information

 

Our Internet website address is www.bioreference.com.  Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to section 13(a) or 15(d) of the Exchange Act are available free of charge through our website as soon as reasonably practicable after we electronically file with or furnish them to the Securities and Exchange Commission, or SEC, and are available in print to any stockholder who requests a copy.  Additionally, the charters of the standing committees of our board of directors are available on our website under “Board Committee Charters”. Information on our website shall not be deemed incorporated into, or to be a part of, this Annual Report on Form 10-K.

 

The public may also read and copy any materials that we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549.  You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.  Additionally, the SEC maintains a website that contains reports, proxy statements, information statements and other information regarding issuers, including us, that file electronically with the SEC at www.sec.gov.

 

Item 1A. Risk Factors

 

You should carefully consider each of the following risk factors and all other information set forth in this report. Any of the following risks could materially and adversely affect our business, financial condition or results of operations. They are not, however, the only risks we face. Additional risks and uncertainties not presently known to us or that we currently believe not to be material may also adversely affect our business, financial condition or results of operations. This report also includes forward-looking statements that involve risks or uncertainties. Our results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks we face described below and elsewhere. See “Forward Looking Statements”.

 

Complying with numerous regulations pertaining to our business is an expensive and time-consuming process, and any failure to comply could result in substantial penalties.

 

The clinical laboratory testing industry is highly regulated and there can be no assurance that the regulatory environment in which we operate will not change significantly and adversely in the future. Areas of the regulatory environment that may affect our ability to conduct business include, without limitation:

 

federal and state laws applicable to billing and claims payment;

federal and state laboratory anti-mark-up laws;

federal and state anti-kickback laws;

federal and state false claims laws;

federal self-referral and financial inducement prohibition laws, commonly known as the Stark Law, and the state equivalents;

federal and state laws governing laboratory licensing and testing, including CLIA;

federal and state laws governing the development, use and distribution of diagnostic medical tests known as laboratory developed tests or “LDTs”;

HIPAA, along with the revisions to HIPPA as a result of the HITECH Act, and analogous state laws;

federal, state and foreign regulation of privacy, security, electronic transactions and identity theft;

federal, state and local laws governing the handling, transportation and disposal of medical and hazardous waste;

Occupational Safety and Health Administration rules and regulations;

changes to laws, regulations and rules as a result of the Health Care Reform Law; and

changes to other federal, state and local laws, regulations and rules, including tax laws.

 

We have adopted policies and procedures designed to comply with these laws.  In the ordinary course of business, we conduct internal reviews of our compliance with these laws.  The growth of our business and sales organization may increase the potential for violating these laws or our internal policies and procedures.  The risk of our being found in violation of these or other laws and regulations is further increased by the fact that many of them are extremely complex and in many instances, there are no significant regulatory or judicial interpretations of these laws and regulations.  Any action brought against us for violation of these or other laws or regulations, even if we successfully defend against it, could

 

8


Table of Contents

 

cause us to incur significant legal expenses and divert our management’s attention from the operation of our business. Any determination that we have violated these laws or regulations, or the public announcement that we are being investigated for possible violations of these laws or regulations, could harm our operating results and financial condition. If our operations are found to be in violation of any of these laws and regulations, we may be subject to any applicable penalty associated with the violation, including civil and criminal penalties, damages and fines, we could be required to refund payments received by us, and we could be required to curtail or cease our operations. In addition, a significant change in any of these laws or regulations may require us to change our business model in order to maintain compliance with these laws or regulations, which could harm our operating results and financial condition.

 

Our business could be harmed from the loss or suspension of a license or imposition of a fine or penalties under, or future changes in, or changing interpretations of, CLIA or state laboratory licensing laws to which we are subject.

 

The clinical laboratory testing industry is subject to extensive federal and state regulation, and many of these statutes and regulations have not been interpreted by the courts.  The Clinical Laboratory Improvement Amendments of 1988, or CLIA, are federal regulatory standards that apply to virtually all clinical laboratories (regardless of the location, size or type of laboratory), including those operated by physicians in their offices, by requiring that they be certified by the federal government or by a federally approved accreditation agency.  CLIA does not preempt state law, which in some cases may be more stringent than federal law and require additional personnel qualifications, quality control, record maintenance and proficiency testing. The sanction for failure to comply with CLIA and state requirements may be suspension, revocation or limitation of a laboratory’s CLIA certificate, which is necessary to conduct business, as well as significant fines and/or criminal penalties. Several states have similar laws and we may be subject to similar penalties.

 

We cannot assure you that applicable statutes and regulations will not be interpreted or applied by a prosecutorial, regulatory or judicial authority in a manner that would adversely affect our business. Potential sanctions for violation of these statutes and regulations include significant fines and the suspension or loss of various licenses, certificates and authorizations, which could have a material adverse effect on our business. In addition, compliance with future legislation could impose additional requirements on us, which may be costly.

 

Failure to comply with HIPAA, including regarding the use of new “standard transactions,” may negatively impact our profitability and cash flows.

 

Pursuant to HIPAA, we must comply with comprehensive privacy and security standards with respect to the use and disclosure of protected health information, as well as standards for electronic transactions, including specified transaction and code set rules.  Under recent HITECH amendments to HIPAA, the law was expanded, including to require certain data breach notification, direct patient access to laboratory records, the extension of certain HIPAA privacy and security standards directly to business associates, and to heighten penalties for noncompliance, and enforcement efforts.  While the Company maintains policies and procedures to comply with HIPAA, HHS has not yet issued final regulations to implement all HITECH requirements, and while the Company believes compliance will increase Company costs, it is difficult to predict precisely the costs involved.

 

In addition, the HIPAA transaction standards are complex, and subject to differences in interpretation by payors. For instance, some payors may interpret the standards to require us to provide certain types of information, including demographic information not usually provided to us by physicians. As a result of inconsistent application of transaction standards by payors or the our inability to obtain certain billing information not usually provided to us by physicians, we could face increased costs and complexity, a temporary disruption in receipts and ongoing reductions in reimbursements and net revenues. In addition, new requirements for additional standard transactions, such as claims attachments, Version 5010 of the HIPAA Transaction Standards and the ICD-10-CM Code Set, could prove technically difficult, time-consuming or expensive to implement. We are working closely with our payors to establish acceptable protocols for claim submission and with our trade association and an industry coalition to present issues and problems as they arise to the appropriate regulators and standards setting organizations.

 

FDA regulation of laboratory-developed tests (“LDTs”) may result in significant change, and our business could be adversely impacted if we fail to adapt.

 

High complexity, CLIA-certified laboratories, such as ours, frequently develop testing procedures internally to provide diagnostic results to customers, which are offered as laboratory-developed tests.  The FDA claims to have regulatory authority over these LDTs and has stated that it intends to issue guidance to the industry regarding its regulatory approach. In such discussions, the FDA has indicated that it would use a risk-based approach to regulation and would direct more resources to tests with wider distribution and with the highest risk of injury, but that it will be sensitive to the need to not adversely impact patient care or innovation. To date, the FDA has not announced a framework or timetable for implementing a new regulatory approach, and in its 2013 Work Plan, the U.S. Department of Health & Human Services Office of Inspector General announced that it would examine the oversight of the clinical effectiveness of LDTs given the current approaches by CMS and FDA with respect to LDTs. To date, the FDA has not issued any of these planned guidance documents. We cannot predict the ultimate timing or form of any such guidance or regulation and the potential impact on our existing tests, our tests in development [or the materials used to perform our tests].If adopted, such a regulatory approach by the FDA may lead to an increased regulatory burden, including additional costs and delays in introducing new tests. While the ultimate impact of the FDA’s approach is unknown, it may be extensive and may result in significant change. Our failure to adapt to these changes could have a material adverse effect on our business.

 

A failure to comply with any of federal or state laws applicable to our business, particularly laws related to the elimination of healthcare fraud, may adversely impact our business.

 

                                                Federal officials responsible for administering and enforcing the healthcare laws and regulations have made a priority of eliminating healthcare fraud. For example, the Health Care Reform Law includes significant new fraud and abuse measures, including required disclosures of financial arrangements with physician customers, lower thresholds for violations and increasing potential penalties for such violations. Federal funding available for combating health care fraud and abuse generally has increased. While we seek to conduct our business in compliance with all applicable laws and regulations, many of the laws and regulations applicable to our business, particularly those relating to billing and reimbursement of tests and those relating to relationships with physicians, hospitals and patients, contain language that has not been interpreted by courts. We must rely on our interpretation of these laws and regulations based on the advice of our counsel and regulatory or law enforcement authorities may not agree with our interpretation of these laws and regulations and may seek to enforce legal remedies or penalties against us for violations. From time to time we may need to change our operations, particularly pricing or billing practices, in response to changing interpretations of these laws and regulations or regulatory or judicial determinations with respect to these laws and regulations. These occurrences, regardless of their outcome, could damage our reputation and harm important business relationships that we have with healthcare providers, payors and others. Furthermore, if a regulatory or judicial authority finds that we have not complied with applicable laws and regulations, we would be required to refund amounts that were billed and collected in violation of such laws and regulations. In addition, we may

 

9


Table of Contents

 

voluntarily refund amounts that were alleged to have been billed and collected in violation of applicable laws and regulations. In either case, we could suffer civil and criminal damages, fines and penalties, exclusion from participation in governmental healthcare programs and the loss of licenses, certificates and authorizations necessary to operate our business, as well as incur liabilities from third-party claims, all of which could harm our operating results and financial condition. Moreover, regardless of the outcome, if we or physicians or other third parties with whom we do business are investigated by a regulatory or law enforcement authority we could incur substantial costs, including legal fees, and our management may be required to divert a substantial amount of time to an investigation.

 

To enhance compliance with applicable health care laws, and mitigate potential liability in the event of noncompliance, regulatory authorities, such as the United States Health and Human Services Department Office of Inspector General (“OIG”), have recommended the adoption and implementation of a comprehensive health care compliance program that generally contains the elements of an effective compliance and ethics program described in Section 8B2.1 of the United States Sentencing Commission Guidelines Manual, and for many years the OIG has made available a model compliance program targeted to the clinical laboratory industry.  In addition, certain states, such as New York, require that health care providers, such as clinical laboratories, that engage in substantial business under the state Medicaid program have a compliance program that general adheres to the standards set forth in the Model Compliance Program.  Also, under the Health Care Reform Law, the U.S. Department of Health and Human Services, or HHS, will require suppliers, such as the Company, to adopt, as a condition of Medicare participation, compliance programs that meet a core set of requirements.  This mandate has not yet been implemented with respect to clinical laboratories, and HHS has not yet provided a time frame for implementation. While we have adopted U.S. healthcare compliance and ethics programs that generally incorporate the OIG’s recommendations, and train our applicable employees in such compliance, having such a program can be no assurance that we will avoid any compliance issues.

 

Failure to maintain the security of patient-related information or compliance with security requirements could damage our reputation with customers, cause us to incur substantial additional costs and become subject to litigation.

 

Pursuant to HIPAA, and certain similar state laws, we must comply with comprehensive privacy and security standards with respect to the use and disclosure of protected health information.  Under the HITECH amendments to HIPAA, HIPAA was expanded to require certain data breach notification, to extend certain HIPAA privacy and security standards directly to business associates, to heighten penalties for noncompliance, and enhance enforcement efforts.

 

We receive certain personal and financial information about our clients and their patients. In addition, we depend upon the secure transmission of confidential information over public networks. A compromise in our security systems that results in client or patient personal information being obtained by unauthorized persons or our failure to comply with security requirements for financial transactions could adversely affect our reputation with our clients and result in litigation against us or the imposition of penalties, all of which may adversely impact our results of operations, financial condition and liquidity.

 

Failure to comply with environmental, health and safety laws and regulations, including the federal Occupational Safety and Health Administration Act, the Needlestick Safety and Prevention Act and the Comprehensive Medical Waste Management Act, could result in fines and penalties and loss of licensure, and have a material adverse effect upon our business.

 

We are subject to licensing and regulation under federal, state and local laws and regulations relating to the protection of the environment and human health and safety, including laws and regulations relating to the handling, transportation and disposal of medical specimens, infectious and hazardous waste and radioactive materials, as well as regulations relating to the safety and health of laboratory employees. The federal Occupational Safety and Health Administration has established extensive requirements relating to workplace safety for health care employers, including clinical laboratories, whose workers may be exposed to blood-borne pathogens such as HIV and the hepatitis B virus. These requirements, among other things, require work practice controls, protective clothing and equipment, training, medical follow-up, vaccinations and other measures designed to minimize exposure to, and transmission of, blood-borne pathogens. In addition, the Needlestick Safety and Prevention Act requires, among other things, that we include in our safety programs the evaluation and use of engineering controls such as safety needles if found to be effective at reducing the risk of needlestick injuries in the workplace.

 

Waste management is subject to federal and state regulations governing the transportation and disposal of medical waste including bodily fluids.  Federal regulations require licensure of interstate transporters of medical waste. In New Jersey, we are subject to the Comprehensive Medical Waste Management Act (“CMWMA”), which requires us to register as a generator of special medical waste. All of our medical waste is disposed of by a licensed interstate hauler.  The hauler provides a manifest of the disposition of the waste products as well as a certificate of incineration, which is retained by us. These records are audited by the State of New Jersey on a yearly basis. We are also subject to the Federal Hazardous materials transportation law, 49 U.S.C. 5101 et seq., and the Hazardous Materials Regulations (HMR), 49 CFR parts 171-180. The federal government has classified hazardous medical waste as hazardous materials for the purpose of regulation. These regulations preempt state regulation, which must be “substantively the same,” “the non-federal requirement must conform “in every significant respect to the federal requirement. Editorial and other similar de minimis changes are permitted,” 49 CFR 107.202(d).

 

Failure to comply with such federal, state and local laws and regulations could subject us to denial of the right to conduct business, fines, criminal penalties and/or other enforcement actions, any of which could have a material adverse effect on our business. In addition, compliance with future legislation could impose additional requirements us, which may be costly.

 

Failure to comply with complex federal and state laws and regulations related to submission of claims for clinical laboratory services could result in significant monetary damages and penalties and exclusion from the Medicare and Medicaid programs.

 

We are subject to extensive federal and state laws and regulations relating to the submission of claims for payment for clinical laboratory services, including those that relate to coverage of our services under Medicare, Medicaid and other governmental health care programs, the amounts that may be billed for our services and to whom claims for services may be submitted. These rules may also affect the Company in light of the practice management products that we market, to the extent that these products are considered to affect the manner in which our customers’ submit their own claims for services.  Submission of our claims is particularly complex because we provide both anatomic pathology services and clinical laboratory tests, which generally are paid using different reimbursement principles. The clinical laboratory tests are often paid under a clinical laboratory fee schedule, and the anatomic pathology services are often paid under a physician fee schedule.

 

                                                Our failure to comply with applicable laws and regulations could result in our inability to receive payment for our services or result in attempts by third-party payors, such as Medicare and Medicaid, to recover payments from us that have already been made. Submission of claims in violation of certain statutory or regulatory requirements can result in penalties, including substantial civil money penalties for each item or service billed to Medicare in violation of the legal requirement, and exclusion from participation in Medicare and Medicaid. Government

 

10


Table of Contents

 

authorities may also assert that violations of laws and regulations related to submission or causing the submission of claims violate the federal False Claims Act (“FCA”) or other laws related to fraud and abuse, including submission of claims for services that were not medically necessary. Violations of the FCA could result in enormous economic liability. The FCA provides that all damages are trebled, and each false claim submitted is subject to a penalty of up to $11,000. For example, we could be subject to FCA liability if it was determined that the services we provided were not medically necessary and not reimbursable, particularly if it were asserted that we contributed to the physician’s referrals of unnecessary services to us. It is also possible that the government could attempt to hold us liable under fraud and abuse laws for improper claims submitted by an entity for services that we performed if we were found to have knowingly participated in the arrangement that resulted in submission of the improper claims.

 

Changes in regulation and policies, including increasing downward pressure on health care reimbursement, may adversely affect reimbursement for diagnostic services and could have a material adverse impact on our business.

 

Reimbursement levels for health care services are subject to continuous and often unexpected changes in policies, and we face a variety of efforts by government payors to reduce utilization and reimbursement for diagnostic testing services. Changes in governmental reimbursement may result from statutory and regulatory changes, retroactive rate adjustments, administrative rulings, competitive bidding initiatives, and other policy changes.

 

The U.S. Congress has considered, at least yearly in conjunction with budgetary legislation, changes to one or both of the Medicare fee schedules under which we receive reimbursement, which include the physician fee schedule for anatomical pathology services, and the clinical laboratory fee schedule for our clinical laboratory services. For example, currently there is no copayment or coinsurance required for clinical laboratory services, although there is for our physician services. However, Congress has periodically considered imposing a 20 percent coinsurance on laboratory services. If enacted, this would require us to attempt to collect this amount from patients, although in many cases the costs of collection would exceed the amount actually received.

 

Our reimbursement for our pathology services is paid primarily under the physician fee schedule of Medicare and Medicaid and is therefore governed by a complex formula, referred to as the Sustainable Growth Rate, or SGR. As the use of this formula could result in a significant reduction in reimbursement for all physician services, Congress usually acts each year to prevent the full amount of such reductions from taking effect. In 2011, Congress acted to prevent reductions in for 2012, and on January 1, 2013, Congress acted to prevent significant reductions for 2013.  The SGR has currently been postponed until March 2014 and Congress continues to work on both a short term and a long term fix to this annual problem.  If Congress fails to take such action in the future, implementation of this formula could adversely affect our business.

 

The Center for Medicare and Medicaid Services (CMS) pays laboratories on the basis of a fee schedule that is reviewed and re-calculated on an annual basis.  CMS may change the fee schedule upward or downward on billing codes that we submit for reimbursement on a regular basis. Our revenue and business may be adversely affected if the reimbursement rates associated with such codes are reduced. Even when reimbursement rates are not reduced, policy changes add to our costs by increasing the complexity and volume of administrative requirements. Medicaid reimbursement, which varies by state, is also subject to administrative and billing requirements and budget pressures. Recently, state budget pressures have caused states to consider several policy changes that may impact our financial condition and results of operations, such as delaying payments, reducing reimbursement, restricting coverage eligibility and service coverage, and imposing taxes on our services.

 

Healthcare policy changes, including recently enacted legislation reforming the U.S. healthcare system, may have a material adverse effect on our financial condition and results of operations.

 

The Health Care Reform Law makes changes that are expected to significantly impact clinical laboratories, among others.  Beginning in 2013, each medical device manufacturer will pay a sales tax in an amount equal to 2.3% of the price for which such manufacturer sells its medical devices that are listed with the FDA. Although the FDA has contended that LDTs are medical devices, none of our products are currently listed with the FDA. We cannot assure you that the tax will not be extended to services such as ours in the future.  The Health Care Reform Law also mandates a reduction in payments for clinical laboratory services paid under the Medicare Clinical Laboratory Fee Schedule, or CLFS, of 1.75% through 2015 and a productivity adjustment to the CLFS.

 

Other significant measures contained in the Health Care Reform Law include, for example, coordination and promotion of research on comparative clinical effectiveness of different technologies and procedures, initiatives to revise Medicare payment methodologies, such as bundling of payments across the continuum of care by providers and physicians, and initiatives to promote quality indicators in payment methodologies. The Health Care Reform Law also includes significant new fraud and abuse measures, including required disclosures of financial arrangements with physician customers, lower thresholds for violations and increasing potential penalties for such violations. In addition, the Health Care Reform Law establishes an Independent Payment Advisory Board, or IPAB, to reduce the per capita rate of growth in Medicare spending. The IPAB has broad discretion to propose policies to reduce expenditures, which may have a negative impact on payment rates for services. The IPAB proposals may impact payments for clinical laboratory services beginning in 2016. We are monitoring the impact of the Health Care Reform Law in order to enable us to determine the trends and changes that may be necessitated by the legislation that may potentially impact on our business over time.

 

In addition to the Health Care Reform Law, various healthcare reform proposals have also emerged from federal and state governments. For example, in February 2012, Congress passed the “Middle Class Tax Relief and Job Creation Act of 2012” which in part reduced the potential future cost-based increases to the Medicare Clinical Laboratory Fee Schedule by 2%. Overall the expected total fee cut to the CLFS for 2013 is 2.95% not including a further reduction of 2% anticipated from implementation of the automatic expense reductions (sequester) under the Budget Control Act of 2011 which went into effect for dates of service on or after April 1, 2013.  Reductions made by the Congressional sequester are applied to total claims payments made.  While these reductions do not result in a rebasing of the negotiated or established Medicare or Medicaid reimbursement rates, rebasing could occur as a result of future legislation.  In 2014, the total fee cut to the CLFS will be 2.55% plus another 2% that will again take effect from the sequester on April 1, 2014.

 

We cannot be certain that these or future changes will not affect payment rates in the future.  We also cannot predict whether future healthcare initiatives will be implemented at the federal or state level, or the effect any future legislation or regulation will have on us. The taxes imposed by the new federal legislation, cost reduction measures and the expansion in government’s role in the U.S. healthcare industry may result in decreased profits to us, lower reimbursements by payors for our products or reduced medical procedure volumes, all of which may adversely affect our business, financial condition and results of operations.

 

11


Table of Contents

 

Change in the billing and/or reimbursement procedures by the federal government could affect our ability to be paid as we have in the past for services rendered.

 

CMS has changed or discussed making changes to certain types of reimbursement which could affect our rate of reimbursement.  Certain cases are comprised of both a technical component (TC) and a professional component (PC).  In certain specified areas of testing, primarily in the area of anatomic pathology, CMS has determined that some providers have over-utilized these testing procedures and CMS has introduced changes in reimbursement policies to discourage over-utilization.  While the Company does not currently over-utilize services for self-gain and does not perform any significant amounts revenue for the areas of testing currently being changed by CMS, we are always subject to review by CMS and cannot be certain that CMS won’t interpret our practices differently than we do.  In addition, CMS may extend this logic and approach to other areas of testing that might affect work performed by us.

 

CMS has announced planned changes in the area of Molecular Diagnostics’ reimbursement, primarily designed to improve transparency in billing.  Molecular Diagnostics is a rapidly changing and evolving area of clinical testing.  Whereas other areas of clinical testing are well vetted and established with specific codes for reimbursement, Molecular Diagnostics has moved at a faster pace than CMS can proceed.  Clinical laboratories accordingly use a process called cross-walking to get reimbursed by CMS.  Cross-walking requires that the clinical laboratory identify the individual processes used to process the patient’s specimen and identify diagnostic results that are already reimbursed in established tests.  CMS seeks to specifically identify the testing routine being done and reimburse providers universally for the test actually being performed.  CMS has not established all of the molecular diagnostic tests that will be included in this revised schedule for reimbursement and it has not determined how much will be reimbursed to providers for these tests.  We expect CMS to implement fair and reasonable reimbursement for such tests, but until such pricing decisions are disclosed we cannot be certain what CMS will finally implement.

 

Effective July 1, 2012, CMS eliminated an exemption that had been in place since 1999, which allowed commercial laboratories to bill for certain diagnostic tests performed on in-patient and certain outreach recipients by commercial laboratories.  From 1999 through July 1, 2012, commercial laboratories were allowed to bill CMS for such tests despite the fact that the recipient was a hospital patient as long as the hospital had been submitting such tests for diagnosis to commercial laboratories prior to 1999.  Upon termination of the exemption, we were required to find out from the hospital submitting the test whether the recipient’s bill for diagnostic testing will be reimbursed by the hospital or should be billed to CMS.  We have systems in place to manage this change, but these systems are dependent upon our getting proper information from the hospital clients.

 

The Federal Government is faced with significant economic decisions in the coming years.  Some solutions being offered in the government could substantially change the way laboratory testing is reimbursed by government entities.  We cannot be certain what or how any such government changes may affect our business.”

 

Healthcare plans have taken steps to control the utilization and reimbursement of healthcare services, including clinical test services.

 

We also face efforts by non-governmental third-party payors, including healthcare plans, to reduce utilization and reimbursement for clinical testing services.

 

The healthcare industry has experienced a trend of consolidation among healthcare insurance plans, resulting in fewer but larger insurance plans with significant bargaining power to negotiate fee arrangements with healthcare providers, including clinical testing providers. These healthcare plans, and independent physician associations, may demand that clinical testing providers accept discounted fee structures or assume all or a portion of the financial risk associated with providing testing services to their members through capped payment arrangements. In addition, some healthcare plans have been willing to limit the PPO or POS laboratory network to only a single national laboratory to obtain improved fee-for-service pricing. There are also an increasing number of patients enrolling in consumer driven products and high deductible plans that involve greater patient cost-sharing.

 

The increased consolidation among healthcare plans also has increased the potential adverse impact of ceasing to be a contracted provider with any such insurer. The Health Care Reform Law includes provisions, such as the creation of healthcare exchanges, which may encourage healthcare insurance plans to increase exclusive contracting.

 

We expect continuing efforts to reduce reimbursements, to impose more stringent cost controls and to reduce utilization of clinical test services. These efforts, including future changes in third-party payor rules, practices and policies, or ceasing to be a contracted provider to a healthcare plan, may have a material adverse effect on our business.

 

Increased competition, including price competition, could have a material adverse impact on our net revenues and profitability.

 

Our industry is characterized by intense competition. Our major competitors in the New York metropolitan super-region, Quest Diagnostics and Laboratory Corporation of America, are large national laboratories that possess greater name recognition, larger customer bases, significantly greater financial resources and employ substantially more personnel than we do. Many of our competitors have long established relationships with their customers and third-party payors. We cannot assure you that we will be able to compete successfully with such entities in the future.

 

The clinical laboratory business is intensely competitive both in terms of price and service. Pricing of laboratory testing services is often one of the most significant factors used by health care providers and third-party payors in selecting a laboratory. As a result of the clinical laboratory industry undergoing significant consolidation, larger clinical laboratory providers are able to increase cost efficiencies afforded by large-scale automated testing. This consolidation results in greater price competition. We may be unable to increase cost efficiencies sufficiently, if at all, and as a result, our net earnings and cash flows could be negatively impacted by such price competition.  Additionally, we may also face changes in fee schedules, competitive bidding for laboratory services or other actions or pressures reducing payment schedules as a result of increased or additional competition.

 

Additional competition, including price competition, could have a material adverse impact on our net revenues and profitability.

 

A failure to obtain and retain new clients and business  partners, a loss of existing clients or material contracts, or a reduction in tests ordered or specimens submitted by existing clients, could impact our ability to successfully grow our business.

 

                                                To offset efforts by payors to reduce the cost and utilization of clinical laboratory services, we need to obtain and retain new clients and business partners. In addition, a reduction in tests ordered or specimens submitted by existing clients, without offsetting growth in our client

 

12


Table of Contents

 

base, could impact our ability to successfully grow our business and could have a material adverse impact on our net revenues and profitability. We compete primarily on the basis of the quality of testing, reporting and information systems, reputation in the medical community, the pricing of services and ability to employ qualified personnel. Our failure to successfully compete on any of these factors could result in the loss of clients and a reduction in our ability to expand our customer base.

 

Failure to timely or accurately bill for our services could have a material adverse effect on our business

 

Billing for clinical testing services is extremely complicated and is subject to extensive and non-uniform rules and administrative requirements. Depending on the billing arrangement and applicable law, we bill various payors, such as patients, insurance companies, Medicare, Medicaid, physicians, hospitals and employer groups. Changes in laws and regulations could increase the complexity and cost of our billing process. Additionally, auditing for compliance with applicable laws and regulations as well as internal compliance policies and procedures adds further cost and complexity to the billing process. Further, our billing systems require significant technology investment and, as a result of marketplace demands, we need to continually invest in our billing systems.

 

Missing or incorrect information on requisitions adds complexity to and slows the billing process, creates backlogs of unbilled requisitions, and generally increases the aging of accounts receivable and bad debt expense. We believe that much of our bad debt expense in recent years is attributable to the lack of, or inaccurate, billing information. Failure to timely or correctly bill may lead to our not being reimbursed for our services or an increase in the aging of our accounts receivable, which could adversely affect our results of operations and cash flows. Failure to comply with applicable laws relating to billing government healthcare programs could lead to various penalties, including: (1) exclusion from participation in CMS and other government programs; (2) asset forfeitures; (3) civil and criminal fines and penalties; and (4) the loss of various licenses, certificates and authorizations necessary to operate our business, any of which could have a material adverse effect on our results of operations or cash flows.

 

There have been times when our accounts receivable have increased at a greater rate than revenue growth and, therefore, have adversely affected our cash flows from operations. We have taken steps to implement systems and processing changes intended to improve billing procedures and related collection results. We believe that we have made progress by reorganizing our accounts receivable and billing functions and that our allowance for doubtful accounts is adequate. However, we cannot assure that our ongoing assessment of accounts receivable will not result in the need for additional provisions. Such additional provisions, if implemented, could have a material adverse effect on our operating results.

 

Our failure or the failure of third-party payors or physicians to comply with ICD-10-CM Code Set, and our failure to comply with other emerging electronic transaction standards could adversely impact our business.

 

We are within the assessment and inventory phase to adopt the ICD-10-CM Code Set issued by HHS on January 16, 2009. Compliance with the ICD-10-CM Code Set is currently required to be in place by October 1, 2014. The Company will continue its assessment of information systems, applications and processes for compliance with these requirements. Clinical laboratories are typically required to submit health care claims with diagnosis codes to third party payors. The diagnosis codes must be obtained from the ordering physician. Our failure or the failure of third party payors or physicians to transition within the required timeframe could have an adverse impact on reimbursement, days sales outstanding and cash collections.

 

Also, the failure of our IT systems to keep pace with technological advances may significantly reduce our revenues or increase our expenses.  Public and private initiatives to create healthcare information technology (“HCIT”) standards and to mandate standardized clinical coding systems for the electronic exchange of clinical information, including test orders and test results, could require costly modifications to our existing HCIT systems. While we do not expect HCIT standards to be adopted or implemented without adequate time to comply, if we fail to adopt or delay in implementing HCIT standards, we could lose customers and business opportunities.

 

Failure in our information technology systems could significantly increase testing turn-around time or billing processes and otherwise disrupt our operations.

 

Our laboratory operations depend, in part, on the continued performance of our information technology systems. Our information technology systems are potentially vulnerable to physical or electronic break-ins, computer viruses and similar disruptions. In addition, we are in the process of integrating the information technology systems of our recently acquired subsidiaries, and we may experience system failures or interruptions as a result of this process. Sustained system failures or interruption of our systems in one or more of our laboratory operations could disrupt our ability to process laboratory requisitions, perform testing, provide test results in a timely manner and/or bill the appropriate party.  Breaches with respect to protected health information could result in violations of HIPAA and analogous state laws, and risk the imposition of significant fines and penalties.  Failure of our information technology systems could adversely affect our business, profitability and financial condition.

 

Adverse results in material litigation matters could have a material adverse effect upon our business.

 

We may become subject in the ordinary course of business to material legal action related to, among other things, professional liability and employee-related matters, as well as inquiries from governmental agencies and Medicare or Medicaid carriers requesting comment on allegations of billing irregularities that are brought to their attention through billing audits or third parties. Legal actions could result in substantial monetary damages as well as damage to our reputation with clients, which could have a material adverse effect upon our business.

 

We may be unable to obtain, maintain or enforce our intellectual property rights and may be subject to intellectual property litigation that could adversely impact our business.

 

We may be unable to obtain or maintain adequate patent or other proprietary rights for our products and services or to successfully enforce our proprietary rights. In addition, we may be subject to intellectual property litigation and we may be found to infringe on the proprietary rights of others, which could force us to do one or more of the following:

 

cease developing, performing or selling products or services that incorporate the challenged intellectual property;

obtain and pay for licenses from the holder of the infringed intellectual property right;

redesign or reengineer our tests;

change our business processes; or

 

13


Table of Contents

 

pay substantial damages, court costs and attorneys’ fees, including potentially increased damages for any infringement held to be willful.

 

The Company believes that no single patent, technology, trademark, intellectual property asset or license is material to its business as a whole.

 

If patent regulations or standards are modified, such changes could have a negative impact on our business.

 

From time to time, the U.S. Supreme Court, other federal courts, the U.S. Congress or the U.S. Patent and Trademark Office, USPTO, may change the standards of patentability and validity and any such changes could have a negative impact on our business. In addition, competitors may develop their own versions of our test in countries where we did not apply for patents or where our patents have not issued and compete with us in those countries, including encouraging the use of their test by physicians or patients in other countries.

 

There have been several cases involving “gene patents” and diagnostic claims that have been considered by the U.S. Supreme Court. A suit brought by multiple plaintiffs, including the American Civil Liberties Union, or ACLU, against Myriad Genetics, or Myriad, and the USPTO involves certain of Myriad’s U.S. patents related to the breast cancer susceptibility genes BRCA1 and BRCA2. The Federal Circuit issued a written decision on July 29, 2011 that reversed the U.S. District Court for the Southern District of New York holding instead that the breast cancer genes are patentable subject matter. Subsequently, on March 20, 2012, the Supreme Court issued a decision in Mayo Collaborative v. Prometheus Laboratories, or Prometheus, a case involving patent claims directed to optimizing the amount of drug administered to a specific patient. According to that decision, Prometheus’ claims failed to add enough inventive content to the underlying correlations to allow the processes they describe to qualify as patent-eligible processes that apply natural laws.  The Supreme Court subsequently granted certiorari in the Myriad case, vacated the judgment, and remanded the case back to the Federal Circuit for further consideration in light of their decision in the Prometheus case.  The Federal Circuit issued a decision on August 16, 2012, reaffirming its earlier decision.

 

On July 3, 2012, the USPTO issued a memorandum to patent examiners providing guidelines for examining process claims for patent eligibility in view of the Supreme Court decision in Prometheus.  The guidance indicates that claims directed to a law of nature, a natural phenomenon, or an abstract idea that do not meet the eligibility requirements should be rejected as non-statutory subject matter.  We cannot assure you that our patent portfolio will not be negatively impacted by the decision described above, rulings in other cases or changes in guidance or procedures issued by the USPTO.

 

The Supreme Court granted ACLU’s petition for a writ of certiorari and issued a decision on June 13, 2013.  In the ruling, the Supreme Court held that claims to “isolated” DNA molecules and the information they encode are not patent eligible, whereas DNA, not a “product of nature,” is patent eligible.  On July 12, 2013, Senator Patrick Leahy wrote to the National Institutes of Health, or NIH, urging that the NIH take the extremely unusual step of exercising its “march in” rights to force Myriad to license certain patents to others on “reasonable” terms due to the public health and cost considerations.

 

Congress directed the USPTO to study effective ways to provide independent, confirming genetic diagnostic test activity where gene patents and exclusive licensing for primary genetic diagnostic tests exist.  This study will examine the impact that independent second opinion testing has on providing medical care to patients; the effect that providing independent second opinion genetic diagnostic testing would have on the existing patent and license holders of an exclusive genetic test; the impact of current practices on testing results and performance; and the role of insurance coverage on the provision of genetic diagnostic tests.  The USPTO was directed to report the findings of the study to Congress and provide recommendations for establishing the availability of independent confirming genetic diagnostic test activity by June 16, 2012. In August 2012, the Department of Commerce advised the House and Senate Judiciary Committee leadership that given the complexity and significant policy implications, that further review, discussion and analysis are required before a final report can be submitted to Congress. To that end, the USPTO held an additional public hearing in late fall 2012, plans to review the comments received during the last year, and then plans to finalize its recommendations to Congress. It is unclear whether the results of this study will be acted upon by the USPTO or result in Congressional efforts to change the law or process in a manner that could negatively impact our patent portfolio or our future research and development efforts.

 

In addition, the Leahy-Smith America Invents Act, or the America Invents Act, which was signed into law in 2011, includes a number of significant changes to U.S. patent law.  These include changes to transition from a “first-to-invent” system to a “first-to-file” system, changes to the way issued patents are challenged and changes to the way patent applications are disputed during the examination process. These changes may favor larger and more established companies that have more resources to devote to patent application filing and prosecution. The USPTO has developed new regulations and procedures to govern the full implementation of the America Invents Act, and many of the substantive changes to patent law associated with the Act, and in particular the first to file provisions, which became effective in March 2013.  Substantive changes to patent law associated with the Act may affect our ability to obtain, enforce or defend our patents. Accordingly, it is not clear what, if any, impact the America Invents Act will ultimately have on the cost of prosecuting our patent applications, our ability to obtain patents based on our discoveries and our ability to enforce or defend our issued patents, all of which could have a material adverse effect on our business.

 

We are facing, and may in the future face, intellectual property infringement claims that could be time-consuming and costly to defend, and could result in our loss of significant rights and the assessment of treble damages.

 

In October 2013, a lawsuit was filed against us by Myriad Genetics alleging we are infringing upon their intellectual property by offering OncoGeneDx, our comprehensive series of inherited cancers testing, including testing for BRCA1/2.  We may from time to time receive additional notices of claims of infringement and misappropriation or misuse of other parties’ proprietary rights. Some of these additional claims may also lead to litigation. We cannot assure you that we will prevail in such actions, or that other actions alleging misappropriation or misuse by us of third-party trade secrets, infringement by us of third-party patents and trademarks or the validity of our patents, will not be asserted or prosecuted against us.

 

                                                We may also initiate claims to defend our intellectual property or to seek relief on allegations that we use, sell, or offer to sell technology that incorporates third party intellectual property.  Intellectual property litigation, regardless of outcome, is expensive and time-consuming, could divert management’s attention from our business and have a material negative effect on our business, operating results or financial condition.  If there is a successful claim of infringement against us, we may be required to pay substantial damages (including treble damages if we were to be found to have willfully infringed a third party’s patent) to the party claiming infringement, develop non-infringing technology, stop selling our tests or using technology that contains the allegedly infringing intellectual property or enter into royalty or license agreements that may not be available on acceptable or commercially practical terms, if at all.  Our failure to develop non-infringing technologies or license the proprietary rights on a timely basis could harm our business.

 

14


Table of Contents

 

It is possible that a third party or patent office might take the position that one or more patents or patent applications constitute prior art in the field of genomic-based diagnostics. In such a case, we might be required to pay royalties, damages and costs to firms who own the rights to these patents, or we might be restricted from using any of the inventions claimed in those patents.

 

Failure to establish, and perform to, appropriate quality standards to assure that the highest level of quality is observed in the performance of our testing services and in the design, manufacture and marketing of our products could adversely affect the results of our operations and adversely impact our reputation.

 

The provision of clinical testing services, including anatomic pathology services, and related services, and the design, manufacture and marketing of diagnostic products involve certain inherent risks. The services that we provide and the products that we design, manufacture and market are intended to provide information for healthcare providers in providing patient care. Therefore, users of our services and products may have a greater sensitivity to errors than the users of services or products that are intended for other purposes.

 

Manufacturing or design defects, unanticipated use of our products, or inadequate disclosure of risks relating to the use of the products can lead to injury or other adverse events. These events could lead to recalls or safety alerts relating to our products (either voluntary or required by governmental authorities) and could result, in certain cases, in the removal of a product from the market. Any recall could result in significant costs as well as negative publicity that could reduce demand for our products. Personal injuries relating to the use of our products can also result in product liability claims being brought against us. In some circumstances, such adverse events could also cause delays in new product approvals.

 

Similarly, negligence in performing our services can lead to injury or other adverse events. We may be sued under physician liability or other liability law for acts or omissions by our pathologists, laboratory personnel and hospital employees who are under the supervision of our hospital-based pathologists. We are subject to the attendant risk of substantial damages awards and risk to our reputation.

 

Discontinuation or recalls of existing testing products, failure to develop, or acquire, licenses for new or improved testing technologies; or our clients using new technologies to perform their own tests could adversely affect our business.

 

From time to time, manufacturers discontinue or recall reagents, test kits or instruments used by us to perform laboratory testing. Such discontinuations or recalls could adversely affect our costs, testing volume and revenue.

 

The clinical laboratory industry is subject to changing technology and new product introductions. Our success in maintaining a leadership position in genomic and other advanced testing technologies will depend, in part, on our ability to develop, acquire or license new and improved technologies on favorable terms and to obtain appropriate coverage and reimbursement for these technologies. We may not be able to negotiate acceptable licensing arrangements and it cannot be certain that such arrangements will yield commercially successful diagnostic tests. If we are unable to license these testing methods at competitive rates, our research and development costs may increase as a result. In addition, if we are unable to license new or improved technologies to expand our esoteric testing operations, our testing methods may become outdated when compared with our competition and testing volume and revenue may be materially and adversely affected.

 

In addition, advances in technology may lead to the development of more cost-effective technologies such as point-of-care testing equipment that can be operated by physicians or other healthcare providers in their offices or by patients themselves without requiring the services of freestanding clinical laboratories. Development of such technology and its use by our clients could reduce the demand for our laboratory testing services and negatively impact our revenues.

 

Currently, most clinical laboratory testing is categorized as “high” or “moderate” complexity, and thereby is subject to extensive and costly regulation under CLIA. The cost of compliance with CLIA makes it impractical for most physicians to operate clinical laboratories in their offices, and other laws limit the ability of physicians to have ownership in a laboratory and to refer tests to such a laboratory. Manufacturers of laboratory equipment and test kits could seek to increase their sales by marketing point-of-care laboratory equipment to physicians and by selling test kits approved for home or physician office use to both physicians and patients. Diagnostic tests approved for home use are automatically deemed to be “waived” tests under CLIA and may be performed in physician office laboratories as well as by patients in their homes with minimal regulatory oversight. Other tests meeting certain FDA criteria also may be classified as “waived” for CLIA purposes. The FDA has regulatory responsibility over instruments, test kits, reagents and other devices used by clinical laboratories and has taken responsibility from the Centers for Disease Control for classifying the complexity of tests for CLIA purposes. Increased approval of “waived” test kits could lead to increased testing by physicians in their offices or by patients at home, which could affect our market for laboratory testing services and negatively impact our revenues.

 

Clinicians or patients using our services may sue us, and our insurance may not sufficiently cover all claims brought against us, which will increase our expenses.

 

The development, marketing, sale and performance of healthcare services expose us to the risk of litigation, including professional negligence. Damages assessed in connection with, and the costs of defending, any legal action could be substantial. We may be faced with litigation claims that exceed our insurance coverage or are not covered under any of our insurance policies. In addition, litigation could have a material adverse effect on our business if it impacts our existing and potential customer relationships, creates adverse public relations, diverts management resources from the operation of the business, or hampers our ability to otherwise conduct our business.

 

A failure to integrate newly acquired businesses and the costs related to such integration could have a material adverse impact on our net revenues and profitability.

 

The successful integration of any business that we may acquire entails numerous risks, including, among others:

 

issues related to revenue recognition and/or cash collections;

loss of key customers or employees;

difficulty in consolidating redundant facilities and infrastructure and in standardizing information and other systems;

failure to maintain quality of services that we and any such acquired companies have historically provided;

coordination of geographically separated facilities and workforces; and

diversion of management’s attention from our day-to-day business.

 

15


Table of Contents

 

We cannot assure you that current or future acquisitions, if any, or any related integration efforts will be successful, or that our business will not be adversely affected by any future acquisitions. Even if we are able to successfully integrate the operations of companies or businesses that we may acquire in the future, we may not be able to realize the benefits that we expect to result from such integration, including projected cost savings.

 

Our operations may be adversely impacted by the effects of extreme weather conditions, natural disasters such as hurricanes and earthquakes, health pandemics, hostilities or acts of terrorism and other criminal activities.

 

Our operations were adversely impacted by the effects of Hurricane Sandy, and may be adversely impacted by other extreme weather conditions, natural disasters, health pandemics, hostilities or acts of terrorism or other criminal activities from time to time. Such events may result in a temporary decline in the number of patients who seek clinical testing services or in our employees’ ability to perform their job duties. In addition, such events may temporarily interrupt our ability to transport specimens, to receive materials from our suppliers or otherwise to provide our services. The occurrence of any such event and/or a disruption to our operations as a result may adversely impact our results of operations.

 

An inability to attract and retain experienced and qualified personnel could adversely affect our business.

 

The loss of key management personnel or the inability to attract and retain experienced and qualified employees at our clinical laboratories and research centers could adversely affect our business. Our success is dependent in part on the efforts of key members of our management team, including Marc D.  Grodman, M.D., our founder, president and chief executive officer. Success in maintaining our leadership position in genomic and other advanced testing technologies will depend in part on our ability to attract and retain skilled research professionals. In addition, the success of our clinical laboratories also depends on employing and retaining qualified and experienced laboratory professionals, including specialists, who perform clinical laboratory testing services. In the future, if competition for the services of these professionals increases, we may not be able to continue to attract and retain individuals in its markets. Our net revenues and earnings could be adversely affected if a significant number of professionals terminate their relationship with us or become unable or unwilling to continue their employment.

 

Our outstanding debt may impair our financial and operating flexibility.

 

As of October 31, 2013, we had approximately $30,302 million of debt outstanding.  Our debt agreements contain various restrictive covenants. These restrictions could limit our ability to use operating cash flow in other areas of our business because we must use a portion of these funds to make principal and interest payments on our debt.

 

We or our subsidiaries may incur additional indebtedness in the future. Our ability to make principal and interest payments will depend on our ability to generate cash in the future. If we incur additional debt, a greater portion of our cash flows may be needed to satisfy our debt service obligations and if we do not generate sufficient cash to meet our debt service requirements, we may need to seek additional financing. In that case, it may be more difficult, or we may be unable, to obtain financing on terms that are acceptable to us. As a result, we would be more vulnerable to general adverse economic, industry and capital markets conditions as well as the other risks associated with indebtedness

 

Possible volatility in our stock price could negatively affect us and our stockholders.

 

The trading price of our common stock on the NASDAQ Global Select Market has fluctuated significantly in the past. During the period from November 1, 2010 through October 31, 2013, the trading price of our common stock fluctuated from a high of $33.46 per share to a low of $12.03 per share. In the past, we have experienced a drop in stock price following an announcement of disappointing earnings or earnings guidance. Any such announcement in the future could lead to a similar drop in stock price. The price of our common stock could also be subject to wide fluctuations in the future as a result of a number of other factors, including the following:

 

changes in expectations as to future financial performance or buy/sell recommendations of securities analysts;

our, or a competitor’s, announcement of new products or services, or significant acquisitions, strategic partnerships, joint ventures or capital commitments;

the operating and stock price performance of other comparable companies; and adverse publicity.

 

In addition, the U.S. securities markets have experienced significant price and volume fluctuations. These fluctuations often have been unrelated to the operating performance of companies in these markets. Broad market and industry factors may lead to volatility in the price of our common stock, regardless of our operating performance. Moreover, our stock has limited trading volume, and this illiquidity may increase the volatility of our stock price.

 

In the past, following periods of volatility in the market price of an individual company’s securities, securities class action litigation often has been instituted against that company. The institution of similar litigation against us could result in substantial costs and a diversion of management’s attention and resources, which could negatively affect our business, results of operations or financial condition.

 

Certain provisions of our charter, by-laws and New Jersey law may delay or prevent a change of control of our company.

 

Our certificate of incorporation, as amended, requires the approval of 80% of our outstanding shares for any merger or consolidation unless the business combination has been approved or authorized by our board of directors. As a New Jersey corporation with a class of securities registered with the SEC, we are governed by certain provisions of the New Jersey Business Corporation Act that also restrict business combinations with shareholders owning 10% or more of our outstanding shares (or other “interested stockholders” as the term is defined by the New Jersey Shareholders’ Protection Act) for a period of five years after such interested shareholder achieves such status unless the business combination is approved by our board of directors prior to the shareholder becoming an interested shareholder. The New Jersey Shareholders’ Protection Act also restricts business combinations with an interested shareholder after the five-year period unless the transaction receives the approval of two-thirds of the shares outstanding, exclusive of the shares held by the interested shareholder or the transaction satisfies certain fair price requirements. In addition, with certain limited exceptions, federal regulations prohibit a person or company or a group of persons deemed to be “acting in concert” from, directly or indirectly, acquiring more than 10% (5% if the acquirer is a bank holding company) of any class of our voting stock or obtaining the ability to control in any manner the election of a majority of our directors or otherwise direct the management or policies of our company without prior notice or application to and the approval of the Federal Reserve.

 

16


Table of Contents

 

A significant deterioration in the economy could negatively impact testing volumes, cash collections and the availability of credit.

 

Our operations are dependent upon ongoing demand for diagnostic testing services by patients, physicians, hospitals and others. A significant downturn in the economy could negatively impact the demand for diagnostic testing as well as the ability of patients and other payors to pay for services ordered. In addition, uncertainty in the credit markets could reduce the availability of credit and impact our ability to meet our financing needs in the future.

 

Item 1B. - Unresolved Staff Comments

 

None.

 

Item 2.         -Properties.

 

We operate through a regional network of laboratories. The table below summarizes certain information as to our principal facilities as of October 31, 2012.

 

Location

 

Purpose

 

Type of
Occupancy

Clarksburg, MD

 

Pathology Laboratory

 

Leased

Elmwood Park, NJ

 

Main Laboratory

 

Leased

Elmwood Park, NJ

 

Corporate Headquarters

 

Leased

Gaithersburg, MD

 

Genetics Laboratory

 

Leased

Houston, TX

 

Pathology Laboratory

 

Leased

Milford, MA

 

Oncology Laboratory

 

Leased

Poughkeepsie, NY

 

Pathology Laboratory

 

Leased

Campbell, CA

 

Main Laboratory

 

Leased

Miami, FL

 

Main Laboratory

 

Leased

Melbourne, FL

 

Main Laboratory

 

Leased

 

We perform cancer cytogenetic testing at our leased facilities in at our main processing facility in Elmwood Park, Smithtown, NY, Clarksburg, MD and Milford, MA and genetic testing at our GeneDx leased facility in Gaithersburg, MD, as well as at our Elmwood Park facility.  We perform cytology testing in Frederick, MD, Milford, MA, Columbus, OH, Houston, TX and at our Elmwood Park facility.  We believe that each of these facilities as presently equipped has the production capacity for its currently foreseeable level of operations. We also lease additional space for patient service centers throughout the New York metropolitan area to collect specimens from physician-referred patients for testing at our processing facilities.

 

Item 3. - Legal Proceedings

 

In the normal course of business, we have been named, from time to time, as a defendant in various legal actions, which may include lawsuits alleging negligence or other similar legal claims, which could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on our client base and reputation.  We may also be involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding our business.  In addition, as a health care provider and in connection with health care billing-related products, the Company may also be named from time to time in suits brought under the qui tam provisions of the False Claims Act and comparable state laws in which allegations may be made that the Company has submitted or cause to be submitted false claims in connection with claims for payment from federal or state health care programs.  In addition, the Company may, from time to time, receive subpoenas from state agencies and from the Office of the Inspector General of the U.S. Department of Health and Human Services seeking documents relating to the Company’s billing-related activities.  These types of legal proceedings could result in adverse judgments, including substantial monetary settlements, significant fines and penalties, as well as injunctions or other relief.

 

BioReference Laboratories, Inc. v. Horizon Healthcare Services, Inc. d/b/a Horizon Blue Cross Blue Shield of New Jersey

 

On December 18, 2013, the Company filed an action in the Superior Court of New Jersey against Horizon Blue Cross Blue Shield of New Jersey (“Horizon”), captioned BioReference Laboratories, Inc. v. Horizon Healthcare Services, Inc. d/b/a Horizon Blue Cross Blue Shield of New Jersey, Docket No. BER L-009748-13 (N.J. Super. Ct. Bergen Cnty.).  The Company asserts claims for breach of contract, breach of the implied covenant of good faith and fair dealing, and fraud against Horizon relating to the Ancillary Services Provider Agreement entered into by the parties in 2003 and amended in 2007.  More specifically, the central claims in the lawsuit arise from the Company’s performance of laboratory services since at least 2008 for members of Horizon’s NJ DIRECT plan, who receive benefits under a program that Horizon has bid, promoted, and represented to be a PPO product for New Jersey state, county, and municipal workers and teachers.  The lawsuit alleges that, despite these representations, Horizon has been improperly treating NJ DIRECT as a Managed Care program in its dealings with the Company, thereby costing the Company more than $20,000,000 in unreimbursed services and depriving state beneficiaries of valuable rights and benefits to which they are entitled.  In addition to compensatory damages, the Company seeks to recover punitive damages from Horizon due to Horizon’s intentional and malicious misconduct.  The Company also seeks declaratory and injunctive relief.  Horizon’s response to the Company’s complaint is currently due on or before January 22, 2014.  The lawsuit has been placed on a pretrial discovery schedule.  The Company intends to vigorously prosecute its claims against Horizon.

 

Univ. Utah Research Foundation et al. v. GeneDx, Inc., Case No. 2:13-CV-00954-RJS (D. Utah)

 

On October 16, 2013, University of Utah Research Foundation, the University of Pennsylvania, the Hospital for Sick Children, Endorecherche, Inc., and Myriad Genetics, Inc., filed a civil complaint against GeneDx, , in the United States District Court for the District of Utah, Central Division in Salt Lake City, Utah. The complaint alleges that certain genetic tests offered by GeneDx infringe, willfully infringe, contribute to the infringement of, and/or induce others to infringe a number of issued U.S. patents. The plaintiffs seek, among other relief, injunctive relief, unspecified compensatory damages, destruction of infringing products, accounting for unjust enrichments, attorneys’ fees, and costs.

 

On December 9, 2013, GeneDx, timely served and filed an answer to the plaintiffs’ complaint denying the plaintiffs’ claims and asserted affirmative defenses and counterclaims for invalidity of the asserted patents. GeneDx, Inc. is defending by alleging non-infringement and invalidity of the patents-in-suit, and is seeking attorneys’ fees and costs on the counterclaims. On December 23, 2013, the plaintiffs filed a reply to the counterclaims denying them and the requested relief. The case is currently in the very early stages. No schedule has been set and discovery

 

17


Table of Contents

 

has not begun. Plaintiffs are also in litigation with industry competitors and are attempting to consolidate the actions in the District of Utah through the United States Judicial Panel on Multidistrict Litigation (MDL No. 2510).  We intend to vigorously defend ourselves in this matter.

 

Item 4. — Mine Safety Disclosure

 

Not Applicable.

 

18


Table of Contents

 

PART II

 

Item 5. -  Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

Market Information

 

Our Common Stock is listed for trading on The NASDAQ Global Select Market under the symbol “BRLI.”

 

The following table sets forth the range of high and low closing prices on the NASDAQ Stock Market for our Common Stock for the periods indicated.

 

Fiscal Year

 

Prices ($)

 

2012

 

High

 

Low

 

First Quarter (11/1/2011-1/31/2012)

 

19.86

 

12.03

 

Second Quarter (2/1/2012-4/30/2012)

 

24.18

 

18.93

 

Third Quarter (5/1/2012-7/31/2012)

 

28.12

 

18.38

 

Fourth Quarter (8/1/2012-10/31/2012)

 

32.42

 

25.10

 

 

2013

 

High

 

Low

 

First Quarter (11/1/2012-1/31/2013)

 

31.05

 

24.68

 

Second Quarter (2/1/2013-4/30/2013)

 

28.22

 

23.58

 

Third Quarter (5/1/2013-7/31/2013)

 

31.90

 

25.25

 

Fourth Quarter (8/1/2013-10/31/2013)

 

33.46

 

25.78

 

 

On January 3, 2014 the last sale price for the Common Stock on NASDAQ was $24.76 per share.

 

Stockholders

 

At January 3, 2014, the number of record owners of the Common Stock was 270. Such number of record owners was determined from our shareholder records and does not include beneficial owners whose shares are held in nominee accounts with brokers, dealers, banks and clearing agencies.

 

Dividends

 

We have not paid any dividends on our Common Stock since our inception and, do not contemplate or anticipate paying any dividends in the foreseeable future. Furthermore, our loan agreement with PNC Bank prohibits us from paying any cash dividends or making any cash distributions with respect to shares of our Common Stock.

 

Recent Sales of Unregistered Securities

 

In 2010, we entered into an employment agreement with Wendy Chung.  Upon execution of the employment agreement, 11,432 shares of Common Stock were issued to Ms. Chung and another 34,293 shares were held in escrow, to be released subject to certain terms and conditions set forth in the employment agreement.  Certain terms and conditions of the employment agreement were met as of December 1, 2011 and on February 3, 2012, another 11,431 shares of Common Stock were delivered to Ms. Chung.  The terms and conditions of Ms. Chung’s employment agreement were met again on December 1, 2012 and, on December 14, 2012, another 11,431 shares of Common Stock were delivered to her.  On December 1 2013 Ms Chung yet again met the terms of her employment agreement and the final 11,431 shares of our common stock were delivered to her.

 

Performance Graph

 

We have presented below the cumulative total return to our stockholders during the period from November 1, 2008, through October 31, 2013 in comparison to the cumulative return on the S&P 500 Index and a customized peer group of eight companies during that same period.

 

19


Table of Contents

 

Peer Group

Covance Inc

Enzo Biochem Inc.

Genomic Health Inc

Laboratory Corporation of America Holdings

Myriad Genetics Inc

Neogenomics Inc

Quest Diagnostics Inc

Response Genetics Inc

 

 

The results assume that $100 (with reinvestment of all dividends) was invested in our common stock, in the peer group, and in the index on October 31, 2008 and its relative performance tracked through October 31, 2013. The comparisons are based on historical data and are not indicative of, nor intended to forecast, the future performance of our common stock. The performance graph set forth above shall not be deemed incorporated by reference into any filing by us under the Securities Act of 1933 or the Securities Exchange Act of 1934 except to the extent that we specifically incorporate such information by reference therein.

 

20


Table of Contents

 

Item 6. - Selected Financial Data

 

The following is a summary of our historical consolidated financial data for the periods ended and at the dates indicated below.  You are encouraged to read this information together with our audited consolidated financial statements and the related footnotes and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included elsewhere in this Annual Report.

 

The historical consolidated financial data for the years ended October 31, 2013, 2012, and 2011, 2010 and 2009 has been derived from our audited consolidated financial statements.  The historical consolidated financial data for the years ended October 31, 2009 and 2010, has been derived from our audited consolidated financial statements, which are not included in this Annual Report.

 

We believe that the comparability of our financial results between the periods presented in the table below is significantly impacted by factors which are more fully described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the Consolidated Financial Statements and the notes thereto included elsewhere in this Annual Report.

 

All comparisons to prior periods are adjusted in accordance with the Accounting Standards Update 2011-7 under Topic 954 of FASB codification.  The appended table reflects the adjustments for the prior period.

 

 

 

Fiscal Years Ended October 31,

 

 

 

2013

 

2012

 

2011

 

2010

 

2009

 

 

 

[In Thousands Except Per Share Data]

 

Operating Data:

 

 

 

 

 

 

 

 

 

 

 

Net Revenues

 

$

715,354

 

$

614,255

 

$

522,081

 

$

424,559

 

$

336,895

 

Cost of Services

 

392,815

 

337,644

 

287,853

 

232,252

 

183,524

 

Gross Profit

 

322,539

 

276,611

 

234,228

 

192,307

 

153,371

 

General and Administrative Expenses

 

240,566

 

200,480

 

174,454

 

143,929

 

115,049

 

Income From Operations

 

81,973

 

76,131

 

59,774

 

48,378

 

38,322

 

Other Expenses [Income] - Net

 

876

 

1,615

 

-5,072

 

1,415

 

-267

 

Provision for Income Tax Expense

 

35,272

 

32,360

 

28,487

 

20,582

 

16,739

 

Net Income

 

$

45,825

 

$

42,156

 

$

36,359

 

$

26,381

 

$

21,850

 

Net Income Per Share - Basic

 

$

1.65

 

$

1.52

 

$

1.30

 

$

0.95

 

$

0.79

 

Net Income Per Share - Diluted

 

$

1.65

 

$

1.51

 

$

1.29

 

$

0.94

 

$

0.78

 

Other Data:

 

 

 

 

 

 

 

 

 

 

 

Net Cash - Operating Activities

 

$

17,662

 

$

53,098

 

$

30,946

 

$

14,305

 

$

24,366

 

Net Cash - Investing Activities

 

$

(44,113

)

$

(21,390

)

$

(15,542

)

$

(18,411

)

$

(10,807

)

Net Cash - Financing Activities

 

$

19,260

 

$

(29,056

)

$

(11,170

)

$

5,790

 

$

(9,260

)

 

 

 

As of October 31,

 

 

 

2013

 

2012

 

2011

 

2010

 

2009

 

Balance Sheet Data:

 

 

 

 

 

 

 

 

 

 

 

Total Assets

 

$

421,528

 

$

312,347

 

$

283,259

 

$

244,131

 

$

197,390

 

Total Long-Term Liabilities

 

$

14,382

 

$

13,626

 

$

10,978

 

$

8,405

 

$

8,378

 

Total Liabilities

 

$

149,934

 

$

85,100

 

$

93,492

 

$

91,743

 

$

72,867

 

Working Capital

 

$

161,116

 

$

151,625

 

$

124,266

 

$

89,459

 

$

75,984

 

Shareholder’s Equity

 

$

271,594

 

$

227,247

 

$

189,767

 

$

152,388

 

$

124,523

 

 

Item 7. -  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

You are encouraged to read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements and related footnotes included at the end of this Annual Report.  This discussion and analysis contains forward-looking statements that involve risks and uncertainties.  See “Risk Factors” included elsewhere in this Annual Report for a discussion of some of the important factors that could cause actual results to differ materially from those described or implied by the forward-looking statements contained in the following discussion and analysis.  See “Special Note Regarding Forward-Looking Statements” included elsewhere in this Annual Report.

 

All amounts are presented in thousands, except share and per share amounts and per patient data.

 

21


Table of Contents

 

Overview

 

We are a national clinical diagnostic laboratory located in northeastern New Jersey. We are a national laboratory in certain focused areas of laboratory testing and a full service laboratory in the New York super-region. We have developed a national reputation for our expertise in certain focused areas of clinical testing. GenPath, the name by which we are known for our cancer and oncology services, is recognized for the superior hematopathology services it provides throughout the country. Our Women’s Health initiative, through which we provide dedicated services for obstetrics and gynecology practices, including a unique, technically advanced multiplex process for identifying sexually transmitted infections, is also offered as GenPath.  Our regional footprint lays within the New York City metropolitan area and the surrounding areas of New Jersey and southern New York State as well eastern Pennsylvania and some areas of western Connecticut; we also provide services further into New York State, Pennsylvania, Delaware and Maryland. As a regional provider, we are a full-service laboratory that primarily services physician office practices; our drivers pick up samples and deliver reports and supplies, we provide sophisticated technical support, phlebotomy services or patient service centers where appropriate, and electronic communication services in many cases.  Physicians outside of our regional footprint send samples to our laboratory in order to take advantage of the expertise that we are able to provide in blood-based cancer pathology and associated diagnostics or to take advantage of the superior service, support and technologically advanced testing we offer in our Women’s Health initiative. These accounts frequently send routine testing to us for processing along with specialized testing in order to simplify their diagnostic ordering and review procedures and to take advantage of our outstanding capability, service and support.  Our correctional healthcare services are used throughout the country at prisons and jails. The focused markets we serve on a national basis outside of our regional footprint do not require many of the logistical and other ancillary support services required within the region. Even within our regional footprint, we provide the same services that we provide on a national basis as well as some regional focused diagnostic services, such as histology and pathology support services, substance abuse testing, fertility testing, hemostasis testing, women’s health testing, and molecular diagnostics that are unavailable from many of the smaller regional competitors; testing in some of these areas may be provided outside of physician offices.  In October 2012, we launched Laboratorio Buena Salud, the first national testing laboratory dedicated to serving Spanish-speaking populations in the United States.  All business will be conducted in Spanish, including patient and physician interactions.

 

Over the last few years, there have been fundamental changes in the laboratory services industry. In the 1990s, the industry was negatively impacted by the growth of managed care, increased government regulation, and investigations into fraud and abuse. These factors led to revenue and profit declines and industry consolidations, especially among commercial laboratories. There are currently only three US publicly traded full service laboratories operating primarily in the U.S. While that means that the two national mega-laboratories and Bio-Reference Laboratories are the only remaining publicly traded full service commercial laboratories, there are numerous hospital outreach programs and smaller reference laboratories that compete for the commercial clinical laboratory business scattered throughout the country. Clinical laboratories have had to improve efficiency, leverage economies of scale, comply with government regulations and other laws and develop more profitable approaches to pricing. Moreover, there has been a proliferation of technology advancements in clinical diagnostics over the last decade that has created significant opportunities for new testing and growth.

 

As a full service clinical laboratory, we are constantly looking for new technologies and new methodologies that will help us to grow. Since the turn of the century, our size alone has made us attractive to companies that are driving the advances in technology. We represent a significant opportunity for these companies to market their products with a nationally recognized specialty provider in our focused areas of specialty or in one of the major population centers of the world—the New York Metropolitan area. We have had several successful strategic relationships with such technology opportunities. In addition to new technology opportunities, we have an extremely seasoned and talented management staff that has been able to identify emerging laboratory markets that are under-served or under-utilized. We have recently developed programs for cardiology, histology and women’s health to go along with our existing hemostasis, hematopathology and correctional healthcare initiatives which have already been established and in which we have been increasing our market share for the past several years. We are currently preparing to launch a comprehensive pre-natal program to leverage our presence in the women’s health environment and we will continue to vigilantly seek focused diagnostic marketing opportunities where we can provide information, technology, service or support that expand and grow our clinical laboratory.

 

On December 21, 2012, the Company entered into an agreement with Meridian Clinical Laboratory Corporation, a Florida corporation having its place of business in Miami, Florida (“Meridian”), pursuant to which the Company purchased all issued and outstanding common stock of Meridian for approximately $1,848 of which $250 is deferred for one year.

 

On December 31, 2012, Bio-Reference Laboratories, Inc. (the “Company”) entered into an agreement with Florida Clinical Laboratory, Inc., a Florida corporation having its place of business in Melbourne, Florida (“FCL”), pursuant to which the Company purchased all issued and outstanding shares of capital stock of FCL for approximately $7,016, of which $1,000 is deferred for eighteen months assuming certain conditions are met.

 

On August 7, 2013 the Company purchased substantially all of the operating assets and certain of the operating liabilities of Hunter Laboratories, Inc., (“Hunter”) a California corporation having its principal place of business in Campbell, California.  The gross purchase price was $15,215 plus payroll adjustment of $111 totaling $15,326.  Of that amount $3,000 was deferred to cover anticipated pre closing liabilities.

 

On August 20, 2013 the Company through its subsidiary GeneDx, Inc.  purchased the entire membership interest in Edge BioServ, LLC, (“Edge Bio”) a Delaware limited liability company having its place of business in Gaithersburg, Maryland.  The gross purchase price was approximately $2,502.  Of that $375 was deferred to cover anticipated pre closing liabilities.

 

While we recognize that we are a clinical laboratory that processes samples, we also understand that we are an information company that needs to effectively communicate the results of our efforts back to healthcare providers. Laboratory results play a major role in the implementation of physician healthcare. Laboratory results are used to diagnose, monitor and classify health concerns. In many cases, laboratory results represent the confirming data in diagnosing complicated health issues. Since laboratory results play such an important role in routine physician care, we have developed informatics solutions that leverage our role in healthcare. We built a web-based solution to quickly, accurately, conveniently and competitively collect ordering information and deliver results.  That solution is called CareEvolve.  CareEvolve has been essential to our own operations. We license the technology to other laboratories throughout the country that they utilize to more effectively compete against the national laboratories. These other laboratories licensing our technology are typically not our competitors since they are outside our regional footprint.

 

                We have also created our PSIMedica business unit that has developed a Clinical Knowledge Management (CKM) System that takes data from enrollment, claims, pharmacy, laboratory results and any other available electronic source to provide both administrative and clinical analysis of a population. The system uses proprietary algorithms to cleanse and configure the data and transfer the resulting information into a healthcare data repository. Using advanced cube technology methodologies, the data can be analyzed from a myriad of views and from highly granular transactional detail to global trended overview. Events such as the Katrina disaster in Louisiana and general pressures from the government have made development of an electronic medical record system and Pay-for Performance reimbursement priority goals in the healthcare industry. A large portion of an individual’s medical record consists of laboratory data and a key performance indicator in any Pay-for-Performance initiative is laboratory result data. Our CKM system is a mature, full functioning solution that will allow us to play a role in these important national initiatives.

 

To date, neither our PSIMedica business unit nor CareEvolve has produced significant revenues relative to the primary laboratory operations.

 

22


Table of Contents

 

Results of Operations

 

All comparisons to prior periods are adjusted in accordance with the Accounting Standards Update 2011-7 under Topic 954 of FASB codification.

 

Fiscal Year 2013 Compared to Fiscal Year 2012

 

NET REVENUES:

 

Net revenues for the year ended October 31, 2013 were $715,354 as compared to $614,255 for the year ended October 31, 2012; this represents a 16% increase in net revenues. This increase is due to a 10% increase in patients serviced and a 6% increase in net revenue per patient. Our laboratory operations had net revenues of $709,592 in fiscal 2013 and $609,763 in fiscal 2012.

 

The number of patients serviced during the year ended October 31, 2013 was 8,549, which was 10% greater when compared to the prior fiscal year.  Net revenue per patient for the year ended October 31, 2013 was $83.00 compared to net revenue per patient for the year ended October 31, 2012 of $78.16, an increase of 6% as a result of increases in esoteric testing.

 

Despite continued strong volume growth, the Company believes there is an ongoing recalibration of reimbursement for the industry, which has resulted in substantial downward pressure from many payers regarding reimbursement in FY13.  Over the past year, the Company has had to negotiate contract modifications to reimbursement rates, conditions of payment and / or eligibility with dozens of health plans representing a substantial numbers of lives nationwide; most of these changes became effective toward the end of FY13 and especially in Q4FY13.

 

Our revenues and patient counts could be adversely affected by a number of factors, including, but not limited, to an extended economic downturn in general or healthcare economic conditions, an unexpected reduction in reimbursement rates, increased market penetration by our competitors or a substantial adverse change in federal regulatory requirements governing our industry as well as a failure to continue the sizeable annual percentage increase in base business from significantly higher levels after 19  years of sustained growth.

 

COST OF SERVICES:

 

Cost of services for the year ended October 31, 2013 was $392,815 as compared to $337,644 for the year ended October 31, 2012, an increase of 16% as compared to a 16% increase in net revenues.  This is basically in line with the increase in our net revenues.

 

GROSS PROFIT:

 

Gross profit on net revenues increased to $322,539 for the year ended October 31, 2013 from $276,611 for the year ended October 31, 2012; an increase of $45,928 (17%), primarily attributable to the increase in net revenues. Gross profit margins remained consistent at 45% from fiscal 2012 to fiscal 2013.

 

GENERAL AND ADMINISTRATIVE EXPENSES:

 

General and administrative expenses for the year ended October 31, 2013 were $240,566 as compared to $200,480 for the year ended October 31, 2012, an increase of $40,086 or 20%.  This increase is slightly more than the increase in net revenues due to additional bad debt expenses the Company recorded as the result of the ongoing reimbursement changes in the marketplace.  We expect this trend to continue in the near future.

 

INTEREST EXPENSE:

 

Interest expense increased from $1,455 during the year ended October 31, 2012 to $1,606 during the year ended October 31, 2013; an increase of $151 or 10%. This increase is due to an increase in utilization of the PNC Bank line of credit.  Management believes that this trend will continue in the near term.

 

NET INCOME:

 

We realized net income of $45,825 for the twelve month period ended October 31, 2013 as compared to $42,156 for the twelve month period ended October 31, 2012, an increase of 9%.

 

Pre-tax income for the period ended October 31, 2013 was $81,097, as compared to $74,516 for the period ended October 31, 2012, an increase of $6,581 (9%) and was caused primarily by an increase in net revenues.  The provision for income taxes increased from $32,360 for the period ended October 31, 2012, to $35,272 (9%) for the current twelve month period.

 

During this fiscal year the Company received a refund of $1,062 for its New York State clinical laboratory inspection fee that was included in other income.

 

Our diluted net income per share went from $1.51 in fiscal 2012 to $1.65 in fiscal 2013.

 

Fiscal Year 2012 Compared to Fiscal Year 2011

 

NET REVENUES:

 

Net revenues for the year ended October 31, 2012 were $614,255 as compared to $522,081 for the year ended October 31, 2011; this represents an 18% increase in net revenues. This increase is due to a 16% increase in patients serviced and a 2% increase in net revenue per patient. Our laboratory operations had net revenues of $609,763 in fiscal 2012 and $517,721 in fiscal 2011.

 

The number of patients serviced during the year ended October 31, 2012 was 7,801, which was 16% greater when compared to the prior fiscal year.  Net revenue per patient for the year ended October 31, 2012 was $78.16 compared to net revenue per patient for the year ended October 31, 2011 of $76.82, an increase of 2% as a result of increases in esoteric testing.

 

During the fiscal year ended October 31, 2012, we increased our sales force by approximately 12%, mostly in the specialty testing services that we market nationally. We believe that this increase in sales personnel accounted for a majority of the 16% increase in our patient volume. This allowed us to expand or increase our presence in a number of markets and we expect this trend to continue.

 

While there is always uncertainty as to the sustainability of such growth in the future, we believe that our historical performance of 20% compound annual growth rate for the past 18 years, the current demand for our services and our continued corporate focus on strategic

 

23


Table of Contents

 

growth, together with our expertise in the industry, should enable us to sustain continued strong growth in the near term.  Going beyond that, however, our revenues and patient counts could be adversely affected by a number of factors including, but not limited to an extended downturn in general or healthcare economic conditions, an unexpected reduction in reimbursement rates, increased market penetration by our competitors, or a substantial adverse change in federal regulatory requirements governing our industry as well as a failure to continue the sizeable annual percentage increase in base business from significantly higher levels after 17 years of sustained growth.

 

Our net revenues for the fourth quarter of fiscal 2012 and cumulative results for the fiscal 2012 as well as operating results during the first quarter of fiscal 2013 have been affected by the adverse weather conditions associated with the hurricane Sandy.  Based on actual revenues and expenses from the period immediately preceding the storm as well as the analysis of the period following the storm, management has calculated the damage from, the hurricane Sandy resulted in a loss of net revenues of approximately $5,000 for the fourth quarter of fiscal 2012 and approximately $3,000 for the first quarter of fiscal 2013.

 

COST OF SERVICES:

 

Cost of services for the year ended October 31, 2012 was $337,644 as compared to $287,853 for the year ended October 31, 2011, an increase of 17% as compared to an 18% increase in net revenues.  The Company’s medical supplies expense increased by 34% due to the higher cost of specialty testing supplies.  Our medical equipment repair costs increased by 26% year over year due to higher equipment utilization rate.  We expect these trends to continue.

 

GROSS PROFIT:

 

Gross profit on net revenues increased to $276,611 for the year ended October 31, 2012 from $234,229  for the year ended October 31, 2011; an increase of $42,382 (18%), primarily attributable to the increase in net revenues. Gross profit margins remained consistent at a rate of 45% from fiscal 2011 to fiscal 2012.

 

GENERAL AND ADMINISTRATIVE EXPENSES:

 

General and administrative expenses for the year ended October 31, 2012 were $200,480 as compared to $174,454 for the year ended October 31, 2011, an increase of $26,026 or 15%.  This is basically in line with the increase in net revenues.  We expect this trend to continue in the near future.

 

INTEREST EXPENSE:

 

Interest expense decreased from $1,747 during the year ended October 31, 2011 to $1,455 during the year ended October 31, 2012; a decrease of $292 or 17%. This decrease is due to a decrease in utilization of the PNC Bank line of credit.  Management believes that this trend will continue in the near term due to the decrease in utilization of this credit facility.

 

NET INCOME:

 

We realized net income of $42,156 for the twelve month period ended October 31, 2012 as compared to $36,359 for the twelve month period ended October 31, 2011, an increase of 16%.

 

Pre-tax income for the period ended October 31, 2012 was $74,516, as compared to $64,846 for the period ended October 31, 2011, an increase of $9,670 (15%) and was caused primarily by an increase in net revenues.  The provision for income taxes increased from $28,487 for the period ended October 31, 2011, to $32,360 (14%) for the current twelve month period.

 

Our diluted net income per share went from $1.29 in fiscal 2011 to $1.51 in fiscal 2012.

 

Our operating results for the fourth quarter of fiscal 2012 and cumulative results for the fiscal 2012 as well as operating results during the first quarter of fiscal 2013 have been affected by hurricane Sandy.  Based on actual revenues and expenses from the period immediately preceding the storm as well as the analysis of the period following the storm, Management has calculated the damage from the storm resulted in a loss of earnings approximately $0.06 per share for the fourth quarter of fiscal 2012 and approximately $0.03 per share for the first quarter of fiscal 2013.

 

Liquidity and Capital Resources

 

Our working capital at October 31, 2013 was approximately $161,116 as compared to approximately $151,625 at October 31, 2012, an increase of $9,491 (6%). Our cash position decreased by approximately $7,191 during the current twelve month period. We increased our short term borrowing by approximately $26,139 and decreased our long term debt by approximately $435.  We had current liabilities of approximately $133,762 at October 31, 2013. We generated approximately $17,662 in cash from operations, a decrease of approximately $35,436 as compared to the year ended October 31, 2012.

 

The decrease is primarily due to slower cash collections. These slower collections are, in the opinion of management, attributable first in part to the expired “grandfather” provision, a rule that allowed us to bill Medicare directly for in hospital laboratory work that was performed on Medicare patients even though the patient was in the hospital at the time the service was rendered. This exemption expired at the end of 2012 and starting in 2013 we were required to bill the hospital directly for such laboratory work instead of billing Medicare for it. As a consequence of this change collection cycle has increased and in some cases prices may have decreased. The second reason for slower collection, in our opinion, involves changes in the molecular coding around the country by Medicare and in some cases Medicaid, who have simply stopped paying at all for these molecular tests. These reimbursement levels are set my CMS. With regard to payments by Medicare, there still remain many of these tests whose reimbursement has not been determined by the carrier. Another reason for slower collections is the change in the Blue Cross Blue Shield (“BCBS”) reimbursement practices whereby instead of billing BCBS for all of the laboratory services preformed nationwide on one bill we are now required to bill each local BCBS only for the services preformed based on the location where a patient’s sample was drawn. This new practice, also effective in 2013, significantly increased the complexity of our BCBS billing and collection processes. In many cases billings were delayed for some time until prices were loaded in the various systems around the country. Lastly, slower collections occurred due to a dispute with Horizon Blue Cross Blue Shield of New Jersey (“Horizon BCBSNJ”) concerning Horizon BCBSNJ’s obligation to pay Bio-Reference with respect to certain of its insurance plans.  Please see “Legal Proceedings” above.  .

 

Accounts receivable, net of allowance for doubtful accounts, totaled approximately $206,261 at October 31, 2013, an increase of approximately $53,014 from October 31, 2012, or 35%. This increase was primarily attributable to increased revenue and slowdown in the collection cycle.  Cash collected over the twelve month period ended October 31, 2013 increased 11% over the prior twelve month period.

 

24


Table of Contents

 

Net service revenues on the statements of operations are as follows:

 

 

 

($)

 

 

 

Year Ended

 

 

 

October 31,

 

 

 

2013

 

2012

 

2011

 

Gross Service Revenues

 

3,524,108

 

3,052,431

 

2,482,349

 

 

 

 

 

 

 

 

 

Contractual Adjustments and Discounts:

 

 

 

 

 

 

 

Medicare/Medicaid Portion

 

354,638

 

320,697

 

293,874

 

All Other Third Party Payors*

 

2,393,872

 

2,070,073

 

1,629,833

 

Total Contractual Adjustments and Discounts

 

2,748,510

 

2,390,770

 

1,923,707

 

Service Revenues Net of Contractual Adjustments and Discounts

 

775,598

 

661,661

 

558,642

 

Patient Service Revenue Provision for Bad Debts**

 

60,244

 

47,406

 

36,561

 

Net Revenues

 

715,354

 

614,255

 

522,081

 

 

 

 

 

 

 

 

 

Percent of Contractual Allowances, Discounts and Patient Service Provision for Bad Debts to Gross Revenue.

 

79.7

%

79.9

%

79.0

%

 

* All Other Third Party and Direct Payors consists of almost eight hundred distinct payors, including commercial health insurers and administrators as well as professionally billed accounts such as physicians, hospitals, clinics and other direct billed accounts.

** Represents the amount of Bad Debt Expense that is now required to be presented as a deduction from patient service revenue (net of contractual allowances and discounts) pursuant to ASU No. 2011-7.

 

Credit risk with respect to accounts receivable is generally diversified due to the large number of patients comprising our client base.  We have significant receivable balances with government payors and various insurance carriers.  Generally, we do not require collateral or other security to support customer receivables. However, we continually monitor and evaluate our client acceptance and collection procedures to minimize potential credit risks associated with our accounts receivable and to establish an allowance for uncollectible accounts. As a consequence, we believe that our accounts receivable credit risk exposure beyond such allowance is not material to the financial statements.

 

A number of proposals for legislation continue to be under discussion which could substantially reduce Medicare and Medicaid (CMS) reimbursements to clinical laboratories.  Depending upon the nature of regulatory action, and the content of legislation, we could experience a significant decrease in revenues from Medicare and Medicaid (CMS), which could have a material adverse effect on us. We are unable to predict, however, the extent to which such actions will be taken.

 

25


Table of Contents

 

LABORATORY GROSS RECEIVABLES BY PAYOR GROUP

 

 

 

 

 

 

 

 

 

 

 

($)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FY 2013

 

 

 

 

 

 

 

 

 

 

 

 

 

30 Days

 

%

 

60 Days

 

%

 

90 Days

 

%

 

>90 Days

 

%

 

Total

 

%

 

Self Pay

 

12,723

 

18

%

12,934

 

18

%

11,244

 

15

%

35,367

 

49

%

72,269

 

100

%

Medicare

 

35,783

 

45

%

12,801

 

16

%

4,732

 

6

%

25,841

 

33

%

79,158

 

100

%

Medicaid

 

5,625

 

20

%

4,377

 

15

%

4,321

 

15

%

14,145

 

50

%

28,469

 

100

%

Pro Bill

 

16,103

 

51

%

6,162

 

20

%

3,085

 

10

%

6,140

 

19

%

31,491

 

100

%

Commercial Insurance

 

196,097

 

46

%

59,571

 

14

%

33,559

 

8

%

137,204

 

32

%

426,432

 

100

%

Total

 

266,332

 

42

%

95,847

 

15

%

56,942

 

9

%

218,698

 

34

%

637,819

 

100

%

 

 

 

($)
FY 2012

 

 

 

30 DAYS

 

%

 

60 DAYS

 

%

 

90 DAYS

 

%

 

>90 DAYS

 

%

 

TOTAL

 

%

 

Self Pay

 

9,620

 

18

%

10,633

 

20

%

9,474

 

18

%

24,202

 

44

%

53,929

 

100

%

Medicare

 

25,898

 

56

%

6,550

 

14

%

2,992

 

6

%

11,186

 

24

%

46,626

 

100

%

Medicaid

 

4,881

 

23

%

3,804

 

18

%

3,829

 

18

%

8,714

 

41

%

21,228

 

100

%

Pro Bill

 

17,697

 

64

%

4,706

 

17

%

1,771

 

6

%

3,657

 

13

%

27,832

 

100

%

Commercial Insurance

 

154,294

 

47

%

53,097

 

17

%

24,752

 

8

%

88,747

 

28

%

320,889

 

100

%

Total

 

212,390

 

45

%

78,790

 

17

%

42,818

 

9

%

136,507

 

29

%

470,505

 

100

%

 

Billing for laboratory services is complicated and we must bill various payors, such as the individual, the insurance company, the government (federal or state), the private company or the health clinic. Other factors that may complicate billing include:

 

Differences between fee schedules and reimbursement rates;

Incomplete or inaccurate billing information as provided by the physician;

Disparity in coverage and information requirements;

Disputes with payors; and

Internal and external compliance policies and procedures.

 

Significant costs are incurred as a result of our participation in government programs since billing and reimbursement for laboratory tests are subject to complex regulations. We perform the requested tests and report the results whether the information is correct or not or even missing. This adds to the complexity and slows the collection process and increases the aging of our accounts receivable (“A/R”). When patient invoices are not collected in a timely manner the item is written off to the allowance.

 

Days Sales Outstanding (“DSO”) for fiscal years 2012 and 2013 were 86 and 100, respectively, an increase of approximately 16%, computed under the new method taking into account the change in presentation for patient service revenue provision for bad debts.  Depending on the period in question, our actual collections represent between 98% and 102% of our net collectable revenues after giving effect to our DSO lag.

 

Overall, the components of A/R as shown above for the two most recently completed fiscal years under review have not varied much year over year. The percent of A/R over 90 days has increased to 34% as of October 31, 2013 as compared to 29% as of October 31, 2012, an increase of 5%.

 

See Note 5 and Note 6 to our consolidated financial statements for information regarding outstanding loans.

 

See Note 18 to our consolidated financial statements describing our merger and acquisition activities.

 

The weighted average interest rate on short-term borrowings outstanding as of October 31, 2013 was 3.50% and as of October 31, 2012 was approximately 3.25%.

 

We intend to expand our laboratory operations through aggressive marketing an while also attempting to diversify into related medical fields through acquisitions.  These acquisitions may involve cash, notes, Common Stock, and/or combinations thereof.

 

Subsequent to our year end, on December 19, 2013 the Company approved a new stock repurchase program authorizing buyback of up to 2,000,000 shares of Common Stock in the over the counter market at prevailing market prices through October 31, 2015.

 

Contractual Obligations

 

The following table summarizes our significant contractual obligations as of October 31, 2013:

 

 

 

Total

 

FY 2014

 

FY 2015

 

FY 2016

 

FY 2017

 

FY 2018
and thereafter

 

Long-Term Debt

 

4,163

 

486

 

518

 

551

 

585

 

2,023

 

Capital Leases

 

16,846

 

5,622

 

4,630

 

3,727

 

2,192

 

675

 

Operating Leases

 

14,847

 

9,015

 

2,556

 

1,509

 

558

 

1,209

 

Purchase Obligations

 

45,556

 

12,505

 

11,938

 

10,854

 

6,559

 

3,700

 

Long-Term Liabilities under Employment and Consultant Contracts

 

16,860

 

5,169

 

3,873

 

3,657

 

2,918

 

1,243

 

 

26


Table of Contents

 

No one supplier who is counterparty to any particular supply agreement is contracted to provide more than one percent of our Cost of Services in any future period. Such contracts are made in the ordinary course of business. No directors, officers, promoters, voting trustees or individuals known to be Bio-Reference Laboratories, Inc (“BRLI”) security holders are counterparties to these agreements. Management does not believe that BRLI is substantially dependent upon these supply agreements, as the goods may be obtained from different suppliers or wholesalers, if needed. None of these agreements are leases or call for the acquisition or sale of property, plant and equipment.

 

Our cash balances at October 31, 2013 totaled approximately $17,952 as compared to approximately $25,143 at October 31, 2012.  We believe that our cash position, the anticipated cash generated from future operations, and the availability of our credit line with PNC Bank, will meet our anticipated cash needs in fiscal 2014.

 

Off-Balance Sheet Arrangements

 

As of October 31, 2013, we did not have any off-balance sheet items.

 

Impact of Inflation

 

To date, inflation has not had a material effect on our operations.

 

Critical Accounting Policies

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported periods.

 

Accounting for Intangible and Other Long-Lived Assets

 

We evaluate the possible impairment of our long-lived assets, including intangible assets on annual basis or earlier if events or changes in circumstances occur that indicate that the carrying value of the asset(s) may not be recoverable. The Company assessed qualitative factors to determine whether events and circumstances lead to the conclusion that it is necessary to perform the two-step goodwill impairment test have occurred and determined that no such events had occurred.  Under ASU No. 2011-08, entities are not required to calculate the fair value of a reporting unit unless they conclude that it is more likely than not that the unit’s carrying value is greater than its fair value based on an assessment of events and circumstances. The “more likely than not” threshold is when there is a likelihood of more than 50% that a reporting unit’s carrying value is greater than its fair value.  No impairment loss was recognized in the years ended October 31, 2013, 2012 and 2011.

 

Accounting for Revenue

 

Service revenues are principally generated from laboratory testing services including chemical diagnostic tests such as blood analysis, urine analysis and genetic testing among others. Service revenues are recognized at the time the testing services are performed and are reported at their estimated net realizable amounts.

 

Service revenues before provision for bad debts are determined utilizing gross service revenues net of contractual adjustments and discounts. Even though it is the responsibility of the patient to pay for laboratory service bills, most individuals in the United States have an agreement with a third party payor such as Medicare, Medicaid or a commercial insurance provider to pay all or a portion of their healthcare expenses.  The majority of services provided by Bio-Reference Laboratories, Inc. (“BRLI”) are to patients covered under a third party payor contract. In certain cases, the individual has no insurance or does not provide insurance information and in other cases tests are performed under contract to a professional organization (such as physicians, hospitals, and clinics) which reimburse BRLI directly.  In the remainder of the cases, BRLI is provided the third party billing information and seeks payment from the third party under the terms and conditions of the third party payor for health service providers like BRLI. Each of these third party payors may differ not only with regard to rates, but also with regard to terms and conditions of payment and providing coverage (reimbursement) for specific tests. Estimated revenues are established based on a series of highly complex procedures and judgments that require industry specific healthcare experience and an understanding of payor methods and trends. We review our calculations on a monthly basis in order to make certain that we are properly allowing for the uncollectable portion of our gross billings due to the contractual adjustments and discounts and that our estimates remain sensitive to variances and changes within our payor groups. The contractual allowance calculation is made on the basis of historical allowance rates for the various specific payor groups on a monthly basis with a greater weight being given to the most recent trends This process is adjusted based on recent changes in underlying contract provisions and shifts in the testing being performed. This calculation is routinely analyzed by BRLI on the basis of actual allowances issued by payors and the actual payments made to determine what adjustments, if any, are needed. The table below shows the adjustments made to gross service revenues to arrive at net revenues, the amount reported on our statement of operations.

 

 

 

($)

 

 

 

Year Ended

 

 

 

October 31,

 

 

 

2013

 

2012

 

2011

 

Gross Service Revenues

 

3,524,108

 

3,052,431

 

2,482,349

 

 

 

 

 

 

 

 

 

Contractual Adjustments and Discounts:

 

 

 

 

 

 

 

Medicare/Medicaid Portion

 

354,638

 

320,697

 

293,874

 

All Other Third Party Payors*

 

2,393,872

 

2,070,073

 

1,629,833

 

Total Contractual Adjustments and Discounts

 

2,748,510

 

2,390,770

 

1,923,707

 

Service Revenues Net of Contractual Adjustments and Discounts

 

775,598

 

661,661

 

558,642

 

Patient Service Revenue Provision for Bad Debts**

 

60,244

 

47,406

 

36,561

 

Net Revenues

 

715,354

 

614,255

 

522,081

 

 

 

 

 

 

 

 

 

Percent of Contractual Allowances, Discounts and Patient Service Provision for Bad Debts to Gross Revenue.

 

79.7

%

79.9

%

79.0

%

 

27


Table of Contents

 

* All Other Third Party and Direct Payors consists of almost eight hundred distinct payors, including commercial health insurers and administrators as well as professionally billed accounts such as physicians, hospitals, clinics and other direct billed accounts.

** Represents the amount of Bad Debt Expense that is now required to be presented as a deduction from patient service revenue (net of contractual allowances and discounts) pursuant to ASU No. 2011-7.

 

When new business is received by BRLI, service revenues net of contractual adjustments and discounts are calculated by reducing gross service revenues by the estimated contractual allowance. The Patient Service Revenue Provision for Bad Debts represents the amount of bad debt expense expected to occur on patient service revenue based upon our experience. The remaining bad debt expense is presented as part of operating expenses. The bad debt expense presented as part of operating expense represents the bad debt expense related to receivables from service revenues determined after taking into account our ability to collect on such revenue.  BRLI recognized the amounts in subsequent periods for actual allowances/discounts to gross service revenue; bad debt may have been adjusted over the same periods of time to maintain an accurate balance between net revenues and actual revenues. Management has reviewed the allowances/discounts recognized in subsequent periods and believes the amounts to be immaterial. A number of proposals for legislation or regulation continue to be under discussion which could have the effect of substantially reducing Medicare reimbursements for clinical laboratories or introducing cost sharing to beneficiaries. Depending upon the nature of regulatory action, if any, which is taken and the content of legislation, if any, which is adopted, the Company could experience a significant decrease in revenues from Medicare and Medicaid, which could have a material adverse effect on the Company. The Company is unable to predict, however, the extent to which such actions will be taken.

 

Accounting for Contractual Credits and Doubtful Accounts

 

It is typically the responsibility of the patient to pay for laboratory service bills. Most individuals in the United States have an agreement with a third party payor such as Medicare, Medicaid or commercial insurance to pay all or a portion of their healthcare expenses; this represents the major portion of payment for all services provided by BRLI. In certain cases, the individual has no insurance or does not provide insurance information; in the remainder of the cases, BRLI is provided the third party billing information, usually by the referring physician, and seeks payment from the third party under the terms and conditions of the third party payor for health service providers like BRLI. Each of these third party payors may differ not only with regard to rates, but also with regard to terms and conditions of payment and coverage of specific tests. BRLI routinely reviews the reimbursement policies and subsequent payments and collection rates from these different types of payors. Contractual adjustments and discounts are recorded as reductions to gross service revenues and are collectively referred to as the contractual allowance. BRLI has not been required to record an adjustment in a subsequent period related to revenue recorded in a prior period which was material in nature. Aging of accounts receivable is monitored by billing personnel and follow-up activities including collection efforts are conducted as necessary. BRLI writes off receivables against the allowance for doubtful accounts when they are deemed uncollectible. For client billing, accounts are written off when all reasonable collection efforts prove to be unsuccessful. Patient accounts, where the patient is directly responsible for all or a remainder portion of the account after partial payment or denial by a third party payor, are written off after the normal dunning cycle has occurred, although these may be subsequently transferred to a third party collection agency after being written off. Third party payor accounts are written off when they exceed the payer’s timely filing limits. Accounts Receivable on the balance sheet is net of the following amounts for contractual credits and doubtful accounts:

 

 

 

($)

 

 

 

October 31,

 

October 31,

 

 

 

2013

 

2012

 

 

 

 

 

 

 

Contractual Credits/Discounts

 

342,297

 

267,921

 

Doubtful Accounts

 

89,261

 

51,274

 

Total Allowance

 

431,558

 

319,195

 

 

Accounting for Employee Benefit Plans

 

See Note 21 to our consolidated financial statements for a discussion on Employee Benefit Plans.

 

New Authoritative Pronouncements

 

See Note 22 to our consolidated financial statement that discusses new authoritative pronouncements.

 

Item 7A. - Quantitative and Qualitative Disclosures about Market Risk

 

We do not invest in or trade instruments which are sensitive to market risk. We also do not have any material foreign operations or foreign sales so we have no exposure to foreign currency exchange rate risk.

 

We do have exposure to both rising and falling interest rates. At October 31, 2013, advances of approximately $26,139under our Loan Agreement with PNC Bank were subject to interest charges at the bank’s then prime rate of 3.50 %.

 

We estimate that our monthly cash interest expense at October 31, 2013 was approximately $143and that a one percentage point increase or decrease in short-term rates would increase or decrease our monthly interest expense by approximately $22.  However we expect to utilize the credit line in the future and we thus expect exposure to short term interest rates changes that will depend on the utilization rate at the time.

 

See Note 5 and Note 6 to the Consolidated Financial Statements contained herein for information on our loans.

 

Item 8. -  Financial Statements and Supplementary Data

 

Financial Statements are annexed hereto.

 

28


Table of Contents

 

Item 9. -  Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

None

 

Item 9A. -  Controls and Procedures

 

(a)         Evaluation of Disclosure Controls and Procedures

 

An evaluation was performed under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer as to the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Based on that evaluation, the principal executive officer and the principal financial officer of the Company have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective at a reasonable assurance level.

 

(b)         Management’s Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America. Internal control over financial reporting includes those policies and procedures that:

 

(i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;

 

(ii) provide reasonable assurance that the transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with the authorization of management and/or our Board of Directors; and

 

(iii) provide reasonable assurance regarding the prevention or timely detection of any unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.

 

Due to its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate due to changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework published in 1992. Based on its evaluation, our management concluded that our internal control over financial reporting was effective as of the end of the period covered by this Annual Report on Form 10-K.

 

MSPC, Certified Public Accountants and Advisors, A Professional Corporation, an independent registered public accounting firm, has audited the Consolidated Financial Statements included in this Annual Report on Form l0-K and, as part of their audit, has issued its attestation report, included herein, on the effectiveness of our internal control over financial reporting. See “Report of Independent Registered Public Accounting Firm” included in this filling.

 

(c)          Changes in Internal Control over Financial Reporting

 

There has been no change in our internal control over financial reporting that occurred during the fourth quarter of fiscal 2013 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

Item 9B. -  Other Information

 

None.

 

29


Table of Contents

 

PART III

 

Item 10. - Directors, Executive Officers and Corporate Governance

 

Executive Officers and Directors

 

The following table sets forth certain information with respect to each of our directors and executive officers.

 

Name

 

Age

 

Position

 

 

 

 

 

Marc D. Grodman, M.D

 

62

 

Chairman of the Board, President, Chief Executive Officer and Director

 

 

 

 

 

Howard Dubinett

 

62

 

Executive Vice President, Chief Operating Officer and Director

 

 

 

 

 

Sam Singer

 

70

 

Senior Vice President, Chief Financial Officer, Chief Accounting Officer and Director

 

 

 

 

 

Joseph Benincasa(a)(c)(e)

 

64

 

Director

 

 

 

 

 

Harry Elias(a)(c)(e)

 

83

 

Director

 

 

 

 

 

Gary Lederman, Esq. (b)(c)(e)

 

79

 

Director

 

 

 

 

 

John Roglieri, M.D. (a)(d)(e)

 

74

 

Director

 

(a)         Member of the Audit Committee

(b)         Chairman of the Audit Committee

(c)          Member of the Compensation Committee

(d)         Chairman of the Compensation Committee

(e)          Member of Nominating Committee

 

Marc D. Grodman, M.D. founded the Company in December 1981 and has been our Chairman of the Board, President, Chief Executive Officer and a director since our formation. Dr. Grodman is an Assistant Professor of Clinical Medicine at Columbia University’s College of Physicians and Surgeons and Assistant Attending Physician at Presbyterian Hospital, New York City. Since January 2005, Dr. Grodman has been a member of the board of directors, served as Chairman and currently serves as Vice Chairman of the American Clinical Laboratory Association, an industry organization comprised of the largest and most significant commercial clinical laboratories in the United States. From 1980 to 1983, Dr. Grodman attended the Kennedy School of Government at Harvard University and was a Primary Care Clinical Fellow at Massachusetts General Hospital. From 1982 to 1984, he was a medical consultant to the Metal Trades Department of the AFL-CIO. Dr. Grodman received a B.A. degree from the University of Pennsylvania in 1973 and an M.D. degree from Columbia University’s College of Physicians and Surgeons in 1977.  Except for his part-time duties as Assistant Professor of Clinical Medicine and Assistant Attending Physician at Columbia University and Presbyterian Hospital, Dr. Grodman devotes all of his working time to our business.  We believe that Dr. Grodman is qualified to serve on our board of directors because of his extensive medical expertise, his experience on the faculty at Columbia University College of Physicians and Surgeons, his leadership role in our industry and his knowledge of trends in the healthcare industry.

 

Howard Dubinett has been our Executive Vice-President and Chief Operating Officer of the Company since our formation in 1981. He became a director in April 1986. Mr. Dubinett attended Rutgers University. We believe that Mr. Dubinett is qualified to serve on our board of directors because of his extensive knowledge of and experience in our business and his knowledge of healthcare regulation.

 

Sam Singer has been our Chief Financial Officer since October 1987, a director since November 1989, and a Senior Vice President since 2007.  Mr. Singer was the Controller for Sycomm Systems Corporation, a data processing and management consulting company, from 1981 to 1987, prior to joining us.  Mr. Singer also serves on the boards of several not-for-profit institutions. He received a B.A. degree from Strayer University and an M.B.A. from Rutgers University.  We believe that Mr. Singer is qualified to serve on our board of directors because of his extensive experience in financial matters, including financial reporting, and his experience with our business gained through his tenure as our Chief Financial Officer.

 

Joseph Benincasa joined our board of directors in June 2005. Mr. Benincasa currently serves as the executive director of The Actors’ Fund of America, a position he has held since 1989. The Actors’ Fund is the leading national, non-profit human services organization providing comprehensive social and health care services, employment, training and housing support to the entertainment profession. For six years, from 2000 to 2006, Mr. Benincasa served as a director of St. Peter’s University Medical Center, a major hospital in northern New Jersey. He also sits on the board of directors of Broadway Cares/Equity Fights AIDS; the National Theatre Workshop of the Handicapped; Career Transition for Dancers; the Times Square Alliance; the New York Society of Association Executives and the Somerset Patriots, a minor league baseball team. Mr. Benincasa holds a B.A. degree from St. Joseph’s University, an M. Ed. Degree from Rutgers University and also attended the Fordham University Graduate School of Business. We believe that Mr. Benincasa is qualified to serve on our board of directors because of his familiarity with healthcare issues gained through his board service at St. Peter’s University Medical Center and his extensive experience with administrative matters.

 

Harry Elias became a member of the board of directors in March 2004. Mr. Elias commenced his employment in sales and marketing with JVC Company of America (“JVC”), a distributor of audio and video products, in 1967, subsequently being appointed as JVC’s Senior Vice President of Sales and Marketing in 1983 and as Executive Vice President of Sales and Marketing in 1990. In 1995, Mr. Elias was named as JVC’s Chief Operating Officer, a position he occupied until April 2003 when he resigned his positions upon his appointment as JVC’s “Honorable Chairman.” In January 2005, after retiring from JVC, Mr. Elias was appointed Chairman of the Board of and commenced to serve as a consultant to AKAI USA, the sole distributor in the United States of electronic products produced by AKAI, a Chinese manufacturer. Mr. Elias retired from AKAI in 2007 and currently is self-employed as a business consultant. We believe that Mr. Elias is qualified to serve on our board of directors because of the experience and skills he gained in running a large business operation.

 

Gary Lederman, Esq. became a member of our board of directors in May 1997. He received his B.A. degree from Brooklyn College in 1954 and his J.D. degree from NYU Law School in 1957.  He was manager of Locals 370, 491 and 662 of the U.F.C.W. International Union from 1961 to 1985.. During the 1970s, Mr. Lederman also served as a member of the New York Attorney General’s Consumer Fraud Advisory Committee. He is retired from the unions and has been a lecturer at Queensboro Community College in the field of insurance.  He served on an institutional review board for RTL, a pharmaceutical drug testing laboratory until his retirement in February 2007. We believe that Mr. Lederman

 

30


Table of Contents

 

is qualified to serve on our board of directors as a result of his legal expertise, his union manager experience and responsibilities and his experience with RTL, including his involvement with health and welfare funds and his familiarity with consumer regulation and the activities of pharmaceutical companies.

 

John Roglieri, M.D. became a member of our board of directors in September 1995.  He is an Assistant Professor of Clinical Medicine at Columbia University’s College of Physicians and Surgeons and an Assistant Attending Physician at Presbyterian Hospital, New York City.  Dr. Roglieri received a B.S. degree in Chemical Engineering and a B.A. degree in Applied Sciences from Lehigh University in 1960, an M.D. degree from Harvard Medical School in 1966, and a Masters degree from Columbia University’s School of Business in 1978.  From 1969 until 1971, he was a Senior Assistant Surgeon in the U.S. Public Health Service in Washington, D.C.  From 1971 until 1973 he was a Clinical and Research Fellow at Massachusetts General Hospital.  From 1973 until 1975, he was director of the Robert Wood Johnson Clinical Scholars program at Columbia University.  In 1975 he was appointed Vice-President, Ambulatory Services at Presbyterian Hospital, a position which he held until 1980.  Since 1980, he has maintained a private practice of internal medicine at Columbia-Presbyterian Medical Center.  From 1988 until 1992, he was also director of the Employee Health Service at Presbyterian Hospital. From 1992 through 1999, Dr. Roglieri was the corporate medical director of NYLCare, a managed care subsidiary of New York Life Insurance Company. Dr. Roglieri was chief medical officer of Physician WebLink, a national physician practice management company, from 1999 to 2000. Since 2001, he has been a medical director for New York Life in Manhattan. He is a member of advisory boards to several pharmaceutical companies, a member of the Editorial Advisory Board of the journals Managed Care and Seminars in Medical Practice. We believe that Dr. Roglieri is qualified to serve on our board of directors due to his extensive medical background, his role as director of the Employee Health service at Presbyterian Hospital, his role as corporate medical director of a managed care organization and the skill and expertise gained through his many other activities.

 

There are no family relationships between or among any directors or executive officers of Bio-Reference Laboratories.

 

Director Independence

 

Our board of directors has determined that each of Messrs. Benincasa, Elias and Lederman and Dr. Roglieri are independent within the applicable rules of the SEC and the NASDAQ Stock Market, and that each of them is also an independent director under Rule 10A-3 of the Exchange Act for the purpose of audit committee membership.

 

Audit Committee

 

We have a separately-designated standing Audit Committee established in accordance with Section 3(a)(58)(A) of the Exchange Act and the Nasadq Listing Rules.  The Audit Committee is comprised of Gary Lederman (Chairman), Joseph Benincasa, Harry Elias and John Roglieri. Our Board has determined that Mr. Lederman is an audit committee financial expert within the meaning of the applicable rules of the SEC and the NASDAQ Stock Market.

 

Code of Ethics

 

Our Code of Ethics is applicable to our senior management, as well as our key financial and accounting personnel. It has been designed to deter wrongdoing and to promote:

 

honest and ethical conduct including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

full, fair, accurate, timely and understandable disclosure in our public communications and reports filed with the SEC;

compliance with applicable governmental laws, rules and regulations;

prompt internal reporting of violations of the Code to an appropriate person or persons identified in the Code; and

accountability to ensure adherence to the Code.

 

The Code requires each covered person to deal ethically and honestly with the company and to avoid business, financial or other direct or indirect interests or relationships that conflict with those of the company or divide the covered person’s loyalty to the company. Each covered person is required to sign an attestation of compliance with the Code at the end of each fiscal year.

 

The Code of Ethics is available on our internet Web site (www.bioreference.com) and will be provided in print without charge to any stockholder who submits a request in writing to Bio-Reference Laboratories, Inc. Investor Relations, 481 Edward H. Ross Drive, Elmwood Park, New Jersey 07407. Any amendment to and waivers from the Code of Ethics with respect to the Company’s Chief Executive Officer or Chief Financial Officer will be posted on the Company’s Web site.

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

Based solely on a review of Forms 3 and 4 and any amendments thereto furnished to us pursuant to Rule 16a-3(e) under the Exchange Act, or representations that no Forms 5 were required, we believe that with respect to fiscal 2013, our officers, directors and beneficial owners of more than 10% of our equity timely complied with all applicable Section 16(a) filing requirements.

 

31


Table of Contents

 

Item 11. — Executive Compensation

 

The table below summarizes the total compensation paid or accrued by us with respect to the fiscal years ended October 31, 2011, 2012 and 2013 to our named executive officers (“NEOs”).  Our NEOs for fiscal 2013 are Marc D. Goodman, our President and Chief Executive Officer; Howard Dubinett, our Executive Vice President and Chief Operating Officer; and Sam Singer, our Senior Vice President and Chief Financial Officer.  This table does not include any amount for our group life, health, hospitalization or medical reimbursement plans, if any, as such benefits do not discriminate in scope, terms or operation, in favor of any or our officers, senior management members or directors, and are generally available to all salaried employees.

 

SUMMARY COMPENSATION TABLE

 

Name and
Principal
Position

 

Fiscal
Year

 

Salary($)

 

Bonus
($)(1)

 

Stock
Awards($)

 

Option
Awards($)

 

Non-Equity
Incentive Plan
Compensation
($)(2)

 

Change in
Pension
Value and
Nonqualified
Deferred
Compensation
Earnings ($)

 

All Other
Compensation
($)(3)

 

Total($)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Marc D. Grodman M.D.,

 

2013

 

1,136,700

 

70,000

 

0

 

0

 

0

 

0

 

233,832

 

1,444,532

 

President and Chief

 

2012

 

1,092,933

 

70,000

 

0

 

0

 

131,152

 

0

 

245,359

 

1,539,444

 

Executive Officer

 

2011

 

1,059,044

 

1,321,241

 

0

 

0

 

63,543

 

0

 

229,638

 

2,673,466

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Howard Dubinett,

 

2013

 

449,200

 

0

 

0

 

0

 

0

 

0

 

45,685

 

494,885

 

Executive Vice President and

 

2012

 

431,911

 

100,000

 

0

 

0

 

51,829

 

0

 

42,474

 

626,214

 

Chief Operating Officer

 

2011

 

418,518

 

0

 

0

 

0

 

25,111

 

0

 

45,044

 

488,673

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sam Singer,

 

2013

 

449,200

 

0

 

0

 

0

 

0

 

0

 

47,145

 

496,345

 

Senior Vice President and

 

2012

 

431,911

 

300,000

 

0

 

0

 

51,829

 

0

 

48,998

 

832,738

 

Chief Financial Officer

 

2011

 

418,518

 

110,000

 

0

 

0

 

25,111

 

0

 

45,087

 

598,716

 

 

(1) The amounts shown in this column for fiscal 2013 represent (i) with respect to Dr. Grodman, a cash bonus of $70,000 paid in connection with his payment of the premium costs for an insurance policy owned by the Company insuring the life of Dr. Grodman pursuant to an Endorsement Split-Dollar Insurance Agreement among the Company, Dr. Grodman and an Insurance Trust established by Dr. Goodman (“Premium Payments”).  The amounts shown in this column for fiscal 2012 represent (i) with respect to Dr. Grodman, a cash bonus of $70,000 paid in connection with his Premium Payments; and (ii) with respect to Mr. Singer and Mr. Dubinett, a one-time cash bonus for their entering into new employment contracts during the year.  The amounts shown in this column for fiscal 2011 represent (i) with respect to Dr. Grodman, cash bonuses of $1,202,241 and $119,000 paid in connection with his payment of Premium Payments; and (ii) with respect to Mr. Singer, a one-time cash bonus for his activity in the collection of $6.7 million sales tax refund from the State of New Jersey.

 

(2) The amounts shown in this column represent amounts earned under the Senior Management Incentive Bonus Plan adopted by the Compensation Committee for the applicable fiscal year.  No payments were made to NEOs pursuant to the 2013 Senior Management Incentive Bonus Plan.

 

(3) The amounts in the “All Other Compensation” column for fiscal 2013 are detailed below.

 

Name

 

Personal Use of
Company Leased
Automobile ($)(a)

 

Personal Use of
Company Airplane
($) (a)

 

Life Insurance
Premium ($)(b)

 

401(k) Plan
Contribution ($)

 

Total ($)

 

Marc D. Grodman

 

27,247

 

5,585

 

200,000

 

1,000

 

233,832

 

Howard Dubinett

 

19,685

 

0

 

25,000

 

1,000

 

45,685

 

Sam Singer

 

21,145

 

0

 

25,000

 

1,000

 

47,145

 

 

(a) Represents our aggregate incremental costs for personal use of a Company leased automobile or the Company’s aircraft, as applicable.

(b) See “Split Dollar Life Insurance” below.

 

32


Table of Contents

 

GRANTS OF PLAN-BASED AWARDS

 

This table provides information regarding awards that could be granted to our NEOs under the 2013 Senior Management Incentive Bonus Plan.

 

 

 

Estimated Future Payouts Under Non-Equity Incentive Plan
Awards (1)

 

Name

 

Threshold ($)

 

Maximum ($)

 

Marc D. Grodman M.D.

 

45,468

 

170,505

 

 

 

 

 

 

 

Howard Dubinett

 

17,968

 

67,380

 

 

 

 

 

 

 

Sam Singer

 

17,968

 

67,380

 

 

(1) The amounts represent the range of annual cash incentive awards the NEO was potentially entitled to receive based on the achievement of the performance goals for fiscal 2013 under the 2013 Senior Management Incentive Bonus Plan.  These cash incentive awards were granted with no specified target level, as defined under SEC Regulation S-K, rule 402(d).

 

Employment Agreements with NEOs

 

Dr. Grodman

 

On December 31, 2010, the Company executed an employment agreement with Dr. Grodman (the “Grodman Contract”), employing him as President and Chief Executive Officer through October 31, 2017. The Grodman Contract is automatically renewable for one additional two year period subject to the right of either party to elect not to renew at least four months prior thereto. The Grodman Contract provides Dr. Grodman with a minimum annual base compensation of $1,059,044, subject to annual percentage increases based on the Consumer Price Index as well as to increases at the discretion of the Compensation Committee. Dr. Grodman’s minimum annual base compensation for fiscal 2012 as determined by the Compensation Committee was $1,092,933 and for fiscal 2013 is $1,136,700. Under the Grodman Contract we agreed to lease and insure an automobile for his benefit and agreed to provide him with access for personal use our airplane, which use will be taxable to him. The Grodman Contract also provides Dr. Grodman with participation rights in any fringe benefit and bonus plans available to the Company’s employees to the extent determined by the Compensation Committee. The Grodman Contract provides that in the event of Dr. Grodman’s total disability we may continue to employ him and compensate him at his then current base compensation for the month the disability occurs and a period of 36 months thereafter followed by an unpaid 3 month period, following which his employment will terminate unless we grant an additional leave of absence. If Dr. Grodman incurs a partial disability then his base compensation will be equitably adjusted based on the time he is able to devote to the Company. In the event of Dr. Grodman’s termination due to his death, the Company will pay his estate a death benefit equal to 24 times his monthly base compensation in effect at the date of his death, paid over 24 months. Under the Grodman Contract we may terminate Dr. Grodman’s employment for “Cause” and Dr. Grodman has the right to terminate his employment for “Good Reason”. If he terminates for Good Reason he will be entitled to continuation of his base compensation and employee benefits through the end of the period he otherwise would have been employed under the Grodman Contract.

 

“Cause” is defined in the Grodman Contact to mean: any act or acts of dishonesty by Dr. Grodman constituting criminal acts resulting or intending to result directly or indirectly in his gain or personal enrichment at our expense; his commission of a crime involving fraud, embezzlement or theft; or his material breach of the Grodman Contract. “Good Reason” is defined in the Grodman Contract to mean: a material diminution of Dr. Grodman’s base compensation; a material diminution in his authority, duties or responsibilities; a material diminution of the authority, duties or responsibilities of any supervisor he reports to; a material diminution in the budget over which he retains authority; a material change in the geographic location at which he provides services; or any other action or inaction that constitutes a material breach by us of the Grodman Contract.

 

In the event of a Change in Control of the Company, Dr. Grodman can elect to terminate his employment by providing written notice within 30 days following the Change in Control, with a termination date effective at the earlier of 45 days after the Change in Control or the next to last day of the calendar year in which the Change in Control occurs. In that event, he will be entitled to be paid a lump sum severance payment equal to 2.99 times the average of the annual compensation paid to him by the Company for the five calendar years preceding the earlier of the calendar year in which the Change of Control occurred or the calendar year of the date of termination, reduced by the amount of any other payment or the value of any other benefit received or to be received by him in connection with the termination of his employment or contingent on a Change in Control that are not deductible by us pursuant to Section 280G of the Internal Revenue Code of 1986, as amended (the “Tax Code”). “Change in Control” is defined in the Grodman Contact to mean a “change in effective control” or a “change in the ownership of a substantial portion of a corporation’s assets” as such terms are defined under Section 409A of the Tax Code, and means either the acquisition within 12 months by a person or group of ownership of 30% or more of the total voting power of our stock; the replacement of a majority of the member’s of our Board of Directors during any 12 month period by directors not endorsed prior to their appointment or election by a majority of the Board of Directors; or the acquisition by a person or group within 12 months of our assets with a total gross fair market value equal to more than 40% of the total gross fair market value of our assets prior to such acquisition.

 

Dr. Grodman is also subject to certain non-competition restrictions preventing him from competing with the Company after termination of his employment.  Such restrictions will run for one year from the date of his termination, other than following a termination by him for Good Reason in which case they will continue until the greater of one year from the date of termination or ½ of the period remaining from the date of termination through October 31, 2017.

 

                                                Pursuant to the Grodman Contract, the Company agreed to transfer to an Insurance Trust (the “1999 Trust”) established by Dr. Grodman, an insurance policy (“Policy A”) owned by the Company insuring the life of Dr. Grodman pursuant to an Endorsement Split-Dollar Insurance Agreement (“Split-Dollar Agreement No. 1”) among the Company, Dr. Grodman and the 1999 Trust, by paying a $1,202,411 bonus (the “Initial Bonus”) to Dr. Grodman, which is equal to the amount of the premiums paid by the Company on Policy A through the date of the Grodman Contract. Split-Dollar Agreement No. 1 required the Company to pay the annual premiums on Policy A and provided that in the event of Dr. Grodman’s death while serving as a full time Company employee, the Company would receive that amount out of the policy death proceeds equal to its “interest in the policy” (i.e. the greater of the premiums it had paid on the policy or the policy cash value at the date of death) and the balance of the death proceeds would be paid to Dr. Grodman’s designated beneficiaries. Pursuant to the Grodman Contract, Split-Dollar Agreement No. 1 was terminated and in a “book entry” transaction, the Initial Bonus was “paid” to Dr. Grodman who in turn “transferred” the Initial Bonus amount to the 1999 Trust which in turn “repaid” the Initial Bonus amount back to the Company. The Company then, in accordance with Split-Dollar Agreement No. 1, transferred ownership of Policy A to the 1999 Trust. To facilitate these transactions, the parties

 

33


Table of Contents

 

agreed that the actual monetary funds did not need to change hands but agreed to treat the transactions appropriately for tax and accounting purposes. The Company also agreed to pay bonuses to Dr. Grodman of $119,000 in 2011, $70,000 in 2012 and $70,000 in 2013 unless his employment was terminated for “Cause” prior to a payment. These three bonuses were equal in amount to the remaining premiums payable on Policy A. The Company will expense the Initial Bonus ratably over the term of the New Contract. If Dr. Grodman’s employment is terminated for “Cause”, he is obligated to pay back the unexpended portion of the Initial Bonus back to the Company.

 

The Company also agreed to obtain a second insurance policy, a second-to-die policy (“Policy B”) insuring the lives of Dr. Grodman and his wife. Policy B will be owned by the Company pursuant to a second Endorsement Split-Dollar Insurance Agreement (“Split-Dollar Agreement No. 2”) among the Company, Dr. Grodman and an Insurance Trust established by Dr. Grodman. Policy B provides for seven years of annual premiums of approximately $200,000 each, to be paid by the Company unless Dr. Grodman’s employment is terminated for “Cause.” At Dr. Grodman’s death, if his wife survives him, or in the event his employment is terminated for “Cause”, Dr. Grodman’s estate or Dr. Grodman, as the case may be, will cause the premiums paid by the Company under Policy B up to said date, to be paid back to the Company and the Company will transfer ownership of Policy B to Dr. Grodman’s estate, or to Dr. Grodman, as the case may be. If Dr. Grodman survives his wife, and assuming his employment has not been terminated for “Cause,” at his death, the Company will be paid the greater of the premiums it paid on Policy B or the Policy B cash value out of the death proceeds and Dr. Grodman’s estate will be paid the balance of the death proceeds, provided, however, that if Dr. Grodman survives his wife and assuming his employment has not been terminated for “Cause,” at his wife’s death, Dr Grodman or his designee shall have the option, exercisable within 90 days of her death, to purchase Policy B from the Company for the greater of the premiums paid or the cash value at the date of her death.

 

Mr. Singer

 

On June 14, 2012, effective February 1, 2012, the Company executed a new employment agreement with Mr. Singer (the “Singer Contract”), employing him as Senior Vice President, Chief Financial Officer and Chief Accounting Officer through January 31, 2015.  The Singer Contract replaced Mr. Singer’s employment agreement that expired January 31, 2012.  Mr. Singer’s minimum annual base compensation under the Singer Contract is $431,911 subject to increases based on increases in the Consumer Price Index as well as to increases at the discretion of the Compensation Committee. The Singer Contract provides for the leasing of an automobile for his use and participation in fringe benefit, bonus, pension, profit sharing, and similar plans maintained for the Company’s employees. In consideration for his entering into the Singer Contract, the company paid Mr. Singer a sign-on bonus in the amount of $300,000 subject to a pro rata claw-back provision in the event Mr. Singer is terminated for “cause” or if he resigns prior to the earlier of a “change of control” or January 31, 2015. In the event of Mr. Singer’s total disability we may continue to employ him and compensate him at his then current base compensation for the month the disability occurs and a period of 12 months thereafter followed by an unpaid 3 month period, following which his employment will terminate unless we grant an additional leave of absence. If Mr. Singer incurs a partial disability then his base compensation will be equitably adjusted based on the time he is able to devote to the Company. In the event of Mr. Singer’s termination due to his death, we will continue to pay his beneficiary his base salary for 12 months. Under the Singer Contract we may terminate Mr. Singer’s employment for “Cause” and Mr. Singer has the right to terminate for “Good Reason”. If he terminates for Good Reason he will be entitled, subject to his execution of a release, to continuation of his base compensation and employee benefits through the end of the employment period he otherwise would have been employed under his employment agreement.  In the event of termination due to a Change in Control of the Company, Mr. Singer will be entitled to the same severance payment described above for Dr. Grodman.  Mr. Singer’s agreement does not contain non-competition restrictions.

 

“Cause” is defined in Mr. Singer’s employment agreement to mean: an act or acts of dishonesty by Mr. Singer constituting criminal acts resulting or intended to result directly or indirectly in his gain or personal enrichment at our expense; his commission of a crime involving fraud, embezzlement or theft against us; or his engaging in competition with us.  Good Reason and Change in Control under Mr. Singer’s employment agreement has the same meanings as provided in the Grodman Contract.

 

Mr. Dubinett

 

On June 14, 2012, effective February 1, 2012 the Company executed an employment agreement with Mr. Dubinett’s (the “Dubinett Contract”), employing him as Executive Vice President and Chief Operating Officer through January 31, 2015.  The Dubinett Contract replaced Mr. Dubinett’s employment agreement with us that expired on October 31, 2011.  The Dubinett Contract is substantially identical with the Singer Contract except that Mr. Dubinett’s sign-on bonus was $100,000.

 

Potential Payments Upon Termination or Change in Control as of October 31, 2013

 

The following table sets out the estimated payments that would have been paid to each of our NEOs upon termination of employment due to Death, for Good Reason or following a Change in Control in accordance with their employment agreements as described above as in effect, and in each case assuming such termination had occurred, as of October 31, 2013.  We have calculated these estimated payments to meet SEC disclosure requirements. The estimated payments are not necessarily indicative of the actual amounts any of our NEOs would receive in such circumstances. The table excludes compensation amounts accrued through October 31, 2013 that would be paid in the normal course of continued employment, such as accrued but unpaid base compensation, and vested account balances under our retirement plans that are generally available to all of our salaried employees.

 

 

 

Base Compensation
Continuation/ Lump
Sum ($) (a)

 

Benefits Continuation
($) (b)

 

Total ($)

 

Marc D. Grodman M.D.

 

 

 

 

 

 

 

Good Reason

 

5,683,500

 

12,217

 

5,695,717

 

Death

 

2,273,400

 

0

 

2,273,400

 

Change in Control

 

3,398,733

 

0

 

3,398,733

 

Howard Dubinett

 

 

 

 

 

 

 

Good Reason

 

1,010,700

 

5,169

 

1,015,869

 

Death

 

449,200

 

0

 

449,200

 

Change in Control

 

1,343,108

 

0

 

1,343,108

 

Sam Singer

 

 

 

 

 

 

 

Good Reason

 

1,010,700

 

5,169

 

1,015,869

 

Death

 

449,200

 

0

 

449,200

 

Change in Control

 

1,343,108

 

0

 

1,343,108

 

 

34


Table of Contents

 

(a) For a Good Reason termination this payment reflects a continuation of base compensation through the end of period the NEO otherwise would have been employed under his employment agreement.  For death this payment reflects a continuation of base compensation for 24 months in the case of Dr. Grodman and 12 months in the case of Messrs. Dubinett and Singer.  For Change in Control this payment reflects an amount equal to 2.99 times the NEOs five-year average compensation, without reduction.

(b) For a Good Reason termination this payment reflects our estimated costs for a continuation of the NEOs benefits under our medical plan through the end of period the NEO otherwise would have been employed under his employment agreement.

 

Split-Dollar Life Insurance

 

We have established split-dollar life insurance programs for each of our NEOs under which we are entitled to receive the net cash surrender value of the policies.  We have entered into Endorsement Split-Dollar Life Insurance Agreements with each of the NEOs pursuant to which we have agreed to continue to pay the annual premiums on the policies during the period of the NEO’s full-time employment by the Company ($200,000 under Dr. Grodman’s policy and $25,000 each under Messrs. Dubinett’s and Singer’s policies). In the case of Dr. Grodman, the insurance policy is a second-to-die policy on the lives of Dr. Grodman and his wife.  In the event of an NEO’s death while serving as a full-time employee of the Company, we will be entitled to receive that amount of the death proceeds equal to our interest in the policy (the aggregate amount of premiums paid by the Company with respect to the policy less the amount of any loans, if any, from the Insurer to the Company against the cash value or policy proceeds, and less the aggregate amount of any premiums paid by the NEO to the Company in reimbursement of premiums paid by the Company) and the balance of the death proceeds will be paid to the NEO’s designated beneficiaries. The premiums paid by the Company on such policies are approximately $250,000 at October 31, 2013. As of such date the aggregate net cash surrender value of the three policies was approximately $1,165,000 and is recorded on the books of the Company at such value.

 

Stock Options

 

See Note 11 of Notes to the Consolidated Financial Statements for information on the company’s stock option plans.

 

Option Grants to Our NEOs in Last Fiscal Year

 

No options to purchase shares of our Common Stock were granted to any of our NEOs in fiscal 2013.

 

Option Exercises and Stock Vested

 

At October 31, 2013, there were no outstanding options held by our NEOs or any of our directors. During fiscal 2013 no options were exercised by any member of the Board of Directors.

 

Director Compensation

 

During fiscal 2013, each director who was not a Company employee was compensated for his services as a director with a quarterly fee of $16,250. In addition, Gary Lederman as chairman of the Audit Committee, was compensated with an additional quarterly fee of $4,500. For his service as chairman of both the Nominating Committee and the Compensation Committee, John Roglieri M.D., was compensated with additional quarterly fees of $3,000 and $2,000, respectively.  No director’s fees were paid to our employee directors.

 

The following table sets forth the compensation paid to our directors in fiscal 2013.

 

Fiscal 2013
Director Name:

 

Fees Earned or paid in
Cash ($)

 

Chairman Fees ($)

 

Total ($)

 

Joseph Benincasa

 

91,250

 

—

 

91,250

 

Harry Elias

 

91,250

 

—

 

91,250

 

Gary Lederman (a)

 

91,250

 

17,250

(a)

108,500

 

John Roglieri M.D (b)

 

91,250

 

18,750

(b)

110,000

 

 

(a) Chairman of the Audit Committee

(b) Chairman of the Nominating Committee and the Compensation Committee

 

Compensation Discussion and Analysis

 

Executive Compensation Philosophy

 

The objective of our compensation program for our NEOs is to reward them for their leadership and efficiency in their areas of responsibility and for their overall contribution to the Company’s performance.  Our NEOs for fiscal 2012 are Dr. Grodman, our President and Chief Executive officer, Mr. Dubinett, our Executive Vice President Chief Operating officer who is responsible for healthcare regulatory compliance and insurance matters, and Mr. Singer, our Senior Vice President and Chief Financial Officer who is responsible for all financial matters.

 

We seek to maintain a uniform approach in how we compensate our NEOs.  Accordingly, as Dr. Grodman already owns a substantial equity interest in the Company and we believe that further equity compensation would not provide him with an effective incentive, we do not currently provide equity compensation to any of our NEOs.  Our compensation program for our NEOs therefore focuses primarily on the following cash based incentives:

 

(i)             Annual base compensation consisting of a set annual cash amount that is subject to annual increase based upon a review of the NEO’s and the Company’s performance and increases in the Consumer Price Index; and

 

(ii)          Participation in the annual Senior Management Incentive Bonus Plan (“Annual Bonus Plan”), which provides cash incentives based on the level of achievement of specific performance objectives.  We annually establish targets under the Annual Bonus Plan that are designed

 

35


Table of Contents

 

to assist in the Company’s profitability by encouraging a “team effort” that rewards participants based on the level of achievement of Company financial targets set by the Compensation Committee with no reward if minimum targets are not achieved.  Annual Bonus Plan targets were achieved with respect to fiscal 2011, fiscal 2012 so that bonuses were earned and paid to our NEOs under the Annual Bonus Plan for fiscal 2011 (the “2011 Bonus Plan”), the Annual Bonus Plan for fiscal 2012 (the “2012 Bonus Plan”). Annual Bonus Plan targets were not achieved with respect to fiscal 2013, so no bonuses were paid to our NEOs under the Annual Bonus Plan for fiscal 2013 (the “2013 Bonus Plan”). See “Senior Management Incentive Bonus Plan” herein.

 

Advisory Vote on Executive Compensation

 

The Company provides its stockholders with the opportunity to cast an annual vote on executive compensation. At the 2013 Annual Meeting of Stockholders held in July 2013, 64.9% of the votes cast on the advisory vote on executive compensation proposal were in favor of our NEO compensation as described in the proxy statement for the 2013 Annual Meeting of Stockholders. The Compensation Committee reviewed these final vote results and took them into account when considering its compensation decisions for fiscal 2014. The Compensation Committee determined that given the leadership role of the NEOs in the Company’s continued steady performance the Company’s executive compensation program remains appropriate and no changes were necessary. However, the Compensation Committee continues to review our executive compensation program consistent with the compensation goals set forth herein and will continue to consider the outcome of the stockholder votes on the annual executive compensation proposal when making future decisions regarding our executive officers.

 

Process for Determining Executive Compensation

 

Our Compensation Committee reviews and approves the annual base compensation and other compensation of our NEOs. Our Compensation Committee also establishes and reviews the achievement of performance goals and other matters relating to the Annual Bonus Plans.  There were no changes to our executive compensation structure in fiscal 2013.

 

In connection with its review of NEO compensation in fiscal 2012, the Compensation Committee considered an executive compensation study furnished by Compensation Resources, Inc., an independent executive compensation consulting firm (“CRI”) engaged by the Compensation Committee.  After taking into account the compensation paid to similar executive officers of a peer group of eleven publicly owned clinical testing laboratories (including the two major national laboratories, Quest Diagnostics, Inc. and Laboratory Corp. of America Holdings), CRI concluded that Dr. Grodman’s total direct compensation was then above the total direct compensation provided to the chief executive officers in the peer group, and that the total direct compensation provided to Messrs. Singer and Dubinett were below the total direct compensation provided to similar executive officers in the peer group.  Notwithstanding the report, the Compensation Committee believes that Dr. Grodman’s compensation level is reasonable as the current levels were determined based on a CRI report for fiscal 2011 which showed that Dr. Grodman’s total direct compensation was 20% below the peer group.

 

For 2012, CRI selected the following eleven peer group of publicly owned clinical testing laboratories to be used as a benchmark, most of which generally have revenue in a range of ½ to 2 times that of the Company, but was expanded to include companies with revenues of up to $8 billion:

 

Alliance Healthcare Services, Inc.

Bioclinica Inc.

Enzo Biochem Inc.

eResearch Technology

Laboratory CP of Amer Hldgs

Medtox Scientific Inc.

Neogenomics Inc.

Psychemedics Corp.

Quest Diagnostics Inc.

Radnet Inc.

Response Genetics Inc.

 

Two companies that were part of the 2011 peer group, Genoptix Inc. and Orchid Cellmark Inc., were excluded for fiscal 2012 as they no longer met the peer group criteria and were replaced by Alliance Healthcare Services, Inc., Enzo Biochem Inc., eResearch Technology, and Radnet Inc.

 

Base Compensation

 

In accordance with the Grodman Contract, the Compensation Committee determined that Dr. Grodman’s base compensation be increased to $1,136,700 for fiscal 2013, which reflects a 4% increase based on increases in the Consumer Price Index.

 

Since fiscal 2008, the base compensation and the increase in base compensation in each year for Mr. Dubinett and for Mr. Singer have been identical. This is because the Compensation Committee continues to believe that Mr. Dubinett and Mr. Singer perform their duties equally well and to distinguish between them in compensation could cause the Company to lose the services of one of them. The increases in their base compensation in each of the past three fiscal years have been as follows, which reflect annual increases for each fiscal year based on increases in the Consumer Price Index.

 

Increases in Base Compensation for Each of

Mr. Dubinett and Mr. Singer Over the Prior Three Fiscal Years

 

Period

 

Amount ($)

 

Percentage Increase

 

 

 

 

 

 

 

Fiscal 2011

 

18,022

 

4

%

Fiscal 2012

 

13,393

 

3

%

Fiscal 2013

 

17,289

 

4

%

 

Benefits

 

                                                Our policy is to provide health benefits as well as access to our 401(k) Plan to which we contribute a maximum of $1,000 per employee each year, to all of our employees including our NEOs.

 

36


Table of Contents

 

All senior officers of the Company, including our NEOs, are entitled to an automobile leased by the Company and access to the Company’s airplane for personal use to the extent the airplane is not in use for business purposes.  The costs for insurance and maintenance of such automobiles are paid by the Company.  All amounts reflecting the personal use of such perquisites are reported as income to them subject to tax in accordance with the Tax Code.  The amounts reflecting the Company’s incremental costs for the NEO’s personal use of the Company leased automobile and the Company’s airplane are reflected in Footnote (3) to the “Summary Compensation Table” below.

 

Change in Control Benefits

 

The employment agreements with our NEOs provide for substantial severance payments to them in the event of a change in control of the Company.  This provision provides an additional level of financial security for our NEOs as they may be asked to evaluate a transaction purportedly expected to maximize shareholder value while resulting in the elimination of their jobs.  The severance payment provision (2.99 times the annual average of the preceding five years of compensation) is designed to minimize the distraction caused by concerns over personal financial security in the context of a proposed change in control.

 

Annual Bonus Plans for fiscal years 2013 and 2012

 

The Compensation Committee adopts an Annual Bonus Plans for each year which it believes incentivizes senior management to push to achieve operating results that the Compensation Committee believes will inure to the benefit of stockholders as well as management.  Each Annual Bonus Plan provides goals which the Compensation Committee believes could only be achieved through extraordinary team efforts by senior management and that are designed to incentivize senior management to operate the Company in the most efficient manner possible.  In developing the Annual Bonus Plan for each year, the Compensation Committee takes into consideration the economy in general and the goals of the Company that it wished to reward, namely to improve Company margins within attainable goals for management.

 

The Compensation Committee has at all times sought (and continues to seek) to provide a mechanism to reward outstanding efforts that enhance shareholder value.  The following is a description of the Annual Bonus Plan for fiscal 2012 (the “2012 Bonus Plan”) and fiscal 2013 (the “2013 Bonus Plan”).  The Compensation Committee has adopted an Annual Bonus Plan for fiscal 2014 that is substantially similar to the 2013 Bonus Plan and is attached hereto as Exhibit 10.5.  Any bonuses required to be paid under the provision of any Annual Bonus Plan is required to be paid to each participant on the pro-rata formula established upon the adoption of the plan and not at the discretion of the Compensation Committee.

 

2013 Bonus Plan

 

The 2013 Bonus Plan was based on two separate financial formula calculations. The first formula provided for bonuses (up to a maximum of 10% of the participant’s annual gross wages for 2013, less any bonus, auto or airplane usage expense charge-back or other unearned revenue (“2013 Wages”)) based on the level of the Company’s achievement of total operating income (TOI) as a percentage of our net revenues for fiscal 2013 as follows:

 

If TOI is greater than or equal
to:

 

and less than:

 

Bonus equal to the following
percentage of the participant’s
2013 wages:

 

12.25

%

12.75

%

4

%

12.75

%

13.25

%

6

%

13.25

%

13.75

%

8

%

13.75

%

N/A

 

10

%

 

The second formula provided for bonuses (up to a maximum of 15% of the participant’s 2013 Wages ) based on the percentage increase on a year over year basis in the Company’s operating income before interest and taxes (“OIBIT”) from fiscal 2012 to fiscal 2013, determined by subtracting the Company’s fiscal 2012 OIBIT from the Company’s fiscal 2013 OIBIT and dividing the difference by the Company’s OIBIT for fiscal 2012  to determine the percentage of change (“2013 PC”) , as follows:

 

If 2013 PC is greater than:

 

and less than:

 

Bonus equal to the following
percentage of the participant’s
2013 Wages:

 

25.00

%

30.00

%

6

%

30.00

%

35.00

%

9

%

35.00

%

40.00

%

12

%

40.00

%

N/A

 

15

%

 

Actual results under the 2013 Bonus Plan were as follows:

 

 

 

 

 

Bonus equal to the following percentage of the
participant’s 2013 Wages:

 

TOI as a percentage of our net revenues for fiscal 2013

 

11.46

%

0

%

2013 PC

 

7.67

%

0

%

Total Bonus Percentage:

 

—

 

0

%

 

2012 Bonus Plan

 

The 2012 Bonus Plan was based on two separate financial formula calculations. The first formula provided for bonuses (up to a maximum of 10% of the participant’s annual gross wages for 2012, less any bonus, auto or airplane usage expense charge-back or other unearned revenue (“2012 Wages”)) based on the level of the Company’s achievement of total operating income (TOI) as a percentage of our net revenues for fiscal 2012 as follows:

 

37


Table of Contents

 

If TOI is greater than or equal
to:

 

and less than:

 

Bonus equal to the following
percentage of the participant’s
2012 wages:

 

11.00

%

11.50

%

4

%

11.50

%

12.00

%

6

%

12.00

%

12.50

%

8

%

12.50

%

N/A

 

10

%

 

The second formula provided for bonuses (up to a maximum of 15% of the participant’s 2012 Wages ) based on the percentage increase on a year over year basis in the Company’s operating income before interest and taxes (“OIBIT”) from fiscal 2011 to fiscal 2012, determined by subtracting the Company’s fiscal 2011 OIBIT from the Company’s fiscal 2012 OIBIT and dividing the difference by the Company’s OIBIT for fiscal 2011  to determine the percentage of change (“2012 PC”) , as follows:

 

If 2012 PC is greater than:

 

and less than:

 

Bonus equal to the following
percentage of the participant’s
2012 Wages:

 

25.00

%

30.00

%

6

%

30.00

%

35.00

%

9

%

35.00

%

40.00

%

12

%

40.00

%

N/A

 

15

%

 

Actual results under the 2012 Bonus Plan were as follows:

 

 

 

 

Bonus equal to the following percentage of the
participant’s 2012 Wages:

 

TOI as a percentage of our net revenues for fiscal 2012

 

11.51

%

6

%

2010 PC

 

27.36

%

6

%

Total Bonus Percentage:

 

—

 

12

%

 

See Item 11 — the “Summary Compensation Table”, column (g) “Non-Equity Incentive Plan Compensation” as to the bonuses paid under the Senior Management Incentive Compensation Plan with respect to fiscal 2013 and 2012.

 

Tax Compliance Policy

 

Section 162(m) of the Code generally disallows a tax deduction to public corporations for compensation in excess of $1,000,000 paid for any fiscal year to a corporation’s chief executive officer and to the three other most highly compensated executive officers in office as of the end of the fiscal year, other than the chief financial officer.  The statute exempts qualifying performance-based compensation from the deduction limit if certain requirements are met.  However, shareholder interests may at times be best served by not restricting the Compensation Committee’s discretion and flexibility in developing compensation programs, even though the programs may result in non-deductible compensation expenses.  Accordingly, the Compensation Committee may from time to time approve elements of compensation for certain officers that are not fully deductible.

 

Compensation Committee Interlocks and Insider Participation

 

During fiscal 2013, the members of the Company’s Compensation Committee were:

 

John Roglieri M.D. — Chairman

Joseph Benincasa

Harry Elias

Gary Lederman

 

No member of the Compensation Committee was an officer or employee of the Company in fiscal 2013 or was formerly an officer of the Company.

 

Compensation Committee Report

 

The members of the Company’s Compensation Committee hereby state:

 

We have reviewed and discussed the Compensation Discussion and Analysis contained in this Annual Report on Form 10-K for the year ended October 31, 2013 with the Company’s Management, and

 

Based on such review and discussions, we have recommended to the Company’s Board of Directors that the Compensation Discussion and Analysis be included in the Company’s Annual Report on Form 10-K for the year ended October 31, 2013.

 

 

 

COMPENSATION COMMITTEE

 

 

 

By:

John Roglieri M.D., Chairman

 

 

Joseph Benincasa

 

 

Harry Elias

 

 

Gary Lederman

 

38


Table of Contents

 

Item 12. - Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

The following table sets forth information as of January, 2014 with respect to the ownership of Common Stock by (i) each person known to us to be the beneficial owner of more than 5% of our outstanding Common Stock, (ii) each of our directors, (iii) each of our executive officers, and (iv) all directors and executive officers as a group.

 

Name and Address of Beneficial
Owner*

 

Shares of Common Stock
Beneficially Owned(1)

 

Percentage
Ownership

 

 

 

 

 

 

 

Marc D. Grodman(2)

 

2,741,800

 

9.90

%

Howard Dubinett(3)

 

365,138

 

1.32

%

Sam Singer(4)

 

14,132

 

 

**

Joseph Benincasa

 

0

 

0

%

Harry Elias

 

0

 

0

%

Gary Lederman(5)

 

30,400

 

 

**

John Roglieri(6)

 

10,000

 

 

**

Executive Officers and Directors as a group (seven persons) (2)(3)(4)(5)(6)

 

3,161,470

 

11.42

%

 

 

 

 

 

 

Black Rock, Inc(7)
40 East 52nd Street
New York, NY 10022

 

1,859,554

 

6.71

%

 

 

 

 

 

 

Jennison Associates LLC(9)
466 Lexington Avenue
New York, NY 10017

 

2,583,152

 

9.3

%

 

 

 

 

 

 

Riverbridge Partners LLC(11)
 801 Nicollet Mall, Suite 600
Minneapolis, MN 55402

 

1,767,970

 

6.38

%

 

 

 

 

 

 

The Vanguard Group (12)
100 Vanguard Blvd.
Malvem, PA 19355

 

1,748,989

 

6.31

%

 

 

 

 

 

 

Manulife Asset Management Limited(13)
200 Bloor Street East
Toronto, ON, Canada M4W 1E5

 

2,146,944

 

7.75

%

 

*

The address of all of the Company’s directors and executive officers is c/o the Company, 481 Edward H. Ross Drive, Elmwood Park, New Jersey 07407.

 

 

**

Less than one (1%) percent.

 

 

(1)

Except as otherwise noted, each holder named in the table has sole voting and investment power with respect to all shares of Common Stock shown as beneficially owned.

 

 

(2)

Includes 2,296,966 shares owned directly. 32,210 of these shares are pledged as security in a brokerage margin account. Also includes 145,834 shares owned directly by Dr. Grodman’s wife, Pam Grodman, and 200,000 shares held in trust for the benefit of Pam Grodman, and 99,000 shares owned by their children. Dr. Grodman disclaims beneficial ownership of these 444,834 shares.

 

 

(3)

Includes 365,138 shares owned directly. All of these shares are pledged as security in a brokerage margin account.

 

 

(4)

Includes 1,000 shares owned directly and 13,132 shares owned by trusts for the benefit of Mr. Singer and his family members, of which Nancy Kelly-Singer, Mr. Singer's wife, and Mr. Singer are co-trustees.

 

 

(5)

Includes 30,400 shares owned directly.

 

 

(6)

Includes 10,000 shares owned directly.

 

 

(7)

Black Rock, Inc. (“Black Rock”) is the beneficial owner of these 1,859,554 shares. In its Schedule 13G filing dated February 4, 2013 filed with the Securities and Exchange Commission, Black Rock stated that to the best of its knowledge, these 1,859,554 shares were acquired in the ordinary course of business; were not acquired for the purpose of and do not have the effect of changing or influencing the control of the Company; and were not acquired in connection with or as a participant in any transaction having such purpose or effect.

 

 

(9)

Jennison Associates LLC (“Jennison”) is the beneficial owner of these 2,583,152 shares. In its Schedule 13G filing dated February 12, 2013 (as of December 31, 2012) filed with the Securities and Exchange Commission, Jennison stated that to the best of its knowledge, these 2,583,152 shares were acquired in the ordinary course of business; were not acquired for the purpose of and do not have the effect of changing or influencing the control of the Company; and were not acquired in connection with or as a participant in any transaction having such purpose or effect.

 

 

(11)

Riverbridge Partners LLC (“Riverbridge”) is the beneficial owner of these 1,767,970 shares. In its Schedule 13G filing dated February 4, 2013 (as of December 31, 2012) filed with the Securities and Exchange Commission, Riverbridge stated that to the best of its knowledge, these 1,767,970 shares were acquired in the ordinary course of business; were not acquired for the purpose of and do not have the effect of changing or influencing the control of the Company; and were not acquired in connection with or as a participant in any transaction having such purpose or effect.

 

 

(12)

The Vanguard Group (“Vanguard”) is the beneficial owner of these 1,748,989 shares. In its Schedule 13G filing dated February 7, 2013 filed with the Securities and Exchange Commission, Vanguard stated that to the best of its knowledge, these 1,748,989 shares were acquired

 

39


Table of Contents

 

 

in the ordinary course of business; were not acquired for the purpose of and do not have the effect of changing or influencing the control of the Company; and were not acquired in connection with or as a participant in any transaction having such purpose or effect.

 

 

(13)

Manulife Asset Management Limited (“MAML”) is the beneficial owner of these 2,146,944 shares. In Its Schedule 13G filing dated February 13, 2013 filed with the Securities and Exchange Commission, MAML stated that to the best of its knowledge, these 2,146,944 shares were acquired in the ordinary course of business; were not acquired for the purpose of and do not have the effect of changing or influencing the control of the company; and were not acquired in connection with or as a participant in any transaction having such purpose or effect.

 

Equity Compensation Plan Information

 

The following table provides information as of October 31, 2013 regarding shares of Common Stock that may be issued pursuant to the Company’s equity compensation plans:

 

 

 

 

 

 

 

(c)

 

 

 

 

 

 

 

Number of Shares Remaining

 

 

 

(a)

 

(b)

 

Available for Future Issuances Under

 

 

 

Number of Shares Issuable

 

Weighted-Average Exercise

 

Equity Compensation Plans

 

 

 

upon Exercise of Outstanding

 

Price per Share of Outstanding

 

(Excluding Shares Reflected in

 

 

 

Options

 

Options

 

Column (a))

 

 

 

 

 

 

 

 

 

Equity Compensation Plans Approved by Stockholders

 

255,000

(1)

$

9.97

 

—

(2)

 

(1)         Reflects shares issuable upon exercise of outstanding ISOs granted pursuant to the Company’s 2000 and 2003 Employee Stock Option Plans.

(2)         No additional options may be granted under the Company’s stock options plans.

 

Item 13. — Certain Relationships and Related Transactions

 

No material transactions occurred between the Company and related parties during fiscal 2013.

 

It is the Company’s policy that transactions involving related persons (excluding executive officer compensation which is determined by the Compensation Committee) are to be presented to and assessed by the independent members of the board of directors. Related persons include the Company’s directors and executive officers, immediate family members of the directors and executive officers, and certain large security holders and their family members. If the determination is made that a related person has or may have a material direct or indirect interest in any Company transaction and that the amount involved equals or exceeds $120,000, the Company’s independent directors will review, approve and ratify the transaction, if appropriate, and the transaction will be disclosed if required under SEC rules. If the related party at issue is a director of the Company or a family member of a director, then that director will not participate in the relevant discussion and review.

 

Information considered in evaluating such transactions include the nature of the related person’s interest in the transaction, the material terms of the transaction, the importance of the transaction to the Company and the related person, whether the transaction would impair the judgment of a director or an executive officer to act in the best interests of the Company, and any other matters that management or the independent directors deem appropriate. Corporate policy requires all directors and employees, including all executives, to disclose their interests (including indirect interests through family members) with individuals or entities doing business with the Company, to management and/or the Board of Directors, and to remove themselves from all decisions related to that organization. No such transactions with related parties occurred in fiscal year 2011 through 2013.

 

Item 14. -  Principal Accountant Fees and Services

 

The firm of MSPC, Certified Public Accountants and Advisors, A Professional Corporation (“MSPC”) audited our accounts and the accounts of our subsidiaries for the fiscal years ended October 31, 2013 and 2012. MSPC and its predecessor firm have been our auditors since 1988. The table set forth below lists the fees billed to the company by MSPC for audit services rendered in connection with the audits of our consolidated financial statements for the years ended October 31, 2013 and 2012, and fees billed for other services rendered by MSPC during these periods.

 

 

 

2013

 

2012

 

 

 

(in thousands) ($)

 

(1) Audit Fees

 

288

 

376

 

(2) Audit-Related Fees

 

90

 

40

 

(3) Tax Fees

 

49

 

15

 

(4) All Other Fees

 

0

 

0

 

Total

 

427

 

431

 

 

(1)                                 Audit Fees

 

MSPC billed us approximately $288 for professional services rendered in connection with the audit of our annual financial statements for the fiscal year ended October 31, 2013 and the review of the financial statements included in our quarterly reports on Form 10-Q for such fiscal year compared to approximately $376 in billings for such services for the fiscal year ended October 31, 2012. In addition, MSPC billed us approximately $9 in fiscal 2013 for its audit of our 401(k) Plan for calendar year 2012 as compared to approximately $29 of such fees in fiscal 2012 with respect to calendar year 2011.

 

40


Table of Contents

 

(2)                                 Audit-Related Fees

 

MSPC billed us approximately $90 during fiscal 2013 and approximately $40 during fiscal 2012 for Sarbanes-Oxley (“SOX”) related audit fees.

 

(3)                                 Tax Fees

 

MSPC billed us approximately $49 for tax services for fiscal 2012 and approximately $15 for tax services for fiscal 2012.

 

(4)                                 All Other Fees

 

No fees were billed to us by MSPC with respect to fiscal 2013 or fiscal 2012 other than for services described in Item 14 (1), (2) and (3) herein.

 

(5)         Pre-Approval Policies and Procedures

 

The engagement of MSPC to render the above audit and tax services was approved by our audit committee prior to the engagement.

 

41


Table of Contents

 

PART IV

 

Item 15. — Exhibits and Financial Statement Schedules

 

(a)         1.              Financial Statements

 

The following financial statements of the Company are included in Part II, Item 8, “Financial Statements and Supplementary Data:”

 

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets - October 31, 2013 and 2012

Consolidated Statements of Operations for the Years ended October 31, 2013, 2012 and 2011

Consolidated Statements of Shareholders’ Equity for the Years ended October 31, 2013, 2012, and 2011

Consolidated Statements of Cash Flows for the Years ended October 31, 2013, 2012 and 2011

Notes to Consolidated Financial Statements

 

2.              Financial Statements Schedule

 

The following is included in Item 8, “Financial Statements and Supplementary Data:”

 

Schedule II — Valuation and Qualifying Accounts for the Years ended October 31, 2013, 2012 and 2011

 

(b)                                 Exhibits

 

Exhibit No.

 

Item

 

 

 

3.1*

 

Amended and Restated Certificate of Incorporation dated November 15, 1989 (Incorporated by reference to exhibit filed with the Company’s annual report on form 10-K for the year ended October 31, 2011. (SEC File No. 0-15266).

 

 

 

3.1.1*

 

Amendment to Certificate of Incorporation dated August 23, 1993 (Incorporated by reference to exhibit filed with the Company’s annual report on form 10-K for the year ended October 31, 2011. (SEC File No. 0-15266).

 

 

 

3.1.2*

 

Amendment to Certificate of Incorporation dated August 23, 1993 (Incorporated by reference to exhibit filed with the Company’s annual report on form 10-K for the year ended October 31, 2011. (SEC File No. 0-15266).

 

 

 

3.1.3*

 

Amendment to Certificate of Incorporation dated March 27, 1998 (Incorporated by reference to exhibit filed with the Company’s annual report on form 10-K for the year ended October 31, 2011. (SEC File No. 0-15266).

 

 

 

3.1.4*

 

Amendment to Certificate of Incorporation dated March 31, 1998 (Incorporated by reference to exhibit filed with the Company’s annual report on form 10-K for the year ended October 31, 2011. (SEC File No. 0-15266).

 

 

 

3.1.5*

 

Amendment to Certificate of Incorporation dated September 26, 2003 (Incorporated by reference to exhibit filed with the Company’s annual report on form 10-K for the year ended October 31, 2011. (SEC File No. 0-15266).

 

 

 

3.2.2*

 

By-laws, as amended. (Incorporated by reference to exhibit filed with the Company’s annual report on form 10-K for the year ended October 31, 2011. (SEC File No. 0-15266).

 

 

 

4.1*

 

Form of Common Stock Certificate, $.01 par value (Incorporated by reference to exhibit filed with the Company’s annual report on form 10-K for the year ended October 31, 2004 (SEC File No. 0-15266)).

 

 

 

10.1*

 

Lease Agreement for Elmwood Park, New Jersey Premises, expiring in February, 2004 (Incorporated by reference to exhibit filed with the Company’s annual report on Form 10-K for the year ended October 31, 1999 (SEC File No. 0-15266)).

 

 

 

10.1.1*

 

Fifth Amendment dated as of July 16, 2004 to Lease for Elmwood Park, New Jersey Premises (Incorporated by reference to exhibit filed with the Company’s annual report on Form 10-K for the year ended October 31, 2004 (SEC File No. 0-15266)).

 

 

 

10.1.2*

 

Sixth Amendment dated as of October 27, 2004 to Lease for Elmwood Park, New Jersey Premises (Incorporated by reference into exhibit filed with the Company’s annual report on Form 10-K for the year ended October 31, 2004 (SEC File No. 0-15266)).

 

 

 

10.2*

 

Employment Agreement between the Company and Marc Grodman expiring on October 31, 2017. (Incorporated by reference to exhibit filed with the Company’s current report on Form 8-K for December 31, 2010 (SEC File No. 0-15266)).

 

 

 

10.3*

 

Employment Agreement between the Company and Sam Singer expiring on January 31, 2015 (Incorporated by reference to exhibit filed with the Company’s current report on Form 8-K for June 15, 2012 (SEC File No. 0-15266)).

 

 

 

10.3.1*

 

Employment Agreement between the Company and Howard Dubinett expiring on January 31, 2015 (Incorporated by reference to exhibit filed with the Company’s current report on Form 8-K for June 15, 2012 (SEC File No. 0-15266)).

 

 

 

10.4*

 

The Company’s 2000 Employee Incentive Stock Option Plan. (Incorporated by reference to exhibit filed with the Company’s annual report on Form 10-K for the year ended October 31, 2000 (SEC File No. 0-15266)).

 

 

 

10.4.1*

 

The Company’s 2003 Employee Incentive Stock Option Plan. (Incorporated by reference to exhibit filed with the Company’s Registration Statement on Form S-8 (File No. 333-111578)).

 

 

 

10.5

 

The Company’s 2014 Senior Management Incentive Bonus Plan.

 

 

 

10.6*

 

Amended and Restated Loan and Security Agreement as of September 30, 2004 between the Company and PNC Bank, National Association. (Incorporated by reference to exhibit filed with the Company’s annual report on Form 10-K for the year ended October 31, 2004 (SEC File No. 0-15266)).

 

 

 

10.6.1*

 

Fourth Amendment as of October 31, 2006 to Loan and Security Agreement as of September 30, 2004 between the Company and PNC Bank, National Association (Incorporated by reference to exhibit filed with the Company’s annual report on Form 10-K for the year ended October 31, 2006 (SEC File No. 0-15266)).

 

42


Table of Contents

 

10.6.2*

 

Fifth Amendment as of October 31, 2007 to Loan and Security Agreement as of September 30, 2004 between the Company and PNC Bank, National Association (Incorporated by reference to exhibit filed with the Company’s annual report on Form 10-K for the year ended October 31, 2007 (SEC File No. 0-15266)).

 

 

 

10.6.3*

 

Sixth Amendment as of May 12, 2008 to Loan and Security Agreement as of September 30, 2004 between the Company and PNC Bank, National Association (Incorporated by reference to exhibit filed with the Company’s current report on Form 8-K (for December 31, 2010) (SEC File No. 0-15266)).

 

 

 

10.6.4*

 

Seventh Amendment as of October 22, 2010 to Loan and Security Agreement between the Company and PNC Bank, National Association. (Incorporated by reference to exhibit filed with the Company’s annual report on form 10-K for the year ended October 31, 2011. (SEC File No. 0-15266).

 

 

 

10.6.5*

 

Eighth Amendment as of November 2, 2011 to Loan and Security Agreement as of October 31, 2010 between the Company and PNC Bank, National Association. (Incorporated by reference to exhibit filed with the Company’s annual report on form 10-K for the year ended October 31, 2011. (SEC File No. 0-15266).

 

 

 

21

 

Subsidiaries of the Company

 

 

 

23.1

 

Consent of Independent Registered Public Accounting Firm

 

 

 

31.1

 

Certification of Chief Executive Officer

 

 

 

31.2

 

Certification of Chief Financial Officer

 

 

 

32.1

 

Certification pursuant to 18 U.S.C. Section 1350 of Chief Executive Officer

 

 

 

32.2

 

Certification pursuant to 18 U.S.C. Section 1350 of Chief Financial Officer

 

 

 

101

 

Interactive Data File

 

The exhibits designated above with an asterisk (*) have previously been filed with the Commission and, pursuant to 17 C.F.R. Secs. 201.24 and 240.12b-32, are incorporated by reference to the documents as indicated.

 

43


Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

BIO-REFERENCE LABORATORIES, INC.

 

 

 

 

By

/S/ Marc D. Grodman

 

Marc D. Grodman

 

Chairman of the Board, President,

 

Chief Executive Officer and Director

 

Dated:           January 10, 2014

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

/S/ Marc D. Grodman

 

Marc D. Grodman

 

Chairman of the Board, President,

 

Chief Executive Officer and Director

 

January 10, 2014

 

 

 

/S/ Howard Dubinett

 

Howard Dubinett

 

Executive Vice President,

 

Chief Operating Officer and Director

 

January 10, 2014

 

 

 

/S/ Sam Singer

 

Sam Singer

 

Sr. Vice President, Chief Financial Officer,

 

Chief Accounting Officer and Director

 

January 10, 2014

 

 

 

/S/ Joseph Benincasa

 

Joseph Benincasa

 

Director

 

January 10, 2014

 

 

 

/S/ Harry Elias

 

Harry Elias

 

Director

 

January 10, 2014

 

 

 

/S/ Gary Lederman

 

Gary Lederman

 

Director

 

January 10, 2014

 

 

 

/S/ John Roglieri

 

John Roglieri

 

Director

 

January 10, 2014

 

 

44



Table of Contents

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Shareholders

Bio-Reference Laboratories, Inc.

 

We have audited the accompanying consolidated balance sheets of Bio-Reference Laboratories, Inc. and its subsidiaries (the “Company”) as of October 31, 2013 and 2012, and the related consolidated statements of operations, shareholders’ equity, and cash flows for each of the years in the three-year period ended October 31, 2013.  We also have audited the Company’s internal control over financial reporting as of October 31, 2013, based on criteria established in Internal Control - Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).  The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting.  Our responsibility is to express an opinion on these consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects.  Our audits of the consolidated financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall consolidated financial statement presentation.  Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.  Our audits also included performing such other procedures as we considered necessary in the circumstances.  We believe that our audits provide a reasonable basis for our opinions.

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.  A company’s internal control over financial reporting includes those policies and procedures that (a) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (b) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (c) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respect, the financial position of Bio-Reference Laboratories, Inc. and its subsidiaries as of October 31, 2013 and 2012, and the results of their operations and their cash flows for each of the years in the three-year period ended October 31, 2013 in conformity with accounting principles generally accepted in the United States of America.  Also in our opinion, Bio-Reference Laboratories Inc. and its subsidiaries maintained, in all material respects, effective internal control over financial reporting as of October 31, 2013, based on criteria established in Internal Control - Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

 

MSPC

 

Certified Public Accountants and Advisors,

 

A Professional Corporation

 

 

 

Cranford, New Jersey

 

January 10, 2014

 

 

46


Table of Contents

 

BIO-REFERENCE LABORATORIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

[Dollars In Thousands, Except Share Data]

 

 

 

October 31,

 

October 31,

 

 

 

2013

 

2012

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

Cash and Cash Equivalents

 

$

17,952

 

$

25,143

 

Accounts Receivable - Net

 

206,261

 

153,247

 

Inventory

 

19,095

 

14,902

 

Other Current Assets

 

9,416

 

5,373

 

Deferred Tax Assets

 

42,154

 

24,912

 

TOTAL CURRENT ASSETS

 

294,878

 

223,577

 

 

 

 

 

 

 

PROPERTY AND EQUIPMENT - AT COST

 

133,599

 

102,701

 

LESS: Accumulated Depreciation

 

(67,950

)

(52,261

)

PROPERTY AND EQUIPMENT - NET

 

65,649

 

50,440

 

 

 

 

 

 

 

OTHER ASSETS:

 

 

 

 

 

Investments

 

5,237

 

4,977

 

Deposits

 

1,017

 

956

 

Goodwill - Net

 

35,185

 

23,408

 

Intangible Assets - Net

 

16,320

 

6,323

 

Other Assets

 

1,165

 

866

 

Deferred Tax Assets

 

2,077

 

2,278

 

TOTAL OTHER ASSETS

 

61,001

 

38,808

 

 

 

 

 

 

 

TOTAL ASSETS

 

$

421,528

 

$

312,825

 

 

The Accompanying Notes are an Integral Part of These Consolidated Financial Statements.

 

47


Table of Contents

 

BIO-REFERENCE LABORATORIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

[Dollars In Thousands, Except Share Data]

 

 

 

October 31,

 

October 31,

 

 

 

2013

 

2012

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

Accounts Payable

 

$

61,614

 

$

41,288

 

Accrued Salaries and Commissions Payable

 

19,601

 

16,490

 

Accrued Taxes and Expenses

 

18,292

 

9,753

 

Other Short Term Acquisition Payable

 

2,438

 

—

 

Revolving Note Payable - Bank

 

26,139

 

—

 

Current Maturities of Long-Term Debt

 

493

 

464

 

Capital Lease Obligations - Short-Term Portion

 

5,185

 

3,957

 

TOTAL CURRENT LIABILITIES

 

133,762

 

71,952

 

 

 

 

 

 

 

LONG-TERM LIABILITIES:

 

 

 

 

 

Capital Lease Obligations - Long-Term Portion

 

10,712

 

9,463

 

Long Term Debt - Net of Current Portion

 

3,670

 

4,163

 

Other Long Term Acquisition Payable

 

1,789

 

—

 

TOTAL LONG-TERM LIABILITIES

 

16,171

 

13,626

 

 

 

 

 

 

 

SHAREHOLDERS’ EQUITY:

 

 

 

 

 

Preferred Stock $.10 Par Value;

 

 

 

 

 

Authorized 1,666,667 shares, including 3,000 shares of Series A Junior Preferred Stock

 

 

 

 

 

None Issued

 

—

 

—

 

Common Stock, $.01 Par Value;

 

 

 

 

 

Authorized 35,000,000 shares:

 

 

 

 

 

Issued and Outstanding 27,683,213 and 27,707,382 at October 31, 2013 and at October 31, 2012, respectively

 

277

 

277

 

 

 

 

 

 

 

Additional Paid-In Capital

 

39,430

 

40,907

 

 

 

 

 

 

 

Retained Earnings

 

231,888

 

186,063

 

 

 

 

 

 

 

TOTAL SHAREHOLDERS’ EQUITY

 

271,595

 

227,247

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

421,528

 

$

312,825

 

 

The Accompanying Notes are an Integral Part of These Consolidated Financial Statements.

 

48


Table of Contents

 

BIO-REFERENCE LABORATORIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

[Dollars In Thousands, Except Share Data]

 

 

 

Years Ended

 

 

 

October 31,

 

 

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

NET REVENUES:

 

$

715,354

 

$

614,255

 

$

522,081

 

 

 

 

 

 

 

 

 

COST OF SERVICES:

 

 

 

 

 

 

 

Depreciation and Amortization

 

15,598

 

13,101

 

11,036

 

Employee Related Expenses

 

173,137

 

146,292

 

126,354

 

Reagents and Lab Supplies

 

135,486

 

121,446

 

100,569

 

Other Cost of Services

 

68,594

 

56,805

 

49,894

 

 

 

 

 

 

 

 

 

TOTAL COST OF SERVICES

 

392,815

 

337,644

 

287,853

 

 

 

 

 

 

 

 

 

GROSS PROFIT ON REVENUES

 

322,539

 

276,611

 

234,228

 

 

 

 

 

 

 

 

 

General and Administrative Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and Amortization

 

4,141

 

3,562

 

3,969

 

Other General and Administrative Expenses

 

177,508

 

154,928

 

131,967

 

Bad Debt Expense

 

58,917

 

41,990

 

38,518

 

 

 

 

 

 

 

 

 

TOTAL GENERAL AND ADMIN. EXPENSES

 

240,566

 

200,480

 

174,454

 

 

 

 

 

 

 

 

 

OPERATING INCOME

 

81,973

 

76,131

 

59,774

 

 

 

 

 

 

 

 

 

OTHER (INCOME) EXPENSES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Expense

 

1,606

 

1,455

 

1,747

 

Other (Income) Expense

 

(612

)

323

 

(6,656

)

Interest Income

 

(118

)

(163

)

(163

)

 

 

 

 

 

 

 

 

TOTAL OTHER EXPENSES - NET

 

876

 

1,615

 

(5,072

)

 

 

 

 

 

 

 

 

INCOME BEFORE INCOME TAXES

 

81,097

 

74,516

 

64,846

 

 

 

 

 

 

 

 

 

Provision for Income Taxes

 

35,272

 

32,360

 

28,487

 

 

 

 

 

 

 

 

 

NET INCOME

 

45,825

 

42,156

 

36,359

 

 

 

 

 

 

 

 

 

NET INCOME PER SHARE - BASIC:

 

$

1.65

 

$

1.52

 

$

1.30

 

WEIGHTED AVERAGE NUMBER OF SHARES - BASIC:

 

27,690,677

 

27,742,257

 

27,971,100

 

 

 

 

 

 

 

 

 

NET INCOME PER SHARE - DILUTED:

 

$

1.65

 

$

1.51

 

$

1.29

 

WEIGHTED AVERAGE NUMBER OF SHARES - DILUTED:

 

27,851,720

 

27,920,920

 

28,207,358

 

 

The Accompanying Notes are an Integral Part of These Consolidated Financial Statements.

 

49


Table of Contents

 

BIO-REFERENCE LABORATORIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

[Dollars In Thousands Except Number of Shares]

 

 

 

Series A

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

Preferred Stock

 

Common Stock

 

Paid-in

 

Retained

 

Deferred

 

Total Shareholders’

 

 

 

Shares

 

Amount

 

Shares

 

Amount

 

Capital

 

Earnings

 

Compensation

 

Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance on October 31, 2010

 

 

 

 

 

27,847,204

 

$

278

 

$

44,562

 

$

107,548

 

—

 

$

152,388

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercise of Options - Employees

 

 

 

 

 

79,600

 

1

 

497

 

 

 

 

 

498

 

Stock Based Compensation

 

 

 

 

 

 

 

 

 

40

 

 

 

 

 

40

 

Stock Issued for Acquisition

 

 

 

 

 

23,096

 

—

 

482

 

 

 

 

 

482

 

Net Income

 

 

 

 

 

 

 

 

 

 

 

36,359

 

 

 

36,359

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance on October 31, 2011

 

 

 

 

 

27,949,900

 

$

279

 

$

45,581

 

$

143,907

 

—

 

$

189,767

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercise of Options - Employees

 

 

 

 

 

31,500

 

1.00

 

226

 

 

 

 

 

227

 

Stock Based Compensation

 

 

 

 

 

11,432

 

—

 

290

 

 

 

 

 

290

 

Net Income

 

 

 

 

 

 

 

 

 

 

 

42,156

 

 

 

42,156

 

Common Stock Repurchased and Canceled

 

 

 

 

 

(285,450

)

(3

)

(5,190

)

 

 

 

 

(5,193

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance on October 31, 2012

 

 

 

 

 

27,707,382

 

$

277

 

$

40,907

 

$

186,063

 

 

 

$

227,247

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercise of Options - Employees

 

 

 

 

 

46,000

 

 

 

 

263

 

 

 

 

 

263

 

Stock Based Compensation

 

 

 

 

 

11,431

 

 

 

 

290

 

 

 

 

 

290

 

Net Income

 

 

 

 

 

 

 

 

 

 

 

 

45,825

 

 

 

45,825

 

Common Stock Repurchased and Canceled

 

 

 

 

 

(81,600

)

 

 

 

(2,030

)

 

 

 

 

(2,030

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance on October 31, 2013

 

 

 

 

 

27,683,213

 

$

277

 

$

39,430

 

$

231,888

 

 

 

$

271,595

 

 

The Accompanying Notes are an Integral Part of These Consolidated Financial Statements.

 

50


Table of Contents

 

BIO-REFERENCE LABORATORIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

[Dollars In Thousands]

 

 

 

Years Ended October 31,

 

 

 

2013

 

2012

 

2011

 

OPERATING ACTIVITIES:

 

 

 

 

 

 

 

Net Income

 

$

45,825

 

$

42,156

 

$

36,359

 

Adjustments to Reconcile Net Income to

 

 

 

 

 

 

 

Cash Provided by Operating Activities:

 

 

 

 

 

 

 

Depreciation and Amortization

 

19,739

 

16,663

 

15,005

 

Deferred Income Taxes (Benefit)

 

(17,041

)

(3,638

)

(5,911

)

Stock - Based Compensation Expense

 

290

 

290

 

40

 

Loss on Disposal of Property and Equipment

 

1,408

 

537

 

1,680

 

Undistributed Equity Method (Income) Loss

 

450

 

323

 

—

 

Change in Assets and Liabilities:

 

 

 

 

 

 

 

(Increase) Decrease in:

 

 

 

 

 

 

 

Accounts Receivable

 

(91,002

)

(11,240

)

(29,254

)

Provision for Doubtful Accounts

 

37,988

 

6,053

 

10,316

 

Inventory

 

(4,193

)

(5,211

)

(3,498

)

Other Current Assets

 

(4,043

)

(916

)

(1,637

)

Other Assets

 

(299

)

(141

)

798

 

Deposits

 

(61

)

(74

)

507

 

Increase (Decrease) in:

 

 

 

 

 

 

 

Accounts Payable and Accrued Liabilities

 

28,601

 

8,296

 

6,541

 

 

 

 

 

 

 

 

 

NET CASH - OPERATING ACTIVITIES

 

17,662

 

53,098

 

30,946

 

 

 

 

 

 

 

 

 

INVESTING ACTIVITIES:

 

 

 

 

 

 

 

Business Acquisitions Related Costs

 

(19,013

)

(5,675

)

(1,425

)

Acquisition of Equipment and Leasehold Improvements

 

(25,100

)

(15,715

)

(14,117

)

 

 

 

 

 

 

 

 

NET CASH - INVESTING ACTIVITIES

 

(44,113

)

(21,390

)

(15,542

)

 

 

 

 

 

 

 

 

FINANCING ACTIVITIES:

 

 

 

 

 

 

 

Payments of Long-Term Debt

 

(464

)

(1,270

)

(1,178

)

Payments of Capital Lease Obligations

 

(4,648

)

(3,710

)

(2,968

)

Increase (Decrease) in Revolving Note Payable

 

26,139

 

(18,632

)

(7,522

)

Proceeds from Exercise of Options

 

263

 

227

 

498

 

Common Stock Repurchased

 

(2,030

)

(5,193

)

—

 

 

 

 

 

 

 

 

 

NET CASH - FINANCING ACTIVITIES

 

19,260

 

(28,578

)

(11,170

)

 

 

 

 

 

 

 

 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

 

(7,191

)

3,130

 

4,234

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIODS

 

$

25,143

 

$

22,013

 

$

17,779

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS AT END OF PERIODS

 

$

17,952

 

$

25,143

 

$

22,013

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

 

 

 

 

 

 

 

Cash paid during the period for:

 

 

 

 

 

 

 

Interest

 

$

1,503

 

$

1,547

 

$

1,754

 

Income Taxes

 

$

44,312

 

$

36,697

 

$

32,773

 

 

The Accompanying Notes are an Integral Part of These Consolidated Financial Statements

 

51


Table of Contents

 

BIO-REFERENCE LABORATORIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

[Dollars In Thousands]

 

Supplemental Schedule of Non-Cash Investing and Financing Activities:

 

During fiscal 2013, 2012 and 2011, the Company wrote-off approximately $4,464, $2,508 and $5,944 of property which was fully depreciated.

 

During fiscal 2011, the Company disposed of certain equipment with an initial cost of $4,558.  During the same period the Company financed the purchase of new equipment through a term note of $5,408.

 

During fiscal 2013, 2012, and 2011, the Company incurred capital lease obligations totaling approximately $7,125, $7,777, and $5,444 in connection with the acquisition of property and equipment.

 

The Accompanying Notes are an Integral Part of These Consolidated Financial Statements

 

52


Table of Contents

 

BIO-REFERENCE LABORATORIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

[Dollars In Thousands Except Share Data or Unless Otherwise Indicated]

 

[1] Organization and Business

 

Bio-Reference Laboratories, Inc. [“Bio-Reference”, “BRLI”, or the “Company”] was incorporated on December 24, 1981.  Bio-Reference is principally engaged in providing laboratory testing services, primarily to customers in the greater New York metropolitan area as well as to customers in a number of other states.  Bio-Reference offers a comprehensive list of chemical diagnostic tests including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology (including drug screening), pap smears, tissue pathology (biopsies) and other tissue analysis.  We perform cancer cytogenetic testing at our leased facilities in at our main processing facility in Elmwood Park, Smithtown, NY, Clarksburg, MD and Milford, MA and genetic testing at our GeneDx leased facility in Gaithersburg, MD, as well as at our Elmwood Park facility.  We perform cytology testing in Frederick, MD, Milford, MA, Columbus, OH, Houston, TX and at our Elmwood Park facility.  Bio-Reference markets its laboratory testing services directly to physicians, geneticists, hospitals, clinics, correctional and other health facilities.

 

The Company’s laboratory testing business currently represents its one reportable business segment. The laboratory testing business accounts for over 98% of consolidated assets, net revenues and net income in each of the three years ended October 31, 2013.  All other operating segments include the Company’s non-clinical laboratory testing businesses and consist of our clinical knowledge management service through our PSIMedica business unit and a web-based connectivity portal solution for laboratories and physicians through its Care Evolve subsidiary.

 

[2] Summary of Significant Accounting Policies

 

Principles of Consolidation - The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  All significant intercompany accounts and transactions have been eliminated.

 

Cash and Cash Equivalents - Cash equivalents are comprised of certain highly liquid investments with a maturity of three months or less when purchased.  The Company had $17,952 and $25,143 in cash and cash equivalents at October 31, 2013 and 2012, respectively.

 

Inventory - Inventory is stated at the lower of cost [determined on a first-in, first-out basis] or market.  Inventory consists of purchased laboratory supplies, which is used in our various testing laboratories.

 

Property and Equipment - Property and equipment are carried at cost.  Depreciation is computed by the straight-line method over the estimated useful lives of the respective assets, which generally range from 2 to 15 years.  Leasehold improvements are amortized over the life of the lease or improvement, which is typically five years.

 

The statements of operations reflect depreciation expense related to property and equipment of $18,745, $16,082 and $13,684 for the years ended October 31, 2013, 2012 and 2011, respectively.

 

On sale or retirement, the asset cost and related accumulated depreciation or amortization are removed from the accounts, and any related gain or loss is reflected in general and administrative expenses.  Repairs and maintenance are charged to expense when incurred.

 

Goodwill - Effective November 1, 2011, the Company adopted revised Financial Accounting Standards Board (“FASB”)  rules promulgated under Accounting Standards Update (“ASU”) No. 2011-08 issued on September 15, 2011, Intangibles—Goodwill and Other (Topic 350) Testing Goodwill for Impairment. Under these simplified goodwill impairment testing rules the Company assessed qualitative factors to determine whether events and circumstances lead to the conclusion that it is necessary to perform the two-step goodwill impairment test have occurred and determined that no such events had occurred.  Under ASU No. 2011-08, entities are not required to calculate the fair value of a reporting unit unless they conclude that it is more likely than not that the unit’s carrying value is greater than its fair value based on an assessment of events and circumstances. The “more likely than not” threshold is when there is a likelihood of more than 50% that a reporting unit’s carrying value is greater than its fair value.  No impairment loss was recognized in the years ended October 31, 2013, 2012 and 2011.

 

The balance sheet reflects prior Goodwill accumulated amortization of $2,401 as of October 31, 2013 and 2012, respectively.

 

Other Intangible Assets - Intangible assets are amortized using the straight-line method.  The estimated useful life of costs capitalized is evaluated for each specific project when completed, at which time such costs begin to be amortized. The statements of operations reflect amortization expense related to intangible assets of $994, $581, and $1,322 for the years ended October 31, 2013, 2012 and 2011, respectively.  The balance sheet reflects accumulated amortization of $8,846, and $7,852 as of October 31, 2013, and 2012, respectively. During the 2013 and 2012 fiscal years, the Company did not write off any intangible assets.

 

New Accounting pronouncements

 

Certain prior year amounts have been reclassified to conform to the current year presentation. The Company adopted Accounting Standard Update (“ASU”) No. 2011-7: Health Care Entities (Topic 954) — Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities commencing with the current fiscal year, the first year such standard is required for the Company. The adoption of this update did not have a material impact on the Company’s financial statements.

 

Although this update does not have a material impact on the Company’s financial statements as a whole, it requires that we adjust our presentation of our statement of operations along with prior periods presented in this report to maintain comparability. As the result of this change in presentation, our “Net Revenues”, “Gross Profit on Revenues” and our “General and Administrative Expenses” would change while our “Operating Income”, “Net Income” and “Earnings per Share” will remain the same. The presentation is adjusted for a portion of our “Bad Debt Expense” that is now reported in our Net Revenues as required under ASU No. 2011-7.

 

Accounting for Revenue

 

Service revenues are principally generated from laboratory testing services including chemical diagnostic tests such as blood analysis, urine analysis and genetic testing among others. Service revenues are recognized at the time the testing services are performed and are reported at their estimated net realizable amounts.

 

53


Table of Contents

 

Service revenues before provision for bad debts are determined utilizing gross service revenues net of contractual adjustments and discounts. Even though it is the responsibility of the patient to pay for laboratory service bills, most individuals in the United States have an agreement with a third party payor such as Medicare, Medicaid or a commercial insurance provider to pay all or a portion of their healthcare expenses.  The majority of services provided by Bio-Reference Laboratories, Inc. (“BRLI”) are to patients covered under a third party payor contract. In certain cases, the individual has no insurance or does not provide insurance information and in other cases tests are performed under contract to a professional organization (such as physicians, hospitals, and clinics) which reimburses BRLI directly.  In the remainder of the cases, BRLI is provided the third party billing information and seeks payment from the third party under the terms and conditions of the third party payor for health service providers like BRLI. Each of these third party payors may differ not only with regard to rates, but also with regard to terms and conditions of payment and providing coverage (reimbursement) for specific tests. Estimated revenues are established based on a series of highly complex procedures and judgments that require industry specific healthcare experience and an understanding of payor methods and trends. We review our calculations on a monthly basis in order to make certain that we are properly allowing for the uncollectable portion of our gross billings due to the contractual adjustments and discounts and that our estimates remain sensitive to variances and changes within our payor groups. The contractual allowance calculation is made on the basis of historical allowance rates for the various specific payor groups on a monthly basis with a greater weight being given to the most recent trends This process is adjusted based on recent changes in underlying contract provisions and shifts in the testing being performed. This calculation is routinely analyzed by BRLI on the basis of actual allowances issued by payors and the actual payments made to determine what adjustments, if any, are needed. The table below shows the adjustments made to gross service revenues to arrive at net revenues, the amount reported on our statement of operations.

 

 

 

($)

 

 

 

Year Ended

 

 

 

October 31,

 

 

 

2013

 

2012

 

2011

 

Gross Service Revenues

 

3,524,108

 

3,052,431

 

2,482,349

 

 

 

 

 

 

 

 

 

Contractual Adjustments and Discounts:

 

 

 

 

 

 

 

Medicare/Medicaid Portion

 

354,638

 

320,697

 

293,874

 

All Other Third Party Payors*

 

2,393,872

 

2,070,073

 

1,629,833

 

Total Contractual Adjustments and Discounts

 

2,748,510

 

2,390,770

 

1,923,707

 

Service Revenues Net of Contractual Adjustments and Discounts

 

775,598

 

661,661

 

558,642

 

Patient Service Revenue Provision for Bad Debts**

 

60,244

 

47,406

 

36,561

 

Net Revenues

 

715,354

 

614,255

 

522,081

 

 

 

 

 

 

 

 

 

Percent of Contractual Allowances, Discounts and Patient Service Provision for Bad Debts to Gross Revenue.

 

79.7

%

79.9

%

79.0

%

 

* All Other Third Party and Direct Payors consists of almost eight hundred distinct payors, including commercial health insurers and administrators as well as professionally billed accounts such as physicians, hospitals, clinics and other direct billed accounts.

** Represents the amount of Bad Debt Expense that is now required to be presented as a deduction from patient service revenue (net of contractual allowances and discounts) pursuant to ASU No. 2011-7.

 

When new business is received by BRLI, service revenues net of contractual adjustments and discounts are calculated by reducing gross service revenues by the estimated contractual allowance. The Patient Service Revenue Provision for Bad Debts represents the amount of bad debt expense expected to occur on patient service revenue based upon our experience. The remaining bad debt expense is presented as part of operating expenses. The bad debt expense presented as part of operating expense represents the bad debt expense related to receivables from service revenues determined after taking into account our ability to collect on such revenue.  BRLI recognized the amounts in subsequent periods for actual allowances/discounts to gross service revenue; bad debt may have been adjusted over the same periods of time to maintain an accurate balance between net revenues and actual revenues. Management has reviewed the allowances/discounts recognized in subsequent periods and believes the amounts to be immaterial. A number of proposals for legislation or regulation continue to be under discussion which could have the effect of substantially reducing Medicare reimbursements for clinical laboratories or introducing cost sharing to beneficiaries. Depending upon the nature of regulatory action, if any, which is taken and the content of legislation, if any, which is adopted, the Company could experience a significant decrease in revenues from Medicare and Medicaid, which could have a material adverse effect on the Company. The Company is unable to predict, however, the extent to which such actions will be taken.

 

Accounting for Contractual Credits and Doubtful Accounts

 

It is typically the responsibility of the patient to pay for laboratory service bills. Most individuals in the United States have an agreement with a third party payor such as Medicare, Medicaid or commercial insurance to pay all or a portion of their healthcare expenses; this represents the major portion of payment for all services provided by BRLI. In certain cases, the individual has no insurance or does not provide insurance information; in the remainder of the cases, BRLI is provided the third party billing information, usually by the referring physician, and seeks payment from the third party under the terms and conditions of the third party payor for health service providers like BRLI. Each of these third party payors may differ not only with regard to rates, but also with regard to terms and conditions of payment and coverage of specific tests. BRLI routinely reviews the reimbursement policies and subsequent payments and collection rates from these different types of payors. Contractual adjustments and discounts are recorded as reductions to gross service revenues and are collectively referred to as the contractual allowance. BRLI has not been required to record an adjustment in a subsequent period related to revenue recorded in a prior period which was material in nature. Aging of accounts receivable is monitored by billing personnel and follow-up activities including collection efforts are conducted as necessary. BRLI writes off receivables against the allowance for doubtful accounts when they are deemed uncollectible. For client billing, accounts are written off when all reasonable collection efforts prove to be unsuccessful. Patient accounts, where the patient is directly responsible for all or a remainder portion of the account after partial payment or denial by a third party payor, are written off after the normal

 

54


Table of Contents

 

dunning cycle has occurred, although these may be subsequently transferred to a third party collection agency after being written off. Third party payor accounts are written off when they exceed the payer’s timely filing limits. Accounts Receivable on the balance sheet is net of the following amounts for contractual credits and doubtful accounts:

 

 

 

($)

 

 

 

October 31,

 

October 31,

 

 

 

2013

 

2012

 

 

 

 

 

 

 

Contractual Credits/Discounts

 

342,297

 

267,921

 

Doubtful Accounts

 

89,261

 

51,274

 

Total Allowance

 

431,558

 

319,195

 

 

Current Income Taxes — The Company recognizes interest and penalties on settlement of tax liabilities in its income from operations.  For the fiscal years 2011 through 2013, no material amounts for interest and penalties have been recorded.

 

Deferred Income Taxes - Deferred income tax assets and liabilities are computed annually for differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.

 

The Company adopted GAAP guidance with respect to uncertain tax positions when it became effective.  Under these rules the Company may recognize the tax benefit from an uncertain tax position only if it meets the more-likely-than-not criteria (over 50% likelihood) of being realized on an examination by taxing authorities.  For the years ended October 31, 2011 through October 31, 2013 the Company had no material uncertain tax positions to report.

 

Earnings Per Share - Basic earnings per share [“EPS”] reflects the amount of income attributable to each share of common stock based on average common shares outstanding during the period.  Diluted EPS reflects Basic EPS while giving effect to all potential dilutive common shares that were outstanding during the period, such as common shares that could result from the exercise or conversion of securities into common stock.  The computation of Diluted EPS is calculated by using the treasury stock method, which assumes that any proceeds obtained from the exercise of such dilutive securities would be used to purchase common stock at the average market price of the common stock during the period.  This reduces the gross number of dilutive shares by the number of shares purchasable from the proceeds of the securities assumed to be exercised.  Securities whose conversion would have an anti-dilutive effect on EPS are not assumed converted.  Securities that could potentially dilute earnings in the future are disclosed in Note 10.

 

Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

 

Recoverability and Impairment of Intangible Assets and Other Long-Lived Assets — The Company evaluates the possible impairment of its long-lived assets under the provisions of FASB codification 350-30-35 and 360-10-35.  The Company reviews the recoverability of its long-lived assets on an annual basis.  Evaluation of possible impairment is based on the Company’s ability to recover the asset from the expected future pretax cash flows (undiscounted and without interest charges) of the related operations. If the expected undiscounted pretax cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.  No impairment loss was recognized in the fiscal years ended October 31, 2013, 2012 and 2011.

 

Advertising Costs -Advertising costs are expensed when incurred.  Advertising costs amounted to approximately $3,200, $2,366 and $2,026 for the years ended October 31, 2013, 2012 and 2011, respectively.

 

Other Income — During the year the Company recorded a loss of $450on its investment in IncellDx.  The loss represents the Company’s share of IncellDX undistributed net loss under the equity method of accounting.  During the year ended October 31, 2013 the Company received a refund of $1,062 for its New York State clinical laboratory inspection fee that was included in other income.

 

Subsequent Events — The management considered subsequent events through the date the financial statements are issued as defined in FASB Codification 855-10-50.

 

[3] Property and Equipment - Property and equipment - at cost is summarized as follows:

 

 

 

October 31

 

 

 

2013

 

2012

 

 

 

 

 

 

 

Medical Equipment

 

$

65,762

 

$

50,338

 

Leasehold Improvements

 

27,974

 

19,768

 

Furniture, Fixtures and Office & Computer Equipment

 

21,621

 

16,503

 

Automobiles and Aircraft

 

18,242

 

16,092

 

 

 

 

 

 

 

Sub Totals

 

133,599

 

102,701

 

Less Accumulated Depreciation

 

67,950

 

52,261

 

 

 

 

 

 

 

Totals — Net of Accumulated Depreciation

 

$

65,649

 

$

50,440

 

 

55


Table of Contents

 

[4] Intangible Assets

 

Intangible assets are summarized as follows:

 

October 31, 2013

 

 

 

Weighted-Average

 

 

 

Accumulated

 

Net of
Accumulated

 

Intangible Asset

 

Amortization Period

 

Cost

 

Amortization

 

Amortization

 

 

 

 

 

 

 

 

 

 

 

Customer Lists

 

20

 

$

8,739

 

$

2,879

 

$

5,860

 

Covenants Not-to-Compete

 

3

 

11,131

 

4,560

 

6,571

 

Patents and Licenses

 

17

 

5,297

 

1,408

 

3,889

 

 

 

 

 

 

 

 

 

 

 

Totals

 

 

 

$

25,166

 

$

8,847

 

$

16,320

 

 

October 31, 2012

 

 

 

Weighted-Average

 

 

 

Accumulated

 

Net of
Accumulated

 

Intangible Asset

 

Amortization Period

 

Cost

 

Amortization

 

Amortization

 

 

 

 

 

 

 

 

 

 

 

Customer Lists

 

20

 

$

4,573

 

$

2,537

 

$

2,036

 

Covenants Not-to-Compete

 

5

 

4,305

 

4,257

 

48

 

Patents and Licenses

 

17

 

5,297

 

1,058

 

4,239

 

 

 

 

 

 

 

 

 

 

 

Totals

 

 

 

$

14,175

 

$

7,852

 

$

6,323

 

 

The estimated amortization expense related to intangible assets for each of the five succeeding fiscal years and thereafter as of October 31, 2013 is as follows:

 

October 31,

 

 

 

2014

 

$

1,917

 

2015

 

1,852

 

2016

 

1,540

 

2017

 

1,063

 

2018

 

946

 

Thereafter

 

9,002

 

 

 

 

 

Total

 

$

16,320

 

 

[5] Revolving Note Payable - Bank

 

In October 2011, the Company entered into an amended revolving note payable loan agreement with PNC Bank, N.A.  The maximum amount of the credit line available to the Company pursuant to the loan agreement is the lesser of (i) $45,000 or (ii) 50% of the Company’s qualified accounts receivable [as defined in the agreement].  The amendment to the Loan and Security Agreement provides for an interest rate on advances to be subject, at the election of the Company, to either the bank’s base rate or the Eurodollar rate of interest plus, in certain instances, an additional interest percentage.  The additional interest percentage charge on bank’s base rate borrowings and on Eurodollar rate borrowings ranges from 1% to 4% and is determined based upon certain financial ratios achieved by the Company.  At October 31, 2013, the Company had elected to have all of the total advances outstanding to be subject to the bank’s base rate of interest of 3.50%.  The credit line is collateralized by substantially all of the Company’s assets. The line of credit is available through October 2016 and may be extended for annual periods by mutual consent, thereafter.  The terms of this agreement contain, among other provisions, requirements for maintaining defined levels of capital expenditures, fixed charge coverage, and the prohibition of the payment by the Company of cash dividends. As of October 31, 2013 and October 31, 2012, the Company utilized $26,139 and $0 of the credit line, respectively.

 

[6] Long-Term Debt - Bank

 

Effective as of October 31, 2007, we executed a fifth amendment to the Loan Agreement formalizing the repayment terms of the $5 million term loan from PNC Bank used by our wholly-owned GeneDX (formerly, BRLI No. 2 Acquisition Corp.) subsidiary to fund the $5 million acquisition cash payment in connection with its purchase of the operating assets of GeneDx, Inc. The term loan is evidenced by a secured promissory note payable over a six year term in equal monthly principal payments of approximately $69, plus interest at an annual rate of 6.85%. The note was paid off on October 31, 2012.

 

In December 2010, the Company issued a seven year term note for $5,408 at the rate of interest of 6.12% per annum for the financing of new equipment.  The note is payable in eighty-four equal monthly installments commencing on January 29, 2011 of $61 including principal and interest followed by a balloon payment of the principal and interest outstanding on the loan repayment date of December 29, 2017.  The balance on this note as of October 31, 2013 is approximately $4,163.

 

56


Table of Contents

 

Principal repayment for each of the five succeeding fiscal years and thereafter as of October 31, 2013 is as follows:

 

Year Ended

 

 

 

October 31,

 

 

 

2014

 

493

 

2015

 

518

 

2016

 

551

 

2017

 

585

 

2018

 

2,016

 

Thereafter

 

—

 

Totals

 

$

4,163

 

 

[7] Related Party Transactions [Not in Thousands]

 

There were no material related party transactions during fiscal 2013 and fiscal 2012.

 

[8] Income Taxes

 

The reconciliation of income tax from continuing operations computed at the U.S. federal statutory tax rate to the Company’s effective income tax rate is as follows:

 

 

 

October 31

 

 

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

U.S. Federal Statutory Rate

 

35

%

35

%

35

%

State and Local Taxes, Net of U.S. Federal Tax Benefit

 

11.20

%

8.87

%

9.87

%

Permanent differences and Other

 

(2.78

)%

(0.44

)%

(0.94

)%

 

 

 

 

 

 

 

 

Actual Rate

 

43.42

%

43.43

%

43.93

%

 

The provision for income taxes shown in the consolidated statements of operations consists of the following:

 

 

 

October 31

 

 

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

Current:

 

 

 

 

 

 

 

Federal

 

$

38,295

 

$

25,794

 

$

24,573

 

State & Local

 

14,018

 

10,203

 

9,825

 

 

 

 

 

 

 

 

 

Deferred:

 

 

 

 

 

 

 

Federal

 

(10,803

)

(2,183

)

(4,223

)

State and Local

 

(6,238

)

(1,454

)

(1,688

)

 

 

 

 

 

 

 

 

Total Provision for Income Taxes

 

$

35,272

 

$

32,360

 

$

28,487

 

 

At October 31, 2013 and 2012, the Company had a net deferred tax asset of approximately $44,231 and $27,190, respectively.  The deferred taxes primarily relate to timing differences associated with the deductibility of depreciation and amortization, bad debts and certain accrued expenses and deferred costs.  For fiscal years ended October 31 2011 through October 31, 2013, the Company had no material net operating loss carry-forwards available to reduce current year taxable income.

 

 

 

October 31,

 

 

 

2013

 

2012

 

 

 

 

 

 

 

Deferred Tax Asset:

 

 

 

 

 

Bad Debt Allowance

 

$

39,275

 

$

22,560

 

Depreciation and amortization

 

1,815

 

1,963

 

Accrued Expenses

 

3,141

 

2,667

 

 

 

 

 

 

 

Deferred Tax Asset - Net

 

44,231

 

27,190

 

 

 

 

 

 

 

Current Deferred Tax Asset - Net

 

42,154

 

24,912

 

Long Term Deferred Tax Asset - Net

 

2,077

 

2,278

 

 

 

 

 

 

 

Deferred Tax Asset — Net

 

$

44,231

 

$

27,190

 

 

During fiscal year ended October 31, 2013 the Company recorded a net deferred tax benefit of $17,041.  This reflects a net benefit of approximately $16,715 in allowance for bad debts, a liability of approximately $281 from depreciation and amortization timing differences, and a benefit of approximately $607 in certain accrued expenses. Although realization is not assured and dependent upon things such as generating sufficient taxable income in future periods, management, through sufficient positive evidence,  believes it is more likely than not that all of the deferred tax asset will be realized. The amount of the deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income or changes in the accrued expenses during the future periods are reduced.

 

At October 31, 2013, fiscal 2010 through 2013 are subject to examination by US federal and state tax authorities.  Through the issuance of these financial statements the outcome of all of these examinations has not been determined.

 

57


Table of Contents

 

[9] Capital Transactions

 

[A] Preferred Stock and Common Stock - The Company is authorized to issue an aggregate of 1,666,667 shares of preferred stock, $.10 par value.  None was outstanding as of October 31, 2013 and October 31, 2012.

 

Holders of the Company’s Common Stock are entitled to one vote per share on matters submitted for shareholder vote.  Holders are also entitled to receive dividends ratably, if declared.  In the event of dissolution or liquidation, holders are entitled to share ratably in all assets remaining after payment of liabilities.

 

On November 11, 2011, the Company announced that its board of directors has approved a Stock Repurchase Program authorizing the repurchase of up to 1,000,000 shares of its Common Stock in the over-the-counter market at prevailing market prices over the period ending October 31, 2012.  During the year ended October 31, 2012 the Company repurchased 285,450 shares at a cost of $5,193.  On December 6, 2012, the Company announced that its board of directors has approved a new Stock Repurchase Program authorizing the buyback of up to 714,550 shares of its Common Stock in the over-the-counter market at prevailing market prices through October 31, 2013.  As of October 31, 2013, the Company repurchased 81,600 shares at a cost of $2,030.  Subsequent to our year end, on December 19, 2013 the Company announced that its board of directors has approved a new Stock Repurchase Program authorizing the buyback of up to 2,000,000 shares of its Common Stock in the over-the-counter market at prevailing market prices through October 31, 2015.

 

[B] Equity Transactions for Services — For the fiscal years ended in 2013, 2012 and 2011, the Company issued 11,431, 11,432 and 11,432 shares of the Company’s common stock for employment or consulting services [See Note 11 for common stock options issued for employee and consulting services].

 

[10] Earnings Per Share

 

The computation of basic and diluted net earnings per common share is as follows [in thousands, except per share data rounded]:

 

 

 

For Years Ended October 31,

 

 

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

Income Available to Common Stockholders

 

$

45,825

 

$

42,156

 

$

36,359

 

Weighted Average Common Shares Outstanding

 

27,691

 

27,742

 

27,971

 

 

 

 

 

 

 

 

 

Effect of Dilutive Securities:

 

 

 

 

 

 

 

Warrants/Options

 

161

 

179

 

236

 

 

 

 

 

 

 

 

 

Weighted Average Diluted Common Shares Outstanding

 

27,852

 

27,921

 

28,207

 

 

 

 

 

 

 

 

 

Net Income Per Share - Basic

 

$

1.65

 

$

1.52

 

$

1.30

 

Net Income Per Share - Diluted

 

$

1.65

 

$

1.51

 

$

1.29

 

 

[11] Stock Options and Warrants

 

Employee Incentive Stock Options - In June 2003, the Board of Directors adopted, and in July 2003, the stockholders approved, the 2003 Employee Incentive Stock Option Plan [the “2003 Plan”].  The 2003 Plan authorizes the grant of stock options, which may be designated as  incentive stock options, to purchase up to a maximum aggregate 1,600,000 shares of Company common stock.  The 2003 Plan provides that the exercise price of an option granted there under shall not be less than the fair market value of the Common Stock on the date the option is granted.  However, in the event an option is granted under the 2003 Plan to a holder of 10% or more of the Company’s outstanding Common Stock, the exercise price must be at least 110% of such fair market value.  Under the 2003 Plan, options must be granted before the June 2, 2013 Termination Date.  No option may have a term longer than ten years (limited to five years in the case of an option granted to a 10% or greater stockholder of the Company).  The aggregate fair market value of the Company’s Common Stock with respect to which options are exercisable for the first time by a grantee under all of the Company’s Stock Option Plans during any calendar year cannot exceed $100.  Options granted under the 2003 Plan are non-transferable and must be exercised by an optionee, if at all, while employed by the Company or a subsidiary or within three months after termination of such optionee’s employment due to retirement, or within one year of such termination if due to disability or death.  The Board (or a Stock Option Committee, if designated), may, in its sole discretion, cause the Company to lend money to or guaranty any obligation of an employee for the purpose of enabling such employee to exercise an option granted under the 2003 Plan provided that such loan or obligation cannot exceed fifty percent (50%) of the exercise price of such option. In fiscal year ended October 31, 2013, 2012 and 2011, -0-, -0- and -0- options were granted under the Plan, respectively. A total of 4,000, 23,500 and 40,000 incentive stock options issued under the 2003 Plan were exercised in fiscal years ended in October 31, 2013, 2012 and 2011, respectively.  A total of 6,000, 13,000 and -0- options were cancelled in fiscal years ended October 31, 2013, 2012 and 2011.

 

In August 2000, the Company adopted, and on December 15, 2000, the stockholders approved, the 2000 Employee Incentive Stock Option Plan [“2000 Plan”]. The 2000 Plan provided for the granting of stock options, which may have been designated as incentive stock options, to purchase an aggregate of 1,600,000 shares of the Company’s common stock at a price not less than 100% of the fair market value per share of the common stock at the date of grant.  However, in the event an option was granted under the 2000 Plan to a holder of 10% or more of the Company’s outstanding common stock, the exercise price must have been at least 110% of fair market value at the date of grant.  Employees of the Company or its subsidiary, as determined, were eligible for the 2000 Plan.  The term of the options could not exceed ten years from the date of grant.  In fiscal years ended October 31, 2013, 2012 and 2011, no options were granted under the Plan. A total of 44,000, 8,000 and 39,600 incentive stock options issued under the 2000 Plan were exercised in fiscal years ended in October 31, 2013, 2012 and 2011, respectively. A total of 2,000, -0-, and -0- options were cancelled in fiscal years ended October 31, 2013, 2012 and 2011, respectively.  Options issued under the 2000 Plan must have been granted before the August 2010 termination date.

 

The following is a summary of Employee Incentive Stock Option Plan transactions:

 

58


Table of Contents

 

 

 

2003 Plan

 

 

 

Shares Under Options
[In Thousands]

 

Weighted Average
Exercise Price Per Share

 

Outstanding at October 31, 2010*

 

335

 

9.66

 

Granted

 

—

 

—

 

Expired

 

—

 

—

 

Exercised

 

(40

)

8.67

 

Outstanding at October 31, 2011*

 

295

 

9.80

 

 

 

 

 

 

 

Granted

 

—

 

—

 

Expired

 

(13

)

9.13

 

Exercised

 

(23

)

8.52

 

Outstanding at October 31, 2012*

 

259

 

$

9.95

 

 

 

 

 

 

 

Granted

 

—

 

—

 

Expired

 

(6

)

8.64

 

Exercised

 

(4

)

7.25

 

Outstanding at October 31, 2013*

 

249

 

10.02

 

 

*Eligible for exercise at October 31, 2010 were 310 at a weighted average exercise price per share of $9.66

*Eligible for exercise at October 31, 2011 were 275 at a weighted average exercise price per share of $9.80

*Eligible for exercise at October 31, 2012 were 244 at a weighted average exercise price per share of $9.95

*Eligible for exercise at October 31, 2013 were 239 at a weighted average exercise price per share of $9.97

 

 

 

2000 Plan

 

 

 

Shares Under
Options
 [In Thousands]

 

Weighted
Average
Exercise Price
Per Share

 

Outstanding and Eligible for Exercise at October 31, 2010

 

100

 

4.64

 

Granted

 

—

 

—

 

Expired

 

—

 

—

 

Exercised

 

(40

)

3.82

 

Outstanding and Eligible for Exercise at October 31, 2011

 

60

 

5.19

 

 

 

 

 

 

 

Granted

 

—

 

—

 

Expired

 

—

 

—

 

Exercised

 

(8

)

3.39

 

Outstanding and Eligible for Exercise at October 31, 2012

 

52

 

$

5.47

 

Granted

 

—

 

—

 

Expired

 

(2

)

3.60

 

Exercised

 

(44

)

5.25

 

Outstanding and Eligible for Exercise at October 31, 2013

 

 

 

 

 

 

 

6

 

7.67

 

 

Summary of outstanding options:

 

 

 

Weighted Average

 

Exercisable

 

 

 

Shares

 

Remaining

 

Exercise

 

Shares

 

Exercise

 

Exercise Price Range

 

Outstanding

 

Life

 

Price

 

Outstanding

 

Price

 

$6.11

 

to

 

$6.11

 

Per Share

 

6

 

0.75

 

6.11

 

6

 

6.11

 

$7.41

 

to

 

$7.67

 

Per Share

 

62

 

1.09

 

7.48

 

62

 

7.48

 

$9.13

 

to

 

$9.13

 

Per Share

 

147

 

1.00

 

9.13

 

147

 

9.13

 

$17.50

 

to

 

$17.50

 

Per Share

 

40

 

4.08

 

17.50

 

30

 

17.50

 

 

 

 

 

 

 

 

 

255

 

 

 

 

 

245

 

 

 

 

Compensation cost recognized for the years ended October 31, 2013, October 31, 2012 and October 31, 2011 was $40 for each one of the years, with a related tax benefit of $-0- with respect to these options.

 

[12] Employment Contracts and Consulting Agreements

 

The Company has multiple employment contracts with its key executives with expiration dates ranging from October 31, 2015 through October 31, 2018.  At October 31, 2013, the approximate aggregate minimum commitment under these employment contracts and agreements, excluding commissions or consumer price index increases, is as follows:

 

59


Table of Contents

 

October 31

 

Employees and
Consultants

 

2014

 

$

5,169

 

2015

 

3,873

 

2016

 

3,657

 

2017

 

2,918

 

2018

 

1,243

 

Thereafter

 

—

 

 

 

 

 

Total

 

$

16,860

 

 

Some of these agreements provide bonuses and commissions based on a percentage of collected revenues ranging from 1% to 10% on accounts referred by or serviced by the employee or consultant.

 

In addition to the above, in fiscal 2013 the Company has entered into seventy at — will employment and consulting agreements which together with prior at — will agreements provide for annual aggregate minimum commitments of approximately $33,555 which have no termination dates.

 

[13] Capitalized Lease Obligations

 

The Company leases various assets under capital leases expiring in fiscal 2018 with interest rates ranging between 2% to 8% as follows:

 

 

 

October 31

 

 

 

2013

 

2012

 

Medical Equipment

 

$

15,013

 

$

12,078

 

Automobiles

 

10,581

 

8,711

 

 

 

 

 

 

 

Totals

 

25,594

 

20,789

 

Less: Accumulated Depreciation

 

13,125

 

6,776

 

 

 

 

 

 

 

Net

 

$

12,469

 

$

14,013

 

 

Depreciation expense on assets under capital leases was approximately $6,494, $3,792, and $1,418 for the years ended October 31, 2013, 2012 and 2011, respectively.

 

Aggregate future minimum rentals under capital leases are:

 

October 31,

 

 

 

2014

 

$

5,622

 

2015

 

4,630

 

2016

 

3,727

 

2017

 

2,192

 

2018

 

660

 

Thereafter

 

15

 

 

 

 

 

Total

 

16,846

 

 

 

 

 

Less Interest:

 

949

 

 

 

 

 

Present Value of Minimum Lease Payments

 

$

15,897

 

 

[14] Commitments and Contingencies

 

The Company leases various office and laboratory facilities and equipment under operating leases expiring from 2014 to 2019.  Several of these leases contain renewal options for one to five year periods.

 

Total expense for property and equipment rental for the years ended October 31, 2013, 2012 and 2011 was $10,568, $8,787 and $8,010, respectively.  There were no contingent rental amounts due through October 31, 2013.

 

Aggregate future minimum rental payments on non cancelable operating leases [exclusive of several month to month leases] are as follows:

 

October 31,

 

Property($)

 

Equipment($)

 

 

 

 

 

 

 

2014

 

8,671

 

344

 

2015

 

2,333

 

223

 

2016

 

1,422

 

87

 

2017

 

558

 

—

 

2018

 

558

 

—

 

Thereafter

 

651

 

—

 

 

 

 

 

 

 

Totals:

 

14,193

 

654

 

 

The Company has entered into several purchase agreements for reagent supplies through October, 2018.  Minimum purchase commitments as of October 31, 2013 are as follows:

 

60


Table of Contents

 

October 31

 

Reagents ($)

 

2014

 

12,505

 

2015

 

11,938

 

2016

 

10,854

 

2017

 

6,559

 

2018

 

3,700

 

Thereafter

 

—

 

 

 

 

 

Totals:

 

45,556

 

 

Reagent supplies expensed under purchase agreements amount to $7,873, $13,338, and $8,379 for the years ended October 31, 2013, 2012 and 2011, respectively.

 

[15] Litigation

 

In the normal course of business, the Company is exposed to a number of asserted and unasserted potential claims.  In the opinion of management, the resolution of these matters will not have a material adverse effect on the Company’s financial position or results of operations.

 

[16] Insurance

 

The Company maintains professional liability insurance of $3,000 in the aggregate, with a per occurrence limit of $1,000.  In addition, the Company maintains excess commercial insurance of $5,000 per occurrence and $5,000 in aggregate over the primary limits.  In addition, the Company also maintains excess umbrella coverage of $15,000.

 

[17] Significant Risks and Uncertainties

 

[A] Concentrations of Credit Risk - Cash - At October 31, 2013 and 2012, the Company had approximately $14,720 and $21,260, respectively, in cash and certificate of deposit balances at financial institutions which were in excess of the federally insured limits.

 

[B] Concentration of Credit Risk - Accounts Receivable - Credit risk with respect to accounts receivable is generally diversified due to the large number of patients comprising the client base.  The Company does have significant receivable balances with government payors and various insurance carriers.  Generally, the Company does not require collateral or other security to support customer receivables.  However, the Company continually monitors and evaluates its client acceptance and collection procedures to minimize potential credit risks associated with its accounts receivable and establishes an allowance for uncollectible accounts and as a consequence, believes that its accounts receivable credit risk exposure beyond such allowance is not material to the financial statements.

 

A number of proposals for legislation continue to be under discussion which could substantially reduce Medicare and Medicaid (CMS) reimbursements to clinical laboratories.  Depending upon the nature of regulatory action, and the content of legislation, the Company could experience a significant decrease in revenues from Medicare and Medicaid (CMS), which could have a material adverse effect on the Company.  The Company is unable to predict, however, the extent to which such actions will be taken.

 

[18] Acquisitions

 

On April 27, 2012, the Company entered into an agreement pursuant to which the Company purchased preferred shares of IncellDx, Inc. (“IncellDx”), a Delaware corporation.  Information about IncellDx and the agreement may be found in the Current Report on Form 8-K the Company filed on May 1, 2012.

 

As of October 31, 2013 the Company invested a total $6,000.

 

On December 21, 2012, the Company entered into an agreement with Meridian Clinical Laboratory Corporation, a Florida corporation having its place of business in Miami, Florida (“Meridian”), pursuant to which the Company purchased all issued and outstanding common stock of Meridian for approximately $1,848 of which $250 is deferred for one year.

 

On December 31, 2012, Bio-Reference Laboratories, Inc. (the “Company”) entered into an agreement with Florida Clinical Laboratory, Inc., a Florida corporation having its place of business in Melbourne, Florida (“FCL”), pursuant to which the Company purchased all issued and outstanding shares of capital stock of FCL for approximately $7,016, of which $1,000 is deferred for eighteen months assuming certain conditions are met.

 

The following table sets forth these final purchase allocations.

 

 

 

($)

 

 

 

FCL

 

MCL

 

Totals:

 

 

 

 

 

 

 

 

 

Accounts Receivable

 

1,008

 

232

 

1,240

 

Autos

 

137

 

48

 

185

 

Medical Equipment

 

225

 

3

 

228

 

Computer Equipment

 

21

 

—

 

21

 

Leasehold Improvements

 

53

 

—

 

53

 

Other Non-Current Assets

 

3

 

—

 

3

 

Non-Compete Agreement

 

747

 

43

 

790

 

Deposits

 

—

 

2

 

2

 

Customer Relationships in Place

 

3,235

 

930

 

4,165

 

Goodwill

 

1,905

 

673

 

2,578

 

Accounts Payable

 

-118

 

-83

 

-201

 

Long Term Debt (Auto-Loans)

 

-200

 

—

 

-200

 

Short Term Acquisition Payable

 

-1,000

 

-250

 

-1,250

 

 

 

 

 

 

 

 

 

Totals:

 

6,016

 

1,598

 

7,614

 

 

61


Table of Contents

 

On August 7, 2013 the Company purchased substantially all of the operating assets and certain of the operating liabilities of Hunter Laboratories, Inc., (“Hunter”) a California corporation having its principal place of business in Campbell, California.  The gross purchase price was $15,215 plus payroll adjustment of $111 totaling $15,326.  Of that amount $3,000 was deferred to cover anticipated pre closing liabilities.

 

On August 20, 2013 the Company through its subsidiary GeneDx, Inc.,  purchased the entire membership interest in Edge BioServ, LLC, (“Edge Bio”) a Delaware limited liability company having its place of business in Gaithersburg, Maryland.  The gross purchase price was approximately $2,502.  Of that $375 was deferred to cover anticipated pre closing liabilities.

 

The following table sets forth these final purchase allocations.

 

 

 

$

 

 

 

Hunter

 

Edge Bio

 

Totals:

 

Accounts Receivable

 

1,700

 

—

 

1,700

 

Prepaid Expenses

 

421

 

70

 

491

 

Inventory

 

369

 

—

 

369

 

Autos

 

62

 

—

 

62

 

Furniture and Fixtures

 

265

 

6

 

271

 

Leasehold Improvements

 

—

 

714

 

714

 

Medical Equipment

 

234

 

906

 

1,140

 

Computer Equipment

 

376

 

574

 

950

 

Non-Compete Agreement

 

1,255

 

926

 

2,181

 

Customer Relationships in Place

 

3,852

 

3

 

3,855

 

Goodwill

 

8,573

 

182

 

8,755

 

Accounts Payable

 

(1,388

)

—

 

(1,388

)

Accrued Payroll Benefits

 

(393

)

—

 

(393

)

Notes Payable

 

—

 

(578

)

(578

)

Capital Leases

 

—

 

(193

)

(193

)

Deferred Acquisition Payable

 

(3,000

)

(375

)

(3,375

)

Deferred Rent Payable

 

—

 

(108

)

(108

)

 

 

 

 

 

 

 

 

Totals:

 

12,326

 

2,127

 

14,453

 

 

[19] Fair Value of Financial Instruments

 

For certain financial instruments, including cash and cash equivalents, trade receivables, trade  payables, and short-term debt, it was estimated that the carrying amount approximated fair value for the majority of these items because of their short maturities.  The fair value of the Company’s long-term debt is estimated based on the quoted market prices for similar issues or by discounting expected cash flows at the rates currently offered to the Company for debt of the same remaining maturities.

 

Due to the non-interest bearing nature and unspecified payment terms, it was not practicable to estimate the fair value of amounts due from related parties [See also Note 7].

 

[20] Health Insurance Plan

 

The Company has a limited self-funded health insurance plan for its employees under which the Company pays the initial $150 of covered medical expenses per person each year.  The Company has a contract with an insurance carrier for any excess up to a maximum of $2,000 per person and $20,504 in the aggregate.  Health insurance premium expense for the years ended October 31, 2013, 2012 and 2011 amounted to approximately $6,797, $5,792 and $4,426, respectively.  Uninsured employee medical expenses incurred by the Company amounted to approximately $32,016, $25,994 and $19,408 for the years ended October 31, 2013, 2012 and 2011, respectively.  During fiscal years ended October 31, 2013, 2012 and 2011, employee contributions of $4,713, $4,124 and $3,593 offset the above health plan costs.

 

[21] Employee Benefit Plan

 

The Company sponsors a 401(k) Profit-Sharing Plan [the “Plan”].  Employees become eligible for participation after attaining the age of eighteen and completing one year of service.  Participants may elect to contribute up to ten percent of their compensation, as defined in the Plan, to a maximum allowed by the Internal Revenue Service.  The Company may choose to make a matching contribution to the plan for each participant who has elected to make tax-deferred contributions for the plan year, at a percentage determined each year by the Company. The Company elected to make a matching contribution which amounted to $1,358 for 2013, $1,106 for 2012, and $993 for 2011.  These amounts were charged to the Statement of Operations. The Employer contribution will be fully vested after the third year of service.

 

[22] New Authoritative Accounting Pronouncements

 

The Company adopted Accounting Standard Update (“ASU”) No. 2011-7: Health Care Entities (Topic 954) — Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities commencing with the current fiscal year, the first year such standard is required for the Company. The adoption of this update did not have a material impact on the Company’s financial statements.

 

62


Table of Contents

 

Although this update does not have a material impact on the Company’s financial statements as a whole, it requires that we adjust our presentation of our statement of operations along with prior periods presented in this report to maintain comparability. As the result of this change in presentation, our “Net Revenues”, “Gross Profit on Revenues” and our “General and Administrative Expenses” would change while our “Operating Income”, “Net Income” and “Earnings per Share” will remain the same. The presentation is adjusted for a portion of our “Bad Debt Expense” that is now reported in our Net Revenues as required under ASU No. 2011-7.

 

63


Table of Contents

 

[23] Selected Quarterly Financial Data [Unaudited]

 

 

 

 

 

 

 

 

 

 

 

Audited

 

 

 

Three Month Ended

 

Fiscal Year

 

 

 

1/31/2013

 

4/30/2013

 

7/31/2013

 

10/31/2013

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Revenues

 

161,256

 

176,452

 

185,427

 

192,219

 

715,355

 

Gross Profit

 

70,922

 

80,676

 

85,660

 

85,282

 

322,539

 

Net Income

 

8,665

 

11,338

 

14,701

 

11,120

 

45,825

 

Net Income Per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

0.31

 

0.41

 

0.53

 

0.40

 

1.65

 

Diluted

 

0.31

 

0.41

 

0.53

 

0.40

 

1.65

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding — Basic [in thousands]

 

27,716

 

27,698

 

27,672

 

27,677

 

27,691

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding - Diluted [in thousands]

 

27,912

 

27,879

 

27,842

 

27,844

 

27,851

 

 

 

 

 

 

 

 

 

 

 

 

Audited

 

 

 

Three Month Ended

 

Fiscal Year

 

 

 

1/31/2012

 

4/30/2012

 

7/31/2012

 

10/31/2012

 

2012

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Revenues

 

$

138,793

 

$

151,443

 

$

160,532

 

$

163,487

 

$

614,255

 

Gross Profit

 

$

60,118

 

$

67,534

 

$

74,279

 

$

74,681

 

$

276,611

 

Net Income

 

$

7,365

 

$

9,306

 

$

12,596

 

$

12,889

 

$

42,156

 

Net Income Per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.26

 

$

0.34

 

$

0.45

 

$

0.47

 

$

1.52

 

Diluted

 

$

0.26

 

$

0.33

 

$

0.45

 

$

0.46

 

$

1.51

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding — Basic [in thousands]

 

27,888

 

27,685

 

27,695

 

27,705

 

27,742

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding - Diluted [in thousands]

 

28,041

 

27,878

 

27,888

 

27,906

 

27,921

 

 

 

 

 

 

Audited

 

 

 

Three Month Ended

 

Fiscal Year

 

 

 

1/31/2011

 

4/30/2011

 

7/31/2011

 

10/31/2011

 

2011

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Revenues

 

$

114,129

 

$

129,465

 

$

137,802

 

$

140,684

 

$

522,081

 

Gross Profit

 

$

49,276

 

$

57,447

 

$

63,206

 

$

64,300

 

$

234,229

 

Net Income

 

$

7,985

 

$

7,817

 

$

10,081

 

$

10,476

 

$

36,359

 

Net Income Per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.29

 

$

0.28

 

$

0.36

 

$

0.37

 

$

1.30

 

Diluted

 

$

0.28

 

$

0.28

 

$

0.36

 

$

0.37

 

$

1.29

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding — Basic [in thousands]

 

27,884

 

27,920

 

27,941

 

27,949

 

27,971

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding - Diluted [in thousands]

 

28,122

 

28,142

 

28,147

 

28,138

 

28,207

 

 

64


Table of Contents

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Shareholders of

Bio-Reference Laboratories, Inc.

Elmwood Park, New Jersey

 

Our report on our audit of the basic consolidated financial statements of Bio-Reference Laboratories, Inc. and its subsidiaries appears earlier in this document.  That audit was conducted for the purpose of forming an opinion on the consolidated basic financial statements taken as a whole.  The supplemental schedule II is presented for purposes of complying with the Securities and Exchange Commission’s Rules and Regulations under the Securities Exchange Act of 1934 and is not otherwise a required part of the basic consolidated financial statements.  Such information has been subjected to the auditing procedures applied in the audit of the basic consolidated financial  statements, and in our opinion, is fairly stated in all material respects in relation to the basic consolidated financial statements taken as a whole.

 

 

MSPC

 

Certified Public Accountants and Advisors,

 

A Professional Corporation

 

Cranford, New Jersey

January 10, 2014

 

65


Table of Contents

 

BIO-REFERENCE LABORATORIES, INC. AND SUBSIDIARIES

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS FOR THE YEARS ENDED OCTOBER 31, 2013, 2012 AND 2011

[In Thousands]

 

 

 

(b)

 

(c)

 

(d)

 

(e)

 

(a)
Description

 

Balance at the
Beginning of a Period

 

Charged to Cost and
Expenses

 

Deductions Charged to Valuation
Allowance Accounts

 

Balance at the End
of a Period

 

Year Ended October 31, 2013

 

 

 

 

 

 

 

 

 

Allowance for Doubtful Accounts

 

51,274

 

119,161

 

(81,174

)

89,261

 

Contractual Credits/Discounts

 

267,921

 

2,748,510

 

(2,674,134

)

342,297

 

 

 

 

 

 

 

 

 

 

 

Total Allowance

 

319,195

 

2,867,671

 

(2,755,308

)

431,558

 

 

 

 

 

 

 

 

 

 

 

Year Ended October 31, 2012

 

 

 

 

 

 

 

 

 

Allowance for Doubtful Accounts

 

45,220

 

89,396

 

(83,342

)

51,274

 

Contractual Credits/Discounts

 

235,922

 

2,390,770

 

(2,358,771

)

267,921

 

 

 

 

 

 

 

 

 

 

 

Total Allowance

 

281,142

 

2,480,166

 

(2,442,113

)

319,195

 

 

 

 

 

 

 

 

 

 

 

Year Ended October 31, 2011

 

 

 

 

 

 

 

 

 

Allowance for Doubtful Accounts

 

34,904

 

75,079

 

(64,763

)

45,220

 

Contractual Credits/Discounts

 

186,372

 

1,926,164

 

(1,876,614

)

235,922

 

 

 

 

 

 

 

 

 

 

 

Total Allowance

 

221,276

 

2,001,243

 

(1,941,377

)

281,142

 

 

66

 EX-10.5 2 a13-13310_1ex10d5.htm EX-10.5

EXHIBIT 10.5

 

2014 Senior Management Incentive Bonus Plan

 

Participants:        Marc D. Grodman, MD, CEO

Wendy Chung, CSO

Howard Dubinett, COO

Charles T. Todd, Sr. VP Marketing & Sales

Amar Karnath, VP Marketing

Gary Reeves, VP, Women’s Health

Scott Montgomery, VP, Clinical

Don Fowler, VP, Oncology

Warren Erdmann, SVP Operations

Nick Cetani, VP Laboratory Director

Ron Rayot, VP

Chris Smith, VP

Sam Singer, CFO

Sally Howlett, VP Billing

Nick Papazicos, SVP Financial Operations

James Weisberger, MD, CMO

Maryanne Amato, Director, Genpath

Sherri Bale, CCO GeneDx

Dean Gaalaas, COO GeneDx

Richard L. Faherty, CIO

John Mooney, VP

Cory Fishkin, COO CareEvolve

J. David Liss, VP, External Relations

 

Proposed Plan:

 

A.            The Senior Management Incentive Bonus Plan (the “Plan”) will be based on two (2) separate financial calculations. The first formula will be based on “Operating Income” as a percent of “Net Revenues” pursuant to the Consolidated Financial Statements of the Company. The second formula will be based on the percentage increase of “Operating Income” from fiscal 2013 to fiscal 2014 pursuant to the Consolidated Financial Statements of the Company.

 

B.            There will be one class of participation.

 

C.            Calculations for the first portion of the program will be as follows:

 

1.              Operating Income shall consist of the Total Operating Income (hereinafter referred to as “TOI”) for the Entire Company including all divisions and subsidiaries.

 

2.              In the event that TOI shall be equal to or greater than 11.00%, then and in such event, the participants will be entitled to a bonus based on the participant’s annual gross wages including any CPI adjustment paid to him or her in fiscal 2014 exclusive of any bonus, option exercise, auto or airplane usage expense charge-back, or other unearned revenue (“Annual Gross Wages”), pursuant to the following schedule:

 

If TOI is greater than or
equal to

 

and less than

 

Percent Bonus

 

12.25

%

12.75

%

4

%

12.75

%

13.25

%

6

%

13.25

%

13.75

%

8

%

13.75

%

NIA

 

10

%

 

3.             The maximum bonus to be paid under this portion of the program will be 10% of the Annual Gross Wages paid to the participant in fiscal 2014 regardless of TOI.

 

D.                  Calculations for the second portion of the program will be as follows:

 

1.              Operating Income will consist of Operating Income before interest and taxes for the Entire Company including all divisions and subsidiaries.

 

2.              Percentage increase on a year over year basis will be determined by subtracting the Operating Income as reported in the Company’s Consolidated Financial Statements for the 2013 fiscal year (“Base Year”) from the Operating Income as reported in the Company’s Consolidated Financial Statements for the 2014 fiscal year (“Current Year”).  This will

 


 

result in a difference (“Diff’).  The Diff will be divided by the Base Year to determine the percentage of change (“PC”) in Operating Income between the Base Year and the Current Year.

 

3.              In the event that the PC is positive (an increase) and equal to or greater than 25%, then and in such event, each participant will be entitled to a bonus based on the participant’s Annual Gross Wages pursuant to the following schedule:

 

If PC is greater than or
equal to:

 

and less than

 

Percent Bonus

 

25.00

%

30.00

%

6

%

30.00

%

35.00

%

9

%

35.00

%

40.00

%

12

%

40.00

%

NIA .

 

15

%

 

4.              The maximum bonus to be paid under this portion of the program will be 15% of Annual Gross Wages regardless of Operating Income.

 

E.                The two portions shall be calculated separately and shall not be dependent on each other. Participants may earn a bonus from either or both financial calculations. Regardless, however, of the Company achievements, the maximum bonus to be paid under the Plan will be 25% of Annual Gross Wages in fiscal 2014.

 

 EX-21 3 a13-13310_1ex21.htm EX-21

EXHIBIT 21

 

The following are the Company’s wholly-owned subsidiaries:

 

 

 

Jurisdiction of Incorporation

 

Name under which it
Conducts of Conducted Business

CareEvolve.com, Inc.

 

New Jersey

 

CareEvolve

GeneDX, Inc.

 

New Jersey

 

GeneDx

BRLI-GENPATH Diagnostics, Inc.

 

New Jersey

 

BRLI-GENPATH Diagnostics, Inc.

Genome Diagnostics, Ltd.

 

Canada

 

Genome Diagnostics, Ltd.

The Genetics Center, Inc.

 

New York

 

Genetics Center

Florida Clinical Laboratory, Inc.

 

Florida

 

Florida Clinical Laboratory, Inc.

Meridian Clinical Laboratory Corporation

 

Florida

 

Meridian Clinical Laboratory Corporation

 

 EX-23.1 4 a13-13310_1ex23d1.htm EX-23.1

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-111578) of Bio-Reference Laboratories, Inc. and its subsidiaries (the “Company”) of our report dated January 10, 2014, relating to the Company’s consolidated financial statements and the effectiveness of the Company’s internal control over financial reporting, which appears in this Annual Report on form 10-K.

 

 

 

MSPC

 

Certified Public Accountants and Advisors,

 

A Professional Corporation

 

Cranford, New Jersey

January 10, 2014

 

 EX-31.1 5 a13-13310_1ex31d1.htm EX-31.1

Exhibit 31.1

 

CHIEF EXECUTIVE OFFICER CERTIFICATION

 

I, Marc D. Grodman, certify that:

 

1. I have reviewed this report on Form 10-K of Bio-Reference Laboratories, Inc. (the “registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)                                 Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)                                 Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)                                  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)                                 Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

(a)                                 All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)                                 Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: January 10, 2014

 

 

 

 

/S/ Marc D. Grodman M.D.

 

Marc D. Grodman

 

President and Chief Executive Officer

 

Principal Executive Officer

 

 EX-31.2 6 a13-13310_1ex31d2.htm EX-31.2

Exhibit 31.2

 

CHIEF FINANCIAL OFFICER CERTIFICATION

 

I, Sam Singer, certify that:

 

1. I have reviewed this report on Form 10-Q of Bio-Reference Laboratories, Inc. (the “registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)           Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)           Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)           Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)           Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter ) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)           All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: January 10, 2014

 

 

 

 

/S/ Sam Singer

 

Sam Singer

 

Senior Vice President, Chief Financial and

 

Chief Accounting Officer

 

 EX-32.1 7 a13-13310_1ex32d1.htm EX-32.1

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

I, Marc D. Grodman, Chief Executive Officer of Bio-Reference Laboratories, Inc. (the “registrant”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(a)                                 the Annual Report on Form 10-K of the registrant for the fiscal year ended October, 31 2013, which this certification accompanies (the “Periodic Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

 

(b)                                 based on my knowledge, the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the registrant.

 

Dated: January 10, 2014.

 

 

 

 

/S/ Marc D. Grodman

 

Marc D. Grodman

 

Chief Executive Officer

 

Bio-Reference Laboratories, Inc.

 

 EX-32.2 8 a13-13310_1ex32d2.htm EX-32.2

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

I, Sam Singer, Chief Financial Officer of Bio-Reference Laboratories, Inc. (the “registrant”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(a)                                 the Annual Report on Form 10-K of the registrant for the fiscal year ended October 31 2013, which this certification accompanies (the “Periodic Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

 

(b)                                 based on my knowledge, the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the registrant.

 

Dated: January 10, 2014.

 

 

 

 

/S/ Sam Singer

 

Sam Singer

 

Chief Financial Officer

 

Bio-Reference Laboratories, Inc

 

 EX-101.INS 9 brli-20131031.xml XBRL INSTANCE DOCUMENT 0000792641 2012-11-01 2013-10-31 0000792641 brli:LaboratoryTestingBusinessMember us-gaap:MinimumMember 2012-11-01 2013-10-31 0000792641 us-gaap:MinimumMember 2012-11-01 2013-10-31 0000792641 us-gaap:MaximumMember 2012-11-01 2013-10-31 0000792641 2013-10-31 0000792641 2012-10-31 0000792641 us-gaap:LeaseholdImprovementsMember 2012-11-01 2013-10-31 0000792641 2011-11-01 2012-10-31 0000792641 2010-11-01 2011-10-31 0000792641 brli:IncellDxIncMember 2012-11-01 2013-10-31 0000792641 us-gaap:CustomerListsMember 2011-11-01 2012-10-31 0000792641 us-gaap:NoncompeteAgreementsMember 2011-11-01 2012-10-31 0000792641 brli:PatentsAndLicensesMember 2011-11-01 2012-10-31 0000792641 us-gaap:CustomerListsMember 2012-11-01 2013-10-31 0000792641 us-gaap:NoncompeteAgreementsMember 2012-11-01 2013-10-31 0000792641 brli:PatentsAndLicensesMember 2012-11-01 2013-10-31 0000792641 us-gaap:CustomerListsMember 2012-10-31 0000792641 us-gaap:NoncompeteAgreementsMember 2012-10-31 0000792641 us-gaap:CustomerListsMember 2013-10-31 0000792641 us-gaap:NoncompeteAgreementsMember 2013-10-31 0000792641 brli:PatentsAndLicensesMember 2013-10-31 0000792641 brli:PatentsAndLicensesMember 2012-10-31 0000792641 us-gaap:RevolvingCreditFacilityMember brli:DebtInstrumentVariableRateBaseRateMember 2012-11-01 2013-10-31 0000792641 brli:DebtInstrumentVariableRateEurodollarMember us-gaap:RevolvingCreditFacilityMember 2012-11-01 2013-10-31 0000792641 us-gaap:RevolvingCreditFacilityMember 2013-10-31 0000792641 us-gaap:RevolvingCreditFacilityMember brli:DebtInstrumentVariableRateBaseRateMember us-gaap:MinimumMember 2013-10-31 0000792641 us-gaap:RevolvingCreditFacilityMember brli:DebtInstrumentVariableRateEurodollarMember us-gaap:MaximumMember 2013-10-31 0000792641 brli:DebtInstrumentVariableRateEurodollarMember us-gaap:RevolvingCreditFacilityMember us-gaap:MinimumMember 2013-10-31 0000792641 us-gaap:RevolvingCreditFacilityMember brli:DebtInstrumentVariableRateBaseRateMember us-gaap:MaximumMember 2013-10-31 0000792641 us-gaap:RevolvingCreditFacilityMember brli:DebtInstrumentVariableRateBaseRateMember 2013-10-31 0000792641 brli:TermLoanMember brli:GenedxIncMember 2007-10-31 0000792641 brli:TermLoanMember 2012-11-01 2013-10-31 0000792641 brli:TermLoanMember 2006-11-01 2007-10-31 0000792641 us-gaap:MediumTermNotesMember 2010-12-01 2010-12-31 0000792641 brli:TermLoanMember 2007-10-31 0000792641 us-gaap:MediumTermNotesMember 2012-11-01 2013-10-31 0000792641 brli:TermLoanMember 2013-10-31 0000792641 us-gaap:MediumTermNotesMember 2013-10-31 0000792641 us-gaap:EquipmentMember 2012-10-31 0000792641 us-gaap:EquipmentMember 2013-10-31 0000792641 us-gaap:LeaseholdImprovementsMember 2012-10-31 0000792641 us-gaap:LeaseholdImprovementsMember 2013-10-31 0000792641 brli:FurnitureFixturesAndOfficeAndComputerEquipmentMember 2012-10-31 0000792641 brli:FurnitureFixturesAndOfficeAndComputerEquipmentMember 2013-10-31 0000792641 us-gaap:TransportationEquipmentMember 2012-10-31 0000792641 us-gaap:TransportationEquipmentMember 2013-10-31 0000792641 us-gaap:SeriesAPreferredStockMember 2013-10-31 0000792641 2012-12-06 0000792641 2011-11-11 0000792641 us-gaap:CommonStockMember 2012-11-01 2013-10-31 0000792641 us-gaap:CommonStockMember 2011-11-01 2012-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2003Member 2012-11-01 2013-10-31 0000792641 us-gaap:AutomobilesMember 2012-10-31 0000792641 us-gaap:AutomobilesMember 2013-10-31 0000792641 brli:PropertyMember 2013-10-31 0000792641 brli:IncellDxIncMember 2013-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2000Member 2012-11-01 2013-10-31 0000792641 brli:ExercisePriceRangeOneMember 2012-11-01 2013-10-31 0000792641 brli:ExercisePriceRangeTwoMember 2012-11-01 2013-10-31 0000792641 brli:ExercisePriceRangeThreeMember 2012-11-01 2013-10-31 0000792641 brli:ExercisePriceRangeFourMember 2012-11-01 2013-10-31 0000792641 brli:ExercisePriceRangeOneMember 2013-10-31 0000792641 brli:ExercisePriceRangeTwoMember 2013-10-31 0000792641 brli:ExercisePriceRangeThreeMember 2013-10-31 0000792641 brli:ExercisePriceRangeFourMember 2013-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2003Member 2013-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2000Member 2013-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2003Member 2010-11-01 2011-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2003Member brli:ShareholderWithMinimumSpecifiedPercentageOfStockMember 2012-11-01 2013-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2000Member brli:ShareholderWithMinimumSpecifiedPercentageOfStockMember 2012-11-01 2013-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2003Member us-gaap:MaximumMember 2012-11-01 2013-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2000Member us-gaap:MaximumMember 2012-11-01 2013-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2003Member 2010-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2003Member 2011-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2003Member 2012-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2000Member 2010-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2000Member 2011-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2000Member 2012-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2003Member 2011-11-01 2012-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2000Member 2011-11-01 2012-10-31 0000792641 brli:EmployeeIncentiveStockOptionPlan2000Member 2010-11-01 2011-10-31 0000792641 2012-11-01 2013-01-31 0000792641 2013-02-01 2013-04-30 0000792641 2013-05-01 2013-07-31 0000792641 2013-08-01 2013-10-31 0000792641 2011-11-01 2012-01-31 0000792641 2012-02-01 2012-04-30 0000792641 2012-05-01 2012-07-31 0000792641 2012-08-01 2012-10-31 0000792641 2010-11-01 2011-01-31 0000792641 2011-02-01 2011-04-30 0000792641 2011-05-01 2011-07-31 0000792641 2011-08-01 2011-10-31 0000792641 us-gaap:AllowanceForDoubtfulAccountsMember 2010-10-31 0000792641 brli:AllowanceForContractualCreditsAndDiscountsMember 2010-10-31 0000792641 2010-10-31 0000792641 us-gaap:AllowanceForDoubtfulAccountsMember 2011-10-31 0000792641 brli:AllowanceForContractualCreditsAndDiscountsMember 2011-10-31 0000792641 2011-10-31 0000792641 us-gaap:AllowanceForDoubtfulAccountsMember 2012-10-31 0000792641 brli:AllowanceForContractualCreditsAndDiscountsMember 2012-10-31 0000792641 us-gaap:AllowanceForDoubtfulAccountsMember 2013-10-31 0000792641 brli:AllowanceForContractualCreditsAndDiscountsMember 2013-10-31 0000792641 us-gaap:AllowanceForDoubtfulAccountsMember 2010-11-01 2011-10-31 0000792641 brli:AllowanceForContractualCreditsAndDiscountsMember 2010-11-01 2011-10-31 0000792641 us-gaap:AllowanceForDoubtfulAccountsMember 2011-11-01 2012-10-31 0000792641 brli:AllowanceForContractualCreditsAndDiscountsMember 2011-11-01 2012-10-31 0000792641 us-gaap:AllowanceForDoubtfulAccountsMember 2012-11-01 2013-10-31 0000792641 brli:AllowanceForContractualCreditsAndDiscountsMember 2012-11-01 2013-10-31 0000792641 2013-04-30 0000792641 2014-01-09 0000792641 us-gaap:SeriesAPreferredStockMember 2012-10-31 0000792641 us-gaap:CommonStockMember 2010-11-01 2011-10-31 0000792641 us-gaap:CommonStockMember 2010-10-31 0000792641 us-gaap:AdditionalPaidInCapitalMember 2010-10-31 0000792641 us-gaap:RetainedEarningsMember 2010-10-31 0000792641 us-gaap:AdditionalPaidInCapitalMember 2010-11-01 2011-10-31 0000792641 us-gaap:CommonStockMember 2011-10-31 0000792641 us-gaap:AdditionalPaidInCapitalMember 2011-10-31 0000792641 us-gaap:RetainedEarningsMember 2011-10-31 0000792641 us-gaap:CommonStockMember 2012-10-31 0000792641 us-gaap:AdditionalPaidInCapitalMember 2012-10-31 0000792641 us-gaap:RetainedEarningsMember 2012-10-31 0000792641 us-gaap:CommonStockMember 2013-10-31 0000792641 us-gaap:AdditionalPaidInCapitalMember 2013-10-31 0000792641 us-gaap:RetainedEarningsMember 2013-10-31 0000792641 us-gaap:AdditionalPaidInCapitalMember 2011-11-01 2012-10-31 0000792641 us-gaap:AdditionalPaidInCapitalMember 2012-11-01 2013-10-31 0000792641 us-gaap:RetainedEarningsMember 2010-11-01 2011-10-31 0000792641 us-gaap:RetainedEarningsMember 2011-11-01 2012-10-31 0000792641 us-gaap:RetainedEarningsMember 2012-11-01 2013-10-31 0000792641 2013-12-19 0000792641 brli:FloridaClinicalLaboratoryIncAndMeridianClinicalLaboratoryCorporationMember 2012-11-01 2013-10-31 0000792641 brli:HunterLaboratoriesIncAndEdgeBioServLLCMember 2012-11-01 2013-10-31 0000792641 brli:MeridianClinicalLaboratoryCorporationMember 2012-12-21 0000792641 brli:MeridianClinicalLaboratoryCorporationMember 2012-12-20 2012-12-21 0000792641 brli:FloridaClinicalLaboratoryIncMember 2012-12-31 0000792641 brli:FloridaClinicalLaboratoryIncMember 2012-12-30 2012-12-31 0000792641 brli:FloridaClinicalLaboratoryIncMember us-gaap:EquipmentMember 2012-12-31 0000792641 brli:FloridaClinicalLaboratoryIncMember us-gaap:AutomobilesMember 2012-12-31 0000792641 brli:FloridaClinicalLaboratoryIncMember us-gaap:ComputerEquipmentMember 2012-12-31 0000792641 brli:FloridaClinicalLaboratoryIncMember us-gaap:LeaseholdImprovementsMember 2012-12-31 0000792641 brli:FloridaClinicalLaboratoryIncMember us-gaap:NoncompeteAgreementsMember 2012-12-31 0000792641 brli:FloridaClinicalLaboratoryIncMember us-gaap:CustomerRelationshipsMember 2012-12-31 0000792641 brli:MeridianClinicalLaboratoryCorporationMember us-gaap:AutomobilesMember 2012-12-21 0000792641 brli:MeridianClinicalLaboratoryCorporationMember us-gaap:EquipmentMember 2012-12-21 0000792641 brli:MeridianClinicalLaboratoryCorporationMember us-gaap:NoncompeteAgreementsMember 2012-12-21 0000792641 brli:MeridianClinicalLaboratoryCorporationMember us-gaap:CustomerRelationshipsMember 2012-12-21 0000792641 brli:FloridaClinicalLaboratoryIncAndMeridianClinicalLaboratoryCorporationMember 2013-10-31 0000792641 brli:FloridaClinicalLaboratoryIncAndMeridianClinicalLaboratoryCorporationMember us-gaap:AutomobilesMember 2013-10-31 0000792641 brli:FloridaClinicalLaboratoryIncAndMeridianClinicalLaboratoryCorporationMember us-gaap:EquipmentMember 2013-10-31 0000792641 brli:FloridaClinicalLaboratoryIncAndMeridianClinicalLaboratoryCorporationMember us-gaap:ComputerEquipmentMember 2013-10-31 0000792641 brli:FloridaClinicalLaboratoryIncAndMeridianClinicalLaboratoryCorporationMember us-gaap:LeaseholdImprovementsMember 2013-10-31 0000792641 brli:FloridaClinicalLaboratoryIncAndMeridianClinicalLaboratoryCorporationMember us-gaap:NoncompeteAgreementsMember 2013-10-31 0000792641 brli:FloridaClinicalLaboratoryIncAndMeridianClinicalLaboratoryCorporationMember us-gaap:CustomerRelationshipsMember 2013-10-31 0000792641 brli:HunterLaboratoriesIncMember 2013-08-07 0000792641 brli:EdgeBioServeMember 2013-08-20 0000792641 brli:HunterLaboratoriesIncMember us-gaap:AutomobilesMember 2013-08-07 0000792641 brli:HunterLaboratoriesIncMember us-gaap:FurnitureAndFixturesMember 2013-08-07 0000792641 brli:HunterLaboratoriesIncMember us-gaap:EquipmentMember 2013-08-07 0000792641 brli:HunterLaboratoriesIncMember us-gaap:ComputerEquipmentMember 2013-08-07 0000792641 brli:HunterLaboratoriesIncMember us-gaap:NoncompeteAgreementsMember 2013-08-07 0000792641 brli:HunterLaboratoriesIncMember us-gaap:CustomerRelationshipsMember 2013-08-07 0000792641 brli:EdgeBioServeMember us-gaap:FurnitureAndFixturesMember 2013-08-20 0000792641 brli:EdgeBioServeMember us-gaap:LeaseholdImprovementsMember 2013-08-20 0000792641 brli:EdgeBioServeMember us-gaap:EquipmentMember 2013-08-20 0000792641 brli:EdgeBioServeMember us-gaap:ComputerEquipmentMember 2013-08-20 0000792641 brli:EdgeBioServeMember us-gaap:NoncompeteAgreementsMember 2013-08-20 0000792641 brli:EdgeBioServeMember us-gaap:CustomerRelationshipsMember 2013-08-20 0000792641 brli:HunterLaboratoriesIncAndEdgeBioServLLCMember 2013-10-31 0000792641 brli:HunterLaboratoriesIncAndEdgeBioServLLCMember us-gaap:AutomobilesMember 2013-10-31 0000792641 brli:HunterLaboratoriesIncAndEdgeBioServLLCMember us-gaap:FurnitureAndFixturesMember 2013-10-31 0000792641 brli:HunterLaboratoriesIncAndEdgeBioServLLCMember us-gaap:LeaseholdImprovementsMember 2013-10-31 0000792641 brli:HunterLaboratoriesIncAndEdgeBioServLLCMember us-gaap:EquipmentMember 2013-10-31 0000792641 brli:HunterLaboratoriesIncAndEdgeBioServLLCMember us-gaap:ComputerEquipmentMember 2013-10-31 0000792641 brli:HunterLaboratoriesIncAndEdgeBioServLLCMember us-gaap:NoncompeteAgreementsMember 2013-10-31 0000792641 brli:HunterLaboratoriesIncAndEdgeBioServLLCMember us-gaap:CustomerRelationshipsMember 2013-10-31 iso4217:USD xbrli:shares xbrli:pure brli:item iso4217:USD xbrli:shares 1 0.98 0.98 0.98 <div style="font-size:10.0pt;font-family:Times New Roman;"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Principles of Consolidation - The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.&#160; All significant intercompany accounts and transactions have been eliminated.</font> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Cash and Cash Equivalents - Cash equivalents are comprised of certain highly liquid investments with a maturity of three months or less when purchased.&#160; The Company had $17,952 and $25,143 in cash and cash equivalents at October&#160;31, 2013 and 2012, respectively.</font> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Inventory - Inventory is stated at the lower of cost [determined on a first-in, first-out basis] or market.&#160; Inventory consists of purchased laboratory supplies, which is used in our various testing laboratories.</font> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Property and Equipment - Property and equipment are carried at cost.&#160; Depreciation is computed by the straight-line method over the estimated useful lives of the respective assets, which generally range from 2 to 15 years.&#160; Leasehold improvements are amortized over the life of the lease or improvement, which is typically five years.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The statements of operations reflect depreciation expense related to property and equipment of $18,745, $16,082 and $13,684 for the years ended October&#160;31, 2013, 2012 and 2011, respectively.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">On sale or retirement, the asset cost and related accumulated depreciation or amortization are removed from the accounts, and any related gain or loss is reflected in general and administrative expenses.&#160; Repairs and maintenance are charged to expense when incurred.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Goodwill - Effective November&#160;1, 2011, the Company adopted revised Financial Accounting Standards Board (&#8220;FASB&#8221;)&#160; rules&#160;promulgated under Accounting Standards Update (&#8220;ASU&#8221;) No.&#160;2011-08 issued on September&#160;15, 2011,&#160;Intangibles&#8212;Goodwill and Other (Topic 350) Testing Goodwill for Impairment. Under these simplified goodwill impairment testing rules&#160;the Company assessed qualitative factors to determine whether events and circumstances lead to the conclusion that it is necessary to perform the two-step goodwill impairment test have occurred and determined that no such events had occurred.&#160; Under ASU No.&#160;2011-08, entities are not required to calculate the fair value of a reporting unit unless they conclude that it is more likely than not that the unit&#8217;s carrying value is greater than its fair value based on an assessment of events and circumstances. The &#8220;more likely than not&#8221; threshold is when there is a likelihood of more than 50% that a reporting unit&#8217;s carrying value is greater than its fair value.&#160; No impairment loss was recognized in the years ended October&#160;31, 2013, 2012 and 2011.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The balance sheet reflects prior Goodwill accumulated amortization of $2,401 as of October&#160;31, 2013 and 2012, respectively.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Other Intangible Assets - Intangible assets are amortized using the straight-line method.&#160; The estimated useful life of costs capitalized is evaluated for each specific project when completed, at which time such costs begin to be amortized. The statements of operations reflect amortization expense related to intangible assets of $994, $581, and $1,322 for the years ended October&#160;31, 2013, 2012 and 2011, respectively.&#160; The balance sheet reflects accumulated amortization of $8,846, and $7,852 as of October&#160;31, 2013, and 2012, respectively. During the 2013 and 2012 fiscal years, the Company did not write off any intangible assets.</font> </div> 0.02 <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accounting for Revenue</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Service revenues are principally generated from laboratory testing services including chemical diagnostic tests such as blood analysis, urine analysis and genetic testing among others. Service revenues are recognized at the time the testing services are performed and are reported at their estimated net realizable amounts.</font></p> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Service revenues before provision for bad debts are determined utilizing gross service revenues net of contractual adjustments and discounts. Even though it is the responsibility of the patient to pay for laboratory service bills, most individuals in the United States have an agreement with a third party payor such as Medicare, Medicaid or a commercial insurance provider to pay all or a portion of their healthcare expenses.&#160; The majority of services provided by Bio-Reference Laboratories,&#160;Inc. (&#8220;BRLI&#8221;) are to patients covered under a third party payor contract. In certain cases, the individual has no insurance or does not provide insurance information and in other cases tests are performed under contract to a professional organization (such as physicians, hospitals, and clinics) which reimburses BRLI directly.&#160; In the remainder of the cases, BRLI is provided the third party billing information and seeks payment from the third party under the terms and conditions of the third party payor for health service providers like BRLI. Each of these third party payors may differ not only with regard to rates, but also with regard to terms and conditions of payment and providing coverage (reimbursement) for specific tests. Estimated revenues are established based on a series of highly complex procedures and judgments that require industry specific healthcare experience and an understanding of payor methods and trends. We review our calculations on a monthly basis in order to make certain that we are properly allowing for the uncollectable portion of our gross billings due to the contractual adjustments and discounts and that our estimates remain sensitive to variances and changes within our payor groups. The contractual allowance calculation is made on the basis of historical allowance rates for the various specific payor groups on a monthly basis with a greater weight being given to the most recent trends This process is adjusted based on recent changes in underlying contract provisions and shifts in the testing being performed. This calculation is routinely analyzed by BRLI on the basis of actual allowances issued by payors and the actual payments made to determine what adjustments, if any, are needed. The table below shows the adjustments made to gross service revenues to arrive at net revenues, the amount reported on our statement of operations.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 86.68%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.1in;" border="0" cellspacing="0" cellpadding="0" width="86%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.92%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">($)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.92%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Year&#160;Ended</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.92%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Gross Service Revenues</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,524,108</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,052,431</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,482,349</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Contractual Adjustments and Discounts:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Medicare/Medicaid Portion</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">354,638</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">320,697</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">293,874</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">All Other Third Party Payors*</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,393,872</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,070,073</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,629,833</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total Contractual Adjustments and Discounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,748,510</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,390,770</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,923,707</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Service Revenues Net of Contractual Adjustments and Discounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">775,598</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">661,661</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">558,642</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Patient Service Revenue Provision for Bad Debts**</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">60,244</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">47,406</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">36,561</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Revenues</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">715,354</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">614,255</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">522,081</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Percent of Contractual Allowances, Discounts and Patient Service Provision for Bad Debts to Gross Revenue.</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">79.7</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">79.9</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">79.0</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">* All Other Third Party and Direct Payors consists of almost eight hundred distinct payors, including commercial health insurers and administrators as well as professionally billed accounts such as physicians, hospitals, clinics and other direct billed accounts.</font></p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">** Represents the amount of Bad Debt Expense that is now required to be presented as a deduction from patient service revenue (net of contractual allowances and discounts) pursuant to ASU No.&#160;2011-7.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">When new business is received by BRLI, service revenues net of contractual adjustments and discounts are calculated by reducing gross service revenues by the estimated contractual allowance. The Patient Service Revenue Provision for Bad Debts represents the amount of bad debt expense expected to occur on patient service revenue based upon our experience. The remaining bad debt expense is presented as part of operating expenses. The bad debt expense presented as part of operating expense represents the bad debt expense related to receivables from service revenues determined after taking into account our ability to collect on such revenue.&#160; BRLI recognized the amounts in subsequent periods for actual allowances/discounts to gross service revenue; bad debt may have been adjusted over the same periods of time to maintain an accurate balance between net revenues and actual revenues. Management has reviewed the allowances/discounts recognized in subsequent periods and believes the amounts to be immaterial. A number of proposals for legislation or regulation continue to be under discussion which could have the effect of substantially reducing Medicare reimbursements for clinical laboratories or introducing cost sharing to beneficiaries. Depending upon the nature of regulatory action, if any, which is taken and the content of legislation, if any, which is adopted, the Company could experience a significant decrease in revenues from Medicare and Medicaid, which could have a material adverse effect on the Company. The Company is unable to predict, however, the extent to which such actions will be taken.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accounting for Contractual Credits and Doubtful Accounts</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">It is typically the responsibility of the patient to pay for laboratory service bills. Most individuals in the United States have an agreement with a third party payor such as Medicare, Medicaid or commercial insurance to pay all or a portion of their healthcare expenses; this represents the major portion of payment for all services provided by BRLI. In certain cases, the individual has no insurance or does not provide insurance information; in the remainder of the cases, BRLI is provided the third party billing information, usually by the referring physician, and seeks payment from the third party under the terms and conditions of the third party payor for health service providers like BRLI. Each of these third party payors may differ not only with regard to rates, but also with regard to terms and conditions of payment and coverage of specific tests. BRLI routinely reviews the reimbursement policies and subsequent payments and collection rates from these different types of payors. Contractual adjustments and discounts are recorded as reductions to gross service revenues and are collectively referred to as the contractual allowance. BRLI has not been required to record an adjustment in a subsequent period related to revenue recorded in a prior period which was material in nature. Aging of accounts receivable is monitored by billing personnel and follow-up activities including collection efforts are conducted as necessary. BRLI writes off receivables against the allowance for doubtful accounts when they are deemed uncollectible. For client billing, accounts are written off when all reasonable collection efforts prove to be unsuccessful. Patient accounts, where the patient is directly responsible for all or a remainder portion of the account after partial payment or denial by a third party payor, are written off after the normal dunning cycle has occurred, although these may be subsequently transferred to a third party collection agency after being written off. Third party payor accounts are written off when they exceed the payer&#8217;s timely filing limits. Accounts Receivable on the balance sheet is net of the following amounts for contractual credits and doubtful accounts:</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 86%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.15in;" border="0" cellspacing="0" cellpadding="0" width="86%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 23.8%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="23%" colspan="3"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">($)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="72%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Contractual Credits/Discounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">342,297</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">267,921</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Doubtful Accounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">89,261</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">51,274</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="72%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total Allowance</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">431,558</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">319,195</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Current Income Taxes &#8212; The Company recognizes interest and penalties on settlement of tax liabilities in its income from operations.&#160; For the fiscal years 2011 through 2013, no material amounts for interest and penalties have been recorded.</font> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deferred Income Taxes - Deferred income tax assets and liabilities are computed annually for differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company adopted GAAP guidance with respect to uncertain tax positions when it became effective.&#160; Under these rules&#160;the Company may recognize the tax benefit from an uncertain tax position only if it meets the more-likely-than-not criteria (over 50% likelihood) of being realized on an examination by taxing authorities.&#160; For the years ended October&#160;31, 2011 through October&#160;31, 2013 the Company had no material uncertain tax positions to report.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Earnings Per Share - Basic earnings per share [&#8220;EPS&#8221;] reflects the amount of income attributable to each share of common stock based on average common shares outstanding during the period.&#160; Diluted EPS reflects Basic EPS while giving effect to all potential dilutive common shares that were outstanding during the period, such as common shares that could result from the exercise or conversion of securities into common stock.&#160; The computation of Diluted EPS is calculated by using the treasury stock method, which assumes that any proceeds obtained from the exercise of such dilutive securities would be used to purchase common stock at the average market price of the common stock during the period.&#160; This reduces the gross number of dilutive shares by the number of shares purchasable from the proceeds of the securities assumed to be exercised.&#160; Securities whose conversion would have an anti-dilutive effect on EPS are not assumed converted.&#160; Securities that could potentially dilute earnings in the future are disclosed in Note 10.</font> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160; Actual results could differ from those estimates.</font> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Recoverability and Impairment of Intangible Assets and Other Long-Lived Assets &#8212; The Company evaluates the possible impairment of its long-lived assets under the provisions of FASB codification 350-30-35 and 360-10-35.&#160; The Company reviews the recoverability of its long-lived assets on an annual basis.&#160; Evaluation of possible impairment is based on the Company&#8217;s ability to recover the asset from the expected future pretax cash flows (undiscounted and without interest charges) of the related operations. If the expected undiscounted pretax cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.&#160; No impairment loss was recognized in the fiscal years ended October&#160;31, 2013, 2012 and 2011.</font> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Advertising Costs -Advertising costs are expensed when incurred.&#160; Advertising costs amounted to approximately $3,200, $2,366 and $2,026 for the years ended October&#160;31, 2013, 2012 and 2011, respectively.</font> </div> 0.08 <div style="font-size:10.0pt;font-family:Times New Roman;"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Other Income &#8212; During the year the Company recorded a loss of $450on its investment in IncellDx.&#160; The loss represents the Company&#8217;s share of IncellDX undistributed net loss under the equity method of accounting.&#160; During the year ended October&#160;31, 2013 the Company received a refund of $1,062 for its New York State clinical laboratory inspection fee that was included in other income.</font> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Subsequent Events &#8212; The management considered subsequent events through the date the financial statements are issued as defined in FASB Codification 855-10-50.</font> </div> 775598000 17952000 25143000 P2Y P15Y P5Y 16082000 13684000 18745000 2401000 2401000 581000 1322000 994000 7852000 8847000 2366000 2026000 3200000 -450000 -450000 P20Y P5Y P17Y P20Y P3Y P17Y 4573000 4305000 14175000 8739000 11131000 5297000 25166000 5297000 2537000 4257000 4560000 1408000 1058000 2036000 48000 6323000 5860000 6571000 3889000 16320000 4239000 <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 86.68%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.1in;" border="0" cellspacing="0" cellpadding="0" width="86%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.92%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">($)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.92%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Year&#160;Ended</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.92%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Gross Service Revenues</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,524,108</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,052,431</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,482,349</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Contractual Adjustments and Discounts:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Medicare/Medicaid Portion</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">354,638</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">320,697</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">293,874</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">All Other Third Party Payors*</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,393,872</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,070,073</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,629,833</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total Contractual Adjustments and Discounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,748,510</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,390,770</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,923,707</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Service Revenues Net of Contractual Adjustments and Discounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">775,598</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">661,661</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">558,642</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Patient Service Revenue Provision for Bad Debts**</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">60,244</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">47,406</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">36,561</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Revenues</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">715,354</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">614,255</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">522,081</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Percent of Contractual Allowances, Discounts and Patient Service Provision for Bad Debts to Gross Revenue.</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">79.7</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">79.9</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">79.0</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">* All Other Third Party and Direct Payors consists of almost eight hundred distinct payors, including commercial health insurers and administrators as well as professionally billed accounts such as physicians, hospitals, clinics and other direct billed accounts.</font></p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">** Represents the amount of Bad Debt Expense that is now required to be presented as a deduction from patient service revenue (net of contractual allowances and discounts) pursuant to ASU No.&#160;2011-7.</font></p> </div> 1852000 1540000 1063000 946000 9002000 15000 base rate Eurodollar rate 45000000 0.50 0.01 0.04 0.01 0.04 0.0350 493000 518000 551000 585000 2016000 5000000 Monthly P6Y P7Y 5000000 61000 0.0685 0.0612 4163000 5408000 84 69000 52261000 67950000 50440000 65649000 102701000 133599000 50338000 65762000 19768000 27974000 16503000 21621000 16092000 18242000 0.35 0.35 0.35 0.0887 0.0987 0.1120 -0.0044 -0.0094 -0.0278 0.4343 0.4393 0.4342 25794000 24573000 38295000 10203000 9825000 14018000 -2183000 -4223000 -10803000 -1454000 -1688000 -6238000 22560000 39275000 1963000 1815000 2667000 3141000 -16715000 -281000 -607000 32360000 28487000 35272000 -5911000 -17041000 -3638000 27190000 44231000 24912000 42154000 2278000 2077000 3000 13101000 11036000 146292000 1 714550 1000000 81600 285450 81600 5193000 285450 3052431000 11432 11432 11431 42156000 27742257 27920920 1.52 1.51 36359000 27971100 179000 28207358 1.29 236000 1.30 45825000 27690677 161000 27851720 1.65 1.65 <div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;TEXT-ALIGN: left; WIDTH: 408px; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="408"> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Medical Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">65,762</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">50,338</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Leasehold Improvements</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,974</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">19,768</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Furniture, Fixtures and Office&#160;&amp; Computer Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">21,621</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">16,503</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Automobiles and Aircraft</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">18,242</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">16,092</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Sub Totals</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">133,599</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">102,701</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Less Accumulated Depreciation</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">67,950</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">52,261</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals &#8212; Net of Accumulated Depreciation</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">65,649</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">50,440</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table></div> <div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><u><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">October&#160;31, 2013</font></u></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;TEXT-ALIGN: left; WIDTH: 445px; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="445"> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Weighted-Average</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Accumulated</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Net&#160;of<br /> Accumulated</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Intangible&#160;Asset</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Amortization&#160;Period</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Cost</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Amortization</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Amortization</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Customer Lists</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">20</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8,739</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,879</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5,860</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Covenants Not-to-Compete</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">11,131</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,560</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6,571</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Patents and Licenses</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">17</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5,297</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,408</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,889</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">25,166</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8,847</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">16,320</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><u><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">October&#160;31, 2012</font></u></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;TEXT-ALIGN: left; WIDTH: 448px; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="448"> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Weighted-Average</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Accumulated</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Net&#160;of<br /> Accumulated</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Intangible&#160;Asset</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Amortization&#160;Period</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Cost</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Amortization</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Amortization</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Customer Lists</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">20</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,573</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,537</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,036</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Covenants Not-to-Compete</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,305</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,257</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">48</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Patents and Licenses</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">17</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5,297</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,058</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,239</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">14,175</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7,852</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6,323</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table></div> <div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;TEXT-ALIGN: left; WIDTH: 244px; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 2.25in;" border="0" cellspacing="0" cellpadding="0" width="244"> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="64%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2014</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,917</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2015</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,852</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,540</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2017</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,063</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2018</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">946</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Thereafter</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9,002</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.7%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">16,320</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table></div> <div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;TEXT-ALIGN: left; WIDTH: 261px; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="261"> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="64%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Year&#160;Ended</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="64%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2014</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">493</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2015</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">518</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">551</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2017</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">585</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2018</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Thereafter</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,163</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="208"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="19"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="10"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="80"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="7"></td></tr></table></div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 80%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.75in;" border="0" cellspacing="0" cellpadding="0" width="80%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="53%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="40%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="53%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">U.S. Federal Statutory Rate</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">35</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">35</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">35</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">State and Local Taxes, Net of U.S. Federal Tax Benefit</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">11.20</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8.87</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9.87</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Permanent differences and Other</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(2.78</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)%</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(0.44</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)%</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(0.94</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)%</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Actual Rate</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">43.42</font></p></td> <td style="PADDING-BOTTOM: 2.25pt; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">43.43</font></p></td> <td style="PADDING-BOTTOM: 2.25pt; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">43.93</font></p></td> <td style="PADDING-BOTTOM: 2.25pt; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 76.66%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.75in;" border="0" cellspacing="0" cellpadding="0" width="76%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41.78%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="41%" colspan="8"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Current:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Federal</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">38,295</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">25,794</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.42%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">24,573</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">State&#160;&amp; Local</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">14,018</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">10,203</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9,825</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deferred:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Federal</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(10,803</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(2,183</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(4,223</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">State and Local</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(6,238</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(1,454</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(1,688</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total Provision for Income Taxes</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">35,272</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">32,360</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,487</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 76.66%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.5in;" border="0" cellspacing="0" cellpadding="0" width="76%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="60%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 34.54%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="34%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="60%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deferred Tax Asset:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Bad Debt Allowance</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.34%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">39,275</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.34%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">22,560</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Depreciation and amortization</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,815</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,963</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accrued Expenses</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,141</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,667</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deferred Tax Asset - Net</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">44,231</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,190</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Current Deferred Tax Asset - Net</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">42,154</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">24,912</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Long Term Deferred Tax Asset - Net</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,077</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,278</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deferred Tax Asset &#8212; Net</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">44,231</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.34%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,190</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="349"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="19"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="7"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="82"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="19"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="7"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="82"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="8"></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The computation of basic and diluted net earnings per common share is as follows [in thousands, except per share data rounded]:</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 80%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="80%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 43.78%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="43%" colspan="8"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">For&#160;Years&#160;Ended&#160;October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Income Available to Common Stockholders</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">45,825</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">42,156</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">36,359</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Common Shares Outstanding</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,691</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,742</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,971</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><u><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Effect of Dilutive Securities:</font></u></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Warrants/Options</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">161</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">179</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">236</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><u><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Diluted Common Shares Outstanding</font></u></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,852</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,921</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,207</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><u><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income Per Share - Basic</font></u></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.65</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.52</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.30</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><u><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income Per Share - Diluted</font></u></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.65</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.51</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.29</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p> <table style="text-align:left;WIDTH: 50%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.25in;" border="0" cellspacing="0" cellpadding="0" width="50%"> <tr style="padding:0;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="68%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.02%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="24%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Employees&#160;and<br /> Consultants</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2014</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.62%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5,169</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2015</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.02%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,873</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,657</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2017</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.02%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,918</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2018</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,243</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Thereafter</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.02%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="24%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.62%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.4%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">16,860</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;TEXT-ALIGN: left; WIDTH: 397px; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="397"> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="4"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Medical Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">15,013</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">12,078</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Automobiles</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">10,581</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8,711</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">25,594</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">20,789</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Less: Accumulated Depreciation</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">13,125</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6,776</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">12,469</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">14,013</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table></div> <div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;TEXT-ALIGN: left; WIDTH: 357px; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="357"> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="74%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2014</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.84%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5,622</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2015</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,630</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,727</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2017</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,192</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2018</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">660</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Thereafter</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">15</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">16,846</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Less Interest:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">949</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Present Value of Minimum Lease Payments</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.84%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">15,897</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table></div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 50%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.25in;" border="0" cellspacing="0" cellpadding="0" width="50%"> <tr style="padding:0;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="40%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Property($)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Equipment($)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2014</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8,671</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">344</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2015</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,333</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">223</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,422</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">87</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2017</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">558</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2018</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">558</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Thereafter</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">651</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">14,193</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">654</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p> <table style="text-align:left;WIDTH: 50%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="50%"> <tr style="padding:0;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="57%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="36%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Reagents&#160;</font></b><b><font style="FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">($)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="57%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2014</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">12,505</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="57%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2015</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">11,938</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="57%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">10,854</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="57%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2017</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6,559</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="57%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2018</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,700</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="57%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Thereafter</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="57%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="57%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">45,556</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p> <table style="text-align:left;WIDTH: 93.32%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="93%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.98%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="4"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2003&#160;Plan</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Shares&#160;Under&#160;Options<br /> [In&#160;Thousands]</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Weighted&#160;Average<br /> Exercise&#160;Price&#160;Per&#160;Share</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding at October&#160;31, 2010*</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">335</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9.66</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Granted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Expired</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Exercised</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(40</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8.67</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding at October&#160;31, 2011*</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">295</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9.80</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Granted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Expired</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(13</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9.13</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Exercised</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(23</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8.52</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding at October&#160;31, 2012*</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">259</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.78%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9.95</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Granted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Expired</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(6</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8.64</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Exercised</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(4</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7.25</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding at October&#160;31, 2013*</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">249</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">10.02</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="414"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="19"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="120"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="19"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="10"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="110"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="8"></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 9pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">*Eligible for exercise at October&#160;31, 2010 were 310 at a weighted average exercise price per share of $9.66</font></p> <p style="TEXT-INDENT: 9pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">*Eligible for exercise at October&#160;31, 2011 were 275 at a weighted average exercise price per share of $9.80</font></p> <p style="TEXT-INDENT: 9pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">*Eligible for exercise at October&#160;31, 2012 were 244 at a weighted average exercise price per share of $9.95</font></p> <p style="TEXT-INDENT: 9pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">*Eligible for exercise at October&#160;31, 2013 were 239 at a weighted average exercise price per share of $9.97</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 86.66%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="86%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="7"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 35%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="35%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Weighted&#160;Average</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 22.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="22%" colspan="3"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Exercisable</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="7"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.04%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Shares</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Remaining</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Exercise</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Shares</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Exercise</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="7"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Exercise&#160;Price&#160;Range</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.04%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Outstanding</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Life</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Price</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Outstanding</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Price</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 7.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="7%"> <p style="TEXT-ALIGN: right; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$6.11</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">to</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$6.11</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Per Share</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.75</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6.11</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6.11</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 7.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="7%"> <p style="TEXT-ALIGN: right; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$7.41</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.42%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">to</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$7.67</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Per Share</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">62</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.09</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7.48</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">62</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7.48</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 7.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="7%"> <p style="TEXT-ALIGN: right; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$9.13</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">to</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$9.13</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Per Share</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">147</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.00</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9.13</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">147</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9.13</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 7.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="7%"> <p style="TEXT-ALIGN: right; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$17.50</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.42%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">to</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$17.50</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Per Share</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.04%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">40</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4.08</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">17.50</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">30</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">17.50</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 7.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="7%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">255</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">245</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[11] Stock Options and Warrants</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Employee Incentive Stock Options -</font></i></b> <font style="FONT-SIZE: 10pt;" size="2">In June&#160;2003, the Board of Directors adopted, and in July&#160;2003, the stockholders approved, the 2003 Employee Incentive Stock Option Plan [the &#8220;2003 Plan&#8221;].&#160; The 2003 Plan authorizes the grant of stock options, which may be designated as&#160; incentive stock options, to purchase up to a maximum aggregate 1,600,000 shares of Company common stock.&#160; The 2003 Plan provides that the exercise price of an option granted there under shall not be less than the fair market value of the Common Stock on the date the option is granted.&#160; However, in the event an option is granted under the 2003 Plan to a holder of 10% or more of the Company&#8217;s outstanding Common Stock, the exercise price must be at least 110% of such fair market value.&#160; Under the 2003 Plan, options must be granted before the June&#160;2, 2013 Termination Date.&#160; No option may have a term longer than ten years (limited to five years in the case of an option granted to a 10% or greater stockholder of the Company).&#160; The aggregate fair market value of the Company&#8217;s Common Stock with respect to which options are exercisable for the first time by a grantee under all of the Company&#8217;s Stock Option Plans during any calendar year cannot exceed $100.&#160; Options granted under the 2003 Plan are non-transferable and must be exercised by an optionee, if at all, while employed by the Company or a subsidiary or within three months after termination of such optionee&#8217;s employment due to retirement, or within one year of such termination if due to disability or death.&#160; The Board (or a Stock Option Committee, if designated), may, in its sole discretion, cause the Company to lend money to or guaranty any obligation of an employee for the purpose of enabling such employee to exercise an option granted under the 2003 Plan provided that such loan or obligation cannot exceed fifty percent (50%) of the exercise price of such option. In fiscal year ended October&#160;31, 2013, 2012 and 2011, -0-, -0- and -0- options were granted under the Plan, respectively. A total of 4,000, 23,500 and 40,000 incentive stock options issued under the 2003 Plan were exercised in fiscal years ended in October&#160;31, 2013, 2012 and 2011, respectively.&#160; A total of 6,000, 13,000 and -0- options were cancelled in fiscal years ended October&#160;31, 2013, 2012 and 2011.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">In August&#160;2000, the Company adopted, and on December&#160;15, 2000, the stockholders approved, the 2000 Employee Incentive Stock Option Plan [&#8220;2000 Plan&#8221;]. The 2000 Plan provided for the granting of stock options, which may have been designated as incentive stock options, to purchase an aggregate of 1,600,000 shares of the Company&#8217;s common stock at a price not less than 100% of the fair market value per share of the common stock at the date of grant.&#160; However, in the event an option was granted under the 2000 Plan to a holder of 10% or more of the Company&#8217;s outstanding common stock, the exercise price must have been at least 110% of fair market value at the date of grant.&#160; Employees of the Company or its subsidiary, as determined, were eligible for the 2000 Plan.&#160; The term of the options could not exceed ten years from the date of grant.&#160; In fiscal years ended October&#160;31, 2013, 2012 and 2011, no options were granted under the Plan. A total of 44,000, 8,000 and 39,600 incentive stock options issued under the 2000 Plan were exercised in fiscal years ended in October&#160;31, 2013, 2012 and 2011, respectively. A total of 2,000, -0-, and -0- options were cancelled in fiscal years ended October&#160;31, 2013, 2012 and 2011, respectively.&#160; Options issued under the 2000 Plan must have been granted before the August&#160;2010 termination date.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The following is a summary of Employee Incentive Stock Option Plan transactions:</font></p> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p> <table style="text-align:left;WIDTH: 93.32%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="93%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.98%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="4"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2003&#160;Plan</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Shares&#160;Under&#160;Options<br /> [In&#160;Thousands]</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Weighted&#160;Average<br /> Exercise&#160;Price&#160;Per&#160;Share</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding at October&#160;31, 2010*</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">335</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9.66</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Granted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Expired</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Exercised</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(40</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8.67</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding at October&#160;31, 2011*</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">295</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9.80</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Granted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Expired</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(13</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9.13</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Exercised</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(23</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8.52</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding at October&#160;31, 2012*</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">259</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.78%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9.95</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Granted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Expired</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(6</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8.64</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Exercised</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(4</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7.25</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding at October&#160;31, 2013*</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">249</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">10.02</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="414"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="19"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="120"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="19"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="10"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="110"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="8"></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 9pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">*Eligible for exercise at October&#160;31, 2010 were 310 at a weighted average exercise price per share of $9.66</font></p> <p style="TEXT-INDENT: 9pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">*Eligible for exercise at October&#160;31, 2011 were 275 at a weighted average exercise price per share of $9.80</font></p> <p style="TEXT-INDENT: 9pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">*Eligible for exercise at October&#160;31, 2012 were 244 at a weighted average exercise price per share of $9.95</font></p> <p style="TEXT-INDENT: 9pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">*Eligible for exercise at October&#160;31, 2013 were 239 at a weighted average exercise price per share of $9.97</font></p> <p style="TEXT-INDENT: 9pt; MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 90%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="90%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="62%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 33.88%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="33%" colspan="4"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2000&#160;Plan</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="62%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Shares&#160;Under<br /> Options<br /> &#160;[In&#160;Thousands]</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Weighted<br /> Average<br /> Exercise&#160;Price<br /> Per&#160;Share</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="62%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding and Eligible for Exercise at October&#160;31, 2010</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">100</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4.64</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Granted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Expired</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Exercised</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(40</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3.82</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="62%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding and Eligible for Exercise at October&#160;31, 2011</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">60</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5.19</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Granted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Expired</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Exercised</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(8</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3.39</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="62%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding and Eligible for Exercise at October&#160;31, 2012</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">52</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.26%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5.47</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Granted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Expired</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(2</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3.60</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Exercised</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(44</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5.25</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="62%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding and Eligible for Exercise at October&#160;31, 2013</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7.67</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="419"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="19"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="105"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="19"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="9"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="96"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="7"></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Summary of outstanding options:</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 86.66%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="86%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="7"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 35%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="35%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Weighted&#160;Average</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 22.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="22%" colspan="3"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Exercisable</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="7"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.04%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Shares</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Remaining</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Exercise</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Shares</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Exercise</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="7"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Exercise&#160;Price&#160;Range</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.04%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Outstanding</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Life</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Price</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Outstanding</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Price</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 7.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="7%"> <p style="TEXT-ALIGN: right; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$6.11</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">to</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$6.11</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Per Share</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.75</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6.11</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6.11</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 7.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="7%"> <p style="TEXT-ALIGN: right; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$7.41</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.42%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">to</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$7.67</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Per Share</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">62</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.09</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7.48</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">62</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7.48</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 7.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="7%"> <p style="TEXT-ALIGN: right; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$9.13</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">to</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$9.13</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Per Share</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">147</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.00</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9.13</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">147</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9.13</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 7.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="7%"> <p style="TEXT-ALIGN: right; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$17.50</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.42%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">to</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$17.50</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Per Share</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.04%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">40</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4.08</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">17.50</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">30</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">17.50</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 7.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="7%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.52%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">255</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">245</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Compensation cost recognized for the years ended October&#160;31, 2013, October&#160;31, 2012 and October&#160;31, 2011 was $40 for each one of the years, with a related tax benefit of $-0- with respect to these options.</font></p> </div> 5169000 3873000 3657000 2918000 1243000 16860000 0.01 0.10 70 33555000 12078000 15013000 8711000 10581000 20789000 25594000 6776000 13125000 14013000 12469000 3792000 1418000 6494000 5622000 4630000 3727000 2192000 660000 16846000 949000 15897000 P1Y P5Y 8787000 8010000 10568000 8671000 344000 2333000 223000 1422000 87000 14193000 654000 558000 558000 651000 13338000 8379000 7873000 12505000 11938000 10854000 6559000 3700000 45556000 6000000 <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">New Accounting pronouncements</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Certain prior year amounts have been reclassified to conform to the current year presentation. The Company adopted Accounting Standard Update (&#8220;ASU&#8221;) No.&#160;2011-7: Health Care Entities (Topic 954) &#8212; Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities commencing with the current fiscal year, the first year such standard is required for the Company. The adoption of this update did not have a material impact on the Company&#8217;s financial statements.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Although this update does not have a material impact on the Company&#8217;s financial statements as a whole, it requires that we adjust our presentation of our statement of operations along with prior periods presented in this report to maintain comparability. As the result of this change in presentation, our &#8220;Net Revenues&#8221;, &#8220;Gross Profit on Revenues&#8221; and our &#8220;General and Administrative Expenses&#8221; would change while our &#8220;Operating Income&#8221;, &#8220;Net Income&#8221; and &#8220;Earnings per Share&#8221; will remain the same. The presentation is adjusted for a portion of our &#8220;Bad Debt Expense&#8221; that is now reported in our Net Revenues as required under ASU No.&#160;2011-7.</font></p> </div> 3000000 1000000 5000000 5000000 15000000 21260000 14720000 5792000 4426000 6797000 25994000 19408000 32016000 4124000 3593000 4713000 150000 2000000 20504000 P18Y P1Y 1106000 993000 1358000 0.10 <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="TEXT-INDENT: 9pt; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 9pt; MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 90%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="90%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="62%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 33.88%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="33%" colspan="4"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2000&#160;Plan</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="62%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Shares&#160;Under<br /> Options<br /> &#160;[In&#160;Thousands]</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Weighted<br /> Average<br /> Exercise&#160;Price<br /> Per&#160;Share</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="62%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding and Eligible for Exercise at October&#160;31, 2010</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">100</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4.64</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Granted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Expired</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Exercised</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(40</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3.82</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="62%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding and Eligible for Exercise at October&#160;31, 2011</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">60</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5.19</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Granted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Expired</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Exercised</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(8</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3.39</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="62%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding and Eligible for Exercise at October&#160;31, 2012</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">52</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.26%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5.47</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Granted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Expired</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(2</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3.60</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Exercised</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(44</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5.25</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="62%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Outstanding and Eligible for Exercise at October&#160;31, 2013</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 62.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="62%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.56%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7.67</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="419"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="19"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="105"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="19"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="9"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="96"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="7"></td></tr></table> </div> 40000 40000 40000 0 0 0 6.11 7.41 9.13 17.50 6.11 7.67 9.13 17.50 255000 6000 62000 147000 40000 P9M P1Y1M2D P1Y P4Y29D 6.11 7.48 9.13 17.50 6000 62000 147000 30000 245000 6.11 7.48 9.13 17.50 1600000 1600000 0 1.10 1.00 1.10 0.10 0.10 P5Y P10Y P10Y 100000 P3M P1Y 0.50 335000 295000 259000 249000 100000 60000 52000 6000 6000 13000 2000 4000 23000 40000 44000 8000 40000 10.02 9.95 9.80 9.66 7.67 5.47 5.19 4.64 9.13 8.64 8.52 8.67 7.25 3.39 5.25 3.82 3.60 239000 244000 275000 310000 9.97 9.95 9.80 9.66 161256000 70922000 8665000 0.31 0.31 27716000 27912000 176452000 80676000 11338000 0.41 0.41 27698000 27879000 185427000 85660000 14701000 0.53 0.53 27672000 27842000 192219000 85282000 11120000 0.40 0.40 27677000 27844000 715354000 322539000 138793000 151443000 160532000 163487000 614255000 60118000 67534000 74279000 74681000 276611000 7365000 9306000 12596000 12889000 0.26 0.34 0.45 0.47 0.26 0.33 0.45 0.46 27888000 27685000 27695000 27705000 28041000 27878000 27888000 27906000 114129000 129465000 137802000 140684000 522081000 49276000 57447000 63206000 64300000 234228000 7985000 7817000 10081000 10476000 0.29 0.28 0.36 0.37 0.28 0.28 0.36 0.37 27884000 27920000 27941000 27949000 28122000 28142000 28147000 28138000 <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[23] Selected Quarterly Financial Data [Unaudited]</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 100%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Audited</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="46%" colspan="7"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Three&#160;Month&#160;Ended</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Fiscal&#160;Year</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">1/31/2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">4/30/2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">7/31/2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">10/31/2013</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Revenues</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">161,256</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">176,452</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">185,427</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">192,219</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">715,355</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Gross Profit</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">70,922</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">80,676</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">85,660</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">85,282</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">322,539</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8,665</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">11,338</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">14,701</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">11,120</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">45,825</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income Per Common Share:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Basic</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.31</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.41</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.53</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.40</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.65</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Diluted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.31</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.41</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.53</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.40</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.65</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Common Shares Outstanding &#8212; Basic [in thousands]</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,716</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,698</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,672</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,677</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,691</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Common Shares Outstanding - Diluted [in thousands]</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,912</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,879</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,842</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,844</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,851</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 100%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Audited</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="46%" colspan="11"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Three&#160;Month&#160;Ended</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Fiscal&#160;Year</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">1/31/2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">4/30/2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">7/31/2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">10/31/2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Revenues</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">138,793</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">151,443</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">160,532</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">163,487</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">614,255</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Gross Profit</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">60,118</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">67,534</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">74,279</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">74,681</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">276,611</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7,365</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9,306</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">12,596</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">12,889</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">42,156</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income Per Common Share:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Basic</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.26</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.34</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.45</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.47</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.52</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Diluted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.26</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.33</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.45</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.46</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.51</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Common Shares Outstanding &#8212; Basic [in thousands]</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,888</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,685</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,695</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,705</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,742</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Common Shares Outstanding - Diluted [in thousands]</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,041</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,878</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,888</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,906</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,921</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 100%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 46%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="46%" colspan="11"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Audited</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="46%" colspan="11"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Three&#160;Month&#160;Ended</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Fiscal&#160;Year</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">1/31/2011</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">4/30/2011</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">7/31/2011</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">10/31/2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Revenues</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">114,129</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">129,465</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">137,802</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">140,684</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">522,081</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Gross Profit</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">49,276</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">57,447</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">63,206</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">64,300</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">234,229</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7,985</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7,817</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">10,081</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">10,476</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">36,359</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income Per Common Share:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Basic</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.29</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.28</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.36</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.37</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.30</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Diluted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.28</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.28</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.36</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.37</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.29</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Common Shares Outstanding &#8212; Basic [in thousands]</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,884</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,920</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,941</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,949</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,971</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Common Shares Outstanding - Diluted [in thousands]</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,122</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,142</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,147</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,138</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,207</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 100%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Audited</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="46%" colspan="7"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Three&#160;Month&#160;Ended</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Fiscal&#160;Year</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">1/31/2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">4/30/2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">7/31/2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">10/31/2013</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Revenues</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">161,256</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">176,452</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">185,427</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">192,219</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">715,355</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Gross Profit</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">70,922</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">80,676</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">85,660</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">85,282</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">322,539</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8,665</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">11,338</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">14,701</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">11,120</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">45,825</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income Per Common Share:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Basic</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.31</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.41</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.53</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.40</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.65</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Diluted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.31</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.41</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.53</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.40</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.65</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Common Shares Outstanding &#8212; Basic [in thousands]</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,716</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,698</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,672</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,677</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,691</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Common Shares Outstanding - Diluted [in thousands]</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,912</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,879</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,842</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,844</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,851</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 100%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Audited</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="46%" colspan="11"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Three&#160;Month&#160;Ended</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Fiscal&#160;Year</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">1/31/2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">4/30/2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">7/31/2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">10/31/2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Revenues</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">138,793</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">151,443</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">160,532</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">163,487</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">614,255</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Gross Profit</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">60,118</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">67,534</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">74,279</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">74,681</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">276,611</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7,365</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9,306</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">12,596</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">12,889</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">42,156</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income Per Common Share:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Basic</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.26</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.34</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.45</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.47</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.52</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Diluted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.26</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.33</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.45</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.46</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.51</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Common Shares Outstanding &#8212; Basic [in thousands]</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,888</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,685</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,695</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,705</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,742</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Common Shares Outstanding - Diluted [in thousands]</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,041</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,878</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,888</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,906</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,921</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 100%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 46%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="46%" colspan="11"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Audited</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="46%" colspan="11"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Three&#160;Month&#160;Ended</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Fiscal&#160;Year</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">1/31/2011</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">4/30/2011</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">7/31/2011</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">10/31/2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Revenues</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">114,129</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">129,465</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">137,802</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">140,684</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">522,081</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Gross Profit</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">49,276</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">57,447</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">63,206</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">64,300</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">234,229</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7,985</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7,817</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">10,081</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">10,476</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">36,359</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income Per Common Share:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Basic</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.29</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.28</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.36</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.37</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.30</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Diluted</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.28</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.28</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.36</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.37</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.29</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Common Shares Outstanding &#8212; Basic [in thousands]</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,884</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,920</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,941</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,949</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,971</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 39%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="39%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Common Shares Outstanding - Diluted [in thousands]</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,122</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,142</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,147</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,138</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,207</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">BIO-REFERENCE LABORATORIES,&#160;INC. AND SUBSIDIARIES</font></b></p> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS FOR THE YEARS ENDED OCTOBER 31, 2013, 2012 AND 2011</font></b></p> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[In Thousands]</font></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;TEXT-ALIGN: left; WIDTH: 100.02%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="26%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">(b)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">(c)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="21%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">(d)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">(e)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="26%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">(a)<br /> Description</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Balance&#160;at&#160;the<br /> Beginning&#160;of&#160;a&#160;Period</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Charged&#160;to&#160;Cost&#160;and<br /> Expenses</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="21%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Deductions&#160;Charged&#160;to&#160;Valuation<br /> Allowance&#160;Accounts</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Balance&#160;at&#160;the&#160;End<br /> of&#160;a&#160;Period</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Year Ended October&#160;31, 2013</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Allowance for Doubtful Accounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">51,274</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">119,161</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(81,174</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">89,261</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Contractual Credits/Discounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">267,921</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,748,510</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(2,674,134</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">342,297</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><i><u><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total Allowance</font></u></i></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">319,195</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,867,671</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(2,755,308</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">431,558</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Year Ended October&#160;31, 2012</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Allowance for Doubtful Accounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">45,220</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">89,396</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(83,342</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">51,274</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Contractual Credits/Discounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">235,922</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,390,770</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(2,358,771</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">267,921</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><i><u><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total Allowance</font></u></i></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">281,142</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,480,166</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(2,442,113</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">319,195</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Year Ended October&#160;31, 2011</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Allowance for Doubtful Accounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">34,904</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">75,079</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(64,763</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">45,220</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Contractual Credits/Discounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">186,372</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,926,164</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(1,876,614</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">235,922</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="26%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><i><u><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total Allowance</font></u></i></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">221,276</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,001,243</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.72%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(1,941,377</font></p></td> <td style="PADDING-BOTTOM: 1pt; PADDING-LEFT: 0in; WIDTH: 2.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.68%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">281,142</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table></div> 34904000 186372000 221276000 45220000 235922000 281142000 51274000 267921000 319195000 89261000 342297000 431558000 75079000 1926164000 2001243000 89396000 2390770000 2480166000 119161000 2748510000 2867671000 64763000 1876614000 1941377000 83342000 2358771000 2442113000 81174000 2674134000 2755308000 BIO REFERENCE LABORATORIES INC 0000792641 10-K 2013-10-31 false --10-31 No No Yes Accelerated Filer 623072381 27695213 2013 FY <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[1] Organization and Business</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 31.5pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Bio-Reference Laboratories,&#160;Inc. [&#8220;Bio-Reference&#8221;, &#8220;BRLI&#8221;, or the &#8220;Company&#8221;] was incorporated on December&#160;24, 1981.&#160; Bio-Reference is principally engaged in providing laboratory testing services, primarily to customers in the greater New York metropolitan area as well as to customers in a number of other states.&#160; Bio-Reference offers a comprehensive list of chemical diagnostic tests including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology (including drug screening), pap smears, tissue pathology (biopsies) and other tissue analysis.&#160; We perform cancer cytogenetic testing at our leased facilities in at our main processing facility in Elmwood Park, Smithtown, NY, Clarksburg, MD and Milford, MA and genetic testing at our GeneDx leased facility in Gaithersburg, MD, as well as at our Elmwood Park facility.&#160; We perform cytology testing in Frederick, MD, Milford, MA, Columbus, OH, Houston, TX and at our Elmwood Park facility.&#160; Bio-Reference markets its laboratory testing services directly to physicians, geneticists, hospitals, clinics, correctional and other health facilities.</font></p> <p style="TEXT-INDENT: 31.5pt; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company&#8217;s laboratory testing business currently represents its one reportable business segment. The laboratory testing business accounts for over 98% of consolidated assets, net revenues and net income in each of the three years ended October&#160;31, 2013.&#160; All other operating segments include the Company&#8217;s non-clinical laboratory testing businesses and consist of our clinical knowledge management service through our PSIMedica business unit and a web-based connectivity portal solution for laboratories and physicians through its Care Evolve subsidiary.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[2] Summary of Significant Accounting Policies</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Principles of Consolidation - The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.&#160; All significant intercompany accounts and transactions have been eliminated.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Cash and Cash Equivalents - Cash equivalents are comprised of certain highly liquid investments with a maturity of three months or less when purchased.&#160; The Company had $17,952 and $25,143 in cash and cash equivalents at October&#160;31, 2013 and 2012, respectively.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Inventory - Inventory is stated at the lower of cost [determined on a first-in, first-out basis] or market.&#160; Inventory consists of purchased laboratory supplies, which is used in our various testing laboratories.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Property and Equipment - Property and equipment are carried at cost.&#160; Depreciation is computed by the straight-line method over the estimated useful lives of the respective assets, which generally range from 2 to 15 years.&#160; Leasehold improvements are amortized over the life of the lease or improvement, which is typically five years.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The statements of operations reflect depreciation expense related to property and equipment of $18,745, $16,082 and $13,684 for the years ended October&#160;31, 2013, 2012 and 2011, respectively.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">On sale or retirement, the asset cost and related accumulated depreciation or amortization are removed from the accounts, and any related gain or loss is reflected in general and administrative expenses.&#160; Repairs and maintenance are charged to expense when incurred.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Goodwill - Effective November&#160;1, 2011, the Company adopted revised Financial Accounting Standards Board (&#8220;FASB&#8221;)&#160; rules&#160;promulgated under Accounting Standards Update (&#8220;ASU&#8221;) No.&#160;2011-08 issued on September&#160;15, 2011,&#160;Intangibles&#8212;Goodwill and Other (Topic 350) Testing Goodwill for Impairment. Under these simplified goodwill impairment testing rules&#160;the Company assessed qualitative factors to determine whether events and circumstances lead to the conclusion that it is necessary to perform the two-step goodwill impairment test have occurred and determined that no such events had occurred.&#160; Under ASU No.&#160;2011-08, entities are not required to calculate the fair value of a reporting unit unless they conclude that it is more likely than not that the unit&#8217;s carrying value is greater than its fair value based on an assessment of events and circumstances. The &#8220;more likely than not&#8221; threshold is when there is a likelihood of more than 50% that a reporting unit&#8217;s carrying value is greater than its fair value.&#160; No impairment loss was recognized in the years ended October&#160;31, 2013, 2012 and 2011.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The balance sheet reflects prior Goodwill accumulated amortization of $2,401 as of October&#160;31, 2013 and 2012, respectively.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Other Intangible Assets - Intangible assets are amortized using the straight-line method.&#160; The estimated useful life of costs capitalized is evaluated for each specific project when completed, at which time such costs begin to be amortized. The statements of operations reflect amortization expense related to intangible assets of $994, $581, and $1,322 for the years ended October&#160;31, 2013, 2012 and 2011, respectively.&#160; The balance sheet reflects accumulated amortization of $8,846, and $7,852 as of October&#160;31, 2013, and 2012, respectively. During the 2013 and 2012 fiscal years, the Company did not write off any intangible assets.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">New Accounting pronouncements</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Certain prior year amounts have been reclassified to conform to the current year presentation. The Company adopted Accounting Standard Update (&#8220;ASU&#8221;) No.&#160;2011-7: Health Care Entities (Topic 954) &#8212; Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities commencing with the current fiscal year, the first year such standard is required for the Company. The adoption of this update did not have a material impact on the Company&#8217;s financial statements.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Although this update does not have a material impact on the Company&#8217;s financial statements as a whole, it requires that we adjust our presentation of our statement of operations along with prior periods presented in this report to maintain comparability. As the result of this change in presentation, our &#8220;Net Revenues&#8221;, &#8220;Gross Profit on Revenues&#8221; and our &#8220;General and Administrative Expenses&#8221; would change while our &#8220;Operating Income&#8221;, &#8220;Net Income&#8221; and &#8220;Earnings per Share&#8221; will remain the same. The presentation is adjusted for a portion of our &#8220;Bad Debt Expense&#8221; that is now reported in our Net Revenues as required under ASU No.&#160;2011-7.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accounting for Revenue</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Service revenues are principally generated from laboratory testing services including chemical diagnostic tests such as blood analysis, urine analysis and genetic testing among others. Service revenues are recognized at the time the testing services are performed and are reported at their estimated net realizable amounts.</font></p> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Service revenues before provision for bad debts are determined utilizing gross service revenues net of contractual adjustments and discounts. Even though it is the responsibility of the patient to pay for laboratory service bills, most individuals in the United States have an agreement with a third party payor such as Medicare, Medicaid or a commercial insurance provider to pay all or a portion of their healthcare expenses.&#160; The majority of services provided by Bio-Reference Laboratories,&#160;Inc. (&#8220;BRLI&#8221;) are to patients covered under a third party payor contract. In certain cases, the individual has no insurance or does not provide insurance information and in other cases tests are performed under contract to a professional organization (such as physicians, hospitals, and clinics) which reimburses BRLI directly.&#160; In the remainder of the cases, BRLI is provided the third party billing information and seeks payment from the third party under the terms and conditions of the third party payor for health service providers like BRLI. Each of these third party payors may differ not only with regard to rates, but also with regard to terms and conditions of payment and providing coverage (reimbursement) for specific tests. Estimated revenues are established based on a series of highly complex procedures and judgments that require industry specific healthcare experience and an understanding of payor methods and trends. We review our calculations on a monthly basis in order to make certain that we are properly allowing for the uncollectable portion of our gross billings due to the contractual adjustments and discounts and that our estimates remain sensitive to variances and changes within our payor groups. The contractual allowance calculation is made on the basis of historical allowance rates for the various specific payor groups on a monthly basis with a greater weight being given to the most recent trends This process is adjusted based on recent changes in underlying contract provisions and shifts in the testing being performed. This calculation is routinely analyzed by BRLI on the basis of actual allowances issued by payors and the actual payments made to determine what adjustments, if any, are needed. The table below shows the adjustments made to gross service revenues to arrive at net revenues, the amount reported on our statement of operations.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 86.68%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.1in;" border="0" cellspacing="0" cellpadding="0" width="86%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.92%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">($)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.92%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Year&#160;Ended</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.92%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Gross Service Revenues</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,524,108</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,052,431</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,482,349</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Contractual Adjustments and Discounts:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Medicare/Medicaid Portion</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">354,638</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">320,697</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">293,874</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">All Other Third Party Payors*</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,393,872</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,070,073</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,629,833</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total Contractual Adjustments and Discounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,748,510</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,390,770</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,923,707</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Service Revenues Net of Contractual Adjustments and Discounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">775,598</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">661,661</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">558,642</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Patient Service Revenue Provision for Bad Debts**</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">60,244</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">47,406</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">36,561</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Revenues</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">715,354</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">614,255</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">522,081</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Percent of Contractual Allowances, Discounts and Patient Service Provision for Bad Debts to Gross Revenue.</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">79.7</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">79.9</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">79.0</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">* All Other Third Party and Direct Payors consists of almost eight hundred distinct payors, including commercial health insurers and administrators as well as professionally billed accounts such as physicians, hospitals, clinics and other direct billed accounts.</font></p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">** Represents the amount of Bad Debt Expense that is now required to be presented as a deduction from patient service revenue (net of contractual allowances and discounts) pursuant to ASU No.&#160;2011-7.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">When new business is received by BRLI, service revenues net of contractual adjustments and discounts are calculated by reducing gross service revenues by the estimated contractual allowance. The Patient Service Revenue Provision for Bad Debts represents the amount of bad debt expense expected to occur on patient service revenue based upon our experience. The remaining bad debt expense is presented as part of operating expenses. The bad debt expense presented as part of operating expense represents the bad debt expense related to receivables from service revenues determined after taking into account our ability to collect on such revenue.&#160; BRLI recognized the amounts in subsequent periods for actual allowances/discounts to gross service revenue; bad debt may have been adjusted over the same periods of time to maintain an accurate balance between net revenues and actual revenues. Management has reviewed the allowances/discounts recognized in subsequent periods and believes the amounts to be immaterial. A number of proposals for legislation or regulation continue to be under discussion which could have the effect of substantially reducing Medicare reimbursements for clinical laboratories or introducing cost sharing to beneficiaries. Depending upon the nature of regulatory action, if any, which is taken and the content of legislation, if any, which is adopted, the Company could experience a significant decrease in revenues from Medicare and Medicaid, which could have a material adverse effect on the Company. The Company is unable to predict, however, the extent to which such actions will be taken.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accounting for Contractual Credits and Doubtful Accounts</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">It is typically the responsibility of the patient to pay for laboratory service bills. Most individuals in the United States have an agreement with a third party payor such as Medicare, Medicaid or commercial insurance to pay all or a portion of their healthcare expenses; this represents the major portion of payment for all services provided by BRLI. In certain cases, the individual has no insurance or does not provide insurance information; in the remainder of the cases, BRLI is provided the third party billing information, usually by the referring physician, and seeks payment from the third party under the terms and conditions of the third party payor for health service providers like BRLI. Each of these third party payors may differ not only with regard to rates, but also with regard to terms and conditions of payment and coverage of specific tests. BRLI routinely reviews the reimbursement policies and subsequent payments and collection rates from these different types of payors. Contractual adjustments and discounts are recorded as reductions to gross service revenues and are collectively referred to as the contractual allowance. BRLI has not been required to record an adjustment in a subsequent period related to revenue recorded in a prior period which was material in nature. Aging of accounts receivable is monitored by billing personnel and follow-up activities including collection efforts are conducted as necessary. BRLI writes off receivables against the allowance for doubtful accounts when they are deemed uncollectible. For client billing, accounts are written off when all reasonable collection efforts prove to be unsuccessful. Patient accounts, where the patient is directly responsible for all or a remainder portion of the account after partial payment or denial by a third party payor, are written off after the normal dunning cycle has occurred, although these may be subsequently transferred to a third party collection agency after being written off. Third party payor accounts are written off when they exceed the payer&#8217;s timely filing limits. Accounts Receivable on the balance sheet is net of the following amounts for contractual credits and doubtful accounts:</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 86%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.15in;" border="0" cellspacing="0" cellpadding="0" width="86%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 23.8%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="23%" colspan="3"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">($)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="72%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Contractual Credits/Discounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">342,297</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">267,921</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Doubtful Accounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">89,261</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">51,274</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="72%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total Allowance</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">431,558</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">319,195</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Current Income Taxes &#8212; The Company recognizes interest and penalties on settlement of tax liabilities in its income from operations.&#160; For the fiscal years 2011 through 2013, no material amounts for interest and penalties have been recorded.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deferred Income Taxes - Deferred income tax assets and liabilities are computed annually for differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company adopted GAAP guidance with respect to uncertain tax positions when it became effective.&#160; Under these rules&#160;the Company may recognize the tax benefit from an uncertain tax position only if it meets the more-likely-than-not criteria (over 50% likelihood) of being realized on an examination by taxing authorities.&#160; For the years ended October&#160;31, 2011 through October&#160;31, 2013 the Company had no material uncertain tax positions to report.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Earnings Per Share - Basic earnings per share [&#8220;EPS&#8221;] reflects the amount of income attributable to each share of common stock based on average common shares outstanding during the period.&#160; Diluted EPS reflects Basic EPS while giving effect to all potential dilutive common shares that were outstanding during the period, such as common shares that could result from the exercise or conversion of securities into common stock.&#160; The computation of Diluted EPS is calculated by using the treasury stock method, which assumes that any proceeds obtained from the exercise of such dilutive securities would be used to purchase common stock at the average market price of the common stock during the period.&#160; This reduces the gross number of dilutive shares by the number of shares purchasable from the proceeds of the securities assumed to be exercised.&#160; Securities whose conversion would have an anti-dilutive effect on EPS are not assumed converted.&#160; Securities that could potentially dilute earnings in the future are disclosed in Note 10.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160; Actual results could differ from those estimates.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Recoverability and Impairment of Intangible Assets and Other Long-Lived Assets &#8212; The Company evaluates the possible impairment of its long-lived assets under the provisions of FASB codification 350-30-35 and 360-10-35.&#160; The Company reviews the recoverability of its long-lived assets on an annual basis.&#160; Evaluation of possible impairment is based on the Company&#8217;s ability to recover the asset from the expected future pretax cash flows (undiscounted and without interest charges) of the related operations. If the expected undiscounted pretax cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.&#160; No impairment loss was recognized in the fiscal years ended October&#160;31, 2013, 2012 and 2011.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Advertising Costs -Advertising costs are expensed when incurred.&#160; Advertising costs amounted to approximately $3,200, $2,366 and $2,026 for the years ended October&#160;31, 2013, 2012 and 2011, respectively.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Other Income &#8212; During the year the Company recorded a loss of $450on its investment in IncellDx.&#160; The loss represents the Company&#8217;s share of IncellDX undistributed net loss under the equity method of accounting.&#160; During the year ended October&#160;31, 2013 the Company received a refund of $1,062 for its New York State clinical laboratory inspection fee that was included in other income.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Subsequent Events &#8212; The management considered subsequent events through the date the financial statements are issued as defined in FASB Codification 855-10-50.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[3] Property and Equipment -</font></i></b> <font style="FONT-SIZE: 10pt;" size="2">Property and equipment - at cost is summarized as follows:</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 73.34%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="73%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Medical Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">65,762</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">50,338</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Leasehold Improvements</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,974</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">19,768</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Furniture, Fixtures and Office&#160;&amp; Computer Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">21,621</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">16,503</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Automobiles and Aircraft</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">18,242</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">16,092</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Sub Totals</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">133,599</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">102,701</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Less Accumulated Depreciation</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">67,950</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">52,261</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals &#8212; Net of Accumulated Depreciation</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">65,649</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">50,440</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[4] Intangible Assets</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Intangible assets are summarized as follows:</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><u><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">October&#160;31, 2013</font></u></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 80%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="80%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Weighted-Average</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Accumulated</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Net&#160;of<br /> Accumulated</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Intangible&#160;Asset</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Amortization&#160;Period</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Cost</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Amortization</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Amortization</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Customer Lists</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">20</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8,739</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,879</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5,860</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Covenants Not-to-Compete</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">11,131</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,560</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6,571</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Patents and Licenses</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">17</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5,297</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,408</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,889</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">25,166</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8,847</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">16,320</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><u><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">October&#160;31, 2012</font></u></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 80%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="80%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Weighted-Average</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Accumulated</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Net&#160;of<br /> Accumulated</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Intangible&#160;Asset</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Amortization&#160;Period</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Cost</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Amortization</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Amortization</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Customer Lists</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">20</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,573</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,537</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,036</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Covenants Not-to-Compete</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,305</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,257</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">48</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Patents and Licenses</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">17</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5,297</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,058</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,239</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="27%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">14,175</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7,852</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6,323</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The estimated amortization expense related to intangible assets for each of the five succeeding fiscal years and thereafter as of October&#160;31, 2013 is as follows:</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 43.32%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 2.25in;" border="0" cellspacing="0" cellpadding="0" width="43%"> <tr style="padding:0;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="64%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2014</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,917</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2015</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,852</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,540</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2017</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,063</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2018</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">946</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Thereafter</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9,002</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.7%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">16,320</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[5] Revolving Note Payable - Bank</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">In October&#160;2011, the Company entered into an amended revolving note payable loan agreement with PNC Bank, N.A.&#160; The maximum amount of the credit line available to the Company pursuant to the loan agreement is the lesser of (i)&#160;$45,000 or (ii)&#160;50% of the Company&#8217;s qualified accounts receivable [as defined in the agreement].&#160; The amendment to the Loan and Security Agreement provides for an interest rate on advances to be subject, at the election of the Company, to either the bank&#8217;s base rate or the Eurodollar rate of interest plus, in certain instances, an additional interest percentage.&#160; The additional interest percentage charge on bank&#8217;s base rate borrowings and on Eurodollar rate borrowings ranges from 1% to 4% and is determined based upon certain financial ratios achieved by the Company.&#160; At October&#160;31, 2013, the Company had elected to have all of the total advances outstanding to be subject to the bank&#8217;s base rate of interest of 3.50%.&#160; The credit line is collateralized by substantially all of the Company&#8217;s assets. The line of credit is available through October&#160;2016 and may be extended for annual periods by mutual consent, thereafter.&#160; The terms of this agreement contain, among other provisions, requirements for maintaining defined levels of capital expenditures, fixed charge coverage, and the prohibition of the payment by the Company of cash dividends. As of October&#160;31, 2013 and October&#160;31, 2012, the Company utilized $26,139 and $0 of the credit line, respectively.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[6] Long-Term Debt - Bank</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Effective as of October&#160;31, 2007, we executed a fifth amendment to the Loan Agreement formalizing the repayment terms of the $5 million term loan from PNC Bank used by our wholly-owned GeneDX (formerly, BRLI No.&#160;2 Acquisition Corp.) subsidiary to fund the $5 million acquisition cash payment in connection with its purchase of the operating assets of GeneDx,&#160;Inc. The term loan is evidenced by a secured promissory note payable over a six year term in equal monthly principal payments of approximately $69, plus interest at an annual rate of 6.85%. The note was paid off on October&#160;31, 2012.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">In December&#160;2010, the Company issued a seven year term note for $5,408 at the rate of interest of 6.12% per annum for the financing of new equipment.&#160; The note is payable in eighty-four equal monthly installments commencing on January&#160;29, 2011 of $61 including principal and interest followed by a balloon payment of the principal and interest outstanding on the loan repayment date of December&#160;29, 2017.&#160; The balance on this note as of October&#160;31, 2013 is approximately $4,163.</font></p> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Principal repayment for each of the five succeeding fiscal years and thereafter as of October&#160;31, 2013 is as follows:</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 43.32%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="43%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="64%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Year&#160;Ended</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="64%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2014</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">493</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2015</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">518</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">551</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2017</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">585</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2018</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Thereafter</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.7%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 64.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="64%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5.78%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,163</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="208"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="19"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="10"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="80"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="7"></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[7] Related Party Transactions [Not in Thousands]</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">There were no material related party transactions during fiscal 2013 and fiscal 2012.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[8] Income Taxes</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The reconciliation of income tax from continuing operations computed at the U.S. federal statutory tax rate to the Company&#8217;s effective income tax rate is as follows:</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 80%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.75in;" border="0" cellspacing="0" cellpadding="0" width="80%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="53%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="40%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="53%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">U.S. Federal Statutory Rate</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">35</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">35</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">35</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">State and Local Taxes, Net of U.S. Federal Tax Benefit</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">11.20</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8.87</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9.87</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Permanent differences and Other</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(2.78</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)%</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(0.44</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)%</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(0.94</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)%</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Actual Rate</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">43.42</font></p></td> <td style="PADDING-BOTTOM: 2.25pt; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">43.43</font></p></td> <td style="PADDING-BOTTOM: 2.25pt; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">43.93</font></p></td> <td style="PADDING-BOTTOM: 2.25pt; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The provision for income taxes shown in the consolidated statements of operations consists of the following:</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 76.66%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.75in;" border="0" cellspacing="0" cellpadding="0" width="76%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41.78%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="41%" colspan="8"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Current:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Federal</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">38,295</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">25,794</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.42%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">24,573</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">State&#160;&amp; Local</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">14,018</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">10,203</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">9,825</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deferred:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Federal</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(10,803</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(2,183</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(4,223</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">State and Local</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(6,238</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(1,454</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(1,688</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.76%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="11%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.74%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total Provision for Income Taxes</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">35,272</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">32,360</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,487</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.22%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">At October&#160;31, 2013 and 2012, the Company had a net deferred tax asset of approximately $44,231 and $27,190, respectively.&#160; The deferred taxes primarily relate to timing differences associated with the deductibility of depreciation and amortization, bad debts and certain accrued expenses and deferred costs.&#160; For fiscal years ended October&#160;31 2011 through October&#160;31, 2013, the Company had no material net operating loss carry-forwards available to reduce current year taxable income.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 76.66%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.5in;" border="0" cellspacing="0" cellpadding="0" width="76%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="60%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 34.54%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="34%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="60%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deferred Tax Asset:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Bad Debt Allowance</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.34%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">39,275</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.34%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">22,560</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Depreciation and amortization</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,815</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,963</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accrued Expenses</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,141</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,667</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deferred Tax Asset - Net</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">44,231</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,190</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Current Deferred Tax Asset - Net</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">42,154</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">24,912</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Long Term Deferred Tax Asset - Net</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,077</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,278</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 60.88%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="60%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deferred Tax Asset &#8212; Net</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.64%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">44,231</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.26%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 14.34%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="14%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,190</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="349"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="19"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="7"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="82"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="19"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="7"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="82"></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-TOP: medium none; BORDER-RIGHT: medium none;" width="8"></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">During fiscal year ended October&#160;31, 2013 the Company recorded a net deferred tax benefit of $17,041.&#160; This reflects a net benefit of approximately $16,715 in allowance for bad debts, a liability of approximately $281 from depreciation and amortization timing differences, and a benefit of approximately $607 in certain accrued expenses. Although realization is not assured and dependent upon things such as generating sufficient taxable income in future periods, management, through sufficient positive evidence,&#160; believes it is more likely than not that all of the deferred tax asset will be realized. The amount of the deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income or changes in the accrued expenses during the future periods are reduced.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">At October&#160;31, 2013, fiscal 2010 through 2013 are subject to examination by US federal and state tax authorities.&#160; Through the issuance of these financial statements the outcome of all of these examinations has not been determined.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[10] Earnings Per Share</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The computation of basic and diluted net earnings per common share is as follows [in thousands, except per share data rounded]:</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 80%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="80%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 43.78%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="43%" colspan="8"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">For&#160;Years&#160;Ended&#160;October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Income Available to Common Stockholders</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">45,825</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">42,156</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">36,359</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Common Shares Outstanding</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,691</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,742</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,971</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><u><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Effect of Dilutive Securities:</font></u></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Warrants/Options</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">161</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">179</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">236</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><u><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Weighted Average Diluted Common Shares Outstanding</font></u></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,852</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">27,921</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28,207</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.54%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><u><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income Per Share - Basic</font></u></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.65</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.52</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.30</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 51.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="51%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><u><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net Income Per Share - Diluted</font></u></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.65</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.51</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1.29</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[12] Employment Contracts and Consulting Agreements</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company has multiple employment contracts with its key executives with expiration dates ranging from October&#160;31, 2015 through October&#160;31, 2018.&#160; At October&#160;31, 2013, the approximate aggregate minimum commitment under these employment contracts and agreements, excluding commissions or consumer price index increases, is as follows:</font></p> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p> <table style="text-align:left;WIDTH: 50%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.25in;" border="0" cellspacing="0" cellpadding="0" width="50%"> <tr style="padding:0;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="68%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.02%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="24%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Employees&#160;and<br /> Consultants</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2014</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.62%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5,169</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2015</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.02%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,873</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,657</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2017</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.02%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,918</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2018</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,243</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Thereafter</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.02%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="24%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.62%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 21.4%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="21%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">16,860</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Some of these agreements provide bonuses and commissions based on a percentage of collected revenues ranging from 1% to 10% on accounts referred by or serviced by the employee or consultant.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">In addition to the above, in fiscal 2013 the Company has entered into seventy at &#8212; will employment and consulting agreements which together with prior at &#8212; will agreements provide for annual aggregate minimum commitments of approximately $33,555 which have no termination dates.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[13] Capitalized Lease Obligations</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company leases various assets under capital leases expiring in fiscal 2018 with interest rates ranging between 2% to 8% as follows:</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 73.34%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="73%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36.12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="36%" colspan="4"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Medical Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">15,013</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">12,078</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Automobiles</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">10,581</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8,711</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">25,594</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">20,789</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Less: Accumulated Depreciation</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">13,125</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6,776</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 59.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="59%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Net</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">12,469</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.4%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 15.06%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="15%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">14,013</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Depreciation expense on assets under capital leases was approximately $6,494, $3,792, and $1,418 for the years ended October&#160;31, 2013, 2012 and 2011, respectively.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Aggregate future minimum rentals under capital leases are:</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 60%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="60%"> <tr style="padding:0;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="74%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2014</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.84%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">5,622</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2015</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,630</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,727</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2017</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,192</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2018</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">660</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Thereafter</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">15</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">16,846</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Less Interest:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">949</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 20%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="20%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 74.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="74%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Present Value of Minimum Lease Payments</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 4.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="4%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.84%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">15,897</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.66%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[14] Commitments and Contingencies</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company leases various office and laboratory facilities and equipment under operating leases expiring from 2014 to 2019.&#160; Several of these leases contain renewal options for one to five year periods.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total expense for property and equipment rental for the years ended October&#160;31, 2013, 2012 and 2011 was $10,568, $8,787 and $8,010, respectively.&#160; There were no contingent rental amounts due through October&#160;31, 2013.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Aggregate future minimum rental payments on non cancelable operating leases [exclusive of several month to month leases] are as follows:</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 50%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.25in;" border="0" cellspacing="0" cellpadding="0" width="50%"> <tr style="padding:0;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="40%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Property($)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Equipment($)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2014</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8,671</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">344</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2015</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,333</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">223</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,422</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">87</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2017</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">558</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2018</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">558</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Thereafter</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">651</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.02%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">14,193</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="24%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">654</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.98%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company has entered into several purchase agreements for reagent supplies through October, 2018.&#160; Minimum purchase commitments as of October&#160;31, 2013 are as follows:</font></p> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p> <table style="text-align:left;WIDTH: 50%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="50%"> <tr style="padding:0;"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="57%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="36%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Reagents&#160;</font></b><b><font style="FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">($)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="57%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2014</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">12,505</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="57%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2015</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">11,938</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="57%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">10,854</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="57%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2017</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6,559</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="57%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2018</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,700</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="57%"> <p style="TEXT-ALIGN: center; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Thereafter</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="57%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 57%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="57%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="5%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 36%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="36%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">45,556</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Reagent supplies expensed under purchase agreements amount to $7,873, $13,338, and $8,379 for the years ended October&#160;31, 2013, 2012 and 2011, respectively.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[15] Litigation</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">In the normal course of business, the Company is exposed to a number of asserted and unasserted potential claims.&#160; In the opinion of management, the resolution of these matters will not have a material adverse effect on the Company&#8217;s financial position or results of operations.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[16] Insurance</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company maintains professional liability insurance of $3,000 in the aggregate, with a per occurrence limit of $1,000.&#160; In addition, the Company maintains excess commercial insurance of $5,000 per occurrence and $5,000 in aggregate over the primary limits.&#160; In addition, the Company also maintains excess umbrella coverage of $15,000.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[17] Significant Risks and Uncertainties</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[A] Concentrations of Credit Risk - Cash -</font></i></b> <font style="FONT-SIZE: 10pt;" size="2">At October&#160;31, 2013 and 2012, the Company had approximately $14,720 and $21,260, respectively, in cash and certificate of deposit balances at financial institutions which were in excess of the federally insured limits.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[B] Concentration of Credit Risk - Accounts Receivable -</font></i></b> <font style="FONT-SIZE: 10pt;" size="2">Credit risk with respect to accounts receivable is generally diversified due to the large number of patients comprising the client base.&#160; The Company does have significant receivable balances with government payors and various insurance carriers.&#160; Generally, the Company does not require collateral or other security to support customer receivables.&#160; However, the Company continually monitors and evaluates its client acceptance and collection procedures to minimize potential credit risks associated with its accounts receivable and establishes an allowance for uncollectible accounts and as a consequence, believes that its accounts receivable credit risk exposure beyond such allowance is not material to the financial statements.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">A number of proposals for legislation continue to be under discussion which could substantially reduce Medicare and Medicaid (CMS) reimbursements to clinical laboratories.&#160; Depending upon the nature of regulatory action, and the content of legislation, the Company could experience a significant decrease in revenues from Medicare and Medicaid (CMS), which could have a material adverse effect on the Company.&#160; The Company is unable to predict, however, the extent to which such actions will be taken.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[18] Acquisitions</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">On April&#160;27, 2012, the Company entered into an agreement pursuant to which the Company purchased preferred shares of IncellDx,&#160;Inc. (&#8220;IncellDx&#8221;), a Delaware corporation.&#160; Information about IncellDx and the agreement may be found in the Current Report on Form&#160;8-K the Company filed on May&#160;1, 2012.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">As of October&#160;31, 2013 the Company invested a total $6,000.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">On December&#160;21, 2012, the Company entered into an agreement with Meridian Clinical Laboratory Corporation, a Florida corporation having its place of business in Miami, Florida (&#8220;Meridian&#8221;), pursuant to which the Company purchased all issued and outstanding common stock of Meridian for approximately $1,848 of which $250 is deferred for one year.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">On December&#160;31, 2012, Bio-Reference Laboratories,&#160;Inc. (the &#8220;Company&#8221;) entered into an agreement with Florida Clinical Laboratory,&#160;Inc., a Florida corporation having its place of business in Melbourne, Florida (&#8220;FCL&#8221;), pursuant to which the Company purchased all issued and outstanding shares of capital stock of FCL for approximately $7,016, of which $1,000 is deferred for eighteen months assuming certain conditions, described, in the are met.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The following table sets forth these final purchase allocations.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 60%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="60%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="50%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 46.12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="46%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">($)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="50%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">FCL</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">MCL</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Totals:</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accounts Receivable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,008</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">232</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,240</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Autos</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">137</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">48</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">185</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Medical Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">225</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">228</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Computer Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">21</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">21</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Leasehold Improvements</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">53</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">53</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Other Non-Current Assets</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Non-Compete Agreement</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">747</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">43</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">790</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deposits</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Customer Relationships in Place</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,235</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">930</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,165</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Goodwill</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,905</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">673</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,578</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accounts Payable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-118</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-83</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-201</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Long Term Debt (Auto-Loans)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-200</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-200</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Short Term Acquisition Payable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-1,000</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-250</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-1,250</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6,016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,598</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7,614</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">On August&#160;7, 2013 the Company purchased substantially all of the operating assets and certain of the operating liabilities of Hunter Laboratories,&#160;Inc., (&#8220;Hunter&#8221;) a California corporation having its principal place of business in Campbell, California.&#160; The gross purchase price was $15,215 plus payroll adjustment of $111 totaling $15,326.&#160; Of that amount $3,000 was deferred to cover anticipated pre closing liabilities.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">On August&#160;20, 2013 the Company through its subsidiary GeneDx,&#160;Inc.,&#160; purchased the entire membership interest in Edge BioServ, LLC, (&#8220;Edge Bio&#8221;) a Delaware limited liability company having its place of business in Gaithersburg, Maryland.&#160; The gross purchase price was approximately $2,502.&#160; Of that $375 was deferred to cover anticipated pre closing liabilities.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The following table sets forth these final purchase allocations.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 66.66%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="66%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="40%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 55.3%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="55%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">$</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="40%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Hunter</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Edge&#160;Bio</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Totals:</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accounts Receivable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,700</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,700</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Prepaid Expenses</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">421</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">70</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">491</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Inventory</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">369</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">369</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Autos</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">62</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">62</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Furniture and Fixtures</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">265</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">271</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Leasehold Improvements</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">714</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">714</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Medical Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">234</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">906</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,140</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Computer Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">376</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">574</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">950</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Non-Compete Agreement</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,255</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">926</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,181</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Customer Relationships in Place</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,852</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,855</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Goodwill</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8,573</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">182</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8,755</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accounts Payable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(1,388</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(1,388</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accrued Payroll Benefits</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(393</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(393</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Notes Payable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(578</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(578</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Capital Leases</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(193</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(193</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deferred Acquisition Payable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(3,000</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(375</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(3,375</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deferred Rent Payable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(108</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(108</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">12,326</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,127</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">14,453</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[20] Health Insurance Plan</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company has a limited self-funded health insurance plan for its employees under which the Company pays the initial $150 of covered medical expenses per person each year.&#160; The Company has a contract with an insurance carrier for any excess up to a maximum of $2,000 per person and $20,504 in the aggregate.&#160; Health insurance premium expense for the years ended October&#160;31, 2013, 2012 and 2011 amounted to approximately $6,797, $5,792 and $4,426, respectively.&#160; Uninsured employee medical expenses incurred by the Company amounted to approximately $32,016, $25,994 and $19,408 for the years ended October&#160;31, 2013, 2012 and 2011, respectively.&#160; During fiscal years ended October&#160;31, 2013, 2012 and 2011, employee contributions of $4,713, $4,124 and $3,593 offset the above health plan costs.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[21] Employee Benefit Plan</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company sponsors a 401(k)&#160;Profit-Sharing Plan [the &#8220;Plan&#8221;].&#160; Employees become eligible for participation after attaining the age of eighteen and completing one year of service.&#160; Participants may elect to contribute up to ten percent of their compensation, as defined in the Plan, to a maximum allowed by the Internal Revenue Service.&#160; The Company may choose to make a matching contribution to the plan for each participant who has elected to make tax-deferred contributions for the plan year, at a percentage determined each year by the Company. The Company elected to make a matching contribution which amounted to $1,358 for 2013, $1,106 for 2012, and $993 for 2011.&#160; These amounts were charged to the Statement of Operations. The Employer contribution will be fully vested after the third year of service.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[22] New Authoritative Accounting Pronouncements</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company adopted Accounting Standard Update (&#8220;ASU&#8221;) No.&#160;2011-7: Health Care Entities (Topic 954) &#8212; Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities commencing with the current fiscal year, the first year such standard is required for the Company. The adoption of this update did not have a material impact on the Company&#8217;s financial statements.</font></p> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Although this update does not have a material impact on the Company&#8217;s financial statements as a whole, it requires that we adjust our presentation of our statement of operations along with prior periods presented in this report to maintain comparability. As the result of this change in presentation, our &#8220;Net Revenues&#8221;, &#8220;Gross Profit on Revenues&#8221; and our &#8220;General and Administrative Expenses&#8221; would change while our &#8220;Operating Income&#8221;, &#8220;Net Income&#8221; and &#8220;Earnings per Share&#8221; will remain the same. The presentation is adjusted for a portion of our &#8220;Bad Debt Expense&#8221; that is now reported in our Net Revenues as required under ASU No.&#160;2011-7.</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[19] Fair Value of Financial Instruments</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">For certain financial instruments, including cash and cash equivalents, trade receivables, trade&#160; payables, and short-term debt, it was estimated that the carrying amount approximated fair value for the majority of these items because of their short maturities.&#160; The fair value of the Company&#8217;s long-term debt is estimated based on the quoted market prices for similar issues or by discounting expected cash flows at the rates currently offered to the Company for debt of the same remaining maturities.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Due to the non-interest bearing nature and unspecified payment terms, it was not practicable to estimate the fair value of amounts due from related parties [See also Note 7].</font></p> </div> <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[9] Capital Transactions</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[A] Preferred Stock and Common Stock -</font></i></b> <font style="FONT-SIZE: 10pt;" size="2">The Company is authorized to issue an aggregate of 1,666,667 shares of preferred stock, $.10 par value.&#160; None was outstanding as of October&#160;31, 2013 and October&#160;31, 2012.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Holders of the Company&#8217;s Common Stock are entitled to one vote per share on matters submitted for shareholder vote.&#160; Holders are also entitled to receive dividends ratably, if declared.&#160; In the event of dissolution or liquidation, holders are entitled to share ratably in all assets remaining after payment of liabilities.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">On November&#160;11, 2011, the Company announced that its board of directors has approved a Stock Repurchase Program authorizing the repurchase of up to 1,000,000 shares of its Common Stock in the over-the-counter market at prevailing market prices over the period ending October&#160;31, 2012.&#160; During the year ended October&#160;31, 2012 the Company repurchased 285,450 shares at a cost of $5,193.&#160; On December&#160;6, 2012, the Company announced that its board of directors has approved a new Stock Repurchase Program authorizing the buyback of up to 714,550 shares of its Common Stock in the over-the-counter market at prevailing market prices through October&#160;31, 2013.&#160; As of October&#160;31, 2013, the Company repurchased 81,600 shares at a cost of $2,030.&#160; Subsequent to our year end, on December&#160;19, 2013 the Company announced that its board of directors has approved a new Stock Repurchase Program authorizing the buyback of up to 2,000,000 shares of its Common Stock in the over-the-counter market at prevailing market prices through October&#160;31, 2015.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">[B] Equity Transactions for Services &#8212;</font></i></b> <font style="FONT-SIZE: 10pt;" size="2">For the fiscal years ended in 2013, 2012 and 2011, the Company issued 11,431, 11,432 and 11,432 shares of the Company&#8217;s common stock for employment or consulting services [See Note 11 for common stock options issued for employee and consulting services].</font></p> </div> 153247000 14902000 5373000 223577000 294878000 4977000 956000 23408000 6323000 866000 38808000 312825000 421528000 61001000 41288000 16490000 9753000 2438000 26139000 464000 3957000 71952000 133762000 9463000 4163000 13626000 16171000 277000 40907000 186063000 227247000 312825000 421528000 271595000 0.10 0.10 1666667 1666667 126354000 0 3000 0 0.01 0.01 35000000 35000000 27707382 27707382 27683213 27683213 121446000 100569000 56805000 49894000 337644000 287853000 392815000 3562000 3969000 154928000 131967000 41990000 38518000 200480000 174454000 76131000 59774000 240566000 81973000 1455000 1747000 -323000 6656000 -163000 -163000 -1615000 5072000 74516000 64846000 -876000 81097000 16663000 15005000 290000 40000 -537000 -1680000 -323000 11240000 29254000 6053000 10316000 5211000 3498000 916000 1637000 141000 -798000 -74000 507000 8296000 6541000 53098000 30946000 17662000 5675000 1425000 15715000 14117000 -21390000 -15542000 -44113000 1270000 1178000 3710000 2968000 18632000 7522000 227000 498000 5193000 -28578000 -11170000 19260000 3130000 4234000 -7191000 1547000 1754000 36697000 32773000 17779000 22013000 19739000 79600 1000 278000 44562000 107548000 152388000 497000 279000 45581000 143907000 189767000 498000 277000 40907000 186063000 290000 31500 277000 39430000 231888000 -1408000 27847204 27949900 27707382 27683213 1000 226000 227000 46000 91002000 263000 263000 40000 40000 11432 290000 290000 11431 290000 290000 23096 482000 482000 36359000 42156000 45825000 3000 5190000 2030000 2030000 2482349000 3524108000 320697000 293874000 354638000 2070073000 1629833000 2393872000 2390770000 1923707000 2748510000 0.799 0.790 0.797 800 4163000 0 0 0 0 0 0 0 0 0 0 0 1917000 <div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;WIDTH: 86%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.15in;" border="0" cellspacing="0" cellpadding="0" width="86%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 23.8%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="23%" colspan="3"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">($)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">October&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="72%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Contractual Credits/Discounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">342,297</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">267,921</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="72%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Doubtful Accounts</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">89,261</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">51,274</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 72.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="72%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Total Allowance</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.44%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">431,558</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.9%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.46%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">319,195</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.14%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> </div> 2000000 2879000 206261000 19095000 9416000 5237000 1017000 35185000 16320000 1165000 61614000 19601000 18292000 0 493000 5185000 10712000 3670000 1789000 277000 39430000 231888000 15598000 173137000 135486000 68594000 4141000 177508000 58917000 1606000 612000 -118000 37988000 4193000 4043000 299000 -61000 28601000 19013000 25100000 464000 4648000 -26139000 263000 2030000 1503000 44312000 661661000 558642000 60244000 47406000 36561000 1062000 0 0 0 0 0 0 0 0 0 4464000 2508000 5944000 4558000 5408000 7125000 7777000 5444000 <div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;TEXT-ALIGN: left; WIDTH: 414px; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="414"> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="50%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 46.12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="46%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">($)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="50%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">FCL</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">MCL</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Totals:</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accounts Receivable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,008</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">232</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,240</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Autos</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">137</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">48</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">185</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Medical Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">225</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">228</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Computer Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">21</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">21</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Leasehold Improvements</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">53</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">53</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Other Non-Current Assets</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Non-Compete Agreement</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">747</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">43</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">790</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deposits</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Customer Relationships in Place</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,235</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">930</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4,165</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Goodwill</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,905</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">673</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,578</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accounts Payable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-118</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-83</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-201</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Long Term Debt (Auto-Loans)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-200</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-200</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Short Term Acquisition Payable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-1,000</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-250</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">-1,250</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 50%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="50%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6,016</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,598</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.82%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.48%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">7,614</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table></div> <div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <table style="text-align:left;TEXT-ALIGN: left; WIDTH: 420px; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="420"> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="40%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 55.3%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="55%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">$</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="40%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Hunter</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Edge&#160;Bio</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Totals:</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accounts Receivable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,700</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,700</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Prepaid Expenses</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">421</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">70</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">491</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Inventory</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">369</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">369</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Autos</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">62</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">62</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Furniture and Fixtures</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">265</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">6</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">271</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Leasehold Improvements</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">714</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">714</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Medical Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">234</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">906</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,140</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Computer Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">376</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">574</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">950</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Non-Compete Agreement</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,255</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">926</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,181</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Customer Relationships in Place</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,852</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3,855</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Goodwill</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8,573</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">182</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">8,755</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accounts Payable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(1,388</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(1,388</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Accrued Payroll Benefits</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(393</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(393</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Notes Payable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(578</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(578</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Capital Leases</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(193</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(193</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deferred Acquisition Payable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(3,000</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(375</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(3,375</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Deferred Rent Payable</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(108</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">(108</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">)</font></p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 40.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="40%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Totals:</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">12,326</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.16%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,127</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 3.38%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 16.24%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="16%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">14,453</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table></div> 1848000 P1Y 7016000 P18M 1008000 225000 137000 21000 53000 3000 747000 3235000 1905000 -118000 -200000 -1000000 6016000 232000 48000 3000 43000 2000 930000 673000 -83000 -250000 1598000 1240000 185000 228000 21000 53000 3000 790000 2000 4165000 2578000 -201000 -200000 -1250000 7614000 111000 15215000 15326000 2502000 1700000 421000 369000 62000 265000 234000 376000 1255000 3852000 8573000 -1388000 -393000 -3000000 12326000 70000 6000 714000 906000 574000 926000 3000 182000 -578000 -193000 -375000 -108000 2127000 1700000 491000 369000 62000 271000 714000 1140000 950000 2181000 3855000 8755000 -1388000 -393000 -578000 -193000 -3375000 -108000 14453000 EX-101.SCH 10 brli-20131031.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0010 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0030 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 0040 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1010 - Disclosure - Organization and Business link:presentationLink link:calculationLink link:definitionLink 1020 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 1030 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 1040 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 1050 - Disclosure - Revolving Note Payable - Bank link:presentationLink link:calculationLink link:definitionLink 1060 - Disclosure - Long-Term Debt - Bank link:presentationLink link:calculationLink link:definitionLink 1070 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 1080 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 1090 - Disclosure - Capital Transactions link:presentationLink link:calculationLink link:definitionLink 1100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 1110 - Disclosure - Stock Options and Warrants link:presentationLink link:calculationLink link:definitionLink 1120 - Disclosure - Employment Contracts and Consulting Agreements link:presentationLink link:calculationLink link:definitionLink 1130 - Disclosure - Capitalized Lease Obligations link:presentationLink link:calculationLink link:definitionLink 1140 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 1150 - Disclosure - Litigation link:presentationLink link:calculationLink link:definitionLink 1160 - Disclosure - Insurance link:presentationLink link:calculationLink link:definitionLink 1170 - Disclosure - Significant Risks and Uncertainties link:presentationLink link:calculationLink link:definitionLink 1180 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 1190 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 1200 - Disclosure - Health Insurance Plan link:presentationLink link:calculationLink link:definitionLink 1210 - Disclosure - Employee Benefit Plan link:presentationLink link:calculationLink link:definitionLink 1220 - Disclosure - New Authoritative Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 1230 - Disclosure - Selected Quarterly Financial Data link:presentationLink link:calculationLink link:definitionLink 1240 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS link:presentationLink link:calculationLink link:definitionLink 2020 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 3020 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 3030 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 3040 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 3060 - Disclosure - Long-Term Debt - Bank (Tables) link:presentationLink link:calculationLink link:definitionLink 3080 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 3100 - Disclosure - Earnings Per Share (Tables) link:calculationLink link:definitionLink link:presentationLink 3110 - Disclosure - Stock Options and Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 3120 - Disclosure - Employment Contracts and Consulting Agreements (Tables) link:presentationLink link:calculationLink link:definitionLink 3130 - Disclosure - Capitalized Lease Obligations (Tables) link:presentationLink link:calculationLink link:definitionLink 3140 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 3180 - Disclosure - Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 3230 - Disclosure - Selected Quarterly Financial Data (Tables) link:presentationLink link:calculationLink link:definitionLink 4010 - Disclosure - Organization and Business (Details) link:presentationLink link:calculationLink link:definitionLink 4020 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 4021 - Disclosure - Summary of Significant Accounting Policies (Details 2) link:presentationLink link:calculationLink link:definitionLink 4022 - Disclosure - Summary of Significant Accounting Policies (Details 3) link:presentationLink link:calculationLink link:definitionLink 4023 - Disclosure - Summary of Significant Accounting Policies (Details 4) link:presentationLink link:calculationLink link:definitionLink 4030 - Disclosure - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 4040 - Disclosure - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 4041 - Disclosure - Intangible Assets (Details) (Calc 2) link:presentationLink link:calculationLink link:definitionLink 4050 - Disclosure - Revolving Note Payable - Bank (Details) link:presentationLink link:calculationLink link:definitionLink 4060 - Disclosure - Long-Term Debt - Bank (Details) link:presentationLink link:calculationLink link:definitionLink 4080 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 4081 - Disclosure - Income Taxes (Details) (Calc 2) link:presentationLink link:calculationLink link:definitionLink 4090 - Disclosure - Capital Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 4100 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 4110 - Disclosure - Stock Options and Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 4111 - Disclosure - Stock Options and Warrants (Details 2) link:presentationLink link:calculationLink link:definitionLink 4120 - Disclosure - Employment Contracts and Consulting Agreements (Details) link:presentationLink link:calculationLink link:definitionLink 4130 - Disclosure - Capitalized Lease Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 4140 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 4160 - Disclosure - Insurance (Details) link:presentationLink link:calculationLink link:definitionLink 4170 - Disclosure - Significant Risks and Uncertainties (Details) link:presentationLink link:calculationLink link:definitionLink 4180 - Disclosure - Acquisitions (Details) link:presentationLink link:calculationLink link:definitionLink 4200 - Disclosure - Health Insurance Plan (Details) link:presentationLink link:calculationLink link:definitionLink 4210 - Disclosure - Employee Benefit Plan (Details) link:presentationLink link:calculationLink link:definitionLink 4230 - Disclosure - Selected Quarterly Financial Data (Details) link:presentationLink link:calculationLink link:definitionLink 4240 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) link:presentationLink link:calculationLink link:definitionLink 8000 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 8010 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 8020 - Disclosure - Accounting Standards Update link:presentationLink link:calculationLink link:definitionLink 8030 - Disclosure - Presentation Other Information link:presentationLink link:calculationLink link:definitionLink 8040 - Disclosure - Other Income link:presentationLink link:calculationLink link:definitionLink 8050 - Disclosure - Laboratory Inspection and Reference fees link:presentationLink link:calculationLink link:definitionLink 8060 - Disclosure - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 8070 - Disclosure - Other Income (Details) link:presentationLink link:calculationLink link:definitionLink 8080 - Disclosure - Laboratory Inspection and Reference fees (Details) link:presentationLink link:calculationLink link:definitionLink 8090 - Disclosure - Reclassification of Prior Year Amounts link:presentationLink link:calculationLink link:definitionLink 8100 - Disclosure - Acquisitions (Details 3) link:presentationLink link:calculationLink link:definitionLink 8110 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 8120 - Disclosure - Provision for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 8130 - Disclosure - Common Stock Repurchase link:presentationLink link:calculationLink link:definitionLink 8140 - Disclosure - Common Stock Repurchase (Details) link:presentationLink link:calculationLink link:definitionLink 8150 - Disclosure - Investment in IncellDx link:presentationLink link:calculationLink link:definitionLink 8160 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 8170 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 8180 - Disclosure - Revolving Note Payable - Bank (Tables) link:presentationLink link:calculationLink link:definitionLink 8190 - Disclosure - Capitalized Lease Obligations (Details) (Calc 2) link:presentationLink link:calculationLink link:definitionLink 8200 - Disclosure - Revenue Recognition and Contractual Adjustments link:presentationLink link:calculationLink link:definitionLink 8210 - Disclosure - Revenue Recognition and Contractual Adjustments (Tables) link:presentationLink link:calculationLink link:definitionLink 8220 - Disclosure - Revenue Recognition and Contractual Adjustments (Details) link:presentationLink link:calculationLink link:definitionLink 8230 - Disclosure - Accounts Receivable Allowances link:presentationLink link:calculationLink link:definitionLink 8240 - Disclosure - Accounts Receivable Allowances (Tables) link:presentationLink link:calculationLink link:definitionLink 8250 - Disclosure - Accounts Receivable Allowances (Details) link:presentationLink link:calculationLink link:definitionLink 8260 - Disclosure - Business Combinations (Tables) link:presentationLink link:calculationLink link:definitionLink 8270 - Disclosure - Summary of Significant Accounting Policies (Details 5) link:presentationLink link:calculationLink link:definitionLink 8280 - Disclosure - Acquisitions (Details 2) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 brli-20131031_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.LAB 12 brli-20131031_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Capital Leases Interest Rate Interest rate under capital leases Represents the financing rate for leasing arrangements meeting the criteria for capitalization. Other Intangible Assets [Abstract] Other Intangible Assets Recoverability and Impairment of Intangible Asset and Other Long Lived Assets [Abstract] Recoverability and Impairment of Intangible Assets and Other Long-Lived Assets Impairment of Intangible Assets and Other Long Lived Assets Impairment loss Represents the aggregate amount of write-downs for impairments recognized during the period for intangible asset and other long-lived assets. Advertising Costs [Abstract] Advertising Costs Contractual Credits/Discounts Represents the allowance established for contractual credits or discounts. Allowance for Contractual Credits and Discounts [Member] Allowance for Contractual Credits Discounts [Member] Contractual Credits/Discounts Represents the allowance related to contractual credits and discounts. Amount of Interest Included in Sales Tax Refund Claim Resolved Interest amount included in sales tax refund claim resolved Represents the amount of interest included in sales tax refund claim resolved. Awards to Prior Owners in Cash Cash paid to Prior Owners This element represents the cash paid to prior owners of GeneDx after achieving certain targets. Bad Debt Expense Bad Debt Expense This element represents the amount of bad debt expense for the reporting period. Amendment Description Business Acquisition Cost of Acquired Entity Purchase Price Deferred for Anticipated PreClosing Liabilities Amount of gross purchase price deferred for various anticipated pre-closing liabilities Represents the cost of the acquired entity deferred for anticipated pre-closing liabilities over the specified period following the closing of the acquisition. Amendment Flag Business Acquisition Period Following Closing of Acquisition over which Purchase Price Deferred for Anticipated PreClosing Liabilities Period following the closing of the acquisition over which gross purchase price deferred for various anticipated pre-closing liabilities Represents the period following the closing of the acquisition over which purchase price deferred for anticipated pre-closing liabilities. Business Acquisition Purchase Price Allocation Current Liabilities Loans Payable Short Term Acquisition Payable Represents the amount of acquisition cost of a business combination allocated to the current portion of loans payable of the acquired entity. Short Term / Deferred Acquisition Payable Business Acquisition Purchase Price Allocation Deposits Deposits Amount of acquisition cost of a business combination allocated to deposits not separately disclosed. Cash paid during the period for: Cash Paid [Abstract] Common Stock, Number of Votes Per Share Number of votes per share for holders of common stock Represents the number of votes entitled for each share of common stock. Represents the credit risk associated with the amount of cash and deposits, as of the balance sheet date, that is not insured by the Federal Deposit Insurance Corporation. Concentration Risk, Credit Risk Uninsured Amount Cash and certificate of deposit balances at financial institutions in excess of the federally insured limits Contractual Adjustments and Discounts Total Contractual Adjustments and Discounts Represents the total contractual adjustments and discounts to be deducted from gross service revenue. Contractual Adjustments and Discounts [Abstract] Contractual Adjustments and Discounts: Contractual Adjustments and Discounts All Other Third Party Payors Represents the contractual adjustments and discounts related to amounts billed to third parties other than medicare and medicaid, or direct billed. All Other Third Party Payors Contractual Adjustments and Discounts Medicare Medicaid Portion Medicare/Medicaid Portion Represents the contractual adjustments and discounts related to amounts billed to medicare and medicaid. Current Income Tax [Policy Text Block] Current Income Taxes Disclosure of accounting policy for current income taxes. Debt Instrument, Maturity Term Term of debt Represents the term of the debt instrument. Debt Instrument Number of Equal Periodic Payments Number of equal monthly installments Represents the number of equal periodic payments payable by the entity. Debt Instrument, Reference Rate Variable rate of interest (as a percent) As of the balance sheet date, the effective reference rate for the variable rate of the debt instrument. Debt Instrument, Variable Rate Base [Axis] The alternative reference rates that may be used to calculate the variable interest rate of the debt instrument. Debt Instrument, Variable Rate Base [Domain] Identification of the reference rate that is used to calculate the variable interest rate of the debt instrument. Current Fiscal Year End Date Debt Instrument, Variable Rate Base Rate [Member] Bank's base rate Represents the bank's base rate used to calculate the variable rate of the debt instrument. Eurodollar rate Represents the Eurodollar rate used to calculate the variable rate of the debt instrument. Debt Instrument, Variable Rate Eurodollar [Member] Deferred Compensation Deferred Compensation [Member] Represents the information about deferred compensation arrangements (such as stock or unit options and share or unit awards) that are equity-based payments with individual employees. Benefit in certain accrued expenses Represents the amount of deferred tax expense (benefit) attributable to deductible temporary differences from accrued liabilities. Deferred Income Tax Expense Benefit Accrued Liabilities Deferred Income Tax Expense Benefit Allowance for Doubtful Accounts Net benefit in allowance for bad debts Represents the amount of deferred income tax expense (benefit) arising from deductible temporary differences from the allowance for doubtful accounts. Deferred Income Tax Expense Benefit Depreciation and Amortization Benefit from depreciation and amortization Represents the amount of deferred income tax expense (benefit) attributable to deductible temporary differences from property, plant, and equipment. Deferred Income Tax [Policy Text Block] Deferred Income Taxes Disclosure of accounting policy for deferred income taxes. Defined Contribution Plan, Age of Employees Covered Age requirement for employees to participate in the Plan Represents the age of employees to be eligible to participate in the defined contribution plan. Defined Contribution Plan, Maximum Annual Contributions Per Employee Percent Contribution by participants (as a percent) Represents the maximum percentage of gross pay that the employee may contribute to a defined contribution plan. Represents the estimated period over which an employee is required to provide service to be eligible to participate in the defined contribution plan. Defined Contribution Plan, Requisite Service Period Requisite service period Depreciation expense on assets under capital leases Amount of depreciation related to assets under capital lease. Depreciation Related to Assets under Capital Lease Document Period End Date Document and Entity Information Permanent differences and Other (as a percent) The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to permanent differences and other adjustments under enacted tax laws. Effective Income Tax Rate Reconciliation Permanent Differences and Other Employee Incentive Stock Option Plan 2000 [Member] 2000 Plan Represents information pertaining to the 2000 employee incentive stock option plan. 2003 Plan Represents information pertaining to the 2003 employee incentive stock option plan. Employee Incentive Stock Option Plan 2003 [Member] Represents the number of additional employment and consulting agreements, the entity has entered into. Employment Contracts and Consulting Agreements Additional Number of Agreements Number of additional at-will employment and consulting agreements Annual aggregate commitments under agreement Represents the annual aggregate minimum commitments, which have no termination dates, under the entity's employment and consulting agreements together with the commitments under additional agreements, which the entity has entered into. Employment Contracts and Consulting Agreements Annual Minimum Commitments Including under Additional Agreements Not Subject to Termination Employment Contracts and Consulting Agreements Bonuses and Commissions as Percentage of Collected Revenue Bonuses and commissions based on percentage of collected revenues (as a percent) Represents the percentage of bonuses and commissions based on collected revenues on accounts referred by or serviced by the employee or consultant under employment contracts and consulting agreements. Employment Contracts and Consulting Agreements Employment Contracts and Consulting Agreements Disclosure [Text Block] Employment Contracts and Consulting Agreements Disclosure for employment contracts and consulting agreements. The disclosure may provide parties to agreement and term of the agreement. Entity [Domain] Employment Contracts and Consulting Agreements [Line Items] Employment contracts and consulting agreements Employment Contracts and Consulting Agreements Term Term of consulting agreement Represents the term of employment contracts and consulting agreements. Equity Method Investment Additional Investment Amount of additional investment made under note signed for purchase of additional shares and warrants Represents the amount invested by the entity for the purchase of additional shares and warrants. Equity Method Investment, Additional Investment Committed Amount of note signed for purchase of additional shares and warrants Represents the amount committed by the entity for the purchase of additional shares and warrants. Amount allocated for an additional investment Represents the amount allocated by the entity for an additional investment as on the balance sheet date. Equity Method Investment, Amount Allocated for Additional Investment Excess commercial insurance coverage over the primary limits Represent the additional coverage over the primary limits under the excess commercial insurance arrangement. Excess Commercial Insurance Additional Coverage over Primary Limits Excess Commercial Insurance Coverage Per Incident Excess commercial insurance coverage per occurrence Represent the maximum coverage per excess commercial insurance claim provided by the insurance arrangement. Excess Umbrella Insurance Annual Coverage Limit Excess umbrella coverage Represent the annual coverage limit provided by the excess umbrella insurance arrangement. Exercise Price Range Five [Member] $7.41 to $7.67 Represents exercise price range five. Exercise Price Range Four [Member] $17.50 to $17.50 Represents exercise price range four. $6.11 to $6.11 Represents exercise price range one. Exercise Price Range One [Member] Exercise Price Range Seven [Member] $17.50 to $17.50 Represents the exercise price range seven. Exercise Price Range Six [Member] $9.12 to $9.13 Represents exercise price range six. Exercise Price Range Three [Member] $9.13 to $9.13 Represents exercise price range three. Represents exercise price range two. $7.41 to $7.67 Exercise Price Range Two [Member] Expense Amount Incurred Excluded from Refund Received Amount of expense incurred in pursuit of refund claim Represents the amount of expenses incurred in pursuit of the refund claim. Expenses Excluded from Sales Tax Refund Claim Resolved Expenses excluded from sales tax refund claim resolved Represents the amount of expenses excluded from sales tax refund claim resolved. Total The aggregate estimated amortization expense for succeeding fiscal years for intangible assets subject to amortization which have been allocated to an intangible asset group. Finite Lived Intangible Assets Future Amortization Expense Total Allocated Florida Clinical Laboratory Inc [Member] FCL Represents Florida Clinical Laboratory, Inc., which was acquired by the entity. Furniture Fixtures and Office and Computer Equipment [Member] Furniture, Fixtures and Office & Computer Equipment Represents information pertaining to equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. It also includes information pertaining to tangible personal property used in an office setting and long-lived depreciable assets that are used in the creation, maintenance and utilization of information systems. Automobiles Automobiles [Member] Autos Genedx Inc [Member] Represents information pertaining to GeneDX, Inc. GeneDx, Inc. GCI Represents information pertaining to Genetics centre, Inc. Genetics Center Inc [Member] Accounting Standards Update Accounting Changes and Error Corrections [Text Block] Goodwill [Abstract] Goodwill Health Insurance Plan Health Insurance Plan Disclosure [Text Block] Health Insurance Plan Disclosure in respect of limited self-funded health insurance plan of the reporting entity for its employees. Hunter Laboratories Inc [Member] Hunter Laboratories, Inc Represents information pertaining to Hunter Laboratories, Inc. Hunter Edge BioServe [Member] Edge BioServe Represents information pertaining to Edge BioServe, primarily a genetic sequencing service business located in Gaithersburg, MD. Edge Bio IncellDx Inc[Member] IncellDx Represents IncellDx, Inc., an equity method investee of the entity. Equipment with an initial cost Initial Cost of Equipment Represents gross amount of equipment as of the date of the statement of financial position. Laboratory Inspection and Reference fees Laboratory Inspection and Reference Fees Disclosure [Text Block] Laboratory Inspection and Reference fees The entire disclosure for laboratory inspection and reference fees. Laboratory Testing Business [Member] Laboratory testing business Represents the laboratory testing business, a reportable segment of the entity. Lessee Leasing Arrangements, Operating Leases, Renewal Term Period of renewal options Term of the lessee's leasing arrangement renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Line of Credit Disclosure [Text Block] Revolving Note Payable - Bank This element represent as Line of Credit Disclosure. Line of Credit Facility Maximum Borrowing Capacity as Percentage of Accounts Receivable The percentage of qualified accounts receivable that serves as a limit to the maximum borrowing capacity under the credit facility. Maximum credit line available as percentage of accounts receivable Line of Credit Facility, Maximum Borrowing Capacity Prior to Amendment Maximum credit availability prior to amendment Represents the amount of maximum borrowing capacity prior to amendment under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. Litigation MCL Represents Meridian Clinical Laboratory, Corp., which was acquired by the entity. Meridian Clinical Laboratory Corporation [Member] Net Amount of Refund Net amount of refund Represents the net amount of refund after deducting expenses incurred in pursuit of the refund claim. Number of distinct payors included in all other third party and Direct Represents the number of distinct payors included in all other third party payors and direct payors. Number of Distinct Payors Included in All Other Third Party and Direct Payors This element represents the number of highly compensated senior management employees of the entity. Number of Highly Compensated Senior Management Employees Number of highly compensated senior management employees Other Income [Policy Text Block] Other Income Disclosure of accounting policy for all other income recognized by the entity not otherwise specified in the income statement. Other Income Restitution Payments Received Amount paid by Mr. Littleton for improper payments made to him by the company Represents the amount of restitution payments received by the entity in connection with a restitution agreement entered into with the former Vice President in sales. Patents and Licenses [Member] Patents and Licenses Represents the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law and also includes rights under a license arrangement. Summary of Significant Accounting Policies Percentage of Reportable Segment Assets to Total Assets Percentage of assets to consolidated assets Percentage of reportable segment assets to total assets. Percentage of Reportable Segment Income to Total Income Percentage of net income to consolidated net income Percentage of reportable segment net income to total net income. Entity Well-known Seasoned Issuer Percentage of net revenue to consolidated net revenues Percentage of reportable segment revenue to total revenue. Percentage of Reportable Segment Revenue to Total Revenue Entity Voluntary Filers The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws and including Series A Junior Preferred Stock. Preferred Stock, Shares Authorized, Including Series A Junior Preferred Stock, Authorized shares, including Series A Junior Preferred Stock Preferred stock, shares authorized Entity Current Reporting Status Accounting Standards Update Presentation Other Information Entity Filer Category Presentation Other Information Presentation Other Information [Text Block] This element represents the disclosure of presentation of other information of the reporting company. Entity Public Float Property Represents the long-lived, physical assets used to produce goods and services, excluding equipment. Property [Member] Entity Registrant Name Provision for Bad Debts of Sales Revenue Services Patient Service Revenue Provision for Bad Debts Represents the amount of the current period expense charged against operations, the offset which is generally to the allowance for bad debts for the purpose of reducing the receivables. Entity Central Index Key Purchase Obligation, Purchases Regent supplies expenses Represents the amount of reagent supplies expensed during the period under a purchase obligation. Reclassification of Prior Year Amounts Disclosure [Text Block] Reclassification of Prior Year Amounts This element represents the disclosure of reclassification of prior year amounts. Refund Received Related to Clinical Laboratory Inspection Fee Represents the amount of refund received related to New York State clinical laboratory inspection fee. Amount of refund received related to New York State clinical laboratory inspection fee Refund Received Related to Dispute over Laboratory Inspection and Reference Fees Amount of refund received relating to the dispute over laboratory inspection and reference fees Represents the amount of refund received from New York State Department of Health relating to dispute over the state's laboratory inspection and reference fees. Entity Common Stock, Shares Outstanding Refund Related to Dispute over State Laboratory Inspection and Reference Fees Gross Refund received from New York State Department of Health, before expenses, related to the dispute over the state's Laboratory Inspection and Reference fees Represents the amount of refund related to the dispute over the state's laboratory inspection and reference fees before deducting any expenses incurred in pursuit of such claim. Refund Related to Dispute over State Laboratory Inspection and Reference Fees Net Net amount of refund related to the dispute over the state's Laboratory Inspection and Reference fees Represents the amount of refund related to the dispute over the state's laboratory inspection and reference fees, net of any expenses incurred in pursuit of such refund claim. Expenses incurred in pursuit of refund claim related to dispute over the state's Laboratory Inspection and Reference fees Represents the amount of expenses incurred in pursuit of refund claim related to dispute over the state's laboratory inspection and reference fees. Refund Related to Dispute over State Laboratory Inspection and Reference Fees Related Expenses Revenue Recognition and Contractual Adjustments This element represents the disclosure of revenue recognition. Revenue Recognition Disclosure [Text Block] Represents the percentage of contractual adjustments and discounts to gross revenues. Revenue Recognition Percentage of Contractual Adjustments and Discounts to Gross Revenues Percent of Contractual Allowances, Discounts and Patient Service Provision for Bad Debts to Gross Revenue. Represents the aggregate revenue during the period from services rendered in the normal course of business, before deducting provision for bad debts. Sales Revenue Services Net before Provision for Bad Debts Service Revenues Net of Contractual Adjustments and Discounts Net amount of sales tax refund Sales Tax Refund Amount Net Represents the amount of sales tax refund, including any interest thereon but net of any expenses incurred in pursuit of such refund claim. Sales Tax Refund Claim Resolved Sales tax refund claim resolved Represents the amount of sales tax refund claim successfully resolved with New Jersey Division of Taxation by the entity. Sales Tax Refund Claim Resolved Net Amount Net amount of sales tax refund claim resolved Represents the sales tax refund claim recognized in earnings, net of expenses. Sales Tax Refund Gross Amount of sales tax refund claim successfully resolved with New Jersey Division of Taxation Represents the amount of sales tax refund, including any interest thereon but excluding expenses incurred in pursuit of such refund claim. Represents the amount of interest on sales tax refund. Sales Tax Refund Interest Amount Interest on sales tax refund Sales Tax Refund Related Expenses Expenses incurred in pursuit of sales tax refund claim Represents the amount of expenses incurred by the entity in connection with sales tax refund claim. Schedule of Employment Contracts and Consulting Agreements [Table] Tabular disclosure detailing information related to employment contracts and consulting agreements, including, but not limited to, aggregate future minimum commitment under the employment contracts and agreements. Schedule of Net Service Revenues [Table Text Block] Schedule of adjustments made to gross service revenues to arrive at net revenues Tabular disclosure of adjustments made to gross service revenues to arrive at net revenues. Tabular disclosure of any allowance and reserve accounts. Schedule of amounts for contractual credits and doubtful accounts Schedule of Valuation and Qualifying Accounts [Table Text Block] Self Funded Health Insurance Plan, Employee Contribution Employee contributions for limited health insurance plan Represents the amount contributed by an employee during the period under the limited self-funded health insurance plan. Health insurance premium expenses Represents the amount of health insurance premium expenses under the limited self-funded health insurance plan. Self Funded Health Insurance Plan, Health Insurance Premium Expenses Document Fiscal Year Focus Self Funded Health Insurance Plan, Initial Payment for Covered Medical Expenses Per Person Initial amount the entity pays for covered medical expenses per person each year Represents the initial amount that the entity pays for covered medical expenses per person each year under the limited self-funded health insurance plan. Document Fiscal Period Focus Self Funded Health Insurance Plan, Third Party Insurance Coverage Aggregate Maximum amount in the aggregate, covered by the third party insurance carrier for any excess Represents the maximum amount in the aggregate, which is covered by the third party insurance carrier in case if the claims exceeds the amount covered under the limited self-funded health insurance plan. Maximum amount per person, covered by the third party insurance carrier for any excess Represents the maximum amount per person, which is covered by the third party insurance carrier in case if the claim exceeds the amount covered under the limited self-funded health insurance plan. Self Funded Health Insurance Plan, Third Party Insurance Coverage Per Person Series A Senior Preferred Stock This element represents series A senior preferred stock member. Series A Senior Preferred Stock [Member] Share Based Compensation Arrangement by Share Based Payment Award, Options Exercise Period after Termination Due to Disability or Death Period within which options must be exercised by the optionee after termination of employment due to disability or death Represents the period within which options must be exercised under the stock incentive plan after termination of employment due disability or death. Represents the period within which options must be exercised by the option under the stock incentive plan after termination of his employment due to retirement. Share Based Compensation Arrangement by Share Based Payment Award, Options Exercise Period after Termination Due to Retirement Period within which options must be exercised by the optionee after termination of his employment due to retirement Share Based Compensation Arrangement by Share Based Payment Award, Percentage of Exercise Price of Option for which Loan or Guaranty May be Provided Percentage of exercise price of option for which the Board (or a Stock Option Committee) in its sole discretion, cause the company to lend money or guaranty any obligation Represents the percentage of exercise price of an option for which the Board (or a Stock Option Committee) in its sole discretion, cause the entity to lend money to or guaranty any obligation of an employee for the purpose of enabling such employee to exercise an award granted under the stock incentive plan. Share Based Compensation Arrangements by Share Based Payment Award, Aggregate Fair Market Value of Common Stock with Respect to which Options are Exercisable for the First Time Aggregate fair market value of the common stock with respect to which options are exercisable for the first time by the grantee (in dollars) Represents the aggregate fair market value of the common stock with respect to which options are exercisable for the first time by the grantee under all of the employee stock option plans of the entity. The period of time, from the grant date until the time at which the share-based option award expires. Share Based Compensation Arrangements by Share Based Payment Award, Options Expiration Term Option term Share Based Compensation Arrangement by Share Based Payment Award, Minimum Specified Common Stock Percentage Minimum specified percentage of outstanding common stock for the holder of which the exercise price must be at least 110% of fair market value Represents the minimum specified percentage of outstanding common stock for the holder of which the exercise price must be a minimum specified percentage of the fair market value. Shareholder with Minimum Specified Percentage of Stock [Member] Holder of 10% or more of the outstanding common stock Represents information pertaining to the holder of 10% or more of the outstanding common stock of the entity. This element represents the number of shares issued during the period as a result of fractional share adjustments. Stock Issued, During, the Period, Shares, Fractional Shares Adjustments Fractional Share Adjustments (in shares) Legal Entity [Axis] Term loan Represents the term loan from PNC Bank. Term Loan [Member] Document Type This element represents the total general and administrative expenses including depreciation, amortization and bad debt expense. TOTAL GENERAL AND ADMIN. EXPENSES Total General and Administrative Expense Represents the medical expenses incurred by the entity during the reporting period for uninsured employees. Uninsured Employee Medical Expenses Uninsured employee medical expenses Write Off of Furniture and Equipment Write-off of furniture and equipment This element represents the value of furniture and equipment written off that were fully depreciated. Write Off of Intangible Assets This element represents the value of intangible assets written off that were fully amortized. Write-off of Intangible Assets Accounts Receivable - Net Accounts Receivable, Net, Current Write-off of property Write Off of Property This element represents the value of properties written off that were fully depreciated. Write-off of property and equipment Write Off of Property and Equipment Represents the value of property and equipment written off that were fully depreciated. Business Acquisition Cost of Acquired Entity Purchase Price Subject to Certain Adjustments Purchase price subject to adjustment for certain liabilities Represents the purchase price of the acquired entity subject to certain adjustment. Gross purchase price Business Acquisition Cost of Acquired Entity Deferred Payment Deferred payment for various anticipated pre-closing liabilities Represents the deferred payment to acquire the entity. Florida Clinical Laboratory Inc and Meridian Clinical Laboratory Corporation [Member] FCL and MCL Represents Florida Clinical Laboratory, Inc. and Meridian Clinical Laboratory, Corp., which were acquired by the entity. Hunter Laboratories Inc and Edge Bio Serv LLC [Member] Hunter and Edge Bio Represents Hunter Laboratories, Inc. and Edge BioServ, LLC, which were acquired by the entity. The acquisition-date fair value of the equity interests of the acquirer, issued and outstanding common stock in consideration for the business combination. Business Acquisition Cost of Acquired Entity Equity Interests Issued and Outstanding Common Stock Purchase price of issued and outstanding common stock Business Acquisition Purchase Price Allocation Deferral Period Deferral period Represents the deferral period for short term acquisition payable. Business Acquisition Purchase Price Allocation Current Assets Prepaid Expense Prepaid Expenses The amount of acquisition cost of a business combination allocated to prepaid expenses. Business Acquisition Purchase Price Allocation Current Liabilities Accrued Payroll Benefits Accrued Payroll Benefits The amount of acquisition cost of a business combination allocated to accrued payroll benefits of the acquired entity. Business Acquisition Purchase Price Allocation Current Liabilities Deferred Rent Payable Deferred Rent Payable The amount of acquisition cost of a business combination allocated to deferred rent payable of the acquired entity. Business Acquisition Additional General Disclosures [Abstract] Additional information Business Acquisition Cost of Acquired Entity Purchase Price before Payroll Adjustment Gross purchase price before payroll adjustment The amount of gross purchase price of a business combination before payroll adjustment of the acquired entity. Business Acquisition Purchase Price Allocation Payroll Adjustment Payroll adjustment The amount of acquisition cost of a business combination allocated to payroll adjustment of the acquired entity. Accounts Payable Accounts Payable, Current Accrued Income Taxes, Current Accrued Taxes and Expenses LESS: Accumulated Depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less Accumulated Depreciation Acquired Finite-lived Intangible Asset, Residual Value Estimated residual value Additional Paid in Capital Additional Paid-In Capital Additional Paid-in Capital Additional Paid-in Capital [Member] Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to Reconcile Net Income to Cash Provided by Operating Activities: Advertising Expense Advertising Costs Advertising Costs Advertising Costs, Policy [Policy Text Block] Compensation cost recognized (in dollars) Allocated Share-based Compensation Expense Allowance for Doubtful Accounts Allowance for Doubtful Accounts [Member] Doubtful Accounts Amortization of Intangible Assets Amortization expenses Amortization of Deferred Compensation Amortization of Deferred Charges Assets, Current [Abstract] CURRENT ASSETS: Assets [Abstract] ASSETS Assets, Noncurrent TOTAL OTHER ASSETS Assets, Current TOTAL CURRENT ASSETS Assets TOTAL ASSETS Assets, Fair Value Disclosure [Abstract] Assets: Assets, Noncurrent [Abstract] OTHER ASSETS: Accounts Payable Business Acquisition, Purchase Price Allocation, Current Liabilities, Accounts Payable Capital Leases Business Acquisition, Purchase Price Allocation, Capital Lease Obligation Accrual Business Acquisition [Axis] Business Acquisition, Cost of Acquired Entity, Cash Paid Amount used in connection with purchase of operating assets Down payment Business Acquisition, Purchase Price Allocation, Goodwill Amount Goodwill Addition to goodwill resulting from acquisition Business Acquisition, Acquiree [Domain] Final purchase allocations Business Acquisition, Purchase Price Allocation [Abstract] Acquisitions Inventory Business Acquisition, Purchase Price Allocation, Current Assets, Inventory Intangible assets Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets Accounts Receivable Business Acquisition, Purchase Price Allocation, Current Assets, Receivables Business Acquisition [Line Items] Acquisitions Gross purchase price Business Acquisition, Cost of Acquired Entity, Purchase Price Purchase price Totals: Long Term Debt (Auto-Loans) Business Acquisition, Purchase Price Allocation, Notes Payable and Long-term Debt Note payable and Long Term Debt (Auto-Loans) Other Non-Current Assets Business Acquisition, Purchase Price Allocation, Other Noncurrent Assets Property, plant and equipment Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment Business Combination Disclosure [Text Block] Acquisitions Capital Leases, Future Minimum Payments Due in Two Years 2015 Capital Leases, Future Minimum Payments Due in Five Years 2018 Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments Total Capital Leases, Balance Sheet, Assets by Major Class, Net Net Capital Leases, Future Minimum Payments Due Total Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation Less: Accumulated Depreciation Capitalized Lease Obligations Capital Leases in Financial Statements of Lessor Disclosure [Text Block] Capital Lease Obligations Incurred Capital Leases Capital Leased Assets, Gross Totals Capital Leases, Future Minimum Payments Due in Three Years 2016 Capital Leases, Future Minimum Payments Due, Next Twelve Months 2014 Capital Leases, Future Minimum Payments Due Thereafter Thereafter Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments, Fiscal Year Maturity [Abstract] Future minimum rentals under capital leases Capitalized Lease Obligations Capital Leases in Financial Statements of Lessee Disclosure [Text Block] Capital Leases, Future Minimum Payments Due in Four Years 2017 Capital Leased Assets [Line Items] Assets under capital leases Capital Lease Obligations, Current Capital Lease Obligations - Short-Term Portion Capital Lease Obligations, Noncurrent Capital Lease Obligations - Long-Term Portion Capital Leases, Future Minimum Payments, Interest Included in Payments Less Interest Cash and Cash Equivalents, at Carrying Value Cash and Cash Equivalents CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIODS CASH AND CASH EQUIVALENTS AT END OF PERIODS Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, at Carrying Value [Abstract] Cash Surrender Value, Fair Value Disclosure Cash surrender value of officer's life insurance policies (a component of Other Assets) Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: Class of Stock [Domain] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Commitments and Contingencies. COMMITMENTS AND CONTINGENCIES Common Stock Common Stock [Member] Common Stock, Shares, Outstanding Common Stock, Outstanding shares Common Stock, Value, Issued Common Stock, $.01 Par Value; Authorized 35,000,000 shares: Issued and Outstanding 27,683,213 and 27,707,382 at October 31, 2013 and at October 31, 2012, respectively Common Stock, Shares, Issued Common Stock, Issued shares Common Stock, Par or Stated Value Per Share Common Stock, Par Value (in dollars per share) Common Stock, Shares Authorized Common Stock, Authorized shares Employee Benefit Plan Computer Equipment Computer Equipment [Member] Significant Risks and Uncertainties Concentration Risk Disclosure [Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] 2015 Contractual Obligation, Due in Second Year 2018 Contractual Obligation, Due in Fifth Year Schedule of aggregate minimum commitment under employment contracts and agreements, excluding commissions or consumer price index increases Contractual Obligation, Fiscal Year Maturity Schedule [Table Text Block] 2017 Contractual Obligation, Due in Fourth Year 2014 Contractual Obligation, Due in Next Twelve Months 2016 Contractual Obligation, Due in Third Year Thereafter Contractual Obligation, Due after Fifth Year Contractual Obligation, Fiscal Year Maturity [Abstract] Aggregate minimum commitment under these employment contracts and agreements, excluding commissions or consumer price index increases Contractual Obligation Total Depreciation and Amortization Cost of Services, Depreciation and Amortization Cost of Services, Direct Materials Reagents and Lab Supplies Cost of Services TOTAL COST OF SERVICES Cost of Services [Abstract] COST OF SERVICES: Credit Facility [Domain] Credit Facility [Axis] Current State and Local Tax Expense (Benefit) State & Local Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Current: Current tax provision Current Income Tax Expense (Benefit) Current Federal Tax Expense (Benefit) Federal Customer Lists Customer Lists [Member] Customer Relationships in Place Customer Relationships [Member] Debt Instrument, Description of Variable Rate Basis Variable rate basis Debt Instrument [Line Items] Long-term debt Schedule of Long-term Debt Instruments [Table] Frequency of principal payments Debt Instrument, Frequency of Periodic Payment Percentage of additional interest Debt Instrument, Basis Spread on Variable Rate Debt instrument amount Debt Instrument, Face Amount Monthly installment including principal and interest Debt Instrument, Periodic Payment Debt Instrument, Increase, Additional Borrowings Debt issued Monthly principal payments Debt Instrument, Periodic Payment, Principal Debt instrument interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Deferred Tax Assets, Property, Plant and Equipment Depreciation and amortization Title of Individual [Axis] Deferred Federal Income Tax Expense (Benefit) Federal Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Deferred: Deferred Income Tax Expense (Benefit) Deferred Income Taxes (Benefit) Net deferred tax benefit Deferred Income Tax Expense (Benefit) [Abstract] Net deferred tax benefit Deferred Tax Assets, Net of Valuation Allowance Deferred Tax Asset - Net Deferred Tax Assets, Net [Abstract] Deferred Tax Asset: Deferred Tax Assets, Net of Valuation Allowance, Current Deferred Tax Assets Current Deferred Tax Asset - Net Deferred State and Local Income Tax Expense (Benefit) State and Local Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts Bad Debt Allowance Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Accrued Expenses Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Deferred Tax Assets Long Term Deferred Tax Asset - Net Entity's contribution under the Plan Defined Contribution Plan, Cost Recognized Deposits Assets, Noncurrent Deposits Depreciation, Depletion and Amortization, Nonproduction Depreciation and Amortization Depreciation, Depletion and Amortization Depreciation and Amortization Depreciation expense Depreciation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock Options and Warrants Stock Options and Warrants Earnings Per Share, Diluted NET INCOME PER SHARE - DILUTED: (in dollars per share) Net Income Per Share - Diluted (in dollars per share) Diluted (in dollars per share) Earnings Per Share, Basic NET INCOME PER SHARE - BASIC: (in dollars per share) Net Income Per Share - Basic (in dollars per share) Basic (in dollars per share) Earnings Per Share Earnings Per Share [Text Block] Earnings Per Share Earnings Per Share, Policy [Policy Text Block] Earnings Per Share Net Income Per Common Share: Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract] Reconciliation of income tax from continuing operations computed at the U.S. federal statutory tax rate to the company's effective income tax rate Effective Income Tax Rate, Continuing Operations Actual Rate (as a percent) Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate U.S. Federal Statutory Rate (as a percent) Effective Income Tax Rate Reconciliation, State and Local Income Taxes State and Local Taxes, Net of U.S. Federal Tax Benefit (as a percent) Employee-related Liabilities, Current Accrued Salaries and Commissions Payable Compensation cost, related tax benefit (in dollars) Employee Service Share-based Compensation, Tax Benefit from Compensation Expense Compensation cost Employee Service Share-based Compensation, Aggregate Disclosures [Abstract] Medical Equipment Equipment [Member] Equity Method Investments and Joint Ventures Disclosure [Text Block] Investment in IncellDx Investments Equity Method Investments Investment Equity Method Investment, Aggregate Cost Equity Method Investee, Name [Domain] Investment in IncellDx Total Estimate of Fair Value, Fair Value Disclosure [Member] Fair Value, Hierarchy [Axis] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Fair Value Measurements, Recurring and Nonrecurring [Table] Purchase of new equipment Fair Value of Assets Acquired Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block] Schedule of fair value measurements Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Measurements. Fair Value of Financial Instruments Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Fair Value, Inputs, Level 3 [Member] Significant Unobservable Inputs, Level 3 Fair Value, Inputs, Level 1 [Member] Quoted Prices in Active Markets for Identical Assets/Liabilities, Level 1 Significant Other Observable Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Weighted-Average Amortization Period Finite-Lived Intangible Asset, Useful Life Finite-Lived Intangible Assets, Major Class Name [Domain] 2018 Finite-Lived Intangible Assets, Amortization Expense, Year Five Cost Finite-Lived Intangible Assets, Gross Finite-Lived Intangible Assets [Line Items] Intangible assets Other intangible assets 2016 Finite-Lived Intangible Assets, Amortization Expense, Year Three Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Estimated amortization expense related to intangible assets Finite-Lived Intangible Assets by Major Class [Axis] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five 2014 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months 2017 Finite-Lived Intangible Assets, Amortization Expense, Year Four Finite-Lived Intangible Assets, Amortization Expense, Year Two 2015 Net of Accumulated Amortization Finite-Lived Intangible Assets, Net Furniture and Fixtures Furniture and Fixtures [Member] Gain (Loss) on Sale of Property Plant Equipment Loss on Disposal of Property and Equipment General and Administrative Expense Other General and Administrative Expenses General and Administrative Expense [Abstract] General and Administrative Expenses: Other Intangible Assets Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Goodwill Goodwill - Net Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Impairment loss Goodwill, Impairment Loss Intangible Assets Goodwill, Impaired, Accumulated Impairment Loss Goodwill accumulated amortization Gross Profit GROSS PROFIT ON REVENUES Gross Profit Impairment of Intangible Assets, Finite-lived Capitalized costs written off Recoverability and Impairment of Intangible Assets and Other Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] CONSOLIDATED STATEMENTS OF OPERATIONS Income Tax Disclosure [Text Block] Income Taxes Income Taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest INCOME BEFORE INCOME TAXES Undistributed Equity Method (Income) Loss Income (Loss) from Equity Method Investments Share of undistributed loss Provision for income taxes Income Tax Expense (Benefit), Continuing Operations [Abstract] Income Tax Expense (Benefit) Provision for Income Taxes Provision for Income Taxes Income Taxes Paid Income Taxes Increase (Decrease) in Customer Deposits Deposits Increase (Decrease) in Other Current Assets Other Current Assets Increase (Decrease) in Accounts Receivable Accounts Receivable Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts Payable and Accrued Liabilities Increase (Decrease) in Operating Capital [Abstract] Change in Assets and Liabilities: Increase (Decrease) in Other Operating Assets Other Assets Increase (Decrease) in Inventories Inventory Increase (Decrease) in Operating Liabilities [Abstract] Increase (Decrease) in: (Increase) Decrease in: Increase (Decrease) in Operating Assets [Abstract] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity Effect of Dilutive Securities: Warrants/Options (in shares) Incremental Common Shares Attributable to Call Options and Warrants Insurance Insurance Disclosure [Text Block] Insurance Intangible Assets Disclosure [Text Block] Intangible Assets Intangible Assets, Net (Excluding Goodwill) Intangible Assets - Net Interest Expense Interest Expense Interest Paid Interest Inventory Inventory, Policy [Policy Text Block] Inventory, Net Inventory Investment Income, Interest Other (Income) Expense Long-term Debt, Type [Domain] Long-term Debt, Type [Axis] Labor and Related Expense Employee Related Expenses Leasehold Improvements [Member] Leasehold improvements Leasehold Improvements Capitalized Lease Obligations Litigation Legal Matters and Contingencies [Text Block] Liabilities, Current TOTAL CURRENT LIABILITIES Contingent liability Liabilities Assumed Liabilities, Noncurrent TOTAL LONG-TERM LIABILITIES Liabilities, Current [Abstract] CURRENT LIABILITIES: Liabilities, Noncurrent [Abstract] LONG-TERM LIABILITIES: Liabilities and Equity [Abstract] LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities and Equity TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY Maximum amount of the credit line available pursuant to the loan agreement Line of Credit Facility, Maximum Borrowing Capacity Revolving notes payable outstanding amount Line of Credit Facility, Amount Outstanding Line of Credit Facility, Increase (Decrease), Other, Net Increase (Decrease) in Revolving Note Payable Line of Credit Facility [Line Items] Revolving note payable - Bank Line of Credit Facility [Table] Line of Credit, Current Revolving Note Payable - Bank Amount of credit utilized Accounts Receivable Allowances Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Long-Term Debt - Bank Debt outstanding Long-term Debt Totals Principal repayment for each of the five succeeding fiscal years and thereafter Long-term Debt, Fiscal Year Maturity [Abstract] Long-Term Debt - Bank Long-term Debt [Text Block] Schedule of minimum purchase commitments Long-term Purchase Commitment [Table Text Block] 2016 Long-term Debt, Maturities, Repayments of Principal in Year Three 2015 Long-term Debt, Maturities, Repayments of Principal in Year Two 2017 Long-term Debt, Maturities, Repayments of Principal in Year Four 2014 Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months 2018 Long-term Debt, Maturities, Repayments of Principal in Year Five Long-term Debt, Current Maturities Current Maturities of Long-Term Debt Long-term Debt, Excluding Current Maturities Long Term Debt - Net of Current Portion Other Long Term Acquisition Payable Loans Payable, Noncurrent Thereafter Long-term Debt, Maturities, Repayments of Principal after Year Five Professional liability insurance coverage Malpractice Insurance, Annual Coverage Limit Professional liability insurance coverage per occurrence Malpractice Insurance, Maximum Coverage Per Incident Mr. Richard Faherty Management [Member] Maximum Maximum [Member] Seven-year term note Medium-term Notes [Member] Minimum Minimum [Member] Valuation and qualifying accounts Movement in Valuation Allowances and Reserves [Roll Forward] Organization and Business Nature of Operations [Text Block] FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] NET CASH - OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities, Continuing Operations OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Net Cash Provided by (Used in) Continuing Operations NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS NET CASH - INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net Income (Loss) Available to Common Stockholders, Basic NET INCOME Net Income Income Available to Common Stockholders (in dollars) NET CASH - FINANCING ACTIVITIES Net Cash Provided by (Used in) Financing Activities, Continuing Operations INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] New Accounting pronouncements New Accounting Pronouncements, Policy [Policy Text Block] New Authoritative Accounting Pronouncements New Authoritative Accounting Pronouncements New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) Acquisition of certain assets Covenants Not-to-Compete Noncompete Agreements [Member] Non-Compete Agreement Number of Reportable Segments Number of businesses acquired Number of Businesses Acquired Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Aggregate future minimum rental payments Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Net operating loss carry-forwards Operating Loss Carryforwards Total rental expenses for property and equipment Operating Leases, Rent Expense, Net Operating Income (Loss) OPERATING INCOME 2016 Operating Leases, Future Minimum Payments, Due in Three Years 2015 Operating Leases, Future Minimum Payments, Due in Two Years 2014 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2017 Operating Leases, Future Minimum Payments, Due in Four Years Contingent rental amounts Operating Leases, Rent Expense, Contingent Rentals 2018 Operating Leases, Future Minimum Payments, Due in Five Years Operating Leases Operating Leased Assets [Line Items] Totals Operating Leases, Future Minimum Payments Due Organization and Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Basis of Presentation Summary of Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Other Assets, Current Other Current Assets Other Income Other Income Other Income [Abstract] Other Assets, Noncurrent Other Assets Other Cost of Services Other Cost of Services Other Income and Other Expense Disclosure [Text Block] Other Income Other Nonoperating Expense Interest Income Other Short Term Acquisition Payable Other Loans Payable, Current Other Nonoperating Income (Expense) TOTAL OTHER EXPENSES - NET Other Nonoperating Income (Expense) [Abstract] OTHER (INCOME) EXPENSES: Common Stock Repurchased Payments for Repurchase of Common Stock Payments to Acquire Businesses, Net of Cash Acquired Business Acquisitions Related Costs Acquisition of Intangible Assets Payments to Acquire Intangible Assets Payments to Acquire Productive Assets Acquisition of Equipment and Leasehold Improvements Employee Benefit Plan Pension and Other Postretirement Benefits Disclosure [Text Block] Plan Name [Domain] Plan Name [Axis] Preferred Stock, Value, Issued Preferred Stock $.10 Par Value; Authorized 1,666,667 shares, including 3,000 shares of Series A Junior Preferred Stock None Issued Preferred Stock, Shares Authorized Preferred Stock, Authorized shares Preferred Stock, Shares Issued Preferred Stock, Issued shares Preferred Stock, Par or Stated Value Per Share Preferred Stock, Par Value (in dollars per share) Preferred stock, par value (in dollars per share) Outstanding shares of preferred stock Preferred Stock, Shares Outstanding Reclassification of Prior Year Amounts Reclassifications Reclassification, Policy [Policy Text Block] Proceeds from Stock Options Exercised Proceeds from Exercise of Options Estimated useful lives Property, Plant and Equipment, Useful Life Property, Plant and Equipment, Type [Domain] Property and Equipment Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Property, Plant and Equipment, Net PROPERTY AND EQUIPMENT - NET Property and equipment Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Gross PROPERTY AND EQUIPMENT - AT COST Summary of property and equipment - at cost Property, Plant and Equipment [Table Text Block] Property, Plant and Equipment, Type [Axis] Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Provision for Doubtful Accounts Provision for Doubtful Accounts 2014 Purchase Obligation, Due in Next Twelve Months Totals Purchase Obligation 2015 Purchase Obligation, Due in Second Year 2017 Purchase Obligation, Due in Fourth Year Minimum purchase commitments Purchase Obligation, Fiscal Year Maturity [Abstract] 2016 Purchase Obligation, Due in Third Year 2018 Purchase Obligation, Due in Fifth Year Selected Quarterly Financial Data Quarterly Financial Information [Text Block] Selected Quarterly Financial Data Range [Axis] Range [Domain] Accounts Receivable Allowances Related Party Transactions Related Party Transactions Disclosure [Text Block] Related party transactions Related Party Transaction [Line Items] Related Party [Domain] Aircraft rentals Related Party Transaction, Expenses from Transactions with Related Party Related Party Transactions Related Party [Axis] Repayments of Long-term Debt Payments of Long-Term Debt Repayments of Long-term Capital Lease Obligations Payments of Capital Lease Obligations Retained Earnings (Accumulated Deficit) Retained Earnings Retained Earnings Retained Earnings [Member] Revenue Recognition and Contractual Adjustments Accounting for Revenues Accounting for Revenue Revenue Recognition, Policy [Policy Text Block] Revolving Credit Facility [Member] Revolving note payable - bank Significant Risks and Uncertainties Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Exercise price as a percentage of fair value of common stock Weighted Average, Exercise Price (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price Exercisable, Exercise Price (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price Weighted Average, Remaining Life Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term Schedule of estimated amortization expense related to remaining intangible assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Sales Revenue, Services, Net NET REVENUES: Service Revenues Net of Contractual Adjustments and Discounts Net Revenues Gross Service Revenues Sales Revenue, Services, Other Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of provision for income taxes Summary of employee incentive stock option plan transactions Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of computation of basic and diluted net earnings per common share Schedule of principal repayment for each of the five succeeding fiscal years and thereafter Schedule of Maturities of Long-term Debt [Table Text Block] Schedule of aggregate future minimum rentals under capital leases Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block] Schedule of assets under capital leases expiring in fiscal 2018 Schedule of Capital Leased Assets [Table Text Block] Schedule of reconciliation of income tax from continuing operations computed at the U.S. federal statutory tax rate to the Company's effective income tax rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Capital Leased Assets [Table] Schedule of aggregate future minimum rental payments on non cancelable operating leases (exclusive of several month to month leases) Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of final purchase allocations Schedule of Purchase Price Allocation [Table Text Block] Schedule of quarterly financial data Schedule of Quarterly Financial Information [Table Text Block] Schedule of net deferred tax asset [liability] Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of information on intangible assets Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Operating Leased Assets [Table] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Line Items] Equity method investment Equity Method Investee, Name [Axis] Summary of outstanding options Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Property, Plant and Equipment [Table] SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Organization and Business Segment Reporting Information [Line Items] Segment [Domain] Series A Junior Preferred Stock Series A Preferred Stock [Member] Share-based Compensation Stock - Based Compensation Expense Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward] Weighted Average Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Employee incentive stock options Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Expired (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Outstanding options, eligible for exercise, weighted average exercise price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Expired (in shares) Employee incentive stock option plan, additional disclosures Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Outstanding options, eligible for exercise (in shares) Shares Under Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Maximum aggregate shares of common stock authorized under the plan Exercisable, Shares Outstanding Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options Exercise Price Range [Axis] Employee Incentive Stock Options Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding at the end of the period (in dollars per share) Outstanding at the beginning of the period (in dollars per share) Weighted Average, Shares Outstanding Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options Exercise price range, low end of range (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding at the beginning of the period (in shares) Outstanding at the end of the period (in shares) Exercise price range, high end of range (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit Balance (in shares) Balance (in shares) Shares, Issued Revolving Note Payable - Bank Statement [Table] Statement [Line Items] Statement CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY CONSOLIDATED STATEMENTS OF CASH FLOWS Business Segments [Axis] CONSOLIDATED BALANCE SHEETS Class of Stock [Axis] Stock Issued During Period, Shares, Period Increase (Decrease) Total Number of shares of common stock issued for employment or consulting services Stock Issued During Period, Shares, Issued for Services Stock Repurchased and Retired During Period, Value Cost of shares of common stock repurchased Common Stock Repurchased and Canceled Stock Repurchase Program, Number of Shares Authorized to be Repurchased Number of shares of common stock authorized to be repurchased Stock Issued for Acquisition (in shares) Stock Issued During Period, Shares, Acquisitions Exercise of Options - Employees Stock Issued During Period, Value, Stock Options Exercised Stock Issued for Acquisition Stock Issued During Period, Value, Acquisitions Stock-based compensation expense Stock Granted During Period, Value, Share-based Compensation, Net of Forfeitures Stock Repurchased and Retired During Period, Shares Number of shares of common stock repurchased Common Stock Repurchased and Canceled (in shares) Stock Based Compensation (in shares) Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Stock Based Compensation Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Stock Issued During Period, Shares, New Issues Shares Issued to Prior Owners (in shares) Exercise of Options - Employees (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercised (in shares) SHAREHOLDERS' EQUITY: Stockholders' Equity Attributable to Parent [Abstract] TOTAL SHAREHOLDERS' EQUITY Stockholders' Equity Attributable to Parent Balance Balance Capital Transactions Stockholders' Equity Note, Stock Split, Conversion Ratio Stock split ratio Capital Transactions Stockholders' Equity Note Disclosure [Text Block] Stockholders' Equity, Period Increase (Decrease) Total Subsequent Events Subsequent Events [Text Block] Subsequent Events Subsequent Event Type [Domain] Subsequent Event [Line Items] Subsequent events Subsequent Events Subsequent Events, Policy [Policy Text Block] Subsequent Event Type [Axis] Subsequent Event [Table] Subsequent events Subsequent Event [Member] Supplemental Cash Flow Information [Abstract] SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Title of Individual with Relationship to Entity [Domain] Accounting for Contractual Credits and Doubtful Accounts Trade and Other Accounts Receivable, Policy [Policy Text Block] Automobiles and Aircraft Transportation Equipment [Member] Use of Estimates Use of Estimates, Policy [Policy Text Block] Valuation and Qualifying Accounts Disclosure [Table] Valuation Allowances and Reserves [Domain] Charged to Cost and Expenses Valuation Allowances and Reserves, Charged to Cost and Expense Valuation Allowances and Reserves, Balance Total Allowance Balance at the Beginning of a Period Balance at the End of a Period Deductions Charged to Valuation Allowance Accounts Valuation Allowances and Reserves, Deductions SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS Valuation and Qualifying Accounts Disclosure [Line Items] Valuation and qualifying accounts Allowances Valuation Allowances and Reserves Type [Axis] Vehicles Vehicles [Member] Weighted Average Number of Shares Outstanding, Basic WEIGHTED AVERAGE NUMBER OF SHARES - BASIC: (in shares) Weighted Average Common Shares Outstanding - Basic (in shares) Weighted Average Common Shares Outstanding (in shares) WEIGHTED AVERAGE NUMBER OF SHARES - DILUTED: (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted Average Diluted Common Shares Outstanding (in shares) Weighted Average Common Shares Outstanding - Diluted (in shares) EX-101.PRE 13 brli-20131031_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.DEF 14 brli-20131031_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT GRAPHIC 15 g133101dai001.jpg GRAPHIC begin 644 g133101dai001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T- M#AT5%A$8(Q\E)"(?(B$F*S7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W M^/GZ_]H`"`$!```_`/9JCDN(86"RS(A(R`S`9IGVVT_Y^H?^_@H^VVG_`#]0 M_P#?P4?;;3_GZA_[^"C[;:?\_4/_`'\%'VVT_P"?J'_OX*/MMI_S]0_]_!1] MMM/^?J'_`+^"C[;:?\_4/_?P4?;;3_GZA_[^"C[;:?\`/U#_`-_!1]MM/^?J M'_OX*/MMI_S]0_\`?P4?;;3_`)^H?^_@H^VVG_/U#_W\%'VVT_Y^H?\`OX*/ MMMI_S]0_]_!1]MM/^?J'_OX*/MMI_P`_4/\`W\%'VVT_Y^H?^_@H^VVG_/U# M_P!_!1]MM/\`GZA_[^"C[;:?\_4/_?P4?;;3_GZA_P"_@H^VVG_/U#_W\%'V MVT_Y^H?^_@H^VVG_`#]0_P#?P4?;;3_GZA_[^"C[;:?\_4/_`'\%'VVT_P"? MJ'_OX*/MMI_S]0_]_!1]MM/^?J'_`+^"C[;:?\_4/_?P4?;;3_GZA_[^"C[; M:?\`/U#_`-_!1]MM/^?J'_OX*/MMI_S]0_\`?P4?;;3_`)^H?^_@H^VVG_/U M#_W\%'VVT_Y^H?\`OX*/MMI_S]0_]_!1]MM/^?J'_OX*/MMI_P`_4/\`W\%' MVVT_Y^H?^_@H^VVG_/U#_P!_!1]MM/\`GZA_[^"C[;:?\_4/_?P4?;;3_GZA M_P"_@H^VVG_/U#_W\%'VVT_Y^H?^_@H^VVG_`#]0_P#?P4?;;3_GZA_[^"C[ M;:?\_4/_`'\%'VVT_P"?J'_OX*/MMI_S]0_]_!1]MM/^?J'_`+^"C[;:?\_4 M/_?P4?;;3_GZA_[^"C[;:?\`/U#_`-_!1]MM/^?J'_OX*/MMI_S]0_\`?P4? M;;3_`)^H?^_@H^VVG_/U#_W\%'VVT_Y^H?\`OX*/MMI_S]0_]_!1]MM/^?J' M_OX*/MMI_P`_4/\`W\%'VVT_Y^H?^_@H^VVG_/U#_P!_!1]MM/\`GZA_[^"C M[;:?\_4/_?P4?;;3_GZA_P"_@H^VVG_/U#_W\%'VVT_Y^H?^_@H^VVG_`#]0 M_P#?P4?;;3_GZA_[^"C[;:?\_4/_`'\%'VVT_P"?J'_OX*/MMI_S]0_]_!1] MMM/^?J'_`+^"C[;:?\_4/_?P4?;;3_GZA_[^"C[;:?\`/U#_`-_!1]MM/^?J M'_OX*/MMI_S]0_\`?P5*CK(@=&#*PR"#D$4ZJ3QI)J_SHK?Z/W`/\56?L\/_ M`#Q3_OD4?9X?^>*?]\BC[/#_`,\4_P"^11]GA_YXI_WR*/L\/_/%/^^11]GA M_P">*?\`?(H^SP_\\4_[Y%'V>'_GBG_?(H^SP_\`/%/^^11]GA_YXI_WR*/L M\/\`SQ3_`+Y%'V>'_GBG_?(H^SP_\\4_[Y%'V>'_`)XI_P!\BC[/#_SQ3_OD M4?9X?^>*?]\BC[/#_P`\4_[Y%'V>'_GBG_?(H^SP_P#/%/\`OD4?9X?^>*?] M\BC[/#_SQ3_OD4?9X?\`GBG_`'R*/L\/_/%/^^11]GA_YXI_WR*/L\/_`#Q3 M_OD4?9X?^>*?]\BC[/#_`,\4_P"^11]GA_YXI_WR*/L\/_/%/^^11]GA_P"> M*?\`?(H^SP_\\4_[Y%'V>'_GBG_?(H^SP_\`/%/^^11]GA_YXI_WR*/L\/\` MSQ3_`+Y%'V>'_GBG_?(H^SP_\\4_[Y%'V>'_`)XI_P!\BC[/#_SQ3_OD4?9X M?^>*?]\BC[/#_P`\4_[Y%'V>'_GBG_?(H^SP_P#/%/\`OD4?9X?^>*?]\BC[ M/#_SQ3_OD4?9X?\`GBG_`'R*/L\/_/%/^^11]GA_YXI_WR*/L\/_`#Q3_OD4 M?9X?^>*?]\BC[/#_`,\4_P"^11]GA_YXI_WR*/L\/_/%/^^11]GA_P">*?\` M?(H^SP_\\4_[Y%'V>'_GBG_?(H^SP_\`/%/^^11]GA_YXI_WR*/L\/\`SQ3_ M`+Y%'V>'_GBG_?(H^SP_\\4_[Y%'V>'_`)XI_P!\BC[/#_SQ3_OD4?9X?^>* M?]\BC[/#_P`\4_[Y%'V>'_GBG_?(H^SP_P#/%/\`OD4?9X?^>*?]\BC[/#_S MQ3_OD4?9X?\`GBG_`'R*/L\/_/%/^^11]GA_YXI_WR*/L\/_`#Q3_OD4?9X? M^>*?]\BC[/#_`,\4_P"^11]GA_YXI_WR*/L\/_/%/^^11]GA_P">*?\`?(H^ MSP_\\4_[Y%'V>'_GBG_?(H^SP_\`/%/^^11]GA_YXI_WR*/L\/\`SQ3_`+Y% M)]GA_P">,?\`WR*H>&ACPSIH'_/LG\JU*J?\Q?\`[8?^S5;HHHHHHHHHHHHH MHHHHHHHHI,T;A2T444E'6EHHI*,BC(HZTM%%)1D44M%)D4M%)D49%+129%%% M&:,C.*,T9S1FBEHHHHHHHHHHHHHHHHHHHHHHK,\-?\BUIO\`U[)_(5IU4_YB M_P#VP_\`9JMT444444444444444444445R?B_4M1;6-%\.Z9>-82:J\IENT0 M,T:1KN(7/&33#+J7@G2[V]U;5Y]:M%\M;6.2-5GWLP7:6X!!)'7I4-[\0)]) MM]3BU31OL^HZ?:+>"V2Y#I-$7V9#@<8/7BFW/C^_MKJ2U;PXWG_8?[0C4WBX M:`?>)..&'8'IKQ8)I7?5I;-/MUZ-BL.[2E<(O&`,' MD@5K7/C&:WT[3V_LEFU'4IS#;6@N4*N0"2_F+D;,#.<9YZ56'CZ3`MFT=QJ4 M>HQV%Q:"=3L9T9E=7Q@J0O?'>M+P]XEDUB_U/3+NP^PW^F.@FC$HE4AQN4A@ M!V]JS[7QS)>R1W,6DD:1/=&S@O6N`"\NXJOR8X4L-N;_`*_:F[T^7]:RI/B&K$VUN\4^M:?/+'*DN#;,L/F`CCD\^W2I1XPNM'\*Z)*\$5 MY<75A%*TES>+$9&V`G`PS,W4],>]9_\`PL*]U;4[1;&S"Z7=:1->N?-V3#;E M3@X."K*0/7.>V*U]"\5C['X;CEMIA;ZQ;MLN9[CS'611N".<#)(SSQTZ5G77 MQ:LK:,/]B3$GFS0^9=+'YMNC;0ZY'+,0VU.^.M7/'^O2CX93ZUH]W+`TJ020 MS1':P5G7^AKG]+U18-)U/4%UKQ/?+`($:*^_T?!>90&1L'G@@^Q([UUU]XTA MTN778K^T,3Z3"D\8$F?M2/PI7C@[OE[\UEI\4+7^UH]/GM(8G6:.VN%^UKYB M3-@$*F,NJDX+<=#Q6MXLN+[1OL_B&VFE>UL4(D,1.V/)/`9L[F;L#[5)I_Q"MM0T6^O8K>`S:?* MLZUHBV[WD^CW3[6=[.4,T9'50V.1^%<9X"GO8/#][XIUCQ#J5[#:BX M1[>9PR;8S]X?[6%_6M4^.[Z-(X[K0A:3WUG+=::&N@ZS;$WE7P/D.#GO]:9I M/C35/^$&L=;U&QM3<71PI-VL4;#'RDDC()/`4!CQ52Q\7R^(?%?A2XLY)[:S MO8KP7%J6X+QC'/K@\@U2^(VLW%AXQL;5M9U;3[%M/:5QIJ[F+ASR1Z8ZGVK4 M@\:7OA[P9HTWB)(WU6_)1!-*(5(&2&D;HOR[K=EXNN)/$-GI&H:0UF=0M MVGM)!.)-P4`L&`'RG!]3734M%%%%%%%%%%%%%%%%%%%9GAK_`)%K3?\`KV3^ M0K3JI_S%_P#MA_[-5NBBBBBBBBBBBBBBBBBBBBBL;Q#X;M_$,$`DGN+2YM9/ M-MKJV?;)"V,''J"."*S$\!6\FF7MKJ&K:EJ$]]L\RYFF^9"AW(44#"X(!Z5' M=>`$U&TU(:EJ]Q>7VH6RVK7;1(ICB5MP554`=>OK5J[\&07>IB^-Y*K#26TS M:%&-K?Q_7VK`L/!6JZ?XJ\NRO;FSM;?18K2*_1$;>ROR"ISSBMC_`(5]80P: M5'87=U9/IB21I(FUFD23_69R,;CZCI2^'O`5OX>U&QO(K^68V5B]DB.@`*M( M9,DCN,XJ2T\&'3]#N=-L]5FB:XNY+KS3$CC+GE2C`AE^M0P_#^SM=(MK2UO; MF"ZM+I[R"\54RDK<-A,;=N#C;C%2V_@>"%H;B2_GGO?[134+BY=5#3NJ%`N! M@*N&X`Z5?TWP['IOB+6-92X>1]5\G?&5`$?EKM&#WS5"T\$0V5W$L>HW!TN& MZ-W%IS(FQ)B2V=V-VT$Y"^M7_#_AZ/0&U-H[AYO[1OI+QMZ@;"^/E&.H&*RE M^'T$5XQM=9U.VTUYC.^FQ3;8B^=QP?O`$\X!IU]X%6ZGU@VVKW5G;ZTA%W;H MB,&U-G?6W]HSXO--@L&;8ORK$``P]SBKMYX&L[^]BGN M;B5XTTIM,:(`#>A_BSV-9M]\-&U*TL;>]\0WTJ(C&:$8XPP(5N.HJK9?#:UL(K-(-2N`;6SN+(D MHI\R&4LV#Z%2V&&NYE6T">3=*`)$93PP_#(_&B^\"V4X MLS8W,^G2VMI]A\R`*2]OQE>1P>,AAR":N>(?"\&O^%Y-`,\EO"RQJ)%^=@$8 M$=>O2K6NZ.NNZ-)ILDSQ+(T;%U`)^1U?OZ[P8`U&W@N%=9FOK;4+FVM[FY6ZN;2,+MEE&.=V-R@X&0#S6OK>F) MK6B7FEO(8DNX6A9U&2H88S567PY!-X8M]#>9]MM%$D4X`W*\>-KX/&-H4?W<=S5=OAVDMY<7EQK%S/<75S: MW,[O&GS/!G&`,``@XQVQ795@:/X1M-+\-7.@R2O=6UTTQD9@%)$A.1Q]:JV7 M@:..X@EU'5+K4A9V[VUFDJHGD1NNUN5&6;:,;C44?@%(M'TJQ35KE9M'F:2S MN1&FY%/&TJ1AN#UZT:/\/K;1M1TR[BU">4::]RT:.H^83=03[>O>M2Z\-PW7 MBF'79)F+16;VA@VC:ZLE:CI,6M7=OI MM]/]H^RK&A$;E@Q^;&2,CIGBM(>#(!:^(H/MDF-?+&0[1^ZRFWCUJS-X9BE\ M0:3K!N7#Z7!)"D848D#KC)/;I6Y1111111111111111111169X:_Y%K3?^O9 M/Y"M.JG_`#%_^V'_`+-5NBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBLSPU_P`BUIO_`%[) M_(5IU4_YB_\`VP_]FJW11111111111111111111111111111111111111111 M11111111111111111111111111111111111111111169X:_Y%K3?^O9/Y"M. MJG_,7_[8?^S5;HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK,\-?\BUIO\`U[)_(5IU4_YB M_P#VP_\`9JMT444E9MIXATF^O[K3[;4();FT4-,BM]T<]^^,<^G>FZ=XET75 MGG2PU2VN&MQF4(_W1_>^GN.*+;Q+HMY8W%[;ZI;26UM_KI1(,1_7^GKVJUIV MIV.K6:W=A=1W,#D@.AR,CJ/8^U6J*6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBB MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBDI:***********S/#7_`"+6F_\`7LG\ MA6G53_F+_P#;#_V:K=%%%(>E>9>%H;FP\;ZE;:?H]S#IZPN]S;72J3$Y9BOE M/W5^>,XY/I4=S87_`(DO->GTS3[NWCN]$^SD7D1C>&<$_N(\@?*1UQ\N3G-4 MKK1]4U:TNKVUT^\2.V@TV-X'A*-,T+$RJ%."=N?H<<9KL?`]K<"[U_4WBFAM M]2U`S6R3(48H%`W[3R,GU`/%:7B[4;O3-%2:RD6.:2[MX=[(&VAY50G![X8U M/_9NJ_\`0>E_\!H_\*/[-U;_`*#TO_@-'_A1_9NK?]!Z7_P&C_PH_LW5O^@] M+_X#1_X4?V;JW_0>E_\``:/_``H_LW5O^@]+_P"`T?\`A1_9NK?]!Z7_`,!H M_P#"C^S=6_Z#TO\`X#1_X4?V;JW_`$'I?_`:/_"C^S=6_P"@]+_X#1_X4?V; MJW_0>E_\!H_\*/[-U;_H/2_^`T?^%']FZM_T'I?_``&C_P`*/[-U;_H/2_\` M@-'_`(4?V;JW_0>E_P#`:/\`PH_LW5O^@]+_`.`T?^%']FZM_P!!Z7_P&C_P MH_LW5O\`H/2_^`T?^%']FZM_T'I?_`:/_"C^S=6_Z#TO_@-'_A1_9NK?]!Z7 M_P`!H_\`"C^S=6_Z#TO_`(#1_P"%']FZM_T'I?\`P&C_`,*/[-U;_H/2_P#@ M-'_A1_9NK?\`0>E_\!H_\*/[-U;_`*#TO_@-'_A1_9NK?]!Z7_P&C_PH_LW5 MO^@]+_X#1_X4?V;JW_0>E_\``:/_``H_LW5O^@]+_P"`T?\`A1_9NK?]!Z7_ M`,!H_P#"C^S=6_Z#TO\`X#1_X4?V;JW_`$'I?_`:/_"C^S=6_P"@]+_X#1_X M4?V;JW_0>E_\!H_\*/[-U;_H/2_^`T?^%']FZM_T'I?_``&C_P`*/[-U;_H/ M2_\`@-'_`(4?V;JW_0>E_P#`:/\`PH_LW5O^@]+_`.`T?^%']FZM_P!!Z7_P M&C_PH_LW5O\`H/2_^`T?^%']FZM_T'I?_`:/_"C^S=6_Z#TO_@-'_A1_9NK? M]!Z7_P`!H_\`"C^S=6_Z#TO_`(#1_P"%']FZM_T'I?\`P&C_`,*/[-U;_H/2 M_P#@-'_A1_9NK?\`0>E_\!H_\*/[-U;_`*#TO_@-'_A1_9NK?]!Z7_P&C_PH M_LW5O^@]+_X#1_X4?V;JW_0>E_\``:/_``H_LW5O^@]+_P"`T?\`A1_9NK?] M!Z7_`,!H_P#"C^S=6_Z#TO\`X#1_X4?V;JW_`$'I?_`:/_"C^S=6_P"@]+_X M#1_X4?V;JW_0>E_\!H_\*/[-U;_H/2_^`T?^%']FZM_T'I?_``&C_P`*A(U* MQU2PCFU,W45S(\;H\"+C$;,""/=:VZ***********S/#7_(M:;_U[)_(5IU4 M_P"8O_VP_P#9JMT4444P1H'+A0&8`%LR?R%:=5/^8O M_P!L/_9JMT44444445S7CS_D`0?]A*S_`/2A*Z6BBBBBBBBBBBBBBBBBBBBB MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBLO4_^0MHW_7Q)_P"B9*U* M***********S/#7_`"+6F_\`7LG\A6G53_F+_P#;#_V:K=%%%%%%%%G44444444445F>&O\`D6M-_P"O9/Y"M.JG_,7_`.V'_LU6Z*** M2HDN[>2>6WCF1Y80#)&K`LF??Y,\03",9]U"RTV`SWUW#;1#J\T@0?F:P3XVMKQBFA:=?ZRW3?;Q;(?QD?"_EFD^ MQ>,=5YNM2M-%A;_EE91^=-CT,C_*#]%KSKQ!\%B/%%C'I^H-]@OY")GG.Z6- M@I9O][(!Q[U[+8V4.G64%E;*5A@C$:`DD@`8')JQ111111111169X:_Y%K3? M^O9/Y"M.JG_,7_[8?^S5;HHHI#7D_@]--LO&]_8"X_M%+J"9O[0C=XW1=[;T MF'J#P&[8&*GT"UTZYN=8U;1YX='T:/37L;=T.6FVD[KEUZG'0$\FL:>--*T" M^T33YK2\T^(Z=)+?6\"Q%XG<[ED*_>Z`\\X8YKN/`/R7OB6&V"#38M486JQX MV+\HW!<<`9QTXZU=\?9_X1^#;C/]HV>,_P#7=*W?]._O6_Y-1_IWK;_DU'^G M>MO^34?Z=ZV_Y-1_IWK;_DU'^G>MO^34?Z=ZV_Y-1_IWK;_DU'^G>MO^34?Z M=ZV_Y-1_IWK;_DU'^G>MO^34?Z=ZV_Y-1_IWK;_DU'^G>MO^34?Z=ZV_Y-1_ MIWK;_DU'^G>MO^34?Z=ZV_Y-1_IWK;_DU'^G>MO^34?Z=ZV_Y-1_IWK;_DU' M^G>MO^34?Z=ZV_Y-1_IWK;_DU'^G>MO^34?Z=ZV_Y-1_IWK;_DU'^G>MO^34 M?Z=ZV_Y-1_IWK;_DU'^G>MO^34?Z=ZV_Y-1_IWK;_DU'^G>MO^34?Z=ZV_Y- M1_IWK;_DU'^G>MO^34?Z=ZV_Y-1_IWK;_DU'^G>MO^34?Z=ZV_Y-1_IWK;_D MU'^G>MO^34?Z=ZV_Y-1_IWK;_DU'^G>MO^34?Z=ZV_Y-1_IWK;_DU'^G>MO^ M34?Z=ZV_Y-1_IWK;_DU'^G>MO^34?Z=ZV_Y-5:^U'^S(#/?WMA:Q#^.9]@_4 MUA_\)E>WW&@:/<:KGI-Y36\'_?;XS^`-/>P\:ZJ@-SJMCH\;?>BLHC-)CT\Q M\`'Z+4EGX*TZTG%R]I!>W0_Y>+YGN),^N7)Q^&*W0MZ!@&W`'8*U+B^];?\` M)JS[[[1_;&C^<8B/M$F-@.<^2_K6S1111111111169X:_P"1:TW_`*]D_D*T MZJ?\Q?\`[8?^S5;HHHI*I)H^G)<75PMC`)KQ0EPX09E`SPWKU-0V7AO0]-G: M>PT>QM964H9(;=48J>H)`Z<=*L6^E:?:6\EM:V%M#!*29(HXE57)ZY`UK M:6]E;);6MO%;PH,+'$@55^@%8'CS_D`0?]A*S_\`2A*Z2EHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHI*,T9K(U3Q9H6CR>5>:E"L_:",^ M9*?HBY/Z5G_\)#KNIG&B^&YHT/2YU1_LZ?78,N?R%20^'=9NG\W6/$UT_P#T M[V""VC'MD9<_]]"KD7A30H[D71TR&:X!R)KC,K@^S/DBM<<4M%%%9>I_\A;1 MO^OB3_T3)6I1111111111169X:_Y%K3?^O9/Y"M.JG_,7_[8?^S5;HHHHHHH MHKFO'G_(`@_["5G_`.E"5TM%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% M%%%%%%%%%%4=8UBRT+39M1U&=8;:!//\`D`0?]A*S_P#2A*Z6BBBBBBBBBBBBBBBBBBBB MBBBBBBBBBBBBBBBBBBBBBBBBBDS6)J_BK3M,N!8QF2^U)ON6-HN^4_[W9![M M@5EW'A?4_%<6/%MPB61(9=+LC\H/8R2'YF(]L#ZUE^%/@_I7AW6I]2N91?[) M,V22+Q".H)]6'K^->ACI2T444444445EZG_R%M&_Z^)/_1,E:E%%%%%%%%%% M%9GAK_D6M-_Z]D_D*TZJ?\Q?_MA_[-5NBBBDI`V?8^E+GVI,TM']/;_EWMG#74@_VI.B?1 MW6EWNIRZA+J$#O!?07)974,WRN.@=1D`C@8]ZK"YO8;/Q1K/A^XNHM,L+ M&2VB>6=G-S<*0.,CK5.^O]1TVWN+2QN[A;::#2WF)F8E3*Y$C`DY!; M`!Q79>")[@7_`(CL"[M9V.H^5:J[EO+7:"5!/.!G]:L^/LCP_!@9/]HV?&>O M[]*W?.N_^?0?]_1_A1YUW_SZ#_OZ/\*/.N_^?0?]_1_A1YUW_P`^@_[^C_"C MSKO_`)]!_P!_1_A1YUW_`,^@_P"_H_PH\Z[_`.?0?]_1_A1YUW_SZ#_OZ/\` M"CSKO_GT'_?T?X4>==_\^@_[^C_"CSKO_GT'_?T?X4>==_\`/H/^_H_PH\Z[ M_P"?0?\`?T?X4>==_P#/H/\`OZ/\*/.N_P#GT'_?T?X4>==_\^@_[^C_``H\ MZ[_Y]!_W]'^%'G7?_/H/^_H_PH\Z[_Y]!_W]'^%'G7?_`#Z#_OZ/\*/.N_\` MGT'_`']'^%'G7?\`SZ#_`+^C_"CSKO\`Y]!_W]'^%'G7?_/H/^_H_P`*/.N_ M^?0?]_1_A1YUW_SZ#_OZ/\*/.N_^?0?]_1_A1YUW_P`^@_[^C_"CSKO_`)]! M_P!_1_A1YUW_`,^@_P"_H_PH\Z[_`.?0?]_1_A1YUW_SZ#_OZ/\`"CSKO_GT M'_?T?X4>==_\^@_[^C_"CSKO_GT'_?T?X4>==_\`/H/^_H_PH\Z[_P"?0?\` M?T?X4>==_P#/H/\`OZ/\*/.N_P#GT'_?T?X4>==_\^@_[^C_``H\Z[_Y]!_W M]'^%'G7?_/H/^_H_PH\^Z_Y]!_W]'^%4-9\0)H.GO?7\(2).BK("\A[*J]R? M2LA3XL\0E)G7^P].G:):Z7==_P#/H/\`OZ/\*/.N M_P#GT'_?T?X4>==_\^@_[^C_``H\Z[_Y]!_W]'^%'G7?_/H/^_H_PH\Z[_Y] M!_W]'^%'G7?_`#Z#_OZ/\*/.N_\`GT'_`']'^%'G7?\`SZ#_`+^C_"CSKK_G MT'_?T?X4>?=?\^@_[^C_``IKW-Q&C.]LJJHR6,P`%2ZL/#^D3ZE M+&C!Y]XCMUQP?WA'/X`U\V/G>WU-?4GPY_Y)[HG_`%ZK_6NFHHHHHHHHHHK, M\-?\BUIO_7LG\A6G53_F+_\`;#_V:K=%%%(>E8=KX-T6RU&_OK>U$98VB:(PR7,DD>UNHV,Q7GZ5+;^$=!M; M&YL8=-B^SW6!,CDMN`^Z,DY`7L!T[5=TS2+'1K3[+80"&(L7;DLS,>K,QR2? M1=7R-:Z.&"*WB6&&-(XU&%1%`51Z M`"L?4M/LAJND`6=N`UQ)G]TO/[E_:MI(TC0(BA548"J,`4ZBBBBBBBBBBLSP MU_R+6F_]>R?R%:=5/^8O_P!L/_9JMT44444445S7CS_D`0?]A*S_`/2A*Z6B MBBBBBBBBBBBBBBBBBBBBBD-_$3P[8>*8_#L]YMN7X:08\N-^R,W8G].]= M1112T4444444445!=W=O8VLEU=3QP01+NDDD8*JCU)-]6AX3MKJZAN]:N9]6GA(9%G.V%&]5B'RY]SDUOX&. ME%+1111111245DZMXHT716$=]J,23'[L"?/*WT1&O M^1:TW_KV3^0K3JI_S%_^V'_LU6Z********YKQY_R`(/^PE9_P#I0E=+1111 M11111111111111112$XK-U7Q%I&B(#J6H0V[-]V-FR[_`$4*H].C?[1:S_.=1(^51_%N' M7=[=Z]=M/">M:;:16]CXQOML2!%%U;Q3``#'H#^M2_9/&MOQ'JVD78_Z;V;Q MD_\`?+T?;/&D!_>:/I-VH_YX7KQD_0,A'ZT?\))KD!_TKP=?@>MO<0R_IN!H M_P"$WM8N;O1= M$"VUFPE8]%6Y0G\LUH+(KC*,&'L`/7 M-W+?\!!I!H7B/5^=:UX6<)ZVFDJ8\CT,K98_A MBM?2?#FCZ&I&FZ?!;L?O2!U-SJ-Y#:PC^.5P,GT'J? MI6'_`,)5J&I\>'M"N+E&Z7=[FV@^HW#>WX+5@Z1KFHV_EZIK9MPWWX],C\K\ M/,;+?EBK6D^%]%T5C+8Z?&D[?>N'S)*WU=LL?SK5P*"`:6DHQ1@44CHDB[74 M,#V(S6?<^'-#NP1<:/8RYZEK="?Y5G-X`\+=8](CMSZVTCPG_P`<(IO_``A% MG%_QZ:MK=H/2+4'(_P#'LU9BT#4(.(O$VI$>DRQ2?J4S4K6&N*/W6N1D_P#3 M6S4_R85YK\7;OQK9:*MO--;R:3,=L\]G$R,3V5P2<*?;KTI?AAIFN^*-'C7Q M%-<2Z#;#;:P/(5$Y!Z-CET'H3CMS7KD4,4$2Q0QI'&@PJ(N`H]`!TI]+1111 M24M%<-\3?&*;Z-CJ&I6FG!ND=A%O=?^!OQGZ+26G@G18;H7=W% M-JEV#D7&H2&9E^@/RK^`%=#@"C%+11111167J?\`R%M&_P"OB3_T3)6I1111 M111111169X:_Y%K3?^O9/Y"M.JG_`#%_^V'_`+-5NBBBD/2N"\*>(]?O_$^J M6>K-#%)$A9=-=3&Z89@IC/1U(QEO4BIM!\2Z]>7GBI+^UC\_2Q']FL[?Y]K& M-FV[L?,2<>WI6/;^,=>TW0+D:G=3MKA>UB^SW5G'&MN9B1O79]\8!Z]U[9KJ MO".LWFH3:OINH3+<7.E7A@,ZQA/-4@$,5'`/4<>E'CTA?#\!)P!J-F2?^VZ5 MN_;[/_GYC_[ZH_M"S_Y^8_\`OJC^T+/_`)^8_P#OJC^T+/\`Y^8_^^J/[0L_ M^?F/_OJC^T+/_GYC_P"^J/[0L_\`GYC_`.^J/[0L_P#GYC_[ZH_M"S_Y^8_^ M^J/[0L_^?F/_`+ZH_M"S_P"?F/\`[ZH_M"S_`.?F/_OJC^T+/_GYC_[ZH_M" MS_Y^8_\`OJC^T+/_`)^8_P#OJC^T+/\`Y^8_^^J#J-DJEFNHE4F3[;?#_`)>[V8S2_@3POX`5N#4+3OVTEM%(8988XXU" MHBD`*!T`%/\`[0L_^?F/_OJC^T+/_GYC_P"^J/[0L_\`GYC_`.^J7[?:?\_, M?_?5-?4K&)-\EW"BC^)W`'YFLRY\;>&+3(DURS=A_!#()7_[Y7)JB?']K.=N MG:/JUZ>Q%MY*_P#?4A6F_P!N^)KO'D:7I=@I_BO+_P`QO^^47K[9H^R:Y=#_ M`$WQE#`#U2PM$3_QYRQH_P"$5T&;_D(ZMJ&I^HNK]RI^JJ0OZ51\2^`_#.M: M$--L#9:4PE5_/A@4L0,\$\'OZUR^G_!C3[#4K6\'B=7^SS)+M\@#=M(./O>U M>M?VA:?\_,?_`'U1_:%G_P`_,?\`WU1_:%G_`,_,?_?5']H6?_/S'_WU1_:% MG_S\Q_\`?5']H6?_`#\Q_P#?5']H6?\`S\Q_]]4?VA9_\_,?_?5']H6?_/S' M_P!]4?VA9_\`/S'_`-]4?VA9_P#/S'_WU6??7,$^L:.L4JN1<2$A3GCR7K9H MHHHHHHHHHHK,\-?\BUIO_7LG\A6G53_F+_\`;#_V:K=%%%(>E75W(D92W%Q(7,08L6&>I'.!GH*M6_AFUM;[6;N*XN5EUDH9BKA3&54J" MA`R#@^]4Y?`VGW4=S]MNKN[GN5A4W$CKO41'*8P,9SR2>M:FCZ';:-]K>)Y) M9KVX8? M[BG:OXD_2GS>#K+49A+K%Y>ZI@Y\FXFVPY_ZYKA3^(-;EM:6UE`L%I;QV\2_ M=CB0*H_`5+2T444444444444444E>8^/_BKJ'@_Q)_95MIMO<((4DWRNP.3G MCCZ5'X-^,BZWJ%Q#KD=EID$4.]9?,/S-D#;@]>O;TKKO^$XL9\_V;IVK:EZ& MWL7"G_@3[1^M']L>*[L8L_#,5J#TDO[U1_XZ@8_AFI8+3Q9,C1V9C0_\``I-HQ[BO(O%G MQ1U2;QQ9WEM$;2+2)"@MV^6MS'>6L5S"P:*9`Z$=P1D5 M-111111111169X:_Y%K3?^O9/Y"M.JG_`#%_^V'_`+-5NBBBBBBBBN:\>?\` M(`@_["5G_P"E"5TM%%%%%%%%)1FN2\=>.;+PIHTTT,L%QJ&=D5MY@)!/\3`< MX%>9^!?B;XKN-5;265=5GOYJ132$?F10-'\6 MRY\[Q7!$#VM]-4$?BS'^5'_"*ZE+_P`?/B_6)/:/R8O_`$%*/^$'LW_X^=6U MNZ'I+J,F/_'2*\W\=?"76+_Q#YWAZT0V1A4?OKLLVX9SRY)K3^%GP\UWPOXA MN+W6;2!8FMRD;"17(;<#QZ<`UZU111111111129I:2C-17%W;6D?F7-Q%`@_ MBE<*/S-8=O_`!P&H_\`A++RY_Y!OA75[CT:=$MU M/OEV!Q^%'F>-[S[EMHVFH?\`GI+)<./R"BE_X1S7KK']H>+KO;W2QMX[RT;3-.`%CIUK;8Z>5"JG]!5PC(QZ MUQ.H?#[PDFIZ8BZ%;!9YW$@Y^8>4Y]?4`UU]E96^G6<5G:0K#;PJ$CC7HH]* ML44444444445F>&O^1:TW_KV3^0K3JI_S%_^V'_LU6Z********YKQY_R`(/ M^PE9_P#I0E=+1111125F:IXDT;1A_P`3#4K>!B<",MES]%&2?P%9G_"7W=\/ M^))X;U*]!Z37"BUB/OE^2/HIJ>V3Q;=Y-Y/ING*>B6Z-.X_X$V!^AJ.3P;'? M2;M6UG5=04]86N/)B/\`P&,+^IJ_:^%]!L;26UM=(LXH9D*2*L(^=3V)ZFJ/ MA?P-H7A*2XETNW82W#$F25MS*O9`>R_Y-=$!BEHHI*I76LZ98@F[U&TMP.OF MS*O\S65)X^\-!MD&I"\<]%LXGG)^FT$4W_A+KFN[XO\`HB_UJU%!XHD_X^=1TV#V@M7?]6?^E5=8T#6- M0TJ[@/B&Y+20NJQ10Q1AR0<`G!(!^M>'?\*?\;'_`)A:?^!"?XUZYX4^'.C6 M_AJPBUO1H)=0CC_?>8QD`;)]\?E720^%/#MOCRM"T]2.A^S)G\\5H0VEM;C$ M-O%$/1$`_E4M&*,44M%%%5[Z]MM-L9KV\F6&W@0O)(W15'4TZUN8+VUBNK:1 M989D#QNO1E(R#4U%%%(3@9)P/6H7O+:/[]Q$O^\X%0/K>DQC]YJEFG^]<(/Z MU4D\7^&H?]9K^FKQGFZ3_&J[>/?":]-?LF_W)-W\JC/Q"\+#IJF__#_`(O:AJ^O7ME<:;)>&YO6NY6^\9W;9BT;3+!._VJ\:5OR1R?R%:=5/^8O_P!L/_9JMT444E`(-+117->//^0!!_V$K/\` M]*$KI:2C(JM?:E8Z9!Y]_>06L7]^:0(/UK";Q[H\[;-*BOM7D'&VQM6R)@#\6H_X0^XO?\`D-^(]3O@>L4+BUB/ M_`8\$_B36EI?AO1-%;=INEVUNYZR*F7/U8\G\ZU**"P498@#U-<9\2O%UUX7 M\,K?Z3-;-3G/I M7IP^)7A^=BFG?:]1;H!;6YP?^!-M7]:E_P"$FUNX.+/PP5!Z-=W\,>/JJEC2 MAO&EYP)]"L%/=/,N6_7:*?\`\(YKMQ_Q^^,+W'I9V\4/ZX8T'P+I4Q/V^YU/ M40>JW=_(RG_@(('Z5-I(X2?F95ZD5:HS13'GAB_UDJ)_O,!5*?Q%H=K M_P`?&LV$./\`GIUVT;_KF^_\`]!S49\?Z`_\`Q[R7ET>P MM[&9\_DM'_"9+(,V_AW7I_I8[/\`T,BC_A)=:E'^C>#M1/IY\\,7_LQH_M3Q MA-_J_#-G!_UWU('_`-!0TN[QS*/]5H-M]7FEQ^BUYG\7->\0VEM%X?O]1M)_ MM2B::.SMFC`4'Y026.P%@H:*,6J/NC)Y^9AG@ MGI[BO1?^$7U9_P#6^,=6Z<^6D*?^R&E_X0^9A^]\4Z^_K_I*+G_OE!2'P19M M_K-7UU_KJDH_D11_P@.AGB7[?,/^FNH3-^'WJ!\//"N[+:0CGU>:1OYM4J>! M/"J=-`LF_P!^+=_.K$?A+PW#_J_#^F)W^6TC']*MQZ/I*/#Z^*-"FTB6\FM8IRN]X<;B`'!`'(P!D4VT\>7XMO%%QJ>F16S:&B,D"2;F8LA8*S M=,YP.!Z]:KW/Q"O["":.YM;5[HQ64D&SE$MRY_X#$N!_P!]5'+XJDU>22?R459BN->=6$^K:)$2.#%"[X_.05$UMK4@(/C&UCST\JRC!'YL:K MG0K^52LWC^_Y_P">2VZ8_P#',TS_`(0_3Y8REWXLUNZ!ZAM4*@_@N*5?`?@W MR]DZM<^\^H2OG\-^*RO%7PU\.:MHBV.B)IFEW"S*_P!HV@L5`.5SG/L,=0'PCX( M(/\`Q)M(&>ZQH#^E,/@WP5VTZR3_`')2N/R-,/@KP:1@0*H_V;^5?Y/0?!OA MMZG&!V35I,?\`H5`\+V*DE?%>M@G_`*BQ M/\\T?\([&O\`J_&>L+CIF\C;'YKS2?V%([SQG()R/UC_P!PJ/Y5+]LM?^?J'_OX M*/MEK_S]0_\`?P4?;+3_`)^8?^_@H^VVO_/S#_W\%'VVU_Y^8?\`OX*C>73Y M#EY+9STRS*30DNGQG,&O^1:TW_KV3^0K3JI_S%_^V'_LU6Z***0]*Y+2O!MQ M9^,9M/P9"UUXE:[N/-@\0!`\:IM,0 M"%>#DY/.?:J2_#Q9;&ZBOM3>XN94MXX;A853R5@.8_ER22W/VJ\O[@W%S-Y80,Q`&`N3@`#U->3_%#X?ZW>>)KG7H3;?9+F6"%,R8;< MVV,9&/4_E77?"[P+J'A*VOQK$-H\LTB-"\9WD``YY(XKT(*!T`%!`/4`TFQ? M[H_*C8O]T?E1L7^Z/RHV+_='Y4;%_NC\J-B_W1^5&Q?[H_*C8O\`='Y4;%_N MC\J-B_W1^5&Q?[H_*C8O]T?E1L7^Z/RHV+_='Y4;%_NC\J-B_P!T?E1L7^Z/ MRHV+_='Y4;%_NC\J-B_W1^5&Q?[H_*EP/04FQ?[H_*C8O]T?E1L7^Z/RHV+_ M`'1^5&Q?[H_*C8O]T?E1L7^Z/RHV+_='Y4;%_NC\J-B_W1^5&Q?[H_*C8O\` M='Y4;%_NC\J-B_W1^5&Q?[H_*C8O]T?E1L7^Z/RHV+_='Y4;%_NC\J-B_P!T M?E1L7^Z/RHV+_='Y4;%_NC\J-B_W1^5&Q?[H_*C8O]T?E1L7^Z/RHV+_`'1^ M5&Q?[H_*C8O]T?E1L7^Z/RHV+_='Y4;%_NC\J-B_W1^5&Q?[H_*C8O\`='Y5 MF:DH&KZ/@`?Z1)_Z)DK5HHHHHHHHHHHK,\-?\BUIO_7LG\A6G53_`)B__;#_ M`-FJW111111117->//\`D`0?]A*S_P#2A*Z6BBBBBBBBBBBBBBBBBBBBBBBB MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBLO4_^0MHW_7Q)_Z)DK4HHHHH MHHHHHHK,\-?\BUIO_7LG\A6G53_F+_\`;#_V:K=%%%%%%%%//^0!!_P!A*S_]*$KI:*************** M*********************************************R]3_P"0MHW_`%\2 M?^B9*U************S/#7_(M:;_`->R?R%:=5/^8O\`]L/_`&:K=%%%%5[Z M[BL+&>\G+"*WC:5]HR=JC)P/PKF?#_CH:S97E](#."P MX#_[-0:=\1%N_#V M:TNK*NY]=!X9T"XTJXU6_O'C M-SJMU]H>.(DK$-H`7)Z]^<"H?'HW>'X`>AU&SS_W_2M[[#!_TU_[_/\`XT?8 M8/\`IK_W^?\`QH^PP?\`37_O\_\`C1]A@_Z:_P#?Y_\`&C[#!_TU_P"_S_XT M?88/^FO_`'^?_&C[#!_TU_[_`#_XT?88/^FO_?Y_\:/L,'_37_O\_P#C1]A@ M_P"FO_?Y_P#&C[#!_P!-?^_S_P"-'V&#_IK_`-_G_P`:/L,'_37_`+_/_C1] MA@_Z:_\`?Y_\:/L,'_37_O\`/_C1]A@_Z:_]_G_QH^PP?]-?^_S_`.-'V&#_ M`*:_]_G_`,:/L,'_`$U_[_/_`(T?88/^FO\`W^?_`!H^PP?]-?\`O\_^-'V& M#_IK_P!_G_QH^PP?]-?^_P`_^-'V&#_IK_W^?_&C[#!_TU_[_/\`XT?88/\` MIK_W^?\`QH^PP?\`37_O\_\`C1]A@_Z:_P#?Y_\`&C[#!_TU_P"_S_XT?88/ M^FO_`'^?_&C[#!_TU_[_`#_XT?88/^FO_?Y_\:/L,'_37_O\_P#C1]A@_P"F MO_?Y_P#&C[#!_P!-?^_S_P"-'V&#_IK_`-_G_P`:/L,'_37_`+_/_C1]A@_Z M:_\`?Y_\:/L,'_37_O\`/_C1]A@_Z:_]_G_QH^PP?]-?^_S_`.-'V&#_`*:_ M]_G_`,:/L,'_`$U_[_/_`(T?88/^FO\`W^?_`!H^PP?]-?\`O\_^-'V&#_IK M_P!_G_QH^PP?]-?^_P`_^-'V&#_IK_W^?_&C[#!_TU_[_/\`XT?88/\`IK_W M^?\`QH^PP?\`37_O\_\`C1]A@_Z:_P#?Y_\`&C[#!_TU_P"_S_XT?88/^FO_ M`'^?_&C[#!_TU_[_`#_XT?88/^FO_?Y_\:/L,'_37_O\_P#C1]A@_P"FO_?Y M_P#&C[#!_P!-?^_S_P"-'V&#_IK_`-_G_P`:/L,'_37_`+_/_C6=?6\<.L:. MR;\FXD'S.S?\L7]36S1111111111169X:_Y%K3?^O9/Y"M.JG_,7_P"V'_LU M6Z****2C`HP#17-^//\`D`0?]A*S_P#2A*Z6BBBBBBBBBBBBBBBBBBBBBBBB MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBLO4_^0MHW_7Q)_Z)DK4HHHHH MHHHHHHK,\-?\BUIO_7LG\A6G53_F+_\`;#_V:K=%%%%%%%%//^0!!_P!A*S_]*$KI:*************** M*********************************************R]3_P"0MHW_`%\2 M?^B9*U************S/#7_(M:;_`->R?R%:=5/^8O\`]L/_`&:K=%%%%%4] M5U6ST739M0OYO*MX0"S8SU.``.Y)(%8=IX]T>XTE[XQW496^X MH7N6'(K:TG5[36M/2]LV8QLS(5==K(RG#*P/0@C%9'CS_D`0?]A*S_\`2A*Z M2BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB MBLS4_P#D+:/_`-?$G_HEZU************S/#7_(M:;_`->R?R%:=5/^8O\` M]L/_`&:K=%%%%%9'BBV%[X=O+=M+_M0,G-IYGEF3!!X;L1U'N*\WTG3/$=SI M5C?-!>W&FZ7JL%S:02@&X:(`B0`9^8`D8SR>:[?P)I=WIFCWCWL3PR7^H3W: MPR8W1H[?*#Z'`SCWJQXVTNZUC0%L[-9#(;NW"R? M^9I\1_\`@TA:X\3^(EF**9%%\.&QR/N^M3?\ M(4?^AI\1_P#@<;G[9\RP,TJLP$8R691]U2.0^1$XD,DNX;7`&2.XK=HHHHHHI*RM9U6[TT!H-,:ZC$4DLLQE6..,*, MX).3D\XXQZD5S]S\2["&RMKN.PN)$ET\:C*I8*T4.]4Z=SEN/4#.:LZEX]L] M.NKY1:M-:Z<;<75PL@&WSS\NT=\9!/(Z]ZG3QE;R:S/8K;/Y-O?)827#.!^^ M9<@!>XSQG/7M7344444445#,UR=WX_336NX-1 MTJ:"YMK2*Y\I)5?B1PBH6P`K9/3GC.,U>@\7Q-#J@ET^X^UZ7.L$MM;_`+UF M9@"I4\<'/4XQ@U!8^.(M1\.Z5JD%BPFU>=H+:V:4`Y!;)+8X&$)Z=Q6QXUN#(#O:+KD=@<'')_"I M-/\`&L&HZUJ.GC3KR!;"U^TF25,-(N2/E3KVX[GTJSX8\3IXDDU%4L9[,V%Q MY#+/C>QP#D@=.O2M^BBBBBBDK-U?4;JPCC:VTYKO=N,C>:(TB4*3EB<]<8&` M:P)OB';"VCFM=.FFSI1U657<(8X0<8[Y8]AT..M6-6\=6FF_V48K&ZN8]4>` M),@"QH)3A0Z<=3CU/3Y;:73K)+R1$D$F58X5"> M,/G`Q^1-6+;QA$[ZG#=6,\5SID<4DD$!\YI%D&5VX`)/8\<4_3O$\VJ^&;+6 MK32W873-NCDG5!`H9@6=O0;>P-7?#>N+XBT=-12UDMT9V50YR'`.-RGNI[&M M:BBBBBBBBBLSPU_R+6F_]>R?R%:=5/\`F+_]L/\`V:K=%%%%%%(37#Z5H7B( M^*[S5=;L=/N1=%H8YENVW6MO@X1$V8R>YSSFH+#X?72Z1-I%_<6YMX=/GL;. M:+<7*R.'WLIX!&U1@$YP:=%X(UF:UU26XU""SU"ZT^+3[>6U+,$2/JQ)P?G] M!T'>M7P;X=OM"DOY+D6UK!=,AAT^S8M#!M7#,"0.6/)XKJ:******2N3\<:3 MKNN0VMAIT=M)IY???12W#0M.HZ(&53A3W]>E9VN^!]1UWRIX_L5A)<:;_9MW M$K,Z11"17!C.!DC;C!`Z^U+K'@&YO;W48+66V73-7-H;KS"WF1>1CA0.&W`` M0.[1C"[HONELX^?T&,=Z[&EHHHHHH MJO>-N3GVK8L]"O+?Q_J6N MNT1M;JSB@0!COW*>EL>$-5U&0W=H MEA:3WNDMI=W`9&*0H3D,A`^;`XP0*O:_X4GN]"T#3-->,)I-[;2MYC%)+KQRNKSV6GWEC:D)81R7;(8,_?D*A"&<]N>*[:BBBBBBBF2E MQ$YC4,X4[0QP">U>?6/@O5[SP]K.DZU;V<5QJRF2;4(KEI7DFW`IE2HPJX&` M#QBMSP[X>OK+5-4U?4VMQ>7\<40CMV9D1(UVCD@9)//3BJ^D:)X@T3P3IVF6 MCV+WEJ[&>*4DQ3(78E0V,J2".<'O6IX1T.?P_H8L[B=997FDF81YV1[V)V+G M^$9K4/_`*'+6G24$X&32*RNH96# M*PR"#D$4ISVK,M=>M+O!A2ZV,"4=K9U5\?W21R>#BM%7!(!/)&0.]4KW6+:R MNEMG2XDE9/,VPP/)AXJQN4$*6&3T&:3S$VAMZ[3T.>*=N&[;D9ZXH#`D@$$CKS MTJ&*ZBEN)X4?<\#!9!C[I(!'Z&BXNX;90TD@&75/7EB`/U(J7>NT,6&#WSQ0 M74'!8`GL34/VVW^V1VOFJ99$,BJ.Z@@$_F14K2*%+;UP#@G/`I$E5D#9*@D@ M;AC/.*=N7=MW#=C.,\TZH+6[AN[:*XAD#1S*&0D8W`].*F#*20",CJ,]*6DI M:I7&M:59S-!=:G9P2KC*2SJK#\":N`@@$'(/0BH;JZBM(#-,^U!QP,DD]``. MI)X`JM'K-M)#+)B=#$!NBDA99.>!A2,G)X&.]1OKUFD<#J)YOM`8QI#`[M\I M`;(`XP2`<]ZG74[9M/DO1(PBB5FDRA#)M&2"O4$>G6H?[;M_(\UHKI"6VK&] MLXD.N.E/_MBS9X4CE,GG`,"B%@H)P"Q'W,Y9C@#\Z>'4DCN\)N&XC.,\XIU4;[5(+"2&.59W>;<42&%I"0,9.`..H_.K%O=0W,"312!D? M@$\'/<8/0CTJ7SU.WOI&2/S4=1N MVS1-&67^\`P&1[U;$B'&'4[NF#UI:3=6UKXLUQ9I8RJ^?=[XS[,`H.#TZU6\+_#R^TS0+:TO_$^KI,B\ MQ6=ULBB!_A7(/3UKH-,\-G2[U;DZ[K%Y@$>5=W(DC.>^-HYK%MM+N_[&-F+/ M4EN4MY5(FGS"2490%&XCJPQP*TI-/N3J!;[*3.T\4D5YD8AB4)OCSG(SA^`, M'?4FK:9J-WJS7-C=2VI6R*(Z%<.^_.UL@D#'<=,U1U/1KN9H!9P/#;_95BAC M\M':VDRQ+;F/R'E?F&3\OYE]H=UYMU-#;IMEOO,E58$D:=?*502"0#A\GD\< MFG#P]=_8=0^4?V@_DK'=/AG=5CC#@'WVN.V<\U%:Z!-++"US9B2W!F98988T M6(E%4?NP2!D@GOZ\59TS3[F"2`WNGO-=8B9;HR`>2JQJ&4MG.=P8X&0=W7K1 MX>TK4+.]\R[+!DA*3/Y:()W)'S9!)?H>3C&[WXNPRW%EK=_NT^ZECN9(RDL2 MJ4`"*ISE@1@@]JYN\T;4KB]@E?2I9=MQONE7RU61=ZMC<3NDZ?Q$#C&*U?[. MD!$TFE/+IYD01@XSWJOI^C7D=VSBPDA=X[E+:>1(P;PX7[@R'X4<9.>N3>MM' M\Z8"32Q#:`1++;RA2))%)+28!(/&.3R?PJK=:+J1@@41DQ*;A1"(TDV,TI9' M^8@+\I^\.1FK5MIUU:Z['*;9YS@&:YF1#TCP2L@.[J!\I&.2:Z*UG2ZM8KB, M,$E0.H=<$`C(R.QKE(-`N1:QO)9`W,-K91QL2-R%)&,@!SQ@'KWK2TNTDM)< MRZ>XN8U;S[L,!]I).1C!R_\`P+&WH*WAR!QCVI&&1C./>N;;P8Q);_A*/$0S MS@7P_P#B:\S\7_"+Q)J7B6ZN]/G^V6SA-DU[=`RMA`#DX]1@>V*](@\$NL$8 M;Q1XA5@H!`OA@''^[5X:,^GZ/);+<7FJEI!(?MD^Z0`$9V,`,$8R/?O5*6VU M&YL;B+;?BR;8/+FP2?0Y'N=DZ9##IT]L(VN?-RTGF/AIF/4DC')P/0?2LB"TNK:XAOHK& MX6TMY6,5FS`S*&0JQ&6QC=@XSTR:6QTZ]L7*26S/]J$9+(01$5E>0AN?1P,C M/(-:^L6\MS#;"%"Y2[AD;GHJN"3^58-MH,UM9V)2Q5)]DXNBNW<^[)`8YYR3 MTJO)HUVTDLT&F-;6;W+.+0PQR%LQQ*K;"VT8*OWR,U?L-*O;>_M))HGDAB14 ME#2`EY@N/.QT..F>O?'%=,.E07UK]MLY;87$UOYBX\V!]KI[J>QK`_X0H_\` M0T^(_P#P.'_Q-<==^"/&A\:I>V^IWKZ9&1")'U(?:/*.-V#MP.><8["NQ_X0 MLG_F:?$?_@$PE$.Q':.8LS-(68C:26!W`$\=.E(=&U)M9E>0N^9'D\T(@W1E2!&9 M,[CU'RX`XSFM>XTE6T'[!:0Q6Y`1@BJ%7I&,^]53'J-_/:-+'/)%:V*_O(XULY(U55LV!)8]MN2<_*#FJ. MKPWJ:-+;MI\RI:_;)9)BRA"KI+MQSDYW@=.*Z#0[9X#=.+8VEM*ZF&V8`&,! M0&X!(&3D\?7O5^]_X\9_^N3?RIUM_P`>T7^X/Y5+1111111111111169X:_Y M%K3?^O9/Y"M.JG_,7_[8?^S5;HHHHHHHHHHHHK+;S;?7IKHV\LD4EK'&K1KG MYE=R0?P859^W_P#3I=?]^_\`Z]'V_P#Z=+K_`+]__7I#?9_Y=+K_`+]__7I? MM_\`TZ77_?O_`.O1]N_Z=+K_`+]__7I/MH_Y]+K_`+]__7H^VC_GSN?^_?\` M]>C[:,Y^R77_`'[_`/KT?;1_SZ77_?O_`.O1]N`_Y=+G_OW_`/7H^VC_`)\[ MG_OW_P#7H^VC_GTNO^_?_P!>C[:/^?.Z_P"_?_UZ/MP_Y]+G_OW_`/7H^W#_ M`)]+K_OW_P#7H^VC_GTN?^_?_P!>C[:/^?2Z_P"_?_UZ/MH_Y]+G_OW_`/7H M^VC_`)]+K_OW_P#7H^VC_GTN?^_?_P!>C[:/^?2Z_P"_?_UZ/MH_Y]+K_OW_ M`/7I?MV/^72Z_P"_?_UZ3[:/^?2Z_P"_?_UZ/MH_Y]+K_OW_`/7I?M__`$Z7 M7_?O_P"O1]O_`.G2Z_[]_P#UZ/M__3I<_P#?O_Z])]N_Z=+K_OW_`/7I?M__ M`$Z77_?O_P"O2&^S_P`NEU_W[_\`KT?;A_SZ77_?O_Z]`OL?\NEU_P!^_P#Z M]'V[/_+I=?\`?O\`^O1]M'_/G<_]^_\`Z]'VT?\`/I=?]^__`*]+]N_Z=+K_ M`+]__7I/MH_Y]+K_`+]__7H^VC_GTNO^_?\`]>C[:/\`GTNO^_?_`->E^W_] M.EU_W[_^O1]O_P"G2Z_[]_\`UZ/M_P#TZ77_`'[_`/KTGV[_`*=+K_OW_P#7 MI?M__3I=?]^__KTGV[G_`(]+G_OW_P#7H^W`G/V2Z_[]_P#UZ/MH_P"?2Z_[ M]_\`UZ/MP_Y]+K_OW_\`7H^W#_GTNO\`OW_]>C[:/^?2Z_[]_P#UZ#>@@@V= MR0>QC_\`KT"^QTM+K_OW_P#7IES>-+;2QK:7.YD('[OOCZU;@!6"-2,$*`1^ M%2444444444444445F>&O^1:TW_KV3^0K3JI_P`Q?_MA_P"S5;HHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHK,\-?\`(M:;_P!>R?R%:=9E[<36FHK*EA XML 16 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Employment Contracts and Consulting Agreements (Tables)
 12 Months Ended
Oct. 31, 2013
Employment Contracts and Consulting Agreements  
Schedule of aggregate minimum commitment under employment contracts and agreements, excluding commissions or consumer price index increases

 

 

October 31

 

Employees and
Consultants

 

2014

 

$

5,169

 

2015

 

3,873

 

2016

 

3,657

 

2017

 

2,918

 

2018

 

1,243

 

Thereafter

 

—

 

 

 

 

 

Total

 

$

16,860

 
XML 17 R54.htm IDEA: XBRL DOCUMENT v2.4.0.8
Capital Transactions (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
item
Oct. 31, 2012
Oct. 31, 2011
Dec. 19, 2013
Dec. 06, 2012
Nov. 11, 2011
Capital Transactions            
Preferred stock, shares authorized 1,666,667 1,666,667        
Preferred stock, par value (in dollars per share) $ 0.10 $ 0.10        
Outstanding shares of preferred stock 0 0        
Number of votes per share for holders of common stock 1          
Number of shares of common stock authorized to be repurchased       2,000,000 714,550 1,000,000
Number of shares of common stock repurchased 81,600 285,450        
Cost of shares of common stock repurchased $ 2,030 $ 5,193        
Number of shares of common stock issued for employment or consulting services 11,431 11,432 11,432      
XML 18 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Details 4) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
Advertising Costs      
Advertising Costs $ 3,200 $ 2,366 $ 2,026
Equity method investment      
Share of undistributed loss 450 323  
Other Income      
Amount of refund received related to New York State clinical laboratory inspection fee 1,062    
IncellDx
      
Equity method investment      
Share of undistributed loss $ 450    
EXCEL 19 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0!O4(MF1@(``-HG```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,VM]NVC`4!O#[27N'R+<3 M,;;CK)N`7NS/Y59IW0-XR8%$)'9DNQV\_9S05E7%J-"0]MT00>QS/BSE=Y.S MN-[U779//K3.+IG(YRPC6[FZM9LE^WG[=7;%LA"-K4WG+"W9G@*[7KU]L[C= M#Q2RM-N&)6MB'#YR'JJ&>A-R-Y!-=];.]R:FKW[#!U-MS8:XG,]+7CD;R<99 M'&NPU>(SKGSWQ_*I_ M1)]FS"X>X'GM4SG2!-:-=T-(LVB>SC^%QV&SQLV.C6T]=4QS M;.]=J>*V?5@^@8B)G:13'&HX<85?= MWFQ?>*24FV+7^ZBRBXL:NI3\(V(T'4\4"_'L)MI<3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B] MSCSBIX3A363X8<'%#U1?````__\#`%!+`P04``8`"````"$`@&%A19X"``"+ M)P``&@`(`7AL+U]R96QS+W=OA4J<0U?WZ_;N[S^%0 MI_RFV.Z'6.15NEBI-J7A8UG&I@W'.B[Z(73YRK8?CW7*A^.N'.KFN=Z%4B^7 MOAPOUU#K5VL6CYM*C8\;[57Q=!KR1_]_\7Z[W3?AH6]>CJ%+__B,\GL_/LRSD!7]C?#XLSZ^0&/8.P0UBTPOA%7;2"$Z:VSEIF5+N+S'3J3_! M=XO@%7;P"<186_;=L>CN&#;)!J)LV%UN8)O;/%7,%WP3MV^C;)=HLZQCE^-0 M.8YM*0PT2U;$18JPK(58:$B'%L1#BK"LW/'P]SQLZ9R M3*=#_@IH>NS\=8P$SF8%H\(VIH/&9+=Q1[]-!S]+%L1%BK"L:<)AZ<) MMB0\E,1J5G9B6X]A\R6-^=>ORQGG\C0:==CD0'#8$0@34-CV%&A/S;:GAO;4 M;'MJ:$_#1L=`=BS;GA;:T['MZ:`]9=8$O&*V$&A/P\Y``T/0LNUIH3T=VYX. MVM.SV?&0'<^6A(>2H*.#1@MV!L((%+8^!>I3V/H4K$_V7AFX68;-L<$1R,X< M!S/'L3/'39E3OOH+W?HG````__\#`%!+`P04``8`"````"$`V='*@&H%``#) M$P``#P```'AL+W=OITK<6@>16=_O_O[K9I_J][#+;".$2>*VT^GT MV@F7RCHJ7.O_HY&N5C(2HS3:)4*9HX@6,3<0?K:1V\RZNUG)6+P<,VKQ[7;* M$XC[,[9:,<],L)1&+&^M+BS3O:B\H7?;^YV,X=.!VW&M]EV9Y%RWEF+%=[%9 M0'I?ZE`OQW.<7OZ?>2E>I-AGITWYLO7Y*M4RW>?_"J4]E"L7`M@7'[W*I=G` MYYU.IWSO439!;WBL@OP% M=S`1/!-L]A;+]=&^L0PFT"8(#M,DD28/IXS"0'G@P24K=]+'.(+_UNQN(LWO ML_'1F#Z'T#>&?*%X$;Z`/H;.(=#A7GV2V?LQYF?0T(9+?#0&SR'@^1'T:@8Q M0\WQ+@R>0\![X%*S%Q[O1.X;#U)!\!)`A$2,KEP=1M`A"#X*'IM-ONV8/YO' M')[=Y8.ECRD\/A.Q^QT)$M#L0HF5-/7M`PR@0P"XZN MEYO)'(4QP``Z!,!0Q"+*'>#G#BQ`Z/B`2C+".IA`AQ`8#A^#T?,D8.,Q>_$G MS_YB/)LR?SIB/Y_]"=;!"+H$P69+AUS*^@XPER[ALED(DCD)85I=0NOYIP/8 M'3@UQFZ`874)K.0I<48!@^L2<*G/GY'`S,)(56MP;-5G-F-B7>*;U'.I!`QM MR/5=@NUE[\VUT*78'0;?1A*M"&%V/ MH(M][5R),:\>X;6YHZN5P14A0O0%G\E++6-L-'8']ZE' M@*9.0S6ZN$UA4?.)AKD4[A[E9,-,>YHONP3E,YY%@[%AID4BA.B*:]'M7=R6 ML*CE\KN_*X-F`7"MJC`A@]6-1R.PUF])YZ M&#A8U+8V#Z@X!MO&5MXCZ%:LG,9APS>;$W0]PN[9&?,,O+U*%)3=XMM*;=8\ M)U.)AN+;."MB6GJ87UC4Z]LX+.+Z]C"_L`"A=F&H\'-/Q.,(?H?*7_(?<@H` MVE^_PMW]!P``__\#`%!+`P04``8`"````"$`M.W*!C(&``#U&```&````'AL M+W=ONAV8=W7YNC\Z7J M^KH];5RQ\ERG.I7MMC[M-^X_?W^XBUVG'XK3MCBVIVKC?JMZ]]WCK[\\O+3= MY_Y058,#%D[]QCT,P_E^O>[+0]44_:H]5R=8V;5=4PSPL=NO^W-7%=MQ4W-< M2\\+UTU1GURT<-\ML='N=G59Y6WYW%2G`8UTU;$8@']_J,_]Q5I3+C'7%-WG MY_-=V39G,/%4'^OAVVC4=9KR_N/^U';%TQ'\_BJ"HKS8'C_,S#=UV;5]NQM6 M8&Z-1.<^)^MD#98>'[8U>*##[G35;N.^%_>Y3-SUX\,8H'_KZJ6W?G;Z0_OR M6U=O_ZA/%40;\J0S\-2VGS7TXU;_"C:O9[L_C!GXLW.VU:YX/@Y_M2^_5_7^ M,$"Z%7BD';O??LNKOH2(@IF55-I2V1Z!`/SM-+4N#8A(\77\]Z7>#H>-ZX>N`>#%X?P^*N+/_(07--&WFLKHRT@WT-:OCS&P^4,WG+./J3R^TFX4-2;&$5%":1SB*2( M;([P?0K)YY`XO$*(&_[/N*$W0=5888RCJ_DQ;"E"()G72$\$1D3V*B*_A2!. MP#%V+F[G0(,W+D3HRBR.&7F$A&,-14+YBM519@-"$4C%LIC;`"6E%T]U1IA# MPRUGKL$L[`ECCA`X_>H<#_NKB/P6@I`/WT)>@VG8$X^11T@TAETHE;"T9&3= M%]X44VQ5LBX\?W*=T([>0EN#&6UV;(H00SORA<]Z(2.`()0)Z^B<`&1HUQMA MKA72J<"I(P3]["7(,9 MUV%L20"? MD0(QF(!`!"RX&5GW5YG%CP8R6F(RAW+6<6]X4I0!$D-<1:-!6V4,H`IC;KDXPB/"^( M61WF!"&B(+#N2-0-+6Z6&Z^D`*70IB\\=G8J;+V,11)-X\_DP`9$H?!9E^3$ M@DJB:!JQE+S6M^7D40WM"32[I*0"03='T*N0_*85ZH*6NN4NH##2^+,9D@I; M/47HS:J'K`>SRS'='P53"Q'F\DWB.Z+I[($K(!T75(C6:QYQ?&0P(3XZC*62&.-HPTS[DUZ'<;#9<3BR$06S=GREY)K>WAZ1$@:1-RKBE!H3D?26M MN!GRMLQ"K8=LS.;$@HP#ZSL^)?\FD=5O3+.:F21PY)8:$'X##U0L65%E%""% MU8FCA9P`?/A*-8D@)?]3*BOG*@OEP8<-@A+\/KL*9S[0=345MG&!KD\=31U@ M^KKLFB"_H[."%4!J0%A"<)5/O#!B998Q3`2W><4P.<,DD;`UG7K#!'>A-RB8 MI"'XUXY4(NC'Z:#KBM\9V'XYI9MZP/1VH0??T5VN3BD\*NO6N>0#KHZ19#G+ M&":1'ORAA:D?IRT[L?0B7TT=B-[@ZS.^TC95MZ^RZGCLG;)]UB_+`FKZ^EM\ M]4[AU7M\(EY?%^#1^5SLJT]%MZ]/O7.L=K#56T4P`3I\ML8/0WL>'T6?V@&> MF\/P?``#__P,`4$L#!!0`!@`(```` M(0#X?(8OW0,``&4.```9````>&PO=V]R:W-H965T%["YA2C)M%!UF[1)T[3+,P$G006,;*=IO_V.;4HPZ=SD MI0WP\^%_+CX^+#\^-;7S2!BO:+MRTO^P]QUN,C;,J]I M2U;N,^'NQ_7[=\L390_\0(APP$++5^Y!B&[A>;PXD";G,]J1%I[L*&MR`9=L M[_&.D;Q4BYK:P[X?>TU>M:ZVLV*"[7560.UH<&](*;821.A>@GQ^JCK]8 M:XIKS#4Y>SAV'PK:=&!B6]65>%9&7:A/14Y\]-OA M!WKZS*KR6]42B#;D269@2^F#1+^6\A8L]BY6WZL,_&!.27;YL18_Z>D+J?8' M`>F.P"/IV*)\OB.\@(B"F1F.I*6"UB``_CI-)4L#(I(_J?^GJA2'E1O$LRCQ M`P2XLR5EC>#>2`#J^^=PR[[8TT*47W>YR-=+1D\. M%`N\BG>Y+#VT`(/2H0#"\KI#X(E<\TDN4DN!YI"%QW4T#Y;>(T2NZ)F-9J#P M!P:;1'9)!&B&(0`B,Q9@CXZ$(8HC MSZ,P-7W?:"8<,;%)9#;"T`9&KM&8"/ M$_]LP1`&%7V],`F;PC">O'BCF40IBY,T\DWEV?AYA''\'UWQ+;HD;.H*ST6J MBF:CD5Y6%$]SG8V?1WX8GF4;X4IND25A4Q;&4UV:@6P-N9[6F(TPM,GS:]0E M[/4OX;?J7S,V;3;"T);>HDW"9MPNZE\C+^E,XDG3R,;/(S\(YD,5&K(0=-'K M8Z9H4U@4G>M7%UH/V:)F14Q]D\YOSRG2S=K>U'K(JD_;>1TQ]?'7-(=VY MK8VM9W1F<9(FX9`YW?T-`*5)_+_4RMX\DG;EH:D[^EAB-)](V"!;V^]5VA`S MA!#FLOUV1!3WTTGA)RSWMJ[/=.G&,5XLH4R`T`Q[-^A M!DQI-QT2Z/*4P#@9+/>[5T/6T-D04]]-IP72C1X*9S@*+D>2'K+JN_K`@"'\ MEM+3S7Z\-2[:LK*X$!#/E=OB??<[:O6N[49`&PO=V]R:W-H965TLDO6_&B3VE:>;KZ? MBK)*7BZP[D_B)^DM=_O!2)]G:576Y;%90#H'B9IK7CMK!S+MMX<,5L!EMRIV MW-G?R";V0MO9;UN!_LG81RW];=7G\N.7*CO\EA4,U(8Z\0J\E.4KAWX_\*_@ M8L>X^KFMP!^5=6#'Y.W2_%E^_,JRT[F!<@>P(KZPS>''$ZM34!32+&C`,Z7E M!0C`OU:>\=8`19+/]O^/[-"<=[:W7`0KUR,`MUY8W3QG/*5MI6]U4^;_(HB( M5)B$BB0>L!=Q^&K\8@>)M.MZ2IIDOZW*#PN:!6Y57Q/>>F0#"6\+PMMW2[RW M0E@:3_*-9VES`?D:RO*^#\)@Z[R#E*G`1(B!G=!AB(J(;PA>`:#7<835Z1P] M*-VPZ#=*_"*5DD?5^T4F1$/$)L+SNB0*1]!.YCC.C8.A])(40;CL\K:21HCQ M)8R&B,<0"C=(,IT;!^]L6'A7)NJ[&C?$+-M"TX`L=69RG/ADU;>"P@M:?CHO M#E9Y!4NM7!%B5BVO,/17*NU8#J_"H+]:8;6;@%^D-UJHJA(A!DK6%5POYQA"D8Z/.&G38+R`!/VZJZ!6HDC$!2]WV388A M:EUGC0""_@V%Z0S4G.8"-'QSP0_S#$-4?O]K%A"T<;G_@G"MN:X`R22"M3ZP M'H!4KK-F`KD-A5Y+\_0A0-B&X3T)W"&C$)7GK(%!;P-#JJUQBA.@^PIB$E'[^PIR`Y\\,RC:O;QG MJ=_W88BJ'&!F\.-H_8"IE2VB"!J^N:CL&$3EI\V.B1UHSA#3 M^_A/<%B,S#-8Z[]1AT!!7Q&5ZZPY0M'_U5IK^S02(.PR0HAG\,,L"/`]MS_" MJM2T$3)^TJ,#H\/X\25`XLZ!:3&81,1I<,_\9@T,:@Z,P-RZ",([+X.5H1G& M\4#H]\:D*J:-BXF-AX[_P/H0)#>>MH=B.@91>/(?A=,W<(M^-#P$Z*Y^(CZN MGZ>-CO&.:]$J+^KK/Q$%:$RW48BJ&_?OR<;LH=NK==6*%@G0*#_,,PQ1^7$+ ME_A-ZS\/C5\V%=/X!$@F$:RU$W;\`*1RA50RUP>UYFB]UKKQ>0C"'@SHNGP*$S+Q0 M/^S'2MRGTD%:9:;-BHF=AW:O[I!^[7AT\1`D=YZVB>)1B,ISUN2`UP1ZUPTH MB"!\TCFDH!P?4!!?).`#]YQ5)Q:SRZ6VTO*-OR0@\`2B^Q9?8$3P`J-]VN]T M`7A_<$U.[/>D.F5%;5W8$2YU%RMHJPK?0."'IKRVS[M?R@;>'+1_GN%-$8/G M\^X"P,>R;&X?^!/V[MW3_C\```#__P,`4$L#!!0`!@`(````(0!A1RM0500` M`#T4```9````>&PO=V]R:W-H965TS+-6)5,D`-X#CS[?>4BMI".,S.Q2C'7T_;_[]O M=/7C,\^4#U)6*2W6JC'15844"=VGQ7&M_OV7]_*F*E4=%_LXHP59JU^D4G]L M?OUE=:7E>W4BI%8@0U&MU5-=GY>:5B4GDL?5A)Y)`;\<:)G'-3R61ZTZER3> M-X7R3)OJ^ES+X[10>89E.28'/1S2A#@TN>2DJ'F2DF1Q#>VO3NFY:K/ER9AT M>5R^7\XO""EO$N@WY_&K,X:7,W#YWT>9J4M**' M>@+I--[0;I\7VD*#3)O5/H4>,-F5DAS6ZD]C&1F&JFU6C4#_I.1:/7U7JA.] M^F6Z_RTM"*@-/C$'=I2^,S3`I,=3#79; MT"/6L>7^RR%5`HI"FLG48ID2FD$#X+^2IVQH@"+Q9_-Y3??U::V:\XGUJIL& MX,J.5+67LI2JDERJFN;_+,JZ56!$0?MK12]MSD`3[JOPH^IFP&Y1PD$)%R4\ ME/!1(D")$"6B(4*P8BY9P3;&&90>7@Y8J;4*J\U=;FOQ)EG"F2%+4,+AQ+S9 M>F>6KNMB'2Z:P4,)'R4"E`A1(AHB!$->>PS!3RJLE&S(0A3+YLR0(2CA<,*` M$RP[#>D3:?UVT0P>2O@H$:!$B!+1$"$8PMZ,GH^.PS.#T:(1PC=$(>$U\.(A(\200^A2R>RL(<1ZXF&",&.Q;?L8+1LAW3XMCDS9`=* M."CAHH3'B MH"$G<,3!$?>&M%*;$[:U//V9[HLT@CT\JX\C`8Z$.!(-(J)+[&5L_.(%RWIW MNDA+O'V#^*8\G1NFM,]L!4#:L9W;CP,>NSCBX8B/(P&.A#C";G.8:/T]XF[P MVQI^(9&3\DBV),LJ):$7=A,SA;WT'N6W1+:QM&?L94N*;XWEMHEK]Q_@\N8< M'\GO<7E,BTK)R`%2ZI-7.,.5_/J'/]3TW+PV[V@-US;-UQ-&PO=V]R:W-H965TTHKTL+V,//@:/DXM!_E]&C7WSZS MB_7!RBHM\HU-)JYML3PI#FE^VMA__T6?%K95U7%^B"]%SC;V3U;9W[:__K*^ M%>5;=6:LMB!"7FWL6Q=6DN+(G.I:LOC0G)1= M',]U?2>+T]P6$5;EF!C%\9@F+"B2]XSEM0A2LDM<0_^KDGKGTU0V\J2U?=37I3QZP7&_4EF<7*/W7SHA<_2I"RJXEA/ M()PC.MH?\])9.A!INSZD,`*NW2K9<6._D%7D$=O9KAM!_Z3L5G7>6]6YN$5E M>OB1Y@QLPWWB=^"U*-XX^OW`F^!DIW[`'Z5U8,?X_5+_6=Q^8^GI7,/M MGL.(^,!6AY\!JQ(P"F$FWIQ'2HH+=`!>K2SE4P.,Q)_-_UMZJ,\;>^I/YL_N ME`!NO;*JIBD/:5O)>U47V;\":D;4!O%DD!GT7AZ'II$GPV6:'L#_]N2)MYB3 MN?^%+O@RRG,;Q7/'CL,13AK%05S'VW59W"R8MS#JZAKSIX"L(/"P4Y#)V1<. M;VQXKD!7!1/A8^N[_MKY@)N72&;79SR5V`L"7MLH&A'T"=]=J%'"$0P=8(BK MQHGZS*,W#DAJ3<'M'F^*P]P4GXU?U;X%(YAP!$,'&$+4 M:T5F1C$Q_8H)#BLF](:]:!"/&W<5Z`WAO:'K:JGVG]Z9N_'HWO`X:3Y[#%H9 M$#S4XV\MAR&%=&\<>4P9<;<%`Z^/FZMV=X\2`4J$*$%1(C(1BB/(7>,=<7AC MPY1ZC)],50,[P<#U'XQ*[%$B$(3?I**YV_RI,4(T!D6)R$0HCB!#=QWQA6H* MRYTYJ?*3=%5V1&'=4=SS9%@ M3(Y0(A@@B+;`A0.,VA,Z0!`MM4<#3!M%\<2KV-$+-(=U3]K"N1.,R=,`0;1T M&PPP;?^;'!BB!$6)R$0HEI9?L<1AS9*GE04[P9@L"4(\+?X2@. M<"3$$8HCD42&NZNZX@7F>%>B'%4J"$^O((B`#"+V.!+@2(@C5")R\9RYB]Y] MBXQ15%>\=AWO2E2ZJBN]@B`",KI"D0"/$N((Q9&H1?B7S,5C,*HF&$U7T\B4 MQL_24YI>3!`!&76A2(!'"7&$XD@D$;D8D>[<4XWQ4K8SL;BQ&;29JR_^8PL8 M@^GQ*-4]K2S:2\I.TX0UR)`MAKECG/)8^I M*]=*<5PFS.50>C>5T-(2BH0$12B.1$9$M<0+VO&61/G;6NH]?N*XS*:DGTSW MQ%1`2TLH$N)1*(Y$1D2UQ`O:\99$^=M:ZCURXKBT-%<>^T;!GI@*:&D)14(\ M"L61R(BHEGA1.]Z2*(%;2]HWK1T1QZ6EINY4*_6])`RI*\"1$$4G_5BB/"TMPW.^N(6(R2<2D"4="'*$X$AD15=.7:G2O M7Z-[,ST[24C\[#1!2*(WQOAB_?P]T5KL3>B]@8R%AY8GMV MN5164KSS?14^:=K6=L_G9XL--NXVW_ M`P``__\#`%!+`P04``8`"````"$`4B'3E\\%``#`&```&0```'AL+W=O69P6T;Q1@+F$SR]UM-M4U7X\%XYR$9NT\5YU175S4U3Q^^UP?KFVB[JCFN M;>9XMB6.9;.ICKNU_?=?GQ]BV^KZXK@I#LU1K.T?HK,_//_\T]-;TW[M]D+T M%G@X=FM[W_>G1]?MRKVHB\YI3N((*]NFK8L>/K8[MSNUHM@,1O7!Y9X7NG51 M'6WT\-@N\=%LMU4I\J9\K<6Q1R>M.!0]\._VU:D[>ZO+)>[JHOWZ>GHHF_H$ M+EZJ0]7_&)S:5ET^?MD=F[9X.8#N[RPHRK/OX>Q[3X_#0'ZIQ)OG?:[U>V;MU_::O-;=100 M;=@GN0,O3?-50K]LY%=@[$ZL/P\[\$=K;<2V>#WT?S9OOXIJM^]ANU>@2`I[ MW/S(15="1,&-PU?24]D<@`#\:]653`V(2/%]^/^MVO3[M>V'SBKR?`9PZT5T M_>=*NK2M\K7KF_I?!#'E"IUPY20`]FH=OIHW=I'(H"LO^N+YJ6W>+$@6>%1W M*F3JL4=P>!:$C[](?$\A2)-./DHO@R\@W\&V?'L.>?3D?H-0E@J3(@9.P@7# M*"([(V37M^%,T=I1#GZG!)(IQ`#D4T1OD^=Y%-( M'%X@1(8_E1'>E"&-(&VT,(8\OO@?XI8B!K;S$NJ1P8#(;B+R.011`8^Y?S.D MT=J&4(T,>6*H0`QC;$@HS_%7%)#=`N0S`"(!SM[]$J21(<'W*,,4,:,$QLR$ MHHC8B2-/_V&?'@R+G%HD3APF^D^H6Q"5X?]1*8U,E<:Y31%S5OG`G2C2&26Q M3@GSSS`)G$!7[7G^IP?S7!DFB6D2Z"9$>$2%SY<)"38%&UN0(N8LV',"/V"Z M8J/T95?POJ[7\)]/\*)3WC*T6CZO4X)I'>&1N;&(@5,TGE*:X-E-1#Z' M(.R3>]A+,-TE'AE13!$3#M7#CWEBE@]]G:^B)*#:K*(Q(0EO!B5[>=@' M-&4>FBTD5:!HH,X"CQD%/J,`CWLC-]4Y):FUC1Z2F(_:*7?981>G#%3B:7LL2E3]F;;9`A2[$/N3Y*'`%BP,K8PIQY8&(\>*'G97Y>3QVZLDV>> M42E3AB`D[Z\F>Y-1`/=#H^7F!,#C(!X?0CU4`[XD,0;-G]28DG_5")!$I?]K+E]+'S4?IC,BKZ"$+Z M+&83]F0]"<!<7W(F+[.P]`0GZOU M!>3Y73UV0-,>RV.S3"H0D@\"[IOL"0#N1HE9:11@"?V[VBS'-DMB;SX\52!% MGS.SB&<$P(/$?//(%6`)?:"R/'6X1!O13XS@I@J$]+D7&:F1T74>&:F7J_4E MY&6W6YSW''LCB?TT=?0&>C5U=,#5U$'`$OJ`N8.^1--;?6B^-J<<0=9/20P!^:-Z!M+OJV%D'L053SXG@G+0X@<8/?7,:QILO30^3X^'7/?RE0,`@U7,`O&V: M_OQ!SKCEY'N8!S__!P``__\#`%!+`P04``8`"````"$`Y`RPAU\$``"9$0`` M&0```'AL+W=OD&6FTVIFY)L1)4`%'F#3MO]]C#`DVK9U.+]KD^/&+S^MC8W?] M^:4JM6?4D`+7&]V:F;J&ZASOB_JXT7_^EWQ:ZAIILWJ?E;A&&_T5$?WS]N^_ MUE?V/?N&0?(3JC(RPV=40\L!-U76PM?F:)!S@[)]UZDJ M#=LT/:/*BEIG"G[SB`8^'(H<13B_5*ANF4B#RJR%\9-3<2:#6I4_(E=ES=/E M_"G'U1DD=D59M*^=J*Y5N?_U6.,FVY60]XOE9/F@W7V9R%=%WF""#^T,Y`PV MT&G.*V-E@-)VO2\@`VJ[UJ##1O]B^:EEZ\9VW1GTJT!7,OJLD1.^IDVQ_U;4 M"-R&>:(SL,/XB:)?]S0$G8U)[Z2;@1^-MD>'[%*V_^+K/Z@XGEJ8;A^G^7HM]>]KHTXW`&W6>V4O7S<-@GG061UF;;=<-OFI0MY`U.6=T%5@^"`_>,B=N;K]G-KA,1;Y0E4X+ M?"10(<];;[Y:&\\PJWG/!(R!17EC+)X(!X).(96-Q$`\/&<@$C&0C@(&I'C+ M$R9+S',.E?AV#0UIT4Y\6DN7'W,P16R>"!DQSGL^YY%HBBP]'HFGB.>8/).\ MQ0@>IV\Q]Q%SELUYR^1649A:-EBHXPF7CY["L"V,:M->B3/-&/A]JU]ACD(E$2F)6$DD2B*5$9Q'L"\][A&% M-SK4SSU_1RCD@#&+;@>P//JSX<5!(1(R"'^W-XC5A))$HBE1&<1[!GCSVB M&Z1ZXZ"=1*\'&./Y&N-PJ(W MXEICC,.\X7T+)6W1T/9^[2B)1$FD,H+SA9Y`A9>KNG9H)]$?8:<)&,/\$2MG M:'O7@TA)Q$HB41*IC.!<6OV)2[23Z)*PUP2,D:R24$E$2B)F!-OSX&9`?_B* M3<;$PG)<5P#2,6`)$IQ5%AQ9/EY172_1K"4_R*"'6!Y+RQ.S"#D`#J^.F$;4 M$Q+#8S62J)%4BO"&T?/@AY>@Q4Z1_+MNJ@_&EC.7-RV)L#] M5-I?!MAC[@H"$/<*4K>8A@2A-UF:S=L(V#V?@:3RR?3@*3^.Q[<.)>!I/;!\.QM-X:OMP/H:X M<7LP7(S/V1%]SYIC41.M1`<8LCE;P"PW[&K-OK3XW-U\=KB%*W'W\03_`D%P M+3-G`!\P;H&ULE%9=;YLP%'V?M/^` M>&^`D&\EJ4I0MTJ;-$W[>';`!*N`D>TT[;_?M9U0;#JG?6D#]_CXG'NOS5W? M/M>5]X09)[39^-$H]#W<9#0GS6'C__YU?[/P/2Y0DZ.*-GCCOV#NWVX_?UJ? M*'OD)<;"`X:&;_Q2B'85!#PK<8WXB+:X@4A!68T$/+)#P%N&4:X6U54P#L-9 M4"/2^)IAQ=[#08N"9#BEV;'&C=`D#%=(@'Y>DI9?V.KL/70U8H_']B:C=0L4 M>U(1\:)(?:_.5@^'AC*TK\#W#U?>J`C^8E^,"'2OQDYZ^8G(H!91["HZDL57^DF*>04:!9C2> M2J:,5B``_GHUD:T!&4'/ZO^)Y*+<^/%L-)V'<01P;X^YN">2TO>R(Q>T_JM! MRE%',CZ33$#].0ZOW(L#+43Y2I%`VS6C)P^:!;;B+9*M%ZV`\&)(;]]9_)]# ML"9)[B2+X@+Q',KRM)W.%^O@"5*9G3&)QL!)Z#"1B=A=$#)ODC;MO0A`;R<: M[-JB8ZCEVU6X:)2+3(WQV!20#"$68C=$Q+%)D@XABUD',6S$I@VW?`F&=NFE M;QI:"4PT!LK8I?AU9Y71W55$ZD(8ZF&;?A'?;NN"G$#!W.TN%]FYMP^KQLQ5[J-P9IGJ#$[X!VN*NYE M]"AGG`A:MWNKYZ]$SE]J@NH",/ZTZ("_(W8@#?Y(C6C<[;?P```/__`P!02P,$%``&``@` M```A`/=K<#M("@``LT(``!D```!X;"]W;W)K&UL MG-Q;<^(X%@?P]ZW:[T#Q/@'+%RZ59&K`]QOVUEZ>:>(D5(#8V;\7!0O6[JA^WKT]WP M/__V_Y@.!X?C^O5A_5*_5G?#G]5A^.?]/_]Q^U[OOQZ>J^HXH`BOA[OA\_'X M-A^-#IOG:K<^W-1OU2M]Y['>[]9'^G+_-#J\[:OUP^F@WO@Y5 MA/G^(S'JQ\?MIG+KS;==]7I40?;5R_I(]3\\;]\.YVB[S4?"[=;[K]_>_MC4 MNS<*\67[LCW^/`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`%X2\ M(.(%,2](>$'*"S)>D)\+?IV>H9_H?SN]9-*' MXOI`?>X4>93>*:;0J[10I-TG3"R[PG9L/8K;-:Q?O:ZP'4>/XG>-R5(HZ!+; MF>AAPFMFJIOHFIGI)NZ:*:MQTB5T\=/#I-<,2XSLFF']D"M#"7+Y]#"QZD;A M[5=T"3^GLDMLZU?S:5E)`YF6E?W9*+7,QG/V+U3!]%*PY`4N+_!X@<\+`EX0 M\H*(%\2\(.$%*2_(>$&N"MJ]8UNLEU?\H((7E*T"K:%IR/]$0TM-=V*M3+$G M[(.T4(;^O603R^TE%"X4'A0^%`$4(101%#$4"10I%!D4.10K*`HHRCZA)1[= MN'XB\:2^&](`VTL28B,D&N*(MA#45IL6NJ65?/;3$H^A;0$[+^WD9J/?.PF>:%,7^)!X4+A0>%#$4`10A%!$4.10)%"D4&1*S%I M1C[+,?G`IP$Q=F;LB:-H`S$SIQ,VYI1]E="RCA[$/I%U4NM99_,?O5"F+^N@ M<*'PH/"A"*`(H8B@B*%(H$BAR*#(E5!9)TR9-/QQ3A/CR7C,;^*+MC`<,9OR MY[VRKQY:XM%$G99X'[O>RJ/T!#3XAV.A3%\"0N%"X4'A0Q%`$4(101%#D4"1 M0I%!D2O1).#$FMH&F[E8:<*`JR`7S1H+X"#>K-1Q6GA[@X MBH>)CTF`28A)A$F,28))BDF&2=X0E8_.6%CLGFZE`6M"BX4\&U47J@BF8_-T M+7MKH2>CG)1M)V/_TXAO46#5+5H\%;&.QA?:F+J6T)-KJ[NI@X MELT^<)XN'%J49JPTX1BTVLT&F$(3MA#C M*1LJRT9<'U_TW).3TNW&%DWD@!Q4<]GMR4`Q9K58R*502M3KM3C-.BTQ M<3'Q,/$Q"3`),8DPB3%),$DQR3#)&V+0:"67=<,=/%Q,/$UZIB&C-C MQFZ*`APDQ"3")-:J(J8&W:'IK9+@("DF&2:Y5I5K';32Q+5V*S1Q[71*70A# MM"Z=>@[*B?!V#G[P7E+-GVO#(A_:%_*7U]"P"(F+HWB8^)@$F(281)C$F"28 MI)ADF.28K#`I,"E[B9Z2 M)CXF`28A)A$F,28))BDF&2;YA9P>:O0.7/5]L^C[9GGYYJ\[N%^/$7KBR:GQ M3R2>FDEO)QX]UNOU7AA]T^U-XD'BXB@>)CXF`28A)A$F,28))BDF&28Y)BM, M"DS*7J*EHN!K+_UCX(GKOV;3?4II4,^-WQ(3%Q,/$Q^3`),0DPB3&),$DQ23 M#),(SE.*T";B+2'X&O6R$3W)ZF+B8>)K51'. M9";8E&B`@X281)C$>E5,FU8`]*M)@H.DF&28Y%I5S"L=M-+$M78K=''E=$I- M&%/';/W&A9Z#=)']Q)592*[/'8HQOR5L4$^&+3%Q,?$P\3$),`DQB3"),4DP M23'),,DQ66%28%+V$CT5Y5SZQV\2A9IZUQZ4._.'#>I-116GA[@XBH>)CTF` M28A)A$F,28))BDF&28[)"I,"D[*7Z*E(V?"95)2B3EM_^J6 MK\2<=GAURPLQIXU>W?*%,:<]I-WRW)C3OM!N^4+,%]?B+,6<-LYUO2OFM'^N M6^Z).6VCZY;[8DZ[Z;KE@9C3IKIN>2CFM+>N6QZ).6VQH_+1I0/H3P:\K9^J M;+U_VKX>!B_5(_4=+233*M5>_=$!]<6Q?CMM5_U2'^F/!9S>/M,?AZAH'_#X MAO!C71_/7\@?OQ+K*0D+A.<B+#NUY\_+0^, M/XN"$(F`H18KJY"R63B.2`I286&SAM00R1BOL(1;GCNBX02G>E%5.A/7G3H5 MIK5E&!;\%@Z6930A,4OV%:FE(>&DQ!+TBX(VXL16);?059@_[YN[A%4-4.QH M2>6;)K50E2R>\IIQO"LA[UA8DI8 M"0+@%U54=088@E_U_X&FLEA9_M0.9Z[O`1SMB)"/5%%:*-D+R:J_!N0=J0S) MY$@2@/IC'!Z-+W:,$)U7C"5>+SD[(.@5V$HT6'6>MP#"4T)F^S;%_V4(J2F2 M!\6BN4"\@*J\K,,P6CHO8&5RQ&P,!EZ$%N/U$=L30OFF:./.`P?TMJ(AW:%H M'VIYO0HGC6I17Z,_Z0O87$(&B.TEPO?[)/$E))JVD%X:?C^-#\?D2W M`@\Z9'[F-1X;S/6=38>\BXC'$#WULX^H5^"AZP-;-P83:-?G\V#0(]UH&`W6 MQB9J*N;YD_.+W9.LYG3G.!QO:@4>2C[S&L,-QC1U%`6S@>9N>!:%@]4PRM0. MU\ME=)M198[TBO"<;$E9"I2PO1I#'EC5/C43<@,34L\3IPW`A&IP3KYCGM-: MH))DL-2U9]"FW,PX&PO=V]R:W-H M965T=G7A^KR?#__\X_TTV8^:[OBZN9<=/!K\[QLKTU9''JE\VDI M5JM@>2ZJRQPMA,TM-NJGIVI?QO7^Y5Q>.C32E*>B@_VWQ^K:*FOG_2WFSD7S M]>7Z:5^?KV#B2W6JNA^]T?GLO`\_/U_JIOAR`M[?':_8*]O]+Y;Y<[5OZK9^ MZA9@;HD;M3EOE]LE6'JX.U3`0+I]UI1/]_-')\Q=9[Y\N.L=]%=5OK;:_V?M ML7[-FNKP[^I2@K/@1E^T>/`IF%L*7EO;U"38`_\[.E4P-\$CQO?_Y6AVZX_W< M#1;^>N4Z(#[[4K9=6DF3\]G^I>WJ\]\HU#,:C`@R`C^5$7^Q\7TOV*QOM^*1 M%=`@*_YB[:RV[CML!&0#?I(-Y_T;69,1^/G>C2S1O7VTXJ(K'NZ:^G4&1P`< MV%X+>:"<$,Z>"A,Z=0C8 M`Z!HZ0Z8+K_J&$OAGJ?:WPX1=TSPR$)B"TDL)+60S$)R'6$N^"8F5X_)3FM#ZF-`I(IZG-`S79,.ZFGN"H(\Z-Z#+V#>XCN,E.*8$3%!`A/`6?D; M8\I(;*54/0V5-FO'T,E&@2$)F!E.7HX<6O:_01X'%&@NRO3.0<@;H8@@/>P* M&I,_4="8'"E!?C^M]V4DLZ&<*7(R#A<;^0V7;P>D$GJ*>N".( M'75W; M2&^<3!AYA(0[^"."$!J1C`D28W`36RHER`L&6YD-Y4R1DY%#Q^UD<$1A9!`R M(KGF08GDS1>*-/*=92#_D-#"-LT;D6%!L0XD-I3:4V5#.($Y&SBRWDZ$)1R>#D#Y%.Q84 MVU!B0ZD-93:4,XB3D7.'1N9C59G&&YTC0CX4HR$=G:TQ#T8.*8Y]-R;('R.= MV%#*%!DA\:YQJ9?FXQ)!4(7DNQ<8>XU6&9&`7H`(^GDM290BUA(_,&\.J1*P M2PD\C(7IYP>HES98T1R$`RBP,GI=I'3&'A$31`.`%Y@U)QD%5/%(F1D>&#EA M:)GV!@6:1[24$@B-@3'+&PG`%M1V8J6#/1[>M!C=)!D%E$[*S'`*Q@CS!@5[ M5H$^+7L7#'"46\9V(A*`)JNV$RL=&L.L0Y2,`DHG968X!3D=W!X%FB7T*"`T M1L&XR$0P99C]F:!`7K^_/02!T;N2<7UDH%OA#&2SOYT!C@;ZF"%?>F,0QM(D M/(L&*>J10"C`RF">H(3LPO+(0C?"6W*DI"4 M!J5,D6_3:-P?:@]P[9`.9[M'B-UD'+O2DJ(>`U+;#RC"B3T-&^KA4&W MP_F]JY?#5<$B@A`+`T(L#`CY8V5*R)8&I02A(M^FT:7?*#QV.Q8(,7^[&^,< M1B3%J@\J4LYO/7.P)A66]/3X/FJ,AONNWMQ+\[0A2/,25*BJXJ_F9K=)>4F4;* M^-$1/V.=R^:YC,K3J9WMZQ?Y01%\]'`WP.IK9Q`^@B4H0F86EG# MRGIR90,K_;!G6(.OJH]]WS'P'7QMG7RZ".'3S<2S7?@Z.X$_>N$CW-TF%+P0 MO@%,X'X([]4G<&`]13H6?BB;@JT1BP!6IG76L#+EJ%AL8&7*4;'8PDI?[@Q7 MQ>XJE*EO[P`N^Z&\W=LK,("'6!$./&?*]3!FP#]N/S_=A/`">0)W5L!EFJ4#*U,[AI=;L#*U8WC#`RO]CI>#.^%K^K5X M+O]3-,_5I9V=RBX>\F2O@`NUK` M+/!4UYWZ!8@LA[_$>/@_````__\#`%!+`P04``8`"````"$`35+?`:T&``", M&P``&0```'AL+W=OM-VH:51Y^.EWK)GN^`.^OCI_EPG;_0S-? ME7E3M_6QFX$Y"QW5.:^LE066MNM#"0Q8V(VF.&[,)R=,W:5I;==]@/XIB[=6 M^M]HS_5;VI2'W\MK`=&&/+$,/-?U"Q/]=&`0*%N:=M)GX,_&.!3'[/72_56_ M_5:4IW,'Z0Z`$2,6'K[MBS:'B(*9F1LP2WE]`0?@KU&5;&E`1+*O_?6M/'3G MC>G-9\'"]AP0-YZ+MDM*9M(T\M>VJZM_4>LK2^0U)S+['0912(2$BR#S.Q> M!6(52%0@E0`+*`X\(6T_@2>SPG@*#W<"&(F[E'8D)(3*7@5B%4A4()4`0LK[ M*:28%=@24O*\I<)BQV5@R0T9GBM$!Y&!J8;$&I)H2"HCA"WLFI^00F8%%CN$ M=&`2>"I=%/(>T1U$!KH:$FM(HB&IC!"Z4)IDNO>+G=B`3+AG);S9(>*-:S72 MD+V&Q!J2:$@J(\1C"-=TCYDP]1@1V6,-V6M(K"&)AJ0R0CR&BB=[C-5OM@"& MW;G,7W8UMH4[L?>@RF'M8S8H$40"R.RPQ)R5LL0BKH;]JJ]V'('+H.8M%W27 MQ9I:$*"0"D`L:Z2<`A4QH+C M!DHT4Z)(>;)./9TG]G4P-V82H3&3BM.1PW7D3"+$LW*'IZ:2<"N@\I"GK$AY MLA8]G2%+G@5IX'$TEX=#WDBHK4K*LNT\GB[,` M(RSW$7M98U58SB-"[@C%NE3"(4DJ)5+4==;F)==_J)L[."L01@CY4)NE MQKRB13+BBB1]?.[`5N/XSDHID[&NE'!H@4KS0.T=1(7R9TW^`?_/]0UR\-U7 M.3XJ0#T9V`9J2]@Y*/5P0AYEQ([?ZU"L0XD.I02BK-F<(+%^/,$X.%60]"(D MSYU<2H+V.A3K4*)#*8&HYVP,F.XY'QKD^HF0MQI*:N1HT%Z'8AU*="@E$/'< M5<:4']IIO1$ZO7"(3,ZNVJLCH3@6F+V`8%4.B]9;J>522/6*E-"[AA+8X^I0 MR:&Q92O;-N("4RM0I(`RPM[!MVA5C(7!G!2O=^G'==O6VS"&([[CG76VJ M$HKR,D9;C^?!F"C22"M]]CN>#_U4;/P=I+=/O/S6S#&R>E$,0B@T8R)%G5+: MX(^59+T[PKD^\]677Q*\I;(L(RXE#W@$!=%*N_!-Y-ZSO1!..'6?GOSP"48[_<;.#^&,\`X>A'`2 M=P>?AW#>!;@U>`3?0F[9J?@C:T[EM34NQ1&":??'7`U^3<$?'1\0G^L.OH+T ML^(9OGH5\)0,``"`/@``&0```'AL+W=O7W8O%2OY=WP9WD<_G'_][_=OE>'K\?GLCP-(,/K\6[X?#J]+4>C MX_:YW&^.-]5;^0K?/%:'_>8$?QZ>1L>W0[EYJ$G[EU$\'D]'^\WN=>@R+`]] MO)50;[I.]`U^JZJL--0\6`O)(L%5]!_YY&#R4CYMO+Z=_5>^ZW#T]G^!V M3Z!'MF/+AY_K\KB%BD*:FWAB,VVK%[@`^'>PWUEI0$4V/^K/]]W#Z?ENF$QN MHG0\A>C!E_)X4CN;<3C8?CN>JOU_74S=H29'C#G@T^>`?O0DITB&3R1/;])X M,IM'5UP!7&O="_C$)-'-9#9.KLDQQ1SPB3EFUU_(#)/`YR]?"`S-NC/PZ2O2 MNYH+Y,+GM>V/G#)JH:TWI\W][:%Z'\#HA9M_?-O8N2!:0EZO,">(1G,?20ZT M9I-\MEGNAM`GD-,1QLGW^TF2WHZ^@[:W&+.2,1&-R'R$%;)-N^9`S@'%@8(# MF@,F`$90A*82(/#?4`F;Q5;"]V'E@;8T,>NVC_"4-0=R#B@.%!S0'#`!0+J= M_)9NVRQW0V@C$,"$]G/E8A(8@DW0E(9D34A3"X'D`E$"*02B!6)"A%0$)JO? M(`2;!>;;H+/IF`\)C#E7D2:DJ8A`^ZO>.60I)TG M,H&L!9(+1`FD$(@6B`D1TBM8V?KWR@;37CDD[)5`U@+)!:($4@A$"\2$".F5 MM<-BC;N9P;T]/>^V7U>5,T$=]S"!MZFA: M$(3BI%6$CVJ+M/91+93+*"6C"AFE990A440%D34^P3"XT#]GDV"V]JIOBG!6IBX.88)A!S$`I0C`.0L'$ M?#*5#(40,-IQ&T^8\2HD4;=$^T3'FS*$0:MC;5/_ZCB31:KC(*8:)H',;H7` M<"*J<1!*8,(TD$N&0@@89ZLCFM(MT3WOTH%K2%.T.M9^]:^.,VND.@YBVA'5 M06(XV3@(M2.*(P@J:@AGBR.(NB7:XK"6#'X+`N)6);(FKG]MG.4CM7$044X: M,;%G=3-,.8Z(RIFE8B)VWP=B4Y@%*2GK92$;T90QXU;0$`H5C75W_0N#7C"< MB!U$12/J@KQ0,PXZ/WODD2`JA/Q$18='(0GZ+,$0`BV-M73]2X,&,"R-@YAF MF`"RR$4%`EA[R#F.)$[8&,Q]0&N&%$(HFD7"3$HA*=I#KAE0,VO&^`!I;.*K M3&T=34TM0E0V$5LH,T\,=(-0/'/&9C%F%YU+CD(()3.=\1$E*9HV8[>6J=`, MX1#=P)V\0C=U-*N-\[5$-WS)R9`7R@8AE,"GB)/QPBQ&3#GL4R3PQEXW*A!#[!@1.]G[GD*(3.3U&%).J6 M:%IQ@I]Q$M M22'D)1=/&*>0'.TAWY`@&1_1,>]8E]J_/&AS@SDY=A"TX#N>(>1<@SL@\%&M M@'(9I614(:.TC#(DBMY^ZP>#_KESDROWE.P9&-M402B%:;MYQA9[&!E&$56@ M\1W7T^UTS"U/+CD*H<1QHLF"S9V%Y&C*F4TC]LAB"(?6S-K$,S7[JWJ#^?72 M45/LS"9,$TV!)ORI>85!9[>1VQBOL+6$<@DI"142TA(R!**EL>92E,:?R_8^ MAH/%U@H*9I:F-O+0P0=!'9LH[@/;F+8VF'O:#,A<1BD)%1+2$C($HK6QUO(W MU`8=*A4.Z_@J=E'GA=/$M,414-YF\E%*0H6$M(0,@6AQKO*^L?2^"(5[]A): M2RB7D))0(2$M(4,@TC^8F\C-/[]I64=3CX90V#\)K2642TA)J)"0EI`A$.T? M\Z"_M([`JL[7$0^U"V/FH6!['B%R/A'';$;/VZA&R1(J)*0E9!""S1'(12MA MC9\8YE>NJ(ESC^&&@(?"2F!46`F$8))K)L64;U/F/E=+5!ZB1%;"PD>U1.VA MD"A6>N.C.NIUE0%-I`%%B%@-N9V/4:'5\)#SA=%,^$\?$/A/A.SM;^HK]R`E M47OHH\:,#Y`>U,HZ5-2%N4-ZT#K!W3`-+QI^O40?2#*,"FTI0O@0D_*=TUQ2 M%*7,N#V7#$T9Z8(_W1$*'6K,O%XHC'2IB8.(=+@'RS"(*`=-JCO42:;L>3"7 M%(70)>&XQ$%;NB76.Y"\+4/:HN5A/O5">9P?)5..@ZANQ&&0]1CL,`@AO__! MSKQRR5`MX^RX$DWIEFC+,V5-&=(4K8[U@<$\?:$Z-IJMR`XBXDEC9L2RQ$4% M=W2-$$C!7G+,=\%R25&4PMHH)$%30CP3@RJ\+%H7:P'[U\491J(:!Q'5Q'*V M06*[G*W!V]@:G]_^R#$JF*942[0%G?%'N4)2]`6*(11:GZN<:B*=*D)$-_(D M$:.(;EPNKQO^P\1<4A1"2%F,A7)HOG3J: M#BF$B'12?CLS3PRD@Q!..,F,]3.7%$4IDQFW.I*B*67!]YX,H1#1V!Y=41GI M@^L$L(2'^RGR.`BC@MNY]A#>SGC"EOW2:B:,YGW!\ M0(=JF&$^/Q>ADC9%MH/%D:\6,/3PQ5XW+!(WN]M,XG;/7()49XE2:8H2(:L2AA^>%HG&IR"J5QDQMN2>&FHSY MM*0PBN223Q,^5WL1NHLH+L)XXD<70<5FK6?O=3]U1C5<]Q&B8N,_15WEDJBZB&G"YO+"$\-:B5NA>^4REW+1BEK7 MVK^BSN,2C3J(:#2:B@DQ-,?N@"9U$$QN@?KX;X]RC`ITI;J(J?@5H(_Z2%?U M16@?%5Z$R&5\U$>Y:$6MY^Y?433MH48=Q#3*3G6S%(GM%+9&B&@T%9[6$\,N M"ZFI[EQLH2UZY=+=N9BA-)=RT2)?]`I0 M7<0T80.E\%$?20UEZ]*3BQ"YS*5"SKHP*-^J@6RF64 MDE&%C-(RRI`HVC_0>S@L?VD['=[HY'L6"!$AB4XV%;? M[$NE\&.T^]L&=F^\KF9+>,\"]NXY'D^7]GRSZQN@@(N7WWR.Y\O/<%7R&SB& M`T[]0H!H9P'?++HXR7AI#UIDMO5\"6]+=.!)M+1G%/(;>*_WMNIH=P+MUEO]O.$)O&C<05A!U>NBCQH"O/_[MGDJ M_[$Y/.U>CX.7\A%NY;@^1SFX-XC='R<\;?]2G>#57[C;\/(GO.E=PGN7XQOP M>8]5=?)_P)6.FG?'[_\'``#__P,`4$L#!!0`!@`(````(0!(VNVI&!4``!)K M```9````>&PO=V]R:W-H965T M1V)=>`W;$Q;)NA=99.S,/JMEVE:T)#I$]>WO]Z"`0P`G,139ZWYHR8G,)`H' M0`$'5=2'?_[Y_'3U^^[U\+A_^7@=W0RNKW8O#_LOCR_?/E[_ZW^R?TRNKPYO M]R]?[I_V+[N/UW_M#M?__/3?__7AC_WKKX?ON]W;%3F\'#Y>?W][^S&[O3T\ M?-\]WQ]N]C]V+U3R=?_Z?/]&_WS]=GOX\;J[_]*+GI]NX\%@=/M\__ARK1UF MK^=X[+]^?7S8+?8/OSWO7MZTR>ONZ?Z-ZG_X_OCCP&[/#^?8/=^__OK;CW\\ M[)]_D,4OCT^/;W_UIM=7SP^S\MO+_O7^ER>Z[C^C]/Z!O?M_@/WSX\/K_K#_ M^G9#=K>ZHGC-T]OI+3E]^O#ED:Y`-?O5Z^[KQ^O/T6P[3*YO/WWH&^C?C[L_ M#L[O5X?O^S_RU\/+CEJ;XJ0B\,M^_ZNBEE\41.);4&=]!+K7JR^[K_>_ M/;UM]W\4N\=OW]\HW$.Z(G5ALR]_+7:'!VI1LKF)A\KI8?]$%:#_7ST_JJY! M+7+_Y\?KF#[X\AF.!XD$=&O?MD=WK)'97E]]?#;X6W__+^:%!DK M;9(:$_II3,8WD^$P'4W&YYL0LZ\)_30FEU=D9#SHY]^OR-B8T$]C$EU^-32^ M^JNAGW^_)A%UA]Y%_6)L)C?C:#!-+FC8B&.L?C$NES=M1#U$U\5VE>E-/!E& MP]$%725*V(9^"33OB5X6<3=3O^!UG%)ROXALQZ"K.*7@3A#97D"_H>)6CZ=^ M>"[NW^X_?7C=_W%%''O9I!HUE$O8`'IK8X#M7_-%)IB"J7S\KFXS7I M:1`>:'KY_=,PF7RX_9VFA`?#N4-.Y#/FS%#C7]DN)+"40":!7`*%!$H)5!*H M)=!(H)7`2@)K"702V$A@ZP"W%)YCC*@/_(P8*1L5(V[=.P9LT&(1$&:P9"&! MI00R">02*"102J"20"V!1@*M!%826$N@D\!&`EL'\`)"<\+/"(BRH1N9,VC2 MH8C`G>'0A'`<62,1I"/E&"5`EH!D@.2`%("4@%2`U(`T@+2`K`!9`](!L@%D MZR)>T&@V_AE!4S8T65+7.`9DF$S]D-QI4G(J:D?*,6J`+`')`,D!*0`I`:D` MJ0%I`&D!60&R!J0#9`/(UD6\J-$RRXM:>,'(MR'%[H/#C7JGD<3.>G-`%H`L M`I/ZFVKLQK,5IV>BVF MU[`W:N_Q]OWQX=>[/;G2XBHP=R2T5M4K6&7B-Z1!G(8TB-.0&DEH^G(J/O0K MOCR2>%;*`,D!*0`I`:D`J35"6VO^K,8@?MN*-43KRKRVG?Z,ME4F?ML:Q&E; M@]B*+PPR&/7[B31*!K)A#<-.[AEKQJR9BEZ4@Z:0FG0B6J<$324UP['8[=2& M8:^G,8BN6CR($K^;M*["BX':5GL=/-"1:6_+/;FG^\UMH+C/\/3]?L6*>8]&Y5"^.X[WS1B')3HB,X$DO7FBE6U3"D5>-HF`S%2&R9TJO\>*A-U`7Q MT'LN+QX:2JEUC_%(A^)JYVI%KB89VWD7!HKUB!L/Z'+])EJB*/-%D\%H+&*8 MHZ@0HN%H)+I+B:)*BN*)J%Z-HL87)7$,FX_64_FQ4)NC"V*A]U+D9\>&AKRQ M$<5BCIVK[!G%PAL;!M)]:#(:B1ZT1$W&D.FM42)32CDS;&TG][F>.VGH=1V M[KDZD)#=UD#V-KY$5L:09>4,V?Y2,&19)4.653%D635#EM4P9%DM0X'.IO8: M%S26WIIXC:6A,0UB9PH6MXZY2EO+SJ:AX;2_)0YN$C$8EZC)#'34I$*3HZ:0 MFJ%87)6HJ:1&S&(U2AI?$MW(6:SU-'Z/5=N7"X)@=CNV>]ZI'#\U[]B[#\H; MS=RPO+E7"Y/H/P9!$QQ-9FR.&@P":`JIP2"`II(:"`)(&E\2"H*K\8.@]CD7 M!,%LB]P@:,A;21N6G5`7ZB1%S2066AJ(IC2^F6;(RI%5(*M$5H6L&ED-LEJ/ MY3>6VI"XC:7VU?'PAJ;$=];49B?C-IN&O'5#.A(#>QYIEM,/%PSIFVP\'D=B M.;9DAIT=,X98-)J*^V+.#"LJ&#J*QF(Y5C+#BBJ&K$BL2VMF6%'#T%$T%0W1 M,J,7>4&)+]L+]G1_+V@@MP).;/LVG1AH*'-U"T1RE"8(ZM`J$1AA:P:H0:%+;)6"*U1V!DH\=?( M8C!M+(N7`5O/RP^/VJJYX?E;F6U:A4#48%LX9Y8;-N/8=L_Q`BF7'QK)8N/6\_$"J;>3_/Y!Z,^IN MS-0C3?Z6:\Z0O:(%0X-)OP-(Z<$L<3M9.A2^GHPQ.VISAM@I&L3"J7`H[%0R M9ITJAHY.42SN(;5#8:>&,>O4,G1TBF5J?>50V&G-F&VGSD#4E=433)2B%_?/ MC26PS=:S\8.N]KYNT-^97,WNV5US:(@F"/ZX>6Q8=K0M#)2.CJPE0AD*D(_%FI+>$$L]`[2&VD:\M9_>"I`N68U M'FGUPQ%;&"BA11FDJO$NF M6._J+.^:A<9[-!@F8M`T3+'>[5G>*Q:R=Y).Q.YJS13KW9WEO6&A]AY%:2S/ M-+9,Z;W]WJ2V]Q?T)I,@<$>VAD3V5ES=/#9"=[`;R$T"!7J39M$5J(EL-(@B ML0'.T#IGZ*1U85AL/1XF8HE3LH^M=<702>O:MQ[3B9:XMS3L8ZU;ADY:KZ3U M:")N-FOVL=8=0R>M-[YU/!Z-(N&]9:/>V^]),L?RSCT",RMQ(+.")S*&YO*19M(50/6F#@5 MU@TSK'5[EO6*A6P]F8@NNF:&M>[.LMZP4%NG,3VP[I]6;IF!$U)R65:HI_M9 M(0.)"4G,&G,6VD&R8*%=1BT1RE"8(ZM`J$1AA:P:H0:%+;)6"*U1V"%K@]#6 M$WJCG++HE]PO>KH(CW*@9Q+L+61N6.Z0-M"P?Q>G?\QCB5"&PAQ9!4(E"BMD MU0@U*&R1M4)HC<(.61N$MI[0C\5EZ2H&*^3]Y.E M$1Z/OV(Q#63HG#-TTKF0SG#G9AM;YXJAD\ZU=$[%27C#-M:Y9>BD\PJYZ__5$I(]B$-O7.69X3>$-="5;<3 MNPDCI%&@[MKT3AWT(6WC..>L.>E<,(N=$[F3P#I7K#GI7#.+G;$/09U;UIQT M7C'KZ"Q:8VT(3FMTK#GIO&&6=J8^)%=^GK/?AV1N[_3*3R7A9!_2D)L=8)8= M#`L#I>[]60L=*$-ACL("H1*%%;)JA!H4MLA:(;1&88>L#4);3^C'(I2>.^>D M,\&,G(&\/`&>=!J6T^,6+-0YNG@\F8C5U](R.+F0H4]N67T2:SR:B,FXL`SV M*=&GLBSC,Q4^M66P3X,^K65IG[%\C'=E&>RS1I_.LHR//-W:6`;[;#T?/^:7 M9>?4NSQR_&%VCEGN^-,L9[`M#\[0)[Y,=")7DNB(7."7E[(@/9B6^>&,@N/!8&>'Y M6\?`O8N_DV7(B1I#3M0,I)9/SA6)Q<#2LOB*,H1RA`J$2H0JA&J$&H1:A%8( MK0WD!I)9?B#%UF%C67S96\_+#R3M2']"()6+"*2!W$`:R`VD@?B@=#`D$_O=&C%!]$ M5T/N1H]9-N`+`[G'P`AE*,R152!4HK!"5HU0@\(662N$UBCLD+5!:.L)_5BH M%,+Y-[I49QS<&YV!U!@_3H9X#&Q8[O+20.\D;EAHSA>B-)+/5V1,L0<,^5G> M!0OY[&*:RL.#&Z9TGO[O4GE42[H33KMXO4FDXFA6??8F_#5MM0(W<%N M(%>(Q\!&:,YJTRD=3OHS68;6.4,GK0O?FFXD32-RT2R;8 ML5V=Y5RST,P;`QC:#3.L=7N6]8J%;)W*@;5FAK7NSK+>L%!;)Z-D*$Z8M\P( M3$B7Y;1HJ0!+#9.MN<8F(7N4#%> M[A@+W+LURQX#3Z;>?V),9OA!.4,G/Z@P+.>#!MY_8F-7LJN]HHJADQ]4RP]* MQ&*D81OKW#)TTGD%SN(>LF8;Z]PQ=-)YXSM'-Z(QMNS2&_L=3*5S+E@.2,V+&_\:^'I&^_2".T9\<0+^T!<:H8?E+/%R4/2@EE\_!J?_J`2 M/ZABBY,?5#.+/P@[F&X8IZU:UIQT7C'KZ`P=#)P[UIQTWC"+3Y!QT>@Z>SV, M)O-+>EA/]]-&!G(3"\RR(V5A(/?6CE"&PAQ9!4(E"BMDU0@U*&R1M4)HC<(. M61N$MI[0CP5-(]YH/_<$:ZB$(BH:\I;R>()LA$Y?7AB(YB0^,1+[Y*5E\"HM M0Y_>J-66P3X-^K26Q3YB2;RR#/99HT]G6<9G M+!-[EL$^6\_'CSF-;"_FIY=S0T47D=:0-_X,RQU_&O+&'T`9VUMA;B!'6"!4 MHK!"5HU0@\(662N$UBCLD+5!:.L)_5C(Q-[9XP]3?/0]Z+"53DPC;ENU9;!/@SZM M91D?^3T\*\M@GS7Z=):E?>*!J,_&,MA'?2N]BH9N9QUS_2WS^FNLGW>OWW;S MW=/3X>IA_YOZ!GEZ)8WFOR.NO]_^+IUM^Y$A\2%][[W:LDI\--OV[U-)/(YG MZGW:@"*9S-01*Y8LALEL29>!)13IF8HEEE#L9BHZ6$+1F*GVQA)JWYEJ02RA M;_?_'*PS?>M_GT6`JZ2+#/C<)72)`?QS.OL<_&"Z)=&EASZ";C)TZ:$2NFW0 MI8=*Z$9`EQXJH:F=+CU4LAC&5(/0Q=#T2#4(E=#\1S4(E=`$1S4(E=`,1C4( ME2S2\6Q)&U$,"^VW9VJ#C26TH9ZI'326T(YYIK;(6$);XIG:`V,)K>"H#?J' MPD6@:8E&;1`JH348M4&HA!99U`:A$EI%41N$2NAPBMH@U#IT^D1M$"JAXR5J M@U`)G1]1&X1*Z("(VB!40@DJJD%H2%,&BFH0*J$4$]4@5$(Y)*I!J(221%2# M4,DBI7:C11W&IZ,2=9",)8N4Q@\=+6()'<%2K4,E=*1*M0Z5T!$IU2!40D>> M5(-0R2*AWDM/\01J0"7J428LH4>79NKA)"RAAY%FZG$C+*''BV;J`2(LH:=& M2#,-E'14HIZD"&F&5.O0Q$Z/1U*M0R7TP"/5.E1"CS!2#4(E]%`BU2!4LDBH MO]$3;U@W>K"/:A`JH2?WJ`:A$GHTCVH0*J%G[Z@&H9)%0GV'=O>A&E#?"9;0 M^QQ4@Y"&7MB@&H1*Z(T,JD&HA)X]IAJ$;KOT<#'5(%1"3P]3#4(E]'@PU2!4 M0L__4@U")?1N]$R]#!UH`RI1;SMC";W=/%.O,V,)O;X\4^\K8PF]GSQ3+R1C M";T?16T0&MOT`A2U0:B$WG"B-@B5T"M,U`:A$GI'B=H@5+*(J=WHJPFP;O1- M!U3K4`E]8P"U6ZA?TS<`4+N%2NB-?FJW4`F]H4\U")70&_=4@U#)8C*C;S?& M.M-7B5#-0HL0^JX0JEFHA+X,A&H6*J%O^Z":A4KHZSRH9GW)[?&F27^1Z,?] MMUU[__KM\>5P];3[2NO-0?]%TZ_Z;QKI?[SM?]`ZE/XNT?Z-_A91_^MW^MM3 M._J3)@/U]5E?]_LW_@==XNWQKUE]^C\!````__\#`%!+`P04``8`"````"$` M^D6%Z\$"```6"```&0```'AL+W=O8N=ET M)URK#BA6LI'NOB>E1/'Y];K5AJT:\'V79HP_#9_1*+GH`_HKQ=;N/1-;Z^U7(\OOLA60-JP3 MKL!*ZQN$7I?X"B;'SV9?]2OPTY!25&S3N%]Z^TW(=>U@N7-PA,;FY?VEL!P2 M!9IHE",3UPT4`%>B)&X-2(3=]?>M+%U=T/$DRJ?).`4X60GKKB124L(WUFGU MSX/2'94G&>U(X+XC22=1-LJGIP-88E]1;_"2.;9<&+TEL&M`TW8,]V`Z!^:7 M'8$5Q)XCN*"PJZ%8"\MPN\RS9!'?0G1\A[GP&+@&3!H0,8@&95`;KHQ@5,9L ML90+_V)?9O2RS/@8&00_D?$O]F7R[!4_V3%""(9=L)_29!8,>(L>`]>0Y"0@ MGB0)>VAXD@@N*,076//L,3JO[#%9O\*ON)T/&:",[7SO7\$N,(9>\O8_@Y,.O6<'WCTF3=,^\22:G0;`DX6>?:0`G'18 M0![X??@>\WX!T&0_$$$_Z["$Q[WL2]B!WJC!MV??O90P:_%%-(TE7&^P]6)V MX6TX%L['?6,/'Z`K=VPM?C"SEJTEC:A@:A)-8<<;W]?]P.FN[XTK[:`?]X\U MG+\"6D\2`;C2VCT,\.0()_KR/P```/__`P!02P,$%``&``@````A`.R3^N+\ M`P``AA```!D```!X;"]W;W)K&ULE)A=CZ,V%(;O M*_4_(.XWX!!"$B59+1_3KM1*5=6/:P>-=*RDSC4\]I;>Z"TWQ8E.!!I=SIRW+G?T"9#H>OMMWV"_BG)E8W^=MB97G_I MRN*WLB&0;:B3J,"!TE>!?B_$+7C8FSS]TE?@C\XIR!%?*OXGO?Y*RM.90[E# M<"2,;8J/E+`<,@HRLWD?1DXK"`!^.G4IE@9D!+_WOZ]EP<\[-UC.PL@/$.#. M@3#^4@I)U\DOC-/Z7PDA$=0@,K^)P!,W$02WS`][,I#>5XHYWF\[>G5@LD'B__G$*(2(M^$2J\%P3,HR]L^7$1;[PU2F=^86#+P)@P, M4HGD3@BS0C;5;V3W>42-P,#@`OSK+@(H[N.RW(,6#ZE!!W,UHGB*:$0R)8)` M%4FGR&JI(MD4"1>K@5&L!JI5LT4!PQH;Y3P(!]D^Q[%$%B-$"RZQ$JF5R$R$ M8@\"&5?2;$_`.Q>2-RRIB3V)+/LUB:)UJ-=O/#X/T4(OGC(^]Y$VGHW'411% MZR&]BBUXM9ZW)6"U:N'BAZXLFV1@]L&Z7C8KD5J)S$0H_I:?\2=@M6QAZ`]Y MD_XD MN?>>6(G42F0F0O$GCB:C#X#YA1.P;65*QN3/2J16(C,1BK_U9_P)6*^?MK)B MR8S]A:&V*R131GL[4RN1F0C%(8(OW?,E[&G=H_9VQ#=H;%(SD-B1U(YD1D1U M*;[]3R]4)$\*\-D9]L?I'GJ#C"ZEC@%)[2J9$5%=BI/`\R[EN6'\`0SU+UPL M#H>PJ,<6PE#?3A]`6L%3.Y(9$=6G.!`\[U,>'U2?6GPQ,ITQY,9J1U([DAD1 MU24D_1,N!6W;79&$QM74$I'8D=2.9$9$=2E."<_74IXIU%KJ>ZSHJ29K5FLH MD@>0EHK4CHAV49_JAXKT*=M!V3;5I#N1A%05@K/E<%>VH3':0.\B MFI1A`+K`%I_([[@[E0US*G*$1_U9!+-WLH^4%YRV?4]RH!SZO_[/,_3[!-HA M?P;PD5)^OQ`3#/]!V/\'``#__P,`4$L#!!0`!@`(````(0!!:3M@_@4``!(; M```9````>&PO=V]R:W-H965T+Y>6*/_QX;_/3U M/3TJ/^*\2+)35V6:H2KQ*_3%5Y6B#$_;\)B=XJ[Z,R[4K\]_ M_O'TEN7?BT,[TXYW&X MK2JE1]TT#%=/P^2DUAXZ^4=\9+M=$L6#+'I-XU-9.\GC8UA"^XM#-=5_W&.IM`U9^?JOC\F\1O1>M> M*0[9VSA/MHOD%$.P89CX`+QDV7>.3K>\""KK0NU1-0";7-G&N_#U6/Z5O4WB M9'\H8;0=Z!#O5V?[J$KT699;^5T/LXJIV8EZ

#/?B!:Z-EX\' MP[M4AFM3^8%@P-RN.@+7QLNG@Q%"4HC5O89C>CUS*T2P2`LP^>G/'M3(+E" M:(ISR%,UZW"/30JH)^PU*?PJ)T`RX%Z^<3>5,YCN!>2Q'\^NPY[T'Y!\H@O3 MJQF0U95Q7!LS_8;AN88['M""(2T8T8(Q+9C0@BDMF-&".2U8T((E+5@U!;?N MD0"L&Z+IW*95H,-X7`<%="8,B@5SX'Y>;L:`U\)CX#LXO#T1,3'1%PG')5X& M(D.&<2@2CNOB7QJ)C&5A9"PBCNMA9G*/\3$SO<<$F)F)C$]:/!<16.NPF\4] MANA@>8\AX[`2&4*L18+&;R,BK3XAQ4%.0HK[O=(X#6M]:R9;!NEDKV8@65UG M.PEG7TH,I,102HRDQ%A*3*3$5$K,I,1<2BRDQ%)*K*3$6DIL?D<@6<'P(UGQ MU46>R'BMK@KBO4G'(>KOU8Q;+36,,9/,PSZRVQZ5YP#9F661E#%LVWV7IL!1 MV\Q,WR?99(SM3D"T/VG;`\L@YFG;[%GTUV=M,S-LCU2?8[OAD[FY:-MAITQ2 MZA*9`[J(K-IFV_%-LCRLD=UD#FG=IFVW7,NYQ0YI!S;-#VB'UZ+:(85#Y4`2>2PDR($C@"\@0(QYS!61$$,,1D#%&W$!$)@3Q162*$=\7 MFSO#2&`'0EOF%&$"LB`(CQP)W1(COF\+R`HC;F#`,.&E=HT1SS;AL0\C&XP$ M'H/V7A&D-MCZ/J`V7HNJC>R%>C4#HK]ELVL3JCUN7TH,I,102HRDQ%A*3*3$ M5$K,I,1<2BRDQ%)*K&JBS@+,%86\1H`G3H9-&S`M-+F1MN!Y_`%M\5I46R35 M]FJFR62^+4ZD/D7N9#*"W.GJ$",!K+>MB52I>$00`\6C0L88N9>#)@3QQ#0U M18AOV.+0S3#"+-'+G""P1:`]6E!$[/22(*:(K!#B^0[SZ&9EC9'`-.`/YX@- M0GS3\"SGMF5!:N/O9ND3O7S/Q6M1M9&%NU`^HB=>B:B)QZ]7,K]2$K8*: ML%E0$S8+:L)FFPS9F)BIFK"9/G1/L5E0$S8+:B)FTK0%-LO4]"EZU:;OJ`F; MZ=L].*;@0UX/)]-,NJFOSR#J5X]IG._C?GP\%DJ4O?+S!1-RRK6T/OKHL0Z\ M8X-79:1\!4G0CG&.W!I:/RU>UX?:M1?RNQ)=E9?,%?EB_GF8]_P\``/__`P!02P,$%``&``@` M```A`&6D3B(#"0``9#,``!D```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`A284!(E,$%7#!`G5G_C**VC(H$N4??EXWS;O M"S59U*6Z2ZFG7GBG`EX%P>5'B?^D4$G307[14898JO&=&I:OCUFZO5]]55VY M-TP.C%H)(Q-BHK@2NM]T6$'_(*_7T6.D!(PJE'ZJ(E:#ZQZ6:Z-U)=SH;8I; ME-M(A(G")N(8(\)&MAE&I(VDR:W_D-082^4E:OAAJ:*/?9Y&I'DY,,F$(:TK MO(3P$I(CD#[5D.E0\OHTK-;0I.UI1&95#@RGSTL(+R$Y`NE3BVRJ3R\X_U35 ME?`X9ND.SZ$!=0SJGT$I(CD,J-K3+S)AY=B:HD*G)@D(J,YAX'@T=<>`G)$4BI MMC!DH_`KU96H4II_@,%*$ZRC<#"8$%Y"<@12NL-*^1FK89R!LHSN(L`@A;CU MA9<07D)R!-(7J@E*A]*?@H9:="S)3I$;"))0E.[L'(2)76H1`A%Q;!/2$.X. MQ5*U89C,6GXL54JQI^L&#U5NH`2R#RXLN$+!%4P0.KMEFZ$; MI2EW]S3N`.TA)AW@2;+@.+!P(B4/`0+AVR"C?@"5[X(A(=VTDO0F#.V68M3. M]D&A]A'SU8+KP&J)FGP(^;`$M1MUE%1.1%)(L@E?HH:9IWYXWI4(OLM-;C M&`-=YV\8#!O^;;NE2%`R*V M0_@1R2)8)S%3'IVVB4KI/4X>`S352204?D3X$J_2>H$#`\'`93V^!`-B6,2$-X9X46*BV([/O3V,P+^C^E!Z!Y09R/IXHN$+! M%A9@H&,+L>Y4($)?2@R=CKN#4]4?(#4.J%$WQ>ZVF04*$1A$LE&P0F)U/`H=%F=#3P\2 M@*Z#26]7"E0>![$UF-/Z<4#/G*2I[]:/Q1%O,W/&@GU!F^*&.M8$(!"YL9X; M%:CR@_YF@1\ MS33%VN<_!F)50AP&$?XHDD60RO1#3F>@26JU#D$,A"18)](NB-@"/R)9!.LD MSF?>PDP=#FA+DGMN(*072RG\B/`CDD6P6N*"^!6::MKW-,5`K$J(PR#"'T6R M"%9)3-#,,04SA)*M=7:I7DO077*]:?:>71J>E0XA&42_#*&OZD9`.KSL`"\% MG*KVI2JJX[%;[)LW_2*#_I;M^%=XR2(/[\3P1L)J+%#O.%S*E^KWLGVIS]WB M6#VKJNM`GS>T\)8$?.B;R_"-^Z>F5V\W#+^^JK=9*O5E_W6@X.>FZ:\?]'?\ MQ_=C'O\/``#__P,`4$L#!!0`!@`(````(0"7T_0>X@8``$&PO M=V]R:W-H965T,#M11KG/(SGG9ES7ISP_/%;<;*^ M9E6=E^>M[2XM_<_?GS\\VE;=).==??WI^ M+ZLO]3'+&@LBG.NM?6R:R]-R6:?'K$CJ17G)SK"R+ZLB:>!E=5C6ERI+=NU% MQ6GI.@+=W]P@2;O8[8M!^")/J[(N M]\T"PBTQT:'FS7*SA$@OS[L<%*BR6U6VW]J?W*#J[^W';@S\K:9?OD[=3\5;[_ MFN6'8P/M?@!%2MC3[GN[YKC MUO97BX>UX[N`6Z]9W7S.54C;2M_JIBS^0\C5H3"(IX/`_SJ(Y]P=Q-=!@CZ( M"_'D#):HIBU.G#3)RW-5OELP<9!O?4G4_+I/$+"K"FKHZW2K3%`?%>23BM+& M@@K4T-NO+ZO'Q^?E5^A'JID0&=A./>-2(NH(57P5-C9^L(1\^Z1!+D_:AX$8 M;V67H[J(Y[BA&81#QJ-$-"1\GR+Q$'E<]0C1`9TT=>;=Z.W.)()FO[LEY67(Y M_9;F@\[J&6I($C"-Q")")2CSNGMJ7+0\>DZNV;1K:(-&NW#9.1KI=4%J+")4 MA[*S^W6@"5(=@SL"A&[KP'51AX10'& M9R0_LPEHDZ:(M3,0@=#M)N"Z.7Y(0JD-YH*%CH@GHF#1_?BOD(B3D%TTC ML8A0"&ZY`6MAU"^/G4HZ_=D.[BM/GKWA M6YHW@WN@ADAY5]P#QR!FY")">\",?.9D#0U]Z($^0G,G"VDBG:N2$*H*PMS1 M&D7SUG`O\1&Z.5G=LC!9$D+39X8^LRE#8Q]^\O,1FMN4::/7`4';]<-.WS>J M2EGI_/V"QFL>R6N'W2.%ON3.:)#32"PB5,)='N^CQ\/47DLS^!RHH?'Z:0D8 M1T!B,0J5P#Q^YFRA1YO=&!JDCQ#.EKM>L-N92*^+.J1[`:KCAXS>'S/Z@26: M1C^F8]K:]?N,2R4Z`F;ML@FV-#^JN`EJ"(^JP=]8^E5C*OL-BQXH(C3[NRP\ M&+-P[H$:,DNW=KB1CT#L;(A%A(I@1CYO2P3J*MJ*H0=JZ.:6T.NFV($.?)]Q MA.I0_CC[@`W03>F6YJZG(1PEG__.N5\51FFV9\,3)23[F5U05_$N#%0@=+L+ MN`Y?KP$YFO:A MDV6_`(^Q7))#]D=2'?)S;9VR/5SJ+-;@PQ4^"(,OFO+2/B#Q6C;P`$O[[1$> M6,K@40QX2L6V]F79="_4HS;](U`O_P,``/__`P!02P,$%``&``@````A`)Z= MJ!NW!```I1$``!D```!X;"]W;W)K&ULE)C;CJ-& M$(;O(^4=$/=C:$X-ENW5VFB2E1(IBK*;:P:W;31`6\",9]X^U13&5./%Y&;& MAX_B_[NJJVBOOGP4N?$NJCJ3Y=ID"]LT1)G*?58>U^;W?YZ?0M.HFZ3<)[DL MQ=K\%+7Y9?/K+ZN+K%[KDQ"-`1'*>FV>FN:\M*PZ/8DBJ1?R+$KXYB"K(FG@ M;76TZG,EDGU[49%;CFT'5I%DI8D1EM6<&/)PR%(1R_2M$&6#02J1)PWHKT_9 MN;Y&*](YX8JD>GT[/Z6R.$.(ERS/FL\VJ&D4Z?+;L915\I*#[P_F)>DU=OMF M%+[(TDK6\M`L()R%0L>>(RNR(-)FM<_`@5IVHQ*'M?F5+6,6F=9FU2[0CTQ< MZL%KHS[)RV]5MO\C*P6L-N1)9>!%RE>%?MNKC^!B:W3U_AH^F(+A;2^ MXJ1)-JM*7@PH%KA5?4Y4Z;$E!+P:PMOW%G_F$*RI(%]5E#86B*\A+>\;SIV5 M]0Y+F7;,%AG8"3W#*+&[$FK=5-AX\($%>GO18%<7[4(N[V?AJE%=1#6ZNL0Q MHA&[,>&ZU$4\1L*@1X@-E]J8EJ]@*)?!\G&NW7J+#*2Q7^+;G=L5W3TDXBF" MJ(?;#),PK5[!:Q.6IE?&N=>O2JMMBTS0EH_+(A;Y%-@-`2=DS-.R$Q/`80Z_ MV2?28:_-EZY@7;JF;(L,;Z4[8<`#KML&;G&Q@I!!`Y[+?%^7/P3NE5@\!+02(]+50!^TS6GI"J;2O5`KW2TR4,#] M!M&RLWM(Q%,$41_]'_4*?M1XD)E2_Y"(IPBBGD&KG[_X+4U7?]QZ.@@KQX?& MH?6F'0$\WW'LOJ2QZ@G@>I%]BT#%JYDVNW(83D#:-_7FTT$HGD'C#/3F0X@P M$=OZUN&T-0&?HS$DPBUH(;=?`LX&F']^N8X?O91C^'0IR8M/$3BR2C4 M@IIS\RW@5!QFX4X7&HY.)^"1,]K(A'#]R-'F2,R&!`L#=_`<3O6K43=?/PY& MJG_4B,CTY%[H,ZU-[AA!W,CF7$-B@C"UD8*?]5(U\`869G8C')/4RJ@;(=3U M&L@%/,;<5+0M?\LK(U<'.!2>\%AQU9XS,8WC3RW9[@7V<#Q MN'UY@I]#!)P6[07`!RF;ZQMUD.]_8-G\!P``__\#`%!+`P04``8`"````"$` M^V*E;90&``"G&P``$P```'AL+W1H96UE+W1H96UE,2YX;6SL64]OVS84OP_8 M=R!T;VTGMAL'=8K8L9NM31O$;H<>:9F66%.B0-))?1O:XX`!P[IAEP&[[3!L M*]`"NW2?)EN'K0/Z%?9(2K(8RTO2!AO6U8=$(G]\_]_C(W7UVH.(H4,B).5Q MVZM=KGJ(Q#X?TSAH>W>&_4L;'I(*QV/,>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6 MF[CMA4HEFY6*]&$8R\L\(3',3;B(L()7$53&`A\!W8A5UJK59B7"-/90C",@ M>WLRH3Y!0TW2V\J(]QB\QDKJ`9^)@29-G!4&.Y[6-$+.99<)=(A9VP,^8WXT M)`^4AQB6"B;:7M7\O,K6U0K>3!`6#?!TVM+$6:]?Y&K9/1+(#LXS+M;K51K;OX`OWU M)9E;G4ZGT4IEL40-R#[6E_`;U69]>\W!&Y#%-Y;P] M?O/R\1?E>%G$__K#)[_\_'DY$#)H(=&++Y_\]NS)BZ\^_?V[QR7P;8%'1?B0 M1D2B6^0('?`(=#.&<24G(W&^%<,04V<%#H%V">F>"AW@K3EF9;@.<8UW5T#Q M*`->G]UW9!V$8J9H"><;8>0`]SAG'2Y*#7!#\RI8>#B+@W+F8E;$'6!\6,:[ MBV/'M;U9`E4S"TK']MV0.&+N,QPK')"8**3G^)20$NWN4>K8=8_Z@DL^4>@> M11U,2TTRI",GD!:+=FD$?IF7Z0RN=FRS=Q=U."O3>H<],9&R;,UM`?H6G'X#0[TJ M=?L>FT1.[P:3?$45*&'=`X+&(_D%,(48SVN2J#[W$W0_0[ M^`''*]U]EQ+'W:<7@CLT<$1:!(B>F8D27UXGW(G?P9Q-,#%5!DJZ4ZDC&O]= MV684ZK;E\*YLM[UMV,3*DF?W1+%>A?L/EN@=/(OW"63%\A;UKD*_J]#>6U^A M5^7RQ=?E12F&*JT;$MMKF\X[6MEX3RAC`S5GY*8TO;>$#6C\S210*:D`XD2+N&\:(9+:6L\]/[* MGC8;^AQB*X?$:H^/[?"Z'LZ.&SD9(U5@SK09HW5-X*S,UJ^D1$&WUV%6TT*= MF5O-B&:*HL,M5UF;V)S+P>2Y:C"86Q,Z&P3]$%BY"<=^S1K..YB1L;:[]5'F M%N.%BW21#/&8I#[2>B_[J&:+T5';:S76&A[R<=+V)G!4ALZ%8JNU'N_*J8E+\@58IA_#]31>\G<`6Q/M8>\.%V6&"D M,Z7M<:%"#E4H":G?%]`XF-H!T0)7O#`-005WU.:_((?ZO\TY2\.D-9PDU0$- MD*"P'ZE0$+(/994FRE)")J(*X,K%BC\@A84-=`YMZ;_=0"*%N MJDE:!@SN9/RY[VD&C0+=Y!3SS:ED^=YK<^"?[GQL,H-2;ATV#4UF_US$O#U8 M[*IVO5F>[;U%1?3$HLVJ9UD!S`I;02M-^]<4X9Q;K:U82QJO-3+AP(O+&L-@ MWA`E<)&$]!_8_ZCPF?W@H3?4(3^`VHK@^X4F!F$#47W)-AY(%T@[.(+&R0[: M8-*DK&G3UDE;+=NL+[C3S?F>,+:6["S^/J>Q\^;,9>?DXD4:.[6P8VL[MM+4 MX-F3*0I#D^P@8QQCOI05/V;QT7UP]`Y\-I@Q)4TPP:&PO&UX.>IKEK?RU[3W->W]]-"ZF/2V,3&]M.KYGS7NO5MC[[N[7O[H-HU?' M^O1L69$&(KQPWGN.HNU-OQ^NGBW7#"_]K>7!)QL_<,T(W@9/_7`;6.8ZQ$&N MTQ\-!E=]U[2]7B+AQEV)"''-X/-N>['RW:T9V4O;L:/76%9/KF*I,=ORF)=^U5X(?^)KH$<7U_L[%75AGEK#_K@Z2[6V_G&FX4:BM_ MYT7SWB@_I"6?O%_/>U<]+3%YX:\!Q._^L_.C;W^3_'KSAS=O!O_ZYMM__&"M M__GC[\N?_?A-KY^I(3+!!_4R+P>U8N'C1'(_M>#N=N-[Q)`)T(1LW7SV_*^> M@9]!,(!Y^+6[V_`G[8OIP)$APEOYCA]H$7@9[(N/>*9K)=]8F(Z]#&S\VL9T M;>U@3^GB),33VC=>"R6RA3]./6*VOAHNU:H?;2^:C_XKNDA ML712B[_-S,E,X'4CG@D!^2JJHJO:V4>14^XCCJ5^1U-#/B](>VQ:1NQN'HP%@^Q7H),%`5'J&$LKCL0^G`_6\A'NIC-9`L= M&?`C6>C;"?Y(%FK`?PMIG*:U19<%,I>G138N.P>7U[/9;#J\FDZG,WT\U/68 MY&4:T;:WMEXL7(E*HZF,8`((9N/I[&H$0`;Z-%9U4@1C`'`]F4PGP]E(A__C M8ML]`MF)0@4>35>^?0E5/XT4V`32+%7"0)%7B4(%'GU6G(% MOE;N58)`D5<)`D5>C?MLB;D*FZN*/2#]9P9BH[W3*\@G5;Z8#+_O9B.QWS4@XTP4GM>:]Z-E>?09E MS$9*@C=1T96&O!+IV.'KU_K@6I^,KI)%E"35KK6V=V[9NEQW9:P`C(`%>$3'5(,B8,I^-0RH8;1S3 MUE:H+Z7+Z=@.6Y`LD>W\S7 M#X,!BI*!&9Z](ECLF1Q3Y06%$XL!5[NIJKT*P1&2>-USG2I>,Z,[A=,@O-G- M:6L"G<[*09FZWSNO'G;NT`B.^8"=6$1_%+?KBW7W!'UBJ*+RB*SUKP\(PY>(:I(!$\Q^C7.?J!)V$^CM$/^UZ53@1>E.J'X!+6 M+S,>\-*I-*C!!32HZ_#(1`"[&QD"<((*!'BI5\H!A*<*!+!JS!!`@!8(`$Y- M5!R3!T-2S2`&"I6@ORN54&,R*QF5'5K)*[^@O\9*@RF_1]%,ZBT$>D$SO*D! M<)1*7HE556*(VR'3"@K@30T%!LRZ,595(`D%5A22>&'=<(OMT MVS391"7[IT-H8OE[H>"A;/V_[ZR73>-.*IR*;AR>+)^2I2,X(UY,D;4T_G6= MF6V>:L]^8/\$JTS\*[L5[*9:00__*C.R5_3(U\#U3?NS&M98"7JV-WMQ@AI!($AJ1H#[C"I MQH#^3C%(#T-):0JS9`91.#IEAPNA"3OZIF*8Q*P!Q&+Q.39AB')<52E3+FPX MMW`?49BD6UX5G8UE@[AB!(Y5Y@KIRH]F`[H7J6QT!@@W+=FYAHBU"AQ!\"CT2>=KO:.Y.1%/3*1M!`*/%'^."A9]Y9G-A&<;/H>-/L= M:07#]6%&J("]1SZXB*U#9T8^L)PMHV@*LE;`EU@C5)3ZKN$USI6$*CQQ\4M? MVVH[BTO9V?2UZ-_TLC%X6=-*<&MXJQ`25LM1[;QV\85 ME(VN"U_2BM3L>+18/5#<4KQ(B90)M.ME3ADW=?^!C+*1,"Q-Y&QF'-@O49R- M:QW>I',VZV[J9^D!*=I.8EU-]ZZY>#J9L)$VD;NU$#SXTB4;%8` M9K8Q%(')ILHI0#/4GN%2@A.R#5S7%2"IK`K!:THIUNMGL#*3$+N=6D%8QY=5 MG6DYE(41R9EX2ARR,=D)&MKU=)TAAW23=-(Y=WS@OV5\8B/](SBVF+/.Y):4 M5J'$.[O1$$E)H:8GFY+](OE=&(="+" M&"4ZM>N2<$#,C9#AJOGET*1L51%XJYI3*.=F6WEF98MAIY'#"7@VS0UAJ)[0/;P0/&Q8L(%[;GA;T2O4!8AO7,7WUZ\] M/T_KPQ[/K8!W6BXX<0R'ET?W=G3B.YI83EUC@)[W1,[O[?'RU3/).P[->_%; MJA/G.WU([T\.B^KFZ\4I4);N5M5"G#0Y9?O#V!)JV%`^:53/_MJ&0EOTV`7,.5S"?T./DK$DIH M$UYUO5*+D]FT:C49)&61V*:DMF%;"CC:\PG/`3^[\&C3.IU'3'`H9DH:O&$K MFDC^"75[%76M*`/?W%"@ MCC]8N9*U*+\E:>""]1R7&3K)BV]7-F^04-R`=*EH7Y4#%$\%Y76'%VQE?XMD MS$$Y(MQ>B0$OK6=^`0Y_7EAYNXM6E0&C)CWKVS"MLE.4XEP[=H^'!2>)CZX+?:A?9V MA0F83Y#(UW)G._"`'KS*!^^KL]J%\!R*^^1@>B.4.EEY!N(&-Y4%(=165G[> M883W6B*XH&-M*RL_!3X&:XDLN.UW:UGY^9LQW@FKP*7#/4':XH(AR7IES'(_ M$>1>K_)C?,^X`A>:+(*+RBK\",P1&]'DMK(*/X+CJ"PPN:VLPH^`D,C204E; M684?P0M4%H1;6UFY'W5P')$U$>3^JM*/;*SB#9Y$<%%9A1_96!T+QBJ55?B1 MC54TN2VNPH\@E?"EPP=M915^9.N$+E@GJ(V%'UGN)X+<[U=4-N)'@A&?2"E\ M!Z\(1S@%BW"42"F\QD;Y6##*$RF%O]CXU@7C.Y%2>`KD$8MT^$#W.=55TV8'">$8&Q,)W5SC'QF0N9(-SK)P;AGS`*27JV5I^U!3R/(A?$ MY@-.HR*"'EZVCNF9D1^\:GC/LEPV]Z0! M+\D$Q\8PWBNJC9@\%UAZ\`[&;<3`Z`0-&W^XQ=Q&#(Q.Q+!%%?LG$3'OO>TN M]Q!;2W'J%A'QP?8^6VLV9@N3NGLQRK&HN"TC=/_KE^*)-C'OD0G/#8N? M=9.O!X"HM;4Q=T[TF'\X[Q6O_QP_L0Z"*?W6]_87/XI%S'O%ZP_X*$#(8MA5 M@G+S(83'R\%O;1?8\]Y_'^ZO9^\>C-'%='`_O=#'UN1B-KE_=S'1%_?OWAFS MP6BP^!]0YCI>>/,RU.>]YRC:WO3[X>K9V7U MPVT`125\MJS(=?JCP6#6G_5=,WZX%PBY"1WX5I`:FX+_5!R;]\B;!'[\_"^` M#??>R8SHA_A@H$^HY.[_````__\#`%!+`P04``8`"````"$`+(_8H2!8```\ M&@$`%````'AL+W-H87)E9%-T&UL[)W;?I5-9_FPEP]&P^*/7]T5TZ_^Y8?_^3^^GTYG&>\. MIW_\ZF8V&W_WZ-&T>U/#.UEYW#K,'#[]_-/OA^T=ZQ5_;WLE>C8:S MFRGO](I>_>?3[FPSV]U>SW:VMG?K/_XI'VYF6\_LQ\?U'UOC"6]N+7_S,\#6 MY_JF_B#L[[RX[D]GDYQ=G^2W17W4-\^/3K/S]HOV>?ODH)T=MYZ?GK@`2)_D`Y/6*#]F_%G?U<=]L\7]/GNWL/]ZN_U3NZ^)NW`1G M>VOC7U>^<59,^B-1KI<=YK/&RRUHVS/ZOACDU_59OKG*!]/&.P?SR83-9"_Z MTRX;^J7()ROG_V9C`_!V&SL*2/FY&`PV?AV.W@^S3I%/8?->=C2=SHM)`Y23 M4?U1F..GT6`^G.63.P`:($TKAD6HSXOQ:#)#QK+.+)_-&\._^:5H/`LKV?S9 M`6B\'DV:]&MUNP4`\'//05D!R=G\K,1MU?U[/. M33XIIMGI?&;J`-CKKY4,DM+D!:+;V,HWRR2N_GI@FN43O/BEOOK!Z4GG]/CH ML'71/LR>MXY;$HO.C^WV16>5?C@:9A=`L&70Z*;",[*1K4.AJ^X_TEO'"JG621Y5K3:=%\/!JMPCVF\[HLVCKSEPYP2]Z$W!;N^?2>`\U/]MTB6 MXZ/6\Z/CHPO4?X/E2DXZR^_$1O4Y^'TRAP4Z^2"?])%Q65D)?W\JKV":?>8] M6">\U/Z`Z9\V59?OOW.#SLLNBLDME(?Q0;>,]XK9SXMWH\$[J#2\WK#U#HO+AMPKE+R"*[WKIENK[[OS8.F__>'I\V#[O?&,ZX>*7QK;/)E'_ MF)7)'FQN;T'J2?93/I@7?\A:\QE,T_\;W+F]OK^_S_\_R:9FB=:S_K`[F,M1 MS7;7\5K"U=^XE_/MEZLK[[="?+9QF>Z>@2 MW1V=4QO2?+ZSGF&2L5*S_KMBT/`%6KV>21@\?I;W>QN8N\!F]?V=%S.\<9#< MSB=#$-K0CD[W922M3Q4XI%)'9A*^Y,U[#3@\4>#)%[,^WM[#50:]1N?UBDK9 M6G^8]48#--PT&X-:8Z*'=>@;$R0,V&2[S[#99RI'G2IGXPHTL MOMW8Q?V+_0:X4I9V!-6G_F>1]'G84\>OODL_[U>82/46&#N54#648=[0XCW4_OD]1*K+K=*>^RTSW\Z M.E@R(/6H3(&T;F7*_K;4Q6K?C@>CNZ+`VW1_;)4I/R_R:R31G83C_#+KS,?C M`=JV#GSP/D>D"5PCO^MWFZ-<7=3W4I_KY?EIIY/A!KXX8L\G)5(:XXHAH<_` M=]N[[0\M@I9VS.)^&B;(X7SY^3?KBSW/B69E;\/4]=]]:R_;)_#@L6G!UN&K MHY/-K/WGL_9)I]VIOQ"X]>2E`OC35^W&[^;:KOF/#\MI&CLZ&LX*[,)*P'S' M:T>D>6X+YG&GK;Y:.8N/J__LNW.W-6Y(GD?3(W=XL^?M%Z?G[;"U[*+UYR8" MSB:C=WB%^(2D=LA1"#X%)DVVD60L1U+U2X;P$P#BASD]:OG3"9ITWR=Q0E=[S5LR0I(#H^.7S/W?R0L"U.N@.8> M!;3,.*_2EQ$3M#\6DJ]`>C70ZEELO9S_JOH8*^\QP MXZ85Z'9W]CE@6BBEL&BIWO5QP>"*ZQ,GO+[Q^\;>!PLY@R!,]1E7H+QAO>(X M.5%APW4R-=Y9A8'[($T9"4LTGD^Z-X9"BTC%'8-F-N:+7KIOU;@[=[!+QFMD M=N*X>["P\IW:W+NK*''/W(UW[A'I@U;GQ^S%\>G/*QV?RMBT#BZ.?EJ1.>C] M91[R)=EL!$6ZHV&7_*;24%$_\]Q26::\R;)GEW?(EC*0BLQ:BDTL(&^8J3+U ME"KZ;.TYEOBJ/VNH4^ M9*2(*<(8_6P;EL>1`GA;YN@#03WO*IT_9@T2M8CPXAF(QFA1(+J6MCM!G='][F^AU39 MU7_KO#X[.[;HE8"A<_!C^_#U<5LPG9R>;-CF$Y8%VF5X;P#R,_G08F-T=27N M1"XJ]5=$\:G#4;+_-OGCP\_YHXUPY1HK:14:\.L(PD5$LINN?/D*+S>S- M/_[^?Q9&_>/O_W<]T\/SXR/[&Z],Q.81LC'.AW<\?9N]SZ?*0(XF5/*L@B%+ M0ZGFEL3=IX\[C]>S[6=/MS<_?_)@I;3Z MEL\<1#COLAF!G-AM6DPL@%[7V[?DZ7D7TTMQ;4:41%*+"03E->:'\`\+_3[[ M933Y-;LM9A!]A%Z'CCF_9@#^GI*G_K<^0YX-Y]J`:#EB.O)DU">+:7,;,)16 MS6$)M&UQ@X.K,'N`W=3+:@50JB[K]?/K(5Q#K5%;,9R%K.WE@-J*D5H2A>,_ MS`=WT_YT/?-?;`[,\-UZIL:"V6@PNKY+$`%*[!%9T+P'G?NWM_/A*)EF-OK0 M[_I;^%4Q6=R;S$$GQKE0JO,A",W'V?26`C(KSZAYS!'L'%MORZU=]D?C*?SR MT"!UI(11$6!AYV?3!FI)R+IR5"=9]VXV(E6BE&5)1=S`T7R2#12_H#=RG"FS MMZ)>^$U]$6(%DB78Q^LXZ$Y#VH/;]\(9V4!59&^1SAEEZ_7LY)?U[(#CU[=6C0ONJK"Z/'OUOV[Q7@*/EQ^*$&E2WX,F<)Z!QG74^9)P"<`E5" M6T<)N#!T1G9F,R\H.Z(_55M^=PX%0*D#,7J_$-C$@U<@@$`6DP-O^X&4VM:L2? MW0%:L:L_1E10\7-'\&_")#=%/D![5D3>K&NR"^2U5"G_OA0Z<.!.4M?['0!O MHDKI%*_5MZ12!H]([5F)N'QA6ES+*=FDQ(U8-A5*.3"/A6:%G[A-D^S9TZ]- MA@F/T1OD0>'5W,K'ZVCX&2`^2JH&H1=Z]T;MP#?^/C&5W$BS4 MG$*#4-?X]#$6-L0F+521BY5LDX<-`?BH+337(JJ&H^&&$P"_]^TS M-V%T3&CI@Y)3M,T-8SFAO.2>J_X0I2@/PNR)>\NNDIVV)1,&W@EB81@2.MZC MC@=W&R@[V*C$!]N*'#1-=M]7`E1V"5N=E3,+V>JGFN8FJ]/L)@>WEYB!K!CT M21:+SQL(MMC6TP^+_1ILTWZ3NQ-:.&1>W1Z28^J9"!%K2I_?]*]O$-T!_6UX MD/VJ#2%S#POVL\*U$=+EAM8;=:XAD]:6\AX+FY4)$>TZT1YLI9<]V'ZR_FR/ M^B'[?+"SM[[]>%<2V97CJF?VQP*TLZ9`VDBZ],K(`R8%G(P>-E5?S*=;?31[/[7:#[+D*/^]*WV[8I; M6ZU6"()L7%=B(U4`TU".6(=E^N@B0)J+&&!"6,PBE/ZNDS^?X%T:`K1G0;]0B`$><:8E%LB42*^IRP_^F&U@4%!$GF8P M1:Q?Y?_!'4S)/I0"&.!GV?[U:U7_+36T[UM6:V(>)BR/?K/P;T<.W_:>ZV2! M5L7,_21FMHWD7BT2J603M-B@?V6I4_O;4K!0*7DQP?GL;BSW#YZ_DEMH1J"! MWPO;/'LKH^=@`5`=[.QJ@";->DEC4%9XK8(?/4O`=I:'-.*Y!]M/UY\\WEOG MC_WU+576)1G;NQ3>'YLNUC[N-4_6X.GO(1-TBE;H'C1U\2G)47JYQ+H3O+Z) M;0N7DE7,>KH0"(@(/KJI;(!:V"=3!/Q;UM@(PGQ0`J]1@;Q-&@PW3AES2M?% M>:^EDX.C`4 MM(#^2!'33VATN2E-+9IT4;4)'%#`,,4)V_%HR7MP^6]MJU3]O=%8;(^W8>KT M16E#6KYQ6;>.M29/>M/L^2B?D)TC2GO1ZCPG1'L(?T_F*,]/'^$1^LQH[V&Z M.9Z(TNR61UNJ\UA3`B)B(]AM;3\$DL8&IK@YEX@@[#&;,H7@R M=H--__'W?ROW+.J$FMO%"+'(=O>V'F87$FQV4`Z3^T7F"J2[WT82TN6.>L44 M*4/ZI%BN8T,:C\+84IN%[2Y@$;^-__2RO\YSQ8"&>7Q2@F`+_TJ5C+Y$\["B MG#LLKJ#N]BTL(MDFMZ]##QE-7J9CUPA^`S7A\7DCT@PBXF% M0QH^>S_:F,Z*\4KHW1B/D`?K1M3B)60LJB4([:9S-'J`3R8OCI-YTBYNSA:,.QS)>\4(J^41&%%176M`M$U=@4\L!)U'4A\Y(\>JF$,D\_5" M@RC[N0O[[\EY*7>/PI2._)56'#T>VFKVNU"@*?[Q]W]'_6,A[C2IKP3:8LQN M+\G;20!QMU+6DO\8+<4=@F\5G=SC1PZ6P0-3`QMJS!*EK&UR"WR`SK]RA[]_ MHRB3-6P*`VMOZVO?:QTMOWU/HM;)2(8C\J_I*254B*-&>+'J]T)3"6V_13\O M-3"7H:QHAP]8P*R*Y6"0MU+X4DV\H'EE1W;6']/Q!7C\HQ'"F*!\@?/MX/\#Q9?RI/?#G'^)@E+),=5JEE?MXM60LGRDXYF#`L6LD> M\82TVGNE>6%0]!:.0`-K#=%0?C`Q@M!\2&&)]*64?SU1<1#"&%*/<(N@$)WG M,A-5$(7L#B"16RGIUI&=T"DMAB/BH7-4^VMNRH-=%-`<#0AKG?&#%&S'\ZT9 M51;E.F@E7&A.B_*`T.*EA1,@FB4@US&=RZ]2G,YN9S<,G[O;$SG) M*)HK(B4[1\0N/8TVX(5D*M/ZRZ+Z!J.U2()9&F5AK1'^A-CVGUM,$D;V!5L& M@7!!PL9Q;&25WZ.-K(!MD5_*;Z'E#'&_.!V:X#1&XT`K+&)X"MFY@8;M5 M8`^LAR_I!8F7$[GS\"'E<9$C^=V84#OB565SB?SL46O1OV^'_GQY`>]'P-=5VU)EMD^O$!`&+T"&NF7*" MS;DOW:UY'$8A$"I>S2UE%G@S0!,E+5;Y-;V1%^23O6,5$<`IHE=2S(D_2F$( MCO^"@_BDR:Y58""(`H[K"C%JAXEK!S@&[0&KE&4=#[($EH5K99H!SS#X_=-0 MT($%8F5B=='$1)S-Q)))+)3(7L#EH7!B--'*"R4'$DG7GF"=;I9J;0'PQ.M" M;$0OL_#V1QU:VZA[]FQ.ND]/2B+X^[C1E3L"./Q.\/$W2U`'P]%`?`.EEP4$ M$%;3IL!+O/X>39>.\21$(,/*"M*=UR8F`;VL''+5`@.QQRJ1;NG.B(:"=C"+ M9SNAZ<.[*^C1Y"TP88K+8QMA`QD>HQ_ZUB81E%Z M.;]CJ<@:GIZ>H`C]+_P"DRBS*G2]29,/L7)FH0RI%EXZS&1J?+1DJ;0-!73T M*@8Q"QYFT![1X[S-_T(E%4!`:\G-869K`UJLPQS'&@3!6"R^*EP/=5;J:ZQA M.#0+K#P9B2=PXH*;@Z;ZWB,Q-]%+630Y6<"06N$9C$I=)"@`.;UHA0+0 MR:_]Y'2QF!PJ>8W"9CU+TJ8E-V%TFG)4%*]&#_3N#2N6*L&;<\1\<&38>A5E2QV0[ MP:>X4\)3W_>T*'[E-6]PJ5)/*2E\WZXL)K=@19"/X'`Q4IFH3-]PQI6V?3JJ_XRGLQ3PN&]MR6$3CHPO*19E:R5%I$,>FN27493T/`JW7:9O2TUD MLH3KP8DS@E(D!1HAK$J(@PBE*B!>J!C(EQAP5)O5NP6=)_PH8/XR[UEU+W@Z MP<9!O=Y4Y!/,,J9XZAML:@3QC/0OM",QHD>V_A9RN]= MGZ!!-C:F39S``MRJ%>#=LOPA!S6`D*DEKNWH/_#JE&\>4AEZ+HG>O:C?T&1B:+%HIN0GFK!`:Z%@B MV4FX1L4"3WT93YO'1L:$DKC4`:\[OH!H/@9'%W48RH`@P9=\GMNH-`UQB>!'608`=8X-9S!ZQ>0QMH)AFG[)HY/$H244$QU59'9C3PD0+:@>5N M><&0%K@;BH6A/'5'P(@#6DK?`NV+5^.1A`TAU+`HF]`/-A[271>S':$$7\#/ M;'3TWCW_Y%4G/;.O<%+X1?4CV(\EW7%R]\7MF?M.\*IDPG6&V!`1]AJ*9+C* ML31)KM9)68O&!HF[+ M(#0:UJ(C\ZCT8\[<*:D#0<`=\NKP*GK^S+RB,WE%TV_K@^W@@@K5I?>W$J+Z MJ_5M6H@!IG_79"OR"ZO2"]\V-G*"'WL>G-HZI&>4O27"=>!*,5BO\&Z*L`[- MV8*S'4,OV'B4.5R.]Y5NLSSEEPS`R%[A9Z\U!]G@::OOT6VHT]B1"4@^711+&([1CH MHB!1`JA!CW*KHL6E@J*8AV!/.;JJ-^]ZBXF*@^.0P\*;4,\@^L*42+:V+`8J M><-V4X9`#]5L,)VKF03B+Y95FE'SS^I.4/-GV1T#W+(/J+)22Z_'*"$"Q-9^ M0U!FVC::!)\5[IA;OFR%.D7;R\I$*V]^:2G_I95URUT7A<#IJP23/8R7TS&& MJ#%>LO_M2EV#2*M8R52OHI%;U_F8(>:@$'.YT^90NILB^]U8QLQUPA9CU&%B M$'BE#.#,56E,$/8C.9#+O^+M^L8;TR3)>^<`>7&A_[S&D;AO54=(?H4;GLWR M7[4[$MB80A='0T1(IPF'P3D4%DU.`WLK##)G@%5C$4G4CYEJ7`XU#E']DXH4 M6I71D\_9\!8>E6*@]98RUQ\J`BC^J-+@;NU!8MDVH>17N1Z"[LF5)&&(*\Y6 M"Z_6I-0),`D-P(9-XW:^JCK7%.3R`VZZN$U[+Z4[V5*"G^4X MD8Z^I"<*M9$J*3,#*!_Z;(%4N6&2FTG#,#K5SMDX4@>ZOVK@:79P3"RF0JMR M"W(-^^34A5NF,Z=12IY>9BLH>Y$)34Q^TO!J,FQM`^)G$9%DM_K1T=RE"HAN M`T]"F.S^G`A<]ON5>1F+LFA>P1T8!1UB+4I3,ICB/P--!Y%(G"@DVU073T%0 MRV\FG(*)CK%0-0B[XQ(>,1.;K'Q$WPW""6=#3^%6[PH)P50GF%KRFJ7K57[3 M6R&1S]M"CN0Y1G2T"%3M?[WJ[)'XP9LU+1%98DEP1`,6UK#F4(K M7#I8PE#5,)Y)24A$3=VO`ZVEI""[:E1>ZJ[)D5G5JD-)B$65HW+_B

SR^7IO#_`66:M(9@J8R[REMQ+WV=>"90K M3.8/JCS)*85@[#\U&?>'&#FZ(52.01I5`O7[,UW<\H"G(VT2'`:Z!`K",&2] MS,X1[,%;_S\=)A80)LHDF#2R7Y36];3H9K#"9;3N%LG9:D$YPU[>F^RX38QS M#,9])=I/,"'.GCCS(&%S03VD$;BFK,R[(GC90[)5YO:8 M.?'$);*TU/*[EM&+P1'!QS5#))Z1W<5Q\UAFB)`WH\'ZUD#$:AK%'Q MKD,#1I*4@YB>Y&""(/->&(M)]26#FJ\V8Z^DUO&D;+F-V.&$6F2UGNHIJBE$XN&<;F8OW$D0(X6M(>\Q&-1K@@/#98#8A%*Q M.NE+9E^WO\79DKWA#GD:\5(^#G9.F30:>#?+'H.X@NPOE0[;38P+P'AY(*4T M3BPDRU>J]TH))DE2PTGPG-VGEB^O^D]4X4S1*X9Z`BF7U%4\L95N.?CF8'NH M6UTYUC4?ZO04AYRZ`"5FCKUXO%Q5_#$HEIX'!17W(BR(Q7":R(M,4%G72G"I MNV:ZP&BA@2<)$[#D?%2OF>!_AFK@AB-WW/(CH6$WO%-,K)=!3CF`75%%9%LZ M#Z#L?2ORP'G)?`H[]&ITU+VO#'*%6%:_N2!HHAA\B&RI.N#X6>FP-%BVD1([ M2!1)<'4>'<8$6MV]^:S_XZFP5E1(]?:=)[I)@ M3D)IV&2GL)QW`JK5EJ=^,D=-4AQ)4BCE`;[-Q1L90JD64%?`$ MF1W#LN?I:EY7D?<,)=1F`G)YSU232;OEAZ2H(D-J@#AU;B%,F=.'?)ZJ$+%R M$MC2ZVYV<]WSU(W>O5Z.,31SN3.OA^GVA`0%*3'[D7L($2%S+#:P?Y'P68A^ MLI>MUEEVS>$9*XN$ZI[\#FS`2-H\%'^%++O($RL3FELIWU\67<7@'L%@KI4J M>)VT5R_IFU907S*YH@UW!C2/]35VU[A-+9FJ4+U&5K0ZP#]Z%\6]=ZWD"!UD+[L&[Q(;<#2[*E M\EGS#Z9L_+9$B9]V&.7'!8?@E=?3I+ZUK9>R5/]EUS8=Y5W=UJF<+=\X&Y4# M(V/4H&K9*'2&SVZ-0AP=>LYAGR[MIW[KH/40*0(O[%1V^ZQ#L\];)@P]NV(O MYU\A)LA@/O.+.B)C>B^K3<(@14G@B-):]U>3(L?@.SJD*.#&7S4:\:JN-FX> M\A="#_LZ$@A:JV6\SMDM<]?`\*P#A4""L^*$&.'78+Q,XMR0)NI@4YIWC\&$#C ME,*5MBLYY!EGE4(6YVH!`YB\Q6QLU:=,"3&GU80ZM.'="\HQRX#"G-^";MNR MFE5QE/R*BM%EN(9R"?#*^[#S$GT)\-[)=HF7I3HZ&XD'PQ9VE'EK4L:A/Z.] MGRYC<67(P89PE6)@.0O@<"C%ACJU'>B\O9KRJE/S%8#.5)).9JX&&'\3-<_M M;B/CVG*[%28VT)(YNS6LG5:#N;%<"B*"_:%TVNH(L^6TC$;R>ZTW=[ MJZ$E7HM1N=F%BH]LNJ[G$AN.42JT5%KZD)^7-9YJ5F#&PN*ZA080[\)38(^K MK2,[Q'CNT4E$0[^>DM-EXVAR#!A&LMZ%6#UP6VCHL?[9R,'!I@&E:SXM$IJC M`97Q,@`RHZG!CE%HU7@,[&1%@=A(L/0=;!VK],!+9-BEB-#<&K@,G#(;J$&Q M'I"RNK]DZ+$84]1O>;N<:Q:I'B4?0\=-X%VQ78FH!E7/<;0D=L16HHW6/JI. M?X"EHZK+OU4AS*N'=J/.L162PF]U9S0>9A!%X!4$TF[D3@Z8L(1\3;7U8H)5 MDPIT\>2SO19+G^9GO>`,&1MED[@\QG81\8:20M^#W M=]%TU[H@`S"=[SPKD7CSV9'_5*ZW,&MS5>D+._8L1\DF+4]-50Y`,(7(%S$G MP43%47:>R!1U60F2YRW@*O=TP?F.O$L2HSH$IMTN65?3&!Y%^R\^R)0>X5AU M'4+MO&E#CEI*Q<^X(A/M=6#'>C;21WX:1[@+D@VQ5)C%4U),9YI\R7A35A`7 M5L''GW!IBE0O2O,!]U-SF[4.0.WN[QOQ^7-K9]^R$$+#?:XED9G.N-AKBMH^ M=WJ6^3@`Z=&@)#PY#*-EC'J5E,64G9]QA?,>\`T9Y,!#2@I7=LV_C`)3\?$2@O`Y.<;[-4>D.G2A$K\6CVVC] MTLIHU?I.BJ6N^&Y]AUX\UWF[*Y:2=''.:6O?SSEIG^4=/QTU`"VIIDHYM"DFL&K5O8BJQ75Q0@??J M=S.$$JL*3X9?#]9-^@2G_EANN.#'#&:;_G/%?T[_IN"8?2-KZ MZM$/WY.A1MO5D\@+S[4,NR"0Y;U8W8MD\^V?!?ZA"^>?RVZ>34!R6S!/=$ MNOP^2E??NDJH;'IWMS[YS]945?0V6G))KI=]!20BJ?XJR/CT<715?UR!^^EC M2UY;?4#+KY`P_^G31^)^.B[J8V3&ZL_2]^J_'219-N M',TV9J,-*79:3.KCSM!#&B4+?PQ++OMHR7*&JN.Y<>/K!=JM\B;P5C#8?N=Z MM,HH]+)L@Q-5.]XJ1\5R&,&;LOLSK'I`QAB[O^!'"'[9S<(SY&@"WJJ#N&OM MNW4E4;$.$(<)ZFAZL_RCU8;E+.2-+I<#<)1 ME(=L$$%)^-3+4&$A27D+B_DT%6,63\"J_HW`7SPA)(6.&0U.3_+[@H2N!:YG#WCOO9V>R2RO)Z*`WWK-'EMRN[%V$ MBWNA<8-[/NPB.,/&)?BW&$/!AR6'E5L2_.TYW314^?#6?$EEZ0(,8ZZ+4.MF M>19`!3R#QKSWO/I82?6*M[.BK$ITW#LJW$NBG2Z!D:L?)W;.P,6>075PDQ$3 MG3:6KV"Q[HTZJ:QN*B0%#M&6 M6DMN8%IL]%'>U\OX01B19'`Y+DAX*!P]AVY`?,F?'5H^'?:61HZ,Z@,HE+`RCSB<'2'=?9GYP$L@<[^^O;N\_LG0=;D<42'OA, M!+=X]?$*"_%F_VWMCN05`]N65U.F?*E5XV-).N!-(K1K.7E=)G:ERVIE4QH* ML]*1R@^*?T4X88%`,#0V) M4B0Z_'.VIJ5TP&G=&V+\*B&<4;S=\.FS`VZ/W7QH4N3W^TE.+=@3:`D,>?*2 M)6PY.)8\-S`_Q).8%RQ8[13IH(V4 M)@$.G7F3@*6B^0=U:Q6#1(TMW"BC0)E3,(DC$H1A MIQ';XJTD-_9N;9/J2`4CAJ(42O`JDVW99I-)\-DP>2]S>W=[ZV MNI:@ORT3)\%*2-G4;DV.NLH6@0[1&Q(N=7SK;N/*&L,7\&JV=#!P_=2M[I$` M#7S(=LZ-3-QB!5KEDVG%!_O;8#32T1+VFDN5:5N,4T=D(!!_!)Q$#LL+#WP81A9*DRV'87=PQS5LFKQ^O; M^[L-FI_%0_J)Y(N4_[4N-SF4[VL?*SX/0<&9G6*ZP`&)%U761[YY(J_<0XCF MZ.S-"54<-&N68GJWTWA>O-4$2^\N.(3/@`A;]@^*.'AN!C3LU#6*V+:5I:97G$M M7J6347FQL<(=U]>;G4WR6SVY)G8:CKP!"DJI;!-*M*HX,-A/\UW+7H!T21LL MSV!UL&1+O0A+*>_F2YWC%]71[%DY"S%':F"YT)>,"%P\M;`P$3]EX<,7]5D( MF\DBX=`DJ6L@1%"M/%(?OK:S^>1I_>'#QO&LM:W-QX_KPWCXK/$P%'^6;5`D M++TD4VT5^7">=0)208CA'D).R^M@\1F77_JH4?$LF"A6-E(U6Z*\2ZGQ/)"F MOC6C14P\'8L<]1&QMZE6(Y_2^$#)VL[Z]M/&L+7'ZSL[C:+K_M#'6DA>ULTOW2>.R2,28#%FO^8L*2;@G'B[& M\0TMK["O.182X9HU?PP"=KD]#89]P%4WR1K MZFK)(AC=THN_;6?]Y9M(4J,5GV07\N:_](TE MXU3]6`++X8*!-+PW&,'SLJDE,@/HK>=-@;H,O68PL*YVWGIL'Y,(#2BA(\KE M,!E9$SXNOGW"?;_H8'EOU>UD)D`8TX1H+&4YF`8H* M)-XHY3T@%OM,YZH_^%T]"T(A.&(%W++4F.FJO"4)]1)6,H$W&1*=QCB)0(K- MAD-S-/X!Z+(+.)E+T4R5PNDUE6@\!N7[CI<+(%)S]@@[N))KZ%XSGOA`H"5@ MC(1G,(! M_J^:(?W!?W.-\P(\[4W?ZWAG90X2)J'78*@@C(R)M-8E[6MR9Q24VL^ZJ9>A>D<. M1UQ7\]I=1NGD7EY0EXME;W`/"&F077)0R#;'0DG->Q_(DBU!SH<\,_) M!<(@K.Q?*C"5*PUB7]7,ZEMQZ,,*PFDK2!DD?7$,23M4: M6%X+OOQ>\*'?5*JL*:I4Z:Y+N_O;=@$&[&IKB9X9'&7>\\#SY^4G)>4:7T]R M:D:!\02IY)H$A7=F&LMQE`EVI.MBX:/NPI>67:!S4(7*@]'>76R@;57Z@++Z M_(QR1/"J?#6ME#:?PIC*G6EQ5Y+J#M*@)A]"_N!H:/0]7L:.31?EJ]I3+]MY M2LYJ;\M9"Q0!&>$TIS?8$^FL[6>[8C+(4.5EN-2V&060SF*#2@_^!BKHA@C7 M/E]`B;#]>WZM`_P\F0K3Q=:P;/EIF#AL_+?KN*9JYF7A_ M:P66::':W1*6:5N(UQ'`9WD4'TI8E\2(:`SY,2Y=,=BN?00A MY*#IGGNL-+;]K[?4A3]-!QMW:I74"G73HP^R)H5]X]UJ(_Q+WB(GA:1HIA%; M;SKTB)U8:S9NOPU*CD_XM<&DY?TJK6I*7I+=7#+CVZ6FLQV;Q,EM^5&0>FCW M9GL+XGYVV`5;9IOI"04JLIPH$3C>D1J97F4?A2=GVV!APV*08A[N&S\!!'QQ1QR0F$^L]%POIJ*\:&->NCW<@$ MP(T;XF[J(]]L\SG)+QUN>B=^+ER@R_,W5IHW7D*B0>5'TU=@(3OC8^[9 M&RW.%:_VAI[H/)Y!@/I+SFE1.1^QC#T`M#FPH4G MEOC+$3>V$(E1>PO+6GIT[D?H;I/0,%2&%V:NK:FG4JCP\5@M_5%?I.>B*N`M M`:ZF&_.#!'\\G*,<9M?<2%#AN_"]F=.DZHOTB'GYI`.&5&TNZUWO5VI&#\ZB M!3027JT19\!X]01Y2[P+7Y2EBS8*[#W96 MT)(],N]"L']H0,?CO1'`-Q!YM\I]+/@>'>/+4R.(J8*RA&@"Q5>R]+$"=W?Y M8*%X/YS*?["]9;ZQOUMR\%*>%,CZ$*25*DF'&=S29Y$#(J-Y#T-D]4(?"X`F M7'03&25\ M#HO',?@-U!!+*,/@2*C4Z$.E/)4G\#,4)`.41M!WJE-KS*>M;H9 M=Z]Y^Q\\\M@"LVQG=WV/J%-S/MXR:[;"+$8?OEJ@TO0&0=RU^0;)!F%A.;;B MDM2UQ5`L"63J9;X$8#[(IY-%O,3_+D<"%-+!'5]L"0B?6W]IZ'$TS%KS:PR. M^3JUAI\%GV@Q`-^3R1#$XK5$3U=))O])@[[0-W*_:,O4H_E%T2OR1Q4?1V$Q MKI"$2"FXX6^Z1M7M%I5HDY/[,O\(,U49&%99YA4)`4$#F$KKIF&FI9-<4*33 MJR-\:'4SZ691&DZ-HC)/)K*HAM0GU3-S;_C=T"`U]SF/1CG?IB09AR50Y2';ANFJBXI;W):H_$ M/E*1NK;3L)&+ROU'2V'.39CP^LX3;;]%W0<[^D_1="J[GS5SI+U7X_ZRNJYD&A,.M?9FL M65#T8>/F)55,&D4E<96U`=D5UG6!&23K MI.%"=XUU/*IT,(G`-@72*U86:$8,2E%#"RNSS4G"_\E*5BK-"?.B:F1S+@2ECHF[D&5%HIC" M/&ZM?JM)Y^5Y;Z!:>`!;^61+2L!.35>"WR"+V,L40PQ1EFXK+6CL93:2>,GY M7S6'U.Q&YYSR[;#E8^VC_H2461O%"K^CX@2WI/*[G0VKF=DO4EXQD5("$?,4 M=]8?G1^%3#P"S%C>8;AH.;7*1R?*4W`EB"TT*XU:."$FM]B_'&#R)7L&*/=` ML>V4KJJ1E"Q)+`KFBU1SJ75)PS_)9&868#Z.=493.),2RU"*W3.;K))^MI@= MXTG=*/NR`G4TL9A/JTF$533?^UDFOZ2C60B=GNP&`Q0^2`T2W=7,1 M4*[IT4HB6%1B=KFZ4BXXHDYV9J$8Y-V7*\9W>ZFNDS7G0V4?!).=D0/E29W= M3`4WTX4SV+12-9B^-C:"3=N4&E);2I5E4IU4B+RS?%:K;3$X3$;+"D@^#2D9 M\JPO8TY,&`WO&'H+.5K7M>6XG_*S(``9YL=2HJ2;<7=; M?YJ&)EE=C1(15##C+W-7S.B*A,X*;(A.J;:"Y9Y[7:_._8H=%/?Y9GG=>GRO M+6]NDX`@8*/ZS?IP*]F.9[`BA2S99_PQJ_;03O(#AHC72.(>0`@UZ>Q<->Z' M2G:P>B/[(>>]>GH$LY+7[>^*3121^!!(J8/>42A[7MX)&!H(;6)8BML@`X)* MG^7+GX:4&GG6%U.`E%1*N3!U^I1/N`/BE%?U^>Q"A=Q4Y5=/F@HU?DQ9OH*# M?`)GXT[1/LW2_Z17-KTP$6\Y22 M2DL[.`>.9<[L3A`I[=-N\U%;M7S^4#[0O#P]G+O.;)P!Q#%Q$^))T7?^V0B\PN;3!01,XUD/-^$'8#> M&%`I2ZW-.HACGQW9I&.[X6&SM`"SL?UM6DBVI9`1P(4L;"YO;:X!?#A4UM:` M0J.76\MKF]LO`ND"9DL:\Q[D=\=>^>33D)(Q_8\13!`)`#\K(D^(K!K+`&&Q M;9@;TZ-$@JS'*5C)4/9(KLO3/\^1)WA?S-,Z(&J?3[?IGZDB*<70SL;_M#J* M8V@M8,_7[=0.Q?PVH<_F?V!1,2#;I)Y;?!DF4\S;%L<\(TWN@">+:'+! MH"0F@Z"`=LA0E5RRCUR%N'A1:7F?AA10Z'V:D_)8HD*Y=$VSNRS;AZ1QGT-G M0JT_N:Z@M[J@Y`5*>A@T,Y;X9U6,`D>R[RPX6G2<B@7,5^L!K%`S;Q0([99? MWYC-6=W,2=9GZ7@\H3NR%OB10WD0NQ)7K)&"C.UG?^=!KJ1RH+8HMLGU/0.< M76S"'+^F)UYN5]4Z_^"@LRX=T@Y&8E@;'"Q_]!Z8;%+U">S>7'4W\,+J<'GU M3<$T36\AE@:#`&>MD_:ZK$8[2/^ZHYX&:9QX!H`O*1D-Z@%@Y%Y87H/JP8^) M+3#&"R@%:`3X!?*?/:<;7<)@$KTM-('PV^0V4DT]OQG"CULW(Z!I7PR)CDH" MF`R.FZI/?_`]A04^"')*\TFFA*8B58HA0_Z"J7(P9)6H>KA5M,KZ+I-30BWU MACC?8Y@`7@W/4?NL6JE.F"YL8K[2F$4O7?HL M*:FD`EPTLERHTG,&]OH!L-81ABB6*_"2C%ATR)AC,_O@U`J7;S\VZ_\^6JP1,Q0 M_(V0(4+VSH`7^K0H$I**R!`F,PKK8/>M%+[;B%'=GQ[YQ4E*U1.^@/N\0VW_[=6OEOPS@(FVC91+,DLXM3^KUQ[W-!!50PQNH)T7/WE:1H3CU$@F%+BGN2IEM8TX;+6^M;6J1# MX,(J:71@6\H]UR"JRV7K`5*T\[:% MN84H=C'QQ#KN)8SZXBNYN@$+'F[A4'$27'$O ME'6@1$-V,:9-55?CL0K$G)OAQ1C[$R9*G">N=(@!HQ`@(4R6N52"=L?GRM8` M$@W/H0[4)J\N]I3K:0)VQ/^);53G"<`!)Q.?3G@!-IM;5!`,O"-"K;2RR5+U M^5#_).-S15\%(M-K05NU(\+S;UT37E0KW=_?W5W*$%`.DU<4.7\<+&EK*ZK0.JFJ`YU*I$@ MXS.T`K1:M^7`4+@8>^7L9JU%!([Z\+I9>-!_MSP^0SU\V8,P-!/L)=$IIIKG<1REVK@"(V$XC=#1='` MV^O$_<(D98XV[_%P8WF5TB96*!`EX`$!->^8R2X6AFH5)T8B5%G@@[75-QKX M4$>$EACL9\'TH5$3092$)B6#8WND9`@J#6P)%HW$CI(F`'/1Y?H8)#D$SR& MRX/W[W?]IN+/X:Z2L!"S5N(V+,OI7E']LUC;]V=6"7AR_O3P91F>__`5M=M: M2XB<]-Y70?A6"51?S>]B88WHJ&]W!0ZA)5KI-'[[E5,J'QR1NZW2D:.>DD2I MH+VA4:QI7XY"*:ZUNA373BAW!*H;D+Y%$:6'7$4"E]:VU\H1#\C%G?01B:6- MNM+;$@G\Y2"IBM$ M5H,9X>'L4L;C:*2(/PESG:SSB\@NA?`>J$8OVG]Y=4YE8JQ5`G50UUJM"+\A M1R+;9;N9#&U:K6DDL.E]:],MRX23=/@U_02I<7Q.QT/B%<+/'*VM03KTD[=\ MBP36(M'+U$(1`C-A*^>M6;CDDF;-*?)!Z_B?)R"55"`O=F%DVL0("L)21Y=4 M+TL:1P=X4(*5U&I9QD1(Y>>P,`FS[WVVID/A,%!F@/X+K_2'Y01OI"E9P0"0 M%!`&U;F&S0XFU`#F6F+]D6S/)0SO>1J5-J`\LD1/S\GAT]J"XJT[I(,OZW3; M%[=KMB?=*%<<;O,6&\6]HHJ:)IGQL.RJVB?MO$=I<8A8JC+^$"IZ4KO&/*N6 MBV_VZ@,EY&_&5/K&%?8#9;$0T\"08,9'=KDMM_AIE4SZN=X\Y13BD5KU%#>` M_!_>%TF\GN`;XQQ7[#%FQ2 M??69WJW0!1N[#B1ZH>`!V, M$F^F/E]HG76'*C,?'4([%[#&&4EO08]]R50I$3%D"-E>LYFZX6',CTUD1:D9+];14I%.#?H]F*/)6:- M0F9.+-QJB5SE2Y]6*2\PUYLY^DWNT4C,1$P>WW#I)UI,X$5':%A1`*HHDU`] MI=?K'PAXEED?YS(6H*"V5@*0$1<39V5-#DU#'N6WTJ`.V<8TDL8IX+]`G;HA M#917HI%`M';BP6E"@2,1+8TKL[^,2=:S0*";[@"3JA534B81B"6/5B#8<"?- M$&-/X9DFB,?F3UJ5=@C#E1,XY>[+0@UTAGQ=B[F1IDJ_DJM;B*H$892%DE)H M<1?7=THZ93AK\&A.79HTL+VT6AT/SS6W@8"@VJA/.D&63]5W*_&6-6BP`8E5 M74F:1#ZDL\0TJ%"$W:*(Q!,A/`%6)KYBNT_T+NXRT+M7+>=).7W??IP8YVA- M1-7:AJ.LE!008[@\?.WMW=S&:;1O&P31`?!3J$$IPT#D8.9.NP`NOSBMT/9. M'F'=QB.!DT.NVY5L7W<`48OU]*YJ.NU8]/#SDYPDT1#H:=6,2,HU#>)U8CGH ME>BFCF@HXLZI;FEPEP/??^/Z4149V%+M69Y-S(DIY MQU-\KXA=4Z-W3CZ:7N:=`3C!`K675!T#XD*S112K^,YXH'P*^!`Q(EE53W[&8<?ML-QB=`M]KKQ1,YG@OA$QFT-.@QE]83D;-W0GGM07L4LWG(Z>* M'1*"9O#'>2$\C=*"?3MA[8/=`AK(&WZLERAQMQW1&FH.B6`@K&Z&*J(TF#U4 MI:XT^I.(8W][@M*IJ0.-S:+[:8^B0"4@?EHE5'3F5X-/'V_/"(-&=/Y'.<*. M_U[^?'J-8^&W7S\@ZER'*D/E*^^`A;,;KT14/OO>VA4[,RF?%25V.&_9E\5Q MZCC'MUTU>GJ*\<3$NMD%BPRV;>AV):;J<)XQY$IJ6MTJ[E0->;+[PVCOX_O1 M8'^?F(J_[[S_N'.Z?W@PV#G8&_SMX\[[_7<_[A]\/]C9W3W\>'!Z4A[>V_W# ME>/1N]'QZ&!W-'B_\_;P>.?T\'A_="*[]<$NZ:L,=/+Q[.8" M!N\.CP>G/XP&/XYVCD\&HX.]T=[@!#[O[AKQ*86\2ZG)/T)3M+7 M)F#IO+)B+EW4/UW6/UW5/YU5/^V9G=J".LMUO?50#H+XR=,'8:OG5R0[2&11 M6SK>0CS"^='17,ZY$F/<_?;K+E4..],"^HP^>UY''%&,C_.19*8PTENN*U%/ M.#)EK`I!+`=*"S+"79'S\O4ERA8.-ZNT3"K; MO]E$9%[K>K*Y@5VUMN=,666=_+5%U.)Z_3-M9S>(IMVLX)8%K:]3;K_.5)TR M;3W*&]2!-Y6Y#"O>UN:;Y3?#>K?#Y>UU1*;-*B\QRS#+X[PR_G]$\P.%:P^6 MXE\50ARYF9RB">)JNU(!;G`\RCU17I0[0Y!YE?8CMTVW+V3732?R_/;VX4@6 MNVDO?713TB@8K";E>H[;G:XE-=(?%)->E`&KI9K.Z-N0%V4E;_!=CI[W+!86 M5]/'X]`NRX^S(ILCE;RJ/G[.W9W*1];AW+FXAE9P#=S;V>5_/WGS86E"&`A1 M(]PJ'O0E)!O34"R$1P%*2*GH`+>HG_%)M8=\_!`<+@'.=`OD&B7,>$"-^WDN M[Y[.'Q&D4[1/.2`"`$)Y"()/4=B#I;[]-0F4]_F7,H?>VQ6O:`O2D\N9ZHOO MG23;Y#@+7D`&&3>`[MZL/M3_WEER\$6BCA\SPW)Q^"&PZ1-FO0J'RLP@`1\<87Q"\DY$Y3]0N&! MQ*Y+&2IWGF/M7.O!7OT']-Q9Q#:8&KIQ(")'2NF4B;?<4GZ9@%NFL#0?UD&V M^5?"I:2`:QJ#FL&GY.VJI+]1+!"*(.$B[UR'R3[^C>*CU<:SJFE^[[%J9>]B MHKD'%)%%Q>`H+PU43=%@@9M/,,OVMK-* M!6G*V7UO1EY@AF;9]5,1:PRE:Y.''\;:1[PR9$QV6[K[]22Q^GYLUDA>?=84 M+86Z;.DQAJI`@/KAP:/-N<$G$[Q5/>FKY0ZGYA+.MZ$I6768G\=F+,1H'2@* M2D#E>0.5K[-ZR0(`E*'2$R^;S]\3?EK"%J0V-&MW_YRFR+ MQ#S70^O!8`1IW*?(J941Y/#AR]EM;-RB9;U](G9"&2!+>U<8G6]J24K>RW+1 M!RGMQT,1+4[IY.J+<+22YK(X/IR'9K-.@7G_&_,MRQD@^J*>LKY*@G.<0D`0 M-J>F9=V21_O33(B3W-?Z/GM6K;H>);*ZCD'\4;F'C"3/5$'BZ0^6/I[L#18J MN$>O?!5M"%7MF9;LF"3`P.7J]Y:W'#W6CG'!Z?SY<^+JSVO>V7@ZG4BC62FK*9]P:D/5K_K M._=,9U*KKW(5,0Q-8OT3U2.0G=I";OG!3D?W^6I4E-0T6/Y!.=A+MKK6N]6U M@9DP)V[)*.>B&G4"P+7JX=GME(?9EY5%@1!NOO20K.HAC5+3L/7#;-C*D)`/ M6SW,AZT>9@8"Z03!=U5?$;%MKN/2_@L?@MQM7Q5=@X^P/)VC;MM_G^F__+PA MM@1I0#XQFJ.UR!?)WY3L`.(0)\X4:"BE)/AEY!6C4`0D?H\8M8M*"TQVJ&JY M+X$JG"`]A$NJ+`LAV/7Z3@N5&TELHMRE&;5%ZPEJ8)N$RUH3Z2ZD`R6>W%5) M@+["X]D?64F<0Z9)RF_TX]W#3^[XZDCNL*PRZWF(.OOYJM)Y]D-L?KG0%K'- M%/59%#P%K!'M//Z%H!\D+UW/H2?T_PGJX MNU2B&^EK'1IX[UP:MYSK0RRFGQ!%+K:0WT7H+=:MGY'U;+5YVH/>LL+,2;'J M&[E[+*($[MMR6\Q+MXQA5!6NP]M,49I]86XF(",H8? M`!/S36T;:Z\&G(@O#I;87`H*J,2SAB2%DR'"A0:)=9W('JO5+%`S.Y>NICR^ M3"Y\7=G`E6!)JI*,S97_E'2=Q%LK@5(%0&Y7A&1>:/\6^"YGMIUPBAY!63XU MFQR13B%2-(0FE&^%8T.*-!Z&<'X+JY(3V3S52;'C(LKH^7(H.R'>4]AA^6SQ M33?^+_;0A7?R=*,<6PQG8RT$P3L5G$63FVZ^EM.&GQ4B'^R-?2.4IY6@SI!B M.NC9MYGEJ%R%CVT-@LI'C63!?L$*G,N/USC2=6_($YV;C9O*WN']&)O;;%6L M+6ZCG/^!_UWOA$3"?N^9*Z+$,F#/MGJ M=5U^$NR4K;ZCC0VG3Q@WHA];UY5#VL/7Q)`JSJQ\2`O(5P-5[>H*6CAJ$F5E MZ5[VRO'PR]#)L6:#U1>H*]X?=+#$*;@@Y('&$T6[5`SW,*L::F^8A_:^O9!J M$\ELI=:=V?#FBX^ME6`B,B3"A"Q7L'^09M[\_6S7,CB=*_`],K++9P\VY5OY M726V]RQCRI<-W>_YMNHG)U:@3`&9SXH6=>66NOPVLV@P`HK<3[/ZKN6P44%$ M5"7FB&D2B/G.JU&F-V0;1.]/[,!F*^H9JEK0S&YLTT83[0K'!`$.#K'0F2T_ M%PN3MQ55>^L9(BYK/L0[F>(1FW7-22])Q?UZX*\A'#('F$W#HWY+8`NVQ$&6 M"=)20#*YJ(74AO!2=QSIA49-8D11=SRV+L*=KOIJ33,L2Q_)6X&5J^.BT%]- ME@7B?()8,R^.&B=+8=/^PA5LNZN!D0(K,W]8J/G2M"PJEX!.;%)=I53]/ZRM M7A>6G+(;4K7`H"KY#-YEYJ25'*0^L8?]J!S.:R^<;G>3L_ M@]GO=RRW^SAF#^6.:9`&501653K=S>5-2/6EI^2CZ@"9(3J[PHQ\60%;<2]W M=C68\ZZGCZ*V,.,OU^8Y(+]9+J](%$)V]7R4.84&#/"J=3M-')%,IR]A9Y$V M#)U6M9U$K"MZ%R&W)?Z8Y@[NRK0J`:A-]L#JN#NS^DBB%IZV>]KI%V]^@I+0 MR(,51X.(95["XM1`*S]X(_8->9_=A^T[2?U*GL/5V-=RC3U+C],.LY9K[*:G MWUIYWOEM_>#]Y%GP\/6?)&;E31SO,DDW/^ARP-$OCGT!9G)S5?"BVOVEQ-)I M8Z4`D'Y0RE_Y)NN?0["8YJ?+PJ8M&$1=@@&/("C)%[Z,+$&H((H"X/7P+XAU M(S94AQE#:!"Y`CUIK:]\OZ3,RS[O9)`1D_*;<&%"@WE>W\T2LI!E:MME]0** M1^H6,`V+J@^5_.>N3$5J14UXVA`+;UY99031%[9,LABU M9XS]V2\YID^18@LX#X-=0T%?,EI]<:EU!$53ZY8.B]L]\E0]4%HHYJZ+%AV; MO3L'BA>-L+#Y:EU%-JA`^^I-91)>='%K,/1M#%;I5O"U8H%TUQE2((,Q]$=Y MG0O#S5=D".NQ_54^7UQW3C)8W>XSFJ5@)B<,=)06M`KJI M;D;4W,P+[`^9*T^A*XA%.60A0LBUQ5CKRY+S-84;/D#?^PK*EY^V M:LF7#_=C[1\0B%0M/KK9 MR^\;9)\>B%A^ARP@11`9BP/)J]>7+^XK/=\J?::0N#YS*FO\C$"!OXH#3I', M"(]QA%B]N)QC[@^-4]P1#O3`JNLJ6*,IU9OCW-]B"*N[9.ITJ[!SN:VPG*IX M<_E>'@VGBLD>"/&1#::"S;-MV59C6:X-??6RXL-(^82BFDCHUH*^BL/E!MK1 MI+/P-'>U5H9U>Q@K)E;S/'UY-7A-80FL[A4;IAS9*QYT/^P+-]WO#<`Y>GJX MN%9T@@MI($JP`NN,YU5"/'4);("\=(5NT"RDVQREW-WNFG;EF43"L&Q*/9GZ M+*^7A!WD@1GN!X- M]YM(II_Z^14*,5=054\KOSZ:^4;7^.4HG55H9J/>?B@40_C/$[1@\!CW3*RZT6F3>^7CNY(/F,6 MB($VDN+MO^E54)9;H<.S(HQC>?'V'F@NA:[QP!_+,8A.?79_JU M\>QN)\[SO#6E5JH`0WDV@WD]LTZ08=\LPZ:N4P&>-5J^T)[QGIM?/Q,&4QJX M<07%M(P_?U5P`.YTD:H*S4+NMU(E!8]O<_?!64_\X:XGG@NDS04KMH*A7%VU MJO&;A/5!]EFSS!2%&ZNB5",4*QR)&9,04:WMSY/)XU__3P````#__P,`4$L# M!!0`!@`(````(0!/3ICV\P(``#D)```8````>&PO=V]R:W-H965T&ULE);;;N(P$(;O5]IWB'S?'`@00(2J2=7=2KO2:K6':Y,XQ&H21[8I M[=OOV.90&YHM7`#!__SY9L;.L+Q]:1OOF7!!69>BR`^11[J"E;3;I.CWKX>; M&?*$Q%V)&]:1%+T2@6Y7GS\M=XP_B9H0Z8%#)U)42]DO@D`4-6FQ\%E/.EBI M&&^QA$N^"43/"2YU4-L$HS"W%P:TM/F+78OZT[6\*UO9@L:8-E:_:%'EML7C<=(SC=0-YOT1C7!R\]<69 M?4L+S@2KI`]V@0$]SWD>S`-P6BU+"AFHLGN<5"FZBQ9Y%*)@M=0%^D/)3KSY M[HF:[;YP6GZC'8%J0Y]4!]:,/2GI8ZE^@N#@+/I!=^`']TI2X6TC?[+=5T(W MM81V3R`CE=BB?+TGHH"*@HT_FBBG@C4``.]>2]76@(K@%_VYHZ6L4Q1/_4D2 MQA'(O341\H$J2^056R%9^]>(HKV5,1GM36*@WZ_#3\/!@0'1>=UCB5=+SG8> M;!:XE>BQVGK1`@Q50C&4Y7)"D(F*N5-!.A34`KKPO$K&R^`9"E?L)=FY9&0K M\G-%'!\E`>`=&2&[ZQE54(K@_<0X.=KK-#(CF>L$0C^R5_/W5BTT*)F+-GYW M/QS*IX("'*R9?>O,2`[-#-UNOKMLP4UMN.%:*;$#-7>@C,2T,9Z$^F5+ M\D&)!9=<`Z?$-MPLM.^<&8F!&R7363R*3@=0GY#7`8"6SVX[/%.;_YD,*J&TRK*PJG MU0ZK!@``^AP``!@```!X;"]W;W)KC0PFMV5=J75:B_/-"$)FA`BH*=G M_G[+E!O;12<=7M*=^+@XKBJ?`_CAX_?FY'VKNKYNSUN?K4+?J\YENZO/AZW_ MS]]?/JQ]KQ^*\ZXXM>=JZ_^H>O_CX\\_/;RTW=?^6%6#!Q'._=8_#L-E$P1] M>:R:HE^UE^H,(_NV:XH!OG:'H+]T5;$;)S6G@(=A'#1%??8QPJ:[)T:[W]=E M];DMGYOJ/&"0KCH5`_#OC_6E?XW6E/>$:XKNZ_/E0]DV%PCQ5)_JX<<8U/>: M'P8$_1O7;WTUO]>?VQ??NGJW>_UN8)L0YU4!9[:]JN" M_K93/\'D8#;[RUB!/SMO5^V+Y]/P5_OR:U4?C@.4.X(5J85M=C\^5WT)&84P M*QZI2&5[`@+PZ36U:@W(2/%]_/M2[X;CUA?Q*DI"P0#N/57]\*56(7VO?.Z' MMOD/04R'PB!'[KVQ8-F@4OUET*U'MM`0+4@ M`6EY>T&P$C7GDYHT3@5T#U7X]BC80_`-$E=J2(80Z/L)PEU$/D<(,4$"H#=Q MA-4MYZ@F$8Z$08:0]9ATQCD-R'&,2" M9#9W$1&WMZU+3BGOW:W&4*<=1?7X3XM);9`!L[@"2*%:F,9BYB`O3[)H;QL!QF5[=#(LL M0-U$T7U*1"O3&+PP"]F,&,:0HTFDD9GN)FR1`["Y!5C.HEO-UG@1L37):*Z# M('$N9&@$QJ6VR`78W`:D":RIV4+/8L%G.]0&P+C91BZS15;`YEY`MU^F,;J8 M+)[E#&-@,=?QM6(N\@(V-P-!9"'3&%VKT.INW?VN&5A>X22,+[*"$>U:`=72 M3&.06,Q"2^>1F0,0Z_6U+N.+C&!$$VK&8;#+-`:I*6/GI`]S!P$/.VMNZNWF M3:GRW6K+4<-MM:4WK)G&@&A-BFR:26<.P[P-<>DIZ;Z?'@H]1)\N'9D-IG.' MF->RQHRX1Y+C*.8.1<(@TQBDR-)XWGD81`/`:HW* MN!0768)Z(B:6$)FNT=E#C+[RFJ?D'B7701"0)E;Z76:+3('/3<%R&\W,-@4N MA:F:[CD M5:9DI^3N<&RZU*TD<80[M\'<&2+J#-Q6_C=DN)(4:G+EF3;9,+'(=/TR73 M`[C+;9$]B+D]T)O(3&,TMY@EY,XE=P$"WBM=H;;('P1J.U3$+-D$UFF[I?^Z MYVY!W,P1BU"B%[_[%E?,K2*F5J$Q3O6(;N>W,2Y18AJ*:`*%?*<-Y^81DS;+ M!&+0//CLMOWJL$N/F,<[M.:F0;=E)FS3$*D4LWUK`V28AJ8"#C6YR#9&M&L; MM/6V(`.@JWC\)JJR$6^,:().>)8F<9H<@F+9B]6701/KK[Q MA?,@1_+NNR,89Q&21E-Q#VL,OBQ_\[G'0;SYW(-'37@DTU3=H)0X4IM MN`[/KO#+T%[&DY*G=H`SI_'?(YPQ5G`D$JX`O&_;X?6+.AV;3BT?_P<``/__ M`P!02P,$%``&``@````A`'D=L+0`!P``G!\``!D```!X;"]W;W)K&ULG)G;)^P)(MRZ9"IH;S&6IK#]<.F.`: MP)3M3&;>?ELV!G6+B2&YB$']J9%:O]HZ/'W]>=C7?H1)&L7'=ITUK'HM/*[C M371\;=?_^7OPQ:O7TBPX;H)]?`S;]5]A6O_Z_.T]'98W^/N$"3?WTY?UO'A!"Y> MHGV4_HR3X&4/_?[)G&!=^LZ_&.X/T3J)TWB;-_ MZ3?!T_/3)H(>J+#7DG#;KG]CK15C]>;S4QZ@?Z/P/=4^U])=_#Y,HLTL.H80 M;1@G-0(O.-*H+*3:/V(!^!55+;A-O@;9_]%;^/PNAUE\%P"^B1ZEAK M\ZL7IFN(*+AI<*$\K>,]-`#^UPZ1D@9$)/B9/]^C3;9KUVVW(:1E,\!K+V&: M#2+ELEY;OZ59?/BO@/(>79SPLQ-XGITP^'AG9?M<&9YE9=9PN)#>(TUPSE[@ M67KA#>98[@/=@`[GL8!GZ8,U/"$X%GZ>7^8,AS97B6E3\1#)C< M>4?@67IY.!C^V0<\2Q^?"`8#01?Z4LH^:^?^<,#,.5>'#V7U3P1$R;%H!GPH M_3P<$E9*57THO7PF**58V2,::18S-T\$O2`+GI^2^+T&V15"DYX"E:M92WDL M4T`Q82])X7):N?&K^@.2S/C.=@@%971CA.ICI MEHS*-+L=`U<)CX`G<@HZ)<$QT34*XQ$O/9,@P]DU"N"[^ MI8')V#9&AB8BJ*I&MQ@/^QG?8GS,3$S&(RV>F@B\Z[";V2V&Z&!^BR'CL#`9 M0BQ-@L9O92):GY#B("L4#"2KRVPGX>Q6$KU*HE]) M#"J)824QJB3&E<2DDIA6$K-*8EY)+"J)926Q^HA`LH+A?T!6BF[70;07RX``[;CD9\88L`2 M-ID<(P0(YC@D\XT18'O2)\`$`;!2]4@*GB+`EIY%VC!#`/<=FN;G"&`.XR34 M"QV03-B"M&&I`RZ#93EYDZQT0'!N>==4B70$"^@'=*1HK"-'D"'J%(S,=>0) M[I'H=+'==8D.>\ANN9)HI*_;I05"Q3H>(#OL$:X=S]<]0VSGDL1^I-M=*6P2 M^C&R6XR15^($V1V;SK,ILMO<(OV;Z78A'8?$=Z[;'9_3^"QTN\VYL$D'ESH` MU5U&(K1"@.UP?NTBT@XL:A_0CJ*Q=A@GL>T4S#D',<:)-KK([DB+M+R'[,RV MKPW/Q[ZOVSV7SLN!;F;<\TCDAM@N?#)T(]WNVW1DQ[I9VO37)[J960X=V"FV MZS,Z[]Q,M\,NG>H&F7VZ@%WH9D=XG"24);)S1E/W2K?;KBVNL4.:@1WT`YI1 M-%T.D3'M%`SDN\N[C0Q+MY+H51+]2F)020PKB5$E,:XD)I7$M)*851+S2F)1 M22PKB=5'!)*5.C?5-]L?K[(5C5.1=*FL"L;/7V-6@R2J+K8*LH;H8;-#TE0? MFVUB'F`S?0$,B9E,U!$V&Z\O;.9DKDRPV29)9$K,I/8,F[EGH3\2I3FE??1' M!F2ATZQ!L^<2F^FF:87-UY8@%<&AV@,J4C15T37KY3FY4S"_4Q&V&BK"9D-% MV&RH")L=,E1#8J8JPF:Z_QUCLZ$B;#941,RD:3-LKE+10_1"IV^H")L%F9DK M;-:6[4A&ZG05Z4@=_56?,N75B*#H*4CG#!7+:UB]20E3#*^`NP8#FSW"]"CC MJ[F*_?0)(YEK,`/*6,)@AH1Q?9,94<8SF3%A/,]L\X0PON,;[9D:##.8&654 M"$E\YH3Q/,=@%H1Q?=C1D*2Z)(R$%3?=5:T(XTL&C;Z,%Y:?.OS47X9WRJ\X M,]4/":0D$Z"C3OXAZ97R\QRSRUV#N24_XD>:P]0G?GS8#FA=SO/K@#*6*=$A M86[)9D09V-73WQICQK,<4S83PC#;]#.E#.QCZ&_-#,;L^YPRL,NG?A:8D9Y@ MDFZJEH3Q.6RJK]+*XZSN2K5Q][@E;7%]01?R*RY#BSN00YB\AMUPOT]KZ_A- M771R6$E=2HM+V`YKP6$_G-F3\H6ZG,VO5R\&N!L]!:_A/$A>HV-:VX=;<&DU MU/U?4MRN%E^R^)0?U+_$&=R*YA]W<`L>PH6'U0!X&\=9^05^N'FY5W_^'P`` M__\#`%!+`P04``8`"````"$`/`+CQ/$"``"4"```&0```'AL+W=O2)<4-;&;N#YKD/:C.6T M+6/WU\^[JVO7$1*W.:Y92V+WA0CW9OOYT^;(^*.H")$.,+0B=BLINS5"(JM( M@X7'.M+"2L%X@R4,>8E$QPG.^Z"F1C/?CU"#:>MJAC7_"`5+3^HZ3;:^+UO&\;X&W\_! M'&=G[GXPHF]HQIE@A?2`#FFA8\\KM$+`M-WD%!RHM#N<%+%[&ZS3I8NVFSX_ MORDYBHO?CJC8\0NG^3?:$D@VE$D58,_8HX+>YVH*@M$H^JXOP'?NY*3`AUK^ M8,>OA):5A&HOP)#RM+.%8LI8#0+@TVFH.AF0$/S$RLG*\TYA+%\O(2G(RQEA.TRF$X0,NWJ6/Z2HHL*U_/E17 M5T%C+O5'D85)WL"8+.D4PM`?F?K5#7[_,J@@V\?"5+#3F"`(^@OM>_9UU>N& M3Y,AG4(8'I:FA^D:*+"MW:K^3F.B7GD0+JY-88FQ'/A6-'00M8..7JU>SY[6 MK+N#?D4;PDN2D+H63L8.ZN57V1IF=5/:05/JGW`T+$!3Z'!)'C`O:2N!:ES#_XGM7P```/__ M`P!02P,$%``&``@````A`$*K'#D]`P``#PH``!D```!X;"]W;W)K&ULG%9=;YLP%'V?M/^`>&^``*%$2:H"ZC9IDZ9I'\\.F&`5 M,+*=IOWWN\:%8&>E75](X)Y[?,Z]-I?-S6-36P^8<4+;K>TM7-O";4X+TAZV M]J^?=U?7ML4%:@M4TQ9O[2?,[9O=QP^;$V7WO,)86,#0\JU="=&M'8?G%6X0 M7]`.MQ`I*6N0@%MV<'C',"KZI*9VEJZ[@% M*!^X^YL+^H;DC'):B@70.4KHI>?8B1U@VFT*`@YDV2V&RZU]ZZVSV'9VF[X^ MOPD^\AV"(:DKW7QE&&>0T&!9K$,)5-.:Q``5ZLAP"W]IB+.R(I;2L_(?DSO/60#@84LN/%E]R"-8DR:UDZ;E`/(>N/.RB,-@X#U#* M_!F3*`P/$H#$V025L;2C0JC,)PK$ZO,5&85;^-O-#5HZF*PG5D,#QFY@_!A)L:K\VM"N,TKZ*8L-:.@V'46P<\6P:#H+EN;>::#G0 MC??FZZ\@F62*CPWQ"J/$^TO7.Z^O3O`TO@SCV&A,-HU[<>">BZ/IC]^C7R89 M^E?&YDX41IW>(/*,5U2JA;VEJ7X:]L/XG*W$J\&L!EB#V0&GN*ZYE=.C'+H> M'+CQJ?H>2.![H)^>SAB`>=RA`_Z&V(&TW*IQ":GN(H(SQ]1$5S>"=OVXV%,! MD[C_6\&'%X;!Y"X`7%(JAAOYS3!^RNW^`@``__\#`%!+`P04``8`"````"$` M\J`D#VP#``#:"P``&0```'AL+W=O-P2G M:E-9N+[G16Z):65KAF4SA8-E&4W(/4N>2U()3=*0`@N(G^>TYD>V,IE"5^+F MZ;F^25A9`\6.%E2\*5+;*I/EX[YB#=X5D/[)[@?5@1^-E9(,/Q?B)SM\)72?"VAW"!G)Q);I MVSWA"504:!P_E$P)*R``^+5**D<#*H)?U?5`4Y&O[2!RPM@+$,"M'>'B@4I* MVTJ>N6#E7PU"+94F\5L2N+8D*')F?AC/)["X.B*5X#T6>+-JV,&"J0%-7F,Y M@V@)S#*S`.IS/C-(2>ZYDYO45D!S:,?+)O;F*_<%2IBTF.TI!G4(%\2["$#U M^@CDIF$$@=_1JR"WIQ"#&`00#`.XG+H$2V'99%F+[?&!U=4BG+V3Z6PH)&L= M?5AKN0EZ8AO^V%N,4M48^.UBB#K$(%68MGZM+ZCE2 MRR&*3$P#Q>@:10GN*88C1;T<*\5@'@?=\D`QOD91@GN*IFPZ1[W<*D9A?%Y1 MVGSO';I<50GN*1I*K:B7M:*_0.:M&N2XN$91@GN*AE(KZF6MB/S9.U5%,*C3 MDU1HJ6DF$IT,4`MJE:-YY)TO+SKC43.8OLMU5KN&(<3(*.C<6]"L];!W]/_+ MH9#VGWX)8F2,H=77(/T2!4$8FI$?]!M=Y5$*/4P]#,>O;PN:8!I(VDMOOJ?Y MEMKUD7&UH"E!C*Q+!C%A"(X>9N8P1N8ST#9!@Q`,@_R4>8YGVC3LPE5FAHYN M9K3#<&PP+6A*`4:^-K$+VL$N?SZ0!DT)8F1U$[MP]#Q3B3-=T"#3A7$3].E, M'UYJO"??<;.G%;<*DL$L>$X,;6STV4S?"%:K(\*."3A3J;\YG*$)?+4]!\`9 M8^)X(T]_W:E\\P\``/__`P!02P,$%``&``@````A`-Q4%IB"!0``_A@``!D` M``!X;"]W;W)K&ULE%G;CJ-&$'V/E']`O*^AN=J6 M[=4"FF2E1(JB7)X9W+;1&&,!<]F_3Q75,'1#&OPRNW:=+LZIKNK#].R^?A17 MXXU7=5[>]B9;V:;!;UEYS&_GO?GW7T]?UJ91-^GMF%[+&]^;/WAM?CW\_-/N MO:Q>Z@OGC0$9;O7>O#3-?6M9=7;A15JORCN_0>145D7:P,?J;-7WBJ?'=E%Q MM1S;#JPBS6\F9=A62W*4IU.>\:3,7@M^:RA)Q:]I`_SK2WZONVQ%MB1=D58O MK_FG6YVP^C]$6>565=GIH5 MI+.(Z%CSQMI8D.FP.^:@`,MN5/RT-[^Q;>)L3.NP:POT3\[?Z\'_C?I2OO]2 MY5=]3;#VVA82=('I\+_'_%((T3/(-L[2Y@'P-V_)V")F[L]Z@E)G`1(2! M2>@Q3$;$'0+KAFF3P1<6\.U)@UR5M`M[.;T+'4=<)'-T'9E`-(8HB'B,/H*A70;E"YG7YVWK%1$&MK$O\>>36T0\BTAT"(D]/&:X M"7KV"-Z;4)J>F>/Y"GO"!&W[.+Z_4=3%4MP.UQMY?4)Q^-D_XU.]Q!Q&;3ES M!,O,W?`S+]6=,&'+G.$LR\SB83P(U>4)A1<0#QXACF"5>"@3BP@CB#M>H)0T MEN*>KJ&>&83?<*..<#,/,8^N^ M/%*_H'LK9^0\>5RDSJO:-X29+A_-ZRPBT2$D%1M9A7Y>$8REQZ/@0$FL&Y_JP^'K:+7K`6^T6$2?B7N#:_893N45NH*M8A1G*@[ M3)W"6,2G>;4;DV@A,G4TL.74R>YZZI\G`)WLK+-#'(0@&/5+%Y[R',%8(YH^71TO!%]`GGD3,HTQ*R+:MCK(#)[=+'E=2?/&[X0L-$I@V_6()'Z MA@5K3YF)6`"`XX3EB_(O-E>&9K9<`%G?4$#(1HW?^2-VS\93W;5]XM[4TN\R M3"F4ZX]>MIP^.=^0_D3])7OTUQM%7\P(H!6@@\@"T,F6"R#?&PKP?>6-,6(Z MLEVGL]W/3?!]Y9R)!$C#+YZ')%J( M+`':>GD?.8A67S7541`@K03*HX$DVBRR!+2]Q:/@D$D.IWFBCP@TZ"/%[F*1 M1JN`DDQ#9`6`>4`!HN5)4BBA<@2'O)DO(*:[R.=GPH) MLY!$/&JZ$+*$AUS9&;OR^)Y!@,1KA3_ZK3:6`0Y<-Y$FT66\)`O MPP7R:)1'EU4"1+=5S/;7ZF6F!%B'3(GC-34^9;H&Q)ZNH>FZMN#5FJV- MK'S%*V9TT_Y;NOZ.X/J[O2NV^@#SGZ7#9P[]S^]P)_9^!P#6NO`'PJRZ;[@#?D_5\N#O\!``#__P,`4$L# M!!0`!@`(````(0"_^*3?_@4``*,<```9````>&PO=V]R:W-H965T/[&*\\[)*BWQG.@O;-'B>%(3QH7DHNUC,ME=6%J>Y21DVY90,YS4E*?DEKH%_=4ZO59LM2Z:DR^+R]>WZ)2FR*Z1X22]I_;-):AI9LOE^ MRHLR?KF`[@]G&2=M[N;-('V6)F51%<=Z`>DL(CK4_&0]69!IOSVDH`#+;I3\ MN#._.9O(79K6?ML4Z-^4WZK>_T9U+FZ_E>GACS3G4&V8)YR!EZ)X1>CW`WX$ M#UN#IY^;&?BS-`[\&+]=ZK^*V^\\/9UKF&X/%*&PS>%GQ*L$*@II%LS#3$EQ M`0+P:F0IM@94)/YH_M[20WW>F>YJX?FVZP#<>.%5_9QB2M-(WJJZR/XCD"-2 M41(FDBR!O8C#1_J'+2+2Z(KB.MYOR^)F0+/`4-4UQM9S-I"P%43#=Q(_4PC2 M,,DWS-+D`O(53,O[WG>>MM8[E#(1F(`PL!(ZC",CPA:!=<.T4>\#"_AVI$&N M2MJ%N1R?A98C/B1S=)E,(!A"%$0X1+BNG"0:0M:K#B+)<&49>OH(AG;IE<]G M=I>WJ5=`&)C&KL3WD1M$^!`1Z1`2>QAF_B3@0SL32M0Q])G2!@%A5DT;.;:W M6LLJPWY\[:]].1Q)8=NYUTAB#\NMSUY?>P2KK)7."`BS;%C?QZ2JM[&[:F5> M(AU"XKV:PQO!:L\H[1H0!HK6S8C"+7R(B'0(B;T_ASV"L>JXG3#;60:#_- MH8W@'FVE"0(*"]KVVE-F(Z2XCK8.(=%V8"N?7NX&W2.N;`>!B!/SE>:W"D.^5O7X4HK!").U%W?5K<5$==2IR'&(3)U]*WIU,GE^ALY M6ZJM[A"(^"\]SU.:*A2`<7;B"$`YQB&R`'2NZ0+(Y_H"?*8T=>`0B`2`TRA[ M9RC%'==5%W,D`=:N?V\^F3K(FT$=T=CQ]RW;9X/:$VB\;N1*SD-(I(7($M#! M>M7'@^3C,QF>G4$*E+ES'Y\I71((D%:*SC]%(^D@LA2TLYX4_7;OD/EUBWC0 M0Q2G'EJO?.6T$XKG->HB+42FCI8VG3H98$=]T$,4)^H,VEMQ6$=GH*+J.HA, M'6UM.G4RP8[ZH&1J:.U3:=.1MA1'QA6:Y1X[O$\ MQ11"IPW?EXPB/M)").9LEM4VZ)[5*M0"$:UJ MLT@2\&`\?08:M+KC*-\%`P'227@,B;006<(L_W6'_NLS]>`C0)*$E;KYC(%D MGXNT$%D$VMWDE>"2.?97PN`K;2!`D@B97_@8$FDALH19/NR2#\-K[_O6H)4( MI)7P$!*)H<:SR!(`,V,6$*U^^QVT$H'Z@WN>52&4GQAO=`#OP\V7U*=U0!W%$U%SI6%X`KHFM\XC_B\I3F ME7'A1WC47OC@TR5=,M&;NK@V-Q@O10V70\V_9[@,Y'!78B\`?"R*NGV#UUC= M]>+^?P```/__`P!02P,$%``&``@````A`.G2JO.)`@``$0<``!D```!X;"]W M;W)K&ULG%5;;]L@&'V?M/^`>*_QI8F3*$[5JLI6 M:9.F:9=G@G&,:HP%Y/;O]P&ITR1ME_8E-O'YSCG?!9C>;&6#UEP;H=H")U&, M$6^9*D6[+/#O7_.K$4;&TK:DC6IY@7? MV^2:LB=NOSBCEX)I951E(Z`CP>AYSF,R)L`TFY8",G!E1YI7!;Y-)G0D,MK4N[NN6%04*")TH%C8JH!`_"+I'"3`06A6__6CJ;:K5!,#2@:3KJ1C"9`//+&4$J#GOKP#X$S!KHPGJ6IZ,I64/IV!YS M=XY)>@0!T5X9U)XKNYIFT)FW';B@8P=9VM-[DW?GD`/BR$!V;.!M80<&@QCU MJ6?CX8ERP%P_PQP01\H`>7_J+JC`D%WO($_')PX"9NA;D\5QW'\^DH>9>[^\ M"SJ1SP[\H?0!DWOYY%7YX4?D7="I_&&P@GS`!/G!J_+Y1^1=T*G\8:R"?,#\ M3]Y="1=O.`<^E,=4*;JZP#^^WU]=8V0L M[4K:JHX7^)4;?+/Z^&&Y5_K)-)Q;!`R=*7!C;9\38EC#)361ZGD'-Y72DEHX MZIJ87G-:^B39DC2.9T12T>'`D.OW<*BJ$HS?*;:3O+.!1/.66M!O&M&;(YMD M[Z&35#_M^BNF9`\46]$*^^I),9(L?Z@[I>FV!=\OR82R([<_G-%+P;0RJK(1 MT)$@]-SS@BP(,*V6I0`'KNQ(\ZK`MTF^F6"R6OKZ_!1\;TZ>D6G4_I,6Y1?1 M<2@VM,DU8*O4DX,^E"X$R>0L^]XWX*M&):_HKK7?U/XS%W5CH=M3,.1\Y>7K M'3<,"@HT43IU3$RU(`!^D11N,J`@],7_[T5IFP)GLV@ZC[,$X&C+C;T7CA(C MMC-6R5\!E!RH`DEZ(,E`_>$>0I>321#B?=U12U=+K?8(9@5>97KJ)B_)@=`9 MRJ`L?S<$3ES.K4ORJ8`VT(3GU3R;+,DS5(X=,.N`@;D?,.D8L3E'9-D`(:!O M$`GV_E^D2QJ+S-XH6`?(M:^N,[8Y"8P$0&5.!5RNC@-#%4^<9XO%8,Q7>3<<*U@$S\_U-)O,T'M_# MGCF.<)\FZ>S/?=`7MBA,F^2ZYAO>M@8QM7,;D@+O$`W+NTYR:`ELS9OX!I;: MQ\EP`4O5TYH_4EV+SJ"65T`91W,PKL-:AH-5O9^!K;*P3OZQ@:\GAV;'$8`K MI>SQX!9_^!ZO?@,``/__`P!02P,$%``&``@````A`&V($W*X%```5+(``!D` M``!X;"]W;W)K&ULI)W;@^_U^?U-M)?$TMC*6VK1_?S9$@A)!B@MR7VHV7-HB""QL`B2H3__[ M^^7'U5^;M]WS]O7SM??A]OIJ\_JX?7I^_?;Y>CJI_79_?;7;KU^?UC^VKYO/ MU_]L=M?_^_+?_WSZM7W[8_=]L]E?2837W>?K[_O]SX\W-[O'[YN7]>[#]N?F M5?9\W;Z]K/?ROV_?;G8_WS;KI\.'7G[<^+>W=S7&-NO7Y\? M-Y7MXY\OF]=]$.1M\V.]E^/??7_^N3/17AY=PKVLW_[X\^=OC]N7GQ+B]^/S:_O6[?UK__D'+_[>77CR;VX7\2X5^>']^VN^W7_0<)=Q,< M:++,#SG9RF!/NU7;YNOGZ^5]U$-_>+US9=/AS,T>][\VIUL7^V^ M;W_5WYZ?.L^O&SG=4E&Z"G[?;O_0:/-)_Y-\^";QZ=JA"@9O5T^;K^L_?^Q' MVU^-S?.W[WNI[X(429?LX],_E*]Y<<0CZ,(G]-.>1<.AZ"E/1P$N3OY<=_ M%WY8_IH/WU]\!HMA$/EK3H)4V'W!*]Q=4`]B]:$<\M=$R7VX+Q3R=_=%]]I\ M"*/(7U,@__)C\>3T!RU+M^F@U;RG8KVHA%.O89OUWU+5G6J_>^#>U;1JP=]*"WZ&Q9YJP MWGA';9NVZ_V[QNN;QJLWS&FYO+9]TW;UA@GS\,'+WUYBM6^:L-X(H[S')-\T M8;UQ^;GU3=/5&^\OC&FXNELSA;F]O)/R3N@>]88[G'3KF3`/6&V&<"SK?G&FY>N/?%,>T MW-RQY4HU79S9X MG3>-6&^88DG([&O4F^!Z_7#Y7UGOUU\^O6U_7FZ\#T')B^`S-(8^[C91\Z,",'9NS`3!R8:9*Q6N<, MB3D2"R262*R04"DZ6H51;*-*T;&8>XA7HTHQ,@FE2)F$4KQ,0BEJ)J$4.Y-0 MJJ!VZ=(,S=]:IR!-T024YF@"2I,T`:59FH#2-$U`:9XFH!11CVWI1I)%E#$D MU\0RAIXJTND].W/H3\4S1^X8_Y!<2DFDD"O$*Z'LP%0EJ)KW<_$FK5)<34(ILB:A%%N34(JN22C% MUR24)FRB="G&%O.6U2I%V224XFP22I$V":58FX12M$U"*=XFH11Q"_='N6.) M148?L<22G5`TK1.*OA>AQR8E^Q_*YA^NHL%*WK,&*Y4TQFK)U33&:LBU)./; MS:&>9/)>/BY$(\GXOI4#FX8Q)6^9?\@H:#N-L0K:26.L@G:33**@O223*&@_ MR20*.C",*>C0_$-&04=IC%70<1IC%7229!(%G1K&'.#,_$/&`<[3&.L`%VF, M=8#+%,:WFOJ7=9`J53#KC*@4P_*> M=4I4FF+V.5&ICMF1(LF.Y4V>E$B\J+RIFMGE3?7,+F^*:/E$45),2]9OBFK) MHD2N'6:=`+>FY-RY#A^OA5^5NK'RP%C/PWZKNMLUA&HH)$ M%8D:$G4D&D@TD6@AT4:B@T07B1X2?20&2`R1&"$Q1F*"Q!2)&1)S)!9(+)%8 M(:$4(VR=8NT4>Z=8/,7F*59/L7N*Y5-LGV+]%/NG6$#%!BI64+&#*E/"6.\O M=Z\NZ/TU_?E:AIE1SU[,'P<$P:5\P$B#C1B[]T>B@D05B1H2=20:2#21:"'1 M1J*#1!>)'A)])`9(#)$8(3%&8H+$%(D9$G,D%D@LD5@AH10C)4;*C+!WBL53 M;)YB]12[IU@^Q?8IUD^Q?XH%5&R@8@45.ZA"">\.]WCO;F^/-T-B7;\\A/V2G`&H"5`B8K!2!10:**1`V).A(-))H!40SNJ-_:LU0M#-!&HH-$ M%XD>$GTD!@$1%-6[S]OWBS'`"(DQ$A,DIDC,D)@CL4!BB<0*":488=]4F:.P M<8J54^R<8ND46Z="[3(Z&<7J*79/L7R*[5.LGV+_5"A@5J&'634=Z__E0;%8 M_Y\]9:]IN]^W)WX")N/HRDA4D*@B44.BCD0#B6:2*.:MZ?Y6DK$&0VTD.DAT MD>@AT4=BD$+<62U@F,+$;Y*,D!@C,4%BBL0,B3D2"R262*R04(J1$B.LGF+W M%,NGV#[%^BGV3Z4(:,FEV#_%`BHV4+&"BAU4+*%*LS!NF,J4,)8!Y!'?"S*` MIN-3_\6\=<)+`9.5`9"H(%%%HH9$'8D&$DTD6DBTD>@@T46BAT0?B0$20R1& M2(R1F"`Q16*&Q!R)!1)+)%9(*,4(6Z?*'(6]4RR>8O,4JZ?8/<7R*;9/L7Z* M_5,LH&(#%2NHV$&5*6&L]Y<5&A?T_IJ.7_][B:G_@`FG!WS[,=5RL#LC.520 MJ")10Z*.1`.)9D"$1;V]M69"6AB@C40'B2X2/23Z2`P,H5>,^/:#OT.S]^SM MGA$28R0F2$P#(JR0XLF1+B,]1OJ,#!@9,C)B M9,S(A)%IA.B1;O/BC5G9,'(DI$5([)43+O[^3K#,UDKQLQ1QL-I M\:W3(NO$.(:#BLK!1>4@HW*P43GHJ(X^'A:]'F^''BX-E(.+RD%&Y6"CKWC!2N)@>>/I%LD-',-!1/<89(W-& M%A&BC_'.>C)Z&=OK%ZWSO`IWAU,V\H*P^&A;NGHCC([^4+#W'X72^XOV\D1Y M5X3Y_-G3(-T\,T>?SL>)2V6?";GZ-U^C#]6_LY24WCVV/V<]9B!7_:?[4*G^,XZ"@Y@.,/S^0.'>ZMU+^@6W=(5OD$-Z>["N:2IAA.": M2-X`8>6?*G]#C9$Z(PU&FHRT(N106GM$U`YW!Z7-^?8+E#K1Q\^V]BXC/4;Z MC`P8&4:(+FW>NCH8Q?8^Y*R:'T>[SY9UPLB4D5F(!"?=]^ZMR_)Y;'].WC<: MORQ?\%P6Z56QKRPK=X7K,&.I`$^$@?Q M)`UP'`?U9$C`<8R`^<-:GH?$*QN.`J9<_TGGS]_@()]T_AS'03_I_+/BQ#M_ MO3;P@J%!L)0P-C1(]/UFN:$^55;C*.M7EVZ?XSAH*7/_'"=; MSWART"O*+D@.P0*T6'+PK$GUDOZI"4D`X467_,Y+_**J'.Z7!!9-/ED)IL)( ME9$:(W5&&HPT0R0HL?=P:UU0M3A$FY$.(UU&>HST&1E$B,X.=T7K^G\8[3Y; MQ2-&QHQ,&)F&2%`Y\CLY5N7,.,2E^PZU`R`W^1@X62&3B.@X>2&3B.,3&KX$<;==OU3EYZ:1X9XN]Q<%&&#!S' MP489,G"%;02PXOR`K!"L73K&#?2BSIWPTZC`KT2?_-O[5& MXN5H_]D"5!BI,E)CI,Y(@Y%FA!Q*[-EILA7M/UOB-B,=1KJ,]!CI,S*(D$.) M[Q-)P32!LP4>11'.(F-&)HQ,0R1("K]YN7OK(F7&,>:,+!A9,K)B1+("GEP9 M,C!C/#Q[8B0M,X M2"D#!HXSS&3BJ4$O-KP@-01K$T]30]Y^"J>D?PLN>\:HS$B%D2HC-4;JC#08 M:3+28J3-2(>1+B,]1OJ,#!@9,C)B9,S(A)%IA!P26N[!RFBS:/_9;F7.R(*1 M)2,K1B1)H&B2))@YVIA^7B1',Y0B]A/,T1;F^?T[_I*6G@-%<4[6-VDLAE#']5V:DPDB5D1HC=48:C#09:3'29J3# M2)>1'B-]1@:,#!D9,3)F9,+(-$(._8&7&$E$^\_VIW-&%HPL&5DQ(K]&QJN) M'624WR+C.`XZ*@&X4':[YQR"%& MC(P9F3`R#9'P6/-Y^Q&\&<>8,[)@9,G(BA')#2B0Y`9FC(CAB9&WW%I/F\OH M@:,XB"BC!X[CH**,'CB.D3'C$E5FF((X0TB.9@;_(P4?)#!S'P4C) M#!S'.)E5\&POXYE!XER2&31N_5""/7%4\@,HXPC+C%08J3)28Z3.2(.1)B,M M1MJ,=!CI,M)CI,_(@)$A(R-&QHQ,&)DR,F-DSLB"D24C*T8D2:!KDB28<1!2 MT@3'<5!2T@3'<9!2T@3'<=!2T@3'<1!3.9@IF8*_R\%-R100+CN.@I>0+CN,@IMR[YC@. M:LJ]:XZ3+6<\7^CE=J?Y`N:<@M5Y\3QAO5NCY&0-=D M9,',44@]/>]YUJ6?9`F.X:"C9`F.XR"D9`F.XZ"D9`F.XR"E9`F.XZ"E9`F. MXR"F9`F.DZUF/$OHU7D79(E@,5\\2UC+DDH^KO@K,U)AI,I(C9$Z(PU&FHRT M&&DSTF&DRTB/D3XC`T:&C(P8&3,R863*R(R1.2,+1I:,K!B1+(&N299@Q@AY M=W@[G5=(NTG!41R$E#S!<1R4E#S!<1RDE#P1Q`E*+@_H6=>\9 M*+K]4)01R]OS-ST3%?S/?OOS\[4\.O7[=K_?OAPVOV_63YLW#0C\=;O=F_^Y M^?+IYM?V[8_#=WSYOP````#__P,`4$L#!!0`!@`(````(0"&\7S60@0``,T0 M```8````>&PO=V]R:W-H965T&ULE)A1DZ(X$,??K^J^`\7[ M"D$1M=2M`6KNMNJN:FOO=O<9(2HU0#@2QYEO?]T$D`27P1<5_/G/O[N3#G'[ M^2W/C%=:\905.Y/,;-.@1`[\RQ$N;$L'I]I'O$9*VD!WQQ9E4<"+JN3Q6GF4%J94V%13--CQF,8T9/$EIX60(A7-(@'^^3DM>:N6QU/D\JAZN92? M8I:7('%(LU2\UZ*FD<>;+Z>"5=$A@[C?R"**6^WZ8B"?IW'%.#N*&CH+&,F%-&`V-LE[2'D,98"Q9HZ+JC'+0`)>C3S% M^01IC-ZDNS01YYTY7\Y(Y14G3B"]KXV( M,UNY[F*Y\J:KS!L5>&]4"'E<9=&HP'NKXDP-R)+)J?,>1B+:;RMV-6#60_B\ MC'`-D0T(MTF6*>G2_JNL0[I1Y`E5=B8L5T@HA]*_[NVM]0K%C1O"EP2\=@11 MB:`EL)(H&O9N6."VLPRUZ%N^/Q]:9PBCLU;5ES?Z1AS-R)"8JT0X)!8=H5B% M@D^WBC!,TEZ*W$ZUSH@O"2A3E\2E2@0?$N$8H7B'8:9[1WAG0EXZ9Y[JS)=$ MW_M*)8(AH447CA&*=UB:T[TCK'I?J\Y\2?2]$VU^!T-$-S]&*.:7CYA'6#5/ MM(7E2T1QKT_Y(:*['R,4]]XC[A'6W&MKS9>(6S>5!7$]?=;([_O1Z=;'",4Z M/F[T>N%X8T%8LWYK`G*Y2J1OC6@K.A@BNOLQ0G&_?L0]PII[;6!?(HI[;4T' M0T03"<<(Q3V!AXKIR:]IS;\V,?R&40+0%G9PA]$C&$74$'##FCQ_B-S>^BW3 MT9J*WS#C(4B=/C,(80Q10\"=;7H(PQL>;*C[?Z[%H1OV& M&8U%RGBU4<=;KEV':%4-1V744'#OZX7R00ARIU1FE-8W?3+<31VM?05W&"T3 MX2BBAH![X/00Y(ZIA*!U3A^.BUBI?A7F6OL*[C"#$(8R-T2&(`^+\M"2T^I$ M`YIEW(C9!0]_!&KU.L\TQL_L"SH5E=*)_1]4I+;B1T2/\U)[A$:Z2)TMY M(5A9'XD.3,")L/YXAK\-*!Q'[!G`1\9$>X'GV.Z/B/W_````__\#`%!+`P04 M``8`"````"$`C+?RJ"(%```!$@``&0```'AL+W=O\^OU97XX4V;_/2=;?0LMKB0JN\ M7;$;K>')B355WL'7YFRUMX;FQWY0=;43?7LI;.[)5Q7OHJKQY>KY]*EAU`XK'\EIVWWI2TZB*\,NY9DW^ M>`7=K\3+BY&[_Z+15V71L):=NA7069BHKGEK;2U@.NR.)2C@93<:>MJ;#R3, M2&!:AUU?H+]+>F^%_XWVPNZ_-.7Q:UE3J#;XQ!UX9.R)AWXY<@@&6]KHK'?@ M]\8XTE/^?.W^8/=?:7F^=&"W#XJXL/#X+:%M`14%FI7CT4\._@`AS=PP.?`X:PVON\%FS4D\L;D\+17`)_#P,V;`RVL0%_0)._RPZYA M=P-6*6AL;SE?\R0,3&.L)$X]U?:_2@LUY20/G&5OPO:"JK6P'EX.OA/LK!?P ML!AB(CV&R!'Q&,$-X[2)"J0JD`F`!8HF66#*#Y#%6;BL,:%H!&:=CJ)AC!B' M)"J0JD`F`)(&5]?@PE997N2C$WP0+&?!"3?PY1RC(0;LGNQ2S(JGD$F'AJ0: MDHF()`76]P^P@[/`.H5Z37G[SEH1AT'N6^*FD$FQ[M+63Q%#*:!=K6P/%SHF-A'.8>L;D!L=RX_0J(41%Q8H8*4K2)E"IJD MB$22E*TL92%E../&G'FPG#,BGMT?!(Y-/#F3&)\[>)SVC1X15[90&98.$]D$ M#Q@2*`HSD5?20Z!MBMZ\+:B/EA4-D(=3@R2EI<;C&&^R*1G'K/MTWA58[4$4%H=D5M^4.`:,LX9H,2`E]IMND<,,Z3 M232R!'[0O5\"CU9<0&AV04DGYD<#'R.Z,(Q!%YPM47?X,,9;3Z7*)!I9`C_A MWB\!ST/)!81F%Y1T8H(!D@O#&'2!.)ZVD*:`V0611I;`SS%!`K[Q?;!/084U MPMB1C$/+G1I8.40*420/E-/F1**3Y_ZS`".]$!+R1K7TQ($GOA_$2GJQ#>./1)T@V8;H4GZW#;`F'LP]*@7?X:6JX@-_R,_TM M;\YEW1I7>@+C[;[Q-'B%QR\=N\&"@&LXZ^#JW?][@9]:*%P([17LN!-CW?@% M4K6F'V\._P(``/__`P!02P,$%``&``@````A`.:,:LS7!P``Q"```!D```!X M;"]W;W)K&ULK%I=CZ,V%'VOU/\0Y;U)@)`/-#/5 M)'Q#I:KJQW,V829HDQ`!L[/[[WN,;<"^-#M1]V62')][P,?7]L7,PZ]?SZ?1 MEZRL\N+R.#8FL_$HN^R+0WYY?1S_]:?_RVH\JNK=Y;`[%9?LU?A9ODZK:YGM M#DW0^30U9[/%]+S++V.NX)0?T2A>7O)]YA;[MW-VJ;E(F9UV->Z_.N;72JJ= M]Q^1.^_*SV_77_;%^0J)3_DIK[\UHN/1>>]$KY>BW'TZH=]?C?EN+[6;'T3^ MG._+HBI>Z@GDIOQ&:9_7T_442D\/AQP]8+:/RNSE@S`]I?LG@-L:)C<"GHOC,J-&!00B>DFB_&8'?R]$A>]F]G>H_ MBOK]G`4,A/39DK[XH0;P-_1.6>I`4=V7Q_')BZ< M'^KCX]A:3.SES#)`'WW*JMK/F>1XM'^KZN+\#R<90HJ+6$($GT)D/5D:L[6U MA,:-N+F(PZ>(,R8KVYXO5M\)A&QSU_@4@8N;%T)KP\?G73>X%''XO.\&,;V: M"^+S0S>X%GQ\WG6#!A*FN1#[;(UN>ON MZMW30UF\C[`@X(K5=<>6%\-AJC)K>:ZT>?Q?:8S\92K/3.9Q#(^1H17FWI(1Q"=(0)"0(!%! M8H(D!$G[B.(/AOT.?QA;]807R"!`0)"1(1)"9(0I"TCRAF MH/!0S.`;Y8251_4QWW_>%+PX&T@B"QLBWR:9B.J10.:=1P+A)6*S"W+$0AZW M4]6:S=4\\UJ2--LG2$"0D"`106*")`1).8)R%U=7;,/D^/^V,1'5-H'T;!-( MSS:.S.=-.6+.#&UF>FU[ZYC0Z!(V:#FLI(&&M@V';;O4B(A&W'*$AK9=)6V[ MU$B%!G431:GBYD"RX6%!9AMCJ[9QQ+2Z;!.X)%\G:JLB"23_SE8JW- M.*]CR"GG4YV@8S43=[FD*/0D]H;5O3!['D';06DY#AGV8+5@WP:&%!62*&(!L:4E5`H M50)59UC-?(G:I4JJJ*B>LE+Z#D]Y MY:UXRJ'^#LW.$-G2V"6-*R`EVSBK!_DT,*"!(84B&AA35D*A5`E4G6%U==\9 M5CZ;"W82>D?Y;/#J7#&,0TN43+T9J^7"5@0J2<@#;;[-FTT(`5I*%E264_Y M2!!Z]QS+F)O*B61)9>U9*U6$U>%@]?T=PR$>!_K#P2%UTS:T6;C%JQ^RC`JH M7V$2TSP1:*__6IB_4=LL')R78#'2<-=8.AXF(&W! MK'?8-*T!>_MGIO1UJZR8>_S!O@;T\$A--796`X.52G^/'>>80=M MV,P=G!T.X+:#,S.*8UM&MX=:L.^BVT,MV%C1[:$6UUA`;;#E0&VK!)@*U MH1;7L*`VU'U4H%`;:D&)";6A%M>80VW(&U1E4!MJ0:4%M:$6US"@-C24>`2# MVE`+'JJ@-M3B&B;4AA(`#R90&VK!DP?4AEI<9.504KHK!^='-`>"E8,S(8K' M*P?G/!1WUPZ.5R@>K!TL\W8`_I+4=3R![M`^_\'3_\" M``#__P,`4$L#!!0`!@`(````(0`)"HZH"P\``'E+```9````>&PO=V]R:W-H M965TG=[W^]/-_\N=[M M-]O7][?1W?#V9OVZVCYL7C^_O_WW'\5OT]N;_6'Y^K!\WKZNW]]^7^]O?__P M][^]^[;=?=D_K=>'&U)XW;^_?3H:#KWS]MWO96[65UB=S+[DANH"\4[WDVF`U(Z<.[APW=@0K[S6[] M^/[V8S3O1LGMX,.[/D#_V:R_[;V_;_9/VV_E;O/0;5[7%&WJ)]4#G[;;+\JT M?E"(G`?@7?0]\,_=S`R(GWCTUCO1J'./X+IZ. MHE%_#R<\Z0[[>Z=7ZYG<34>C=#R=$#OA.3:>]&H]+WS/B?&D5^,9Q9>])XW8 M_FKIU;[GA5<[,Y[T>N5[1I2/.CU48NJ^G]Q-HN$L.1.AZ)A8],>5UQO9A%)_ M&-_Q,2FQ6P8ZI_LADBT/RP_O=MMO-S3OT%OOWY9J%HOF2LL.#BUQ'"X_&BTT M3)3*1R7S_I;B3B-A3T/\SP_1.'DW^).&YPM<.&,1*FMA73()<@D*"4H) M*@EJ"1H)6@DZ#[!0T:3U*T*E9-[?TO]/))JQH9GG:#06X3N:'.,')`=2`"F! M5$!J(`V0%DCG$Q9(FL1_12"5#`UZZJYCD'#(:J/D5"2/)L=(`LF!%$!*(!60 M&D@#I`72^81%DAY@+)+A@L!.<6P#)@.1`"B`ED`I(#:0!T@+I M?,*"0;U\13"4-0^&)A0,/UDBD2Q'HV.R`,F!%$!*(!60&D@#I`72^83%AV[L MBO@H:QX?3?QD`9(!R8$40$H@%9`:2`.D!=+YA`6#RD@6#%U5W:F"\/"T67VY MW]*,045%8,9)J'K2-942X3$R)#T6"@M#]+*E+YDT26C2@5^$AL,B+@45>$"R:]*5H/(Q$+9I;`SH"TF="IS^GP@*LZ]E3`_]B^_:A"\Y_*NAQF$?E/BZ@-9IX MP%3.P,K4]@*=3..LC(Q8@K7.P,IT5B806JJ3KABXL3(7>:B17VE8*Q>/S*!T M?`Q1CJA`QQ*M*D0U.C9HU2+JF"-/.E6Q7SZET?U#9#3BM[* M#!KU'_/VC]0<48&.)5I5B&IT;-"J1=0Q1QXL575?$2Q=I/L/2ZHN5?SX`FTB MALC"6'G5:681#3BW+(C%>B(W5K'>($FF\4PL'`JKXY*VM.BD=,6EX]%D)MZ\ MMCI.NK'HI'0KI-/11$P]G=7II7F7J$+^BBXQ=;_W2%:?U%.73-@URBM8&"N6 MO]HQG?83)ITL,K$S'9'A@585_16#U@H#END8TG.S;+6)CY5(D,RAU3Z(<48&.)5I5B&IT M;-"J1=0Q1QX95>1?$1F])F"1T4A,F6(\+6@4J\1D*:<1FS(!%>A8&N0Y5HAJ M=&S0JD74,4<>K.O6%S&N+PPZ-V4:1S^S-!JS?<:)&!2YD2C/R1&RN5,[*RM<7R3?.T9<7,TSKK*Q\=TZ>=X])R MA\)8L137CA.VLS45R\G<.)*5O>_"(+YQ,8%>"\J+:J5"^?HB^<8Y>KTV%<_W MUEG9J^_.R;->2^1JZ_2BO3?GY:Q!_MQLK;P19)!?SB(JT+%$JPI1C8X-6K6( M.N;((T-CELW-/Y7/]`F#K'(-XOD\%0_JA;'R\]DZ4I5\HG`S5G1CZMF=C&)9 M$Q8H75XD70GI.)%G&6J4;BZ2;KET/$VG8OKKF#3O*;DDDSUUV5:=&NYBJ6:0 MO\>"*$.4(RH0E8@J1#6B!E&+J&.(1TPNU53$]`=%5Q[K2W`59Q`_R#"5)8FS MLA-7ABA'5"`J$56(:D0-HA91QQ"/XW6K.+6I)#-,(Y9A@#+CZ%GEB`I$):(* M48VH0=0BZACBD9&+*3DF+SK@D.`:RR+W;%E8Y.K^S"!U?<>I,IJ)AV?NK&P. M%HA*1!6BVJ#`9IPZ'/<+'B2X*NJ%Z6'LA\)8^:'0Z,>;<4;&WXRSRFZU63HK MLXLF@EDY`QO,VLK@+IHZ$L=B@NTW%AYJ$#'$JTJ1#5S MY/>L"N++5[.)KI]9IYJ2FE4X4U%X+ZRCR_O,(K;.@CTM8T5+S+XTFL5R"5=8 M'2==6G12NN+2<3S"TLC<;B_-XJ:Z^(JX]>:\!C>(;SS)"FIAK/Q<,;*_<@96IF8R/!Z_I/)6JWPQI`R:\/02"^&%=70Y MD!F4ZC,M292*55[N#.S]%2A3.JM^#AV/18U;.0,K4S,9'B99]IZ>0U,L;PVB M%_MV"X-8CFC'D=MOSXV5APIT+-&J0E0S1WZ#H2KUZA,U*5:H!JG0'JN#>"IW M%*RCGP=::Z(_V$K3.(%$.%K8D!:H4QID=.))-!.[$I6SL#HUT^&!4A6C/_'* M8NNR!1!5`#!B-*(^LI>Q,%8L0[05'5ZU5KFQ\E"!CB5:58AJYLAO7%:99X8` MEI.T6:SNF:>"[(V%L?(K"^NHGR5I'(W$"B=W%C8J!>J4SJJ?$](9?,KI+*Q. MS71X1'Y)L4G%$62"*2/9%NA,I/_".++DT(ZCV'P8+/PNG$ZQOJ4"HH^GRY`%H@Q1CJA`5"*J$-4, ML1NG]0%_CIR>3GMS7H@:1&L$VX4+1!FB'%&!J$14(:H1-8A:1!U#/#*ADC29 MJJ^#FZ\X7_Q%6"J:Y)@R2*VL7$K+XXL+9V5CFR'*$16(2D05HAI1@ZA%U#'$ M`WE=T4H/!0B61BS%`&7&T;/*$16(2D05HAI1@ZA%U#'$(Z,J1[^(.S/X=*'I MKY[I)Q)4L$0:B;)DX:Q<&AT=++]?/S_F:U_:I^GX%6=A_>';'^\8C[T9!^/:+_3!9:U.]*],L: M:(FII2](H"6QOT4A6\9S^FX@7:CDDSE])R[`IW/Z>EB`1^1`IVQ#+>1"1TI# M+3-JF05:LG0R5R4'^E"),5A.VE$DGU`B9>F0KBTT*&DOB:XM MU)(EY$,%'5X!?4A,[Q-JH4^!Y^IC7_2ACPC()]BG"?4I;5VC#VV"DT^HY3ZA M3*?/V]#G/E&Y'HKU?4))39]0H$\64T3I\`6VT%&1N3H(@BUTRF.NSG!@2Q;/ M2"TT.934H@XHH`^=/B"U4`N=LB*U4`SH&!6IA5KHG!2IA5JRF/*-]F/Q"NB< M$:F%6N@@$:F%6N@<**F%8DT'/4DMU$(G.4DMU)+%-!]0@1>Z-LJ=8`N=G".U MD$]&H0['DS*43G+CNV0QS1-ZY2/'%;6HP\_H0X>=22W40@>*22V4H71BF-1" M+70DF-3ZEL'Q$NB'C]Z6G]?_6.X^;U[W-\_K1WKP#ONON>WT3R?I?QS,]V,^ M;0_TFT>T3*"?CJ&?N%K3K[8,U3<2'[?;@_T'W&PO=V]R:W-H965TS"4W4)(JW:J[E7:EU6HOSXXQ8!4PLIVF M_?N=P02%)&W)"Y?A^!R?\8S-\O:E*IUGKK20],UD*NI\Y?[Y_7"S M[+A-7S) MI*JH@5>5$]TH3M-V4%62T/=GI**B=BU#HL9PR"P3C-]+MJMX;2R)XB4U,']= MB$8?V"HVAJZBZFG7W#!9-4"Q%:4PKRVIZU0L>BV!-\OP82R`W?[A_%T29XA=:S#W%D,7'M, MT",(B/;*H#9>&<&HC+G%J=S9P+%,>%DFND8&P2L7KOWDSPU:S.0(,[NL#)#Q M!A$,:P"VWI&VH!'24`_CI1'<2O?)[2+0)T>3>2G61P:2_@N<00W-^0^J0)GT_R_K_P```/__`P!02P,$ M%``&``@````A`'KS;G@P"```C",``!D```!X;"]W;W)K&ULK)I;C^*X%H7?1YK_@'@?(!=(@:IJU)![,M)H-.><9QI21=1`$$EU M=?_[68[MQ/;.T(5.OU2HS]LKSLJVO1-X_/W;Z3CZ6ESKLCH_C:W);#PJSKMJ M7YY?G\;_^3O\[6$\JIOM>;\]5N?B:?R]J,>_/__ZR^-[=?U2'XJB&4'A7#^- M#TUS64VG]>Y0G+;UI+H49[2\5-?3ML&_U]=I?;D6VWW;Z72:^7SJ#Y4[]&UW.?E MN8#;N$_L#GRNJB\L--DSA,Y3TCML[\"?U]&^>-F^'9N_JO>X*%\/#6[W'%?$ M+FRU_^X7]0Z.0F9BSYG2KCIB`/@[.I4L->#(]EM[?"_WS0&?O,G? MB[H)2R8Y'NW>ZJ8Z_4\$"2DN8@L1'(6(L[A;Q!$B.`J1Y<2S9DO'PT!NG-P5 M_7"45S!YF,_=Q<,/.D*VO70<1J(?CO<-$'.T/2&.'QK@ M4L3C>-<`+60=3P*6?N(&?\Q#J\L??/C0("V9+.S#1X8YY1G;3@!_VVR?'Z_5 M^PBK"LY87[9LC;)63$RF/L^5;C+\VUS`)&`JGYC,TQ@>(\UK3."OS\[,>IQ^ MQ:3;B9@UC3$B-C*"S3`FZYL@,$%H@L@$L0D2$Z0FR$R0*V`*XSKW8-C/<(_) M,/?D=:\EZ.VT=3,W,D)V\4T0F"`T062"V`2)"5(39";(%:!9A17I9UC%9)[& M^'LCT40,EI@N:&'8UX5T_A$2$!(2$A$2$Y(0DA*2$9*K1#,22_3/,)+)8-+C M=G4FT2G+@YQ;3G8AG9.$!(2$A$2$Q(0DA*2$9(3D*M&`$9JC)XAC+4A?4 M)0LA`2$A(1$A,2$)(2DA&2&Y2C1_<&%W^,.B=7\X49.%$)^0@)"0D(B0F)"$ MD)20C)!<)9H9*!XU,WA5-6&U=',H=U_6%58,%!4#*XZ#ZHG75$Q$]T@0MRL4 M-H+PAY*V9.+$P:*G+$JNGF=!%R3S+"0D(B0F)"$D)20C).<$#U@XNV8;JZ'_ M?]]:%=TXB13G)%*L$\AUVP+6GEG&]`SZ@,XW*=,OI@R!A;0MP'2)F$ MRJ1]E)`QJN6L#Y`RN909L):5L&JA/Y!Z>%B5N<<>28SD$\AV^NR34;VMOD#N MHHL**`IIQXA&Q10EM&-*HS**'KJ-MFY-5=K3;M'3G#[8A'A.FD?U>H\V#-CV<$NEW;!3+*XLOC9&%6 MC50YDGUN%J2QC)+*9LHG5#F5?6XJ9S)**AL/8+DFK-^.^YYO8*?Y?".0OFE; MQBS;,5+:- M!9%]*=N7,/Q^\"]9^7=,I^+Z6FR*X[$>[:HW]@4JWN\\/W:8?[N[7JSPV@V+ MD^B MVR<6D]OXCGI`9^VL\"Y_0-^%_J"0N\(K:]IA/5_A52WEON7ALH>,PCZ-RQYJ MP4:,RQYJP88&M2%[L45!;:@%FP[4AEI\:PZUH5&C8H7:4`M*4J@-M?C6`FI# MJ8(J#FI#+:C,H#;4XEL.U(9N#1[9H#;4@H-T" MM;9EV@T!OX6X;%^+/[;7U_)>6_IN#_--4%6R!^$5$U^!5$ M^_&`7[T4^*IWQA[N7ZJJD?\@T:?=[VB>_P$``/__`P!02P,$%``&``@````A M`-JXG(OA%```GVX``!D```!X;"]W;W)K&ULK)U; M#? MD2R?Y"%.?@1X`4@09+>D3__^X_GIXO?MV_YQ]_+YLMFXOKS8OMSM[A]??GR^ M_)__9/_J7U[L#[-W>OVA4J^[]Z>;P_TOV\_KO:O;]O;^U+I^>FJ=7W= MO7J^?7RYM#4,W]Y3Q^[[]\>[;;*[^_F\?3G82MZV3[<'ZO_^X?%U[VI[OGM/ M=<^W;[_]?/W7W>[YE:KX]OCT>/BSK/3RXOEN./KQLGN[_?9$X_ZCV;Z]O>WVN^^'!E5W93N*8QY<#:ZHIB^?[A]I!,;L%V_;[Y\OOS:'FU[S M\NK+I])`__NX_;4/_OMB_[#[E;\]WD\?7[9D;?*3\<"WW>XW(SJZ-XB4KT`[ M*SVP?+NXWWZ__?ET6.]^%=O''P\''1F0&-KS_,]GN[\BB5$VCU3$UW>V> MJ`/T[XOG1S,UR"*W?Y1_?SW>'QX^7[:ZEQ??MOM#]FBJNKRX^[D_[)[_SQ:6 M(ZF46ZQ,?UDYZC8ZO>NH26V]MY*(*Z&_K@=1H]>\'D0]JN1(ZVU6I+\UK1]1 MI&K+,=-?5J0JCLB304IY^LORS4ZCW^FTN_T37>RQ)OUUFLU&N]7I]4L+'6F3 MUF?9)OUES=9Q7PQ8@?XZA?>9L4ESSDX!,_EX#E"'CW2N6?*>UMSFBVC M.32UN4ADYU$5F_XJ-%%,,K5\-=5\OJ214/394SS]_0M%DT]7OU,,O&.9&Y1I M2HG829B`9ZI--$@UR#3(-2@T&&DPUF"BP52#F09S#18:+#58:;#68!.`*_)7 MY31:A'^'TTPUQFG.W#<.>"\J'\9.PJDD&J0:9!KD&A0:C#08:S#18*K!3(.Y M!@L-EAJL-%AKL`F`\!#%O+_#0Z::SY?T[R/+BF4H9E5"7;6N*I'*;4!2(!F0 M'$@!9`1D#&0"9`ID!F0.9`%D"60%9`UD$Q+A1MI__@XWFFHHP-)DJ5R$X=$* M1[S34$B`ID`Q(#J0`,@(R!C(!,@4R`S(' ML@"R!+("L@:R"8GP#DWY,[QCI*5W+(G\1A8#28"D0#(@.9`"R`C(&,@$R!3( M#,@3B\K#CA'GM\IK3;K8,;.T\)A%T:!R M8FS.4<:)'B6(4D09HAQ1@6B$:(QH@FB*:(9HCFB!:(EHA6B-:".0=(\Y^(;N ML;=_#7,_?GAXO/OM9D=[%ZV9FH46T2T?W_W9XS,UXY;+C;GS-3M7NT*Q0_9Q MAKW=XW,W'=N"8U5/[F8I*T:^K@Q1CJ@0+.'ZD*U=2T5)1A^D"U]AVJF`PVR99_*V95@47=@ MK\XCE=&EJ)(QZG=+E4&CJW:QW`OXV1&V+&>'.5B$)CFQ(NPY1(S=HC9%BV#L M^H[$/"I3E56+H)A[*6^&L!/2#":I/\,,]@P@ MS&!1FS+)JE-12Q]SS3,?/04LBD+[P6A25,P8=2F85BV"8NZEO!G"3D@SF`PY M-,/'%HC-LX5U+%*31,WVV#R'TI/$HBY-X&J040LF"2L*&_:45,;5=_OERNDW MNFK'R;V`MU78)6&KECXS?,A692TRKC)2P43U-6:I,)@PXF#2&BCSIJB2,:J" M2?]:_*,:S;UX92!1J300>4-,IN.AA492.C_()ABU_`89.ZD@CC@ICU*4RABU MN]5FFR,JA*("EBJ>\V;:#,2\UY5 MFGMQ;Z*P@])$)JT+3?2QP,`I9&@YB]0$4JL\-J]GJ"V&$06&,(CJ'(RE(IJY M5:AM01!EJ5Z+@VA'93FY%_"V"KLD;662O/^_K3C'#&W%":78CB.52,?F:DYM M.(QHPS$O,[0Z8"50R5BE+Z:X7[L;FG3$:=MO;*V8DPHZ5HHXX1Z8HE3'J^'B5(RJ$HAR-R@0K16>NN9=R]BM$7=(,)B<[ MPPPVA1-.M4A%!XBK8>YGW[5I622VERA2!ZW429V(#K8NVG',ZJ$42[6?DH(YF.1GIYL508/QBY=+2M M(RFJ9(PX'6U>-ZZ5:7,O4!FKV<3T:B\*'%"P5H`11BBA#E",J$(T0C1%-$$T1S1#-$2T0 M+1&M$*T1;022[C$)81BL3DPVSA_#R6:1?$@1J0@:1Y646P$)HA11ABA'5"`: M(1HCFB":(IHAFB-:(%HB6B%:(]H()#UFTM(S/&:S6!$>+%(>4W$\-E>8M!+% M&@.4HE2&*$=4(!HA&B.:()HBFB&:(UH@6B):(5HCV@@D/6:2[S,\QKEZN,8L M4AY3-T5Q5$GY-08H1:D,48ZH0#1"-$8T031%-$,T1[1`M$2T0K1&M!%(>NR\ MPXIY"U)O6A8ICZF;J9@5Q1JK%)T34Y3*$.6("D0C1&-$$T131#-$T M0+1$M$*T1K012+K'G);"$/BA,Y%93=IKC,)4EY&_`4A8T83HZF@31>J^+/52 M;NEEB')$!2-ZA$>*W,/1;%#ZOI%<)C!GLHT)[&F9D'J(% M`X2SBU4,']VRHGQTVX;S"RMZDQ:B$V+,YBQ_QIA+<7E^812.V2%_JDRB,"]G M).\LVCK+8ZGPSH(1WUDTKV$-V+8"E8Q5^,ZBW>A&X;7N0"4JN1?W!@HKE08R MQP1M(/HTZWGOZ;3M84,8R"(S2_W"A3M3I^B=F3`2%V!X9XJ*&:,^;2E5BZ"8 M>REO'>Y]V0EI'9.2A]8YOB6T;08OS&"1B495I_"A/2L&3D\8FRIO!=M5V0IK!Y+EGF,&(JUW"(C4;U-*.Z=%IJ1C.!HO$#3H^ MG7>*PECP8(FE^)%*.$79)&T5GLQT(+)K=MBU1H4:L\9BDQ9:PB MAY8N1!9;'&ADKBG[Q*C3T&]-Y5[`6R2L1EK$)'-G3!/._8($JFT1/0QUS<6, MPJM5."6A-&I MM0^*&2N>>!SOI9QE"M$)88;.>1EB*2[7/B.U]E4Z$SM%[]2$D5C[&`)1,6-T MXNF9EZK,(.J29C"I53@;/I1`T3-,'1D9J4FB(R-+A9.$D7SDWM;G))8RE\I^ M-X#(R%+\R#UJ1.HTDGL!;RL[%MLE:2N3CFE;G9UT=6Q2%RXH1GVQF>JG/K%3 M#&>2K8L?N>L7"E+4R%Q38D>!)^Y.RL7/MHK2A:A9&DEGIL=3BPZFH(S4S-'A MA:7$S+%UG0@OJ)@Q.I%:>"D_5_XR_^SH_/.$&3#1+&N`A_,07L(2";RB(9 M:SKZ*,O5GXHUMBZ.-1U\*,W5D("W5=@E:2N3GT&LZ9B/E9Z829S8^59N.A;) M\**#1;"(9G;L"E"!*$66(AF9V^8J[XHZ>G/V4LZ) M":(4488H1U0@&B$:(YH@FB*:(9HC6B!:(EHA6B/:""0]IO/SXPNJBXDXHV#U MQ(@21"FB#%&.J$`T0C1&-$$T131#-$>T0+1$M$*T1K012+JG[DAP]M[5Q2,! MHX'_Q&:,*$&4(LH0Y8@*1"-&]IE2F3&-&."F_$T\9F9<6`D5U*)BAXKQ>49TJ%T[1/^);.G2T MJRLGY;NZ?E>+&Z=8XWU]@/O08:6+YSJ'KL5IOZ,N..)`S$W?I(:E-2RK87D- M*VK8R#'O@[%#E"@'7E=7*1,GY16G#@E%?7\[<>Z05%3GLH63\HI+AX2B M_B3"RDEYQ;5#0K&K6MPXJ9KI8DYR[T]\N_;@%R:^C`;V@S7=1E,U'CL!_WF! MQ"':/[QGNNKZ/W527C%SR+YMCHWE3L#K%`[1E`X:4ZG?B*6"$]:8$=W+F%?; M5;28H,)4*ES30SMY*INASESJX(@6J+-4.K*1%2JLE0+X:"-TY&YB#N%G3!![ M9A<3Q**!^93][U]ZC39,$-8)3GWF::/9E&C7"7P&$P04,U8W+7BPH M,G7(-S]SR#<_=\A++1SR4DM&KGG]SM@*5=8.^8HW#I45"W]2Q7*/T?[\S^Z5 M]I13SQS*:N3>PRB\=4*4($H198AR1`6B$:(QH@FB*:(9HCFB!:(EHA6B-:*- M0-)MYI;O_;DD_2R'3@T8R6M<_9'3V$NY]98@2A%EB')$!:(1HC&B":(IHAFB M.:(%HB6B%:(U(O/[)\;0=M);C]G?,[&_'_"\??NQC;=/3_N+N]U/\ULEO3;M M)Q6V/Z1R$_6&YBUV,KDNZ0R&YG*_IJ1[/327R'4E]+LL=']94](C'9IC=275 M;[GH'C1;0_/E:#4Z$950LE97$E%)^>:3KBUJ4TFY9T))ATK*$`8E72HI-P!= M0@6UG,Q9:\W^<%/>%^EZR,BU-FZ2O>B;%FM&V"1[T8-T+*&;RJ&Y=,22FVXT M-+=U=25M*JFS"OW$SM?:NDSS=3612VKEC4-JY+^VAU]I"M=TB?Q4UZ$;\E*= MD[).>VA>#<":LDZ'2NIUNE12YT!ZX$HEM2XD\YI[:VR'[JF'YC(92^C=P*%Y M_:^NI$\E=5."WC^CDKI)0:]D4=_J)D76:5))G37I=1,JJ7-`UFY1.W6]IH\Z M#(O:$GJ+FG3J:R,OT&O!=2,E+]";LG4EY`7[)%\MBZQ%UJ'O(*C1:9%UZ./U M-24168<^9(XE]&D8*JFK[89&>E,[TIA*XMJ2E$K,B_?83D8E.7U,I*:D37VC M=XSJ2LAS]%9?34F+2FS&"-8AS]%W_]3ID'_LBY^@0_ZQ[U9`"7F!OOBCKC:: MO?1=&%A2-"ELV$M^75N3:J-/Y:`.?1\SV[[@_L?ZM15]=-R7_XK`````/__`P!02P,$%``&``@````A M`+"VZ8\/!@``I!<``!D```!X;"]W;W)K&ULK%A; MCZLV$'ZOU/^`>#\!3LQ\S'_/-V#/&FZ_O]=EZI4U;L:%VT"W:E%WAR M8$U==/!G]4GQW/=2.G+JJ++1CBYAX.=CA4)4U9^5+32R=(&GHN M.HB_/577=F"KRWOHZJ)Y?KE^*5E]!8JGZEQU/WI2VZK+^-OQPIKBZ0RZWTE0 ME`-W_X=!7U=EPUIVZ!9`YXA`3M_4CBW/-LYV'3 M)^COBKZURO^M]L3>?FFJ_6_5A4*VH4Z\`D^,/7/3;WL.@;-C>.=]!?YHK#T] M%"_G[D_V]BNMCJ<.RAV"(BXLWO](:5M"1H%FX86J*+PW(2/'> M_[Y5^^ZTM?UH$2Y=GX"Y]43;+J\XI6V5+VW'ZG^$$9%4@L23)/`[0W+#T9>. M\#LX!HLE<=?^$MY^PS&0CO`K':.[_("UEPN_TL\C"V\5DC#B>F^\,9*>\'M7 MJ(Y(=%^WM.B*ATW#WBS8#)#*]EKPK45B(!L*)EX]EO"_*@BEXR2/G&5KPRZ& MXK2P[%X?_"C<.*^P5$IILS-M"+9(!@N^+CAMJ@.9#N0*X("B41;4_G^0Q5FX MK"&@W0!,.CU-PV`QN*0ZD.E`K@!(`RQ#78,/.W)^+PV5X$ZP:VY60MI`N<=R M19J,T63482"9@>0J@J3`QM"E\+;PP57&66"=0K[&N,UE)HS\6^)&DU&<@60& MDJL($@="5'&WZ\.->PW#NW<"\9=(E5Z/T6AP2PTD,Y!<15#(D)W[0^;&.&2! M^-/&2`PD-9#,0'(50?%!,M3X>%?RP@7(^>"*X3PX=(%`Z.H:6FJK?S0:LVT@ MF8'D*H+4\-.-TF-O+Q!NC$,6B+\>VU!B(*F!9`:2JPB*;_V1^+@QCD\BKKHO M/4]OC,(JG-9,*A`?FH:RG5>X%-EH-)0B5XF0#`+-4F9K$9!B`LKXN/M[I5# MQ#"$_CA0[R04N/U,]EP2X'`2:>")$Y08NH+&Q^74'+/A92[IJ4,2:4IS1(UE M\8EWORQNK55$0(%X-\C2SAH)GQ'<)QA3D4HH6(KCR6KIXU1DD\&0OAS18`E\ MU-TO00Q&H!NH=T1`4V7TCB\-4&6DSTI(B$*M;V4#Z;3)^X^LY@?3.9Q>2.Q/OSH_A9L+4 M\1@`_ZS#.M[!H=ST2-9Q,OL@7S73ZR#V]&^=9_@-IS"99K+/Y\/ MC'7#'Q"M,]ZO/_P+``#__P,`4$L#!!0`!@`(````(0!19=K;P`@``+LE```9 M````>&PO=V]R:W-H965T\ZS)W$;8Y(XL-WIS+]?RI1L4?1IW6)>FN83R>@C19&2 M???;]\MY]JVHF[*ZWL^=Q6H^*ZZ'ZEA>G^_G?_^5_+J=SYHVOQ[SJOS:DHVAE8N#;W\U/;WH+ELCF+*I;<861IZJ^Y"U\ MK9^7S:TN\F.G=#DOQ6JU7E[R\CI'"T$]Q4;U]%0>BJ@ZO%R*:XM&ZN*&FWM!3,+$0WC4-UA@G`W]FEE$L# M/))_[SY?RV-[NI^+S<(3_F;K@/SL2]&T22EMSF>'EZ:M+O]#*4?.JKO,\@B"$%SRV5..@$8TY%& M)_6Q_W^AAVA)(X_2ROT<]"&H#:S7;P_N1MPMO\$:.RB9/9=QJ$2H)>0BD&8C M&XAM(+&!U`8R`U@"YYXXK*J?0%Q:D<3UE/<:&#QA^2'4$EHELH'8!A(;2&T@ M,P#"$E+@)["45N[G\/>-\"H9R(!>:&W%MQ?IJ3,D9DC"D)0AF8D0_I#1/X&_ MM`()`D[NN?'UC4+N6P[H17H',"1F2,*0E"&9B1`'P%9F.F!\!]=I+(4[GGI^ M>T13HM*4QI(>(.>1LR)&)(S)"$ M(2E#,A,A',"ITSE(8!@AL:S0M,+]:%A2,R0A"$I0S(3(;1@0M-I26%* M"Q$S-`R)&!(S)&%(RI#,1`B''>6`57$ANX?V5!Z^[BO(!B@L(]GD0O7#FBAM M4&H*\?IJ$2H$>ZBNY"'B0C[W"2>$54+B7DA'-6%(RI`,$>CC0(NP=:!!-$/V M*;J=$#C^"'DE,2@E MRHYKEB,AK,Q/]317#MH6J\V6;@X9F1!=$;*?F.X1[#Z(1Q#R8/:]1Z#[IA,( M9465.3(LD$A!`E>#L_*W5I<8.I9,.`CIF&3%#R6>WP_:%D$=(N/V*#QTE989?20U0S*42!7GKWE;*H8PH4C*R M#9E.!IL60@8A*Y(;&I3002D2206IK5MX:VNEQEPI4=![6S.ZI!`FY&A;)*9#A(ZZ>/M2(6$7]MG_02+=!9IJQD@9_."ML!DE,(06.G6%F=2"BO MZJWN7$&J/?/6[HH6RG@0T)Y(B!E*0;8(TRFH'L,,#$)#8.P.3*@FQ`R,TL$. M#*[QK%H?*QUO6&X),4,IR%(]G0(6=A(%A(8H6-,)H7]F45`ZZL3,DBA6.A"F M(0JF&4I!5O?I%+`7(!00&J)@%U&!`B0]$%K+ZY)O#^LU6T?]^,#`M$(96&W" M.^6%]P("(>N,PV@HQ:&CC93B&G<&Q\J@>!@>6)A&"`OW0Q6_DZ857T'FL5-! MIN<59!PH8PXE1)%.TZKEGRH/+B_Q"B(Q<-A.JQ6-&&C%'1ZIUEO/V@7B0:(/ M`[%#^7VHELO]7>Z1QJ:D(!(&E")A0,@?=J98*1I0HB!4I-,TJS1L:6^O>9>7 M8P41?[M;*P]#K6CZ&VVI-;_SK"XL5BHP/GA;_7QGA=*095)O/N_3P*)*O(T0 M\39"Q-L(D47/H$3>NO;G=3I-L]C"-#^WZ'D-AH?X\A>M(%BW5Z&2@FL.[=%( M06O(H[Z98G>`L9;2UXO;G55=$F(:*>-;`?B0^%+4ST58G,_-[%"]R"?^$-V' MNQ[&UQ'V0@2RH83962/PHL+C&+Z'%QBZE6_)[Z6A$3M[%UYX&,$?O>`1*/`? MWGL!/!,;P?T`'BJ-X.L`'M2,X)L`GG2,X-L`GAYP'"I"(+?]D1%W%V@9$QKT5B"R-C?ML[X%"X".`S@(,ZC(QY="]6L%K&/+H7L+XP_ZT%%NT" M>#+"?P6>*(!OQFS!Y3*,C,4`[F9A9,QK<(T)(^,Q\&&D\^>RGQJ\.G/+GXO_ MY/5S>6UFY^()$FW5/6ZJ\>4;_-)6-R@U\/Y,U<([,]V_)WA)JH"KXY6\%'FJ MJE9_`8K+_K6KAW\```#__P,`4$L#!!0`!@`(````(0"-R.M&PO=V]R:W-H965TO^ZMK2JSC;<$;W4).G\'2F_7'#ZN]-@^V!G`$ M&5J;T]JY+F/,BAH4MY'NH,4OI3:*.UR:BMG.`"_Z3:IA:1S/F>*RI8$A,Y=P MZ+*4`NZTV"EH72`QT'"'^=M:=O:%38E+Z!0W#[ON2FC5(<56-M(]]Z24*)%] MK5IM^+9!WT_)E(L7[GYQ0J^D,-KJTD5(QT*BIYZ7;,F0:;TJ)#KP92<&RIQN MDNQV0=EZU=?GCX2]/?A-;*WWGXTLOLD6L-C8)M^`K=8/'OJU\"'ZGWG\!6=4.NSU#0]Y75CS?@1584*2)TIEG$KK!!/!)E/23@07A M3_U[+PM7YS2=1HLD7DX6R+(%Z^ZEIZ1$[*S3ZF\`)0-5($D'$GP/))-Y-%O$ MDP0UWR%A(:'>WQUW?+TR>D]P9E#2=MQ/8)(A\7E#Z,1C-QZ<4YQIS-5B$Q[7 MZ6RQ8H]8.3%@;@,&GR,F&1$,14=E5+M"< MXG-,_M1@P$P/,//SR@BYW*`'8P_0UAO2`72!-,[#H;0?UW3Q7G?]ICZ%L-YU@XO@OYGC?<^X-#'$8)+K=W+`H79^$^R_@<` M`/__`P!02P,$%``&``@````A`($+H@_D!0``Z!8``!D```!X;"]W;W)K&ULK%C;CJ-&$'V/E']`O*]Q<[.-;*_&!I*5$BF*-LDS M@]LV&F,L8"[[]SE--]`7=N1=S74HKJ>-_<_7]-/2MIHVNQZR2W6E&_L;;>S/VU]_6;]6]5-SIK2U8.': M;.QSV]XBQVGR,RVS9E;=Z!4KQZHNLQ9?ZY/3W&J:'3JE\N*X\WGHE%EQM;F% MJ+['1G4\%CF-J_RYI->6&ZGI)6OA?W,N;DUOKE3>8>"PN M1?NM,VI;91Y].5VK.GN\@/<;\;.\M]U],MO=7'XH[A21!MY8AEX MK*HG)OKEP"`H.X9VVF7@K]HZT&/V?&G_KEY_I\7IW"+=`1@Q8M'A6TR;'!&% MF9D;,$MY=8$#^&N5!3L:B$CVUGV^%H?VO+%=,O/=8+$DD+<>:=.F!;-I6_ES MTU;E?UR*"%O'"?KWOA+%C,O<[(.XJ^4,2G4%S,%F2^\A;8_!T]K'9N MX[-W&P27`0E"YO8[FJ'0Q.==KCH\8%W\XZS-MNNZ>K5PJ!&1YI:Q*T(B&.L# MS[<>4O&]3"`%S,@#L[*Q<1L1XP;'YV7K!F3MO"#EN9#9F3*:Q+Z78/EE9F,= M2'0@E0`'C`9:2.4'T&)6&*W>H5T/2#Q5EOM>HE>)=2#1@50"%`XXAA_`@5G9 MV/C[3FJ$#/(_"(4:KT%D(&8@B8&D,J)PPTWY`&[,"@XN`CCX;9X[+N2]1VX0 M&<@92&(@J8PHY'!U97+31:R_.DRXX]#OO>.(MU!8N5H^!J%>+3:0Q$!2&5%< M1G3N=YD)JRYSQ!MORMY`8@-)#"25$<4_!$/VCY6I`'?_!\L4LZ(ZSA$X+I\@ M3XOU(#3$VD`2`TEE1.'"AA:IY+Y_/)BPZC)'Y%@;2&P@B8&D,J+XMU+]8['V MEJSO_FBXF2'5=XYHX?:U<`]"0[@-)#&05$84.@33R/WQ[J15IP7DK88^L#>A MV(02$TH52'63M;*[CP7AC0^EKP_23D!:<`,MN*-4KQB;4&)"J0*IGK,&=K_G MO-TIGG-(/M*LIN/L2%!L0HD)I0JDNLF:T?UN\M8%R[RIUT%?W`@)BJ) MAV%,C&B\72F$.!3@0R*D=QHB%&5"0E$F9$"IHJ@28GU((C3A.,K-X#F3UJXD MA]PYGS7G1*\A[,<#=%P^X/,L<"AD(7G9^BNMRB="!>M]QE/%BLJ`=:K[&?"^ MIL2>0V[8,S`NJM#Q!W=BPJ&0LP[(4KW;R;@^,I"MJ`Q8?[J?`>]F"@,.C3G0 M1T8B!.0<<$CD(-!_(R1"14$B2@$$$?BIH;Z!Q'J8&C8DOE MJ+7FG^-H=FQ4IZY((82CJ[YVHO:]E)1"`?GH*Z.BJ]7`1$B%"U[P2*A5O%2Q MK#+66KK.^&MU^U['D0HW7HSTPMU#8\+V)A2;4&)"[$&J,]_9XN[S!R;^P%'2 M^D3W]')IK+QZ9H]'4-BN!YB_;.T6$29U'`(=7T:8D"?P5811#S#]#2UXF*EFS"TW6.RBM@]-'5B=QXE.*KF"M[H'J9L[=CV$_([;#XI[T5I MUP,UGQY\V)]4\"/\%C8=V@41?G!.X&&$'WHF'A,/I*>VCHF/E:D]8A)@96H7 M=$NL3.^SP,I4TF.RQ$J7=F=@CW?&6W:B?V;UJ;@VUH4><93FW?15\Y=*_J45 M=^*Q:O'`V%V/,UZ4*1ZRYC/,'L>J:OLO(.\,;]3;_P$``/__`P!02P,$%``& M``@````A`)CYM56'`@``AP8``!D```!X;"]W;W)K&ULE%5=;YLP%'V?M/]@^;T8:#X:%%*EJ[I5VJ1IVL>S8RY@%6-D.TW[[W>- M*6J:;*(O$%^.S[GG^OIF??VD&O((QDK=YC2)8DJ@%;J0;9737S_O+JXHL8ZW M!6]T"SE]!DNO-Q\_K`_:/-@:P!%D:&U.:^>ZC#$K:E#<1KJ#%K^4VBCN<&DJ M9CL#O.@WJ8:E<;Q@BLN6!H;,3.'092D%W&JQ5]"Z0&*@X0[SM[7L[`N;$E/H M%#R^ZP_@NR$%E'S?N!_Z\`5D53L\[3D:\KZRXOD6 MK,""(DV4SCV3T`TF@$^BI.\,+`A_ZM\'6;@ZI^E5-$OGRZL$\60'UMU)STF) MV%NGU9^`2@:NP)(.+/@>6"X7T7P97TX@82&CWN`M=WRS-OI`L&E0TG;G%-L:LS5XBD\;N;+-7O$RHD!\_K[-HM7$>+_ MWZ!^W['$$#GJE'G\QDVX^.%>*#`5?(*FL43HO;_4*7;Z&!WGS3;UW?@V/LNV M_1QBXP><`QVOX!LWE6PM::!$RCA:8IE-F"1AX72'F>,PT`X'0/^SQH$/V.UQ MA.!2:_>R0&$V_H5L_@(``/__`P!02P,$%``&``@````A`$0J>UC'!@``A"`` M`!@```!X;"]W;W)K=3O?CF4U(@AI"!&RW_>]OS#@$#\B0OFP2_/'$WYEA/,'[ M_.%[<5Y\RZHZ+R];BRT=:Y%==N4^OQRWUC]_?WI:6XNZ22_[]%Q>LJWU(ZNM M#R^__O+\7E9?ZU.6-0NP<*FWUJEIKAO;KG>GK$CK97G-+C!R**LB;>!C=;3K M:Y6E^W92<;:YXZSL(LTO%EK85'-LE(=#OLN2RBI]/8/N[\Q+=S?;[8>! M^2+?565='IHEF+-QH4/-H1W:8.GE>9^#`NGV194=MM9'MA$NM^R7Y]9!_^;9 M>]U[OZA/Y?MO5;[_DE\R\#;$24;@M2R_2O3S7EZ"R?9@]J_OZ MGN^;T]9R5TL_<%P&^.(UJYM/N31I+79O=5,6_R'$E"DTPI41>%5&PMES7347 M7M5,H*O"HK'-[.7#X(;7T`K[+D1U/!X0"#GGHYS43@6ZAB3Z]L*8^VQ_@\#O%!,A M`_=MC_%T)AYC?)U)QIB5SH@A$[`.L4%I)Q="_KA<.4F7NR:KC!!9MVDF7133 M"PF]('H7M"5"9O67:(Z$A+<6F.IY.>BDM]&*D%EAG'SNKM9#F^FS1'V=.X'MW`YHN2/"^KGF9)B=!1FKZ[O91'S+PM_,!R8]XDD@F"6$B M-)UP%_5UFN,G81J_4'=PA(S7QL\+B?JX/WI/^M8S27_,"TE>B-OHF-\T12M= MT;S(R4E$&7>(,F1,D4,B:+4'XB%X:!@3IL11D27*??^GLQY.P/#CL&\J2O(*!?M&)!DVHHP(KI: M^*:^6G,M99(F-R4C&1LZ"KDVW!?'781.CJ2`I&S-1IJ"Q% M1-5=*(ND*4BF;0@CHFN4+<)\C=A0Z!H'6R-"*,#C\%->[U-C9FI+5`PG$:&L MC'V-KE"V"3V%,^]';"YTI>3'0L00PB4\^2PD75"L`"Q(3V0T&4PGR2ZZZ9.I MRDF',T]D.XL454Z+JH*42'@VX_EDG?$TDBC$4+J$$=%"RA_J=EJ:J'2)A$A! MJ)+S@'ODUHT5<>MVR'"B&?"ZVYFV(HR(KA86\T!0 M)4V".NAVY#-.@%1"]K()]Y%N>*QX8)7MD':GI!9$-SQF05?W4SV/?,)+50X> M:BC(&$NT@ZGKP5,-AX^I^=1$"I]X@[=26,%&)5J?=/0AC#:T)3*TY5^ M+.)1!$&9P@CHFM]J.UQ1Q[RT-\2D8+P-(,' MS`_)8Z"8$+3MT8;=T*/I(#2`NVS=.R_1U3W4]L"IZF#O<.\-55L5(P49O!\K M!(/,@]7:Y?3L+9DV(P]Y<2\>*]$H$P]Q\;2PR*IC%F?G<[W8E6_R@%;6_NXJ M'AY';!.U9\?D>LPV\=CUA&W@6`P.>0DOX!"ZO6YW`W`&?$V/V1]I=*< M'6`)SC*`C;3"4V3\T)37]J3NM6S@]+=]>X+3_@R.Y)PEP(>R;&X?Y#EU]_\# M+_\#``#__P,`4$L#!!0`!@`(````(0"72?Q=M@<``*`B```8````>&PO=V]R M:W-H965T&ULG%I=;Z-&%'VOU/]@^3TQ,S!@HB2KPFC;2JU4 M5?UX)C:.T=K&`K+9_?>]PQU@[L7!N"^[L>_ASKE?<\;`XZ=OQ\/B:U[517EZ M6HI[;[G(3YMR6YQ>GY9___7Y;KUNCEEQ6J*'AVJ.CW*W*S:Y+C=OQ_S4H),J/V0-\*_WQ;GNO!TW<]P=L^K+ MV_EN4Q[/X.*E.!3-]];IBJK[.4`<7\30;;I?+G[<%A"!2?NBRG=/RY_$@P[D3Y`N"+E[QN/A?&Y7*Q>:N;\O@O@H1UA4ZD=1(`>VN'KZ8O7B&1-BZ= M-=GS8U6^+Z!98*GZG)G6$P_@L`L(E^]#_"A"",TX^A+2B`9 M0Q@B'2-\GSK18\@Z["$D#)^&,4W?@*%=W/3YJO?;YBM!#)2Q3_&P,0>QB&O.N)77G>4#Q".[J%M@%3VL*/&&_$(.\[$7F!H("4 M`*`MUM2NB5W%8KB>$#<*[NR3T_DV8$ZS/8]\>Q5C[V0' M^]R"D%^@!@+8YL3L2][EO?G2C)/T"Z-=LQNF1;/]A7=R8D%3&\QUB)Z$T!", MDLT/`76/;/$!D\]$(,B.:RP\CR%2BA"@$JQ$FB)D+-4@))2_D;+Y_%'X*']6 M_T0@"/G[4;SFW4\`H:>8`TWL`LY]@T10[D;,YG-'Z7.Y\\E+!&)LZ@,1,VHI M!2CI[(3M;&@*\(-X")YR-R(VGSM*'N$^.+9#BYB.NQ>,N'>Z:8Z>=[&354N= M.!"ADQU*WB[U@.^6`C&XW]S)F-E3:A=\Z#6Q0\/UZD5Y&Q6;SQLU MC_`>^M"F'#&6=SBH8FM.!3%'PP3:?+MFY0VB35D;'9O/&E4/)K`_7XF`+9R( M3AH'$(LLO0[1DQ`:@A$T)X292H4RZ!9`!,.)R5;`U4JY#KU1#5S`6L8L4"U< M>ZB;%LU%EJV<6!#.JXC"D._R!*!\S^EK;"`"`'LP+$')WR2S M$G]0TA8:FA/S;D%3,GL=HB%KN3?H'G^AUW!AH`@NU^*V!-\PY0$ MH<*(=9^F`!$XO\8H>Z.(-P^`1!T%$LXLLZTQL2`;A51P6NAWOS;.E"*$BL0H M#%RHRT0@Q%!N&L=-@BO'@BOX63*Q(+MV`&N/JD`T60J?_P[0U(=0RCE24?Y& MX9PZ7.DBU$,R"(KM+XFY)06M-CD(5R%ZT@L-X2;QE6/Q%8KM,XD%614+0B87 MJ;5W[2$CUF&:`40TC!KE;@1O?OI1'DG[\Z-B(A'4M4\8#$O;[B<`/Q(C\@0` M`C%XH.29#L\3,8E22X-@"4XL"(.0(70X'V'TTE5@'?*;?9)U_R8!;M&_B6RMG*C'U MQ,6=@%U_\$'I0P.XV9_7^KZYBH;1#;(J77(7H2 M0D.X28/]"QK,S_J)!=G\*X\?@I@]8-N!IO;HH[L]OA$[IX.F#T`MFDTPW]\3 M"T+F00`/Z9AX$8`?AO&(NZO`OHRB(7B:]@L*?/VAA(_:24YQ_(B36-!D!Z&? M"8B>]$)#N4F&_0LR''(9MJ"N#CS$E-BEXK>D-;&KV+EI0)@'-REQB^8=-/Q* MQ0W4@B8RFUZ':`NQ\2LU*`WE?Y,4!RBB=.]D_9M8T"1_]#,!T=8+\E?N(P/* MGVGQ]`3#8_Z1!CL'7)M_!.$SQ0@>LK,!MDZL'>2)VLV[!&81M*M@U#GXH@`^ M4#_FU6N>YH=#O=B4;^8E``$/=_IO\06%!%Y0:)_FKWH#O!]PSE[SW[/JM3C5 MBT.^@TN]^PCDH<(W#/!#4Y[;Q]E'OW`-Z59=-],.\P M].^6//\'``#__P,`4$L#!!0`!@`(````(0#7IX(/I`(``%8'```8````>&PO M=V]R:W-H965T&ULE%5=;YLP%'V?M/^`_%X,)$T6%%*EJ[I5 MVJ1IVL>S8PQ8Q1C93M/^^]V+*0U-U-$7/B['Y]QS?7U97SVJ.G@0QDK=9"0. M(Q*(ANM<-F5&?O^ZO?A$`NM8D[-:-R(C3\*2J\W'#^N#-O>V$L(%P-#8C%3. MM2FEEE=",1OJ5C3PI=!&,0>OIJ2V-8+EW2)5TR2*%E0QV1#/D)HI'+HH)!26ZTU84+@8[Z1$\]K^B*`M-FG4MP@&4/C"@RLHW3ZQ6A MFW57GS]2'.S1D/6B"-#35=&D$=])#9>+]T@A>"S51[I. M'[7'[E!<-1;H(\>=$B_C\UYP6D\^#`@>2_614R^K,6\W/98K M'!7_L8,+QQI]9&SG=>O[.>;/N1*F%)]%7=N`ZSW.J`1.[A`=QN M5M&J*HI\1=@];E^^?;S^G]_TWY?7 M5X?C^N5Q_;1[V7R\_FMSN/['I__XVX>?N_WOA^^;S?&*>G@Y?+S^?CR^WMW> M'AZ^;Y[7AYO=Z^:%6K[N]L_K(_VY_W9[>-UOUH^]T_/3;3V9S&^?U]N7Z]## MW?X]?>R^?MT^;+K=PX_GS$]W3VO][__>/W[ MP^[YE;KXLGW:'O_J.[V^>GZX<]]>=OOUER>*^\]JNGY(??=_0/?/VX?][K#[ M>KRA[F[#@6+,J]O5+?7TZM[ZH4$9 M6?_Y\;JF+]X^'K]_O&[F-[/%I*G(_.K+YG#46]_E]=7#C\-Q]_Q_P:B*785. MFM@)?<9.ZNE-O9Q5L[GOY83G-'K29_*>8W+J(G?9[UC72J]4=*G^D;3Z=S%1WH\SU?=!M*VH^0;GU< M?_JPW_V\HM..ON7PNO8G<75'?:6A$9(Z#)9?C14:)+Z3S[Z7C]=T\#0,#C3` M__A4+9H/MW_0H'R(-O',,>W[X0$'0@&7E9V)R@Y&0V6!*"`:B`%B@;B2L!S0(98Y M.#V$O3$/-)"RLD`Z(`J(!F*`6""N)"PJ6J'+J"ZNK.^'!QR(J*RCH;)` M%!`-Q`"Q0%Q)6`XJ6IW*))PN;6_-0XVH+"ZB#I%"I!$91!:18XC'YP6*D&07 MG;Y54#JT)J5RW4RFK'951 M7L6Z[)CZ4H@T(H/((G(,\6QX25)DXXUJ!P'#0HZ:)@?35H`Z1`J11F00642. M(1Z?5R+OCR_H%A9?E#*T0A3::B5+.EBE^G5>TLH!#DBCE4%D$3F&>,A>IKP_ MY"!J6,BESNFO"]L*4(=((=*(#"*+R#'$X_,2I(CO\A,X:!D6^B!OBFHO)[+: M@U6N-B!5`=*(#"*+R#'$L^&E2Y&--T[@('18R*7VB=4&U%6`%"*-R""RB!Q# M/#XO2XKX?+47M!EVMK:N@KYAH0^2IZQV):L]6.5J`U*Q^V(]TX@,(HO(,<2R M49\EQ7IK+L4B*@ZS1=0A4H@T(H/((G(,\?B$%#L]FFO46Q'Q%7@)&T#!L'PC M>FM&^3_STKA&M161J+78!6VS52ILAT@ATH@,(HO(,<1S<9;:JE%M150,W!91 MAT@ATH@,(HO(,<3C\P+G_6,YR"$VE@>%5,[(08 MXB&?I;9J5%L1L9*BVD(KA4@C,H@L(L<0C\^KF**D?OUMEOZVU=EG<-!#K-R# M1"K++;>WZL$JG\&`%%II1`:11>08XNGP.JA(QQNS=5!-+&004FT-J$.D$&E$ M!I%%Y!CB\7EE4\3GRWW);!T$$@M\T$QEK>6&5SU8Y5H#4FBE$1E$%I%CB.7" MWY4I6V&I0;$4D%F"YN96MAI(B M4H@T(H/((G(,\9#/$EL-BJV(6$E!?W5HI1!I1`:11>08XO&-B*V+MC(;E%L1 MB6K+S:ULE:L=^BIRIM!*(S*(+"+'$,_&67*K0;D54;,:MOA:1!TBA4@C,H@L M(L<0C\_K(#%95_/937[8XMW/$S1!4I43=D2BWG+G*UOE>H,\4VBE$1E$%I%C MB.?C+"WF[PJ+>S(1%2.U1=0A4H@T(H/((G(,\?B\ZBGJ_<:"%#02*VE$TV(\ M1Q0>0^H?`O'WD;V\IM,V;WFNQ":8RE:I\!J10601N8AH3Y/ZXB&?I;?\6)4E MC:@,.:(RY(!$R&(G2,7NR2J'/#@F9-#*(G+I4$="]GJGJ+*78%4XJ8_?MP^_ MW^\\&'U@I*$G@<+S031E028B*C,149F)@/RD4Q1?;*"HV#U9I;`U(H/((G(1 MC11_*@3819GH.^&Z+*%\]&U"12826O2/5]632NPLJ&20;WWHA%;)1R3.)(/L M8Q,:?,2P<\D`A\KT+`776XM,!%'G-^2*:HM`V^A(>UBIVEU"=1]H,ZNGU41( M`95LLIM.*+I-R*\1X9IDD]UL0L&MGB[K9BH6(I=L>CE M2RB?-2JA;*43RE8FH6QE$\I6+J&1DIZE[*:H["+R^Q[%P)<[#\DQE[1+CF%6 M:&;3>0/C/GY=]M+"JY[,5^(RR>!W6>Y5KYKE0A3%,2\^*L;$X;G+R!1E841B ML,CK^&25"]PEM`QS8^/#$=.C2C;932<4W2:+R40^Z6J237:S"06W:EZOEHV8 MUURR&1E?0DGZE<=O"KU_`9ZBNHQ(C#DQ#MKDF$=/EQSC"K&8TD/<4HZAFQ9N MS6JR6`@W@VZ6NU6KNEE,Q$$ZYL:'G1>/0KV51 MT"441L%B,9NMA)=*)ME+)Q2\YO.*_N4W!4TRR5XVH>`UFRWG4S&\73(9&7!> M1_[_TA95;9FV@,2`$PMG.XV.Y8"+CF'`S2?U5,P["IUT1+2?YA]'GRZF$S$I M&'2RW*F9SV2F'7/B0\U+59&SLX7R-$K@,FT!L=%&/Z#A(Z"-CDP41>T\Z3.P MJ&:T/'`OA5XZ(MJG\WF;5_1#"[$.&?2RW&M6UY.E&*..>;',S=X0UK_M7G]U MB4$;_^D:H^^%*Z6(2J64K(KAE:PR4FBETB(F$IVLAFY6D_(? M>>(E\Y.=VF25.N5#UZ7F7W7",^TE;;-5SL;@F)!"*XW((+*('$,\&T)YOS'V46+/`F)C'U"' M5@J11F00642.(1[?B#BNJNDEV\XS5,D1B7J+%;'-5JFX'2*%2",RB"PBQQ#/ MAY"\;]0;Y>TL(%9O0!U:*40:D4%D$3F&>'Q>#;Y_+H]RLA!4LX!$2<4BU6:K M7-+!,2&%5AJ10601.89XR%[)O3_DH/O*G?99E(+E\@6H0RN%2",RB"PBQQ"+ M;SXJ`&DI.O.IK+X?OG!')(HM9$Z;K5)E.T0*D49D$%E$CB&>#*$*3Y^_Y>_ M=C3)L?]&'M^(PCJ_AJBNYA&584=4AAW1+V^%I&ZRCTYH\!%9,LE@)%@O=MX] M^\Z#-"IGWXC*R]!DE0/MDE5&"JTT6AEFQZMT3:DG)QBW]E+`R&59`[>MY;U3Q.?GM,L>>E]$Y53&'I`HM]S>BXXL'8-C+C<@C8X&D47D&.+I M.$N/^:C;.$VA*%6D2LVBC4T$HATH@,(HO(,<3C\_I'"+6+9/DR"*ER$RDB M46UQ.=UFJUQM$&4*K30B@\@B<@SQ;)RETY:HTR)BU0Y6!>K02B'2B`PBB\@Q MQ.,3.NWT4D4O>)4Z-")14KFSE*UR24-?11846FE$!I%%Y-]%ZP\U=!]"#N^6 M#6\.?=[LOVW:S=/3X>IA]\._-Y8NQ#]]&'!XJ>W]TK_5MM_6@9::6OI+$&AI MJ*5_KAE:IM32;ZY!RXQ:^EU;:)E32_]>7=FR(!\2X)10:"$?$J-C+0MJ68RV M+*FEWUV'WE;4TO]<2[8L)W1L_6M[96:-K''6BC7X=%)B)1R36\3&?&IR(?> M6S?60CYAZ9:]591K>OO9F`_E.MP\`!_*=?@U$K10KNG%5".]^8$XQLEAU-Y/ M;6/VE.31'%.*1S-<48;IS89X1%VSN/,_M1MK65++V+=TS8I:QKZ'[N+>^1NR MV!N]2OWS&+_WQ1JQO_?E'>/^1!KAGZ=WG\>7%*I?/RG<#E6B5ZB_KK]M_G.] M_[9].5P];;[24CGI+_7VX27LX8]C?+SUR^Y(+T^G*SIZ#3>]+']#;\">^#=+ M?=WMCND/BOAV>/W^IW\)````__\#`%!+`P04``8`"````"$`_:Z=4I$&``"3 M&0``&````'AL+W=O:6@#H]ZH1PD7:EU6HOSS0A">H0(J"G9_Y^R]@&V\7VI$?STND<5QUYM^=JULG MV.KB'KHZ;U]>;Y^*IKX!Q7-UJ?IO`ZEIU$68G:Y-FS]?(.ZOQ,T+P3U\0?1U M5;1-UQS[!=`MV41QS,$R6`+3X\.A@@BH[$9;'C?F$PDSLC:7CP^#0/]4Y5LG M_6]TY^8M::O#;]6U!+4A3S0#STWS0DVS`X7`>8F\XR$#?[3&H3SFKY?^S^8M M+:O3N8=T>Q`1#2P\?(O*K@!%@69A>Y2I:"XP`?AKU!4M#5`D_SI\OE6'_KPQ M;<K^TG`<@@#/CF)MU@1*W`^P+'B'/#YXQ.!=35,!#X_.I$E2\V0Z2CO M\\>'MGDS8/E`$KI;3A(3%"$H2D",ED1%$$-HN?H`AE@44%LK\C"3-RWI-D-!DE0<@> M(3%"$H2D",ED1)$$MCY9DOD#0&P&U'B(7,QXRQ`'-C])"WWUCT;"+4+('B$Q M0A*$I`C)9$0)%#)Q?Z#46`V4(CD(%#]#7)>=B19Q MM-#'\3%TSC&54#+:#.>J133YTG%<<&2<`PL!)[PLQ$S"H;D2&:?&:L0,@29. M/&G';28-(H:X_FBS1TB,O!)DDR(DD[V4]!+H;.\/:[!6X^*0"SQ2F6JYVG$K MF_6IK$&A3X9S3]WE72W)PM$>JL#W5KZ6PEA83-0)A]ZG3H4CH_8LQUFK#\^$ MQ4"MRD8[(6E9O%\-A/5-<*")Y&\YY,*())NG3F`G'*4:$8XKMBQ6P0I)QI[F MKL:GQ9@G47E(L/*UZ-/)0LPZ4WA406B/)`E"]TG;6\`V^1UI6&^E2,,@K:+T M=H=V!U`^2D5QQS63AOBV=D[NN9,[[1`QYDDF*[IK$!]*0\U+.EE,TLCS4:6A MW9(F#8'7H`\=(82U7/!@\<0MA[026JE3W0E'N808EQL,.I&U[6IK:B^H@_%I M,>9))BNFDQ5H/.ED(6:=*3RJ3K2%DG3Z3N&PADL1A$'NI-&.,$BI$@9YTWZQ MYU82%&/'!%NE&,H41S4^VCG='Q^UUK9:!FD)UY;MCMXR4$/'S>KP-->Q??<"2Q$?#'F228K*I1GVS[2:7R2X,D4'E4GVIY) M.GUG:?!F;IKBEC!(;C\XI-0)LY(;$&XE03%V3+!5BJ%,<53CHUV7%-^/U0%O MW>2P>7^G-">.EM(=W`.BHX0[PDXI'<_HI&56CL6;$]_52BS&U`F'W'>I4V[% MJ3W+=;59T]O+:=9,378;R>ZHZK(]E;OR%2`.-/;O@$$\4#6S>$5^89W`OA#7,&]T-X1\-X1+R0 M;EYX!#:KD.Y&>"0B/OC,L<&Z!9^YD8BLP&=HJ31)H/C!9VXD(C;XS,D%+0;X MS(U$Q`&?.2GAN`6?N9&(N.`SIR:<6>`S-Q+!I&?GO`[W<_E*UB&\+,UH&83P MDH+Q)`CA-03C$2$PU[G2@HX4YLI:[5%BN!*_Y:?R][P]5=?.N)1'*&1KZ)U: M=JG.OO3-#8X\N-MN>K@4'_X]PX\?)=R$6K0)/39-+[[`I);CSRF/_P$``/__ M`P!02P,$%``&``@````A`"$0$YLE#@``*$4``!D```!X;"]W;W)K&ULK)Q;;]LZ$L??%]CO8/C]Q)8MWX0F!XUUOV&Q.+O[[#I. M8S2.`]N]G&^_0Y$T.?RSB5WTI4E_G!E)P^%E1E0^_/EC]]S[MCDOVQN^W]OCOT_[_[YCP_?]X[%\W+]3RN#_L5B?Z[^'SX/AZV*P> M.J7=\V`T'$X'N]7VI2\M1(=+;.P?'[?K3;Q??]UM7D[2R&'SO#K1_1^?MJ]' M;6VWOL3<;G7X\O7UC_5^]THF/FV?MZ>_.Z/]WFX=%9]?]H?5IV=Z[A]!N%IK MV]U_P/QNNS[LC_O'TPV9&\@;Q6=>#!8#LG3WX6%+3R#\>G_??LL'VHMR\;\C;UD^B!3_O]%R%:/`A$R@/03KL> M^->A][!Y7'U]/OU[_SW?;#\_G:B[)_1$XL&BA[_CS7%-'B4S-Z.)L+3>/],- MT+^]W5:$!GED]:/[^7W[<'JBWZ8WH_DDF$Q)OO=I5H@':W M23_U`U[HFH72I)_G&[W(IP%%GPP&$8:RGV>7=4=PCB/ZY\;81#H"!*_7';'`SEVNJ$8KTZKNP^'_?<>S6_TS,?7E9@M M@TB8TX-07OX\+'\V*FDX"BL?A9G;/G4XC;A;1:#"0!D@+)@.1`"B`ED`I(#:0! MTMJ$^9#"YPH?"FGN0TG&9I9=`HF!)$!2(!F0'$@!I`12`:F!-$!:FS"'4;1< MX3`AS1TF"3G,#KJQ$W1GH7/0`4F`I$`R(#F0`D@)I`)2`VF`M#9A/J2'O\*' M0IK[4!([Z(#$0!(@*9`,2`ZD`%("J8#40!H@K4V8PVAO?X7#A#1WF"13FDFM MF2YT@NXL=`XZ(`F0%$@&)`=2`"F!5$!J(`V0UB;,AR+=N<*)G3CWHD)VW"&* M$26(4D09HAQ1@:A$5"&J$36(6H:X_\1VW4Y[WEYN18KH1*%"D]EY2[[4R*P? ML4)CVF19P3KAP9J@8HHH0Y0C*A1RKNAL74LCI<='A;9J(V7?_8S??6.DM*V6 MV>*.%UO[*QPO,P':/6K;]V(G27W!'*^0[7B)R`U:,=&*1BI%E"'*$14*6>9+ M1!4JUD;*=JG3/8V1TG??,EOMJNO]SO*?8H@CTQ/J94 M727P,@^@R^A+WHO"A/`TGVGGO/N72HH*=UHQUHC63"OJ%UPQT5)&,55HS*X8 M#KEB9J3T%7.T51@IZR9"I^)0&BEMJT);M9%ZPU9CI+2MEMGBO28R`;O7/+U# MUH?J7$YX)JB1 M*C2F2*/5`IUEWH,B+;FB!V46PWI0HI#F-N/6T,T_`J5H1D"LD9C^OMTY M"HEN-0JI0N&L4PB"P"UN9D9"#_X<[11&2EPXG+CN*HV`-E.AF=I("3/3R!E&(C3"(UP@)GQY&@1JK0 M1,7A:.'H9$9`>R1',X61$HZEMT#.:E<:`6VF0C.UD>KB:SYWQEMC!+29EIGA M_2-2*;M_WEDJ9.;%.D(BME0H*1/D<:"069`3C8Q4JA!;*J2BA7)4+%"Q1%2A M8HU2#:*6*7+_B33*]M^OQ;=,QIA;)7+BV]G=+P,IQ>);HHE9;A.42A6B5[#6 M](:KAK0U'LK5:!),G=UDCJ:+BTR72DJ9GL]#9U!5:+F^R'+#+0?3L;N*MLPT MZ\Z1F_NZW?G7_O5G^UUK1]69X3LJA>R<&%&,*$&4(LH0Y8@*1"6B"E&-J$'4 M,L3]>EU.3/'L[D@5XJ69T`G'I9'2^9Y>^8>R:35GF(48B&I4EN3Q\8HE2!*$66(+^ M2)*[6J!1K;_I)13-'$F\@054T09HAQ1H9!S16>HE$9*#Y4* M;=5&REHGQLY"JO-,J'HPD8HY7R':\1%8=)=&*1BI% ME"'*$14*6>9+1!4JUD;*=JG3/8V1,BZUGY&[U$U8W67KHC*-."#DU`$4>J=, MHQ7-YB[6B#;;)GURD\Y$2QG%5*%WRC1&2GLG1UN%D;)N`LHT1DK;JM!6;:3> ML-48*6VK9;9XKUV7I(XP256(QIJ^W%)+F5UUK*4,2E`J5(SE6Z&=E&M1(%7JG M3*,59:H93F9._2#7`N9>BHLLEUI1E6DF[AQ>:0%CN;[(7AV)G*6BV` M99J12.ZNZ$&51-I+@4H/WR[3=-?AM4N-9)D&EF-U)3-D4J6@RC3A>.CH9$9` MATFN+V+,%$:JJ]+0R4Q>@2Z-@#93H9E:H:G,S$*GE-"89FVD94;X.!)9GMT+ MO[9ZR%R1#2^)G.'EUFA&4HH-+XE^5J-!C52AG]=HC(#V2(YF"B/5U6B&$\>Q MI1'09BHT4QLIV&6J43CK',ML\Q[T\U[W=Z\K$0C%F)GLZN0G0\CBA$EB%)$&:(<48&H1%0A MJA$UB%J&N%]%GFJO`N_,,C*MM:=[D7"22\E_5KRZ=;VED=)37XPH090BRA#E MB`I$):(*48VH0=0RQ%TJ$K8K7"KS.^92E<.:A'4I,B/I9>,_0`E*I8@R1#FB M`E&)J$)4(VH0M0QQ__V6M':,::U"+*T-%L[LMM2*9CV,M:+ICP11RA3Y$UV7 M\HE#R^XD)1&M.6*Z'PT#=SNE=-AR(W7$V/_Y0I)H1;F/#Q;NJ[%4"^`^7AP- MOB;0,1/K+-SVZ76K>BQG$5LJ`7II;\)>96_JQ2DL3XDV:LY1I^(>2$FT41-Q*3/#GT'LFZ]X!KG- M9A..1*8?G/1D.58Z=C\H'=4/PZFSF"=*AU(GW70>RFKGB&3ISO=A4R M_>!LXI=*P.X'A:8R'5RX+Q82TWY^!&:%/\)OV7"*HP?.X%=(_#`#V4W^EEK1 MZB*MN.C";#$<.G-=8@3,\ZGK=V;X\[E;L+>W"B%NM12B'_IR2X58ITC%B2E) M)$K*0BE3Y/?I;FG)%95'QCM3M!XE8/P0P$VM%NQ^DXI1UH+NE3Y3B5,W$ M^`8S9:;E,\M/8>7W=[O-X?-FN7E^/O;6^Z_B,]>9&)QG++_!O1^/(K$AI"Z` MEC&U=%5%:`FII7LBMV4>T;ELCZU%1&>-/3P81N(4K:=E1"WT+M'70I\-RPAQ MKSZB9Z&7/:@3AZ-(A`VVT#?('WW\GB[2A1Q<@R[AL7,OG.7A'\/H(W447OB> M?.AUX22B#U`\\M.(OK/P\%E$WPX@IVU*)/8EOI89M?AUYM3BZ\!XO*`67Q?& MX9!=$JM1$&=4Z\-ZH^!*)^@JV4#TE$B43;*%J1)11ZHLM5&Z( M1'T!6ZB>$(D"`K90#9SNS>=I*G+3O?E:J(I-]^9KH8HA6?-YE(J`9,W70G4] MLN9KH;=ZI..+&GIM%XGW3/@\]/:.K/DBD%Y"48M/AU[<493[6NC5##V/+ZKH M10O=FZ^%7IO0=7PM]W2=>^]UEM2R]+;$U!)[6^C]:23>[J$/Z#4JW;6OA5Z= M1N+%GDVT"&N2)S3PA8ZEQ6)HU?80J>:R)JW3ZE%G%-"'3J71-9\ M+7279J\>G0-P`T0_M:Z)0W/8\OXNG,-MV;KX5.8--U M?"WW=!WQ30#>-7V/$2V]+?191A1[6^A3C$A\*(#6Z(L,NFM?"WV%$8EO!$AG M<%Z-Z.]4O*X^;YK5X?/VY=A[WCS2`C_LSN0?Y%^ZD/\YJ;-*G_8G^@,5M$>F M+_#I+Y)LZ./WX0TEQ8_[_4G_1US@_#=.[OX/``#__P,`4$L#!!0`!@`(```` M(0!Z91<$=!0``)AJ```9````>&PO=V]R:W-H965T7[IU9KU1N]@]W>[O[I^^ M7-7^\T?VKU[MXG"\>;J[>=@_[:YJ?^\.M7]__-__^?!S__SGX>MN=[P@"T^' MJ]K7X_';X/+R=P\W1^K_X>O]MX.S]GC[ M&G./-\]_?O_VK]O]XSG^X?[X=VFT=O%X.QA_>=H_WWQZH''_U6S?W#K; MY3_`_./][?/^L/]\K).Y2]M1''/_LG])ECY^N+NG$1BW7SSO/E_5KIN#;:=? MN_SXH730_]WO?AZ"OU\[^R][^'NT.M^11,E-OQ<;2[?Z! M.D#_OWB\-U.#/'+SUU6M10W?WQV_7M6B3CWN-J(FB5]\VAV.V;TQ6;NX_7XX M[A__WPHUV90UTF8C]"<;:7;KO3AN=WK=UULAR;(K]*>S\N:>=-@&_>EL-.O- M=J-C1O/""+JL1W^R7N\U:K2*RB[3GZ#V2M\U*>2E#?,7U^=&O=V*N[VWQ*!) M$;1V?"C[]58O;L;EX%_;'1?+I@]F]^2*UQIQ86@&<7C/F)Q_F][!K^W,I9WH MY;H9W1QO/GYXWO^\H&1$4_GP[<:DMN:@V:]=N!5C9\=I#?W3$J*U8ZQ<&S-7 M->H7K8X#K?L?'^-6X\/E#UJKMRPS1)FFE$B61#Y5)D!& M0%(@&9`<2`%D#&0"9`ID!F0.9`%D"60%9`UD`V0;$A$*FM]O"(61EJ&P)`P% MD!&0%$@&)`=2`!D#F0"9`ID!F0-9`%D"60%9`]D`V89$A(+*>Q$*6_O5S2;E M^/7^]L_AWNYU*E9+1#6>K?R,$1DA2_KE-J^428",@*1`,B`YD`+(V!+:]+G% M.[$DHN1PRKZ1+DZG)R&G-@,R![(`LK0D:'YUD@F:C]OR#KT^";GF-T"V;+IM M1B;B2&6WB&-%O&C#YP)FI&7`+`D#!F0$)`62`FS"A>>L#%L?2 M8U,6\BEY9DED9J_;A$2Q*H7FH+:H5.O*UI:LYF?5BLF+G5Q#:YO7M+9E-8PT M;=!$I-^U8HT1.0&8-&C/';BN)WV0>"DW24>(4D09HAQ1@6C,R'M]PH260M#1 MONSH%-1F56H=M3^=@]JB4DW5WTM06U6IQ:J3:U#;5*EU5&M;%L*I80Y,Q-QX M.0N4XG(6,.HWROU[I]Y4;2=.P!YWV0VZ:?6JU@]+VZBC2ML4%3.'S(WDQT=L M+'<"OK'"(9').Y&,_IBE6EYQPBAJVL:DPA059E*A0;=$J3-'G874P1$M46>E M=&0C:U38*`6(T5;HB+M$TYPFA$<]9R:(/7R@38M;[CT$<-->#$;)`IF00K=\0H%C=U/>X4%3-& M_=ZKFL[10L$HHDZ]-)F@SQ.G:+--LZTF[A3;FBD5F0?FJ+"0"N<\NT0+*VD! M>KE&E8U4.=?H5EB0,\LVU`S+@$,&7&&HLOY)%# M9S(4-^85,]>8S5#86.XL>YW"H3,9"AJ;L&+'-M96M'Y]YMB#(C%S+&K[R9289SXZ M'5D4=TY3+D6IS"%?M^8.^:*D0#1&-&'4M459"[9!J#)SR#<_=\@WOW#(2RT= M\E(K1J[YMEI/:U39..0-;QTJ#O&$U$ED^TP@HK;JFCL6'32KV\;$\R M+FHCK^90BBA#E",J$(T131!-$$AX^+PO!8%`7'\^:]#Q,QCT:(4D09HAQ1@6B,:()HBFB&:(YH M@6B):(5HC6B#:"N0"$]+'\*]:V-36I%G=;&4.B7,$_1`H]U+.,P6CN.R$'+/9^8=C?E^L[?F!<(5%PA6,0E>P M(MWY`E>H4^:T9:5Z?MYDC.0DT155[J6\*\).2%>8_>JONX)WO4&R:EG4I03E M!ZG?G$A8BD+E^CIB1.^:FJ/**%+[EA15,D8]N\/NUSOJT5'N!5PSA3`C76)V MBJ%+7KZ/MNS&4DP#B]KBJ$!O:A*GZ`,\8D0;?^^TEGX0EJ)BQJ@73BE0S+V4 M=P/WONR$=(/>WYUQ@]VB"3=8U!;/IG21F)@76BFCB"E@$1WZO^@&4,S85H?F MWFG25;C!*I*4=T-H2[K!;#3"V?"^7&&W*\([%JE)HF9[TF+%<))81*5W1$(7UFDDHFZ.R8M M*R5FDD6<3%I]Y=X453)&IV32$P??#=5H[L6]@\)^2`>]K41O88G.B+*7:RYQ M4N$4L8JTWIU4BE(9H[8_$LL1%4)1CL84GV&XSV0(6ZN*N%JD,H0Z_4E:5DK$ MU:)S&0(4,[9U+D-819$A0EO"#9&N'%]V0RDN*RA&*A6HW73B%'U01XS$_2)J MZ:+**;Z<"EBJ8X\KSSTBR+VXFV*%:Z?LH'01-2UFRKN2J(FVJCT9J0FD5GG" M4N$$8D2)(4RBN@9C*?$@J05)E*6ZK;)BZ=5C]1`R]P+>5W8LMDO25Z96"U?5 M^WS%-690D9E1D/MZXG:L#_T3EJ)S7]?7$2-^3-#2[T.DJ)*YML24T[?^W$E9 MQ_7K_78__$_E@4*T(WVFJ]@S2Q#+U%4!ZA3#4%M%D5"@@$I1,6-$V<.O)U#,O93S7R%L23>8 MFBQ<"&>":DNX\/9B7B@CSZCL`'DUK/WLJP^L:-;MJ8Z,(G5TG3HI6E^LDB6 MHY%*@:DY`S:3-/1HA:_8EBU'N_1)/_D\/6C!2$5-Y//%2/F+65K#L4I3*$.6("D1C1!-$4T0S1'-$"T1+ M1"M$:T0;1%N!9,3T=N'E%$@%+D3,(A4Q=5*4L&(0GA&B%%&&*$=4(!HCFB": M(IHAFB-:(%HB6B%:(]H@V@HD(_:VS4H;-RN,5,34R53BI?P:L[:"(*8HE2'* M$16(QH@FB*:(9HCFB!:(EHA6B-:(-HBV`LF(Z0V9+;K?_$),V^ZNPOU"K$O< M(0N]^-*$E_&AM;9)S:$4I3)$.:("T1C1!-$4T0S1'-$"T1+1"M$:T0;15B`9 M6K,["V]X[PVMW>71^CK5*?BN4YN%:,=RDH(\>Y)Q<1QY-8=21!FB'%&!:(QH M@FB*:(9HCFB!:(EHA6B-:(-H*Y`,K=D8_H[0\@93+EM5@P[I%+W<-;P8VY., M"^3(JSF4(LH0Y8@*1&-$$T131#-$ICCDSX$2A_R)^8B1.?@]W06C2#^T\E(N,6:(+P.(*&_7+.**7E:02C\/4>A_SYT<@IAG>"*-)'?2P5ONGD$%4`WC%M?=SG MI9QC"D85;SK1,PB?)\\/&;?SI8&KFABRE;*MV7--EC+O'0<]5Y\G25DJ?*.) MD7D6$BBJD]3<2_DAAYT0DSLVVUEW:S@_9+OY#>\,I0$U9"LEALR*?8[@V%)RP2P6<4SG=&OJLIVQ+# MME)RU>L/I>2L2%)^V&&+/O?BWC^A4>D?LY7XY6EA]R/" M/Q:9,RF_:.'U-O/!3W,VZ$,Y8B0>%<%#PA05,T8]"O*I15#,O91W3M@)Z1Q3 MBP?..7,S,-+J9F"1.4L]]2G2C[@3^KR940Q"/F(D'B["8%)4S!CUZ,9[:A$4 MUE*S`6K*)XTXUML3C&<:OC8D*7X MU96HWH-[IFV,!+Q/>"SE])0^(3^$,\-DT[>G%6-$31B+5%I1*SRA>PQ,&(LX MK>@OOTA1(V/$;Z3$]::J/G(OX!T2-BP=HLK%,TL%ZT(39+,(_!TB821F!$OY MA)&B5,:(MH:NYSFB0BB*P9@W%,+HOCR84EJ&D9%:]ZID25@J7/>,SJQ[5,P8 MG7EGS4LYQQ3"EO2"*9]>G?TZMM@*[P&,U+I754SB%'U(1XQ,@/XYB:6HF#$R M8_IGQ=Q+>2]P[W&E=TQ%%7CA7753:41-$5NIJ2FBDR(KBBEB%>5;:?K;)5)6 M-*]#>4_`6VDLQ3D@JNL=2.X%O*ML^[9+&E_$P);4DOF)+K]5[@`BUX$ZEC MT;G4$E9V[`6+1&J)8EV$L_DS;R*Q%&6;\E,H=57]Y_ZZ=TG8(^D24W\%+GE? MGK%%G)@O%JGY`GDFK/[84Q;)/!/KS:NITVFYGLLS5NI4:^@'6CF;(0'OJK!+ MTE6F+%.N:L5UUTR&=LGI6.L-VEZZ4G^*$*SVZ4A[YZ"MDK-)6 MDWIFCV"U1I-4Z*`0>W;=[`ZNJSU`5\P'WU&'/K).5RI[UNS3E4H/1'2%7EJK ML-9NT#C+3:+N=9M^_H+N2*B3=3H#D^*JKG3I2E6O:3'1E:I>TZ]L7%?.#FJ^ MJO4A3:=*>9I,57/INCVXM@L$!DCCJQC$D.)8-<%H'S8P&Z^J83=H<%5.I!*> MKE0-(^NTZ$K50*A"H2M5/H*6:,#I*HK M%&`Z5*FZ0@&FLX>J*Q1@VF-77(G(FGU)0T6`WO2E*U76Z(G)P#SI0&M#&NFP MVJGT:(MB6JE#GZD?%)57AMT!?:,SMC+I#NBKEI&ONH-- M%1_V!O1%PR@_[`_H:V:1TQ?I-J8__%0```/__`P!02P,$%``&``@````A`'\+E2SI!P``_R(``!D```!X M;"]W;W)K&ULK%K?;]M&#'X?L/_!\'MC2[+\"TF* M1#II`S9@&+KM6;&51*AM&9+2M/_]2/%..AY51RGZ4C>?^%'\R+LC9?GZX]?C M8?(EK^JB/-U,O:OY=)*?=N6^.#W=3/_YE'Q83R=UDYWVV:$\Y3?3;WD]_7C[ MZR_7KV7UN7[.\V8"'D[US?2Y:<[;V:S>/>?'K+XJS_D)KCR6U3%KX,_J:5:? MJSS;MZ3C8>;/Y\O9,2M.4_*PK<;X*!\?BUT>E[N78WYJR$F5'[(&XJ^?BW-M MO!UW8]P=L^KSR_G#KCR>P<5#<2B:;ZW3Z>2XV_[^="JK[.$`NK]ZBVQG?+=_ M"/?'8E>5=?G87(&[&04J-6]FFQEXNKW>%Z``TSZI\L>;Z9VW38/E='9[W2;H MWR)_K:W_3^KG\C6MBOT?Q2F';$.=L`(/9?D937_?(P3DF6`G;07^JB;[_#%[ M.31_EZ^_Y<73

LCK)BG0U72R>ZF;\O@?7?2T"R+[F@R?FNPO+Q("38!/0UA< MK<-PL5RO(.@+MUIH)GP:)BSA"P1PUPJ#3T,8>2N0T#+A4S,#*,N%6ZTT`3[' MW6I&16AK&F=-=GM=E:\3V"B0[OJ]6%LJ*3._1R,X7T M0`%K6))?;H.U?SW[`LMHIVWNI8W'+2)C@6L&W<8NH%P@<8'4`F8@L=,)"^8G MZ$0OJ--$>&^`7K@C.S(6AA*[@'*!Q`52"V"B8%'_!%'H!3;AQ>)I&UB@7867 M3O4ZDTZI0)1`$H&D-L+4PD;\"6K1"RQV2&FG1*Y5,H)3M#=RY78FG5R!*($D M`DEMA,F%8\26.WR\F@V(QJTJ$\T](0'L:4MGX-2L,S*T6"!*((E`4AMA(B"# MXT6@,1=!2-!ON$@@L4"40!*!I#;"(H:$C8\8C7G$A$#$=MH73MH[HR[M`E$" M2022V@@3@;.6=:I?7CMHS$408J==(+%`E$`2@:0VPB+>\(BQ#_GA%:RK=W8B M],/%$.)4)'0JTAEU%1&($D@BD-1&F#X/&OKXDK367(:&[*)(*):0DE`BH91! M/')LJ:,7DT<-&,Y7D\E[#3D5<,_3WLH08PDI"2422AG$Q6`K'2^&&B\30Q`K M@X!B;"^P#"TK):%$0BF#>.38%ZW(:5*[PB&V>2YVG^]+V#*0_(&]'L!$INX^@$/I0URB\C3O%:"N8\PTQ-A`<0ATQ6*_XQE+&JBF MQJHE\DQ@R[0R,:`8'CPZR=1@F60-S1>=FL@CS*?'#9H^-=2'KJ158J#>*C50 MZXN'CHUR?.C45EGH!*WG[9#MSSVWM>"3&!Z`O;180_ZJY:R7*V?N5I*3:"C< MM)Q@X=PF910N$3OK>(G4AYE$@E9T:Y#HGM4>&;!2:(G4I9E$@OHJBL-0<^PJ$J2KZ"U\9XLJ3W`2#>DJNGLS M90RN$/OT>(74U9E"@OHB.N="Y)$!*R)!NB!AZ)P(2E(2#>$7"-T9Y(=.-E-& MY#JQ7X_72=V=Z22HKZ03=.1ICEU)@G15!G0*2J*]`.6B3IO(=/KOFCY::SY] M:`CJ:06P<,5J*[NH&M)%78;NV2,I24^Q[B6*RHA<[+L&%@C6G1@--._/],A@ M5ATUY/>0DE:)M$J9%0\=YP9K/?Y0D_=I^+"7J886L`RZ?1*L-[SE1MH*PNN: MO(;@ZR@\)+V%MW&.225)B8961%J&;O-@%*[_C2'G4WG^WI!CM7Q?3CD:"C:= MM$A"L824A!()I0SBBG"(L"IZ>5B!M206(T%\>M[,W=)U5GWI!*2T>VLL3224 M,HB+>=?X`A418@AB91!0K(F6E9)0(J&403QR'!"L,OS8QJ(I@VTL@MCT[+NM M.<+OJ'$HZ\^3V$#0M/L=N1&GHTWD@K#;6X+>6%=Z-K#F?A@D,*:^0SN[--(& M[#0@#NS?]C3PP[DSFRE&X@%C=Q\?,,T"+-4$]:W6N7?D:TY_'L<:,D,3G%Y. MRU*,Q`/&;CH^8-U[[0P3U&?8F4LBGPQ8AC6D,SQ?NX>G8B06,+XS&!]P:\V; MO(;Z#+M#F^%8&=:0SO`R#)VFHAB'Q_NN/HTS'NXA*\$:ZA/L%#?2!G:"#40) M#E9SYR15QD`^O`5.<[Z\Y5IK)UYJS)#??L_[8H@R1#O)1+P\_BE&Y)EVVNH; MDO>^2`R]Q:8WGL>\>LJC M_'"H)[OR!=]0PV/5[74'T^OS>S_O+^'+S"'KOAPI^6VSOH"`#,B"BH8#N(;N#R87<#OI9;>$%R(#_]19>,P`^ZQ3# MSP_.V5/^9U8]%:=Z&PO=V]R:W-H965T]?FZL;C(RE;4$;U?(?/RT/ M2C^9FG.+@*$U.:ZM[3)"#*NYI"92'6_A2ZFTI!:6NB*FTYP6?I-L2!K',R*I M:'%@R/08#E66@O%[Q7:2MS:0:-Y0"_F;6G3FA4VR,722ZJ===\64[(!B*QIA MGSTI1I)E#U6K--TVX/N87%/VPNT7%_12,*V,*FT$="0D>NEY018$F%;+0H`# M5W:D>9GC=9+=S3%9+7U]_@A^,">_D:G5X:L6Q7?1&04&!)DJGCHFI!A*` M)Y+"=084A![]^R`*6^=X$4WG\20!--IR8S?",6+$=L8J^3=@DIXI<*0]![Q[ MCLEL+`D)^7A[]]32U5*K`X*6`4G34=>`20;$;_L!(PZ[=N`<0TM#K@;.8+^: M+&9+LH?"L1YS%S#P'##)@"`@.BB#VGAE!W;*KK(NE;L0.)5)WY:9?$3&@7,, MSR'Y2X,!$,P-8[T@$T0AJ::KRT`WOIH;A]!&[)23+S MM^L[^XB4`Y]+]1'?Z6?5FY_S^@L7I]$<[ M(;FN^!?>-`8QM7/7.H5N'Z+#Q%FGKB%?QZ^SM9]$9/@`DZ"C%7^DNA*M00TO M@3+V7G28)6%A50>9PT!0%H:`_UG#R.?0\'$$QDNE[,L"A,GP)[+Z!P``__\# M`%!+`P04``8`"````"$``=/]MO81```,8P``&0```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`R>]/.L3Z2I-AXI_8R?>#J=Z^!`/]_R0;=^2,<*Z>^/]Q_>O>Y_7-&THT\Y M?+MWD[BZH[YB:?BD3L7RLUJA(G&=;%PO[Z_IX*D,#E3@?WZ8K^?O;O^DHGP( M-ENTJ;A%%RUPD&"90$6@(C@+Z-)+,$B@)-`2&`EL!EC8-!]EV`VM,.6U(8ZW8IVOFYYO%MO MU)Q*R60RI03(`$0!T4`,$)L3EA(*7Z:D;F_.3XKK9TQ*#&;K29.O%-52I*F; MC*);#V0`HH!H(`:(S0G+`0V2S,$%9>%Z$671B'"WWN9D54PF4T:`#$`4$`W$ M`+$Y81FA&)J`JY6$Q&4PZ`#$`4$`W$`+$Y83F@PI4YN*`J M7"^R*I9BK?`V)ZMB,IDR`F0`HH!H(`:(S0G+"(D&F9&+JL+UPZO"$U$5(DW= M9#3E`,@`1`'10`P0FQ.6@XI.F#()%Y3%V(VHB[J>B<((5B,:Z9!4=>T0#(H5((S*(+$,\ M&TZ'9=DXK;.H1#8@4(HW((+(,\?BLE==+.0@Q/(A!=17 M@`9$"I%&9!!9AGA\3B-E\;EKQ,LFL!=;+/1)?V6CO1)+7N?64IH&6@]%IB9RZ-->J\@+C.6XD=IRY9I5SXOK(SQX!6"I%& M9!!9AG@NA,Z[<&.UG@1@/D/DUFJP.ETHOB>R2HI5"I!$91)8AGIRS M1&*-(C$@40\B+5VRBL'TB`9$"I%&9!!9AGC(3KV]>:VLO=;+U\J`LDKN$/6( M!D0*D49D$%F&>'Q.HF7QN7IO5NY^TMG3W_7$=P)<+U[_Y;-`[*-UR2H-]^08 MT8!6"I%&9!!9AG@ZA$H\?>JO)S$8#W,;$!ONH.J2&NC1:D"D$&E$!I%EB,?G M-)48[DN6>B_-6)U/:BT?:W%J[.K)*F:L1S0@4H@T(H/(,L1SX?27R,4%5P2U MEW&4BSQPL=^U#5:GE_H@"/.E'M"0>HHI5(@T(H/(,L23XY1:EIQ?3`2OZU@] M3%+O1%JZ>K**P?2(!D0*D49D$%F&6,CN]MG;0QZM^7(74#[W$?6(!D0*D49D M$%F&>'P%F7?1?D"#0B\@<6(7E\5=LII&&]&`2"'2B`PBRQ#/AA-1;R[PQDNN MO,`#:M:3,.L0]8@&1`J11F00689X?$*KC4)VT=ZD1RC>_)1`@T(N(#'>(>D0#(H5((S*(+$,\/B>9 MWE[/*-::@,8'FL;]J"XB_W#1^&A'0"[/T_Y7M18;?T.RB@.O$&E$!I$-B,[, MU!B:#>:')D@R_V?8;0 M%Y5J#%LATH@,(AM0:?"+ZFUG,9@='KE]HVRT1:!= M<*0=E9C"/J)Z#+1IZWDU$U)@B#;)3444W&;DUXAP=;1);B8B[U;/5W4S%R0NXK."E]N6T3'-*1]=/2K0M/.%XVL>_12PJN>+=;BZE&CE^%>];I9+<6@ M6.;%J\*IL$PL^%W.,Q?/N9=RN28.2!2+W`2(5FF`^XA6?FUL7#AB>1RB37)3 M$06WV7(VD\\SZFB3W$Q$WJU:U.M5(]8U&VT*]264I$N>VV5X^VEGCNHR(%%S MH@ZZZ)C7G.^++FO=X[OU=D*C7I`YU*USCT3-B7G71:M4!7U$O@J6R[9="Z\AFB0O%9'W6BPJ^I<_ MY*"C2?(R$7FOMETMYJ*\;30I%)S3D6*VGEEP7HFRJ>J1*#AQXNSFP3$ON.#H M*VI;_`Q,O?.K)3HWLE$=C8_//.F&9;L_2W*,UU]P!T;7/ MI+D1]8@&1`J11F00689X?$)SCZ>YBY[#1SGN;M;(6VKU3(B7+EG%!/6(!D0* MD49D$%F&>#:7T$<5]7\DFWG%E5R0&*\Q1FQ M2U:I^GU?6=8&M%*(-"*#R#+$\U&0O!?<9&PGW9L7NEC*M\'*;1].TT'8=,DF M)<=W3FX1#6BE$&E$!I%EB"?'2B'B#DR2K&UR?'B`9$ M"I%&9!!9AGC(0I?^(F04H*U'625WB'I$`R*%2",RB"Q#/#XGW[(A=><^TKIG M/TW2!F68#[9'8K"%1NJ"8Y:?'M&`2"'2B`PBRQ!/AI-663)^,=A>B.47:6W0 M9KG0`=2CU8!((=*(#"++$(MO(82<'^PSMY'&3OAI/:*D[KN(T@Y@'Y"[)3:M M=G@K*EG%F:X0:=8]CU&(N=-CN$#%%E$>3+#*@PF(EJHL&"'MA]A7J@<5D+M+ M]G-''1W'3^3Q%>39V1?*"Y1F$>5A!ZL\[(!^>A\E=I-\5$23C\B2C@:%8,]2 M7PM47P'EU[#1*@7:1ZN$!K12:*69%1\FH:M^488HG18>B8T+L>'51:OLJC2B M<%MF7M=R>WJ()LE+113NRBR6ZUI<`>MH,GKQ8(NBZ=QU99),<>)O%QZQ/:]Z M)O>\@E6VW=!'1[_GM5K7_(3 MRL(C7@5RO[B+5FD\^X#"]A7=F*,]3![-@%Z*>S75NI+?K=?,B^=`2"69@[=M M1"TF"976Q[FLX&VP.JF+9$#K+5\K9FG,Q";"\5$29;X/5Z5()(BU= M4?7)+24'K!1::40&D66()6=9$&D7E?C+EG%T'M$`R*%2",R MB"Q#/!MGR;DERKF`LNN+#E&/:$"D$&E$!I%EB,=7D'.7/<^_1$T7D!ANN?F8 MK-)P^[ZRI`UHI1!I1`:198BG0PB^"U>&Y:0$T\K0R"W];;`ZN3(DFY0C*#K//HFXYVO]+G4JE?E::,QML#I=*KZGK"[ZY!;S-2!2B#0B@\@RQ)-3 MT*,7+BLH2I<>B5J1N[K)*L;>(QH0*40:D4%D&>+I*$A3]^#]F=^87!:T:2MO M)F^#U>E:\3VQ6@$TI)YB"A4BC<@@L@SQY!2TZ:*YY`[`$L5I0*)6Y(YOLHJ! M]H@&1`J11F00689X.GZ/.%T6Q&F+IZ!)4J;5!Y(SV:3D`!K"YV45I1!I1`:1 M98@E9_6[Q.G8$1>G`8E2D?O%R6K*!J(!D4*D$1E$EB&>#2%.+U0KJTFUIB)H MY6,"VV!U0(87MZLY1>X2N?*PA(U(,0<5VRBO'UB`9$"I%&9!"YMPV'IS_H$WW(_NW! M_MVPS[O7+[MN]_1TN'K8?W=O!B:'#^\F'%Y;O*KN-E19U(5HH36!WF@\[OI! M2TTM)9_-JJ'>QIUN\&G(9WPN'EKF\A(#6S8MY9HV MFK&%'ID@GV*N6\HUW<#2RV4-[J1BBV;>G6W*1XU?6?\ MSGU#&WVV-?5&S](66AH:!;H2*;70*-"CA:46RC4]4UAJH5S[;[3)2FPHU_X; M7K*EI2.@9^,*O;5T!/2<&+9LZOIN0T\T8\N66MP+24HM=&S^/IP\@IJ.C=YX M4?*AT::'5$LM--IT7ZC40J-=/+9-M;C;T"N'"C[4XMZV56JAWNC-4Z46&FUZ M9U.IA4:[^#F;>D9Y*V64WD%$1UTBSJ:@W_TT[F5%J<6^*+!T;]49O M32RUT,CY6T_0&XTBM&W3<+:BD=4]\LJ:5T5/3PPYU[C@%[HS]* ML"G.%S=0!?NMFV`E[J9^@6_FM%P5^):&;IQSM]/0T=\B^';_9?>?]Z]?'E\. M5T^[SZ1(9N-&P*O_:P;^EV-XHOSC_DA_A8`NXNA]]O17)W;T*OF9>P?=Y_W^ M&'^A@&^GOV/QX?\%````__\#`%!+`P04``8`"````"$`30@%#TP)``#R*``` M&0```'AL+W=O6#W][Y_Y;ZOII+UL3_?;0W.J MKZ<_ZG;Z^\T__W'UK3E_:9_J^C(!#Z?V>OITN3ROY_-V]U0?M^VL>:Y/<.6A M.1^W%_CS_#AOG\_U]KXS.A[FRO.6\^-V?YH:#^OS>WPT#P_[79TVNY=C?;H8 M)^?ZL+W`]V^?]L\M>CONWN/NN#U_>7G^;=<CPU MY^W=`>+^[B^V._3=_2'<'_>[<],V#Y<9N)N;+RICCN?Q'#S=7-WO(0*=]LFY M?KB>WOKK*EA,YS=778+^VM??6N?_)^U3\ZTX[^__V)]JR#:,DQZ!NZ;YHJ75 MO49@/!?6>3<"_SY/[NN'[YU:4!&MM^OIPINO+^_/%U/@^4LC+S`!_GDKFXO^5Z[G$YV M+^VE.?YM1+YU99P$U@E\6BU6\X6 M*HQ6W9=^XX9+:PB?'[IA9.W@\V,WA&G6?5/XM(9^/%N%X6*YBM[.36PMX?-= MMYR;@>WJ)-U>MC=7Y^;;!"8?#%W[O-53V5^#,RP0DZ6^9%ZK&"@5[>16>[F> M0AA0#"V4^=>;T%MZL9B,U/E4DJ-!UJ-VF'&0B"9(+D@A2"E()4+B$)@.6%)T`O MD1^<`=H+S"'(U,3[; MUS(4#,M;CBA&&Y:S`@6#38FHMV%U5J%`S@1?MS#OG@J=FF7"]$`*$NW,:!9H M8@V5Z>9-0V8-51=H$*J%[ZW80B#-?8(>)1;Y0PFEJ!I0)E6Y5!5254I5150T M/MW1O+\*3/\#[H;X#&)5P-KVQ+>J85Q21,.LR1`-JAS1H"H0#:H2T:"J$(T, MJ>Y8WA^RZ6](R`8IV$V=PF=M6@+#VZV>PY"F%BFS*@3PA!:(NA=6.;-2WC*. M:/T6\EXEM5)QL(K8H%3$BE:%;G^<%'UJ]]#]+]L^+&+%PAMZ5`T#G"):F;4Q MT.&PY3%#S6"6([)F7N1Y_`FC0,U@5B(R9OY2Q:N`K6L5:D;J2W=9+'DPY!_8 M=WW3IY&:,XC5'*N#!`W=FK.&=H>(%JO0YUV7-,LM4M8LB+TH8F:%-"NIF1^K M(/+8EZR(&2T[W;;]6N9LX^"OI&;L%9 M0U,Y2T\MV+J32:/<(EMNBPC.]7C2Q)U*:A0L0Y[IBMR)EIIN'%G._/"#_;%O MNT\W;0:1:H/C:AI,8@U)4V0,X=1$'WQ%?@C;`[7*I%5ND;5:^G!"R?:A0EJ5 MU"I4RENQ&JV(%$*J>\4#6@3*IR MJ2JDJI2JBJAHW*Q?UGMB`(,V\@3EQFEZ77P$5GZR!A:-#0X M";3%W3KO!F,1%'3?1,#C%MUV,S0'DQHS+IA@!-4.5TJ(GM,NU"*'U=E*!FL MG-?:@%7NJ)@ M5VY5N+Z%.,:\P1>#_F?L"GPU*,2Q*Q%WP'> M.'O>/M;_VIX?]Z=V&PO=V]R:W-H965T[__[&V(#MX;KM:K\TS>.9!\_C M\7AP[CY_;2[:EZKKZ_:ZT\G&U+7J6K;'^OJTT__^*_FTU;5^**['XM)>JYW^ MK>KUS_>__G+WVG;/_;FJ!@T8KOU./P_#+32,OCQ73=%OVEMUA9%3VS7%`%^[ M)Z._=55Q')V:BV&9IFC/9WJLHK:\J6IK@,CZ:I+,<#\^W-] MZR>VIGP/75-TSR^W3V7;W(#BL;[4P[>15->:,LR?KFU7/%X@[J_$*_R" MZ)NZ[-J^/0T;H#/81'',@1$8P'1_=ZPA`BJ[UE6GG?Y`PIQL=>/^;A3HG[IZ M[87_M?[F56*:SNOV?\L&ZT5)'BC+3H=YP8KTD&M?[EW3OS.^0'Z4 MW&:/;8AL<9@L:#)0VD@%8A5(5"!5@4P%<@$P0(19"4BTGZ`$9:%*3#'L)V"1 MQE+"GBPFET@%8A5(5"!5@4P%<@&0PK9_2MB4!7:HD`"69(G)`)E@4T%L@M[8BO'NV=&]EN2S":S)`B) M$9(@)$5(AI!<1"1)H/2)DJS7\*D84.,Q\FG&>X;8RZXX("1"2(R0!"$I0C*$ MY"(B106ROS\J:BQ'Q1`Q*H1$"(D1DB`D14B&D%Q$I*C@B!&C8A5]0\^JX5R7 MS_N6G9HK:VA#Y6;UG'+(P7+$F0O;@2/L[![+-4-LR*(YY2U+J7;Q;#1E1X*0 M%"$90G*&0$+GB!`_0QQG/``MD]CR;H_G\3ET MSK%LC'2VH8B$"L+#IW4M.+46(Z8(9:]K#BW632( M&.)XLTV,D`1YI<@F0T@N>DG+2Z`3?7]8H[4<%X<R6#_)NA'Z M9#CDQ))N68ZRR).C-6:!Y_J>LH3)9+%0IQQZFSJ;'!FU:]JVYOCSTQ+, MD\H\)/`])?ILL9AFG4L\LB"T(1($H7724]X3`YBBG$N)Q@U(EL+4?94_%$'2 MB@8B2A>K<<5-RS>5+98M)LN2BT2R)+3M$B3YH>Z*L-Y-R@0&*25$B?G`':7D M8(XN/V[\P%5>NV+N!!93?`GF21NHEA\_Y. M:DYL94D/<&^'CA+N")52.)[12-RZR9FNSVD%U(-57W5!VJRZ77RO:%W@Q:=/O/\'QM^3#JI>![>IU),US% MK1"N/E9P.X0;`(P_..$#3!0/[)T0WH]7<#>$-\P5W`OA'0WC$7%#6KSP"!2K MD%8C/!(1#WS6V&#?@L_:2$1\\!E;*D422'[P61N)B`4^:W)!BP$^:R,1L<%G M34HX;L%G;20B#OBLJ0EG%OBLC40PZ=4Y;T-XL<*:I=L07I8P'@4AO*1@/`U" M>`W!>$0(S'4MM:`CA;FR5GN6&*ZP;\53]7O1/=777KM4)TAD<^R=.G8)SKX, M[0V./+C(;@>XO![_/<./%15<>YJT"3VU[3!]@4D9\\\?]_\!``#__P,`4$L# M!!0`!@`(````(0#YJ3O,H`T``+9!```9````>&PO=V]R:W-H965TGW/WG?CX6#S MNMX_;E^_W@__\T?VVVPX.)Y6KX^KE_WKYG[XU^8X_/WAG__X]'-_^'9\WFQ. M`U)X/=X/GT^GMW@T.JZ?-[O5\6[_MGFEDJ?]8;NR==B\C M?SR>C':K[>N0*\2':S3V3T_;]2;9K[_O-J\G+G+8O*Q.=/W'Y^W;4:KMUM?( M[5:';]_??EOO=V\D\67[LCW]U8L.![MU7'Y]W1]67U[HOO_TPM5::O=_@/QN MNS[LC_NGTQW)C?B%XCW/1_,1*3U\>MS2';"P#PZ;I_OA9R_N0F\X>OC4!^B_ MV\W/H_;_@^/S_F=^V#XVV]<-19O:B;7`E_W^&S,M'QDBYQ%X9WT+_.LP>-P\ MK;Z_G/Z]_UELME^?3]3<$=T1N['X\:]D/I^?[83"YBZ;CP"/SP9?-\91MF>1PL/Y^/.UW_^-&_1V=17PA M0K]"Q`_NIMYX'DRO%PF%"/T*$6]R%_K1=';+I5!]_?W0KU");KZ2B="@7WDE M=[,H"B>S&VYG*D3H]\,7,A<:]"LT?.U"+C2(1_V(-ROK4+S)IE>ZRL;TM-94 M/>)2I8&LE/Y'5#J[\\+QA'4E=!SQKMCW[&1U6CU\.NQ_#FBXH,YV?%NQP<>+ M/>H.LD]SB7,O_U4GI][-5#XSF?LA#734?X_T9/YXB,;S3Z,?]#2MA[7.Z@=65UP(&QJ6SCUZ8@7X;'*.,)`42`8D!U(`*8%40&H@#9`62*<3(]@T M&/P=P68R-+A0DYX#&7EC,Y0+;A1-D0CWX_"#[06@^R,NSD>R8"9`42`8D!U(`*8%40&H@#9`62*<3(X8L MD]-72Y>?4F9MQI`3O=,!28"D0#(@.9`"2`FD`E(#:8"T0#J=&`&CU?0-`6/6 M9L`XB:;GA<]2$#70)9P$-)%I'3,R.V8*;AF0'$@!I.3$JLQ:&51G(_D4U"#4 MG&WTJYZ:5]V>C:10IPL9D69IR`VA[LW-6`ND!ULB+=H"403D-:5HE2'*$16( M2H$T^0I1C8Z-LM(#:K5,JZSDU7>&EAE2MJC7'W>>'-VQS/3TO%U_6^RIQY&1 M8Q@(*`D2J1%/#6@%)*M<>!Q%YE@Z,QM_*:QHAT$Z)A+1`*7U=2O12J657BR830/1[[JXDNV?F5#4ZBUA;!2*$6K3*!PFEHYZ?"RN?;6SS=YXX1:YT? M#[[5/5/TR`0*J"U45;ZU*LFEH]_KSJ:!]<04TD!=2WF5F0"1:(?^G/+)U<&,B(%RI3*B@66-BJMV:Y2!E*F1IE&6?7]:S:S MGK=6&4B9SI`QVXUIE]ZW,KHWQQ% M:KI-T2H3**3IYM*LP;6",9^-(F]BK28+E"ZODJZ$E9">S4+KH:I1N;E*N365 MO4E@SZ*=(6TV)TOC+C7G'_NW7ZUW]145SP:-]M03Q'Y9O/0`)8A21!FB'%&! MJ$14(:H1-8A:1)V!S+BRI$V/ZSO##,_QC/AQ9&Z^A%9W7'IG*SGV)8A21!FB M'%&!J$14(:H1-8A:1)V!C)#ZMV6[O;FYQ!%(WXM!E"!*$66(5EFID.KW:(:498UZ2#^T"J$E M''1QD8Y23J.6"8&U<%U*1[6X2R2B!83F:"U54VFE'#.!WMFF458R.@5JE)I?X@<$15R.J6TDJM MJA.!Z$=:I6B5":0MM'-$!3J6:%4AJM&Q0:L646.)G[ZH8"=% M*#VT%MGV-HVPHA%-QB\1Z%?;-.B1"?3.-HUTY*EF&$VM_8-"&JAK*:]2KJ2C MV*:)[#&\E@9*N;E*N96.0GD<6$-9)PUPF\9GR=T-+2B22/T)$.GAY6V:OAY: M_*@G()&(;]/`="QJ4@Z9C`F;FE5"D# M*5.C3"/0A&=FH34BMZI8BG2&B/D+XZLQ\O>H_&YE?%X MU+J``J7+JZ0K4WHZBZR9L4;EYBKEUE2F+1IKGNL,9:,UZ48OCU;7;='T M,GT^K-9SD6?M=2^$U<5C6PZ($D0IH@Q1CJA`5"*J$-6(&D0MHLY`9OQ8!J?/M)='Y](2[4,#.=L7L:/J M2'.]N37:+:6CFA\3@2(5^Q119CB:-Z2G@'1#[_0'S`!9GLPS&+;2\,>>O;H2 M!OKL(Q`+L\K-[3?&J73DRWIO;K\IRZ0!+NL#/3%[_ZXP+^L%*"_S^'N'L6=- M:4MAH"_HI8]XC0J35:H,Y#B=&3)FP[`$0#ZI[]\"LS8W5]F4832,E14MA8'1 M,,)GQM\$1_;IE%2*JNZ6&3+F+;!%]/6WP)?<^O(]X$BU@I6J+(6!T0K"1[3" M>&)-[*D45>?9,D/&O`6VL+S^%L225DL/:9PT6\%:SR^%@=$*W&?",\.Y_8XA M%2Y4KOH1=^$JYAWH:T]JWH^-6+CT#,32T\Q[X>Z$HUJ^)])QWO>Q^7ALC7*I M,E"WI\L8M\>6OMIKYN^6@KL*,@ MUD,N$/LYCZ0>#,'246L%@2:ZHP]#L+020S"^RNJ#/ MYV`DJH>\9:3GE*O&II.\UUE4GX3AFO0-]Z./(SRZ/!57B MK(.J<-H'5+5+/R1]9U!"^BK3X;"(8CK=CQ>ZF,1TB-W!IS$=S$9.RY"8K3M< M)1&5N.I(@@F5N&I)@BF5N.N948FK0]"P0B6N>Z>=F3BGO0V\-MILB=E^"I;0 M_DG,MDBPA'8?2,UU!;2]0&JN$MH_(#57">UYDYJK96A3F]1<);1K36JN$MHA M)#571&G3C]1<);2/1VJN$GJ+1SZN[D>OZ6+V7@FC0V_K2,W5E>FE$Y6X?.A% M'?5R5PF]BJ'[K%"U^8JH=/%\7L$!>6T*&MF)W+PA(ZAQ6SHU980J>82,W9 MIE3"SB6A#YU#(C57"1V?)3775=/Y6%)SE=`!6%)SE=!A0U)S]5XZ/DAJKA(Z M$4AJKI)R3BZND;:>Q^R`NN,^YS&=Z'=P;TQUN#PZ-M.X"NA`-]V*J[/3\6RZ M+E<)';:F:EPEBWF\<%:SG,=+9T$RCQ-G04I#H;,@F],%NVZEF,?L0P`*R^@\ MF=%7\V^KKYMV=?BZ?3T.7C9/-'N/^X/W!_[=/?_C)`XD?=F?Z'MY6ES1&I/^ M?80-?3L\OJ/,ZFF_/\D_6`7G?W'AX?\```#__P,`4$L#!!0`!@`(````(0"B MQ-WX_`0``,H1```9````>&PO=V]R:W-H965T]=?7^O*>L%M5Y)F8Z.9:UNX*E;75]WASS MBC1X8[_ASOZZ_?FG]8VT3]T%X]X"AJ;;V)>^OT:.TQ477.?=C%QQ`RLGTM9Y M#U_;L]-=6YP?!Z>ZKU\*4E^!XE!69?\VD-I6743?S@UI\T,%NE^1GQ>">_AB MT-=ET9*.G/H9T#DL4%/SREDYP+1='TM00--NM?BTL7RP9!MJ!.MP(&0)VKZ[4@A<'8,[VRHP.^M=<2G_+GJ_R"W M7W%YOO10[@`446'1\2W!70$9!9J9%U"F@E00`/QKU25M#+Q0,!R4`.?G,1_F,1AF1D2G>1]OEVWY&9!]X+V[IK3O8"BT+9$ MAED^QIS_6\HAUY1D1UDV-FP[R&8'??*R#9"W=EZ@M@6WB4T;I%KLA04M)*5- M="#5@4P"'%`TRH)B?8(LRD)EB8!B`4PZ-95[82%<$AU(=2"3`$7#_%,T4!;H M>ZDT7J`E/N8V4/^Q?J%6F]%D%&8@J8%D,J)H@XWP"?6A+-"XD,`Q[@#-UN[%3 M8Q@V#`FFM*<&DLE>2LCTQF&,T1D=[OVE+)YB`J'`K+K3"G,8EVR(4@Y5"4," M:#1)B3YQN)NDA+M)2@PDD[T4)2M5R9V(X=P3(5-C-62&>.YP"'@N\M7=N.?K M[(@=\LZ0D.;A9>NOM.V;CLMB?V0RA1(Z@@N&7(7W8Q^LU>`YY(4B^D"+7OCX MXY&0<"ADB@.T5%W2:7T4H+"H"NAY)O71?RA@IQ_,/T$=(P9-^=?GN#"0"L`A M7H%`/QW2:5W\3*:PJ`KH:?:X`G;V*0H8--5@H29T3\<];3JY!@P2-5AJ94NY M"ZQ/"F0650$]M!Y7P(XX10&#IAIH+;%'W$"N`8/\I>@\K6XI]P),HTJ@ M1Y,D@=WJ/CB.(,'ZYN80U&8:2)YOR...9%Q@:1ZM)H\RE:J3' MV__6R,Y(I7H,@NI)H?I:1^WI*P2:T)-+R"`?JC)I]+3YEW+'<,'&'0JU>9F"^H_@'N<*VN'O(2",;WFM&63DT%6POK"8H,:'4A.AS<-J=+'SVO&.O MCAJW9[S'5=59!7FF3S=PV*Y'F+TK$S2/:,=#&Q@K/JP,46DK\!;=#8-0PV/Z M1KW#%'L1W+S-7XCG$5Q;37SG1SN(U5R(_0BN@G?P(((KV!T\C.#J8^+)(H(; MQQU\&:7#KM>$):L(#L<[]LB%%`VC3O=`"%;N)2-!'JP,Z7!&)WA)7_,S_BUO MSV73614^0;G<88JT["W.OO2\[PZDAS?TT((7^)L)AA><.X--<2*D%U\@7&?\ M*\SV'P```/__`P!02P,$%``&``@````A`+VB<8(`#@``\D,``!D```!X;"]W M;W)K&ULK%S;;B.Y$7T/D'\0]+Z6^J(K;`=6WR4% M"()-\JR1Y;$PEF5(FIW=OT^Q6119/!S+\NX^K,>'ITZ3Q2)99+-]^X_?=R^= MWS:'XW;_>M>-;OK=SN9UO7_'U/S;'[ MC_N__^WVQ_[P[?B\V9PZI/!ZO.L^GTYOTU[ON'[>[%;'F_W;YI5*GO:'W>I$ MOQZ^]HYOA\WJL37:O?3B?G_8VZVVKUVM,#U\1&/_]+1=;_+]^OMN\WK2(H?- MR^I$]3\^;]^.1FVW_HC<;G7X]OWME_5^]T827[8OV],?K6BWLUM/FZ^O^\/J MRPNU^_ M%43&/;`NVQ[XUZ'SN'E:?7\Y_7O_H]YLOSZ?J+L'U"+5L.GC'_GFN":/DLQ- M/%!*Z_T+58#^W]EM56B01U:_WW5C>O#V\?1\UTV&-X-1/XF(WOFR.9[*K9+L M=M;?CZ?][G^:%+&4%DE9A'ZRR.`F'@^BP?`*$7I<6Q/Z>1891?U),OIX18:L M03_/&E=79,0B])-%DILH[5_3%AI=;5OHY[D>U[9EPAKT\[/5B"B#-+A^`JO1B9(U#\^W9Z(0DQ7QL9:]-%0Z^FP;4=!OCJM[F\/^Q\=FEJH M1L>WE9JHHJEZ@HE_':WG$?&S`4$C0:D\*)F[+G47Q?J11O%O]X,HO>W]1B-O MS9P9N2XL_?(87^%]Y2, M\IYI]\P`UIVQYRK#,":Y#Q0^4/I`Y0.U#S0^,/>!A0\L'4"X*OEK7*5D:(YU M`BT:)M(W,^;0)':.QJ&D9&?*V7^`%("4@%2`U(`T@,P!60"R=!'A2%HD_HJ8 M4S(TZ*F[SDZB!4>Z::9)R7N>/%/.G@2D`*0$I`*D!J0!9`[(`I"EBPA/TKHH M/!E>\\T4I]BMPTQ#9QI)[+C-`,D!*0`I`:D`J0%I`)D#L@!DZ2+"&=3'5SA# ML:4S-.(Z`Y`MZNO\WV M.J<+1$Q"JY]>$Y6(]!$CZ7FBSQC1F66[Y&DDH:`]C\LX]F;_XDPRL5@"4@%2 M`])HA/)=TA$.4-L;3`NN=(`2D0Y@Q'$`(XX#&!FU643!R.^I*1B;& MPO-6!1:U;^$E(@V7HU\HF11^"00`I>PF`A1;.D`C<6(C@#G6)3ES+%(`IP1. M!9P:.(W+$=VM\MLKVM729<,82DG(QNW0ZXF,6;'>_N@43SV:5O2H[;W$6X$* MMDC<=2KN>[JE885%*E/\KDAM6&&1QA3_3$0Z5&6,_@"*!SE^K#FN-I59S24LZ7R6N;N1?B'>=Y](CS%(VBS3D3I(, M16YP,\M"!;)*HV59%;)J9#6")1NH\DFW@9]*#J@I$%T:\J)K(CLC8T,17=IP MU&^GT#2Y2;TQ6;"1C`8@X/(&UTS=?:GEB-*#<\LCY-9CHG9'*$"H1*A"J$:H0:A.4(+ MA)8"DEY5R:_KU0OC5.?*8IRZZ7.;\F810#E"!4(E0A5"-4(-0G.$%@@M!20] MH[+B*SS#2;0[@W&F;7/4+`(H1ZA`J$2H0JA&J$%HCM`"H:6`I&=47NQZYG-3 M'V?7KL,8LM-T%KDY.)\&:NC"WH@-B65&9XE0A5"-4(/0'*$%0DN&:/CY.ZM( M)>%_WH>:6Q3+>1FQA"<9F:630M?%UNYB6+GX(O>`LG;6[*V.L(;EC M&WE#)&,6Y4+66:Q%SCYG'W'L;3`*-HSU$4DRCB?>3J)$ZC";> MPQNC8VL]-]"[T@M/.AV,O*EG:71::=DEUVTJ:/SZR35#(U%'OP89LR@V;)=H MK73<3ICT'C/RMD<%&Q'#&)6H4UF6FNJB?MSWFE];AM%I4&=N64IG,HZ]OE]8 M@I%9"AGI6)7R7Q'K>H<@8EU#]`CSN"QFE@V1G*'4KD0%0B4:5LBJ$6K0<(ZL M!4)+82@]X^\Z+LP"Y]V%<<-,O;NGK80W97KC*6.6"#EM**9,@$HTK!AR#&N$ M&C2<(VN!T%(82F==MYF(<3/!T*4IDPW=R-+04!P\CKQ!4;`\L4SWE*826];*5&^>9#\G-K MZ-;>6]\7EF5JO[PD+WM-;7>NF)MYPV2=-8LU).9F9KDC2$,BG06H9"TG6ZD8 M<@QKA!HTG"-K@=!2&$K/J`V)ZYG/Q3-O:UR':4C&\]A;J+-8LT0\LR$E"S:> M,7'3K$0?U"6#V,\)2Y2N&$K?E:Z99:3C9.@-I@:EYQ^27DCI>)R.O>EO*:1% M3U%]WN^ICYW=M3+MAL2Z=Q!YU9@QZ]VS.\LQ@S)'J$"H1*A"J$:H06B.T`*A MI8"D5VG-$O'_?FY"[];\B9LA]W4]0CE"!4(E0A5"-4(-0G.$%@@M!20]HS90 M[LQPP3.\WW*F`+6RJ`-@F\UG".4(%0B5"%4(U0@U",T16B"T%)#TC-K'&,_0 M//2I*3/1FR$W_S>075`R`]ED/V=('-U%$V_%+"S+#,X2H0JA&J&&H<`)G*K$ MG_<$[H1:79JD7$\PR_6$AGY^`,0`SA*,3&,JB"=GB=I> M.,%Q8=3HS8B(`@VYF4:K*=R1,^0D#`5")1I6R*H1:H2A#'YW?T+!?Z%]N#U1 M:PKLY<;>+B-CEIL8,.1LR0J$2C2LD%4CU`A#V625`G^\2W7"++J4`"YD-%II:7; M5.;[<;=Q-NVN'QJ2!TU^QI31\J+B242*ALQ!T]B_C%FPC7O.A#*59;7G3!/_ M=FQM"79B<&LCW:$R5L<=GULU=-HK@DM#(QE$EM5]PO?3^]-*RY>DZ0ZF-HXPA-T(8 M&MC3R0*A$@TK9-4(-<)0ML_--ZE//A4%ZFB'0MZ-`H;DH<_8/SXPADX4,#32 M;['2-$[\,+`,TW\EZE26U8;!*)IXNZ;:,HQ.(W2DG]SL,^"GCVUV*`K`41H2 M\:$A$1\:HENJIJX%:SE0R9!C6"&K1J@1AK+=7FYY(?XQB52;6[6\BGG=[XN, M64Z"E1M#O8JD<33PSE<+RS!.*5&GLJPV$-()O-"T#*/3"!WI$)6P_=EIDS)` MB`-.'L5AY\2+_8P-G1[.&1K$_-K7/\$L+,$TKT29RK):-\4C;\:N+<'(-$)& M>NFJK)/>'8`[,.LT+'>RT"PWZV26`Y5H6"&K1J@1AK)]7M;YN6D3DU&J=CM: M9!1XFZF,62(*M.%HV$9!<-H\,TS_E:A3F0J(U=O/\&IFT3'&3R;71DA+UWG9 MJ^^Z#\ZDF-72MZ1M%-GXR!#*$2H0*A&J$*H1:@2DVZT_4-6?YNTVAZ^;;//R MX_G.2_O2!6A*PH1)U>A4JH<]YZ?0F5!)329O_>,_)T\&TH$&& M-C1`IVI$8DF>#LDFU![ZGO@A])0952Q8+ZI6D)]0=0-/?DBG#WJ!\IHQ2^E# MYH#!C/HDW(28FA!Z-"W7U.Q0"2V'9!.J%BUP9!,JH:6!;$(UH]F>;$(EE(5/ M5:*-CJ?$>JIR9RS)TSX])Q04E)[21J13:A;*',CFU`)'3)0W4(>I5,$ MJENH)$\H7&@KC;6F;3C9A$KR9$PV[8F,U].T!2.;4$D>DPV]U@@\ATK4RQ,L MH9$^S3A/J43GO0ALZ-R"94DL?D`WJK&+"A$O6&$TOH]275 M+522QR-2"TT.%96H-V\AM1&IA4KH^@"IA6I-]P-(+51"%P!(+522QQ0A]"X; M:T`OT$DM5$)OR$DM5$(7G$@M%(ET@XG40B5T18G40B5Y3"-8GZ+Y444EZHH( MUIJNA)!:J"0G5P?]&5%,Z7MXWE/RB$8VW;##I]"5OZFZU8'K]O78^=E\T2+8K_]H..@ M_V:#_N7$-\&_[$_TMQ9HLTE[5?K;&AOZEKROOKUYVN]/YA=J2._\USKN_P\` M`/__`P!02P,$%``&``@````A`#&ULE%7+;MLP$+P7Z#\0O$>TY%WKRHFCR#L5(W&8VC$270")W+ MILSH[U_W5]>46,>;G->Z@8R^@J4WJ\^?ECMMGFP%X`@R-#:CE7-MRI@5%2AN M(]U"@U\*;11WN#0ELZT!GG>;5,V2T6C&%)<-#0RIN81#%X44<*?%5D'C`HF! MFCO,WU:RM7LV)2ZA4]P\;=LKH56+%!M92_?:D5*B1/I0-MKP38V^7^()%WON M;G%"KZ0PVNK"14C'0J*GGA=LP9!IM>/A)T] M^$ULI7=?CR^[P[@AR$Y%'Q;NY]Z]PUD M63D\[2D:\K[2_/4.K,""(DV43#V3T#4F@$^BI.\,+`A_Z=X[F;LJHXLHN9[& MTQG"R0:LNY>>DA*QM4ZKOP$4]U2!).E)\-V3C&?1=#X:Q_\G82&ASM\==WRU M-'I'L&=0TK;<=V"<(O%Y0^C$8]<>G%'L:W`G/12WC^`U.4AFZ3C]J MC_DQK[]Q"TSH_0;UFX[Y^\AAHXP7TS=6PKT/]T*!*>$+U+4E0F_]G4ZPTX?H M,&[6B6_&M_%)NN[&$!L^X!AH>0F/W)2RL:2&`BE'T1QK;,(@"0NG6\P\!F'T4(+K1V^P4*L^$?9/4/``#__P,`4$L#!!0`!@`(````(0`V MM;%&$`D``,PH```9````>&PO=V]R:W-H965T9Y;Q#&@!(\SL[/[[5+NKZ.XJ9XA7 M>5EV#J?*[=.GNZJQ[W_]=M@/OE;G9EW7@XJ(Z;^GEW?'T8_OE'\LM\ M.&@NZ^/S>E\?JX?A]ZH9_OKX\T_W[_7Y2[.MJLL`,AR;A^'VC0[KW7&H,RS/_R1'_?*R MVU11O7D[5,>+3G*N]NL+C+_9[DX-93ML_DFZP_K\Y>WTRZ8^G"#%Y]U^=_G> M)AT.#IME_GJLS^O/>[CO;]YDO:'<[1\B_6&W.==-_7*Y@W0C/5!YSXO18@29 M'N^?=W`'2O;!N7IY&'[REJ4_'XX>[UN!_K>KWAOK_X-F6[^GY]WS;[MC!6K# M/*D9^%S77Q0U?U80!(]$=-+.P'_.@^?J9?VVO_RW?L^JW>OV`M,]A3M2-[9\ M_AY5S084A31W_E1EVM1[&`#\.SCLE#5`D?6W]O-]]WS9/@R#V=TT'`<>T`>? MJ^:2[%3*X6#SUESJP_\UR<-4.HF/2>"3DGB]DTPP"7QB$B_LG62&2>"3DLSN M)OXTG/>Y'U@&$+/CW(&:G]S8D9ZDEO/1.O+ M^O'^7+\/8"'"-#:GM5K6WM*#/\@M>FZO_OD[^X!O5)9/*LW#$-0!9S3@^:^/ MDUEP/_H*/MT@YTER/)>Q(H8RI4H;<2#F0,*!E`,9!W(.%!PH+6`$.EW%`C?_ M&V*I-$HLNLTG`HQZ/E.&&!02<2#F0,*!E`,9!W(.%!PH+0"*012VHBC&VQOCFX?NTJQ M6WGHMIX045NGI=B$V!TIMJN+1@)3N58"B002"R012"J03""Y M0`J!E#;BW#JT7#UN7;'=6T=D;Q++%QURPMUB! MK(+&,C!!R',#V5::RL"L.Y`MBUP&%IV!<^YP)]`57_6XMO@=(L-)^*JR;HD= ME34T<=J-N;"X9OGZX*R/.PB9/25671[,F,5*"#*LE""3*R/(L'*"#*L@R+!* M@EJ6JXQJ;'LHH_M@R&?\IZ$0/HR-YL)_&&@VV\C3D!^V9\NIYX?">R(H<8,\ M;^'-V"2D2/',I3*$IK`'6F-D^TQ.@;`NKBP_9+XNW!',%SX?0$EYV@&X:JMV MN(?:NGMVU-90Z(QQS);0"NZ=.2PBR&_5]F?APF?"Q40Q7DH(PJAP,I]Z;-FE MQ#%A&4*!/BAQ!,?'_!MNO2&8$KN&JT>PB.?;EM;PWY MP=7Q*_7+FVHEC,$BA'P#Q9*52%8J69EDY9)52%;IL%P95%]MR_!CQ0>[IED[7D30O/5C``MYP7/9^&,]QDI<4Q8AM#, M'B58V>V0N5I MEN,[A$QUC"4K(A]#11Y1$D>X&!?JXNZ4SP54&V-BLC*]_XIB+90BQL0K)*A^7Z4;78/630';E= MCN'.E#)N.5ZP^K%"EN6@B"!3'&."C&$2@@PK)26XP4[ M'>84^'$Y=@?0T424E*>C'*O.NH<-\>QA-<>^AFZ58^S@C2DB#(2=0CWG]N:S M(!3;GXA*6)3Z*6#&)BDECKE8AI!;CA?L>CFQ8-?]X'1,Z:DCD'U$290.=ZM3 M0@_!\9QA"X[G#'O[0Y9M9609*`9;MRO%0`E"L!BI*J62E4E6+EF%9)4.R]W^ M5!MOR_!CY5@?!IQ=$:%;Y1B/$<8B$;Q,I.2!#^5'WX;(NE6.W8'/91^A7I1J[\WRHW[Q2;_$\:C_=76+]Q]319PK-E,`K'ITMXN-J!SY;P<+$##Y?P<*T# MGR_AP9/$5]YXN8(?FN4W\)ABJ7XME]_``J6\%:#O/*G">1O;WUTO0*\2W9:OU:_ MK\^ONV,SV%8+GBCK+[`6V3M?[?PUF`%[_V,[Z`0 MOM3UA?Z`*X^N[R$^_@4``/__`P!02P,$%``&``@````A`)3KG].U`@``.@<` M`!D```!X;"]W;W)K&ULC%7=;YLP$'^?M/_!\GLQ M$)(V**1*5V6KM$G3M(]GQQBPBC&RG:3][W?&"8,FS?*"X#C_/NZ.8W'_(FNT MX]H(U60X"D*,>,-4+IHRP[]^KF_N,#*6-CFM5<,S_,H-OE]^_+#8*_UL*LXM M`H3&9+BRMDT),:SBDII`M;R!-X72DEIXU"4QK>8T[P[)FL1A.".2B@9[A%1? M@Z&*0C#^J-A6\L9Z$,UK:D&_J41KCFB270,GJ7[>MC=,R18@-J(6]K4#Q4BR M]*ELE*:;&GR_1`EE1^SNX01>"J:5484-`(YXH:>>YV1.`&FYR`4X<&5'FA<9 M7D7IPQR3Y:*KSV_!]V9PCTRE]I^UR+^*AD.QH4VN`1NEGEWJ4^Y"<)BCV%`PY7VG^^L@-@X("3!!/'1)3-0B`*Y+"3084 MA+YD.`9BD=LJPY-9,+T-)Q&DHPTW=BT<)$9L:ZR2?WQ2U(GR6)VT1VKI?! MY\"USXGZ#`)J>DD@8RCI?'F.S"[9,;MR.2D//C"DB<_33,8TSOD$>GJ9SAV" MO(&)4Z,^)QGDS,XK@)3KC;ID:!+8Z^MW2NV3KJ"&@1E2._/Q[?_,NT.=A+[8 MAPB4[9^H:7C>[6Q,>;G.+GE,=8CX:1Z."\A^:R5*H/^7"=RI,<$A,IR<9/K. MB+J-//AJ+E.YY#'5(3+IOLRAE_D8MVM+F`2W4.?+'.[@F.,0&=J)[MX.HM]5 M?B%(KDO^B=>U04QMW1Z*X4ONH_V*7,5.]MMXDJZZU4GZ%["Z6EKR;U27HC&H MY@5`AIT7[9>??["J!>6PP)2%I=7=5O"/XO`QAP$8+Y2RQP<@)OU?;_D7``#_ M_P,`4$L#!!0`!@`(````(0"ZP4(AR0(``"4(```9````>&PO=V]R:W-H965T MN=)"MAF.@A`CWC*9B[;, M\.]?=Q>?,-*&MCFM9456!)@VZUR``]MVI'B1X6V4WD01)INU:]`?P0_Z MY#_2E3Q\42+_)EH.W89SLB>PD_+!0N]S&X)D,LF^IM`?-D(9YF"]MP4YZ:&X?@==C*"8)P_,NE^^1LN"Q5!]QDSX:CZLQ MKWW35F%P!:7]?T9MWEBBCXS=O#*4=E'/?ATL>"S51Z9N5F->ZR9.DN!--S9O M+-%'QFY>F?T(4//M./18[!B:&H(M.Z)VFW`)^^BM\W&)+U3ZG7'Z-B?AXL6\ M^:7LEU?#5J M%*U&-2^`TX^;\FO>WQC90>VP;:6!->W^5O`YYK"20NN]D-(<;T"9#!_XS3\` M``#__P,`4$L#!!0`!@`(````(0!4`M5I5@X``&])```9````>&PO=V]R:W-H M965TW?/'L>9&)/$@>W9V?WWUQ2;$KM+<>RY?5GOE+I(=;-(%B7''W_YX_GIZO?- M_K#=O=R.DNO)Z&KSLM[=;U^^WH[^_9OYL!A='8ZKE_O5T^YEO6Y>Z,K#;O^\.M(_ M]U_'A]?]9G7?DIZ?QNED,AL_K[8O(]_"S?Z<-G8/#]OUIMRMOS]O7HZ^D?WF M:76D^S\\;E\/H;7G]3G-/:_VW[Z_?ECOGE^IB2_;I^WQS[;1T=7S^J;Y^K+; MK[X\4=Y_)/EJ'=IN_P'-/V_7^]UA]W"\IN;&_D8QY^5X.::6/GV\WU(&KNQ7 M^\W#[>ASV0/_9;GX5M^?CO_:_;";[=?'(PWWE#)RB=W<_UEN#FNJ M*#5SG4Y=2^O=$]T`_??J>>ND0159_=%^_MC>'Q_I_Y+KQ72:SQ9S:N;+YG`T M6]?FZ&K]_7#(&1/I,Q#3ZWDR66:N M]Q,]YDRD3R:FU,8)`C77)DJ?3)B>=8*JT3(X2X`?6E2E7:(")12`Y4&C`9J M#5@--!$@TJ:9]!>D[5JY'=%_3PB`8VAR=4$S58HNI*L%(!4@!I`:$`M($R.B M(K3,_`45<:W0I**R=]GBG/!!V:F2="%=20"I`#&`U(!80)H8$26AA30NR?"& M$Q8#%]QF'N[XSB,9K8Y1+:9J[+N@0"L!J0`Q@-2`6$":&!&)TDBH83CD=6S MN@OJ1A:0"A`#2`V(!:2)$5$#NL6X!J=GY8)E5AY1PS=7$[,+ZH8/D`H0`T@-B`6DB1&1:$)N^?Q,VVB9*D/Q M"")4(E0A9!"J$;((-0*2^3E;HHS83\W1Q/L;VGC"<-TQI(9YH8:YCPK$$J$* M(8-0C9!%J!&0K(9S*U$U3L]6M\DJ83,D1MM'15")415"!J$:(8M0(R"9GS,? M47YN1IHB4V;GTR10)0"5"%4(&H1HABU`C()F?\QOGY^?=BTBXJC%_I'@_0U(A$7R%D$*H1L@@U`I(I.S-R?LK>NHB48S?3'@>+ M!*`2H0HA@U"-D$6H$9#,SQF-*#]_<+YV3S*.C]OUM[L=36E:B@>DG-$!F8_- MWJV(M!G*N_E<)`SY1SK^8.RAC#3>.>IDJ?10,9&B@AX,0C5"%J&&(1IP:DM6 MPIF3_[L2WN&(2C#4WWV1,!17@B$J2%>)/%%/%JI`[-<'$R!R'!%1G>\I-^QJ&YK1Y=[7) MDTQM!('8CWW)T'3I:Y,IDU\AQ4A*KHI9(\-*1K)01_Q&4&1A+C)\*1H^AH1H MTA0*XXET'V'JE$P,`DC5/5=\/:(825%]U$BPDI"FJI2-H,BZ**/XCF#0#+HG MY60`EL]F"H\C!]'7Q1!9,JE=49!B&B-%K,YVJAP$U$FU/=$^.=5>-8,CJ M.(]W]E)*2R%,)P\IU2@)%$R,)%`RQ*J9*@U4R#`]XV1U_`U%7=F>Z*JCNVI$ M5[(ZSON=7QWO%..-QAU'4#M0'2;&VO$0:P>*`P3#/;TG'2#:GNB*HWIJ^*J7 MM:S-1?8T17O*D%!.GBBQ%QP5#6?)$"MGGL-"[/N**$92Y+0B!YD M:9S5/+\T;$SCTGA(:48)H$A]5"2`,D#><61IIN9@%0+Z?7QNVJW%M/"1EDZB-LDB9&.O&0S1L;@6@0Y"ZZ0HY MAB&6S&P.,PJZL4SA;MP;6NFY&M&-T$UVD2%NHZ4A9DCH1N\#!0?%LF&()?`A MT>6LD&,49Z%+@Q2K*.E$>85&<&1I+O+#E(C>P!E2LE&'L2(0(]DPQ!+X0-]D MD>-9(*4R/'!BATE&I2$R)PW3;3EJ9!C&&).,EVJM;-&CI6<^2Q11Y9&<&3-G$V,]B)=L]]VKV\] MFB/#&!Z\9&PVHSV*H6S9C6^!4(E0A9!!J$;((M0(2.:M/.W/OU1P7TC0@O&0 M?`*MCVH%$Z/'S25"%4(&H1HABU`C(%D.Y_PB&9P^.KLO)^B4/10E4W!4!)4( M50@9A&J$+$*-@&1^RHZZX?ZI-X9N3'7J'G)7NN4A3Y6W+I@HJM$1PQ)8891! MJ$;((M0(2%;#6;;S1YL-7CRY/40]A#LO:**[PD10B5"%D$&H1L@BU`A(Y.=6 MZO/S:Z/E1L>0JV`_I/`*J8\*52@1JA`R"-4(680:`IM2!&@Z,4)0VX;[?20IFJ7K?JH MH`>#4(V01:AA:.`54JY_5D#F>"$!`]B6#(G7&ZSO"Y,!)M@-[JK`D!>"[(E0=\IT+H]=H&;D=N]G8W M35_,EH?$@J,B@94,\<$RUQ:I0HJ1E+D^,B'#2D:^U"=N09'242;QG<*@$Z0`GTUHB]9'N?YSK81 MN8M6VZR'I&[@!5T@]@M3R5!X)J6\5H4,TS-ZB0[,*[['OBO;$]LSG.JJ$5W) MZCAW=WYUO!<4"[*'A'CR5#\=SGU4-*(E0_Q<(=5/)BND&$E1?=1(L)*0SF%2 MQ;I%Y;:/EK&)(Z`;?[G)4K!N&@FXRM3E72#&2LIQHY2#%!H@WJ@2^$1`" M<*.:7F1RVVA5&N][A71R/9Q%(/8**!GB!2>;JSPKI!A)F)%M,U>Y1(<JYB)K/$5KS)!2C7IB67"44(UOBU6SF.JW2A5R#$.LFF2A MBEDCQ0;(JX;^)MM#UA+;ZF[!#1+B))A#?N@DI-F<]S_9#4V]48S_$D!2;_GI0P5%" M;)V;[O?]/-6>FHGN]4EWB!FHZ$!;`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`X&C44[%.,N:_JYF]?5U\T_5ONOVY?#U=/F@<0\:?\L:^]_,,?_X\C?`?FR M.]+OW-`Z1S]]0C]LM*%?'9FX/XQ_V.V.X1]TH^/NIY(^_0\``/__`P!02P,$ M%``&``@````A`"W5/-(F%0``8FL``!D```!X;"]W;W)K&ULK%W;KSZ<_=R>-@_O[^.;@;7 M5[OG^_WGA^>O[Z__]W^R?TRNKPZO=\^?[Q[WS[OWUW_O#M?__/#?__7NQ_[E M]\.WW>[UBAR>#^^OO[V^?I_=WA[NO^V>[@XW^^^[9RKYLG]YNGNE?[Y\O3U\ M?]G=?>Y%3X^W\6`PNGVZ>WB^U@ZSEW,\]E^^/-SO%OO[/YYVSZ_:Y&7W>/=* M]3]\>_A^8+>G^W/LGNY>?O_C^S_N]T_?R>*WA\>'U[][T^NKI_M9^?5Y_W+W MVR-=]U]1>G?/WOT_P/[IX?YE?]A_>;TANUM=4;SFZ>WTEIP^O/O\0%>@FOWJ M9??E_?7':+8=)M>W'][U#?1_#[L?!^?WJ\.W_8_\Y>%S\_"\H]:F.*D(_+;? M_ZZHY6<%D?@6U%D?@>[EZO/NR]T?CZ_;_8]B]_#UVRN%>TA7I"YL]OGOQ>YP M3RU*-C?Q4#G=[Q^I`O3_JZ<'U36H1>[^ZG_^>/C\^NW]=4+0;[O#:_:@K*ZO M[O\XO.Z?_J4+(V.AQ;$1TT\6CVZ&XT$2T6>=:Y(:$_II3,8WD^$P'4W&YYL0 ML[\,^FE,+J_(R'C0SY^OR-B8T$]C$EU^-30X^ZNAGS]?DXCZD@ZMZE0Z?).; M<328)AH7XS*]B2?#:#BZH*M$"5\2_6)LW.8]T54C M[F;J%[R.4TKN%Y'M&'05IQ3<"2+;"^@W5-SJP=B/[<7=Z]V'=R_['UDWFD74"WA4:XOC./__ACF-;^7R4=F\OR8]C>0#S4U_?DB'\;O;/VD^ MN3><3\B)?,:<&6KR4+8+"2PED$D@ET`A@5("E01J"302:"6PDL!:`IT$-A+8 M.L`MA><8(^H#OR)&RD;%B%OW$P,V:")D02*"102J"20"V! M1@*M!%826$N@D\!&`EL'\`)"<\*O"(BRH;O@R4%C.#0A'$?62(R:(^48)4"6 M@&2`Y(`4@)2`5(#4@#2`M("L`%D#T@&R`63K(E[0:#;^%4%3-C194M`U/O?>"AE=LO^$-DAYO_7.#Z'U:O]0"9`E(!D@. M2`%("4@%2`U(8Q!J$V?@IO[`;5V9UV*T$O5:3"]K;]1VY/7;P_WOG_;D2NNM MP'22T/)5+VJ5B=^0!G$:TB!.0VHDH1G-J?C0K_CR2.(9)P,D!Z0`I`2D`J36 M"&W5^;,:@_AM*Y85K2OSVG;Z*]I6F?AM:Q"G;0UB*[XPR&"DMQA1,I`-:QAV MCLE8,V;-5/2B'#2%U*03T3HE:"JI&8XG?M!KP[#7TQA$5RT>1.+&U+H*+P9J MR^UU\$!'INTN]^2>[C>W@>(^8]3W]SFS;`@6S++0$ED9LG)D%<@JD54AJT96 M@ZS68_F-I396[B;WC<;2^S!:XO&`^:1R$]1=4VKUXZ"F]*,?W[EAQ3IUI3>P M6AC'?>>+1I2N$CUIB:J,(:,:CV"%F3/%?E;!D%%-AFD\]FM8,L6J*H:,:AK' MT=17U4RQJH8AK1I'PV0H1F++E%[EQT/MJRZ(A]Z&>?'04$JM>XQ'.A17.U>+ M=#7)V,Z[,%"L1]QX0)?K7^P219DOF@Q&8Q'#'$6%$`U'(]%=2A154A1/1/5J M%#6^*(GC82(BV'HJ/Q9JOW1!+/3VBOSLV-"0-S:B6,RQZ`+(J&W3%XD-"1&A6B@N4I+RE&AH=@.E"6R,@,YK!Q9 M!;)*9%7(JI'5(*OU6'Y/5ON6"]I/;W.\]M-0:COW7!UPR&YK('L;7R(K8\BR MXT+&DMO3;S&TM"8!K$S!8N) M9ZXRV;*S:6@X[6^)@YM$#,8E:C(#'36IT.2H*:1F*!97)6HJJ1&S6(V2QI=$ M-W(6:SV-WV/5]N6"()C=CNV>GU3:GYIW[-T'Y8UF;EC>W*N%=`*G2MIP[(3 MZD(=KJB9Q$)+`]&4QC?3#%DYL@IDEQU+XZ'M[0 ME/C&FMKL9-QFTY"W;DA'8F#/(\UR^N&"(7V3C\&>[N\% M#>3V8&;9OKE@EH66R,J0E2.K0%:)K`I9-;(:9+4>RV\LM2'[F1Y,/;"_DSD] MV$"B!XLN,C1D*T9(;M(AE#+)J,Q!FP];S\\*BM MFAN>G\ILTRH$H@;;PCFSW*AIUAO9;2,D%E]1AE".4(%0B5"%4(U0@U"+T`JA MM8%H\\2U[YCE!U(L.S:6Q<*MY^4'4FTC__-`ZLVHNS%33SGY6ZXY0_:*%@P- M)OT.(*5GM<3M9.E0^'HRQNRHS1EBIV@0"Z?"H;!3R9AUJA@Z.D6QN(?4#H6= M&L:L4\O0T2F6J?650V&G-6.VG3H#45=6&R5*T8O[Y\82V&;KV?A!5WM?-^AO M3*YF]^RN.31$$P1_W#PV+#O:%@9*1T?6$J$,A3FR"H1*%%;(JA%J4-@B:X70 M&H4=LC8(;3VA'PNU);P@%GH'Z8TT#7GK/SP5H%RS&H^T^N&(+0R4T*+EF#N) M9[.\MZP4'N/HC269QI;IO3>?F]2V_L+>I-) M$+@C6T,B>RNN;AX;H3O8#>0F@0*]2;/H"M1$-AI$D=@`9VB=,W32NC`LMAX/ M$['$*=G'UKIBZ*1U[5N/Z41+W%L:]K'6+4,GK5?2>C01-YLU^UCKCJ&3UAO? M.AZ/1I'PWK)1[^WW))EC>>,>@9F5.)!9P1,9P_+F)2U\:U[2+-I"J)XT3F3& M,T/GW$"GG0L6:N=I,A`KK)()=FQ79SG7+#3S1CR<"NN&&=:Z/8?=/*[?,P`DIN2PKU-/]K)"!Q(0D9HTY"^T@6;#0 M+J.6"&4HS)%5(%2BL$)6C5"#PA99*X36*.R0M4%HZPF]4:[>?;G@?M'317B4 M`SV38&\A<\-RA[2!AOV[/?UC'DN$,A3FR"H0*E%8(:M&J$%ABZP50FL4=LC: M(+3UA'XL+DL_J4E,;;!LPW\RT!N'82QTAXKQ.GD_61KA\?@K%M-`ALXY0R>= M"^D,=VZVL76N&#KI7$OG5)R$-VQCG5N&3CJOP%FLD=9L8YT[ADXZ;WSGZ$:^ MPK)EF][9[T,JZ77^^D^EA&0?TM`;9WE&Z`UQ+51U.[&;,$(:!?K$#_N0MG&< M<]:<="Z8Q@SBUK3CJOF'5T%B-J;0A.:W2L.>F\ M899VICXD5WZ>L]^'9&[O],I/)>%D']*0FQU@EAT,"P.E[OU9"QTH0V&.P@*A M$H45LFJ$&A2VR%HAM$9AAZP-0EM/Z,#R9B-77TC(XN9"A3VY9?1)K/)J(R;BP#/8IT:>R+.,S%3ZU9;!/@SZM M96F?L7R,=V49[+-&G\ZRC(\\W=I8!OML/1\_YI=EY]3K/7+\87:.6>[XTRQG ML"T-RX$R%.;(*A`J45@AJT:H06&+K!5":Q1VR-H@M/6$?BQD=N[<)PW4JSXR M*H$\73H2.:FY$7KCSPC-^)L,Y",O2R-*;>XY0Y_U9;!/@SZM96F?J=QHKRR#?=;HTUF6\9'Y^HUEL,_6\_%CKE)4%ZRA M3-[+78=KR#GSG=/OJC\XT`*A)4(90CE"!4(E0A5"-4(-0BU"*X36"'4(;1#: M>I`?"Y7DN2`6.B?D[8D,9">^>6(@N_!8&,@]!D8H0RA'J$"H1*A"J$:H0:A% M:(70VD#NZ:&!U,+ON$!/AR)'NK$L.U3<]O+"H]827GA^ZABX=_%WL@PY46/( MB9J!U/+)N2*Q&%A:%E]1AE".4(%0B5"%4(U0@U"+T`JAM8'<0#++#Z38.FPL MBR][ZWGY@:0=Z2\(I'(1@320&T@#N8$T$!^4#H9CT2^7*O^GO(G"UY,Q9J&< MH:/3:"3V@85#8:>2,>M4,71T&LMSF-JAL%/#F'5J&3HZ35*1*U@Y%'9:,V;; MJ3,0=?C^3D>G)WXB=F,);+/U;/R@TQ;2"_KIC1ZE^""Z&G(W>LRR`5\8R#T& M1BA#88ZL`J$2A16R:H0:%+;(6B&T1F&'K`U"6T_HQT*E$,Z_T:4ZX^#>Z`RD MQOAQ,L1C8,-REY<&>B-QPT)SOA"ED7R^(F.*/6#(S_(N6,AG%]-4'N:43+'> MU5G>-0N-=S*>#,22NV&*]6[/\EZQT'BG@]%$3%MKIECO[BSO#0NU]S".!_)@ M<,N4WMOO32J/93`S-NL?>A*^VI4;H#G8#N4(\!C9"Y3'.],QJKZABZ.0'U?*#$K$8:=C&.K<,G71> M@;.XAZS9QCIW#)UTWOC.T8UHC"V[],9^!U/IG`L6AR;[8T?VIU1#;YP1&Y8W M_K7P](UW:83VC'CBA7T@+C7##\K9XN0A:<$L/GZ-3W]0B1]4L<7)#ZJ9Q1^$ M'4PWC--6+6M..J^8=72&#@;.'6M..F^8Q2?(N&ATG;T>1I/Y)3VLI_MI(P.Y MB05FV9&R,)![:T"IA%O MM)][@C540A$5#7E+>3Q!-D*G+R\,1',2GQB)??+2,GB5EJ%/;EE\TB.^#:.P M#/8IT:>R+.,C3]1JRV"?!GU:RV(?L21>60;[K-&GLRSC,Y:)/< M1K87\]/+N:&BBTAKR!M_AN6./PUYXP^@C.VM,#>0(RP0*E%8(:M&J$%ABZP5 M0FL4=LC:(+3UA'XL9&+O[/&'*3[Z7G45*#'^1#IK;EC>^#-"/D&.X/N&V-JF MK3/TR2VK[Z<3>CG!WX`5EL']M$2?RK+81]RV:LM@GP9]6LLR/O)[>%:6P3YK M].DL2_O$`U&?C66PC_J6>Q4-WFO"/19 M!+A*NLB`SZ>$+C&`?TQG'X,?3++6DCBF&A M_?9,;;"QA#;4,[6#QA+:,<_4%AE+:$L\4WM@+*$5'+5!_U"X"#0MT:@-0B6T M!J,V")70(HO:(%1"JRAJ@U`)'4Y1&X1:ATZ?J`U")72\1&T0*J'S(VJ#4`D= M$%$;A$HH044U"`UIRD!1#4(EE&*B&H1**(=$-0B54)*(:A`J6:34;G13P?AT M5*(.DK%DD=+XH:-%+*$C6*IUJ(2.5*G6H1(Z(J4:A$KHR)-J$"I9)-1[Z2F> M0`VH1#W*A"7TZ-),/9R$)?0PTDP];H0E]'C13#U`A"7TU`AIIH&2CDK4DQ0A MS9!J'9K8Z?%(JG6HA!YXI%J'2N@11JI!J(0>2J0:A$H6"?4W>N(-ZT8/]E$- M0B7TY![5(%1"C^91#4(E].P=U2!4LDBH[]#N/E0#ZCO!$GJ?@VH0TM`+&U2# M4`F]D4$U")70L\=4@]!MEQXNIAJ$2NCI8:I!J(0>#Z8:A$KH^5^J0:B$WHV> MJ9>A`VU`)>IM9RRAMYMGZG5F+*'7EV?J?64LH?>39^J%9"RA]Z.H#4)CFUZ` MHC8(E=`;3M0&H1)ZA8G:(%1"[RA1&X1*%C&U&WTU`=:-ONF`:ATJH6\,H'8+ M]6OZ!@!JMU`)O=%/[18JH3?TJ0:A$GKCGFH0*EE,9O3MQEAG^BH1JEEH$4+? M%4(U"Y70EX%0S4(E]&T?5+-0"7V=!]6L+[D]WC3I+QQ]O_NZ:^]>OCX\'ZX> M=U]HO3GHOVCZ1?^-)/V/U_UW6H?2GRK:O]+?..I__49_RVI'?^5DH+X^Z\M^ M_\K_H$N\/?YUK`__%@```/__`P!02P,$%``&``@````A`.+BC[.%`@``B`8` M`!D```!X;"]W;W)K&ULE%5=;YLP%'V?M/]@^;T8 M"$E:%%(EJ[I5VJ1IVL>S8PQ8P1C9SD?__:XQ04D35?0%XLOQ.?=<7]\L'H^R M1GNNC5!-AJ,@Q(@W3.6B*3/\Y_?SW3U&QM(FI[5J>(9?N<&/R\^?%@>EMZ;B MW")@:$R&*VO;E!##*BZI"53+&_A2*"VIA:4NB6DUIWFW2=8D#L,9D50TV#.D M>@R'*@K!^)-B.\D;ZTDTKZF%_$TE6G-BDVP,G:1ZNVOOF)(M4&Q$+>QK1XJ1 M9.E+V2A--S7X/D8)92?N;G%%+P73RJC"!D!'?*+7GA_(`P&FY2(7X,"5'6E> M9'@5I>LY)LM%5Y^_@A_,V6]D*G7XJD7^7304%WM?VE#M^X*"L+IST%0\Y7FK\^<<.@H$`3Q%/'Q%0-"<`32>$Z M`PI"C]W[(');93@.@R2>SN\CP*,--_99.$Z,V,Y8)?]Y5-1S>9:X9X%WSS*9 M!=-Y.!E!0GQ&G<$G:NERH=4!0=.`I&FI:\$H!>+;CL"*PZX<.,/0U)"K@5/8 M+Y-DLB![*!WK,6N/@>>`B08$`=%!&=3&*SNP4W:U=:FL?>!<)KXM,_F(C`-G M&)Y#\M<&/28YP\QN*P-DO$$'AC,`6^](>]`(:6BJ\=(.W$D/Q>TC<$_.DDEN MNYQ]1,J!+Z7Z2-?I%^TQO^1U5RY.H/;O=ZC;=2G01\X[)4FF;[SXF^\OAN2Z MY%]X71O$U,[=ZAA:?8@.`V<5NVY\&T_253>(R/`!!D%+2_Z#ZE(T!M6\`,HP MF$.1M1\E?F%5"YG#-%`6)D#WLX*)SZ';PP#`A5+VM`!A,OR'+/\#``#__P,` M4$L#!!0`!@`(````(0!YA8U1A`(``(H&```9````>&PO=V]R:W-H965TKJ237D$8R5NLUI',TH@5;H0K953G__ MNCV[H,0ZWA:\T2WD]!DLO5I__K3::_-@:P!'D*&U.:V=ZS+&K*A!<1OI#EK\ M4FJCN,.EJ9CM#/"BWZ0:ELQF"Z:X;&E@R,P4#EV64L"-%CL%K0LD!AKN,']; MR\Z^L"DQA4YQ\[#KSH16'5)L92/=N/O%";V2 MPFBK2Q%3Z$F]G)[MO^`'X84D#)=XW[J???0%:UP].> MHR'O*RN>;\`*+"C21,G<,PG=8`+X)$KZSL""\*?^O9>%JW.:Q-%\.3N/$4ZV M8-VM])24B)UU6OT-H'B@"B3)0(+O@>1\,96$A81Z?S?<\?7*Z#W!GD%)VW'? M@7&&Q&\;0B<>N_'@G&)/8ZX6#^%QG::+%7O$RHD!D`FB"-335=VH-[Z;&X0P2OR4$RR[?KN_B(E`(; M\G4\S3;]*&+C!QP%':_@GIM*MI8T4"+EK/=BPC`)"Z<[S!P'@G8X!/J?-&PO=V]R:W-H965T/NXLKC(RE34YKU?`,OW"#K]=4E,JSG-NT6R)G$8+HBD MHL&>(=53.%11",9O%=M)WEA/HGE-+>1O*M&:`YMD4^@DU8^[]H(IV0+%5M3" MOG2D&$F6WI>-TG1;@^_G**'LP-V]G-!+P;0RJK`!T!&?Z*GG)5D28%JO<@$. M7-F1YD6&-U%ZL\1DO>KJ\TOPO3EZ1J92^\]:Y%]%PZ'8L$UN`[9*/3KH?>Y" ML)BAS=]^+W%89GL5!?#6/Y@O`HRTW]DXX3HS8SE@E?WM4U'-YEKAG M@?N!91',+\-9]#8)\1EU!F^II>N55GL$30.2IJ6N!:,4B,\[`BL.NW'@#$-3 M0ZX&=N%IG&2#3#3HP[`'8&NIV*NU!$Z2AJ:9+.W`G/12W MC\`Y^9M,$IYWN7B/E`./I?I(U^FC]K@<\_HC-PLN(;?_-ZE;.-;H(\?-DB3_ MZ$HWL2>?!P<>2_614SO+,:^SLTB"-\VX96.%/C(V\[KW_23S!UUR7?)/O*X- M8FKGIE0,1W>(#@-T$[O3]3J>I)MNL)+A`PRVEI;\@>I2-`;5O`#*L-L8[4>C M?[&JA(#-Y)WO8$:[<&C);N\J(2EHG?PX'H+ M+BCP22093X6M41N"I1A[T8+F/HL-$\-M[S0/\>@:;+EXYPW@19Y?80V!2QXX M/@!3.Q/1A)1B1MH/UXT`*3!TH,$$CTE&\';-GNS?7 M)=ZW%?Z=55*,=E0XX`%D$M^C1[M3\ESJ"IE22`42 M`]:$[M)RPP$L'#NS'=ZR7[^3I*6A-=[*76*?C^=\/,=V\.TQYYTM*,VDZ'GG M9UVO`R*3"R96/6^>WG[ZS^MH0\6"]_"CQ^"F9(%*,-`=]"$T#UO M;4QQ[?LZ6T-.]1EN"]Q92I53@[]JY4:`O]E(1@"K9(VHTSI,-B:ZRUD1JJ.9K\Q M;1=>YX%JJ.#TO"U5C`J#L"JQYJ?^YH4V*OPIU4:O`8P.?!1H%NO/MFS[FUV& M5U]K"?PZE*PL-$APXQ!CR@P'/5W.J#(6R%=?VYAK%`WB!M!S%0GV!HF%P7R1 MD6BJS60;^3Z&_G223,>C093&`W(3C:-)/R;),([3Y+WR9$;_KI*DZ.E[/$D3 M,KTETUG\7I5D&+U7I1_98YFJ%17L=]V!=VC,Q MPF&4`TGI(]@%^K1@AO*_6XJI$AB-)C-0)%E3A?S=!ULQL>GKQ,AL0Z9%#:E. MYD^J$.4A&_?B<5YPN:M23?I2&(6QZ%H+_W1I]?"$&.?"@HP!IP*9/G"VJEOC M2(PRSYFIG.QM&PP%!S6.7ZN/,3-/%JW;(\2&,65'4M!JN3NF-XW3.8HK0YG5 M8)1AQVET>JR.MS@7R3WE)51-?F=8-D1BE#U/.*VX65<2#58RXU18O3=% M`&Q.$+!DYKCD!/XG46G6$N<[)GR+#&@X5?7YS&H\`8Z3'&OUH\26!<5W+?@# MNTI_&`_FXYB,1N0^&L^C=#2=D&@R(#_FT=BNXF3\^0DZ%U8=^YA`?B&W[:WT M9EJXA-\.`9=TF]PNN;?4=4D?9W"E9VU7:Q'(&[>Q2 M>P1'SR0?+"3I75ITC=*CB9_Q?^>"2=IRBF&4K)@N' M7!X.2.02M)V4=:6/16JAGH9@W5K6+O6C=7[5//S56['S=9[3HO9Y4S M4<[SU6[Y8`ZXC%M/37>9ZRO,J]/3J>$^$NTE2)QGXD'0!V^65Z^4,1,;/2]2 M.7 M9]W/77P/MM8"_VEZX"4L_`,``/__`P!02P$"+0`4``8`"````"$`;U"+9D8" M``#:)P``$P``````````````````````6T-O;G1E;G1?5'EP97-=+GAM;%!+ M`0(M`!0`!@`(````(0"U53`C]0```$P"```+`````````````````'\$``!? M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`/A\AB_=`P``90X``!D`````````````````@A<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-1X?*=9`P``?PL``!D````````` M````````E38``'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`+09I0<<"```SB$``!D`````````````````ZT<``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`$C:[:D8%0``$FL``!D`````````````````[6,``'AL+W=O0``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$%I.V#^!0``$AL` M`!D`````````````````9X```'AL+W=O&PO=V]R:W-H965T MX@8``$&UL4$L!`BT`%``&``@````A`)Z=J!NW!```I1$``!D````````````` M````[Y8``'AL+W=O&PO=&AE;64O=&AE M;64Q+GAM;%!+`0(M`!0`!@`(````(0"*#;MG\@T``*^+```-```````````` M`````**B``!X;"]S='EL97,N>&UL4$L!`BT`%``&``@````A`"R/V*$@6``` M/!H!`!0`````````````````O[```'AL+W-H87)E9%-T&UL4$L! M`BT`%``&``@````A`$].F/;S`@``.0D``!@`````````````````$0D!`'AL M+W=O1VPM``'``"<'P``&0`````````````````; M$P$`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$*K'#D]`P``#PH``!D````````` M````````>AT!`'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`+_XI-_^!0``HQP``!D`````````````````2BH!`'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`&V($W*X%```5+(``!D`````````````````^#4!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`(RW\J@B!0```1(``!D`````````````````7T\!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/O;$03R M`@``!`D``!D`````````````````"&P!`'AL+W=OO-N>#`(``",(P``&0`````````````` M```Q;P$`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`+"VZ8\/!@``I!<``!D````` M````````````L(P!`'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`($+H@_D!0``Z!8``!D`````````````````L)X! M`'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T M&UL4$L!`BT`%``&``@````A`->G@@^D`@``5@<``!@````` M````````````C6.!!$``,-?```8`````````````````$RY`0!X;"]W;W)K M&PO=V]R:W-H965T&UL4$L! M`BT`%``&``@````A`"$0$YLE#@``*$4``!D`````````````````3=$!`'AL M+W=OF47!'04 M``"8:@``&0````````````````"IWP$`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`."N92:"`@``B08``!D`````````````````=/P!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$#]AD^)!@``0QD` M`!D`````````````````W1H"`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`+VB<8(`#@``\D,``!D````````````` M````IS0"`'AL+W=O0@(`>&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A`)3KG].U`@``.@<``!D`````````````````X4X"`'AL+W=O M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"W5 M/-(F%0``8FL``!D`````````````````6F,"`'AL+W=O`(`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,M!/WVH`@``6`<``!D` M````````````````+GX"`'AL+W=O XML 20 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings Per Share (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended 12 Months Ended
Oct. 31, 2013
Jul. 31, 2013
Apr. 30, 2013
Jan. 31, 2013
Oct. 31, 2012
Jul. 31, 2012
Apr. 30, 2012
Jan. 31, 2012
Oct. 31, 2011
Jul. 31, 2011
Apr. 30, 2011
Jan. 31, 2011
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
Earnings Per Share                              
Income Available to Common Stockholders (in dollars) $ 11,120 $ 14,701 $ 11,338 $ 8,665 $ 12,889 $ 12,596 $ 9,306 $ 7,365 $ 10,476 $ 10,081 $ 7,817 $ 7,985 $ 45,825 $ 42,156 $ 36,359
Weighted Average Common Shares Outstanding (in shares) 27,677,000 27,672,000 27,698,000 27,716,000 27,705,000 27,695,000 27,685,000 27,888,000 27,949,000 27,941,000 27,920,000 27,884,000 27,690,677 27,742,257 27,971,100
Effect of Dilutive Securities: Warrants/Options (in shares)                         161,000 179,000 236,000
Weighted Average Diluted Common Shares Outstanding (in shares) 27,844,000 27,842,000 27,879,000 27,912,000 27,906,000 27,888,000 27,878,000 28,041,000 28,138,000 28,147,000 28,142,000 28,122,000 27,851,720 27,920,920 28,207,358
Net Income Per Share - Basic (in dollars per share) $ 0.40 $ 0.53 $ 0.41 $ 0.31 $ 0.47 $ 0.45 $ 0.34 $ 0.26 $ 0.37 $ 0.36 $ 0.28 $ 0.29 $ 1.65 $ 1.52 $ 1.30
Net Income Per Share - Diluted (in dollars per share) $ 0.40 $ 0.53 $ 0.41 $ 0.31 $ 0.46 $ 0.45 $ 0.33 $ 0.26 $ 0.37 $ 0.36 $ 0.28 $ 0.28 $ 1.65 $ 1.51 $ 1.29

XML 21 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Details 2) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
Goodwill      
Impairment loss $ 0 $ 0 $ 0
Goodwill accumulated amortization 2,401 2,401  
Other Intangible Assets      
Amortization expenses 994 581 1,322
Accumulated Amortization $ 8,847 $ 7,852  
XML 22 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Property and Equipment (Tables)
 12 Months Ended
Oct. 31, 2013
Property and Equipment  
Summary of property and equipment - at cost

 

 

 

 

October 31

 

 

 

2013

 

2012

 

 

 

 

 

 

 

Medical Equipment

 

$

65,762

 

$

50,338

 

Leasehold Improvements

 

27,974

 

19,768

 

Furniture, Fixtures and Office & Computer Equipment

 

21,621

 

16,503

 

Automobiles and Aircraft

 

18,242

 

16,092

 

 

 

 

 

 

 

Sub Totals

 

133,599

 

102,701

 

Less Accumulated Depreciation

 

67,950

 

52,261

 

 

 

 

 

 

 

Totals — Net of Accumulated Depreciation

 

$

65,649

 

$

50,440

 
XML 23 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 24 0001104659-14-001779-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-14-001779-xbrl.zip M4$L#!!0````(``\P+43VN58IW%(!`*/E'``1`!P`8G)L:2TR,#$S,3`S,2YX M;6Q55`D``TW'TU)-Q]-2=7@+``$$)0X```0Y`0``[%W[4^-(DOY](_9_T'%[ M$S,1&"Q#-]"O#9YSC@.:`7IV[RXNB+)4MFM:4GFJ)(/WK[_,*LF6C0TVC7!) MJHF8QM:C'IE??OFHDOSI[P]AX`RID(Q'GS?:&0R./^RSJ?=Y(9(-(C[&- MOW_YZU\^_5NCX1P+2F+J.YV1QN-;=:6^_U#0\=$;`/^*\#PXFD^L@^;_3C>/!A>_O^_GX+ MCVQQT=MN-9L[VRR2,8D\NI%>_^CR#N."=JF`N=`MCX=PF[OC-G?<[`Z86H^0 MP?BF+I$=U7YZ`F]H-9IN8W*+3R=]J.%(ZFWU^'`;3LRY/]R>F@*<[1(ZG MP"3?;;E[3TU:7Y'=\/"H@_L==;%[<'"PK1K% M+!ZEQ\9'F8_'NXP*1PV%3@T]4^IQ^[\VOC3AO[V#UOM=]]/V[,U95]MS^DI[ M&E#!N#_;/TA9Q"=@'%\4:%P7<).U,CDW+N@D4L3$+];0WBGDB1]D(X M-SZ;G^AJ#9THD%0-F)8!G-;V,ILE#-36=GU?--=TN MC;?645$\1Q;9F=>01:MLLF@5(XLT"*$0&/=YX+?#@>!#Y:IEN?D`TA^01CRZ M"D!,AY%_^F?"!BH$&=U"_#O-%$_,O^:\<5(:6YD2H+NZ`%O%"=`MGP";JPO0 M+3)&:4.>'`0G#_"WW+R$N;^?!/1K%QDI'EW0N,_]=C2$I`<;?7R4TDL2TERF M]$@6EJ/4G'.9-E]UQFD*#$]9T,*$``WWV.=@!Y*26-Y-+H@?W!Q M'!`IIWW8G/FO!1=F46_K[I)''@\'-*:'/4&K$-J\"!Z+Q6!1`BBY@J:P'A7Y MY\P#@=,Z843UMD@"%AX0?ECG8H9S,2OHV+'.Q4CG8AI*K',QRKF8`X^VS5S6 MZUR*+["V;1)BDI]X&X7;@-$,FRYP`"Q0ZR]J\]T)[<1MZ$\D.)G?B6`$!'<-LCDB4OTM M-RZF)SW-ZT]*YCD8+#,(-?JG)9P#Y+*JJ'E&J5&]6%BGB>`^#P(B4H@_J>:R MX?JU(#4KI=>`>^$V5W%DMY_GZ[+!M320>*L(^W6\<36V+M?0-Z\B'E-V=IMN M&H\U?".(J,,DS9#O]6YO%:$6^Y?4<9D+E6T[7>X\<"*^L[#/$=;QM8 M5=ESV`I@S8RA5`!M[MW=4A&>]&&:&6IT\D*6:G9[P M:W);]DCYH?=GPB3#5VCD^IV1[-OCJ+E7Y%+'M%AKCYN*ETM/YG"'U7D!.F^^ M7UGGLW;^JL\:_N;>7;BMNPMPV4F(XKGD<=G7K^<#8!R>SIOJ6LR_V5`O)5K% M_-4MA:R66/,ON\>V-EQK%]ZV85O)LS=KPQ739^MN_!Z1CS,QY#2HM M=*^^56GEK-2^T&CM+S1Z*^NUJC9)U85:]5DB(A8G@IZQ!_R#V]._=KO,H_#A MF(>#!(*3.K&YZN4E4JD:"5ADE!@9A7+&K2"1''`1JQ>FUPD"V<5/2J!J1 M;9JZ"ZVNW,!]0&M7ZK<'!/5O8NY]+[>RQ^]*5X_D?>VJ*4VK^(E95TS!>C&K M^;X4+]"F9.*6Y*6B.9FH=WJY!2V50#03\J@>YO]HKC5?)TG? M_VD14/.7])V&@X"/*,7WX\*,AE0)Z.L`XR`,G?!'?_`>_P M+U[92P=CS7*CX&7!6-,&8Q.,/%#A,4FO!/.H>N[L:U3RYZEN^D2HYY'4^@J< M5558=52"N^YSP?Y%_6^13\4,-N31Z+$\\MA:+"P+IKE@NKWG%DS+@FDL+`NF M^6#J"VJY:7DX3<1E`3474&<\$19/R^)I(JV:PZEM(Z<21DYOE6+;(*A<0=`: M<6'C&JV)=LJJ%N])\):MQG6;?3/;B\O MKCOE7/$Y)"K^P>)^^CK%FP'U4*_^%;A-:()`\M6MP":M0J&URD!.TCW`^3CG M4`@,3'!RJ(IVY+,A\Q,23,*B*S)2#XH=C6Y9C"N9DXMR4WJ93FM>H5EU_=-: MSNOY8&LYM;"G,R.ER*7RS MN(J-3>'-4[=;Y+/L5MVFJ;O`AQJ6(G-;CZT5F5MUUXK,K;JK0.8GUG>;X[L- M?H#94H(AE&`P1FR48")&#%NU_:TJ/3\`MNXV= M9C$BW"FE"-^M+L*]PE"X6TH1[IM1$3_1+\LJGPA?%'(4QH6M,G)A:W4N;!7' MA:TR%K3)R86MU+BPR=R@C%[XHM"Z,"]TRZQ7&A6T8N M=%?G0KS)A-$=_[?DTE%4,JY[Q%[%E)5&NE;5KWQW!6$"].2*!_YAJ%=<)DG9"@ M.EI5*!4#12D8]:V6HBTY&DV.!:Y+NY8<2TJ.18*B;.18Z,8-2XY&DV.!6_): MEAQ+2H[%OGS:$H+)A%#H.Q,L(923$`I]LX(E!/,(P>`-.S;G*A6+&(PDFYP8 M3SUF[2>U&4UYJ<=A]<>`L=13)NHQ!TDJ"[\Z*UN!>F;C]:O6 M)&Z^EDT:N[ACJWE03,G6_D3T^G\BNL`G*UW[PZ\U3GKU?AZ+@.KLP[D[]"'0 M`:F0X(HPOQT=DP&+25!YQ3XY[ZHI^9K&A$74/R4B8E&OY`'^$MJ=/^'JJ#6M M8UO;79_M&NRB;9#VUF9>[!9!:^9&N.A"E6Q==`75VK)$7(W21[H=T1*Q$41< MJ)(M$5=0K3N6B*NQXR_=!FJ)V`@B+E3)EH@KIM83&T2MVW;-WM%DD6$(,LS9 M<')BBR-O[PH,+6V?V/QLS5@PS6-8+%@?H=.%W=_R`0D^>J; M\;1]G`5<,)\8>1?0+,^(]'C\\=<#/`CX+/<-G64 M2+`7*0^]/Q,F59B5V_W[>O*IN0EJN/UG`D?$6$J,2BW'4[]'CQB_H6)X?GY< M94"M(H&:0T85>31KM^#?NE.1@5PS79IO-5J%5(0L!DS&P"QY``J:JY#'#'`* M((\G@YPJH^7Y>:^+*(HI':?ZWG&MQM>N\<>TL+,Z+10:4RP!DKM3$/(`Y6!! M\UH_&WTE.*@M'N'/!,48^&8B/AH]?G!W1O[5H:L5<7B8Q#SD'1;0DE>P2HO$ M1QJH+1:/>3A(((>UW+A>1"[00VUQ>4Z)I'T>^.UP(/A0U0:]Q/2<#:G?CD"]/=8)Z*&4-)9'HPOR!Q=JS6P: MIHM54EN4'B<2`ATJKFF@BDFRSP86INN%Z1,ZJ21.5ZOTUB4Y>L7:;_6SI-=? MB7@Y/FN1*)4!G89D2B9ALVY!Z9I@6I'HU"3DUBY0+1-T#8Q8"\*NW4%7N1UT M;_7XVNM)IBXIT-MAJ=(94EE078O$J0*87G]>519$V[73EU*YV9"?3R5];*@O?:%=PJ!'BSZG%%(OZWW;N+YGYS;_ZCAE6& MZQ,37HN.F_N-YEZ!.FXU[W(/3=(JJ_;Q/->ET58Q/Y&SC-76I(;`W&Q#NJ(R%J4$4V$H0GUP#5CKU:E;!,Q M:%)M>LU8K%LI[HW@6(7:VKI9LFY%,Y.A:5H5;"T5DMJE,:L73VJ4O11:SYF/ MO]JM$!L$0--6>M>#P%JD+`:ASI`,90U(JU62;!#B#,N-UX"\NJ7$Q8*O(IGP M.ABP;@FP@4`T,.\M"(GV!=-&OF#ZK7:[K3+W6F\G>"$>"HO7S-A?8`HRZU:A M*P5$#:O=F8+5VE7S2@%6T^I\IJ"U%G684B#4A,J,*:BL596P%.@TJ7YH"DKK M5E%<%U"K4<!;.UJSZ6"K2FU25?#;4)"$-!]MO-R0S.0HC,(77\PB3?;;E[ M'^"*K*'L5+YQ;&ENRS=]`@GH@L93V:A+7M3Z%5SY9-L#^/BBEMLQ#1>TK,4. MYU_4,`CRB@HEEIGV?38$4YS5/-YXF0#ZT$YF,;^TGO+8F-]BKKL3&O&014]W M^)SN9GM\W&AV-C?OQ](;.XX$[>IK]YH.N(@)6.V--BFII'I+>NZ&DT+\FG;3 M'UK:<+`E]5TIU/&IQT(22/A^>;;Q!:SH^0[T0-2X0',>'"(].N="32.W_);' M)-!?LK&UYHSM;O(@[BV5,8MZ&66F3N$"N"I,PM0-3&:B0)^;20M(?>M@_]/V MBX:X[.RNZ9!&"4WO3;]E\]LQ9'YS![GL#-L8FF3WZB_9_'8-F=^<(4Z;R3%X M)QXP7_FI*_CDP>`>XJ.`>]^SR;R;9RA??@KBCV")CHQ'`80/7;BB(=F_Z`>W MN=4EK5Q]O7RMG%V M>-$^_^\/SNP]CCI[T_Z?TP^.BQUL.-@=B@-;NQ(L\M@@@'MXUYF:EM-P;OL4 MYY`>H[[3!6:!ZTD`?:>_/0W&%WE!XE,GAJN)Y_$$#T)K^!TS)Q*-'!+Y#H/# M]WT>!*,&OX^@-9ET)#XSCW')UD\D''S\=_=]\Z-S&$#[K!=!L.2!SX4.((CQ MLI:R'K#)6)!($D]%"TZ?#*G3H31R:,`4!U)_"X6UC=*:R&X;Y(_?)J3TE#IG M%$]D'^(G_(/)X)`$*((%"'A?!@3@5)0LU8?#IJ,AF*I&QSV+H7TG)'$B(`K3P("_\S=W;/'C74H/^6^O=IKN[`STZ7C81[]&H M8^>K%W.@ATFK.^ZF@_I0=^!+03<=\+`#"E@:TF"T)&Z60<,T@-H@F@C);`%F M]LJ`F?$D`".3STQJ5O!1X&C\`;^']`!1PF7L_*\/Z:@(\=?H'6`7`F0B9-Q@ MT6;ZB2>QTR&2R?]#4(1$?*=Q'@>3GI"3F-0L,X:,$XP=!3#+`/($*C"*=6#N4R9V*B);1_"(U3BM[89%I@?+WBU3^(&O@]O2? MMXWVYT'I[GUCH&^+PZO?VU?PE>0D/H?=8[WOJZST>)0-C>6!6!HZ@0= MGU!L0P1H14$*493'PPD="/#NVEF!ACU=I?.=SDC!3X)W`%J*&P%@S@EIW.>` MO"%`$L^BZD.%5D!&-PF`NX9T[+=;J"AT[+ MB;GCOG-&E(@I3S9>>'%8;N5%38R$$'.`<')#"EB79@,(\$ZT@]R-.33'HP&^ M9`:&T<4QIAWGD:N^#'Y8_>.YO%)[KPBG6Z7C<1@"@D,4Z=(!*+`;@`(A_LN! MA#X,:"11NX'2/&AM,!]ZT-C?W/W-O=UWF_#A_69S/_4W[L[F^_U=I\NURI3@ M'1KYT-I"'Z/^;66>QGW*TU1?:U\C1X*?1&@+&C.1(EL%CVAIVEF@K#(M0<27 MA(G^/*5.:"*U(OT=S0K:`VOQM5WF(])-U2;&$%F[/0Q<,/S@$'ZP,62TFTCM M7-_D@]=B2">*$%(431DZI!`$G)BZ/"08L&*@3#6%0?+>TVC+`*B"'8B;$R%F M8]19C3WV/THP*:$?.[^#;`!&VJC\.;;_DN8&XY MP.*<&LU]@+U,=#QV0V%*,W-_ETY^?G6PX>RMEY MU_S%2?-V9WP9LF<[1(M!V&XYW]3$X#XP#0D.+\`R.1AH=CT;7SL.V6;$-*4= M`+5$M?R9D(#%VFB[D"5R,%`PPG$LD@9@3G0D5,#7-._$];\B8#A;.0N>KW-,DH#K/ M1(#?<_5\::CZM\0VBHVBG@,N`7*$)J2((KP M%+FJ47=AA!`>!XD*1`AX0&>H+"4(2^&0L&N0%U5)2//!^E.LY<]2+] M;:G<,6<3\\:7,Q*5F4H=KZ49*>)#C8SH^UB?.?=_=*.>VE_/_M]VN^[S3*4(+27FP>MQ;F"#.%I[FI(DZ2<,P%:UZ`!XFT&8(QH?6JRNE@"5*@+M1 M\5C(Q$SC#\Q(%*U@KAH`V_N;F-GJM`XZHIKO==L=VD/+YO!A,GQ-:<^F/5.( MG9/VL$="0E@?'.Q"NO-NW]U,DYW-G5;K57.=:>$NL,0G36]_X6<6H);U!.>COQ\YBN?=B]8C##HJHSBD327*R*M M;**Y)99C#3Q58,"KP4O)^!K=>&;&\Q;J5ELL:;;2Q9*%G4U33KH0=*T]TQ-+ M(^Z\A;K7SRW>Q*/DPG$TE%0&R[G5'W&A;S(YW"#"/&0.-2M-I0.]9J2J3SI- MCK.$.U>"S0)UJ9O(EHGP$&Z=P>H56!/I1"YD2B-21;GJP^QHU41U.)\&Y[H% MC._&]T.X-O$/D:(P]`5$$4&HR@ZK!%B'Y^U?0:.X+DG%@H#(@0YZT><-?9'9 M8.G0+E=XX9`F(W^C@70(YCF=U"WG,IXD9B`[5$)/8)`K9YM#`2O'&X'?]N($ MJS/^'TFVT*02*"!N+7;G=*BB=Y[T^FERDM5U`+`88GV*16H[!8Q!9N'W-]SRY&-.#F#2R1TF*MG^NVPA+.XS MX4,W6'.$SJ"K#/07U`>K$'0S_02N!BM<&"N$5*CR`HMD(I3+5$)56;,>,UBC MOEHE(-I7:H3V`9-Q'QN>6[E"/QSBCJQ4'F,+2'M0Y?0CQAO`U,#[V'=^/]E4 M;<#;FJI`'%V?MZ=*$#@&-5XE;JS8#ZD8%S;FR293]A:$=>/%1@_=D/;+$SV` MQ"4FS!,1P>T^1]R`OTXGDSO+(K3MM'`8Z:4A%5.JUE,^FF8!/B+%CY.=/KH`^D!>J+8,Q]+I4K3Z8#>:Q$M">-PK$M9?"5*JM6HP:3Q7A9MR+G MM",!IQB!=0&'2JD\`@^DS$K0'I;80"/HC$`,G01BX$#RV=.+!I[-&\_HL2E' MA?@D/>K\/-8,7O6+FM$XL%=0@=&//<&4TX&3X`\8A+A^KH*!@F!ZN2E=.M<9 MP0/V[E$?'R=3@_DC\=/]5ZK$D%9N$/=`?$A.V2AFS!Q:5_5G5?/6FL.BB)J6 MGB^NL:J4)]M*`9$]3.,?BG$9D#ZNE&;5(2TG'+A:MH?QJI5:934BI:&0@"8S M&U6CO:=IP(`92J!(BM]GD9*N"'D\P*!?N)6.G]!<*>YY%Z!G MAG\GE_]G[\^;&C61? M`/U_(N8[(/K:+^P)B(V52[?=$6I)[:-WU2V=EGQ\_1P.!T@4)1R#``>+U)I/ M_[*J`!(DP1U+`=<#)^<<32SCJF# MQ4F:Z=0.?_L2VV"8<#%-TC&7[S^)$:*J;9F9RS,0IBGMX4QK'%"RY+``3^:94T+L-`#G@!T2>"L,U'_AWD46B^G3US@SU'@$`5M? MCA+7D?^2+(4Q[W'N;_H6[U,= M"-BD(=,ENQYN[_@W;VC*EOGD0S^*_,F,6G/P_7Y1:KM0ZPHV`&A,*/9N$L@`<-CPK&^O!D_OFW*S["H>_:L_!, M9:_YX;L?5]7$<%%A%,=YM:,:1S->K1IN_,\@,W[4,*AA4,/LIF%^)U8F_WY% M%PI0XZ#&08VS>=")WYR.&0)DVW]AVUS5*4@JW9@PF8^T M`(65O(3Q;.$=R0_)M;FO/Q4EE[?.B%H.M1QJ.9&TG*ITUHE)N4I.58IG=#6* MC:[!'Z/(EB8XC[7'S^L&6LT<;[1(:2A2*%(H4D6*E(KN M=A/<[8_G%__WEZ^WOWZY?"?]G]&(D/$XEVG#1X@)_>#G-__GXN+JZM.G?;WR MA5KR,U:7E,?'I&*IZ**G7]CR7EKZE%3_A6O6XRJ)"0KG>[YZ+BH8JL3&;0H' M\MA54(RP,XMWT,?P#N.7 M&NQ_\1YNLQ33*6-BO^@408&@.&508)J@<6F"`EV8=%/[V]F>]CN^R[-.KZ6Y M$9"(Z8@B<_*F(7?U6A>:FHL-(:/C(L&A*7)WT$-P(#ARECT&NMSO&74N>F!" MIO4)&7HR">\\^,"ZD]RQ[B1WK,_`OS`/(V[!)5;_'+Z>K#/5FE/(C/`6!=Y8 M+W$$OI6>`O_D['U!?".^&X]O5>YJ`[FOEX]O3/2=WJ\KP#Z(;T=U" M=)MF7^X:Y:^98<[UE'.N=\FY14O.LW2W<.+21PM<97KBTK]J+5$XV;0"9EY7 MC;\B:T;YQ5J(1DQR[0)'HR<;2A?AB'`4`HYZ5S8KB(PPX7K*"5>:7\5V=04J M2*VCF3!;MA\/7>Q=)X@J[:FFK)NU>IH(<,PTE1E*J8:LF28B'!'>4H2;FB8K M_5K]8,VR,#V+GA]CD>0#UQTGC\%DF2U\&M`GK,C$ MW*!3:R>7VF%6("^_+S\T;G9_NV)Q6WYG?<0MXK9XW):_J4SD#%JUN,VXQ?Q/ M:^B28]V0.L;Z+RF_YQ'??Q.0492T/Y)&OANOHV)5Y(X&I+C6>]HU@HB)[\]$4_RX.IA'#H>0)*R';!$G&=@\?!5^OCUYEI>YB?, M3`X_E[:YV?.@+B#2R')'L6M%_*D!G38J08\L@%MY/%Q"(4)`\B;LGMR)ZX!H MDY5P<4LU,;QD#0R'<(E-84@2&-+_CB(./7\TB@,)'K8.8D,KA"OC*5SBPY7T MW@`N3*D,R,0"J84AK[S&"1=1/05-1>GQX0GP,K@EN3+DCUIYP&YW+P]\Y3$! MX?,#H^4(H,H_Y(*U,D,VB4@`ZHV^=`Q_2I'U-WV9X\'MB0)BC+!`*3F@>>%K M,)$N55/`(J;A@C1NGPD#@QM]N__H`4KMS`P!,NEMPQ#T`>4_9:]OAVQR5R3Z M[1Q\\-Y1/EN>]4BHX``5%)_/#GE) MQYXWI`Q_\GE"7S,DK@.O"!=8R'6H,Z%"%8#9ZDCGDA=/AC!0&!=8I:D?@HEA M3'7)HQ,"(J@$P<>`/,;))RJ,#L4\?QS826:"PE',3)KT\N3`[`*QKLWYRF1Y M/&9S/V8$1Z!>'6;[9JH@;;D,WSB3(:A@PG4)I85;/."::PU]9DX=&!G\`!,0 M^,D#1M1VAT]60#\PTCPRIN:37MP!Z0>8,[/-A)32Y%D16&M*4S(Z/WBE\P.# M`#,/_H#W*B>C`2$%A%-X>'QF*!.2M%:&4SFW6;8_!3C)[*X+?S*%GQ/FS)4$ MF+(0W$4'Z*6&QR:C@%A4-WAS\#!!G'&)TI$VIY9766Y)Z1P#`0#D<#X#7I82 MKE)2LH#'U'7XP5H"/@(R#QN'9HV5-WR6*^RM'-WW@G>\ZH]<'>.5'UQ_]_>&?_Y"DG]++ M'P++)N>>S9R\\\3E^3I37/Q>R;$AE+$>5?T-G[%OT59^_$P M&L>NE/*F)2[+-7,-H]T"=9JJ%J?9P0$$\.W9,=:##Y>17@"(HVOL(Q"E,9`NTP&-`N,I^<<#MM^!2 M&F1,69#!`H69$Y]*K#P35ZJX,J$#BQF8S4@(A6'12RQIRGO.)^-Q@B3*8/*? M^@3OZ:M7O)J)];_PA,S]\%Q&+C.7\/QD]"P4@1'/G;V.=`T:G@3,L(U`!X5< M[N>L85;*\S-TPS-MGWJ%?I0^+_.KX\%+)TP]OD^YRMTAF]L=ID[YFYC]=S)4 MT=^RO*6SQ?V,V4-E*09WG<51*1K&)&!68!9`R4PD0D+^#N>LH/IT^?GPQ>+C4\ M<"/$P9W$!_-CT#"$&6CJCX0)9S.F&>`%*M9)W)JL&\)?E-+`G#X*0T;WC.TP M?#Y.)J*O4Y(2"5SH+&BUS9$%]88"FSN_01H.KO?[$B>,AB0)9<]\E!0SW/NU MPIF%SXDY&'NX"$3<8\R&J)P:IB)F5%/06ZM^VJ+#S:.(V6#8+5.X+$BOYN;V MQ0KGEATNXBX,^'&/%.\TAS&:>XF)*:0"-?%!C_D!E_-4B.#)H>_!+#.>C'TZ MR+-XRLSY,P"'A`O)CME$@B>67( M281&/5ZJ-%W)CCT6BXY>1T`4!3.+;P/JIE(=YL>/3XF,4GT$+)BCEYI<4.QA M1EX6:,CP$A2,!SX8?_V0T#=FR.HDF;FL&MT\:PP&Y-N()(8![B$!]TOZFMI[ M'[+0#`@<.PS?KC-QJ$9+/2!I[AZF;G`:KH5/A/"<$\]LT-^X0-`'I?$3BT4R M:F&4\;=6H+ONA+OC'2Z6EDWOIS[M&4LVOW/).'J?)+7[M.H@J3:YN+VY.;^[ M!W^*3HXU#4F:S$^SX1W5Y'ELJGV"G]\HX"X3\(NF%@VM9I^3V@CV.4EHPWL2 M3[C<0HJ>UE&/K^'L";6LKG4&)15295=O:/4%";8LW_"+Q-][J>F=>FJN-/U[ M&D)2D8`?]<*9#@\:'A4J]6E9#_O\VQ4?Z=!W[5GPI++7_/#=CZM::;BHGQI1 M^%4BP"NK#4.5U@R55EY]NK`%ZH*JK]M1Y`]3EX].IZ[*Q^BS2B9ZO4ADIWFC MW3S2=)V,/*VMM*V&T2A8Z"B@HW"ZCD(%3;G08]A/L=%UO@H5&:*Z-+N-J%Y` M=4Z33C3/+33/XFTO+TO#-6WSI[BV6*3-GX@7\:V<2'@YYR)^0!^O;TE;Q MV;YOH\Q]WX5EO?E@)#X:"88#=\_V-6GO%_;HS[H_T,UY$0E(R+=T3HEGN6S/ M'NVO0:+(Y;LTZ68FZYOD.KP3!]_4)SFLH09['=N0F;0+\;TPVXZ#;JQC.Z&< MD'9?>"56$$JT`PY\&[!-8I2?,MT-/&\WD-DKM8;`>;.-=+_C8J^`99#L,N,9 M;%PF>SFW@L-L3U.`=,R+&#J39M\GDTVA8(4`#[YI+8L*OIMS,HW99D[/XWNJ MV:[,9)\NW2^>]C7AL/#`DZ63'M+M\;/=Q?0EM!\.;ZJ5_S;6XXGUBP"`Q"[; M)`OW\;UY0=K8B7[*]']A+XU9TP[>;X=NV/0LWJ2'@MQZX6_B6XVMZ10F/NUG MP78,)AU2G+1+"?TR.[QT:WW:]\?B33-2RC@7V]+]*:M6DC8ETB_GYW?28^S8 M;%MDLK6<;A%G?11B+VT-0-D]]<-D>SG;GNG0_=`CVBR'MQIQGA=Z^_R:;JVG MO89BEX3SW[*M4>B&TYF.X[OM*9Q8,Y=DT[[EK2&$;Y=WQI24"2%I,P0_(&=T M#[[[>@:P\\[HSNT1W9H,"DOZ@?7Y,97OV39]UWGR??M'U@^*;5@-"-C+_W"H MP7O)-Q!\C_?!H>T&K&]L?V@^N1ZDWAT8W=>I?6B2EUWA;[00>;) MLA?4[KJ989O+Z?[B7=NQ[*1"%UNQ7%D!W4X#D6`T M$AL.J-&/5NB,))+^!&J$=1HBTA^IF=:4]U=W][-/ZOL_:4\!NA-ZN<]8HHFM M*`J<81REZHG0SA#\H:RSVF1"[7A$^3?3=5;2M2']E5X-2C:.:$,EMDO?CGG[ MHYFNR^+QTG&9<@="Y\3QH=&O0","*8_.,^L:EB@^G^U7G_JTZP_%F4V?`9*] M1`-7YW0;_$9JY%E;E)S;>?NBQ!S,NG.0;[1/2DAXUQ2/]C)*MLJ'9!0'J4?# M^HO->98=]L-3:MBL=)=]EA-.N-2=CK;"XT1'M$=`3)O%L'F8$!#S6;%C.(,:<`S,V9@;QPL9/^PV$W/A,XV#T1-M`+:#! M2AHG)%B86,'?A/9=H4TNTFXJV>LW0N*!-X\!8YNT"N--,^9-P>:$\IE*>JS, M+TB^3VAE:)X->\X13E=FL)Q[:5O'E#\+M-UG6//D,S;,IO\ET^J**N;(.9M1 M.F]T1:>7"A15^.D+^4.BM:_*0'&&>O>5\X',5<"B-\)Z4X"3[/HA;][Q!6ZE M4?9&OW9'_;FH;'\-R>WX*NF,&,YT:Z\)NO57+@%SZL^8<$[!0EG!3#ASW$K& M;Q@?;?I#.SPQO^01?(*`38X%$3#S7JQY;RP0"'C(E/8;21JTT,XILU9[K'_? MW_,>DTE?&`J2:6(YF5PG:I`UOZ%FE+XD<4C7.[=IEQJ`0YSJ-":G^#1,12%H1)1)- MA7#&L-VPO0C712A?@ROC!'18M\&E$[+F@[?C&]][O*']1\\9HZ[3#C37'IB5 M1QH2\!^XE*SS-?I-D`?:ZXZJ\:1O&9VU.4_HA,['+)W/86A*G2)GP=N^XJ-, M&Y[EC!),WE#GOG?$Q.VM?_!4"7JSE'J[;(9AC\5K3L#ZB$`D=,3&=>4G!G_Z[,%HXXGGPGUM-^`Y#O\USM0.&]H MBUC@B1O2^?@`".BG:=)U+\L0Q.P'#^W78%!3FX!!;@>3C&?6^%W./1X*AX7$ MR;Q?(-M0\>35SW\MNR$6,W+K7=#_X_J; M!_Y``FTVQIXU-[/4507SPT/-3$,_&,]"*+\TPBUX7^8`[^].6]"-8X^]YCM5 M5KH:S]I'?`Y^]X._>>/3G`;,K[3#YS1I]#8F2=-^JKIYRT"NN/GQ!'E9T]RT MTWI@+FK2^UDWNJMG.@$;74%-:P*6YT.2^)A6O+E,\,(.K0#$D(6^F^0Y`6.0 M]N_CT<3Z4"*@O2'#F#=OM,F8)2U@VIAW=Y'U[OJF2?TY<\>(=J<)RFBD>PN\ MEJ0!=-+(/_Q"HH\$\$AFG?P_^<%'R^9M_-/)S6WL/%>6O]Y?9G7E&4Q\KV>: M@[ZB*`GH]G[W(A8OP/LZ]VSZGRN07?"`Z(#/HXO$`?H?YA*EY"ZM1UYO)U?M M#4R-4;O7&X\ATEPE4MM,I&:JAGXLD$YB7BKYK\^@I.86\\.=]ON?C@U>YLR%3`C[BC:+JDE!.7"-$5*1(X7NP5$8+#ZBTC//GC[*_4<-TK=\DJ] MVS>.>66NG[3YE?T>N!N[O?(7W[?I&BD/32`&&8WB"4]4SZ.5&Q:T)?1H^XNN MH:@+Y.S\TF-IU??6A471>CZA6;#_,([?CI=#N1F!.<4C6YAI]A?IV_RB@XC* M*5K8"G)-*YNJW*6]C50-!L;!1'UR:%=^%I8O7YA!0/:),T)[>PM(K[]D?_=_ M>V'4]_<6F7[?Z!5*?2;N3<_K2JG;7^5K$,0OHF#EZ;N^W=A?^VN*5MC;]S<$ M.D75/F_G@1'59I\"?W+%`L7/+$Z\GD6M,XDT\J*>O]*`%OZ[DE?((?&,6:H, MB3N1<`S5^[OS1="X7B96O2LCSRK\=1&'$;PUN*%G"5>]71ENN\ MUS^?N4[\QOG4JR,N+T5=RWR&_`CXA"Y3R;'NN7.Y4:489D_?U6:R]Q](K9I' M[88IWDRTKIA5$+U_A*$::J\2TO("BOUGO]_3!U50FY<*.GCV5575U2JHSLD- M;9#\S<&2-MC9-3V&Y.[^<::I+OFE)9&6%XT(Q\TM08F9$Y02N_\J35?7=O9K#Z4JS]CN/]UF M?W?5C]_LX^[J'DYAC1;4LC79X3*Y.L M7FZ(>!@7#6WW2&%&+E]S'CT1.W;)[1B^3Q:=DR7H\('6T*]4,?1*K<@I><_: MD2?9=;K]_0ZS<\0^R\X<=)3C&XZ9`Y$Z^VF=_KJ#V1K4^G[/0>O=SD`[>M1Z M-WNTG-G0GO1XM)Q`W990PZ"&:9V&^9U8F=+6*UKQBAH'-0YJG$.[2Y7187*3 MPBJWPV0[E!R>Q(=:#K64+DEXS MQQLM4D<=`X@BA2*%(K4L4CFG$J"[+9Z[77@'W#5>>;U-XWFY6+)"**5+A*L( MK2XF:'9O[?).=\1NVH=VTY9-S9!5I8J&\8CJHAP)A/566"NF)AMZ%8<<(:P1 MUA7!&B#=UV3=&)0.ZU:N\334XZ._9IWOWQE,^D1"32Q?PG,#B;9_/[?^-TV8,M"WF9=)F-GR'\4L-]K\!AZ'795]: MCXG]HE,$!8+BE$&!:8+&I0D*=&$^$]L960%YR_]P;.F.[E?VO3J]EN9&0"*F M(XK,R9N&W-5K76AJ+C:$C(Z+!(>FR-U!#\&!X,A9]ACHQ@N@5_OWJ!^&_,`\C;L$E5O\T9?-E4%`2F433]E1.H#1>[U$)&(2#$0J:F#T=WMJC+\@^A&=+<0 MW:;9E[M&^6MFF',]Y9SKG14YX`TOMQ^1[@+_V0GI.35C/Y`^6N`JDV$4_JO6 M$H6332M@YG75^"NR9I1?K(5HQ"37+G`T>K*A=!&."$< M<*7Y56Q75Z""U#J:";-E^_'0Q=YU@JC2GFK*NEFKIXD`QTQ3F:&4:LB::2+" M$>$M1;BI:;+2K]4?QERJF+G44V^A57OSY(8%Z8B7NONW(F`0,`@8S-AAQF[_ MU5X2T"-`5JHB7==_L;P1">5Y122KCUQ>'EZS+"Q%OL2/L4CR@1T,)K&C8-F) MN4&GUDXNM<.L0%Y^7WYHW.S^=L7BMOS.^HA;Q&WQN"U_4YG(&;1J<9MQB_F? MUM`EQ[HA=8SU7U)^SR.^_R8@HRAI?R2-?"]T0G`GP3^UW(D?1A*A4):>8L\. MB"W9\*OCP0U3=H,LP0H+?PC@@`7=D+7OB>'!W M8$7T358HO1"@"OX[#?PQ":E/:[GNJS1T7!?>9(T2+SB,1T_LLJ?7T(''>_#6 M)S^<.I'EPI\C%QX[XN_PV1!M/J2EYZQSB&N9D'^!FSX-2,BV00'1DC6A1%*V MIRZ]=/5M2KR0P,]6)#DAQ,4O4D#^'3MT'L#='Q(I>00=)3!`LHD=CR(6&P3^ M!*:(APYA$CH$267I#Q[?EC7*!"#6+`!AC+33&.1':1H'86S!8^"5Y_>_2E_\ MSAS7]"3'L]YFUKZUG6?ZZ:>WP\!UWMV/GH!,E]R.OY`HB6K2&H8'*F$/Y%OT MT?5'?W_XYS\DZ:=A2*+P?$+;D?[' MHD-/N/8[L8*'%U]R;%#>UF-/>\.&"X_^2L8_O[FF!R6_D6)X)/O\Z_WE&V#? MR)D`IGY^'D7`T6-X"@B9C4+??Q2FH1P["DK"L>/XY,?! M;!C&_L-0NOJ1PZ`4'#T*N'8V"G/O40R,[K&#@&N/&<3Y."+!RDBZ^X]$48X1 MC@4R%L=S83'%?D.LD(2?X@@,R&=X]B2>@(EBVT8O8_(`:IY8]"&S,?0.$(V% M$>SYXD6JJ<*^]L"XQ?3*2Q*.`F=*!WP[_A\K<*A:^VI%Y*,%UG5&SI!:AY)_IDC1S7B5X_D\F0!'\MOF?IT>R__,(W'X;P60);2^8C MW(?(`H8WR!O>^@%DF'VE1S@;:%](RP-"LL%9.Y#%A\0,[3[W'8>)HE)ZQ'N.4]< MIJ]D1)QGRK#9:-5C1GL',I4=[O673V\^*!U325R#(BG>!&`V]??@/%GVK9?% MQ&R8>>Y"0:+Y5Z)5MG)'H[Q1U'7`7CN(XT:>YV(Q&Q6//<\O M*4QC"3[O>=Y,88BO9-:9"EF\`]X"]AJBFH6AYKD[1=G=]8,SV.#TF;+;0.F2 M5?*]QP<23.@-GRWP2QP(ZT#331.WY'9\%T`4[DPM]]K[`J-Z@,#ZF7R&(3[- MK'%_?__(&"RZW$?1<<20ED*Y?G_OD9AJ__"1Y`9R^S\A&\?U!_L/P52/',)J M%+?W,[)!W"#/[]DRAKYYW!A60[C]'Y&)>P9YSLSF(<`5W2/'L!+Q?(Q#\'O" M\'ST[]@)'>JI7OAA1)T:GNRY\B+01!=6^'1'SUY)J5_U493>7Y26&]_R$KWU M"_&(_>W:&VWU/+LP/\N.YYZ4;3)`GVCF"O3;*S"$!(YO.Z,DK)J-1\^+%Q;' M\^8#TR;NZSH3L?XU:VU$,FNO]$TS6HP56E9X^^;#7??W7%V>?>)^KS576:#^ MM_K79U7[ZS,KCJ%7?_$C$LYHZ.U*PQJ&62-RSG./*1&KYG%U[/OA:-TK-Q&V M#B6]/)3D,V>C)'?5#23F8B?_TFN@)2!A1.WV?03_LN=QR8SH/).UGJ5KPB2E MVS?7$;R)BJ.IS[-66UF^=A"J=OP@LEHW)1/F8OO=V?/7OV'*74)\9B':(T%U' M9+*"@+Z1JZXVTK&'FI@9VSGMNYB5S9IBL+NFF+U_D>;ST2B>Q"Z%]"5=]QDY M+!L*?[N$_G'NV=DLZ5W@3TD0O=ZYEA?!;\`59YK5@JJ2$ZIJ6^"C:4LZKRBJ MRA[K_HGV;F]@*A6,=>UE=&/NC/Z<>'/;7"G&TK+-IC<=0M/^X6#7[!J#HFGB M)8LSJG+LY!9.@6[J*>IN9+&7'4;8_@&;JNOF8$=^'4Z8FF/SM+]F%^]D5A1= M[Y=.9V[>>"\ZNV:OJY5.9T[B5_N+K0D]^:Y]/9D&_C-A5FD7FM5!KUL^;W-3 MM@?3K/4&/:-TFO/LUU^?X@`(`\?QD_.-_B>$!]R.QP[$"YY]X4^F,3B(>X%& M[0*\2Q],;NZT^,%H:E=;JKX?`\L(IV$>^BKO?%"B#\N4VSYX=175? M,PZG^FH\)J/(>2;@E/L3\F!]HS'-5P(DTK0R(^<\^D1L$E@N#77BR`]>%RZ> M#RUGF5C;'FCIF5BQ`')*'%_..K':HO%I2DX`TH#QL0@<<'[CCVCN,KF.S&5. MRPEO-P&3+X#T^[W]!K:.CC)&E!/G;H(B']%`Y!'E1;_;1@1>D%+DB%B\O\MC M()B>6!XMVG#&R7(8LYJLJG,VI-7<[#;8G<$L04259!Z.I:240>5E?G<8U$#H M077W!A\=E-;K%SJHS4"FN_`<+W:\QULP[^R1&?')R39O57&&;NC;Q"?OK<=3 MF^,I;%5?ACZHB=J\^K`=>*L=3^U%'`1T(8(;3+@M*4O\2#PR=N99$CW'=&_) M1VAF;[`8/6UYV8&4Y:66MU!FF#V]`LKRD#K6?6._[M"XO&_HNHZJ";K\:VO_9XR_**IUN[TB(+5"5-E#W7^M50=M6N)0DP(,?OL: M[;J;9CC$%>CV$E`>2\;N@\DN^2^M],_'LB4>S743^^K.(]E`PQZSLAYFYI8\ MF0,U7UL52]G^T>:9VE/6*-)B23L@PM2[:US?P[S= M;'&/F6-PMMG6GCK8XJ^N%/5LIF'_71J&H>E;K-Y.-"09A3DI.<4[V]AA#%1M M*RG)B_:GJ'M`I:JFK@E)#Z+HB^^-EHG**='9&N7T\C&<_ZK#R-J_!&`7SQ>?L5)NP!^ZLN:[ M7*>RB8ZEM!W;E)'TT@AW<7:Z6Q;1<@O:U*5"NYU?>S2U6U;'\JA5%;U;!+4W MUM`/X(JOA!6/IDU99J3MK_HA]M&6*F+R7Y)Q"R_\R80NLP(4TE+I_Z%%UW(#;WK+(&7;=5S*-@]&3%1*()!\#:Y+>N(S8!_\CF5^< M$:0\0\&+Y&GA[#:AZ4%8;&8X>111I8POS_JP\:D+&%XS/G5Y+TUY`[09`".Z MK^LR#ASOD=>V\T?.QM/;$F:L&4>?[IM;.XJ-KRZ"Z"VQQQJBM;YI;`!7Z53G M;KO(".FNEJ5BYO^/Y<9SC;36V+CSRXLA?,O:G+B$;\G0;2!<+89P\+5Y2'L#*#I_MAR7-7GS,_)$R]1) M$-+^#J,YY?NOV]$@:='IV_/EBY3_QEH?@I@^D\!Z)(LV]C:.PLCR:.?#1;J7 M&P)MQ[A"X^^>H6EFII!PKY?O1/>EX\;P[#+#K(%@WN^?JF0 MR`H\NF,Q=3F7>)MC$9%'4]*ES0168@,L=VT=!W,BJRV]6$%C9U9'E1C/;Y8F%A[W!EF MOR2UL"*-6TH?-TFC-MA3&@O!QI9=#_G8T)9R&H5A8[/:7>[UL@]W=64OM7NH MIEONY;+#ZH!A+E?,U:#IEKNX;/?/F*;K#I1NKQAOH0@TY_9NV:[IEO:CUZ[I M>T>S=M5GU&6W*_4Y4.;=#-OAA;$\=]?;?R^3E?1^ MRHDSUG__G4O&T?OL60;LB[3SOZ'TI]]FAW)=W-[YQ]3DZ+8I^3%O_PT(0AZX^66CFA@)*Q=$)!]JOT3(+L M=_SX`?BFH'.JU+).R*SIT")][9E%NX](WWHV!NW60X(MAV/PBXH]]5>=1E+H MNXY=X)%V>K>C:K4<::=WOZ=*C,H7_&@6SG5XT/"H,PWZ]-0T]OFW*S[2(3A& MLU,.5/::VU'D@^6;S[&><_[OQ(Z`]*_78^B89J^//5XW\:0D&K<"3 M+VG3Z)'E2K,$?NGGV6X(6(H^SK9LME1UEJ+PCEI"GS\ M=->4>]V<&`H%%@46!59`@3456=?[Y3-\O6M8.W)/S(/1!ST"8($PVPD0=@/-:JRW$-`FF279%Z^SP"%E* MCX^0+,^6^`$2F0FG?]%_I/1$"NTU*($+V(6535M!;A(S=J7 M-:/.9#\B$Y&YSN8K@_*1B9%\$R+YMA7Q-2R(J;]>*X]?!2E*0<(E1"(B\020 MB#&V,&:YR3'V?3R4'OS(*)O>4\I?MQKFI MR5JW5J<$PW)APO*VI<%%"8SJSRHV>,T/L8/8$1([&&ACH%V`!\;3S!*?V;ZF M:N\E>@2B/\;HN\2H1.MH)DRI[<=#MU!-NM_VV\KCDD9MV:UA^O;=]5OY!(J\ M4[AKREVCSI405$^HGE`]H7I:V\C`,,K/Z;8BU\7_I`<`S#[9SC/].WNX\+;C M%)8.GQL]$3MVR>WXD^,Y$;EQGHE][466]^C`B_BAR@_L@([5\QAR3Z`[K?,8 M=E.(<=%BD].`79;RNPS'BS)U_)`//(+",$LX@L)(.^@W*+36>AWC^"2%UA.I M;D1??Y["L4F["OL_[VM4"IE(-7\B&]!W.3T-Z2PY#FE5]PP7=0_B[3B\Z9U> M`<59>KD]OU'/G.:\5Z-S,OE75#<(NZI@]X5$/(I6Q(V`:9K(1/`@>!`^"Y[3!4Z*K?EJ[KS9Z MU(5NORK.@SXT]LRI;KR(0T`$":0;)ZSDG*BU.J]AFQ>*],<++XLN9P6GL$,N MJF@L1?T8/S211SI:D MT\N7%I@4*'3!KOKB"ARNP!V/UCLK(M2;IF?9WCC@A(4$U^%P':X"SUSM(SIC@#IJP-$.>(\[;C7)4-I8\X1YRW'.>ZW.^7O[J)BR7BQ("[1].X1TG` MJ*K>A8Q3GTBLX!>U@A_!@^!!\"!X<.]0*[W6$UBYX$?^G+?P!5K5$^HGE`] M":B>U*ZL5]#!H14KL/S/]!C!8YZ_CS!7=@2>MHH"88[`ZY=Q!%X_P4E+SP"#P\&@"/P"LG M2JA&G/`(O(:>(B/R&0:"F@X\`J^Y<&]*+:.@T,H8YS; MC#@7C\#+SBMN+\4C\,3<#X2`:9C)1O`@>!`\")[3!@]N8\5MK$54-^(1>+B= M%8_`:Q'.\(`>/*"G4%X;LMFK]1@+%%@46!38?8[`,W7<0HD"BP+;&(%5]/); M,K1B3V%+$@L;4C3B9PSP"+R3V-56V!D$"(QF[`>I,\34%80)PF0K3#2SUL`& M8=((F)1_$@BNON'J6Q%0Q>/O1'&W3VT-#H^_:V;QO!`=NIKB">#Q=XCS4\"Y M*BLF'G^'.&\[S@U9T_'XNU.*`7>/IG%_DH!15;V+&*<^D5B]+VKU/H('P8/@ M0?#@OJ%6>JTGL'*!Q]_A6H60SG?#8('GMS2ZYAG/;VE6J;5JR&JOUE(SU$^H MGU`_H7[*G^*>W#=S#A9"]20.OE$]H7HZ5?5$3[\K?R]X*Q9@^9_IZ7?LD^T\ MT[]_>AN'9X^6-7UW/WHB=NR2V_$GQW,BL)^UZ0\?Z#,>0"8^NO[H M[P___(P M@_4\+$M-FYW>\>O^9L,RCUJOTRND5J6QY\)I:QW@/1B`/:++6Q?=J"=K M<7&SJUEK=&F]JUG@X1BEN[4;]&7A;FV^6JWKQ%I14IG)': M!B&M/0A5Y4$%NY?6F[GBN8WE%!N-U@:_H@F6I?SEIA(]\9I,1AUN=IT:K8JL M?WF..ZJJ8/B*][O:(Y^-(WR>T:CQR>,&FVXQU=^=((> M7],UFM(M?R$5/3[T^(K1:.5W%T"/#SV^.>0&1ODQ!OI[PBC1)OM[#T\D(-8X M(@%Z?567A&S2G:6?AML,12HK"J86VZ`C"S=*Q6G34OVC]CB&59T0OI<[675] M<[F:LZ;*)W08T6'<;^L\^HIU[/Y8*[^E.HO-*DNJ?E8V53:5Z\4+7>9$-]O4 MN>HE@.O._]QM$TT1>V#R=]?IC!/9:=?:4L,!0;6N-D/RUFJ/KAB4&>Q'ZY. M-"T^KUU!XIZU9CB,-9ZM5D%-J-"YZ9;H*H'+2HI5:;AI#7V^2A6DJ:+/=SIZ MM/D^'^Y:0Y]OBTKKEQ\7H,^'/A]N6VNTYCM=GT^3JX@ST.L31I,VW.O#O6NX M=TU<;1=Y<8LEIK`R*,5'8QOH=5D1V@L>9L5/IO]A/Y"HA2!P+2I(A'4U]` MFGK+)&5$B_^YZQE)NVW"6K>%ZVH\)J/(>2;7WLB?D`?KVU+[9&% M$.JD\`V'.>X^I/P155B:7FWNQ0`)K6>#B:%DDR]FX5QWZ]J/LNI+EK8=I9F( MW\FE1"77IBFO5\FIF\[1+%7)J?FG:C9`L5'/[AA-5LFVGTW'-Q><[$!)VD>2 M2N1XHT4JIP$ABA2*%(K4X2*%_O9I^-NB=>,L$0N-:K,IM',M4M-,!`P"!@&# M@#DIP`CA>Q1[,DUQ_LFAKG%.%<.OG?N.](G8)+!)KNRM^L?5 MP:[V@ZU+E;>-BJGHD1>OBPJ$GU[^=BB1458@)[\OG9&(6D0MHA91BZC=`;5" M^*\;G'?A'5/JBQ+)\FSIQA^!;_I@?2.A#/='DC^6%MQ6^$GZ2#PR=J(Z$2Y* M;%V@@JPSXBT02W2(Y9\#4`LT6F.+6P*U?J=??A<01!HB[?T`D=8>3^T$,HUW M)("K"#S,=L9C$A!O!+=3!^\V>JI@^[S(L4ECZTQ$V.XIM);^0>OTBNBAT]%[ M)I779N*[0(;^>(#S@`+3((%1.D81S>518%!@3D5@!B@P%0N,$$$#ED;6[GMC MX=(V38>`0<`@8!`P"!@LC6Q6PO)\%,66BZ60HO>BP_#QJ#9F>L?(V5VZ+[[Y MY#85XO6N;:+(-$]D"NC\AR*#(G-"(E/$`9XH,@?5-?`_TRZ!G-Y-?0+W[_2W MKF?@A3^9^G31/[P=SQYV]6U*O)`D)9OK6@9JI]HRL-?M=+O5=`V$\"YA2LF1 MI-KI&<=GL?,U7&T-M0JH,#NQGB6&NJ'G>KE=`]5LU\!^X5QW3Z)K8`&GN+2X MBPDJ.4&FO/9RAO5IT])SZWN<2R.HDFM(!\&ZFV^A5-71[JP5XM6$;H(H7BA> M#14O],E/PR<7KWRN-&>]:<4MS7#`Q2IT0?`@>!`\")X:P'.Z)78;_)."2^P* M\V$*7,:\B(,`G,9WQZ\,'Q%/UKTL7'9WEQ)K.%NEA!`@"!`$"`*D>#=&<(`( MX>ULC&BA%G[*I>.7D";ID:=][XOAY3.\0E,51&X-E3OR]J@ MBMZD*#PH/&T3'LV4>X6T?T#A0>%9%9[C$W-B2X\AF[T"]B5@AK/Y&4ZMO#;6 MF;F@?]%_>%=KS'MBUJ)*?:<:LJ(6T8X048>HVQUUBJPIE5A91!VB;M8?6^YK ME605,.M;2M87:_#$URZG4I^"4XI3BE,J^I1BCD7T'$LYRZ^79$R"@-A81H8A M1OU:"`&"`$&`($`PH2!80D%X/P;+R-H<_10(E!]41>[7FU$O#R@%\NG'TCET M:L#39+6/N$/<58T[0]:TEM;I5(L[(9RT$\A)+1U?CYFI)O:]$:6M53;,JDYQ1.%!X6F9\'3[E5D>8;.S)QA(8/E8[?XY M-E(2:>D(P8/@0?`@>,19M,;BNW8G.A_\R'*EN\!_=D+']Z2Q'TC\I"?IP?I& M0LQ\BGQTZOI-\&*$H(W:7U_#_*WO;R'&_(F\^5\W9:U7P-&WJ)]0/Z%^0OU4 MN'[29+VKH'Y"_83ZJ43]M%<^'Q54MGM27S;ZO2H4E+!K+COG(/B?NQ_!O/?! MR>M.8$XWQ\'MYV%(HO#OKSKZ:V=:-;&;;+)SK;EV'+\NKQF]8EAD$7[.` M;HRM/>D-M1QJ.28F9J=;CY93S9:<7XFG+Z-4'2A591X/VQ;Q.NKT970:&N,T M8&VAH!4^3?$0!*OP0?`@>(2S0L*7AVTR,<66AQ5GA@I<(TC3S[083&():.S2 M5IZ<;5).A?=8:JX^0H`@0`XU6,6SJ7UV;8-1+]!@E7-@RT?+EB[),)+.7==_ ML;P1J=->B>);[R\_E?M[!6*@@K.UC(Y>P,ETAL#5(?I`UGIXK",*#PK/`:55 MFFQ64/N)@7D#`O-R_)Q+,@W(R+$BNFF+]JFR)GX0.?]A7V"(CA%8E>I.E?MJ MK:X"@NX403?HEM]3$E,))YM*.!^-@IC84E*V7>M6:%%B(3'+5IJV6E=DF"ZK MAHK(1&0*ATQ-[G;+WUV$(7!%SDGSJZ0:%B347P\CQ`[*YJY"(A01BH)`$:/8 M!D2Q555P26=P=X0Q0RT="S!NV`98PY`U'4-:A*>8\-1ZLCK`I5V,:S&NQ6#B M)(,)A")"41`H8EQ[LG'M10Q1+3P*X]OBI&F#IFJA)V]HLEK(H5V(DU;C1#/D M05[7!XSX&A+Q"6_+;GSO47H@P41(:]9LI[[.0I#V>_=%JEE9Z572C19QCCBO M%>=:KXC3+C$RKBC,'-+.??%9`E"H@33WQ2.IKXM&$4]?8J>LODY318_S/W8^TV^LDNG7' MV5U9@0?*,KPCP?V3%9"/5NB,X$&7CAM']-GYQ]D9-1]G5Z"I?7@B,);)-(YX M[R9_+`TI$U@3)YNS0?(@4B8)JZ0I">@=$[@XI#R3G%"R0FGLTPZ7H?0'4!H] M^7$(#PAEB7P;$7"PZ$W\:MN*+"GP8\\F]I_KNC1G3N#['71<./]X1574_&/M!_9I!12YM?;L'52(J!"9F&@=LYXE M,:TE!XHUX;R^M7*!Y_75*%1E'M?7%NDZZK@^E*ZV2E?=IV&V1;QR%C71(V^A M1RY>/6-IKGJS2M(:XGZ+5)&&V$'L(':J\:$0/-4X,,*7PF[R3HHMA2W.@REP MV>_:&_D3(IT_6X[+5LHB7[K@BWKWD3_Z^PF\:Q)4T6-^?;#9K!+!H-"BP*+`IL`0)+^[UT46!18,47V.J.^Q)9 M8O6NK)N#\AE>);_;%[UM"%V%#\M^(Q2XQ(;`C`36(YG%9+1T,I1NXRB,+(\R MLDZ[(4IFJ;C\HBCIG@*AI/7D[J"*/7X(DX;#I&>4WTVNG3`I('O:()P,>N6K M$TQ)5^3X-7]=O>71ZX;%T,*#@.8N82$^$!^(CWT7Q!$@F&QI;K(E+MJWO1J/ MR2BB6U_9OE_GF4CW9!0';"-QSA;5&0$8);4@F#[U^BR<49Q1X3,96`?7R*2# M^`LN5A!87A2^O9W2]A=8\(8!:Y595;5;ZPH-(N[T$-OE5;IC&*2N-T[IUHP9'::<Y3 MRUK'"DO#0A-Q.D`)T">GE![\0B(IZ3YV1P*> M#93.)';R$B8"JY!!;(N"?8P*9+7:Z6+;,117%->FB"LN/Z"X-D%D8EU>] MBI.P,;M<3G:Y\8%94KTA1F@F2HJI,*M07MJC<>K^>`Z)K<;KC9)0AHM;8K%F!1A_])CSB9/_^M[3S33S^]C<.S1\N:OKL?/1$[ M=LGM^,H*/`@:0G"!F0?,UB7./3MQ@Q_HDQ[(M^BCZX_^_O#/?TC23^E#+H#) M@36*8LN]'<(H+;JC_),3CBR7GBS^V8IH2YG7]%V+CY(<&U!C/6J*25?W/%KY M]96,?WYS28_D??.!T@UDIYRA$WI&I_J=JG0H6]@78VOBN*_OEE%R-&LW@+N( MTPD3`+)S:))7T.&?L;O?N60W-S?G=/2`?`D_7FH8DI2(% M:46CJ!S:!R%0!SA*7+IR.8(IGGY,XD7U.(S4EQ>.>066U57S=?F?0KV41 MNMO?WS0,CU)O.YT`>CN*_"$)YB#3JSP0]/C=7.9IG7RK&1UEE[.&B\Y#WA.1NGN;V4M1O)M0Z.*YK1.=Z]EP:HW'>3K'%'CW6JF M3.TL0HU-VFDZ9'UDN^F-K_3&MHYG`?-N/AVY5-3#ENF1- M+FZI8F(V5+J4.S$B5ZZH7;G?+7\#NL"N,?]SVPZ2HS9_+.XCF6]&N;"F#FCI M&V*%Q#X/PY!$X;IM(]W"MXWL"9MCN7_\O1MWD&3%B7TQV_HWZ$V_;=I5Q7J5QDO^-R`=\4X>J8@R)V09H#D?*]^EJEOON(\O=U MMG97AM[=T+VG5$NH=[-AE-'071GU;D)2._KQ3;"W>R1U;+Y`A8D*4T2%J7;7 MRUS)O8"[Q7.Z&B5)W=-CM&(E>F-AB!9K4RK>90&OZW0?%2- MZDR1S7X5K401&L6CI,24"5JS\FII"[-[-:WA-"R^*SOY(%8B M`3'1!DPTM`XOXIS M"S`":T`$)KS!NR%A^$XZ'XWB2>Q:$;&E2S(-R,AA6P!P+:^!I49"+.N);,E5 M75:U*LXS0VRW%=N-<$6Z(TJK?T@C_+KG?:=EF/\U7WM5;DJL\*!-ZM[ZKZZM]?I5Y:D4'L"AYBF MW-5R.J=49^N:$V$V*)V^R7)M<"Z:8%[*+\(IT1NORVY4[FK7I]`,N:N7W[ZY M1.<=-54Y"W^B*K3RRZU.UU]>I_>*]Y:;HAYUN:>5?]8K^GOB:-&&^WOE@Q7] MO28K-$U6![4&L.COH;\GUD''Z.^AOS?;T%'!64;H[8FC0YOL[55X;#+Z?$U6 M:A4D@='A:X3#MUMYD6A;U-!!:[B#5E=A$+I3Z$X)=N!Q`SRI:HMKU^NX<@_5 M;8SSUI7[1A4]!M"!0P<.';C]=&,YA;3[N7U5-V=!5Q%=Q1-W%6E+-^F:[@$@ M8?0.?4;,OFT`R\"HHEF_HO:'WANDW]*E.6$,UV:>Z`U^*P*/^QW)C(OEC M*>D9(+'N`%+:-0"=K4T).JVCF3!#MA\/W4(CTKHVP#=K6UWU$[-Q9UZY;>A$ MWJ:GFG)_4&O=M@!N-_]SUQ8OAS9JV:GQRU=XCN5F'G@[)8$5@8G=W/NE7WCO MEZ-Y77(WE[3!'W4]UW=N260JA20H%^Y([=W.!=Z3<&2]"Y3KM52[2&3`Q*[M M=UBJFC.4_2W0\"AUUH0.+.;QW9'K;K]2\2IG/49:*Z'+334`OPM\,!'1ZP_? M_8BX1ERW!M=7_XZ=*?6"J@6VVAGT6]H]:1?WI)QUVHU>2>T-C]9X+J)EE]>I MW.+/YFU!837@J+PS8KI1%2EPC\!!X-:V8K+7%;5@Q*6*18Y-EW7&18Y/Y M6_)6]C.):WS'1K4$+"O.J6NA]O@C:8K7(05BHB]W>RJ"`D&QT)K&*%]/E!@V M-MH&%=MZH<&FJOR=I2UQTTMUN,5RGHM$F*SKY1_H@1`[98AI59P8@Q$?1GRU M-K5$Y[Y16DF5C0KZC",H&@6*?A45;1CP88]@GMLUM?]A7GZY##U]([52G^4-("`D)00P61G\G'_U5V&\87?03 M=M&[9GVU+@BP$P"8("858\!*8L`&['5`U[LAI=LX@0V?0(QPZHYPZNWO'9;? MK;$EKF4-389.;)-1@=A6#5D=8*$D0KM]T.Z:M6YS:$Z0QO],VSWQY^_<\&F_ M!DV+/9]N?._Q@023NS@8/<'%%_YDXD3T03D=G0;"=W0JNI]!@LWCFSZUN+^3 MV:NEC8B9W\-.P.9.JRIP6+61/S;&;6T/'+V>UICPVL+97`V^OQ+KD?5R79S5 M?'BOIV>/-U;;;.>`9.9.;4]/M]/.>OM0>YN=-39$^-7<6OL,-#M@+`?CZ\V( M"#'B#M:FQO2')IM*^5N1RTN>'MGU6I`$\UHMO>,J7H-5:7W[X!NZ]+16VQ7J M`->HDE1YH)=?S%F6J]E<75/L2E:#55)]>XH;YMV5ZJ>UU^=2Y'X%J7GTN=#G M$FXK*OI<0JJDKFR:Y9^UB"X7NES"[>=#E^L$7"Y=[BD*>ERBJL&6>UP";/]" MOTM(O53E?AKTONKSOAJPDP;](%']H'(WLJ#/4IO/WXJT^ M)\@P9=,L?\U%8/^'_[FM`'V':O%U1PK?/UD!^0CWV'#3E'BA%3F^=Q_!+;=3 M^F=X/HJ<9R=Z77.>L*KD5)__=369NOXK(=<>C9R<9Y)YXIUK>9JBZ)_)9`@Q M%1:J,Q`.](ZN%5ZK/M`/K%7?5Y\/.MKQFT#-@4B>H5;$2>255YW67;>]8=M/ MZ8:,R@H(!?QH-+2,F^K%^0133;EJ_4JKL58[RDD=:(HZ#G7<`3I.[774>IQU M=?_(J')S\.+<\._SQ&(59S ML.=ZF"Y9D92SCE!]*!\``DN' M^09?I#E-<(3,JNSJ:-2VDOI+8'G4E:Y1D]:U?E5+U"UT5N9$ZL@0B@)`L1'6 MM]IVX:4E!!IM7:N+]FLSPE??IDY0KQ%N6#A3=CS2VJA9$$.+<"L4;FA,,:+% MB#8UIGS9!V-:L=)^IQO<_F`4L76SH_=,*DF"X;%`/N4TZD1\-\S(]SO=\IMS M8*A<=ZC<@H5Q%1?&&^E'B+)\**P*U@:X,([(;GLV8=#IE]\0!=,(9:41=MMN M(%KO@>9%_&U<.BQ6)R%@6@^8\@Q:R2>68IA[HBO"`I1E-$ MVPBW1L1PN"+<&)O;[!7AVLNK1''V"U1;;5F<5A[]CJEAK"VV@U)` MK-V"^BRMUOHL40)V@?1LP]9U"T2L5L798HC%92.BU].B=5^+4B#0OA/>$3,[ MO5UFI

=ODM]<70%(-.!<67F-BIR+=L?E5:[5%JTVJ11`DFB]5P"#^$GR"Y MC+HJYC#QT.Y%?@$JYD2)TW"17]`:MY,'2"-2Y()4I6$HU_8U^MJKTAKFGI?M M:(L5LQ4(M1\J.)Q08)05R,EZ*^%.MU*\W^D:=1ICC![;'3T*43`G2GB`:\X" M:+P?BM!WV#/LQ.'="./>ZVBX:-K^2+L%-6EZK35IM0=2C74C1%E6$U8%:T:M M%6Z([*8CNQ&.AJIT%*Q^+\,A.:QRX@"@SD9NJ,:;_<2T`J+4@8`T:8J`1(G( M*!'Y)")1_662,GJ#_VD-77*L7MJ4'QRL"1:*SR_\ZPKTK@/#D<9^()$D3;CQ MP%WIA01$TN$/N,J"3_RT:LGBAU3/'S*EQU%+4P)*EAX^+?ECZ;L-YSTVE2$J M9XC6,P]CR-H^GTUEB)8PQ#`.8\C:$O.F,D1/&*(/#F3(NI;SG"%O;>>9?OKI M;1R>/5K6]-W]Z(G8L4MNQ^S8]X]62.P+?S(E7FA%CN_=1_[H[]LI_3,\'T7. MLQ.]/E"E]@!._D<7?OSPSW](TD\[/X]^&Y['T9,?`*?L7SV;!)F7W+F6%WY\ M3549]WRB?W;&Q-'/?UW?)\'NU"'G\OLQCI_71L9\S??>>2+/N<&K-N MZD*7FX/3N^OW,^V>@-2[V5"KUXS=":96T@I#7EIQ8UB9S1Z*'/+K9BTK!O#: M#+K,PED.#QH>96WZ%,SL\V]7?*1#W[5G]D=EK_DML1[S&3[G9F352`P7S461 MH#>.%_83`[VV@6GEXE[3LKC7&XK[Q'M@L5=U2%<[JG&JZVIHT]NDWDK:[@7^ M]SH!*7G]7RF>P=5H,AXN':/$*IG:'>U5B7OA3T6$:NXXT%A!^DHFEN.!P4-9 M0EE"62K"O<8HLKFX1A\+?2RT"V@7FFX7,.T'[QAEC8(F8;A6FN5>"H$90MPC4Z(,@ MM%L*[:KU=:NR&)4DZ7H=\^"-@$7D[G;>EK;S5M?#-H&7LSOPNVY'55?Q+T1Z M5NMHZU(L8LU\"QHT&QVC&;PV2K$T18E3Y*,LG;PL=3OF7GNA:^-U=U>+5<.V M=31,*$S,85:/:`11*;/5&L]0NB.!Q(H;]I>8XM:]FMW0I(9*:"'ZF&P/W>LS M`E6T\%U?:H-PWB._A%C>@F6ETRN_X1_"&>%;F2,; M=%2]SI"W8:L.Q:72"A\X9MQ.%67[EOH>,W"A\W>HS.I*\Q6_VG;JV<"68VG? MBM36KI.K1A5+#FVI^BBU?J.]&.LHZTYR0I`AR(H!647.%X+LE$&&UA(QU@I% MAI6+QR1O=T]<-S,KJ\+8J_#8VE:)A*6+B(O3+%U$C8&UBS5F*T69?6PE+8`R M,FI--HD"1:QU601%1\&Z.(3%2D*G(K]%>%Q@B]:ZH:@C#E$_U:.?L$:S]AI- MHEHK!]0$/X-H$,*:B9T#L?2B>AN'B$!$M!,1=5A`-'^'FC\#S1\JNZJ572O*!/F?%JBR M^?/?VLXS_?33VS@\>[2LZ;O[T1.Q8Y?NY84?7],SNMF9:NP\[@?0J!]=N.[#/_\A M23^E[[MTPI'KAW$`;\R^YRMQK8B^.HS".25WUNN$>%$X>YCDV``;ZU%3-7J> MN4?U]E$+I]R=PS\&L6RJ\G4]5\)D:X]FD1TGLD2`\^VEZ(E('WTKL"5_+%TZ`1E%?@#S9_M3D`.93:1#;W5?\VX- M*=%/,#Y";YI.`_^9WD5_HA=)6\8I4;F5_J"7\Z?W-8T_GOTR^TY]_V=G_GKI M(7T\N]U*M4+(WOM(04='PVB3?,Y067IY-8W9P+.C_7X&)!'>)BDREU%D15%D4*FL"@9 M5+U8WBNHBNWXPE(..S89B16P\)-%I\!,H-?I$N(S3Q<<*8X#K`J"+ M*D7Z9M<%ARRBXW1)R![EL4>-+2<`JH._243M0,R>1G^XX+3QJ?'YQ38=$/TC M>9<3IJ_+4O]?_@MY)H%,0<*H?0;^92BNSD^#72!=SF/8)`X9*X"=+K'@;Y6]!?`1`QY66)(=W*^K%,LI M)&;/38+I/^*R@DE.PXH>IA@6B[Q;"M@/(1/'I4=\@V<*EOZ M3E64+!-2];P)TW0($`^=17!-."8!&P?5HREB4H#:;"CI'!$"0C2F,(71,'4% MMQ&N/]F5F='1Z;,`P,/0L1TK8)\I7]G\!\`68'?T!-PGY@PUF8)0H9)XH2ILS5]8\RE1"F;IPHI*4QA+YG1`GU03I'5AR2!58!(71^ M*4L(^T2A'UMT`E_9_/M#\(AGW('Y(*G12L$'FG_J.Q, M[:Q*71Y*$D5OPGOH%/U@*M__F,)^U4IDIKD# MYA=N#@'I?-Z`'_"X6[#U0Q+,IT17N:IB_]889N$/^/),.6/_8E_1_Z;B^D+M MSNHPN:9,A!S4D_O:D!,4=(,:B+A);IL@JFDSS2XU5QC?L&*A/$:/C(* MYA+E+`PT3$8*W^X^V`6R,WC-#*#+!P`W*\D`5I@",S50@$$GL>/H`$7W$A%7I#5!;>3FDDR(I,%+JDFY4]ZWV;W4]G1_5QT/955 MUS/UT90ET4WU`Q,`JA0V>9W,J`\)F/`%YW,WEY.:E9GMI8Y2CJ.YSOIE'4]F M7A(=017+W#\$0_=]^I15XS[ECN7<+5M^Z,QCA-\9._9Q$E^L-195*4=&:Z9M9;IC"P"3>B%+]QCJ69@O5FZWG)A/G1X]UL!O/MK1'C_+O=V%)T=5F27&;11?(*FH8\8W>_<\DX M>I_DD0=Z1Z=U(\G*S<7MS2-1O(93:P3, MF7U.JC[9YR1C/-#3E'&Y):+FH*,=7S=M#D1:\M`ZW>/W'>8OXE18Q%CMK@6] MVQFL72`K=>."WOV>9OFI4,"/1AD;Q(='Z;C^YI2SRM#ZM+&D_ M_YBXQXR80'K+Q_C'M3>_XN')CT/PL\,_CU&(E1Q)N4&FLO#8B-+C<(("637' MJ63.O0^MH5+Z&Z%%,\2>S_;Y,PFL1[(HF&D!1\91H>F9S,>L;*_I?(%>C'A> MS/$%2Y$_W>;IY#'QL-9>)?5ONLVD)*UH;?)'^5<%U8;K+4FSJ@T%,@A"U-'N MW/2NCEWV>A5UM(CLUB)[#T>HSAZBW6[I,-_@BS2G.%C(K,JNCL9^30,*Q-M(XXIP&^'6B!@.5X0;8W.; MO2)<>WF5*,Y^@6JK+8NSJMY.8-2[,%L;T!IA^`:="E"'X>/)AH]"U$`US*/' MA:`&&6VM"/5Y5$55[>BNU[ZCM#33\^AW3`UC;;$=E`)B[1;49VFUUF>)$K`+ MI&<;MJY;(&(U%JW[6I0"@?:=\(Z8V>GM,BME]K`S!=84@TX% MQ9>8V*G(MVQ^55KM46K3:I%$"2:+U7`(/X2?(+F,NBKF,/'0[D5^`2KF1(G3 M<)%?T!JWDP=((U+D@E2E82C7]C7ZVJO2&N:>E^UHBQ6S%0BU'\IO(2PRR@KD M9+V5<*=;*=[O=(TZC3%&C^V.'H4HF!,E/,`U9P$TW@]%Z#OL&7;B\&Z$<>]U M-%PT;7^DW8*:-+W6FK3:`ZG&NA&B+*L)JX(UH]8*-T1VTY'="$=#53H*5K^7 MX9`<5CEQ`%!G(S=4X\U^8EH!4>I`0)HT14"B1&24B'P2D:C^,DD9O<'_M(8N M.58O;%(8S^02)(FW'C@KO1"`B+I\`=<9<$G?EJU M9/%#JN5,9HB<,T0<',F1=R_DC&+)6(S'EECZ1.OUGS#5[YY)Q]#YQ`0?* M]S-->G%[?$VV*?$Z4+ MCTP\KW)S15VMHQV?$>X*50F@K=^T83?.=:WJJ.&BYJJT8D MNTL$?&7Y<-1QJ..2W8QF36MSVSU-__P\.3'H>79X9_'J,=*-NYLD+"*MKZB>-:QV7B/U+:@,OM; M$D\M2N0Y#ZX6OTP+H3*N"PVY%B^ZR\9P3"&@;],$WZ;8M?XU_D^SUOH]6UI( M5USMDN&K8*ETO:G!I=(#+8802Z4B-Z]0%40V(OL(9#>B",#`K03".RH[;B78 MY(&K85",J^7'KI:K&)DT,3DI2H@BK&[NXF(Y`KOML;?94T%5J(X^[AZ*JCY.WF`H,'"Z`^C/X$*?AKF MD.,Z3G-L[@_]`H"]RPDBXH*[0&Z*?]!($X2E$?Z'WM%QT5-P_Z2`2+G555?E MEPTV(,P22`$W;+FV0"B;",7JH=C1ZP%B??[9=\+[9\:&:+NB;G:&R'JB8ZQK MXXWI'DSWX&)_W3;KA/?)"JLT!5E706`W%-B-R,<(LAZ$:1DL8#B1:!4+&%86 M4UJ:Q:AWA03K(#:O0U2PQQ`CXI.-B+$`0O@\;A-B"&'UYP]&$8V>L0("*R!. M+>(V.]JZ,T8QU!;$0<$*B"V'RK8S8&M:IK-AA0^X3[WU@,%]ZJVR@X7["LWO MDE)[U($Q=5MCZB[FBA#7+8]^>YUNK95HK8U^#W,N#\#I;.2&.GBSGY160)20 M-"FF@$0)R"@12>J*1U-OF:2,UN!_6D.7'*N5ZDB#W\>3B16\2OY8\C,Y*I\? M>O]NC>$X?I2,8>G]U(LX8\K^G4O&T?O$J/2[G2[U`9()NKB]N3F_NX=Q@*%P MK6E()VCH!S8!HZ&`,28NM<8CH'_V.5'A[',RE_UN:C_*C?+T;D<_/L35NUDW MH]>,4,[42LH+E7BD>;WNKF[6DD#2%YQ8LW"6PX.&1VFL/@4S^_S;%1_IT'?M MF0Y3V6M^(]1Q)O9\AL^?26`]DE7M-5S48T6"WB@K&=I:T&L;F%8N[C4MBWN] MH;A/UHV8ZU$=TM6.:IQJYA9M>IO46TG+04I'62<@)2\'*<4SN!I-=O]D!20\ M1HE5,K4[VJL2][R>B@C5O+.XL8+TE4PLQP.#A[*$LH2R5(1[C5%DQ-BPXK"[B,2.MM?28?&]@%C M4W9\CWJ24\]<-W7V-R27"RW>JM&7K>*4OM+J#&O#1;M!H7:4`<("8?%^N"[)1!AM82,=8*18:5B\#[1"J.&ETLB*"K.W8E?W8B0 MJ#II5W\E8LESWI:*P?4!#^#:!'-K^_'0Q3:8HGC"FHF=`['THGH;AXA`1+03 M$7580#1_AYH_`\T?*KNJE5TKR@3YGQ:HLF.?7T=]Q84_F1(OM"+']Z21'T92 M0$;^HP>7V-+8#Z3HB4BOQ`I"B7@V?'<[BOPA">;TZZHL:8JJRVM_TB3+6W^C M*KU8H?2=H;#7$6OT)(&NE?SQ_-4R3&+T)%E`FVM%0$1D?9.&Q"-C)Z(7?G>F MG/%+`A).R2B2(I_>'<)CIG1D86>-=N,L?VL[S_333V_C\.S1LJ;O+IUPY/IA M')#;<99%7SD!%\"HD)6E?+1"8M]9KQ/B1>$#6+>/KC_Z^\,__R%)/Z4/NX#7 M!M8HBBWW=@C@9$^ZC,FU]P5N>'@A[C/Y#-<\A9)C@[1:CYJJTV/D/6HNOY+Q MSV^N*8??2+'G\,^_WE^^D6PR9CV/VUNY)[#]#P M[-]A2N:$&GL3JO=[^HZ$SE^X*XD/3TZP1*&Y/X5=L[%*J:L>LLS]ZW`X%SDOK[D]3M=Y7M-'$J MAH'KO+N:3%V?R79Z97CN@?1[8>Q&CO=X_A@0PD3_H^_%(>&_3B9.&%*M MD8#FT*U'ID=<%W03L;^29^+%9#Z4P>)0+NE0_OKL>,XDGGPF$]":F8'=@5+* MCDQ[\T'I*.I/;\NGN'+.:$HN9ZQONW-&583ES+EM.Q1PEOLEID.Y'<]_F[-` MS6%!9M#7$9ED!WW]Y=.;#[W]![V)F,-&YWD@5@F*&2,C]OVU-W)CNL+Z*_@3 MP?RU\SN_^-%]//Q?X.^#_T""B>,MBKZF[:_1==,TF>C7/8HE'6=-GDS81; M2J$MQ^IK?YW'$!+X0\09_7^)4Q>R70UV.L=>VN".`L$$I MM.QOY373'!A'TA+>$+@,G'O7\D;D_HF0B-_W\?6S];]^<.%:87@^&L63F,4# MEV0*8=.2EAKLS<9NK]==2_D1-)4[4%W9WQ/35*2;'_>%1/,!J7O/G&IL MTF/;WUT,W?O;1?#2EZ/&`^AF-I7/@I,-DQ]\?A.SD=D'STG65[V;+:S6>P-M M;LGW>>O1Q!JKQ*K;<)'$:=43:V[V&_/4CY$HS@.)S870IS@"MSQQH-)$"81] M%W$0P)]S>OO_`V.CJROY4S]]]&.%/ MX)8ND;Z_:=5[6N\@TF=O/XAXFL%8HCW'MFYS"]3!`6#)O/PPTIWG);8;^UO+ M[G+68L]W'T#YG-P<6[@]S6)L<&/6O7)?*J]I:2()(QZ)$?O:2W^9$[^_01P8 M&\SAGG3L.Z([>`S\]W\L-R:W8["N2[_/Q[5_=E@U^X-]97<;/1D3Q3TV^BP: M/0>!Y3WR*/AV2@*+AM3\/5^)1UXLE\;#\]'DF-7E]->'._7WQ"X=\*JB",TS MJ4O9J`]WYM&$IC.T>EUT]8TN19"LUV=T]W:A^KW^(A8VOND@HGI[NTI]155* M)JJ_MTL$07:W7Q!5NWI"1IYQ^^LN\.%QT>M.>8MN3]U$]%ZNT8&C,//LW'[) M(=TPJAY%CHMGYEG`O:8#HAS]D(&L\_F.&$N>0=QO4C2MIK&L>K!FGAG<:V94 M8RF".("<`L=S?#YULUXO;3CS(>0MMNXY)>K@((0=27AN2G8OWG?-@]35@?A9 M#8K,O%AT+]Z;YD9;MW>0M/O]*V&2F1>=5C28_+AIQ_L?GB`:L,80$\S'U`]M)BE]U(22=X]<+-]4+=`R)"<-$6<_`[OG0G2G-*A;K[EPJI M8`OZN]"XKE!HS>6K54+=_:N$5*6_I/&WO6TGVG(*A+K[YT:[ICG8A;9UU4'K M+E\I#>KNGP'5J9.R"VWY=4&K5\^)V3^G:9BFV=U"S>+[J5-`U7;TY-O7WC,) M647`^>-C0.!R0FL#YP3EJOYK;T1<]_(;_'SD!XP>L>%:R M)G3$H?1D/1-I2(A'*WSI\ITS=F@IK4\G>.P'DZ1H5AHED3R[>\IS@$P,.A(X M%!(MA[6\5\FR_2FMQ]=])_$C)M>"U1$7#(VETXW1S3.89[\^/%I MD54^/*(X7DD6_%]Z>?)=P)D3I?,7PD.L2'JA4_:_,H#:^BX8#4Z MTGG(Q@1WQFXTPPZ8/.^12$QWS`F3&5D9,:;YU$22PHP\R]EK>`D/B!DKS_?R MKF>RMO3H7X@'`W;93^?V!**9,*(,@(E),JP+3WCQ8]=.R7YYA2+_LAGRYW2JDO0R]<>*&RJ;'FEY87_#)/V2&Z^Z(P&`Q[&SR>_>_H&BN@N]ZU^=+=']-B)A2&M524#U MT^SNC13G%.)L*[](*=[[K;L0.R^I31]P"_^Y"X"`X)7-U#SZ[>6M(!9"_`Y4 MK`SFU\DP`/?>V@W9^Y?IJ'FT[_+2#*47OD=KV;E]^>J$?U^`AH!7PE^_@IJC M/I1]SAS'.:4Y0>BVLE!5ZV8HW?VE1U)ZP&X5HZ<=2^D]<<>?J)*UN5,XFXH[ MU_*6OP);X<23U*[-2<]9HMS"9'.A'NX((HH>2LZNEBUY.\/0NB(.I9\;!6\I MY4W*+0HKGF+@M4VJHFK$C!/->70S9.>9MRYSK MYD"OG>R<2>6@79UT`"."C)(L\G/V`6GMA+F`-G"_X?9H>44Y&SDZ.Q MRXCVI6K7T;+,^9T51*]Y[N3R"/;M#MPW+5'85 M_5UH6:A%'SL>W0`_ARY]RCG=%)GB.DQF?S:$07X6^4[M_SXK-M_]L=NI^4I# MWM")2)+[NV/9DCDYN=%DIL1PK\?T M;PD#-V]M+H"21>;?CYZ(';L@?/,F%]DV&/>1/_K[EK?6.!]%SK,3O3[0%BBK M*TB#/%/Z5_KV:Q9G.<\D\T1*.E7,:45MT8M-"PV1!VO:(>^E-=W-[>DKS7[G/3$&OTRFIV7V&; MYFK/9=#U3G]M"[!2CV;0]>^I&J)"`3\:91R!-SQJP:I/-0?[_-L5'^G0=^W9 M$I;*N[2!5IQ/,-63JUG[X6+^OLAF7/V.64.)N+7\[O^./:FW]X>/+CT/+L M\,]CU.,2;/+FZWBT;)"P+%@V8O8XU*!X5LUQ*J=S7T1KJ,S^1FB34&(O2N0Y MSQPM?GGUC:ZJIA4,S'4)G-'217?9UI!K3OQ$WT8\W^;X1JV1/]WF_^0Q\;`C MS4LZM_HVCEC='BTVHH5#5_`VA\;TM,HGQ;]D16N[H%9Q.MMZ4].L]LL"60PA M&HMO]_MJ/&%.060CLH]`]AZ>4IW'_W:-TF&^P4EI3K=T(9,PNWH@^YVB6""^ M?@DL+_&UZ]*DQT:4+521=6=SZM-WF6TXB,G3PF0C['&5^"PQ=]!H>UM=8J`V MLWSU;4IWUF"`IWHBX!G4G`KN5P$8'`>-VC-M3!X%G_C%R/T!L-BB[ MEH31/QBU)L?+`T:!//JQ?/U<&-`:8?KT3E_#H+CU07&K5\M5C$R:F)P4)401 M5C=W<;$<@=WVV-OLJ`,,NL7V4W9WTHJ+NYNZE:$]*<2&+6@C8%H/F/(,6KFY M*PQ_3W5-6(!2K8;Y\64[XJV-%G&EMHUP:T0,A^NGC;&YS5X_K;W`2A1G'U=/ M!35_)P\0-%@8_6'T)U#!3\,<L^D8ME,? M?2>\?V9LB+8KZF9GB*PG.D8/TSV8[L'%?D&3/2>\3U98I2G(N@H"NZ'`;D0^ M1I#U($S+8`'#B42K6,"PLIC2TBQ&O2LD6`>Q>1VB@CV&&!&?;$2,!1#"YW&; M$$,(JS]_,(IH](P5$%@!<6H1M]G13`RUQ790L`)BIM\H.%NXK-+]+2NU1!\;4;8VINY@K0ERW//KM=;JU5J*U-OH]S+D\ M`*>SD1OJX,U^4EH!44+2I)@"$B4@HT0DJ2L>3;UEDC):@_]I#5TRI_6M[3S3 M3S^]C<.S1\N:OKL?/1$[=LGMF)TP_=$*B7WA3Z;$"RUZOOQ]Y(_^3HZ:/Q]% MSK,3O3[0ASZ`A?WHPH\?_OD/2?HI?=ZY"]]9$;'S'W?UC?Y)),<&,V0]:H,> M-58>-==?R?CG-Y=T4\T;*?8<_OG7^\LWDDU&SL1RPY_?G.EO/A@*_&\^@-U> M>!R1_54B5>&('*P2J9=.Y-5DZOJOA-R3X-D9D?P['ZQO'XE'QD[T*?`G&P:A M*\K><,@,H!ABRAV@NC>4&C9`;6\8ECS`-7J-?AN>Q]&3'X!3:O_JV23(*+L[ MU_+"-`%^%P`Q7RWOD=SX+R3@?SD3)YH/6\\9]E^K]]]ZY#.9#$FPR)([>#[& MR%SSD<_'I3Q2?6P<%O32U9?]1N@:&+'/GTE@/9*O9&(Y'OQ\`9P,K%$46^X# M"2;:G,T[1AUSU?GA;O!YB8GUCT=P)N\8I,/,5*A`C'Q6Y#$R'",;)7>")$KR`1(AP;^P>E MTXT*TND[L:HH^[;ZLDWV+6/*!PV+0O8>R=+XP#O5=_`\)K#X3*\3/Y)LO4` M7D-9,.=7_KK:SOSZBQ'PY+N@CGYSHJ?/CN=,XLG]%)@V=H`J_C[0-(`*^I`5 M-@.M*QJQHVY5B$5PH7INYR^P'2++N6Q;$>*6L"U_N6QGMK4`I,/`=0Y_R?*` M5]\"8Y^S.W_9[!`=FL,WA?&M@O%4SS@COY2P(/&NC7&;3%RXLXVCRYAS3N7L MVZG"['RX,W_/\K"XH57!M+R]0/LP[;/UC7)I7E"@-)@9^3N$=K<)S6+&^>-C M0!ZMB'RRG."S%?Q-HO^QW'C18E!)^$I"$(+HP?_MR1D]I3M-@VPD^,D/'I[( M)R<((]IC8,[2_!U$A^)KXR8U-0DYQ&7+/M.V%0])D,U\_/-Q1`(*#,=CS[F, MR8/_E41.P)XUGX[\W4F[F^$/=_KG73EOT(U_G/CIU) M11B'AB_;%$2NMV/NK![*''RQJ8O,JCW/E$I-,6C#5K"*3-G848KE%/FH"6VB4=G?4,F\^I MG$6.G?34KISJMH51.2L<.ZFI71EE[E+7U`1&Y5=\%8NHQO!ITS*0>:SK7RVG M=EL)*HM7>3VCBN25JK>(64.3!/C:\YVPH.-$B;^-HO)^X1F*_%Y9LW\;7;/36^YN\_.,0` M'=?%K&5\[1V:R]Z'KV;'.#F^YF2^#W28-O%5'9P:7XO+DZ_GJ]'I&J+S=?=B MF5F*8C<&'QK3[&?`MG<^+&^LHG#ZR+J@G3C=WP_*HG.:/WM//N<4_!2.Z'[' MW"0RSFK$84[Q7I'W\=Y M:R&7#UWHV,]%/G$L]W,660H/1/1.OSW6[S!OKG_HUHO]^-S=)Z%6KS>WVR33 M$O&E>HQ^_H;P(M<%BZT:6QE*99S*J84J=@5U>;&ML9S**88JMKJU5VQU:WV< MREG**K9B6BVVP*XZ3NUF"/([7Q6^8E5@1G7'(=;,UYP5*\%7`IO!UYP5*\%7 M`IO!UYP5*\%7`@_CJ^62\"MY)EZ<'H@7?B'S_7:#O-W;_[WE-$&UJVKF4C%H M_GL6B?DE\,/P+O#'F9-H!GF>^38">LI`6ZP9S#QZ\9U`!,RF/R$W<,'YL^6X M[.!1/[-5DN^H#H'OSFA.5UZAU#:Z^MWNHI^QY]N73E6T`MJ]-$S1M41@WE[@ M90+7`%/IZ)G.;KGOV4S*I>/&4:8":9"7+2^$F.1-B^0LX7^Q`T]F16>)8WE[ M2Q>(7.<\]M1%M._U_IU(3X:Y\H0Y\7G%W3L1/U"U78A?1\&>^B0O!?K?6XY? M57M=8WF[PL'Z)*]6>1L!?:7;ZY:L3_+R:5L9H^IZOR*%8N2=F[M"X5H9-@I5 M*$;>&;?%$%.<0C%RSZE=('*=3'8'_9H5BI%[VNQ.Q/=[@\H4BI%[PNM_;SD- M6.V;AM8K1*$8N>>E;B.@;W:7-JH5K5",W"-)MS+&Z"EJ90HEUQ;H.\JPJ1>K M4'+M0A'$%*E0]W>3D:^3(62>Z;D3L3WC>H\%&/YZ$9.IK%%;B#> M4`?%*)3E`Q%W(J!O:OUR(QYC^8S!W1BC,N^R&H6R?'Y?+H7KG0*E4(6R?`9> M<<04J%!R3Y!;('*]0NG5KE!R[<7%D;*52AYEF5+_D(U==,H2)WDV8S- MK]\__JW$Y.AV;6N09:J&408Q.7I> MV^J@=153/R`4WDI,7N'H5N7>U8W^`6[T5F)R]/B62>JJQLKIR8=*S/(9,CM! MMJNH:G\WDF;?'?1L`>W#;CJHA]YUYQ5G;<-8SNGWU MB'?F:,`MG`7[UE5W?.6A_M3R"1$[P:RG%YE!/ICT0_0H*/2N`*0?I'4UY8$OD9*KQ7?-$.I&D:3D*O==#FL/(R=7Y.R-G MW\DZ+)[-ZP:M[;0*UN^7G7'?1GJND MW`FRQD#;M<0D]YUY&SBW(=/L&4N'\N[WSAS]O16`75U3CAEGCM+=BK,N2]\> M_LX<3;EE-C7=T+0=TX&'9@/R&O!MA5EOT!<@?Y3;4&\;6GM]M2<`Z0=I7659 MN=1#^T%*6C%Z!>:^-J+T?6D](LD)5>Y[YH)T(O, MJBUW'LN%T'I2BLT?+;?KVA,M&Z;HH`S)KXA!S$#G+S:&*0\UAY.3J_"*0 M4V#^:+E!T2JBUL=T.Y44E)?)R&O]H^X430^6*G2J)SU7Z^\220]VRV.42'JN ME=@IBC9VJI(M,W^4V_5EI_R1JA58D7NV`^KYJ M[%1[53+YN=9N!^3W5;W`]-=_QU80D1XEC=R+/?:&_O!)#EI\%OTT05_ M=$9U7D,-(.K_XT;O;>=9"J-7E_S\9@Q7G(7.?\@[VK5W&KUG7XRMB>.^OJ/G MX(72%_(B??4GEO?^S?_G,7K_SW_01TS3!WP^__K+]9=WDN)X_!]X!KN.7C5, M_W#2/^CCTUL_W7YY.+M_^/WFZIWD1);KC-Y+[+M/YY^O;WY_)RV_G_]Z?_W_ M@QM4^B+^Q6]7U[_\U\,[:0BN^/LW$AT-M:7TE7]H^I_2/7')B!KH&0>E&0NE M2RNRI#]^]:S8=N":/RF1;RF5*<5O9[2_G0WG[70O3EB3Z?O_HW:5E7LC&DZD M]].9.@,N/'KO7#*.WO]V??GP7W2@RO?OI8^W7R^OOIY=W-[[\\O+ZR^_G'V\?7BX_,LXRSC+.,LXRPW9I6]YIQ[ZZO.^I*+7B"[C^=VU0#C?P:9P:.7?S+: M)`D8TP&_.)[MO]`04U*G()2^Z]BSJ)(S8$)L)YY(GN^1^4AW9)C17<.QY`V, M80LO2'Y(KLU]]W8NPVMIDH.&O/!CKZ'*[.$I(&0^O9_A14_SCU>>7:FB:P'V MT9+N#KY/3CBRW#F#?R=6@&85S2JJ%@',ZEK-5*Y9K5R;[:&OU+>Z^I8N91RC MI)9F,8^#QT_>.K1GYVXC?HZ;1!252MG=7`_`>*LK*%$H42A114E4#VT42A1* M5($2I2I%B!2&*P+@NP7A2F&PKAC0F&RI(]G"N'/]Y?+J"SSRC->MY7"'5[0U M.`M35%*I$L='7%45T!+1+?+#KD&H(%00*@@5A`I"!:&"4#EQJ)05W!P*E?HC MEX_G%__WEZ^WOWZY?"?]G]&(D/$XEQW#QY'O^L'/;_[/Q<75U:=/VRV+0#?$WL*'EJR+H<3;&-:FQD3)!1YH-7GIB,J MA$1%7Y&[O?HR!(@*,5%ARMVN@JA`5"RA0NNC!4%4+*!"US39U,N/FG&M[$37 MRG@W:\S*8%:F1-,&_D[Y.1F$V`E#3%5E7>\CQA!C)6+,D'N*BAA#C)6JQU2M MOMP`8NP$,&:8$`\(!X8!P0#@@'(2!`^;B MA<[%:Z7DXMEIR9AT;T'"H4!0*!V]OA(&Q(2@F#`0$XB))4R8.8UH$1.GC0D# MMRTA)A8+UCH5E';CFDCQ@9OPX!L!J#*T38 M22"LQE`-$782"*LQ\$.$G0#":@TC<14,3SS")%.C%K1Q`G$"<0)Q`G$"<0)/ M=0)Q543H59%R-EC_1BBZB"V=/Y/`>B0+6ZQ#Z3:.PLCR*+,E/EU]3=6`,[06 M3/H#2(N>_#B$*\(_,:+'B+Z\B%[KR3T53\=!C)6+L>X`NWXAQDK&6`\/8$*, ME8TQ/'\),5:VK2R_$@'76'"-!?-+K<@OX03B!.($X@3B!.($GNH$XAH+KK%L M6F,YDY)M*KBV@K%\E;'\0,6<)&*L7(SU>WA<-V*L9(P9J,<08V5CS$",(<;* MQ9B):RO;8U;^IS5TR;'/3UA)'Y7>'Y%OT1D;T#N7C"&,2S%*0?KQ]NOEU=>S MB]N;F_.[>YA&8(5K34-"^>('-@&V*&^D$7'=<&J-(+:;?4X":_9YAL89')NZ M7%23QB@K(Y95!"/B1238H@GX1%1LTZ<++>SS;U=\A$/?M6?1CLI>`H(F<_O9WC1T_SCE6=7JNE: M`'XTJXJA[4+I M0NDJRS-4BA`O#'X$P#H&/_D0KQC^^/TE_E.$3-4%LB[79$V"!L M$#8(&X0-P@9A@[!I$VRPD\,*5-K?R>$+B:2OY)EX,0E7@W#<`EB$7'5T4;>E M%0BD[TI'3[_3JXJ/?8&W4JIZ7^X-\#Q#%%845O&%U51EPT!A16%%815?6+N* M;.K8;06%%86U`<*JRT8?CP1`845A%5Y8NZHA:R:>7RULIG-#CE?X%.8O@1^& MTEW@CYVH-G,@RMI*87J^O*Q_2Q3X[@P26C,KLJK6=T`;>GT] M,U%L4&R:*#8]"`-J;)F-8H-BTU"QZ?;+[YZ+8H-BTR:QT7I=N:O6UW6Z/)B) MGDXZD<*Y:V_D3P@N0>`21".U_$DM0?1DO5O^`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`%*\4L!]OOUY>?3V[N+VY M.;^[AVD$5KC6-"24+WY@$V"+`F@C+H7;".+"V>?9\A44A8U=9FJ)NU1 M5F8MJPA&Q(M(L$43\(LJ&+'1/7K(\(B,(E359C'@]*:\^GSKWN.'!PV/,H-] MFL]CGW^[XB,<^JX],XPQ[>3V1IN]NRG)WA+!5G\^&(U);9HE\4O2`;\X MGNV_4$]&4J<@E+[KV#/GA3-@0FPGGDB>[Y'Y2(^U1V0+N.MKJ!TH72A=)4A73VT72A=*%UE>89*$>*%P8\`6,?@)Q_B%8,; MTSAUI'%P>^A1^JL_)?:7\)J4HK"BL**S'"JNAR-V^@<**PHK"*KJPFIHF*WUL M%2%LIG-#CE?X%.8O@1^&TEW@CYVH-G,@RMI*87J^O*Q_2Q3X[@P263,;`UGK MU=*S[<)GW6BA7/7WLB?$%R"P"6(1FKYDUJ"Z,D#/,\; M115%M0FBVE?KRZVAJ**HHJCN6H6C5+*NC[**LHJR>KRL&C4N]:*LHJRBK.[( M:+TKZV9]F_BLVO"YY@N'3>.B%V;1FYY M;ALW'."&@Y9$Z2BI**DHJ2BI**DHJ:V2U!J3>"BI**DHJ4W('**DHJ2BI.Z< MKJRQH6?MB!4]J[E[/K?A>W2:NMISTEOO<#)Q,G$R<3)Q,G$R<3)QY;X%*_?E M=(CZC5!T$5LZ?R:!]4@6>D2%TFT0^G@>->*L0;P.MOD.9$&\GB#<#6VTCWJK$6WW;'1%O M)XBW7OGZ#==V<&T'\U2MRU/A9.)DXF3B9.)DXF3B9.+:#J[M'+^V`_D6?73]T=\?_OD/2?HIO>=^]$3LV"6WX\UWTW?/'B$Y-D#(>C3Z*@6: M%\$/7\GXYS>7FJ+J;SY0\H"ZE`%T;L_HO+]3E0X=/?MB;$T<]_7=,F2.YN#Q M]S)&I_?3L9VQZ7[GDC$$R*DT4W'^>/OU\NKKV<7MSI)? MU)S49*/&C+.,LXRSC+.,L]R4,>,L"S++\*#A4=%;GRY#L<^_7?%1#7W7GL5S M*GO->6P[N2T]9^]NRAIEB0"K?QD3O?S:M$D2,*8#?G$\VW^A(::D3D$H?=>Q M9U$E9\"$V$X\D3S?(_.1[L@PH[LN\\'?P!BV\(+DA^3:W'=OYS*\-I-_ZC54 MF3T\!83,I_,G;^WB8V;N-N+GN$E$4:F4 MWFG.K-/12H>11[4V`X042$D*OJ*W.W5ER%`5(B) M"E/N=NL[G@M1(2HJM#Y:$$3%`BIT39--O?RH&=?*3G2M[-H;^1."61G,RI1H MVL#?*3\G@Q`[88BIJJQC^V#$6*D8,^2>@L?<(L;*U6,J'MV-&"L38X8I]S5< M(Q,V\FSR&MD\I)3N2+!P@M<[S&VU(+=UTL7].($X@3B!.($X@3B!N&NI.2LQ M[6K+@$&ZJ$$ZP@'A@'!`."`<$`X(!X2#,'#`7+S0N7BME%S\1RMT1IAT;T'" MH4!0*!V]OA(&Q(2@F#`0$XB))4R8.8UH$1.GC0D#MRTA)A8+UCH5E';CFDCQ M@9OPX!L!J#*T3822"LQE`-$782"*LQ\$.$ MG0#":@TC<14,3SS")%.C%K1Q`G$"<0)Q`G$"<0)/=0)Q543H59%R-EC_1BBZ MB"V=/Y/`>B0+6ZQ#Z3:.PLCR*+,E/EU]3=6`,[063/H#2(N>_#B$*\(_,:+' MB+Z\B%[KR3T53\=!C)6+L>X`NWXAQDK&6`\/8$*,E8TQ/'\),5:VK2R_$@'7 M6'"-!?-+K<@OX03B!.($X@3B!.($GNH$XAH+KK%L6F,YDY)M*KBV@K%\E;'\ M0,6<)&*L7(SU>WA<-V*L9(P9J,<08V5CS$",(<;*Q9B):RO;8U;^IS5TR;'/ M3UA)'Y7>'Y%OT1D;T#N7C"&,2S%*0?KQ]NOEU=>SB]N;F_.[>YA&8(5K34-" M^>('-@&V*&^D$7'=<&J-(+:;?4X":_9YAL89')NZ7%23QB@K(Y95!"/B1238 MH@GX1%1LTZ<++>SS M;U=\A$/?M6?1CLI>`H(F<_O9WC1T_SCE6=7JNE:`'XTJXJA[4+I0NDJRS-4BA`O#'X$P#H& M/_D0KQC^^/TE_E.$3-4%LB[79$V"!L$#8(&X0-P@9A@[!I$VRP MD\,*5-K?R>$+B:2OY)EX,0E7@W#<`EB$7'5T4;>E%0BD[TI'3[_3JXJ/?8&W M4JIZ7^X-\#Q#%%845O&%U51EPT!A16%%815?6+N*;.K8;06%%86U`<*JRT8? MCP1`845A%5Y8NZHA:R:>7RULIG-#CE?X%.8O@1^&TEW@CYVH-G,@RMI*87J^ MO*Q_2Q3X[@P26C,KLJK6=T`;>GT],U%L4&R:*#8]"`-J;)F- M8H-BTU"QZ?;+[YZ+8H-BTR:QT7I=N:O6UW6Z/)B)GDXZD<*Y:V_D3P@N0>`2 M1".U_$DM0?1DO5O^`@2**HHJBNJ1C![(NM)%445115$57515338'**LHJRBK M39#5?A_/JT1915D57E8-35;-\NTJULL=F.#"C%3HC3/87M<9;7O!>X)SCAI)C M.:ATM/IJG5!H4&B:*32X41Z%!H5F3Z$QZMNL@D*#0M-0H:FO'R0*#0I-$X5& M[9CE=SS&1>_BLVO"YY@N'3>.B%V;1FYY;ALW'."&@Y:DME!245)14G?/I^%Y M,BBI**D-D-0:DW@HJ2BI**F[2RIZORBI**G"2ZK:,>MKZ%D[8D7/:NZ>SVWX M'IVFKO:<]-8[G$R<3)Q,G$R<3)Q,G$Q_#B$*\(_,:N".]NJR0QH/;G? MK^\D0\3;Z>&MV\?U'<1;A7@;(-X0;]7AK:<@WA!O%>+-J*\4'==V<&T'\U2- MS5/A9.)DXF3B9.)DXF3B9.+:#J[M'+^V*L0;[AFC7BK$&\#/%H;\58EWC3G]$?D6G;$!O7/)&$+`%*\4L!]OOUY>?3V[N+VY.;^[AVD$5KC6-"24+WY@ M$V"+`F@C+H7;".+"V>?9\A44A8U=9FJ)NU15F8MJPA&Q(M(L$43\(LJ M&+'1/7K(\(B,(E359C'@]*:\^GSKWN.'!PV/,H-]FL]CGW^[XB,<^JX],XP< MH^>Q[>3V1IN]NRG)WA+!5G\^&(U);9HE\4O2`;\XGNV_4$]&4J<@E+[KV#/G MA3-@0FPGGDB>[Y'Y2(^U1V0+N.MKJ!TH72A M=)4A73VT72A=*%UE>89*$>*%P8\`6,?@)Q_B%8,;TSAUI'%P>^A1^JL_)?:7\ M)J4HK"BL**S'"JNAR-V^@<**PHK"*KJPFIHF*WUL%2%LIG-#CE?X%.8O@1^& MTEW@CYVH-G,@RMI*87J^O*Q_2Q3X[@P263,;`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`/S_LJ M/?S7E?3[U?G7>^GJR^75I71[\7#[\>JKI*NR1/'#_JVQ1\`?.>O`@O/DCVM/ M>MB0(CF4_!P5DFA+*N7I_506SYC.>N>20!M6ZGVS\^H]T5R0O1.II14I(^"ZH1`?T? M;'$J^$55N%Y&QSP^F6T4/^JCE4]_L^Y1V6M^&/ZX5>$4BK`N(NS$$#9"A)6M MN-5.KX#EU?P0I0D0LQ%B92LQK0A_1RUAV!5!C%0),:5S>"EEM;#*)"+J]-Z3 MD"1]P8OCV?X+C6PD=0J(\%W'GL4M_(438COQ1/)\C\Q?4H#SG[R$D;OPCN2' MY-K7479)P%#A3FB.J5C.W(("I%LL;O--RH=QB,RGU8KF?T=/9%$4/I)'Q_-`$9>^=_WI'`\7.:GJ,G@_+29'FY M>+*"1V)G9,2?_WWAAQGIL3Q[47JNODV)%Y(0I4)HJ=@4@9;L$34V:KTD=CRB M'E*8D89-HC);=EL4D7/7]5\6#5*Z%(=2([34;`JJ2S8FC0W$MSI?LP]7R[9$ M%+<+H_OCHOL\<2@YJ,^K!BE(0G?;$+`F\*]W0\#OQ`HD$#-B2[>CR!^28(ZG M='%^5:ZJ"_H;5C16"DC5`;W!Y$'Z(/T2<2^C9&J2+`;X=@ M%N'76/AM#/=$@-\.4:%(\%L?1Q6&O@(A)T@L56!4M"%:+3!T*>>$V5G23!K[ M@73IQ\-H'+O2^L19.'_JJK+95<13(IYP*NZ96,=8'MOY`UBI01`6O8:!375SH M(KSO?0'/":Q1%%NN=!%`\!J%;^FFT=H][X8E+4K.O8J51RT0?UJ7]M^OU5E# MI)T&TN2>T9=-M8*S'DX5:WOG],7*SQ<99FARMV?(JEYKI%$[VEH3D!2O*D6. M6W1#D[5!^0U?<-%`V$6#W?8Z"7<6`&;RVUU)@;.(LRBD>UMG>ARGL16)YYKJ M,S!'W)X<\6)IN9/^$:\-$.X??K^!&,")@)91$A8<�\^/`0:;X!:B5XF%'Q M=D88YI,%V?QTMGW8V31,J:-2#YB7A!O`B'%Z%;4"%@Q`.,T-V71`(,KN..=B9 MKC-Q7"`3*VJ/AMGH4\A&8^>9-F42&IUR+!!_FF[*`ZU6>XQ(.PVD05"@R+T> M=I[!I'D5!>VZV0>TG?:.C=8$)`W([A>I*BMJ!X=K!L*N&6!EN1@F5=!L[:F7 M8^(LGN`LBIH>QVEL1>(9*Y:;Z$,)E2/&SC-MR2=C08!4YP_CIUG@_+]A%II2--'FA=6>W6&C.V M&VL-3YH7&6:H M>CDFSN()SJ*HZ7&!>9=,?.,XN)^H&ARGJO=SS`5>PZXU=&^!_6D.7S#[9SC/]^Z>W<7CV:%G3=_>C)V+'+KD=_X_EQE;D^-ZY9_]W M#/2-7R$(3BO?:26.ZX=Q0!Y`&CZZ_NCO#__\AR3]E#YH?GL:=X7PH*\D),$S M"3]:+JNJ=VQ`C_5H]/4WT@CF#)[UE8Q_?G.M*:KRU^S63WZ0UMZG!'PFDR$) MWDBQY_!;?KV_?"/99.1,+#?\^&J5%V5SJ0WK:! M'(\C33<'6M4XZN>,:PN9?174>L5D#E;)U([&D0D"4;$^&BC;!E(`CKJ]@:96 M/"XU9UQ;K($Z4`=FQ61JJV3J1^.H/]"Z5?,[QT#K!>-(-S1MT*MX7#GV6M]B M#735-/OEDGGQ9`6/Q'[P+_PP@N^OODV)%V;(7C+'EX78N9ZI]`9[#&P-E84. MM+MMH`7X4U2&P#I=?;QQ4M?^!@47,&OF4<1E]1NV)-H*FHJ^,XWE:KX'7L9:RK&*FV M;:0%0+4',:,J&E3UG(%OBSZZO6ZOX@F\)'8\HK^&<]*-,BQ^U^AU]S$8<\*. M'O%#2_/;=GFA1BJWMO'_2V.VAQ?HP`;K>M[A>W%#6>K MRU%([J3?VTLM%#>\/$=CF[TU-%6M1=#5'.^@@`A85??*I!0WG*U.0B'Y%%`% M]0POSS/89NA-4U?VB8>7J;6)\^[*BYSH]2MY=$+@GA=]L29SLZWFFNT/'Z]O MI:]7GZZ^7GVYN))NSC_>?CU_N/UZ?74O77^Y^.GMNNN$A\W>\2^#L.8!/-WY:A.>-<7/SN3:QZR_*[_\5T0:"MX_>2X))B+D):G M\);?L73S"B+Y>+^2J1]$CO=X'UE1G'E%GA)Z\^%W$BX@,O!RN-J6V(W9]RT\:?DU=_'0=4:?7-^*YB_)RRG>?5JO;A1P M6#5=Z6EZ?T'V,@]?X:0_F?C>?>2/_KX'OYR$MW$41I9'"WKGA.0E`>]O,X3P M>[.T7'_Y1'5?=P"SH2^P?<,;5R5Y#NE/\$UFBO,5!/WWHA0O/6#=&[BP+[TC M7U]\^CWO#9D'+-J8+X"J@-R.;Z<4&`O61,M7&G3EV7:>TY5MNE9_1A?RWZE* MARYKLR_&UL1Q7]\MUP#L73PR7*DY+K;4F'_QVQ4O`QCZKKU4EO"'^J=T&SQ: MGO,?QAX)H"!]C$/'(V%.'XMY!?)PL8#AF'J`347;NMHQUU1M%U^"\]'QSP`* M!!33B$@WUM`'S/B!0T)Y3O>U-^I(?_#/?4U3%N^:?:^^EZ7L15]OKA=^\P,I M>B+92T`TIY;WFKGJ3^G%`KQZ(S^8^EROP0Q=DA%ST^8D:88LJ8.^VIE_)2V. MQ0FE:0`/&6O ML@1_`5M<__$UPQ#XBWTE2X%E`W'.9!)[?N8QD?_-&?&[?IB_U@YB8.LH(,2# MCS\"8RT`_@04)+W%H;8DAN'CC\-`7\_,DHY]TDNNW,D+Y="=%?PM2_<3)WJ*P!^1I2^_R]*%"]^&PSAXE*7/EXSJSXX+ M%-GP^9Q]7D/.+_#UY;#X`&"`S**N-A-GV"^1X[E`24)$P&A\.')#Z?4/L"?(]?QG!']PP_HG:#2 M00[FX'DBEAL]92:]LZ8B[3BEO%W+5Z+0'T`W+:E5M?<^E^/#Q.:!:F*.*;`\ M(*!;0OB;3Q,XV_0K<%=ID=K\AI`\4D>D(]&W;7JRE:006+=6_QEF8]#_GNDK M<$MHL2;3\%88$CJI,+_PNF?BQ3!B.H'T"VH+:.CI2<0:/=%[J?J-GD"?2*]4 MB8!JWW1"@IY%)(2_"2I\[ATQX+'!I)J2L.?GL=#SO3,.-L#7AE$GQ-,A)MJ9 M2LOLSK\AE'&)_4@EP@.;1%^>HI^.RX\?G]@==_?7GXD-]\SY2?U?+H*@#89G M0Z8XX$4>Q?TS51YLLEQ:"1LSYX8RWLV8=7;W7*QF+Z33?0%F2[IZ]ETP+&$\ M#,%(0D2T65Q6*Q97_<]%_S3K>UW,8,#K&N\X^MC'V_$GQP.5[E@NC908GS)E MCG#UO?/H.6-@D!6&%3XPS[(^K?\?.L^6R63KC7Y', M5U3Y,>?:H4J5VB@"JA1(>W(>G\`VN@Y<3`.(9]#W?*Y?P$L#53RA&H\J7S;- MU#!-8`!/(8UX7*JV7\!=EZ9Q,'JB"CL[N1ES#3-F2]^I/7E@:HSH[S135@V= MFKY1.I#1"M71>LO'[J"+$>"QDW#*;`1QMRCT]J'@&F;,8Y;Z3)K_#?$ADUKF MSE+A=/T7'I"-('R2_K`)B!G(#8]`+1#V((S.'/""^5]^'$E@?YWP3SK-W+G- MSNS\38DCP+3`#`19!R*,IU.7AMP`%`=\'"`M#GFL2OV`9U`)X('/_(RL.3^U MN;P+J.,6<15*!7K*W*$',ON!";45`*O8/-.IS4[2)?5W08,S#0]LI_(? M4TP,7QDFZ!H%W1MSYM*`&4+\)XAWF!]+?Z7S,6$0@NFBQQ"X(%\S93\7N9F# MRZ>7!C(!2TJ`O@8W\2F<)W*1X$O._%Z83 M'I%(49(+#NC43D!:;"Z763=.YJ&7]SI[[B/U#ZB5]\'*.S/(<-V=R#F_R093 MPI8\F4)(4+0@Z%_)U'("[LG19%1$/%89S508+V&B:$L!R'P*<#9I['YRCMTO MOF^_..`8GTE7XW&B9;]0';<@/M/Y_.6C,YS1V-=4;7,00U?L#2Z#.WC`H`(Y8FC)(`:.0$ M(.=T<8\F$L'^,8F)>-P&85E(13QZHDN>$157C]!L+PV%J1I/GU6[#G[8+YSYU@&PQ#Q5#75 M`YY/,V1@8@*N#,!^CYA:8U2/@4*Z*/98,`)7OB;\8&'J MC!N@!ZD#\3>AN=4A)R47PPRBQ^G_-$\]7P3O8H]@Q3 M^9Z/<9E=AX\U.[M?_"QRF)F@"UQ@@'R(Z/_##<6A7L"I:7V*AV&R7RA\(BQ; MS.PM6^H#M31791E[OV#?J5.FR8:BTH44^("Q\Q97BZG8N>&0SEDHPR+IV7<\ MO%D*26*VBK8NB%K.@>2$4CR0H:XMF6:?3'0Q]X$>&:F3][2!ZI#/KPQYQ\KGRVA@8+V,H) M#9P5)E$`#@8&A`1F7Y63@$#6-:W0>&"1N6MD9J.0].6^T4WHZ\E]FI+:+##R M.HF1+NER,X?"@F1!W$D+6?B`%WTTV[&9]7D)G(BM?3.O>X6;-4EC)9)'+\QX MBP!K#_X><3CN-F[AQWB19%BY]J8XH$",N;N4IJ_!5KHPW=RKI#Z/[W$_+?'L M^.(EOWN:63_J+"174Z\_QP$_S/_NO9/^BZ\L\V6SU$U+?.>!:?PH9;QL*;NT MQ41@OI1%Y>H.?J##N$\6`K_R=5"9)K8@3DF7\CZ"%WE)AFDL2AFPY4A,]FW* MZ%R*04D"J$:4)2RAG>5J1D2YA++D)V::K*$N;SF6`SD*B7 MZ(GF.#G;4UEG,\Z2Z22@T1CUFT#%^M[:!=F\]9<=58+PHG$.\\069A=8Y9.P M0%ZQ8A*V"`4XKT,,M3GIK+,4AX4HVQI*["&O)P$'(XTFQJ[T0P[HR>6.F6Z8TZ8S,C* MB/$7L'>))(49>5ZH4_LEH%XYB-G881S,N9Y7DRP^^I=,=N=\,;N3;#!;>,*+ M'[MV2C8X(C1]M?C`VUE%PC4K>5A'+QW3RA6,C,Q%5U9`JZU"RGJ)E;TN$$-] MY("PDB?FH5D3PH5T89IIX,00D(BTQ:H+,@#(5OLEBBD=_&)@9O%PVW]))GR^ MN)&=(@"S49/($:92F6C<5A_3=J]C:A^#;;T>^,7B0V6(1G[ M#"]9]V=HT3S;,`DV,QFW.`)S\1\Z"8],G8?+CZ,,YG5GLT,,N6Z;S+)/=KHG MK"-=/;/L45(9Q5;+DA4]NI;+35.ZS#9-/#>:0K1>%PNN9N6S$MQ#BQ4G=&7" M\6SGV;&!AEDY\:^>0V'`"IT2YYO6#&>AY MI5@`AIS_!4X5T]C,N0N8X7<\<#:9H\@KH&GVBM-LT;*X)?W.$O,<]ZX$OEXS^R&6?T,G93M_69S`U%'F_2R>Z` MO9Q5@./4/&58!+?/O*UD,)E?'1:"S'UY:LQ8IH0]/=%'BUJ` MDYF21$=BT0>/:;DQJUCULWL2?DCG-5L!FREZ9=E27OCZ8Y+7"(@S&<8!?3_E MW:R.=K$H(0$R-?TV+W=@[CYG"KO/R

+[6<\Y6BF) MY_K&Z]?M.$CJ//\WMI/:5N:");X5Q7U,Z_SG5"R).3R=K3RRU4X^<[,]6GR\ MM.2%)?+2RC/BV3",WYC&=4#ILY+79'6"\XD2SNJB@%Y6.,.D)DC4T,2"F4QE M=!9_<`,`!+E,2?DOJ:?$5R1&ODM36`TE.R:9I:#M)B")KI-* M]]1.AZG3'-+M%\S7AX?2^AR^XL2@P5Q\7AN6^+B<7T!1/$U6-19HF,7O&7ZQ M]1@+=$X2TG&&L0D/J>X<+=S(<#OC2UHO-$^)9MZ?-P^)<4F7-%X(S=:"`6;F MU&&FD+..62_0*LS_?8EM,$RXF"X2,9?O/XD1HJIMF9G+,Q"F2ZK#F=9( MLRS)I8FH)Y.SM!Y)5Y'F@(*0FJ4M9;YR1XB=II63:GH";X6!^B_&&H\@8)5%T4+5?%($P;S'N;_I>YO"]?)B*3[.Y'Y:=GW&_,]W+AE'[Y/F MO?WDP)2D0?+%[@65-`:X%I-+9K` MFGU.CHAAGY->R?W9@2GKSY,IX@@8<]!1CC\'R1R(=!"2UND7<#+@UE[5100O MQ0U:[W8&QQ_BI0/L*)@!H?"C63@+LIL*#@K&^INW#:B\^?UW.?SCC]K,$"H8;_W/+B56H85##H(;)T3"T8\*#V@)GL3![ M@M.(TRCR-):8?VJT\3R-Y%+FW#/I?&F?P^SXLW<8O]1@_XOW<)NEF$X9$_M% MIP@*!,4I@P+3!(U+$Q3HPJ2;VM_.]K3?\5V>=7HMS8V`1$Q'%)F3-PVYJ]>Z MT-1<;`@9'1<)#DV1NX,>@@/!D;/L,=#E?L^H<]$#$S*M3\C0@YQX/]T'UIWD MCG4GN6-]!OZ%>1AQ"RZQ^N?P]62=J=:<0F:$MRCPQGJ)(_"M]!3X)V?O"^(; M\=UX?*MR5QO(?;U\?&.B[Y03?0\^/;1XIQ5+C.!%\H#KW@Y;I^GO&7W95!4$ MI%`V_901J0\4N==#1"(BQ4"D*@\T7>XIY:?=,;-ZRIG5Y1V4[%0)?RR^0XFA M.V9>RU&]O9XIFP/<=2DPN#$O=3"ZNUU5AG\0W8CN%J+;-/MRURA_S0QSKJ>< M$HQ!P MU+NR64%DA`G74TZX+IRKC$'X\0I2ZV@FS);MQT,7>]<)HDI[JBGK9JV>)@(< M,TUEAE*J(6NFB0A'A+<4X::FR4J_5G\8TDP2HY^7ZB*=%W_Q?)&].CX644DJX]<7AY>LRQ,SZ+G MQU@D^V/I)'O MA4X([B3XIY8[\<-((A3*TE/LV0&Q)1M^=3RX8!/R8A]6DMUWV5AH[K MPINL4>(%A_'HB5WV]!HZ\'@/WOKDAU,GLESX<^3"8T?\'3X;HLV'M/2<=0YQ M+1/R+W#3IP$)V38H(%JR)I1(RO;4I9>NODV)%Q+XV8HD)X2X^$4*R+]CA\X# MN/M#(B6/H*,$!D@VL>-1Q&*#P)_`%/'0(4Q"AR"I+/W!X]NR1ID`Q)H%((R1 M=AJ#_"A-XR",+7@,O/+\_E?IB]^9XYJ>Y'C6.YJU@LC);T_$DSRX>AB'C@>0 MI&P'+!'G&5@\?)4^?KVYEI?Y"3.3P\^E;6[V/*@+B#2RW%'L6A%_:D"GC4K0 M(PO@5AX/EU"($)"\";LG=^(Z(-ID)5S<4DT,+UD#PR%<8E,8D@2&]+^CB$// M'XWB0(*'K8/8T`KARG@*E_AP);TW@`M3*@,RL4!J8<@KKW'"151/05-1>GQX M`KP,;DFN#/FC5AZPV]W+`U]Y3$#X_,!H.0*H\@^Y8*W,D$TB$H!ZHR\=PY]2 M9/U-7^9X<'NB@!@C+%!*#FA>^!I,I$O5%+"(:;@@C=MGPL#@1M_N/WJ`4CLS M0X!,>MLP!'U`^4_9Z]LAF]P5B7X[!Q^\-Q=D[^<,F%BOTI/U#"PA(`TI,J%`% M8+8ZTKGDQ9,A#!3&!59IZH=@8AA37?+HA(`(*D'P,2"/'V;Z9*DA;+L,WSF0(*IAP M74)IX18/N.9:0Y^94P=&!C_`!`1^\H`1M=WADQ70#XPTCXRI^:07=T#Z`>;, M;#,AI31Y5@36FM*4C,X/7NG\P"#`S(,_X+W*R6A`2`'A%!X>GQG*A"2ME>%4 MSFV6[4\!3C*[Z\*?3.'GA#ES)0&F+`1WT0%ZJ>&QR2@@%M4-WAP\3!!G7*)T MI,VIY5666U(ZQT```#F4!:EV[K]>!B-8U=* MKE]7GMBTX5\S5RQZG5(!=+EA!CLRI7YSHMNI3H1O4]-(L0,JE2F15%Y?9_J7 M.JE4ZU%I=4`@GQT[ICK'X;C\U7.H\KV/`+YA@F60NL>`>.>8SISF5$'DF'E119%QUYJ,S'9T0"L.BEUC2E/=X3\;C!(E7S^0MM<'O MZ:M7O(B)];_PA,S]\%Q&+C-/\/QD],SUAQ'/G:N.=`T:E03,D(Q`YD,N9W/6 M,*O@^1FZX9FV3[TP/TJ?E_G5\>"E$Z:.WJ=Z'S?4\4U_\3.AFJZ&]9 MWM+9XG9]]E!9BL$]9G%+BH8Q"9C6G04L,A.)D)"_PSDKJ/Y:?CXW'NQ;\">X M)(%J!:EB"B6A=G6V*5^3F"L%5C(&B+11WAZ;CY+Z!`P)57T<"/$ MG9W$Y_%CT#"$&41J_\.$LQE3"/!R@;F)&Y$U^_Q%*0W,R:(P9'3/V`[#Y^-D M(OHZ)2F1P(7.@E;;[,E3[R.PN;,9I.'7>C\K<7IH")!0]LQ'23'#O4TKG%G4 M'!^?L8>+0,0]M&Q(R*EA*F)&-06]M>H7+3JXW&N?#8;=,H7+@O1J;MY>K'!N M2>$B[C*`W_1(\4YS!J.Y5Y;XS%2@)C[H,3_@19/ MF?E\!N"0<"&Y,)M(L-R@69)`"C`6CQ)GWX-WAJ$5O"9L>@F,&%MQY! M^$'=+GB43(3LU&C-AO%"(T*X\)6]S:9:%\(:+Z4&GM>1/G&7C+(V&9H\?P"] MC=(!;@(CA#V0JD#JT?CN4<)RIR.#"CKS`*\]`W4VP$4+Y@Z&RG\DO91#SZ#4QECN615X:<1$34 MPZ1*TY7LV&.QW^AU!$11,+-X,J!N(=5A?OSXE,@HU4?`@CEZJ\:2N^]<,H[>)TGD/EWE3ZH[+FYO;L[O[L&? MHI-C34.2)L_3['-'-7G>F&J?X.GS-9$^H96RM,RBI<"F[6D*K'4BP9;F$7R3^7D=-[]13XZ3IW[^A MX@,B`3_JA3,='C0\*E3JTS(:]OFW*S[2H>_:L^!)9:_YX;L?5[72<%$_-:+0 MJD2`5U:+A2JM&2JMO'IP80O"!55?MZ/('Z8N'YU.796/T6>53/1ZD:3I.AEY6EO96@VC4;#044!'X70=A0J:8*''L)]BTQ0UY\B6TA09HKHTNXVH M7D!U3E-,-,\M-,_B;>#GES;F;#$GA.S^* MLS<%%G?E%+.]K?)\DK69NKKWBY6^G1;WT])GZ88F:X,JMM2>+M(JTW!"(TWK M]N2!ANVX!#>[=<1O!:)LUR+P$_;W3SEI6Y_ZZP]DK9)CBQ"-;0U#"T2CJPZ,KLJF6<6)FPCP,OP`!/BV M+)$ZD-5!^R-_0J0'ZQO$NQU;*]D MTCG#]\)L9PJZYXUM4G)"VHC@E5A!*-%F,/!MP/9OT=(7F6[4G>^\SVQC6D/@ MO.]$NA6Q+=OF+],=G@M3>2;-OD]X3F?$"F&6^+:N[.3P_8Z3:WW7, M]BTF.UGICNJTTP:?'0]\/`=8.B61L_B;6,HUJP7_B:^&=>:3EUGE'98 M8'OJDIX=3MHW@WZ9'5ZZ^3SM1&/Q-@XI99R+;0%-5KJ3QAG2+^?G=])C[-AL MXV"R^9INHF:=!F(OW3Q/V3WUPV0#-MO`Z-`=PR/:OH4WOW">%[K-_)IN/J?= M;V*7A//?LLTZZ);,F:KA^]$IG%A[D61;N^6M(81O*'?&E)0)(6F[`#\@9W27 MNOMZ!K#SSNC>YA'=O`MZ0_J!=9XQE>_91G;7>?)]^T?6H8AMZ0P(6)3_<*C! M>\DW:P*H9R^C&_*M;VP'91P]^0$#=IX6X^J+>'3K%OM#3Y,FR M%[3?NIEAVZ_I#MRV@/;*"NCNWE"Z@VF[?Z(">R9]M$)G))'T)Q!SUIN&2'^D MUDQ3WE_=W<\^J>__I+OBZ5[>YQOPA[)>7),)-7>1 M/_I[KHNLI.]`^BN]&I1@'-$6/&R?N1WSACDS793%RZ7C,N4+A,Z)XT.C7X'& M`E(>G6?69RI13#[;<3WU:9\8B@.;/@,D;XD&KF[I1NZ-U,BSQAXYM_.&-XFZ MGO67(-]HIX^0\+X?'NU^DVSV#LDH#E+#SSI2S7F6'?;#4VIXK'2?>)833KC4 MSXPV3^-$1W27>TS;G;!YF!`0PUE_'C`\\22EG8K,-/#IYFJ8D"$5%'A8SB#& MG`,S-F8&\<+&3W?,A]PX3.-@]$0;!RV@P4JV_B=8F%C!WX1V#J%M&M)^(-GK M-T+B@;<_`6.8-)?B;1_F;:3FA/*92KJ$S"](OD]H96B>#7O.$4Y79K"<>VDC MP)0_"[3=9UCSY#,VS*;_)=,>V"('IF3?SZ?.]Y']L;W M'L]N6&/,Y+=U<2F!F#]F0&,J#=0C>Z*S\"H:=KKTD2Y[9`*5>3^D:=J_DDWW MI_/[CS!/-NL0QZ1'-Y4S'?YO,A+UKG*FTD_+9FP>*V?;"BVP82TQW,'D@1=U M*9P%7_**CS)M>)4S2C`4,T&3-'9]&-4"?BEZ_'B^Q:> MNOI6JL5=VC:5>O%)8ZT@>)WW,)F9;S8@VA8KRR#7GW5<33LZCA,/?1X"+@2X M\Y:H8W@(32[%O!=@SGMG?,S.VA=_A8`7:[FGY$JB8W.DH+-_:XP.&CBT15V< MT\Z)D<.!JRQ1QU9RDF++Z^')N"2FW M%B+5>0LS+@`@*]\9IN*GN*9=L<:QQU[S MG2HK78UG*R,^![_[P=^\%V-.#]97VG1PFO2>&I.D;S?5)KR+&=0Y@4V0-O_B_N!Z9S"@C>7"F'=^L\F8 MQ8LP0N8:7&1=@[YI4F?`W!),O+6=9_KII[=Q>/9H6=-WM\&C!4:`/>4"R*;5 M,.S#N6??<:2SC[?C3RF)]S,*+V=>,%Q]/^]F.^^?>I/Q#_U/*>4>4_@SUDEGJQ"841-6F/1UJ[D_6T_OZ,;&%FV'=&/KZ=5T8S,' M';6L`VQK*DW7UQXIMON(]*V+UJW:NJUW.ZI62S6AWLUV8S,;NHT[QS=:U4DE M[NI>>Z@3[NI&%8[U<5-0X#(6J\E9M M;9&N:OO`H,=0D\<@6AN8\ER)9K7U:(I[(%*+#\0.8D=`$R3\%KH-]N7X[0"1 M/RW!!A6XQL%/SW+GJ>0UZ=LJ]%3ANR_*56?[RYBHNTX*Q--WI>-'-3M*=$5WIN[H<<) M/_DN*WBE1^VQDHT:+80HH6>!0:0H`6&!L-%Z\J""1BT(DV;#1!V`OUFK^<)D M1*N3$9_BP'-HY;\L?7*^T3^2G1GCL3,BF3FB?]%_6*5K3,]!Q?Q%G+>R M*3I14^5N!?U&$70(NHPA[LJFDE,`@G&D0/:ZR7'D>0QSXP\=-S'`YTXP"JQQ MG<95E!!!S)J>IJUF%JD,^[)FU)D%1V0B,M>9:650/C(Q7J[&16E\#5G#0H7Z MRX6$:-G9W*HB1"(B40PD8B1[JI'L?3R46(MX7`7%Y:TM[KJNR^9@@#A!G&S& MB:+)/:6*,\8PKCO-==`;VFOL?#2*)TGST4O:@6CDL*XLN-;4P(18^_WW`N%/ MSW`T%<0YXKS=.#>U2D[KP^"WI."W;?EA4<*/^M-M#5Z_0NP@=H3$#H:SIQK. M\OSK0O/4+X3UKL88MSS?O[1##O?;%EFY]]^HK90U3-^^NS$KGT"1=W!V3;EK MU+E$@.H)U1.J)U1/:S>8&T;YF=-69)3XGXLGZ*[VRM^G6_UBG_OY(4/\'*%- M[>UU!=O;O__#^'/U9*95+"_UM9]/\S$0J4,?9\::GB`6D*J;ZN\VY+CHL:\] MOV1UH''10][E'(&^\GW1APCT9V>OEYMKT'H=X_A$B]83J<)$7]\1_]C$8X7M M@/>ULH5,I)H_D0UHP_L;H3X2L<_.^8FFJZIAR0`@WH[#F][I%5#&I9?;`AKU MS&G.>S4Z)Y.01G6#L*L*=E](-&>V/V9O#:2W?##U8%+M:`7,3G.ZTE=;1+7) M22]W!7EOQ[X:"9@'P_,99AD`5,-B5P/6!N3F!C;G$WID.S]_\(F(99600/@@?!@^`Y;?"4Z%T+OT]KHQ-0R.\ MG*J\BSB$222!=..$E1P;M%9--6R;0Y$N=.$%U.6LDQ1V@$(5C3Y.%6=X@F$Q M?-0Z1G6G4&@";S#IRSV]BNUO*+`HL"BP19A7N=]#@46!18%MB,":Y45PBQ^=1?X9/4.11#G;:TXO*UE@'%_HLE:= M`7KYY\RU$!AU[&VHL2.V*JMZ%8=@(DX:C1-#-BOP;1`F#8=)5S9[5;3%Q76N M$UWGNK,B0AU@>K3IC0-^4TAPM0M7NRIPIM4>XJR)Q>!"=!YKBOTV96V`.$>< MMQWGJFPH?<0YXKSE.-?E?K_\-41+9@OU$^HGU$_BZ:>^W#=P71C5$ZHG5$\"JB>U*^L5="-HQ3HG M_W/Q\+P6'4.FK:(`CR$3:*T:CR'#8\C8$(=':00\ADQ$O#7B7"#4,ZDH*'I!3*:T,V>[6>2X`"BP*+`KO/ M,62FCEO_4&!18!LCL(I>?BN!5NR%$W(?E?A!/AY#=A([M`IK*H_`:,;>ACJC M0EU!F"!,ML)$,VN-11`FC8!)^4<[X!K7R:YQX1%DHGC(I[;2A4>0-;,07(C^ M34TQWG@$&>+\%'"NRHJ)1Y`ASMN.8%??:"!@(U;M4<.H3 MB97HHE:B(W@0/`@>!`_N@1'%T3R!]0$\@@Q7!(3TEQL&"SQ#H]'UNWB&1K/* MAE5#5GNUUF"A?D+]A/H)]5/^%/?DOIESN`NJ)W'PC>H)U=.IJB=Z`EGY^YI; ML-80\L2$/QZN8'9:E2\U.[_CU=+-AZ4&M MU^D54@/2V!.ZM+5>ZAX,P-:_NZNV6ES'["K1&O57[RH1V&NC='=Q@XHKW%W, MUX1U'?-UB[%UBV)JH3*;QMULA[I!EU5 MO'5OCDHSC?*[]Z)?=<)^5?EN._I535="2K?\E3OTJT[8KRI_GS?Z5>A7S2$W M,,KWY-&K.E6OZF%6D("^5=5%!)O47>EG;#9#]\F*@FFRQKISNY6NB-9NHCWN M5U5'!>_EM%5=:5JNLJNIO`7=LI:[973?,7ID=93.KQ6Y4EVR9M6>5#\KF\I7 MRO65A:YEH3L5ZEQT$)58:3&RZ@<27+$^R M)L2SX7,PXYI'N39-N.;Z])K'@!"X+@(!BIZDNR\7C)>R]*5SWIF_3*);6";6 M-V<"NLV:^#'+<=E#P<*LJ1-XR",+;@I^7[IW4[(OR4@ M-`%]\`_.C_.7?V>8$*`KDA_`]]D?3.7[E(KD1?RWOJ;VWH?2OV,`XMBA6VY& M(TIR"*P8$>>94?B'%4HV&0/9E&/L(3."_EP>.F,E(S49P`T;@&=+]V04!T[T M*IW/1C,-_&?')GS?#ESFL'D)(RFP@/T^W&<_6]X(+H"'#>E.GN'_DE$D2U;$ MGDU<^$0W!RV.3::7$X?N[6%?#RGFL^,=6G0C$7L'O^(J#GR;[IT)DJ_'^A0DN7B8_?#A`F'43I`:4!W8,'+1D\.>:87OV:YG1WB>;1^`]6B"#Y9-I\^OI7KR7H& MYKAN.I,1];?GT^_'$>4YV\.U`(4499NF.#.7\+?>`6%8GI:L:`)CV#8JN`6D MXC]\O/`Z2D`$['!?LX3FB1/?C-9A3V:/A&N3-]!-9'/1?PK\^/$I5V-UV21- MK%<=$K)3!"I MS80YEZG&`A;[3'28=(8`5@!Z0/X=.P&[F$OKQ'+8+71&4N7@`CI<]OB1-:7& MC6_:@W&#L8:'C)UO<%6"\9'_#`Q^)'*Z#X^^[\D9.EF!!@W,Z%M$'']#^"2! M30?UX=G`Z_,MN_?H2];]JBU",XXK'@?3R!,KU]*$H0\T+[B75!'2RYQO;&,R?Q902:A; M)H%"CI[`YDP#!ZSQE&I^/A!&D36%IWYC^Z7AFN^Z`YGY*W.+!YX2\[^8S4CM M8;?3-[_GA#-*7@`_4\L!7V(\IO[$6D6Y6<4U1W(@3+@$!W>R;'6514L`LQ4S M@0G!LGF9V6%2!X13 M"SNE$[MLM-G+G'"&%PH-FKUX/1M3@5J$"7-.79<#9.1/X`_^$D_Z_UH`@N`U M,^`!FU654O!=5X5[1V[,?*PYV)BKF`Z';WY/<3V$]_CPW%2P4IN=?V_6A?.] M>6PSURIVPKV&$]I8Y`Q10_Y`_#SC$.+7+/OY%J3%DM:OO".VB]Z'6@?Z[ MV0S-F8^=$Y+."94V2:AF=:49'0M^!VC-)_>*QCNK4,&&!4VO11:,`R?=L`"; MLF!3%M1QJ./:K.-.I2E+:;5]!08>V)<%=VM4?4+>H,[M9U@66$'@6KM.P_8B MS7#+:CQWN8)=BD(7A>&NB=*U$/870<^J4IUFJNA9":WZFN]988,1]*RV:*%^ M^=XW>E:G[5EAAQ'TK*K4:9I/OM4)^U;89@3;C(BK`&>[*;3WZ-RA,DD9:>!_;NO$D;NY=''_Z5=^YN:= M%42O#X'EA1;;/)?7M&.^*U7'7:GO_^C15AS\P%+&/2G+/NF/+S[;C_CPY,>A MY=GAGZM:OC6[55G*07JA__)\B>Z]"EAS@80]4\:>*,L>.PXR6X]FV[CGG[?L M1US%^AY`7I2`:V_D3\B#]6TCY`V$_/L_^G]*G%L2L(OD!%=M0C3MD^)[(\=U MK+1O@<,''UG?^"YHB@C'B]F^1[ZGF&(;KIGRW=A\Z^BOG?N.-"8V;3H!M%E1 M'-&-PO0I;%?I8IN8A7839+8-//-J=I-`&^_ZRL9==XOG%2N=WJ'G%<-[*MF* M9^J=WKK3PO=(:^X;0)9[L"/=JGSLD/)'5.'NB&J3N0;H\'KV.!E*-IMK%LYU MMZXM4:MZJK0=4+%/K;I^%OBW:L2XE8:-1Y M+4([UR*=OH*`0<`@8!`P)P48(7R/8@\2+LX_*7`MCZV_?4K6W^YGZV]?K8BL M63>K!':%EUX)E8O=J)B*'GGQNJA`^.GE[V(4&64%T62)LN4*![6C0YYV)1]`,M4[9N9D9@$82X2X;+XUBTJ2)$>;XM88H_(OSNE M$&CT9B_N"=2\D<>?O`>0!DA[/0&D]<=2&T"D\0M)Z;?*AD=A$)"4E!TNR_Z$ MK*?.H'T39?-,9"A&EUI+_VZ,W#9XM$:F:S-Y51/?+4[H'\\P'D!@%!*8\ZI+#\5WM;BJ0ESLV2:(C'HBTP(O*8@,B,R` M1*:-AK0@,L_*:ZA>WB=$58MN<)4F5V'&F`:#)-WA^Z/WR1;)=E$2:W)Z`3)DL1YQE)&[Y$0QEF851^SJRJF0.8XU4SK\5/V%*Y`UQDY3C=T M@=2O6V.7LPNICUSK^/#U?M4FC$FKA=2R@9&56'I#*PB^=('Z+EV@U_JL1X.@ M"VRA'U2/Z4M`R4FRY,+S&.KCI=R#Z@=TN))4R2E"'2B:=0ND2@3/62_$2P4: M01`O$"]%Q0ML\F'8Y/+ES7$SUE7+:E'#`)=MG2@HX>?!O&E=."9O]DH)`4``(``0`$C[9HSD M`)'"VFDP]:0W8]8,="*M&%G"?CXP.8^ECBI%#3 MTXQ)%Z2D(#P@/'T3'L/6W%9X'T!X0'@>"\_Q@3FYI%@@2(<*H?X33X M\5?OK`5[Q?ZKZ*PA[@E1BR[UG6YI8[T-'D)`':#NZ:@;:\:XDUT64`>HVQ)C M:Y[1250!HKY_=AE*?@HL*2PI+*GL2PHQ%MEC+'R.7\])0-*4S""- M#%P,\5H(``(``8``0""@(%E`07H[!M+(^NS]M`B4W_6QYHF-J/,#2HOS]`?W M&1H:\`Q-]P!W@+NN<6=IAM'3/)UN<2>%D3:`F-2#OO40F5*1]T86/FP/K5\UO(L7XR%_^;MF:X+?2\!?T$^@GT$^BGUO63H9G.&/03 MZ"?03QSUTT'Q?%!0N^Q)GF9Y;A<*2MHSER?'(*J7JO9>/LO1GM:C&F*M^LHD M)]943"N;*+]/EBLQQHU(YQE]*,D0'BU2I.;<(ES$MVB M$\O2#%,O[W5BN)H^&6LH)=F*^'EX1;\QNOMAQ#I![]Z4/LDJI7=*0WJGE$0L M\RI/4!XNPWB.9F%`OTIBGWZ-_GKBAV57Z.LP7Y0#GI%907]D&D9A?LM&-B.K ME+!OL7`&&Q!>)FD>_E_Y@8:F],%F9)IGY=]\DN:83COV_;2@MR4W*Q)GI/KC M=I!^DN79[B/\E:0H"#,?1^B6X#1#)*;CV#?);&IU.M`T*>:+^E5X//EQ@MCD MIB']#;8,Z\;7=$:B),N0C]/T]F60I-L,FWX3&MDUWI, M7$\?3&OW],%N?=8C40VRM<>J:LK+5*'^0`N,F;WMQ@=:#K1<*2;VR!&CY72[ M)SU&H4,V2-4SI8IG"]^^B-=1';+!:%#&:(#\3TFSL%2Q$"3+P@+P`'BDVX6D M3^%KVF+:3>%K;QMJ,;J_X<]C"7OHC`7H@4F/GYPU*:?6>;#4U4<`$`#(L M]J>I?_M:PZ;>XH;%IZG..SQ#YV2:H[,H2JYQ[!.1^Y4LMO7A\M.YO=5,F&KCH MX(%UJ>YTS=.%F@H`NB&";N+PY_V$4,)@0PEGZ[SM#^N\;?"%9$U;4>VTKDTW M7=,M'9`)R)0.F8;F./PKP,`%[L@X43]+2C$G07P^C!15KNJ>0@(4`8J20!&\ M6`6\V*XRN-!+>G4./H,05@GP&WX&V*K<'^`)\)02GA4#!?BUX->"7PO.Q!"= M"8`B0%$2*()?.UB_]OV:@0K\V_:DJ4%3]="2MPQ-;Z6Q&N"DUS@Q+&VRC_4! M/#Y%/#[I][)/23Q'ER1=2KF;J6W4BTP$Z;]UWZ::U<9N)XS!@'/`N5"<&VX; M'4G!,Q;C&?`!\`C)WC`KQVL7[O'FZU6QC-TXS7XM2IG M@X#-KU1.$X#]Y]N4U%!7BA%$P/(UD(K(L8!2\Y4(3VKK;5#B>8[),]"YTZYE M\N(P^>Q@4+J$8W+E&Y)GR#(@KQ78O!!S

V)M9Y&F)`K)%<43?7`Z8#I3A,[R#_;8^0+' MY1/0%SE;%38S^8.VD>M>E-GMTJ+ILILC2`,$`DR\N5RM@/K>?FP:11 M'/GT:>;L.:L[/&HU.:O$A/WM_OPBG&Y_GU_'1GE:D6H;54'?C+=XJIJ4TIG( MBNG_4H%F'2[)#::R5(%]>HO^?8$"0A>37LJPGN5E"U&VU@65CI1BD&3W]4-U M:S;E(1624N0KK&1T$>B=8Y_UW2QOQ-"=E5]-BKQ:TV`'D_2"G=%D:($KX9L2 M$E/@,:B$\<_6[]4LO&+OWKPJLI=SC%>G'TOX7.*;8'G,9,F+^0]&*!=[Z&PAGU7?#<-FT6@8F9;_>5!'^^.&=3^N(M M^V'ZNYM596-[R9;J5!^/V,*5'P3TT:+;TX>K?+"C.]V\"&L1=7'YSR<*FC"G MXNBO;N4)TLE`Y6X^793O`ARV#5!,UI@L49Z%?[0=A5+`^NFQK))M9H7J'7;&D7\[8Y#"]3.$<)&Q?S-"W4H,E149O M0)4_N?')*B\OJKX]PSE&5++8'O^]K@?!\;/XE!:SWOBWIOZRS^DEZVVC]WS/ M(VQ]Y!U_DF>WZUL?'?34CS]?&E@_.,LI=Y(G_8T&M:Y)VT2FEWME4*]&=;Y;Z<#+.#YU'JL0ZF\B?.VL" M*U-LS3.ZZ-T&`@L""P+;@L`RUC('!!8$5GZ![:YII+?L?PH!+9M0Q(RF>DZU/QE(G,_2YR+,X;LD26VHLORA+N M:1%*AJLYDRXJU0$FBL/$M?ASHO83)BU$3Q7"R<3EKTX@)-V1X:?^N7K/O=>& MP]#6G0!UC[``'X`/P,>A!^(`$`BVJ!ML*=JV;3\$`2L93P)TS@I>&1?!!?&+ MJB1\3XGJ=@#@)?7`F1YZ?A:L**RH])$,R(-3,N@@_X$+3E,NF`'<`.8`<(QR`\*(EU,J3PX+](CM;L8]O^2N@E>L>:#D$@L`L9!%H4 MX#%J<:KUD0.T8R"N(*ZJB"LB(XAE*Y8 M@D.=ZB5K<7)W_U>S\(J]>_.JR%[.,5Z=?L!I3%V%C!J^I=U[26[R=U'B_WC[ MZR\(O9FF47CZ8;F*DMLEB?/W=#93[.?963RCK[,BRNG%9_.4$/;G[#S,_"C) MBIW[H'!&08'GMNFPP[N8)79])<&?+\Y9Q]T7;]FPZ*@V#\[6ZR5;R5-]/&)/ M77X0X&48W9X^!,'!,CK=O`AK`7=Q^<\GBJDPI\OEKV'V9!`V-&JL(W!"_)"Q:?TYN5F&*&9,!FN&,XF,DB3 M)=K7P1Y1_-DH7Z1),5_4?L,;W7V$SO+:[YD:O15!>+5*DYMP28>`\)RNX9R] M6H9QN"R6]%F6RS`O'ZN(9]35I)=D-4_+\("W(-#H`_I1P;SZZBY9QD@;4)*R M2[)B26^V2D.?H)#>^(;^ZZ<$9X1>&-)[92A(HBBYWL?IM&_UV^["N5:T9;^E M]4\P/?"RO/HT(D'^>A-L&/^VS19X__G3I[,O%Q0[/AT]7F5D,XJ-,AX9=A6" M25(ZG7^^&%,50R*6(.#3F=J^7\=#RO>;B,1XHW*.))R39PO$. M-X&F1RF()W6ZW2-_CR']0"VVM^,?7[5H#ZO#LV&-QD_IJ=T^?JEIUH/&SI6I M0$AVM\IT8RA_/$6OJF=:6PUXKZW`312.=QH-=1I`=Y)8UZCKA50F[(;P:_8# ML216U/"RN+MYG5'I[-\;E$H.-4;.0JA&ZZ'U MM9,YX&1KNL,_XM19:LFATIE!61H$]T#>PKL*5X*B#^XP)X">VJ;$*49ECCW$.RI?MM3EPN2$ASD M)!V\507GZY)IOFK]/$,W7H,YIZ8Y][34)-F(RGIB?G5S"'FHT=;YP3%7=W=+$P#9DN?!=&YLP5 MW=$\AS_1@L2F4)W0HOY47^WY2 ML)]+24#2E%XTO65E*1E)KT*_>LLJ8\@ZDWE;LE)F+(]J<*?:(GRD$T%MDK+^ MB,Y-60HT3:Z(AN@O!F'FXZBL$BK_LEOR5"8OTUD*8WI9QJ8[OT4X1SM>*\5_ M%.T6"54+N2T5VUGRZT7H+^@`YH3^3EI51JW2D$[YOEONP4K`OAK'!8X:RY?>'SA857`N*ES?(]7 MK*3O4UD4]3'^BPXJ]D,<7>1T5.4M/@>?2)81TEC#Z$(-X^MONOD=K>>3?CQ# MY:2BSU.JM7%-+^%>EBQ&)9CH=D4EK&!5=AFADE%5]OG5_&R^4Y8G,F&]IPZ\ M=4UCJ0.RG&K9W;(M!K+])Y3D>=N M200XTQE-VF`\L"!J8^K-V`ZNZ$D2]'*-+&% MF/K(/+[AQ<^],FD*T$#'@8Y[!E6_4R\FG*GZG?9GNAN]QBSZ8Q19)\S1^MA+JE!]!_SFWE$!M9&ACEW_)0X/!!W3^1\6&I+?FS@JZ.,DTC,B> M\R=E8E&B.),;3*U6HSX"-=!8L[TN^+0!&L>'+\3!Q--9Z7;3(`3]GH*>K+)O^%)WY?K$L(LRJ2<[)*B5^6.:(P[F4@IDN M4AQ1R;SYZJ:F&UUTNP1L]Q7;2E@/CN:Z_/E@P<'EY>#V+4@JB\\A/BU*=%:W M3`$RP(L$>.E?M1,2IW!:G623]\+I[=ZJ2JCTFZ$N(X MFC6Q-'1B:N[$T$K6GA-=LW2O9-EA1$"W!*>,`FA&9DV-Q5G17'DY?4$_3$FV M(C[K?1[=]H4_Z6Q+-A04>9'><0ZEC)8JJIETG!*Q3"A.<[?RY]"@.&HT)G>M MD2[&J70M51J3:X^QR:W2M6$YGCZU^V>VPZKN`Q_:&!]/*CCF6U;-V MW$FXK%&S"6_#7:/]A'>SX9]Q=.BR'&,8'[K%\-5R'3ZX6A3"AZI+=^1U%@W1 M78E]65MSC#T\'-UM3^JXLGQ#[4V;3<,6KL*.P#\-AJ/-*TK5=V[0BM-!EN:8 M_&G'.9K(2BN7=L_Q9-5!_'.4AFN5UJFJ]FU2532:J;D&_[;"8%4-V:KBCR^P MJE3608:F3X1Z=F!5]=ZJXD_C!%856%7;6H,.FE.!3358FZK#UM5@6:FLASH( M:()9U9$.;D\3<14O,(,4-X-$97^`T=)SHZ63ULX*V"O=)CW6JR6^[8.5,9$< MS;.ZJ`L',PG,I#Z:29TD.!YF7'7-@0$&&1ADZAEDC.P*?5SW\:VK21F490:1 MI%JP3*PNB/?`1@(;J8\V$H22P'*13*FH;+E\H18+H;?Z#XX*@I(`_;VNO/W$ M:FS1%WS+.B/RYYI6P*2I#S89(\.F*S1+BFG4JJLFJLA6K3J@[A>FL92(+Z>6 MS'5%NJUY$Z$IL!(8M]7+^^07KV;A%7OWYE61O9QCO#I]7U$9E%HV^QC_%<8X M]D,<7>0X)Z7*_1PPKY*0\S#SHR0K4G))(?TN2OP?;W_]!:$WVULERV68E]>< MQ;/W=.+IMD?HW4BVYUH4SBA<\-PV/6:NQ$Q.OI+@SQ?GC&WBQ5LV7#K:S82P M=7S)UOA4'X_8;)0?!'@91K>G#^%QL-*8;EZ$M5"\N/SG$T4;FZS07P/PR?!L M*-NO$/M-M[ZCG0DL>3;N3>%C-&_'^K"<7S76C:);!HGK^DYDA6A7Z0SM[D;N5F%*7L? MI,F2T9=8*$_8_R>CNSE`%^2*7AG'#QAG[A:NS)U"U^R?."F7JY2:[:#P,BF83,VH M99DOTJ28+^H'U9>5^PF5#5JM+6K&*$0W?^13O4^BDFSFD?Q\(S=^5&0,Y%0X MLK6<+.E(%PS]U8OJN]\9&P["3#JB*+G.Q!+CV,W$.&O;9+.U4R.M\B$/9LNQ MU6#+L>C66K?^_>0/P#7@NC>X_K`Q/+L%MCZ:>,!TU7(B2*-5(ISIJL9RD>U@K4[EMM_) MN`>91P>Q+W6>>?1SI2S3F1T`#X`GZ+"X=B^&P^*?[ZQ//"QNVOX>6"N';8DU MMJ-27)"\_!Q1.2K']REJ7X>TB`E/69/'7$QS=1J7WH'9Y2A3> MJOC7=/?$3.=J<,ME/+>),,TT^;>,`8@-&6)&%SV)P.,#CT\HSRH8]TII)5VS M.B"8!U`H!0JOB\Q@`UNG]Q[ M;O_=/G&Z#BQ\*;63R.T/("$E)"39L,#[&[SWUR'3-YCH`S;1'5MWAB.7\KZ5U`-/RR77$W,C:!E9D MU"*V=4O3)Y`H"=#N'[0=6VB9@SI.6O7R/FT>MR+])P^_W?CCEFUM@1E)%Z.+ MGZ$PSI,MM].J2/T%(U[%\Y14/(`EMU=*<,FLE16K5<3XUQ[P:94<6MXN.=>& MQW5[1W^7Y8XQO-5S<3V/2XK/(K5`-]5C9BG;%4)@8N]G(9605NHQ=*>\U#"P M[QPX8:88/TV(H-W^H3=1F#@Q=#L,?\B:'YAVR/[%D@2 MVJ[5TD\\/U18E8JKP%?TT*M6V[5J``M42;HV,?FGD?(R-=75->V>H2FLDL15 M,RMFW7&UT_IK^X?'7AZGIZZ[5 MLW57\'TI[55G:-;#^,35/-?4T(EN:J;I:9O&TZ8[.:JI]<.NU?OA555D+^<8KTYW.L*?Q;-[_>#/P\R/DJQ(R275%.^BQ/_Q]M=?$'JSN?83 MF>/H;YQ3?^_1Q=M+4#BC\H?GMCEY47;.IG_X2H(_7YRS9WGQE@WK_]F[MMZV M<6W]?H#]'XA!!F@!)6/)MZ3=9P-IDG:"DTZ#M+,W-@9]H"4ZYE0658IRXG]_ MUB(E6W:<-&E\4>SU,%-'%W)Q\5NW3R(%4I7S@Y+OH]+?^(T#G`)[H,^',AZ_ MF9^OGW\S6]Z+C<]?_GL!TR\A<,BP0,2C\?+`6Z8.0G_Y[:_L0AIYS?$3[WTVLT&G#,@I]?0Z@#7R8\,!LS`&M)T6S#,-=:X!VQA/!B[_/QOCDKQ0H& MK6#6&4P%$K8= MQV*1H(I0=^4")Z5%'',0$!>U73NA_+8;Z=/L^B$CG35G,'GD;YW_N)+9MP?- MVB>S!K/N?F6?(=.5?1ERZ!JUEEF@_`FZU#BI!OQG#0U^\[H[_LIF$&?CUXF& M^LSID>VS$YX-V/X/M<<6BW^?CSHV#ZW;=-EO,&NF`PYY0@IN[%9BU(['8(TM MKQLTG%,(?"_H-&839@^=1(@#P$L0#!8DQMIR)&S\9CT>HVD"9$PEMH,G,-+D M3BDW`QD.V(W0`ALL'(3++5A?1+CF-2Y<*60OI>MYR$?L`KC>S8'K+K:.PQ`K MJ(Q=B5#(D5TCNW2H%5UJ[-+&L0(A-ADM!=!3`2!=A92KF%/PHY"+`6I@7J-< MX#TXZ3'7$!"FB6P*`[0E(40SB$"0!5_;Z\(8#P/$,E$-1=4('2G0L\U&LXH3 MJ\@SP:<5_AJC48+)+G0Z5MIYNA'74N59)8*&7&L)HE>[_5`.:]:PK`28$VOQ M/9=:N"7'QJ[DALQ6P;6:90)B,"8,N,P;:F2E#0OSS"@(WA5I9_K[7=W@@O#9 MWD*;U.96NT.52%..08QXG$.W,`I4I-,<3)!(#2]#/TJ&Q@U@`D<0B@@,+D.1 MAKA.'":]6CI,YQV7BF<*[!J+"ZM&[&+1Y%M!,F0Q9#9`GP!)`ZX>MQ)@)9\G MI0SV\K()O(_#/SB\#-2(R8K'>@)&,;+KW,&YW-=G15!7*,&@X-:Q@C:S'!S/ M5`+I)FI2M11PG+HM$-TX=F+3_F=9V>QQU8@]!N&`!:=W_(B+TZ^?CY M-5PBASVL<1WM`UT`.A.X`A)IWE/@W138V@ST3T4J$F3P69X6M63"#4XL#`-R MUCS&FR#W#%T^BKU:AX'I7&*3ZLKPYBT(1X'\%/1J+6/&=40"`(5,%']K`( MNEBJPUP:_DTD3Z>^?IQ'SV;>[PKN`L3O@3GA?0_FW@'EWI!['WZ%(`Y1PQ$A M=4RRE^6'/B7L&$)[/)4GZ'H+TM29#5$P?)1\,5+(6*_>5Q+,$=I*7VAL M(QMPC&_@#,X3W.'C]-:;=@^'#MBKDIH*[`%[S>20_Q;LFH,OBOD-MW%=I\J9 MQ&QAW$YF?0V<4O300SY&(VR#U$L*HF"$UN=0U8G;%H`S;R'!J<] M'.[_W\Q0^S*&P<%E'_EX>I7+_H.MB5L_V)QFAB%-($FP/"A@`TR5[75^3#.\ M'%6`Z9Q"NC.<443@/\UZ;-KV$>)1).'X21F`+\H`/(8V)O!&V+^/(2I'O(IZ M#&P8DS$32V,>SI#6B.:/$ERS-[FU:EUEU[/6]5B;AE0#`F*6%UPW&!FF(#9! M0`(,1(-4&L(+R#,9(^8X\P6O=]@ZQ(M<7WM!NX%Q-BH=!MZB$O>L::O1TYR@ MYYU4^UF,J-SY#Y.Z(_P5P)C`?SF>OMI!(H87+!.Q&(4 MOC^Y6#H`IU$FY"EF"E,L0G>+8-CU&G['J^#0=XSL'!(%/FD7(L$ZSPQL$98/ M+>0=+8<)E"-D,P_NS$(M>R+R)OPSA*RA,-N"8\R-W59DEAUP&X()MS.:&13/ MJ;"2J^Z?!I>'CWF6]!PU/&9OLL[R]R;K_.S>9$]]?Z?Q_!=X%F^ENZD-HP^> MOWORVG<8VNP>7:W.@7_O2X(K?6FIU?D5"T4T"#C97KK6X[5LV;7>#;3\@\:J M]@>OY1Y:Y-#(H3W51)H'K7MWRUVI0_.;+W7?0W#6NO,NE:+ M+N\/K`08`@P!A@!3W]2D_DNV[\L[EKS?P_-RDV`UKT[PT[-C]`1Q#0=@)H03,@F!',5N_/@M;JMPM\ M($=[.5]MK!^%5/\<+3=JP>O>.\=)+=$];;*.6Z;?::Y^9^X70"40,.YLD;31 M[)IP45=<^(>K_WP244F[226Y58XQ._N>RQ3?XRM/FDG"FDW*21XP=9`Q1$['Z9:C=S.8,0M43VV8I_6IJJ?4+8KJ17!;3?@ MM@:G1AS3;G),G^SFQ7^H9+_3U0(%G6%14VR(0)(70&R MT?2%>*8MYIELXJ*&J3""'9=;D1+-1!79BCU:M[71=[@)9KL!LQ:QF82RU3NS M(UH&5^<\[B7S2Z?N(W+$)U%=2,0!`>2I;Z@0+`@6FX`%\4F[R2>=E%_LO!+N MRX+90*;VNS.7^#$:8I:H&%LU5^X%35H>1T!;.=".FJNO^@EF.P^SEN=W-KI] M`=%+6TPO?5`JPN\@$[U$9>*"#=Z.&AM-I0@:=85&ITOOLA$P%E%+7KN[T17] M1"]M,;TTV;C[DH]IUVZJO];@T/9]GS;M)IRM'F>']*X2P6SU,`L:&]VU@-BD M+6:3+E1RS;X(/62GHF?8*]S#>_]"\21;\'5O(IAVOE@$9[319RB$C+HB@]YL M(X!LWG40S;2;--/G@=+&)3+'X?=<9A)?92+2B:JTM9%.7F.SJ1$A;4>0%K0) M9X2S=7BT=2"-F*>5,$]S(W]FTN:OR?J($EJ3G]CUK[K3--(T[L@T$B52=TK$ M7PDE\D49'F=OB/MXK%V]^W1U>G8U&?:-3")U8\2M@2$&;9BG2.6]6,"XW(5. M%4,1R7S($I6(Z>!656P4/5O=S71(7WI,ENQ^VD=9#\]F*!(C]`^FTUUTKPB/%G^)6/B4L./\ M.L_,5*"NQX*&WV1F(!AN>,F3,4MS'0YX)@`,>2\S/#&2Q_$8!A8SU;>7JE1H M;J"$8-QNZ\UX$H%:M.$@^YUK8LE[,I9&@K!P\O<<-<,N>$_!!4K#86\JT7D2 M'GCL5?FF0]!XZZZ?'/#?OF:1`S["'B6(E&J9A#+E M,4MQCP7LN9=G,A&9W7CA!-KKB3CV*DT=3,5@7V`(UUK!Q:4^L$5HYX9G;,]O M>X'?AI9S.,_'6H%N>/0WZ!9W"L6^]GS?9P;+`Q0(;V@&G6H'GU!-W#`^Q'?W MV5X3GVW9UB/1%UJ#_HV"P8U`5S@'.!8#!U,M6!BK;$ZS!_<8^7/LI"8@#1H+ M4&H&6N77`SO5B%,92:['[(-(Q.GM/)XJ:I^B&UN#R9*@SZ$8]H3&33D`&@`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`+U<@&P[J;0&QT&H^)@+;Z`!H0Q404T^H)<\\_I'>9:I[0 MO6B**<]@=H1F5R)V7XD9R-1^V><2/_=#U2/1"@OX)N^P3>OG"!J+H$&P(+YI ML<=8?5U&C-/.,DX?E(IN9!Q344:U_ZJ=V:'7[FXTSA'0=@-H_N%&L^RMAQF1 M3(4_ZVXV.2.2:;M)ILG7;"[Y>-.?LGFY->*V4P>O?*]Y>+B=V%BBFEZOWE-O M/]9H62815G5P1AMAK-;KC&J1/>T``P9)ELY%A#F65G',WHE$].5F]R78^@J2 MB`KG+9M'NTV(;4U^MUNXK4D:N''X$M&V/6ZRSCS;#F:>+YFW^T,90:0=$2GU MCZ`$D+H"Y%6[2YQN+7+^K:?LUH$T(NR(L%O6J_<\E8;'S&XG2C0=T72[DJP1 MW'8#;J]\8H6W(T,DW!)-M]WYYDNFZ4Y%7V@M(G8A::1I MW,EIK"6SM-I!TU9CNTK:?%&&Q]F;G:YGGF9;[SY=G9Y=3<9](Y-(W1AQ:UAP M$+1AHB*5]V(!XW(7.ET,123S(4M4(J:#6U7I7?1L=3?3<7&B:&"A3%M7]OB! MUZ3]S0G@6POPP/.#+N&[WOA^&@=%^*XZ\);7:N_V.VR/SI7=3_O@;=+^;Y$< MX5___"W/]J\Y3]^\RS.9B"P[4<.>3.Q.^:.L#L]_E0QN,W\QAY,M/7*W_(>_'X^/,'I")-)+';,]O-YCJ`^A&`I]`#XOOP8O; M5"09M)1"._!?IA(F.+0V%EP?3)7&[LJ-^-4\-&"R("J(-Y4VY%I+:!`%QAO$ M;0C&Q/*4&05W#OFM'();!GGV`GPUK=H[3R(XVO#:C19^EP('P:^OM;CF1E0% M^OV.BK08HK,OAF0[Q[MQ)*`SJ]=/H5$]H:?--'V/H>W9_P>V<_CA,S[$+0SA M#A0X3;4"B4&`>,SV.E[WJ.NQO3;\Z^[8`_\;=#RF19:*T,@17%<5]<_$2@FM ME3-W5_\R"7/[;D!O/#.3#PC2!-WYT.U>T/:.CEI.%/_(:S4.GS7X^P=RFFN9 M7+,^>#:0_>?:GJC`XD?VQD1+F&:0-#C)/H$8NA+Z%0+([7]UEVY^=*# M+K]%+A]3X6\U`J4L?]YP*V1H5+8 M7PCY\NV-`*Y!395_^F^_5HWS;!(5>B)40\$$9%82$AWK#%*NC0QE:G,9QOOX MG6EN#(<``9TY+RO0"@6FJ$(X1PSMI#'`'"Z!%-I:/%Z3"3V2X8P[OBS;QXU? MAQQ\?@P>!+W6Q,Y%$0`,-`[./L27H*`QZ%MJVQ.8F!7/8Q!@(H!&`IZEB`$X M6TXX#SP:BUK"8\D\P2/?Y*2=_`5T] M)Z6,8\`RZ^?5&I#-E1N_5Z$G_\`-P\I(;HG5P4`9 MN-[2%7LX6R.)EF;=QSL.-XJ>R9Q;06L^1F=N\WB\X%3E/0-VSR9[B>/1$Z$Q M8"V6&`((("%$E=B"!!NU*36(4TE8/7NB+W5FG._(.U6>DC?Y#.+J2?,&@(_0/^R5U4*W@?PU2J_'HPJTT%32Q/G04X3#)>"RK!B\U"5Z@557"+=52V1I6JB@K M&RG3%XNJ5&GC(K-,+(PQY>&:]V0L#:#KV%7L<&<>FPF\0AL\L)FJ8)X5JV+I M?T!Y5!A;5C%YKWK-!ZV@"'=I)FIPP?76'.>:_@!14(,Z\=1Q!.F(A!CIW/%9 M4;U66[A1>1R58D.B`?GG7(-%]`?-G2>8J-XG+X[ISA56C,I%9UQC!NL(#,R= M9RZV*00$G8(**P>LC"8K`H`*AV6OJL)R+TI M)MPA`)NHSA#B<>)F'(<#KGJ1>WYJ/K.,3&0VMWG/I?XWCW,Q]?2+DI8.)2UO M__*/OC+4%[,*0_"\GWBC\P3,)M_V9.4]6$]8A.FI)Y;3L7O(=,5Y9&L2G@U< MF8D_T!Y&/'87@8>)T!>&`HY!#5L>JM0L:Z^1NL MR#)C";/(&:?-"KC68^S?U2M56@W,'Z=O9*>OC/]#_C=FH..B6(5"1T(TL&4V MSS,QK6&M#!BK][KO#8D.MO MX%L@`(7_W]ZU]S:.(_G_%]CO8&0?F`7B'E%O=4\/D&=/[O+:=!9[#RP:BL4D MVK,EKR2G._OIC]3#DFC*$BG)EFT>L#=IQV$5B\6J7Q7)*IC@I-!%&PI!&S<, ML;'QXZ#10=LWPXPXZQ@'BK'@GQ'R"D>I<)!EQF`J`4Y3/.?G.&&A=4%*D*1K/#QC&*OBPL/9 M4_?916)#2AKC!KR>X5(I,;*9X]RY.\$JC`?.UCB!IR5%R<)J!^MDX,^0G*>Q M-L09"#2)__T*$>5IZ(]P"<^1\0]6K['6QI?=P=<(?82`%/)9X07:L=$[IKDV M\6D(U_#I?Y%GR"J`/0:V%^+%1Q!R@*Y@^[(Z^0>.,].L6:QP\;Y"MF>&3%_R MP;A6-1P\31SHPSKQ[].#%K\ M-Z4SQI0//$!L7XM$$G""(_\WUX$>BOJ0[T3F_!V9^6?D'"?(!4.G.-Q5XK=Q M$!`[3N220W^:)#L1)U,7V5,GC>]>"Z2+5)/9I)1P;&&C",<.0QB%!?^;9$DS MYX-(3=TDSMPCCWSGH1WT!F>EG0"2G0".RX>H7A('I2`0GZ$_^3C=$R\"6L@( M'\G$Q]H8"[[A/'.J6@]PO@A0-(MP'@JG7@)[MC0-V<%)D'\%C9><<0!\K!T? M;>>F`9,MJ6T:E.(C^3'Z81SC,[1N*:*S,4B`;S9:MQA2%6$>_IOD^"#...!3 M6/RE-99AY10W.QZN.<&52Y+,Y^J,9%,[5K7E#./3"WP8&Y_E:L?`4HI4T7*= MHQU37B[].#U=:+U:'E*;QBOVM'A_LM%7E\ME`/58T_I:K.@UB#-3 M]0[@N'(Y3.2.I(K5D(\E12I2^;IX"E'`%4-3/\Y/9*IPC$WEZDH!*W5`6UXI MN>>-5;=6VK;-Y_;AV>D_1@GR+R'9V)FF>?^P>&;0-5"[3,-RRBT4)"OJG9.H MA.U"W#<+?:SB)8W_FWPW_3'7JRKL,4ET+09XR7EP?'Z9^-KX$!.G<+%NA9D\ MXA`MCLX`B/^D-$9RI!!FO.5#0I@>PZ^,R!SC-0[=@#SL$S%W,+H+#U7 M689X9CG$N\+R/T*!L)O\^V]?SX\P(D(1[C3\?#1&X1_0%%DUT#[..5Q'JLS4 ME80.0,'+PD892:M5WE0V?F0U=DA=AV]00KMR-M50QFGDQ=K]J0 M54M239[='BJF*=&VQWK:.45VXZ<`V90U"LFUA'2*K:O9^JH,-)DVMX;2U"E& MKH:D#B0)L$@S=3UI32[2WND4>U=G;I!T3:I[*],@[%[J]1^2#.]U'K6OL,1N M`8&.W%W9!-:16Y$2[CF:G,D^VC\H7'%80T-32#G1J5`,P+6/`&C5HE'L8YV3 M4A5SU0A0B)19N<9O1>Z>SP+HN"O82*>8QSHV=*!8)3YH%`@>?._E$08S?#2] MP@*[-51UM!?'B6N9V]-[VT7F/SLN6S+`CC-5R9*(4(=.I,S)`\3W%Z"3W2U"'FDQ6\0N M\AP^NQ.WL"SLIA68ND0H:3W!ND/8G"%V`RO+!AF*KQ*HU-43SUG'3B>XM(X< M)W-F)UB6C;EU[+#C7-D`FJ4Q+=WR9#7^XKT=W`7QW7PGWI+W,(@OT>5,U8?Z MV=\4F;NZO3SZ5?H`"HPU(]R.V7I3W0.S\9NR\A_$OPU/EF?(5]F=IZ\PP'KR M'X@E_)@SX[O&N"?#K;`,=/Q_1OJJC8>#SB90XQQZGL!R*]I/?H`V81K/I##-:_4T2*1>F9RN>8,T3S' MMU3:Y3%NXL.A>F;+7FX]'^P"K'$MW0FP@%MJ39!5[U/6F"`)4-%2,V/)Q&8] MV-\`FY6Z:-5XG2I]PZZP"G*N5[A&7-6XEPUP1>P!JR;?4L$1!N:&8LIK.*K9 M!\F7[@H7EY8L\;F"!BP5J#%*J28%4\F2;BHR4'J1$I_U;\#2&BF%T=US=D)[ M'A_/WZ3O:O+\KF6N^LBZ@$8&JJH3"KZ&%A=;%KOKEB1-MWC9BC-_Y>]GS*"I M,LM(TTU)6TTME@DP<`"8Q:%:IJ6R<5!%7&:>/LY;J>J:M6A&F%(UIV;6LFF8 M1'Z9AS"U=D--UE(V@=:8\#F<(V5TXW09PI8G,_S^Z-_IZZ2,"\K#X#JY:T2Z M<`T=#H;8\;1B$5NR,4/I,S3\G=(C-`+DZQ+ENGGM7035(H+Z&FJW@M.<*&Q1;6IM6M=*C(\K`]10!Q6#6*8JI`;,!Q;@\:],% M`!2S69<('N-F1RX7>,WHDN&*`:W M[H@$_5$YZ4PAP,`!Q?+6B`1A*T-MQ@''$E&+,]0<*B(V1-2'E^MO.@"+ MO'Q4MT17Z7.G%7%P&%M5*[M%8NR&A#E,J4$DN6L(9S>"$IED7\XY8+>BX]5K M+W0BC*S([.95UXE+2,U8B2'CK>_YF<*0ZR*S6]@Q>6171825%79KVA4KB0A7 M&&*WIH@A0`D;*FGQ\<5A8R5#YF8K-S*7@3\[\_&;U`7ZD[PJT"E\]@-8N`%R MXWKQ$]Q,*Y'=+(]2Z:JH#D5A3U:>^35V_ M)4V#6,_0]`EC3PLKB;$PQ+/^8%"X+_F/*T*-GM8Y!;2 MRBK'.8(,0,T2%BAQ,<5^M*"HEMD=4\FQ1'(WL?SX0%?93QZL50Q?2Z\-A^Q' M%"CF7,%:W;"X3.N03%)<16W6ID[M:!3;<4GQ%'4.S:A51!XVSQ9AA!Q.D#W4 MREED=Q1CH\X$D]3XN6-W$9I4IXJLW!&O7C!&3=YW%*Y-YARS.PY3MNHV>!,6 MNIT&N[/1M=H-QCX-_'S6#E]CM^5`Y_3];R&^1Y=K/R[QGSP=H`1TR^F0SUN; MN"E%(G9B.U[ZF1>'IY,L(L,QQ'E1O&3=4P%#)PZ*NYS7?5*')GST3R9QTA[4DXR;#SV(_#QG+RUJ]^ZS5DII^)L1^W MC8&FJ8ULRE8G1G'5=0E@%6F;TMO$'F!:MBN\>RX^7ENR3+[`;G1#SRBK6!41 M5E;8/2C:J&9'K%0\-LRYX[BG%C^8J^&N@FX'#'/<;[/T>G$V8A@_,&%_: MD[@H.0E"DZ,.6%``CDC2U!7R"6MSREWPS!Y7&IK<%).4O&R0":OUQ+AY8P\MR1P1*V^I5E_Z05XV#"U!?OTY M9XX]BM2`I5#Q0S6Y1NXH+?_=V!V1;](;`0A3,QK%6@V9Z65BY&/W1@`B`74# MGQC%!=8%6U;\.'RS\UH_"0Y/&4.@^CGTQ#"[IU1Q\:/M,7=@S)5]JA,09:8=@%B.7A#RNQA MDR(;!NVTLX)RG`[P'/R?B[Q_P@G2DZ3'0:F&@TY[C2_5R=\PB$Q_7_TV>?JW';.1+ M_E@9OQ403=-7O0;.N!,%!YA8:C2E>(%J9D3S`FMG1'\F5C^9:F::5G?0:6_\ M)59F90+I\5>;T&E/]J5O%?51FO"FJN1CHS;<49YL2M_(.BG-UA=YD.ZD1GFW M66=!-5DQ.1C@VQ(TC]-J52U*99A^-@C%.3'O9IEP5BV6FO:2OYTH-B?'BJ42694VW-'*B7%M#UD!)B."8;N\;-!* M"M2E1\!*+6N.R\NT>B$&66>@'JI7ENLP54.65&)34\N&T#FA.`2NF`WA(A4_ MX>;GA.H*N#@A"[VP`T^-D^P[6!PW\ M*D.KUM#*^\LT"+J-S4`K^U!;LGQSO*]%W@:U8D2[F*7YS/@A>Z.IL=]QL;0`:!6]0V]FL4&^*^F;K1;O;QJAL8 MAKK1"GVT1L[I0&:[]C4=&@U0-KY<8F6 M-][8=#A<=V<,EXNX$XPUZ5/Y(W0_>N[T\U$4+.#1Z&>&X9MT!EH_/,Y4AP^X M(SR"*&EEV"]!H<"?P5'70T:^35&)@_`J0LS\L%=`5#19!42ROH:?N%(BOM@8 MV)-H84]/G'\NTL(>2#-PU]HXJW,#'7>",%'R7]>YQ_>F"J"2HY*'(DO9W;]V M3'0[$9YR'XIIJ(.;"'LU*D53=<7<]$1.IM/X!I,HL6-)NRW\O&35TL7CXMX9I.6M\>U7$9RM9+[, MY49LS0CQ.)3R8MD@2[,DEPI&(7!484D4V<.LETQS>X5!\`T^^%F:Z8S%5I6M<&:$[\0>O:#[W;@%-AC M[SY;K!%<28"=D9K.4=TP0FN-1^EC99"%0;KI8EC9PZHQ6[WT!JQD*YT MO\/I&[Q!P[X6N&?O50LLHD9/.U8*9N?KY!4Z"WSE$^?GLE9"?T5@R'U^CY]/ MIQ@HSK*C<4ZG?EXOP*#5"4'\_GD:?7+ M?8H_>+9G[O3]XZ,[0U#O%GX?/?@SV_MT].>7Z-/O?X>'F&<#W)P\?+FZ_3B2 M7"_Y'QHC_MZ?[=G\TQ^`+GW"W_]YWLW?1O'MJO3O\=S&2!POWLG=P_G%P_CL[OKZY/[KQ4%T&LYM_$9]^>^Y[3C9O[^[3O3Z^0C12262\A9DC*5? M_B@5118YV:_O3\[/KVZ_C$_O'A_O;N+Y?QIE'Z9LX8_2^1CR!X"GE'WCX>K+ M;X_$7SW>W2>?'(W>8HE\/GKRH\B?+;DUY#^U7K_XI\CI8$[R!ZOUC.@3>KSX MK\?QR?75%S0I'$G`(%MQ8I*C=-3D2SQS3G4LF_)WUW/\[U@I1V`>C4)_ZCI+ M14Q$,(LA^W%Q=__?'$6F+1O%OOU[]#]K:)AHY^???+Y*9 M/OE3!Q'#ANWS$8C)_/3'O\1+B2DLUW5)MVO]!A^`VEK!P:85//DQ*,Q?F+2# M-FDT8]+>DB&HH5;MCGY-&9"Z%_!FS-?=)/*?8)`OIP*.V]BSC2QT]98H+O-: MO]G2=1W,?JJRIAL2M-A8`B@(H'"X0*'GV$<@!G;#AO,]&S1D0JM[\]M"JTM: M+0OW?!#N.1;0U>WYQ2T:<@RP+&@"&H&=]]M=`1$1O0?NRRM=3?)]%']'Z,O0 MHM.#UY<>?0VOP@S"D9R>G/WGEX>[O]V>?QS]83*!\/F9*I&GEXD_]8//1W\X M.[NXN+S<@+_AA3K)$"FPD>.Q"I?=1DD)_O#GY3VW5<2S,5O5N?0'%8NO=69= MS[Q[>]2A_BFJ?"Q;AM"T'C5M8Q9NT)HFZ\:Q)8/>-6V-/^U>X/OG=K<1OW6H M95DKXU%V3VJ+EFV@>/^0D[;;,W^F=2SK_5L_H8W[&X9VJ(T:.)8-=9N^6,2V M>Q_;/OH1BFI/IE/_N^U-H(@QVIM(^8.LH?5R$,J9;BR[2Q->1[9S/T(;50'' MFF8*!1^V@C-98Z'@Q2P1L(Z!I8G8O0FL2'[$+U;R\7]VW#?\K_21']\CG[7% MC>X#_R6P9]F[X[2ZWB)Z]0.TD,ZC?PH+%8GR]T*4LC_J7\&W&R#CHI.UI?XD M:6WI(S:NFK_NFDP6L\74CB"UH9E!MO)-RZHO0J0`,+AVPZA9KP"3Z,##SE)Y M2JL%G'$;Q$40%/L'D#U]&SQ'DR4=!91(BM;OZ'/_."]T%C8(!OV-GH3 M)UGETG#%D8E'AO@9:R*XE>FSOPFU5%`NLK@M")LN$I(D8<*&BMM^OS01=H3\WKK>Q-2&K0W_G7U]8FWB55$Z._:EZ3) M-K<-2"L:,,LJD(VZTE"SM'F0?ES\P*41D.U;Y8/C>6;2EKO<:;.68J6*4M:% M[#+;A"F@:U5:6K4HV2Z^M]_Q%B;W"MDZM@$7.M"!2K4491K$AIG-I_X[1,8Z MMG#7KOV$^X3C)KXD2S336V$`A+VOFNL,)A M;$DSLYY4([9HFYS'^!I`;L):U8XO2I7"$JV?;)U1UHG.XW02=#:N?=O++$/. M!(=%-DR+RD21`+%.>477"F]L.H)DHL41@C7IT4OBSV`*YH-&V2OUB;-AC6- M:%O8F"RAU?:3'\356.,9I=48[%(W-4M=A3QE`M5]JRLUB-8-H:["E0I( M3-Q,9;Y`#WG;*?Z.,T/A7QAAW_L&2=TA.ZPVTAU#(]N^K:=6J!-R:CO8?J^P MP5XP4C.S8B:4@5=P>]RO?H4J>]$K%+'I)$(OCKT:HR8!5(*^LB_G'+"W^=$! MV6^)3H.R19#7]#,0MB(+]H)58P#,U6U"(4(6$/+?W!!I[*4?9/<>,C"?L\-1 MXMBP"*^PCE)=FZPL">`6;`G9[;31#B;@YUI*=4PE=B@!/D3M+HYNIZJDUO&V M2K`1BTNH3S+);HQERVK"(T&QCLLLIY;E&'(.V8WTF$AAU5-KVJ(MQ9?8K"8Q M7"&BS#@VR0ZH361JDI$K'P_$OK;?XU31HQ_WZ@C@Z2)$F`RM!TY;W#V?V>%K M^ALGYY[=\`,+?:6\SQDHU_",3(:SF&#?559=DZ,]JIS4N%W'*$F.A-'S]`_N MGFFE-$VR2VJ33:^K!'*FTZCGI")"S)EC]RB(.1+7-Z9+0&:T_FCAXZOIE_8$ M*^P[J>2)NX(%<;([G;&L`X4($1E(KWC&"81.>!GXL[7M`4VR`2M'>\!:8O2= M@EQI?O2!J]XN(]*<.8[&VV0OBGIR=(B'@]*<$79W`S2)](GYP"MV.TNHE:ER MX'Q564%UI<&+E?8H71N0)IW"9S^V)TO$DR+B?$/2>I36U,_4=:"G[HV/>#>, MLU?'U3135^5N&*?]&@6"E!%SCMF]A2[):J%51'.B+3EEKZZK&FH:!&V64_8N M+(JN%;67BU,T]@)G1?!Y),RR(X_^V13%N1/DAG#:Q,:GA5=>.(<3;$,O(_4_.3I?Z88B]BY]FJ3P2NL(]@NQI\[N>Q()6%I;USIYJ,3Q7R651C=8KI*K M'#E+U-:LZUDR@-SH9DU&BY,QBB>O46;#(*]P],(8K0=ZW2*J*C]C^4WP^^65 M:10WXT=3D_COZ'T>3+)=:^+B+Z=^X#HV+:2=H,UU@RRBX]K>ZN_/_&#N)Z%" M:K!;M8Q@?&O0]AY^SPTFBF\PX@^RYPHJ4.<_UC6=X.DO@0:M[2^Q\JP"LT$\ MJRA^E#VD*'Z6O)E`GW3QV%&36C_SU.@/8+96K;6JZX*H:UDA,E7_`.2M/+56 M]6*K"FU':UQNNE6%U%[#AUGB4EA'81T'9QV!\D'=3B,?H.QJU=_+L^LV%G%# MS2[,)D[O@+I=#&0C]=GV8F=WU(W846)'B1W5X8Z*B]R$'P5R%\B=";D/K\Q] M7Y!^M\J6#QFF#ZEL^1HO+11&*(Q0&*$PP\4YO1:/W!T0T[ZF5N3/NP(Z.)6D3Y2"K$R5"T0Y"T62% MTA9/J)E0LZ[MF:Q*O2O:&L"W.]4_]P$7KH'7PP=\B\C?1-./H6?+.K1UVXPP MNS1BRB;:7`T^R2$48Z5\^U:ANM"+H>H%,#=1\5PDN422JZ6BWD`'7^#53A)())>O?EO4?`8CDUD#PX"XGM_"#^$4$@T$@ M/1&X#M:>;:+/K$AH[)Q>)`(T92!_$@HB%&0KAD,DO$3"J[6>QK4U7OVI,[J: MS0/_+2X+M,U3/Q$I'D:DJ(E\A-"R0\%I0MT.0]TV8-1$]FL@X'"7LU]QKX?1 MK>^-L\K;29$\D0,3H>RP#HZ$6@Q5+08"K82"#%5!MHJ%1`9,9,":J6F,@G!Y M[`B.3EX"",6U+Q$K;L`\&NI6+]$+-3L,-5-%GE5H6?_&S!*/&@\&%.YRYBOK M=RPR72)B%2D-H2",MWJ$6@BUV(9:B$R7R'2UO_.^")$ZP&`4=^S%G91>W7DX M0C3OI_9$5/,286+O1P+'LB(>.PI%ZUW1+*7_?(10LX-7,_48Z%NM;"$27R+Q MU4Q5O_B^\]V=3D7B2P2PE*J$EK157"948ZBJH1OB_I]0#%K2ZU@SMEKL022^ M1.*+L73]O?TNZM:+R'`#UG$,@"A;+_2L?STSQ?TNH6;]JYDL;;6@AH3!;'0.GZ+13[B*_?C:M[WP+R+U)<)8FF7;ZE&1T(RA:H:X#2@4 M9/NF0R3`1`*LM:9^??6#*$%%)Y-_+=S0Q=>_1#I,Q(\;2X<=2]O%64+3#D33 M9$WHF="S35BT36B:R(D-!"4V!]LM$2#8T%86R:H-&9V^5U$D#L0RBF4H[_/8(_(C1%64/KY/B+ MIRE$\TJ^F(AB!AUW,1MYO@?SR?45!J648]F5"*>_2`>@\K1WH9-^+`%=Q.A" MO_=4O\&Q9HG+?T*_]U6_C6,=J"+SU01R)S_&AVS9OQSW#?_\R\^+OT%E,X=WS_2*8O-HAO`_<"3R93OU)7*;A$?_](]H/I^B3__OU][\;C7[A M_..1ZR`MLE],13T:3=#JH5\\P.?/1^>R!)1OORW0)\&U_>0'=N0'+@ROO,F) MYUPX+_#4];_"X.WZ^NP&SIY@N=/W MCZ2*,>I?V]59!_"E#QI6*H[QXH7-QL2B',?J]7$*GQ&,+^S5^(-,L54YCIM2 MRW%V=WU]AQ`KKA\X$.FMA!8)3J?AW)Z@0&WY[S1PB_^=:C`: M-!72#D5Y*M(3M76\K-*#N"WE/90/2OL40+WUGT"\4VO,?_*E;ETR0/XX]*>N MTZ$[UK0/2I6I[\;Q5J7JM3]A,X@W&/JEUKG0T4!/K;ROB5,/\;__?I',],F? M.DM_#&(R?USUQ4_]>66YKPQ7C^J]FTDP81Z%>8SWG/X!Z%NQCXCLCMK$!,EN MT#`*Q1:*O0G%QJ%8OJ@H*!,Z/G0=EZNS`IK5[!F7#.)XH-ZT;_/XR]C`57^A MTD*E]_(IJ%#L[O"U4.Q!V.HUZ'IWCG+W!&&O"6<&#YWO`SBW76=T\6,.O1#V MW\2IQX3'MJYEK\$!G:86MEB46^Z_5)%0C!U4#&.K4O%6DND+P'.C10!'MN>,+MT?^.>MXJ&]#Q)%3B(>2]Y`7U^A9@>O9OV7 MP3ED)1,)K\26&5L]WQ0)+Y'P:MZ^"=HA?/6GSNAJ-@_\-SB#7B0R8"+3(3(= M0D&8+WQMH$S57BK&OJ?`-J$8(@.1X2+MSE%-B9/YLO(A@,`_'M;A"[ M[]D-Q=BJ\Q2*,53%T`R1]A)I+QKQ\LBIQ$&BS*FKC[)12M?V\LB^272'[UG\H_!J:X_W5(Z'"GDU^+$"TU M#$8/NW?>$AW)L:N(UI%`-FFH(M1"9,+K% MZ#_($[DPD0OK0EN_^+[SW9U.1;@HLA)]6T;S6#.VZC2%HAV&H@%SJY!][]5, MI+]2>V9L%^F)])=(?[$WA[JWW[?=&6IWH]=]3VK\!(X5T]Q/W>A03'_IW^SO MOZZ)1[8BE38$8[257-IFC='^0;$#R,TAQ!8LH(,!6^!/IZ-3Z,%G=[LE*_8^ MMA4IE,3T*M9AI^KV!BP>EMX.!%-N77U%"G!_S.20,X`"QAYN1O'6CZ!()XH4 MS_#=L5"0H2K(3YHALLV#""#V/IFX"4T3J<0=Q&`'D$H\L^=N9$]'<0UA`)Q'/X#(,`.J.3R;\6;NCB1[DB MGRC21>O.6XXEJ?]*4R)A)'0-Z9JQU6(]0M,.)C6I'&]"UT1R<@?QW0$D)Y

XML 26 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Financial Instruments
 12 Months Ended
Oct. 31, 2013
Fair Value of Financial Instruments  
Fair Value of Financial Instruments

[19] Fair Value of Financial Instruments

 

For certain financial instruments, including cash and cash equivalents, trade receivables, trade  payables, and short-term debt, it was estimated that the carrying amount approximated fair value for the majority of these items because of their short maturities.  The fair value of the Company’s long-term debt is estimated based on the quoted market prices for similar issues or by discounting expected cash flows at the rates currently offered to the Company for debt of the same remaining maturities.

 

Due to the non-interest bearing nature and unspecified payment terms, it was not practicable to estimate the fair value of amounts due from related parties [See also Note 7].
XML 27 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Intangible assets    
Cost $ 25,166 $ 14,175
Accumulated Amortization 8,847 7,852
Net of Accumulated Amortization 16,320 6,323
Estimated amortization expense related to intangible assets    
2014 1,917  
2015 1,852  
2016 1,540  
2017 1,063  
2018 946  
Thereafter 9,002  
Net of Accumulated Amortization 16,320 6,323
Customer Lists
    
Intangible assets    
Weighted-Average Amortization Period 20 years 20 years
Cost 8,739 4,573
Accumulated Amortization 2,879 2,537
Net of Accumulated Amortization 5,860 2,036
Estimated amortization expense related to intangible assets    
Net of Accumulated Amortization 5,860 2,036
Covenants Not-to-Compete
    
Intangible assets    
Weighted-Average Amortization Period 3 years 5 years
Cost 11,131 4,305
Accumulated Amortization 4,560 4,257
Net of Accumulated Amortization 6,571 48
Estimated amortization expense related to intangible assets    
Net of Accumulated Amortization 6,571 48
Patents and Licenses
    
Intangible assets    
Weighted-Average Amortization Period 17 years 17 years
Cost 5,297 5,297
Accumulated Amortization 1,408 1,058
Net of Accumulated Amortization 3,889 4,239
Estimated amortization expense related to intangible assets    
Net of Accumulated Amortization $ 3,889 $ 4,239
XML 28 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions (Tables)
 12 Months Ended
Oct. 31, 2013
FCL and MCL
  
Acquisitions  
Schedule of final purchase allocations

 

 

 

 

($)

 

 

 

FCL

 

MCL

 

Totals:

 

 

 

 

 

 

 

 

 

Accounts Receivable

 

1,008

 

232

 

1,240

 

Autos

 

137

 

48

 

185

 

Medical Equipment

 

225

 

3

 

228

 

Computer Equipment

 

21

 

—

 

21

 

Leasehold Improvements

 

53

 

—

 

53

 

Other Non-Current Assets

 

3

 

—

 

3

 

Non-Compete Agreement

 

747

 

43

 

790

 

Deposits

 

—

 

2

 

2

 

Customer Relationships in Place

 

3,235

 

930

 

4,165

 

Goodwill

 

1,905

 

673

 

2,578

 

Accounts Payable

 

-118

 

-83

 

-201

 

Long Term Debt (Auto-Loans)

 

-200

 

—

 

-200

 

Short Term Acquisition Payable

 

-1,000

 

-250

 

-1,250

 

 

 

 

 

 

 

 

 

Totals:

 

6,016

 

1,598

 

7,614

 
Hunter and Edge Bio
  
Acquisitions  
Schedule of final purchase allocations

 

 

 

 

$

 

 

 

Hunter

 

Edge Bio

 

Totals:

 

Accounts Receivable

 

1,700

 

—

 

1,700

 

Prepaid Expenses

 

421

 

70

 

491

 

Inventory

 

369

 

—

 

369

 

Autos

 

62

 

—

 

62

 

Furniture and Fixtures

 

265

 

6

 

271

 

Leasehold Improvements

 

—

 

714

 

714

 

Medical Equipment

 

234

 

906

 

1,140

 

Computer Equipment

 

376

 

574

 

950

 

Non-Compete Agreement

 

1,255

 

926

 

2,181

 

Customer Relationships in Place

 

3,852

 

3

 

3,855

 

Goodwill

 

8,573

 

182

 

8,755

 

Accounts Payable

 

(1,388

)

—

 

(1,388

)

Accrued Payroll Benefits

 

(393

)

—

 

(393

)

Notes Payable

 

—

 

(578

)

(578

)

Capital Leases

 

—

 

(193

)

(193

)

Deferred Acquisition Payable

 

(3,000

)

(375

)

(3,375

)

Deferred Rent Payable

 

—

 

(108

)

(108

)

 

 

 

 

 

 

 

 

Totals:

 

12,326

 

2,127

 

14,453

 
XML 29 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings Per Share (Tables)
 12 Months Ended
Oct. 31, 2013
Earnings Per Share  
Schedule of computation of basic and diluted net earnings per common share

The computation of basic and diluted net earnings per common share is as follows [in thousands, except per share data rounded]:

 

 

 

For Years Ended October 31,

 

 

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

Income Available to Common Stockholders

 

$

45,825

 

$

42,156

 

$

36,359

 

Weighted Average Common Shares Outstanding

 

27,691

 

27,742

 

27,971

 

 

 

 

 

 

 

 

 

Effect of Dilutive Securities:

 

 

 

 

 

 

 

Warrants/Options

 

161

 

179

 

236

 

 

 

 

 

 

 

 

 

Weighted Average Diluted Common Shares Outstanding

 

27,852

 

27,921

 

28,207

 

 

 

 

 

 

 

 

 

Net Income Per Share - Basic

 

$

1.65

 

$

1.52

 

$

1.30

 

Net Income Per Share - Diluted

 

$

1.65

 

$

1.51

 

$

1.29

 
XML 30 R52.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt - Bank (Details) (USD $)
 12 Months Ended 1 Months Ended 12 Months Ended
Oct. 31, 2013
Oct. 31, 2013
Term loan
Oct. 31, 2007
Term loan
Oct. 31, 2007
Term loan
GeneDx, Inc.
Dec. 31, 2010
Seven-year term note
Oct. 31, 2013
Seven-year term note
item
Long-term debt            
Debt instrument amount     $ 5,000,000      
Amount used in connection with purchase of operating assets       5,000,000    
Term of debt     6 years   7 years  
Frequency of principal payments   Monthly        
Monthly principal payments   69,000        
Debt instrument interest rate (as a percent)   6.85%       6.12%
Debt outstanding 4,163,000         4,163,000
Debt issued         5,408,000  
Number of equal monthly installments           84
Monthly installment including principal and interest           61,000
Principal repayment for each of the five succeeding fiscal years and thereafter            
2014 493,000          
2015 518,000          
2016 551,000          
2017 585,000          
2018 2,016,000          
Totals $ 4,163,000         $ 4,163,000
XML 31 R67.htm IDEA: XBRL DOCUMENT v2.4.0.8
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
Valuation and qualifying accounts      
Balance at the Beginning of a Period $ 319,195 $ 281,142 $ 221,276
Charged to Cost and Expenses 2,867,671 2,480,166 2,001,243
Deductions Charged to Valuation Allowance Accounts (2,755,308) (2,442,113) (1,941,377)
Balance at the End of a Period 431,558 319,195 281,142
Allowance for Doubtful Accounts
      
Valuation and qualifying accounts      
Balance at the Beginning of a Period 51,274 45,220 34,904
Charged to Cost and Expenses 119,161 89,396 75,079
Deductions Charged to Valuation Allowance Accounts (81,174) (83,342) (64,763)
Balance at the End of a Period 89,261 51,274 45,220
Contractual Credits/Discounts
      
Valuation and qualifying accounts      
Balance at the Beginning of a Period 267,921 235,922 186,372
Charged to Cost and Expenses 2,748,510 2,390,770 1,926,164
Deductions Charged to Valuation Allowance Accounts (2,674,134) (2,358,771) (1,876,614)
Balance at the End of a Period $ 342,297 $ 267,921 $ 235,922
XML 32 R61.htm IDEA: XBRL DOCUMENT v2.4.0.8
Insurance (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Insurance  
Professional liability insurance coverage $ 3,000
Professional liability insurance coverage per occurrence 1,000
Excess commercial insurance coverage per occurrence 5,000
Excess commercial insurance coverage over the primary limits 5,000
Excess umbrella coverage $ 15,000
XML 33 R47.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Details 3) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 12 Months Ended
Oct. 31, 2013
Jul. 31, 2013
Apr. 30, 2013
Jan. 31, 2013
Oct. 31, 2012
Jul. 31, 2012
Apr. 30, 2012
Jan. 31, 2012
Oct. 31, 2011
Jul. 31, 2011
Apr. 30, 2011
Jan. 31, 2011
Oct. 31, 2013
item
Oct. 31, 2012
Oct. 31, 2011
Oct. 31, 2010
Accounting for Revenues                                
Gross Service Revenues                         $ 3,524,108 $ 3,052,431 $ 2,482,349  
Contractual Adjustments and Discounts:                                
Medicare/Medicaid Portion                         354,638 320,697 293,874  
All Other Third Party Payors                         2,393,872 2,070,073 1,629,833  
Total Contractual Adjustments and Discounts                         2,748,510 2,390,770 1,923,707  
Service Revenues Net of Contractual Adjustments and Discounts                         775,598 661,661 558,642  
Patient Service Revenue Provision for Bad Debts                         60,244 47,406 36,561  
Net Revenues 192,219 185,427 176,452 161,256 163,487 160,532 151,443 138,793 140,684 137,802 129,465 114,129 715,354 614,255 522,081  
Percent of Contractual Allowances, Discounts and Patient Service Provision for Bad Debts to Gross Revenue.                         79.70% 79.90% 79.00%  
Number of distinct payors included in all other third party and Direct                         800      
Allowances                                
Total Allowance 431,558       319,195       281,142       431,558 319,195 281,142 221,276
Recoverability and Impairment of Intangible Assets and Other Long-Lived Assets                                
Impairment loss                         0 0 0  
Contractual Credits/Discounts
                                
Allowances                                
Total Allowance 342,297       267,921       235,922       342,297 267,921 235,922 186,372
Doubtful Accounts
                                
Allowances                                
Total Allowance $ 89,261       $ 51,274       $ 45,220       $ 89,261 $ 51,274 $ 45,220 $ 34,904
XML 34 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Property and Equipment
 12 Months Ended
Oct. 31, 2013
Property and Equipment  
Property and Equipment

[3] Property and Equipment - Property and equipment - at cost is summarized as follows:

 

 

 

October 31

 

 

 

2013

 

2012

 

 

 

 

 

 

 

Medical Equipment

 

$

65,762

 

$

50,338

 

Leasehold Improvements

 

27,974

 

19,768

 

Furniture, Fixtures and Office & Computer Equipment

 

21,621

 

16,503

 

Automobiles and Aircraft

 

18,242

 

16,092

 

 

 

 

 

 

 

Sub Totals

 

133,599

 

102,701

 

Less Accumulated Depreciation

 

67,950

 

52,261

 

 

 

 

 

 

 

Totals — Net of Accumulated Depreciation

 

$

65,649

 

$

50,440

 
XML 35 R62.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Risks and Uncertainties (Details) (USD $)
In Thousands, unless otherwise specified
Oct. 31, 2013
Oct. 31, 2012
Significant Risks and Uncertainties    
Cash and certificate of deposit balances at financial institutions in excess of the federally insured limits $ 14,720 $ 21,260
EXCEL 36 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\W-&%D.3(T85\S,C$S7S0U,3-?.&0P95]C.6$S M8S0R-C9A.#'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=OF%T:6]N7V%N9%]"=7-I;F5S#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E!R;W!E#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DQO;F=497)M7T1E8G1?0F%N:SPO>#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E)E;&%T961?4&%R='E?5')A M;G-A8W1I;VYS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E M;%=O&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U M#I%>&-E;%=O#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D5M<&QO>6UE;G1?0V]N=')A8W1S7V%N9%]#;VYS=3PO>#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O5]O9E]3:6=N:69I8V%N=%]!8V-O M=6YT,3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U M;6UA#I7;W)K5]A;F1?17%U:7!M96YT M7U1A8FQE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DEN=&%N9VEB;&5?07-S971S7U1A8FQE#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/DQO;F=497)M7T1E8G1?0F%N:U]486)L97,\ M+W@Z3F%M93X-"B`@("`\>#I7;W)K#I% M>&-E;%=O#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E-T;V-K7T]P=&EO;G-?86YD7U=A M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D5M<&QO>6UE;G1?0V]N=')A8W1S7V%N9%]#;VYS=3$\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O M#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D]R9V%N:7IA=&EO;E]A;F1?0G5S M:6YE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E-U;6UA#I7;W)K#I%>&-E;%=O5]O9E]3:6=N:69I8V%N=%]!8V-O=6YT-3PO>#I. M86UE/@T*("`@(#QX.E=O5]A;F1?17%U:7!M96YT7T1E=&%I;',\ M+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D-A<&ET86Q?5')A;G-A8W1I;VYS M7T1E=&%I;',\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-T;V-K7T]P=&EO;G-?86YD7U=A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-T;V-K7T]P=&EO;G-?86YD7U=A#I7;W)K#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7V%N M9%]#;VYT:6YG96YC:65S7S$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-I9VYI9FEC86YT7U)I#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DAE86QT:%]);G-U#I%>&-E;%=O#I7;W)K M#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M6QE#I!8W1I=F53 M:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N M9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S M:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'10 M87)T7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)T))3R!2149%4D5.0T4@3$%" M3U)!5$]22453($E.0SQS<&%N/CPO"!+97D\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^3V-T(#,Q+`T*"0DR,#$S/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)RTM,3`M,S$\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!&:6QE'0^)SQS<&%N/CPO2!&:6QE3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)T%C8V5L97)A=&5D($9I;&5R/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M2!0=6)L:6,@1FQO870\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA&5S(&%N9"!%>'!E;G-E'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879AF5D('-H87)E'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&-E<'0@4VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M/B@V,3(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-2PR-S(\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA3PO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65E M'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!O9B!/<'1I;VYS("T@16UP M;&]Y965S("AI;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&%D.3(T85\S,C$S7S0U M,3-?.&0P95]C.6$S8S0R-C9A.#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-S1A9#DR-&%?,S(Q,U\T-3$S7SAD,&5?8SEA,V,T,C8V83@W+U=O M'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XR.3`\2!A;F0@17%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XQ+#0P.#QS<&%N/CPO2!-971H;V0@*$EN8V]M92D@3&]S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA MF%T:6]N(&%N9"!"=7-I;F5SF4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@ M6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9#LG('-I>F4],T0R/ELQ72!/6QE/3-$)U1%6%0M24Y$14Y4.B`S M,2XU<'0[($U!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CY":6\M4F5F97)E;F-E($QA8F]R871O7-I2P@7-I2!I;B!%;&UW;V]D(%!A2XF M(S$V,#L@5V4@<&5R9F]R;2!C>71O;&]G>2!T97-T:6YG(&EN($9R961E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!#;VUP86YY)B,X,C$W.W,@;&%B;W)A M=&]R>2!T97-T:6YG(&)U2!R97!R97-E;G1S(&ET M2!T97-T:6YG(&)U65A2!T97-T:6YG(&)U2!P;W)T86P@'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O M;&EC:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S M='EL93TS1"=F;VYT+7-I>F4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;CLG/@T*/'`@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9#LG('-I>F4],T0R/ELR72!3=6UM87)Y(&]F(%-I M9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-I97,\+V9O;G0^/"]I/CPO8CX\ M+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^)B,Q-C`[ M/"]P/@T*/'`@2!A;F0@:71S('=H;VQL>2UO=VYE9"!S=6)S:61I87)I97,N M)B,Q-C`[($%L;"!S:6=N:69I8V%N="!I;G1E2!H860@)#$W+#DU,B!A;F0@)#(U+#$T,R!I;B!C87-H(&%N9"!C M87-H(&5Q=6EV86QE;G1S(&%T($]C=&]B97(F(S$V,#LS,2P@,C`Q,R!A;F0@ M,C`Q,BP@6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P M:6X@,&EN(#!P=#LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)U1%6%0M24Y$ M14Y4.B`P+C5I;CL@34%21TE..B`P:6X@,&EN(#!P=#LG/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E!R;W!E2!A;F0@97%U:7!M96YT(&%R92!C87)R:65D(&%T(&-O2!T:&4@2!R86YG92!F M65A6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@ M34%21TE..B`P:6X@,&EN(#!P=#LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$ M)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P:6X@,&EN(#!P=#LG/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!S=&%T96UE;G1S(&]F(&]P M97)A=&EO;G,@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P:6X@,&EN(#!P=#LG/B8C M,38P.SPO<#X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%2 M1TE..B`P:6X@,&EN(#!P=#LG/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/D=O;V1W:6QL("T@169F96-T:79E($YO=F5M8F5R)B,Q-C`[,2P@,C`Q,2P@ M=&AE($-O;7!A;GD@861O<'1E9"!R979I2!T:&%N(&YO="8C.#(R,3L@=&AR97-H;VQD(&ES M('=H96X@=&AEF%T:6]N(&]F("0R M+#0P,2!A2X\+V9O;G0^/"]P/@T*/'`@2X@1'5R:6YG('1H92`R,#$S(&%N9"`R,#$R(&9I6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CY#97)T86EN('!R M:6]R('EE87(@86UO=6YT65A65A6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CY!;'1H;W5G:"!T:&ES('5P9&%T92!D;V5S(&YO="!H879E M(&$@;6%T97)I86P@:6UP86-T(&]N('1H92!#;VUP86YY)B,X,C$W.W,@9FEN M86YC:6%L('-T871E;65N=',@87,@82!W:&]L92P@:70@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CY!8V-O=6YT:6YG(&9O6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`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`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.#@E.R!0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ M('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO M;F4[(%!!1$1)3D'0@,7!T('-O;&ED M.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4^#0H\<"!S='EL93TS1"=4 M15A4+4%,24=..B!C96YT97([($U!4D=)3CH@,&EN(#!I;B`P<'0[)R!A;&EG M;CTS1&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/C(P,3(\+V9O;G0^/"]B/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO M;F4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T M('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y M+C`V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE M9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU M;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L,#4R+#0S,3PO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.#@E.R!0041$24Y'+5))1TA4 M.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@ M;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C,X)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@ M4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR+#0X,BPS-#D\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1) M3D6QE/3-$ M)U!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$N,30E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C`V)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C0E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.#@E.R!0041$24Y'+5))1TA4.B`P:6X[ M($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DUE9&EC87)E+TUE9&EC86ED(%!O6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,U-"PV,S@\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS,C`L-CDW/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#4Y+C`V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$P+C0E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM' M4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$ M15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C(L,SDS+#@W,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(N.#@E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXR+#`W,"PP-S,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1O=&%L($-O;G1R86-T=6%L M($%D:G5S=&UE;G1S(&%N9"!$:7-C;W5N=',\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR+#6QE M/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$L.3(S+#6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#4Y+C`V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!" M04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO M6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1% M4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXV-C$L-C8Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4U."PV-#(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1%6%0M M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O M;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT M(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C0E M.R!0041$24Y'+5))1TA4.B`P:6X[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE M.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C8P+#(T-#PO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.#@E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$P+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@ M4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P M)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXT-RPT,#8\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE="!2979E;G5E6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W M:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I=6T@ M;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[ M(%=)1%1(.B`Q,"XT)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$ M.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5)) M1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(] M,T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXW M,34L,S4T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$P+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!" M04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@ M0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG M(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P M)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXV,30L,C4U/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]2 M1$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C,X)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I M=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU4 M3U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXU,C(L,#@Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%2 M1TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$P+C0E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]5 M3D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXE/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXE/"]F;VYT/CPO<#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXE/"]F;VYT M/CPO<#X\+W1D/CPO='(^/"]T86)L93X-"CQP('-T>6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ M(#!I;B`P:6X@,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^ M/&9O;G0@2!R961U8VEN9R!G'!E;G-E2!H879E(&)E96X@ M861J=7-T960@;W9E2!A8W1I;VXL(&EF(&%N>2P@=VAI8V@@:7,@=&%K M96X@86YD('1H92!C;VYT96YT(&]F(&QE9VES;&%T:6]N+"!I9B!A;GDL('=H M:6-H(&ES(&%D;W!T960L('1H92!#;VUP86YY(&-O=6QD(&5X<&5R:65N8V4@ M82!S:6=N:69I8V%N="!D96-R96%S92!I;B!R979E;G5E2!I M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`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`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.24[ M(%!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D M:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3`E/@T*/'`@6QE M/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/C(P,3,\+V9O;G0^/"]B/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/C(P,3(\+V9O;G0^/"]B/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P M/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I M=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C0T)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@ M0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.24[ M(%!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D-O;G1R86-T=6%L($-R961I=',O M1&ES8V]U;G1S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS-#(L,CDW/"]F;VYT/CPO<#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXR-C6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1O=6)T9G5L($%C8V]U;G1S/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1O=&%L($%L;&]W86YC93PO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.24[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR M-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C0T M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!" M3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@ M;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXT,S$L-34X/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C,Q.2PQ M.34\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CY#=7)R96YT($EN8V]M92!487AE"!L:6%B:6QI=&EE65A6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E9F5R"!B87-E"!L87=S(&%N9"!R871E&%B;&4@:6YC;VUE+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS M1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^)B,Q-C`[/"]P/@T*/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E1H92!#;VUP86YY(&%D;W!T960@1T%!4"!G=6ED86YC92!W:71H M(')E"!P;W-I=&EO;G,@=VAE;B!I="!B M96-A;64@969F96-T:79E+B8C,38P.R!5;F1E2!R96-O9VYI>F4@=&AE('1A>"!B96YE9FET(&9R M;VT@86X@=6YC97)T86EN('1A>"!P;W-I=&EO;B!O;FQY(&EF(&ET(&UE971S M('1H92!M;W)E+6QI:V5L>2UT:&%N+6YO="!C2!H860@;F\@;6%T97)I86P@=6YC M97)T86EN('1A>"!P;W-I=&EO;G,@=&\@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D5A&5R8VES92!O2!S=&]C:R!M M971H;V0L('=H:6-H(&%S&5R8VES960N)B,Q-C`[(%-E M8W5R:71I97,@=VAO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/E5S92!O M9B!%6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@ M,'!T.R<^/&9O;G0@2!T;R!R96-O=F5R('1H92!A'!E8W1E9"!F=71U"!C87-H(&9L;W=S(&%R92!L97-S('1H86X@=&AE(&-A M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CY!9'9E&EM871E;'D@)#,L,C`P+"`D M,BPS-C8@86YD("0R+#`R-B!F;W(@=&AE('EE87)S(&5N9&5D($]C=&]B97(F M(S$V,#LS,2P@,C`Q,RP@,C`Q,B!A;F0@,C`Q,2P@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D]T:&5R($EN8V]M92`F(S@R M,3([($1U65A2!R96-O6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-U8G-E<75E;G0@179E;G1S("8C.#(Q,CL@ M5&AE(&UA;F%G96UE;G0@8V]N'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!A;F0@17%U M:7!M96YT/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!A;F0@17%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z,3`N,'!T M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@6QE/3-$)T9/ M3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#LG('-I>F4] M,T0R/ELS72!02!A;F0@17%U:7!M96YT("T\+V9O;G0^/"]I/CPO M8CX@/&9O;G0@6QE/3-$)W1E M>'0M86QI9VXZ;&5F=#M724142#H@-S,N,S0E.R!"3U)$15(M0T],3$%04T4Z M(&-O;&QA<'-E.R<@8F]R9&5R/3-$,"!C96QL6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N-"4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/C(P,3,\+V9O;G0^/"]B/CPO<#X\ M+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO M=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@ M;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]2 M1$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$V)2!C;VQS<&%N/3-$,CX-"CQP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#,N-"4[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXV-2PW-C(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXU,"PS,S@\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR-RPY M-S0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C,V M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C$Y M+#6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C$E.R!0041$24Y'+5)) M1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/D9U6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ-BPU,#,\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@ M0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5)) M1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$V)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ."PR-#(\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$V+C,V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@ M4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$V M)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ-BPP.3(\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE M9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ,S,L-3DY/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ,#(L-S`Q M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI M9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0 M.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$V)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXV-RPY-3`\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD M;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$V+C,V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-% M149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$V)2!C;VQS<&%N/3-$,CX- M"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXU,BPR-C$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C8U+#8T.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#,N-"4[(%!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52 M+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O M=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C`V)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@ M4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$U)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXU,"PT-#`\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\W-&%D.3(T85\S,C$S7S0U,3-?.&0P95]C M.6$S8S0R-C9A.#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S1A M9#DR-&%?,S(Q,U\T-3$S7SAD,&5?8SEA,V,T,C8V83@W+U=O'0O:'1M;#L@8VAA'0^ M)SQD:78@3I4 M:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SX\8CX\:3X\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L M:6,[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/DEN=&%N9VEB;&4@87-S971S(&%R92!S=6UM87)I>F5D(&%S(&9O;&QO M=W,Z/"]F;VYT/CPO<#X-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@ M,'!T.R<^/'4^/&9O;G0@6QE/3-$ M)W1E>'0M86QI9VXZ;&5F=#M724142#H@.#`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`Z(#!I;CLG('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#(W)3X-"CQP('-T>6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SX\8CX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#AP=#L@1D].5"U714E'2%0Z M(&)O;&0[)R!S:7IE/3-$,3Y);G1A;F=I8FQE)B,Q-C`[07-S970\+V9O;G0^ M/"]B/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I M;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[ M(%!!1$1)3DF%T M:6]N/"]F;VYT/CPO8CX\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U14 M3TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3DF%T:6]N/"]F;VYT/CPO8CX\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU M;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$W+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I M=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU4 M3U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$W)3X-"CQP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$ M24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$S+C6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@ M;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T* M/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(W+C0X M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$W+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!" M04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$ M14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@ M6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXV+#4W,3PO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,C8E.R!0041$24Y'+5)) M1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP M.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(W+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$W+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!! M1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/E1O=&%L6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$W+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(U+#$V-CPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P M="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU" M3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q+C,E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[($)/4D1% M4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$V+#,R,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]5 M3D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/CPO M=&%B;&4^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^)B,Q M-C`[/"]P/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D]C=&]B97(F(S$V,#LS,2P@ M,C`Q,CPO9F]N=#X\+W4^/"]P/@T*/'`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`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3DF%T:6]N)B,Q-C`[4&5R:6]D/"]F;VYT/CPO M8CX\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5)) M1TA4.B`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`Z(#!I;CLG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#(W)3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P M/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%2 M1TE..B`P:6X@,&EN(#!P="`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`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W+C0X)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,36QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0L,S`U/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXT.#PO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#(W+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$ M.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W+C0X)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y' M+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U1%6%0M M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q M-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[ M(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N M;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E1O M=&%L6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W+C0X)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$T+#$W-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C M8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[($)/ M4D1%4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@ M4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q+C,E.R!0041$24Y'+5))1TA4 M.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU M;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C8L,S(S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S M='EL93TS1"=-05)'24XZ(#!I;B`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`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(W+C6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#8T+C(R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXQ+#4T,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(N,R4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,3<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$L,#8S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P M=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(W+C6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P M:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52 M+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(W+C6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDL,#`R/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#(N,R4[(%!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1O=&%L/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@ M,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,E M.R!0041$24Y'+5))1TA4.B`P:6X[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE M.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^#0H\<"!S='EL93TS1"=- M05)'24XZ(#!I;B`P:6X@,'!T.R<^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXQ-BPS,C`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/CPO M=&%B;&4^#0H\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6%B;&4@+2!"86YK/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T* M/'`@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9#LG('-I>F4],T0R/ELU72!2979O;'9I;F<@3F]T92!087EA8FQE("T@ M0F%N:SPO9F]N=#X\+VD^/"]B/CPO<#X-"CQP('-T>6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ M(#!I;B`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`Q,R!A;F0@3V-T;V)E2!U M=&EL:7IE9"`D,C8L,3,Y(&%N9"`D,"!O9B!T:&4@8W)E9&ET(&QI;F4L(')E M2X\+V9O;G0^/"]P/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&%D.3(T85\S,C$S7S0U,3-? M.&0P95]C.6$S8S0R-C9A.#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-S1A9#DR-&%?,S(Q,U\T-3$S7SAD,&5?8SEA,V,T,C8V83@W+U=O'0O:'1M;#L@ M8VAA'0^)SQD:78@3I4:6UE6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\8CX\:3X\9F]N="!S='EL93TS M1"=&3TY4+5-464Q%.B!I=&%L:6,[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CY%9F9E8W1I=F4@87,@;V8@3V-T M;V)E&5C=71E9"!A(&9I9G1H(&%M96YD M;65N="!T;R!T:&4@3&]A;B!!9W)E96UE;G0@9F]R;6%L:7II;F<@=&AE(')E M<&%Y;65N="!T97)M2P@0E),22!.;RXF(S$V,#LR($%C<75I65A6UE;G1S(&]F(&%P<')O>&EM871E M;'D@)#8Y+"!P;'5S(&EN=&5R97-T(&%T(&%N(&%N;G5A;"!R871E(&]F(#8N M.#4E+B!4:&4@;F]T92!W87,@<&%I9"!O9F8@;VX@3V-T;V)E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN($1E8V5M M8F5R)B,Q-C`[,C`Q,"P@=&AE($-O;7!A;GD@:7-S=65D(&$@65A M6UE;G0@;V8@=&AE('!R:6YC:7!A;"!A;F0@:6YT97)E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E!R:6YC:7!A;"!R97!A>6UE;G0@ M9F]R(&5A8V@@;V8@=&AE(&9I=F4@65A6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\=&%B;&4@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\8CX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#AP=#L@1D].5"U714E'2%0Z(&)O;&0[)R!S:7IE/3-$,3Y9 M96%R)B,Q-C`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`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXT.3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8T+C(R)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-C0E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXU,3@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8T M+C(R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXU-3$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8T+C(R)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-C0E/@T*/'`@6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXU.#4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8T+C(R)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE M/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXR+#`Q-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N,R4[ M(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E1H97)E869T97(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([ M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P M:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM' M4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$ M15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXT+#$V,SPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N,R4[(%!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D M:75M(&YO;F4[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE' M2%0Z(&UE9&EU;2!N;VYE.R<@=VED=&@],T0R,#@^/"]T9#X-"CQT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52 M+5))1TA4.B!M961I=6T@;F]N93LG('=I9'1H/3-$,3D^/"]T9#X-"CQT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]2 M1$52+5))1TA4.B!M961I=6T@;F]N93LG('=I9'1H/3-$,3`^/"]T9#X-"CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52 M+4Q%1E0Z(&UE9&EU;2!N;VYE.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@ M0D]21$52+5))1TA4.B!M961I=6T@;F]N93LG('=I9'1H/3-$.#`^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]2 M1$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93LG('=I9'1H/3-$-SX\+W1D M/CPO='(^/"]T86)L93X-"CPO9&EV/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO2!46QE/3-$)V9O;G0M M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S M='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^/&9O;G0@'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQS<&%N/CPO&5S M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS M1"=F;VYT+7-I>F4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;CLG/@T*/'`@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9#LG('-I>F4],T0R/ELX72!);F-O;64@5&%X97,\+V9O;G0^ M/"]I/CPO8CX\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T M.R<^)B,Q-C`[/"]P/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!R96-O;F-I;&EA M=&EO;B!O9B!I;F-O;64@=&%X(&9R;VT@8V]N=&EN=6EN9R!O<&5R871I;VYS M(&-O;7!U=&5D(&%T('1H92!5+E,N(&9E9&5R86P@"!R M871E('1O('1H92!#;VUP86YY)B,X,C$W.W,@969F96-T:79E(&EN8V]M92!T M87@@6QE/3-$)W1E>'0M86QI9VXZ;&5F=#M724142#H@.#`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`P<'0[)R!A;&EG;CTS1&-E;G1E6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/C(P,3(\+V9O;G0^/"]B/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$ M15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U14 M3TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3$E/@T*/'`@6QE/3-$<&%D9&EN9SHP.SX- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#4S+C6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q+C(V)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I M=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$Q)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I M=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q+C(V)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@ M0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)3X-"CQP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$Q+C(V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@ M4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q M)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#4S+C6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS-3PO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM' M4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXE/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,U/"]F;VYT/CPO<#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`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`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXI)3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$Q+C(V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!" M04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@ M0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG M(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q M)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXH,"XT-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,"XS-S5P=#L@4$%$1$E.1RU,1494.B`P:6X[(%=) M1%1(.B`S+C$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`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`C8V-E969F.R!" M3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@ M;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)3X-"CQP('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXT,RXT,CPO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXR-7!T M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5)) M1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXE/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O M=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q+C(V)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@ M4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$Q)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXT,RXT,SPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXR-7!T.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P M:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXE/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@ M0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q+C(V)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E. M1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$Q)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXT,RXY,SPO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXR-7!T.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXE/"]F;VYT/CPO<#X\+W1D/CPO='(^/"]T86)L93X-"CQP M('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\ M<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^/&9O;G0@&5S M('-H;W=N(&EN('1H92!C;VYS;VQI9&%T960@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M#0H\=&%B;&4@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y'+5))1TA4 M.B`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`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`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[ M($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q+C6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D9E9&5R86P\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(U+#6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,S8E.R!0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-T871E)B,Q-C`[)F%M<#L@3&]C86P\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ-"PP,3@\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ,"PR,#,\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXY+#@R-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#,N,C(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C M8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Q+C6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q+C6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C(E.R!0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#4Q+C6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y'+5)) M1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q+C6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q M+C6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/B@Q,"PX,#,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@R+#$X,SPO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y'+5)) M1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXI/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@ M34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@V+#(S.#PO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XS M-S5P=#L@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`S+C(V)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXH,2PT-30\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`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`P:6X[($)!0TM'4D]53D0Z("-C M8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXS-2PR-S(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T M(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C0E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[($)/4D1% M4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,R+#,V,#PO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y'+5))1TA4.B`P M:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT M(#(N,C5P="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU"3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q M+C,V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I M=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149& M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C(X+#0X-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N M,C(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/CPO=&%B;&4^#0H\<"!S M='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^)B,Q-C`[/"]P/@T*/'`@ M6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%T($]C=&]B97(F(S$V,#LS,2P@,C`Q,R!A;F0@,C`Q M,BP@=&AE($-O;7!A;GD@:&%D(&$@;F5T(&1E9F5R"!A2XF(S$V,#L@5&AE(&1E9F5R&5S('!R:6UA2!R96QA M=&4@=&\@=&EM:6YG(&1I9F9E2!O9B!D97!R96-I871I;VX@86YD(&%M;W)T:7IA=&EO M;BP@8F%D(&1E8G1S(&%N9"!C97)T86EN(&%C8W)U960@97AP96YS97,@86YD M(&1E9F5R2!H860@;F\@;6%T97)I86P@;F5T(&]P97)A M=&EN9R!L;W-S(&-A6QE/3-$)W1E>'0M86QI9VXZ;&5F=#M724142#H@-S8N-C8E.R!" M3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!-05)'24XM3$5&5#H@,"XU:6X[ M)R!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@ M=VED=&@],T0W-B4^#0H-"CQT6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#8P+C@X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C`E/@T*/'`@ M6QE/3-$)U!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$ M15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^#0H\<"!S='EL93TS1"=415A4+4%, M24=..B!C96YT97([($U!4D=)3CH@,&EN(#!I;B`P<'0[)R!A;&EG;CTS1&-E M;G1E6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C(P,3(\+V9O;G0^/"]B/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P M=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$U+C8T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE M/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`R,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C,Y+#(W-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#,N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR,BPU-C`\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`R,'!T.R<^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXQ+#@Q-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#,N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$U+C8T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C$L M.38S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/D%C8W)U960@17AP96YS97,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^ M)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q M,'!T.R<^/&9O;G0@6QE/3-$)U!! M1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@ M0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C8T)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5)) M1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$U)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXT-"PR,S$\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#$Y,#PO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,S(E.R!0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#8P+C@X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/ M54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$U+C8T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-% M149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2!C;VQS<&%N/3-$,CX- M"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]5 M3D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C8T)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$U)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,S(E.R!0041$24Y'+5)) M1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#8P+C@X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-C`E/@T*/'`@ M"!!6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C8T)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,34E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0R+#$U-#PO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C8T)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,34E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(T+#DQ,CPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,S(E.R!0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#8P+C@X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/ M54Y$.B`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`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[ M($)/4D1%4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I M;CL@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q-2XV-"4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O M=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$T+C,T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!" M04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@ M0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG M(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$T M)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXR-RPQ.3`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[($)/ M4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N M;VYE.R<@=VED=&@],T0Q.3X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[ M($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU M;2!N;VYE.R<@=VED=&@],T0W/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^/&9O M;G0@2!R96-O2!O9B!A<'!R;WAI;6%T96QY("0R.#$@9G)O;2!D97!R96-I871I;VX@ M86YD(&%M;W)T:7IA=&EO;B!T:6UI;F<@9&EF9F5R96YC97,L(&%N9"!A(&)E M;F5F:70@;V8@87!P2`D-C`W(&EN(&-E'!E;G-E"!A MF%B;&4L(&AO=V5V97(L(&-O=6QD(&)E M(')E9'5C960@:6X@=&AE(&YE87(@=&5R;2!I9B!E&%B;&4@:6YC;VUE(&]R(&-H86YG97,@:6X@=&AE(&%C8W)U960@ M97AP96YS97,@9'5R:6YG('1H92!F=71U6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CY!="!/8W1O8F5R)B,Q M-C`[,S$L(#(P,3,L(&9I&%M:6YA=&EO;G,@:&%S(&YO="!B965N(&1E=&5R;6EN M960N/"]F;VYT/CPO<#X-"CPO9&EV/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS M<&%N/CPO6QE/3-$)V9O;G0M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\8CX\:3X\9F]N="!S M='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($9/3E0M1D%-24Q9.B!4:6UE M2!IF5D M('1O(&ES6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/DAO;&1E6UE;G0@;V8@;&EA8FEL:71I97,N/"]F;VYT/CPO<#X- M"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^/&9O;G0@65A2!A;FYO=6YC960@=&AA="!I=',@8F]A6)A8VL@;V8@=7`@=&\@-S$T M+#4U,"!S:&%R97,@;V8@:71S($-O;6UO;B!3=&]C:R!I;B!T:&4@;W9E65A6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9#LG('-I>F4],T0R/EM"72!%<75I='D@5')A;G-A8W1I;VYS(&9O M6QE M/3-$)T9/3E0M4TE:13H@,3!P=#LG('-I>F4],T0R/D9O28C.#(Q-SMS(&-O;6UO;B!S=&]C:R!F;W(@96UP;&]Y M;65N="!O7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!C;VUP=71A=&EO;B!O9B!B M87-I8R!A;F0@9&EL=71E9"!N970@96%R;FEN9W,@<&5R(&-O;6UO;B!S:&%R M92!I6QE/3-$<&%D9&EN M9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Q+C@V)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-3$E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#4Q+C@V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3$E/@T*/'`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`P<'0[)R!A;&EG;CTS1&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C(P,3$\+V9O;G0^ M/"]B/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5)) M1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R M+C4E.R!0041$24Y'+5))1TA4.B`P:6X[($)/4D1%4BU43U`Z(&UE9&EU;2!N M;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@ M,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E(&-O;'-P86X],T0R M/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/DEN8V]M92!!=F%I;&%B;&4@=&\@0V]M;6]N(%-T;V-K:&]L9&5R M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1) M3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C0U+#@R-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[ M(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C0R+#$U-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXS-BPS-3D\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXR-RPV.3$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$R+C4T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E(&-O M;'-P86X],T0R/@T*/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#DW,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$N,C0E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#4Q+C@V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R+C4E.R!0041$24Y'+5)) M1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T.R<^/'4^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R+C4E.R!0041$24Y'+5)) M1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^ M/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R+C4E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXQ-SD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXR,S8\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%2 M1TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R M+C4T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E(&-O;'-P86X],T0R/@T*/'`@ M6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E=E:6=H=&5D($%V97)A9V4@1&EL=71E9"!# M;VUM;VX@4VAA6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S M;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R+C4E.R!0041$ M24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[($)/4D1%4BU4 M3U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#@U,CPO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W M:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$R+C4E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C M8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C(W+#DR,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R+C4T)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$R)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR."PR,#<\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T M.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@ M;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R+C4E.R!0041$ M24Y'+5))1TA4.B`P:6X[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$ M15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/DYE="!);F-O;64@4&5R(%-H87)E("T@0F%S:6,\+V9O;G0^/"]U/CPO<#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$N-3(\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP M.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Q+C@V)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-3$E M/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$N-3$\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/CPO=&%B M;&4^#0H\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF4Z,3`N,'!T M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@6QE/3-$)T9/ M3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#LG('-I>F4] M,T0R/ELQ,5T@4W1O8VL@3W!T:6]N6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9#LG('-I>F4],T0R/D5M<&QO>65E($EN8V5N=&EV M92!3=&]C:R!/<'1I;VYS("T\+V9O;G0^/"]I/CPO8CX@/&9O;G0@&5R8VES M92!P&5R8VES92!P&5R8VES86)L92!F;W(@=&AE(&9I28C.#(Q-SMS(%-T;V-K($]P=&EO;B!0 M;&%N6UE;G0@9'5E('1O(')E=&ER96UE;G0L(&]R('=I=&AI;B!O M;F4@>65A2!T;R!O2!A;GD@;V)L:6=A=&EO;B!O9B!A;B!E;7!L;WEE M92!F;W(@=&AE('!U&5R8VES92!A;B!O<'1I;VX@9W)A;G1E9"!U;F1E2!P97)C96YT("@U,"4I(&]F('1H92!E>&5R8VES M92!P2XF(S$V,#L@02!T;W1A;"!O9B`V+#`P,"P@,3,L,#`P M(&%N9"`M,"T@;W!T:6]N65A M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN($%U9W5S="8C,38P M.S(P,#`L('1H92!#;VUP86YY(&%D;W!T960L(&%N9"!O;B!$96-E;6)E2!H879E(&)E96X@9&5S:6=N871E9"!A&5R8VES92!P&-E960@=&5N('EE87)S M(&9R;VT@=&AE(&1A=&4@;V8@9W)A;G0N)B,Q-C`[($EN(&9I65A2XF(S$V,#L@3W!T:6]N M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!F;VQL M;W=I;F<@:7,@82!S=6UM87)Y(&]F($5M<&QO>65E($EN8V5N=&EV92!3=&]C M:R!/<'1I;VX@4&QA;B!T6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C(X)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-3DE/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$<&%D9&EN M9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C(X)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-3DE/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N M;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/ M4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE' M2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3&5R8VES928C,38P.U!R:6-E)B,Q-C`[4&5R)B,Q-C`[4VAA6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!! M1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C,S-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(N-C8E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$W)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXY+C8V/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D=R86YT960\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W M+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@ M;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z M(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$W)2!C;VQS<&%N/3-$ M,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXF(S@R,3([/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D5X<&ER960\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([ M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#4Y+C(X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-3DE/@T*/'`@&5R8VES960\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!! M1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`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`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-C8E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$W+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]2 M1$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G M8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$W)2!C M;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`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`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C(X)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N M/3-$=&]P('=I9'1H/3-$-3DE/@T*/'`@'!I6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXY+C$S/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D5X97)C M:7-E9#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-C8E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$W+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/ M54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52 M+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L M;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$W)3X-"CQP M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXH,C,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C(X)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I9'1H M/3-$-3DE/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D]U='-T M86YD:6YG(&%T($]C=&]B97(F(S$V,#LS,2P@,C`Q,BH\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D M:75M(&YO;F4[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!" M3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDN.34\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q M,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W+C$V)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,36QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D5X<&ER960\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXH-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(N-C8E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C M8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXI M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#4Y+C(X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-3DE/@T*/'`@&5R8VES960\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#4Y+C(X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D]U='-T86YD:6YG(&%T($]C=&]B97(F(S$V,#LS,2P@,C`Q M,RH\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$P+C`R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[($)/ M4D1%4BU43U`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`Z(&UE9&EU;2!N;VYE.R!" M3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R<@=VED=&@],T0X/CPO=&0^/"]T M6QE/3-$)U1%6%0M24Y$14Y4.B`Y<'0[($U! M4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXJ16QI9VEB;&4@9F]R(&5X97)C:7-E(&%T($]C=&]B97(F(S$V,#LS,2P@ M,C`Q,"!W97)E(#,Q,"!A="!A('=E:6=H=&5D(&%V97)A9V4@97AE6QE M/3-$)U1%6%0M24Y$14Y4.B`Y<'0[($U!4D=)3CH@,&EN(#!I;B`P<'0[)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXJ16QI9VEB;&4@9F]R(&5X97)C M:7-E(&%T($]C=&]B97(F(S$V,#LS,2P@,C`Q,2!W97)E(#(W-2!A="!A('=E M:6=H=&5D(&%V97)A9V4@97AE6QE/3-$)U1%6%0M24Y$14Y4.B`Y<'0[ M($U!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXJ16QI9VEB;&4@9F]R(&5X97)C:7-E(&%T($]C=&]B97(F(S$V,#LS M,2P@,C`Q,B!W97)E(#(T-"!A="!A('=E:6=H=&5D(&%V97)A9V4@97AE6QE/3-$)U1%6%0M24Y$14Y4.B`Y<'0[($U!4D=)3CH@,&EN(#!I;B`P<'0[ M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXJ16QI9VEB;&4@9F]R(&5X M97)C:7-E(&%T($]C=&]B97(F(S$V,#LS,2P@,C`Q,R!W97)E(#(S.2!A="!A M('=E:6=H=&5D(&%V97)A9V4@97AE6QE/3-$)U1%6%0M24Y$14Y4.B`Y M<'0[($U!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\=&%B;&4@ M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-S@E.R!0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ M('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO M;F4[(%!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-S@E.R!0041$ M24Y'+5))1TA4.B`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`@6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D&5R8VES92!A="!/8W1O8F5R)B,Q-C`[ M,S$L(#(P,3`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1% M4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0N-C0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1%6%0M24Y$ M14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@ M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT M(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C4V M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)3X-"CQP('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([ M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D M:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^ M/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C4V)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0 M.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$U)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`Q,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXS+C@R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D&5R8VES92!A M="!/8W1O8F5R)B,Q-C`[,S$L(#(P,3$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#8R+C(V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C(E/@T*/'`@ M6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$U+C4V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$ M15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N M93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$U)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(N-S@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C4V)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52 M+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$U)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$N,#@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8R+C(V)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE M/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C4V)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q M,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C4V)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,34E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D5X97)C:7-E9#PO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-S@E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W M:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$U+C4V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4 M.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C M0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)3X-"CQP('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXH.#PO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,"XS-S5P=#L@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`R+C6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS+C,Y M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D&5R8VES92!A="!/8W1O8F5R)B,Q-C`[,S$L M(#(P,3(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXU+C0W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D=R86YT960\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N M;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$U+C4V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$ M.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5)) M1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(] M,T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2!C;VQS<&%N M/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXF(S@R,3([/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D5X<&ER960\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXH,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N M-S@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXI M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP M.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8R+C(V)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO&5R8VES M960\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXI/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E M>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1) M3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C4N,C4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$U+C4V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$ M15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N M93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$U)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(N-S@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C4V)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52 M+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$U)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$N,#@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8R+C(V)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P M="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C4V)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$ M15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N M93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$U)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXV/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[($)/4D1%4BU43U`Z(&UE9&EU M;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R<@=VED=&@],T0Q M.3X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N M;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[($)/4D1%4BU43U`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`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE M.R<@=VED=&@],T0Y-CX\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[($)/ M4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N M;VYE.R<@=VED=&@],T0W/CPO=&0^/"]T6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CY3=6UM87)Y(&]F(&]U='-T86YD:6YG(&]P=&EO;G,Z/"]F;VYT M/CPO<#X-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^#0H\=&%B;&4@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/E=E:6=H=&5D)B,Q-C`[079E6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/D5X97)C:7-A8FQE/"]F;VYT/CPO8CX\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,30E.R!0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#,V+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,S8E(&-O;'-P M86X],T0W/@T*/'`@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4^#0H\ M<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@,&EN(#!I M;B`P<'0[)R!A;&EG;CTS1&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/E)E;6%I;FEN9SPO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@&5R8VES93PO9F]N=#X\+V(^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/E-H87)E&5R8VES93PO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q M,'!T.R<^/&(^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O M=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/E!R:6-E/"]F;VYT/CPO8CX\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$N,30E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`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`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#0N-#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z('=I;F1O=W1E>'0@,7!T M('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO'0@,7!T M('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0V+C$Q M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1) M3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52 M+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q+C$V)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!W:6YD;W=T M97AT(#%P="!S;VQI9#L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$Q)3X-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CY097(@4VAA6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E. M1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXP+C6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C8N,3$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!" M3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@ M;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXV+C$Q/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#0N-#(E.R!0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/G1O/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B0W M+C8W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1) M3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ+C`Y/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@ M,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C8R/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@+3$P<'0[($U!4D=)3CH@ M,&EN(#!I;B`P<'0@,3!P=#LG(&%L:6=N/3-$6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8N-3@E.R!0041$24Y'+5)) M1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXD.2XQ,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(N,C(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C M8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$Q+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/E!E6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P M+C`T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$T-SPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-#@E.R!0041$24Y'+5))1TA4.B`P:6X[ M($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!" M04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C$N,#`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXY+C$S/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!415A4+4E.1$5.5#H@+3$P<'0[($U!4D=)3CH@,&EN(#!I;B`P<'0@ M,3!P=#LG(&%L:6=N/3-$6QE/3-$)U!!1$1) M3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I M;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[ M(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C0P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3`E/@T*/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$W+C4P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,P/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(N-3(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[($)/4D1% M4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$ M1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q,"XP-"4[(%!!1$1)3D6QE M/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-#@E.R!0041$24Y'+5))1TA4 M.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T M97AT(#(N,C5P="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I=6T@;F]N93L@ M4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1( M.B`Q,"4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CY#;VUP96YS871I;VX@8V]S M="!R96-O9VYI>F5D(&9O65A65A M"!B96YE9FET(&]F("0M,"T@=VET:"!R M97-P96-T('1O('1H97-E(&]P=&EO;G,N/"]F;VYT/CPO<#X-"CPO9&EV/CQS M<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6UE;G0@0V]N=')A M8W1S(&%N9"!#;VYS=6QT:6YG($%G6UE;G0@0V]N=')A M8W1S(&%N9"!#;VYS=6QT:6YG($%G6QE/3-$)V9O;G0M6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`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`Z(#!I;CLG('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#8X)3X-"CQP('-T>6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SX\8CX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#AP=#L@1D].5"U714E' M2%0Z(&)O;&0[)R!S:7IE/3-$,3Y/8W1O8F5R)B,Q-C`[,S$\+V9O;G0^/"]B M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ M(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U1%6%0M24Y$ M14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@ M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(T+C`R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C0E M(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L.#6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,38\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXS+#8U-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8X+CDX)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I9'1H M/3-$-C@E/@T*/'`@6QE/3-$)U!!1$1) M3D6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE. M.B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(T+C`R)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$L,C0S/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H97)E869T97(\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#8X+CDX)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@ M;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(T+C`R)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@ M4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#(T)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8X+CDX)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I9'1H M/3-$-C@E/@T*/'`@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[($)/4D1% M4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$ M1$E.1RU,1494.B`P:6X[(%=)1%1(.B`R+C8R)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#(E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS M1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/DEN(&%D9&ET:6]N('1O('1H92!A8F]V92P@:6X@9FES8V%L(#(P,3,@=&AE M($-O;7!A;GD@:&%S(&5N=&5R960@:6YT;R!S979E;G1Y(&%T("8C.#(Q,CL@ M=VEL;"!E;7!L;WEM96YT(&%N9"!C;VYS=6QT:6YG(&%G7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO6QE/3-$)V9O;G0M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^/&9O M;G0@6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\=&%B;&4@ M6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N-"4[ M(%!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N-"4[(%!! M1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1% M4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,38E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C$R)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y' M+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$U+#`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#,N-"4[(%!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%U=&]M;V)I;&5S/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXQ,"PU.#$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E(&-O M;'-P86X],T0R/@T*/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C@L-S$Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,N-"4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^ M/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXR-2PU.30\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E M(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P+#6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#4Y+C$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]2 M1$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G M8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$V)3X- M"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXQ,RPQ,C4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!" M04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@ M0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG M(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$V M)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXV+#6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y M+C$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3DE/@T*/'`@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXQ,BPT-CD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ-"PP,3,\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CY$97!R96-I871I;VX@ M97AP96YS92!O;B!A&EM871E;'D@)#8L-#DT+"`D,RPW.3(L(&%N9"`D,2PT,3@@9F]R('1H M92!Y96%R2X\+V9O;G0^/"]P/@T*/'`@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CY!9V=R96=A=&4@9G5T=7)E(&UI;FEM=6T@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\=&%B;&4@6QE/3-$<&%D9&EN9SHP M.SX-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@ M0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@ M34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(N,38E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C`E(&-O M;'-P86X],T0R/@T*/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0L-C,P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,38\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXS+#6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#6QE/3-$)U!! M1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@ M34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C8V,#PO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N-C8E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE. M.B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$N-C8E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z M("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S M;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(P)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52 M+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#(P)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ-BPX M-#8\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE. M.B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q M,'!T.R<^/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXY-#D\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P M:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$N-C8E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C M8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\ M+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@ M,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W M+C@T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@ M;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z M(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$W)3X-"CQP('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ-2PX M.3<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&%D M.3(T85\S,C$S7S0U,3-?.&0P95]C.6$S8S0R-C9A.#<-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-S1A9#DR-&%?,S(Q,U\T-3$S7SAD,&5?8SEA M,V,T,C8V83@W+U=O'0O:'1M;#L@8VAA'0^)SQD:78@3I4:6UE6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SX\8CX\:3X\9F]N="!S='EL93TS1"=&3TY4 M+5-464Q%.B!I=&%L:6,[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CY4:&4@0V]M<&%N>2!L96%S M97,@=F%R:6]U6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ M(#!I;B`P:6X@,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@ M,'!T.R<^/&9O;G0@&-L=7-I=F4@;V8@6QE/3-$)W1E>'0M86QI9VXZ;&5F=#M724142#H@-3`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`R)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$ M15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N M93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG M;CTS1'1O<"!W:61T:#TS1#0P)3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P M/CPO=&0^#0H\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS-#0\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXR,C,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U!!1$1) M3D6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXX-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$N.3@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#0P M+C`R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C(P,3<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXU-3@\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([ M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(T)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,C0E/@T*/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4U.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#4E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#(T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C0E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C M.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#0P+C`R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-#`E/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(T M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,C0E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I M=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P M:6X[(%=)1%1(.B`R-"4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#(T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/ M54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52 M+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L M;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(T)3X-"CQP M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`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`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4W)3X- M"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\8CX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#AP=#L@1D].5"U714E'2%0Z(&)O;&0[)R!S:7IE/3-$,3Y/8W1O8F5R M)B,Q-C`[,S$\+V9O;G0^/"]B/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,30\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,V)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,S8E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$Q+#DS.#PO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#4W)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,38\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ,"PX-30\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#4W)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,V)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1O=&%L6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0U+#4U-CPO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X\+W1R/CPO=&%B;&4^#0H\<"!S='EL93TS1"=-05)'24XZ M(#!I;B`P:6X@,'!T.R<^)B,Q-C`[/"]P/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E)E M86=E;G0@65A7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0M6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CY);B!T M:&4@;F]R;6%L(&-O=7)S92!O9B!B=7-I;F5S28C.#(Q-SMS(&9I;F%N8VEA;"!P;W-I=&EO;B!O7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA6QE/3-$ M)V9O;G0M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!#;VUP86YY(&UA:6YT M86EN&-E7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N M/CPO6QE/3-$)V9O;G0M6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ M(#!I;B`P:6X@,'!T.R<^/&(^/&D^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#LG('-I M>F4],T0R/D%T($]C=&]B97(F(S$V,#LS,2P@,C`Q,R!A;F0@,C`Q,BP@=&AE M($-O;7!A;GD@:&%D(&%P<')O>&EM871E;'D@)#$T+#&-E2!I;G-U6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SX\8CX\:3X\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L M:6,[($9/3E0M1D%-24Q9.B!4:6UE2!T;R!S=7!P;W)T(&-U2!C;VYT M:6YU86QL>2!M;VYI=&]R6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^ M/&9O;G0@2!A8W1I;VXL(&%N9"!T:&4@8V]N=&5N="!O M9B!L96=I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPOF4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@ M6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9#LG('-I>F4],T0R/ELQ.%T@06-Q=6ES:71I;VYS/"]F;VYT/CPO:3X\+V(^ M/"]P/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CY/;B!!<')I;"8C,38P.S(W+"`R,#$R M+"!T:&4@0V]M<&%N>2!E;G1E"8C.#(R,3LI+"!A($1E;&%W87)E(&-O"!A;F0@=&AE(&%G6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CY!6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T M.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^/&9O;G0@2`D-RPP,38L(&]F('=H M:6-H("0Q+#`P,"!I6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CY4:&4@9F]L M;&]W:6YG('1A8FQE('-E=',@9F]R=&@@=&AE6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\=&%B;&4@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N."4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(N."4[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1) M3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!" M3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E/@T*/'`@'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,B4^#0H\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT M97([($U!4D=)3CH@,&EN(#!I;B`P<'0[)R!A;&EG;CTS1&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/E1O=&%L6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@ M4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S M)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#(N.#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@ M0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5)) M1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$S)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.#(E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I M=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU4 M3U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S)3X-"CQP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$N,#@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T* M/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4P)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXQ+#`P.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.#(E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(S,CPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(N.#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!" M04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C$L,C0P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/D%U=&]S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ,S<\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXT.#PO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#(N.#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3,E/@T*/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$X-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$N,#@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4P)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y' M+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$ M.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(R.#PO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,#@E.R!0041$24Y'+5)) M1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#4P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-3`E/@T*/'`@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(Q/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3,E/@T*/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DQE87-E:&]L9"!);7!R;W9E;65N=',\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C4S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C4S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/D]T:&5R($YO;BU#=7)R96YT($%S6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C M.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYO;BU#;VUP971E($%G M6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXW.3`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`R,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3,E/@T*/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXR/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#4P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/ M54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS+#(S-3PO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.#(E.R!0041$24Y'+5))1TA4 M.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/CDS,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(N.#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0L,38U/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D=O;V1W:6QL/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ+#DP-3PO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(N.#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3,E/@T*/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C8W,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(N.#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E/@T*/'`@ M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C(L-36QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/D%C8V]U;G1S(%!A>6%B;&4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BTQ,3@\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXM.#,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXM,C`Q/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DQO;F<@5&5R;2!$96)T M("A!=71O+4QO86YS*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(N."4[(%!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXM,C`P/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-H;W)T(%1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BTQ+#(U,#PO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,#@E.R!0041$24Y'+5))1TA4.B`P:6X[ M($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#4P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3`E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.#(E.R!0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S M+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/E1O=&%L6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[($)/4D1%4BU,1494 M.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$1$E.1RU, M1494.B`P:6X[(%=)1%1(.B`Q,RXT."4[(%!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$L-3DX/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0 M.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$S)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXW+#8Q-#PO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$N,#@E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/CPO=&%B;&4^#0H\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([ M($U!4D=)3CH@,&EN(#!I;B`P<'0[)R!A;&EG;CTS1&-E;G1E2!P=7)C:&%S960@2!A;&P@;V8@=&AE M(&]P97)A=&EN9R!A6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D]N($%U9W5S="8C,38P.S(P+"`R,#$S('1H92!#;VUP86YY M('1H&EM871E;'D@)#(L-3`R+B8C,38P.R!/9B!T:&%T("0S-S4@=V%S(&1E9F5R M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!F;VQL;W=I M;F<@=&%B;&4@6QE/3-$)W1E>'0M86QI9VXZ;&5F=#M724142#H@-C8N-C8E.R!" M3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R<@8F]R9&5R/3-$,"!C96QL6QE/3-$)U!!1$1)3D6QE/3-$<&%D9&EN9SHP M.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#0P+C`T)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-#`E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#0P+C`T)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE M/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C$L-S`P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P M:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@'!E;G-E6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E/@T*/'`@ M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C0R,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E.R!0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V M+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C

6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN=F5N=&]R>3PO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E.R!0041$24Y'+5))1TA4.B`P:6X[ M($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C,V.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXS-CD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%2 M1TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXV,CPO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,38E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXV,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$N,C@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#0P+C`T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO'1U6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C(T)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$N,C@E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#0P+C`T)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P M('=I9'1H/3-$-#`E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,38E/@T*/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$V+C(T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#0P+C`T)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(S-#PO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E.R!0041$24Y'+5))1TA4 M.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/CDP-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#,N,S@E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$V+C(T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$L,30P/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D-O;7!U=&5R($5Q M=6EP;65N=#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,W-CPO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E.R!0041$24Y'+5)) M1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,38E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4W-#PO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C(T)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,38E/@T*/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDU,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$N,C@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T* M/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#0P+C`T M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXQ+#(U-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#,N,S@E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDR-CPO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E.R!0041$24Y'+5))1TA4.B`P M:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C(T)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C(L,3@Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D-U6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS+#@U,CPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E.R!0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,38E/@T*/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXS+#@U-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,C@E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#0P+C`T)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C@L-36QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U!! M1$1)3D6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q M,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V M+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@Q+#,X.#PO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E.R!0041$24Y'+5)) M1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXI/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$V+C(T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E/@T*/'`@ M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/B@Q+#,X.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,C@E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXI/"]F M;VYT/CPO<#X\+W1D/CPO='(^#0H\='(@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%C8W)U960@4&%Y M6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@S.3,\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXH,SDS/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/BD\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE. M.B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E/@T*/'`@ M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXH-36QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXH-36QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/BD\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXI/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXI/"]F;VYT/CPO<#X\+W1D/CPO='(^#0H\='(@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/D1E9F5R6%B;&4\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXH,RPP,#`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@S-S4\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B@S+#,W-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$N,C@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXI/"]F;VYT/CPO<#X\+W1D/CPO='(^#0H\='(@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D1E9F5R M6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXH,3`X/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXH,3`X/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@ M34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,38E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T M.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T M97AT(#(N,C5P="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I=6T@;F]N93L@ M4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1( M.B`Q-BXQ-B4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/ M54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52 M+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L M;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$V)3X-"CQP M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXR+#$R-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[($)/4D1%4BU,1494 M.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$1$E.1RU, M1494.B`P:6X[(%=)1%1(.B`Q-BXR-"4[(%!!1$1)3D6QE/3-$ M)U!!1$1)3D7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO6QE/3-$)V9O;G0M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\ M<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^/&9O;G0@6%B;&5S+"!A;F0@2!D:7-C;W5N=&EN9R!E>'!E8W1E9"!C87-H(&9L;W=S(&%T('1H M92!R871E2!F;W(@ M9&5B="!O9B!T:&4@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CY$=64@=&\@=&AE(&YO;BUI;G1E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&%D.3(T85\S,C$S M7S0U,3-?.&0P95]C.6$S8S0R-C9A.#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-S1A9#DR-&%?,S(Q,U\T-3$S7SAD,&5?8SEA,V,T,C8V83@W M+U=O'0O M:'1M;#L@8VAA'0^)SQD:78@3I4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\8CX\:3X\9F]N="!S M='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@ M,'!T.R<^/&9O;G0@'!E M;G-E65A2`D-BPW.3&EM871E;'D@)#,R+#`Q-BP@)#(U+#DY-"!A;F0@)#$Y+#0P M."!F;W(@=&AE('EE87)S(&5N9&5D($]C=&]B97(F(S$V,#LS,2P@,C`Q,RP@ M,C`Q,B!A;F0@,C`Q,2P@7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA6QE/3-$)V9O;G0M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!#;VUP86YY('-P;VYS;W)S(&$@ M-#`Q*&LI)B,Q-C`[4')O9FET+5-H87)I;F<@4&QA;B!;=&AE("8C.#(R,#M0 M;&%N)B,X,C(Q.UTN)B,Q-C`[($5M<&QO>65E2!E;&5C="!T;R!C;VYT"UD969E65R(&-O;G1R M:6)U=&EO;B!W:6QL(&)E(&9U;&QY('9E65A'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQAF4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;CLG/@T*/'`@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI M8SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9#LG('-I>F4],T0R/ELR,ET@3F5W($%U M=&AO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T M.R<^/&9O;G0@65A2X@5&AE(&%D;W!T:6]N(&]F('1H:7,@=7!D871E(&1I9"!N;W0@:&%V92!A M(&UA=&5R:6%L(&EM<&%C="!O;B!T:&4@0V]M<&%N>28C.#(Q-SMS(&9I;F%N M8VEA;"!S=&%T96UE;G1S+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=415A4 M+4%,24=..B!C96YT97([($U!4D=)3CH@,&EN(#!I;B`P<'0[)R!A;&EG;CTS M1&-E;G1E28C.#(Q-SMS(&9I;F%N8VEA;"!S=&%T96UE;G1S(&%S M(&$@=VAO;&4L(&ET(')E<75I7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ;&5F=#M724142#H@,3`P)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S M93LG(&)O6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`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`@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I M;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[ M(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E M/@T*/'`@'0@,7!T M('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4^#0H\<"!S='EL M93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@,&EN(#!I;B`P<'0[ M)R!A;&EG;CTS1&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/C6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$ M<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,SDE/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]2 M1$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I M=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]2 M1$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$ M24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I M=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU4 M3U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$ M15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N M93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@ M0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4 M.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXQ-C$L,C4V/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C$X-2PT,C<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ.3(L,C$Y/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP M.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I9'1H/3-$,SDE/@T* M/'`@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXW,"PY,C(\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXX,"PV-S8\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXX-2PV-C`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXX-2PR.#(\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXS,C(L-3,Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE="!);F-O;64\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXX+#8V-3PO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5)) M1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$Q+#,S.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$T+#6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!" M04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C$Q+#$R,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y' M+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0U+#@R-3PO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]5 M3D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T* M/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N M/3-$=&]P('=I9'1H/3-$,SDE/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3`E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[ M($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!" M04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO M6QE M/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`R,'!T.R<^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXP+C,Q/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C`N-3,\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXP+C0P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C`N-#$\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXP+C4S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$N-C4\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q M,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3`E/@T*/'`@6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E=E:6=H=&5D($%V97)A9V4@0V]M;6]N M(%-H87)E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\=&%B;&4@ M6QE M/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,SDE/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/D%U9&ET960\+V9O;G0^/"]B/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O M=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/E1H6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@ M,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,SDE/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O M=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O M;'-P86X],T0R/@T*/'`@'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4^ M#0H\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@,&EN M(#!I;B`P<'0[)R!A;&EG;CTS1&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/C6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$ M<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,SDE/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]2 M1$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$ M24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I M=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU4 M3U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N M/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@ M0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4 M.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N M;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E. M1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS M<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5)) M1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@ M,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXQ-3$L-#0S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$V,"PU,S(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXV,30L,C4U/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D=R;W-S(%!R;V9I=#PO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXV,"PQ M,3@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXW-"PV.#$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$ M.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDL,S`V/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$R+#4Y-CPO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P M:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ,BPX.#D\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE="!);F-O;64@4&5R M($-O;6UO;B!3:&%R93H\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P M86X],T0R/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I9'1H/3-$,SDE/@T*/'`@ M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1) M3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXP+C(V/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C`N,S0\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[ M(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXP+C0W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$N-3(\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`R,'!T M.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXP+C(V/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C`N,S,\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXP+C0V/"]F;VYT/CPO<#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$N-3$\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^ M)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$ M)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3`E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E=E:6=H=&5D($%V97)A M9V4@0V]M;6]N(%-H87)E6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/@T*/'`@ M6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$ M.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M#0H\=&%B;&4@6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,SDE/@T*/'`@6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/D9I6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$ M15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4^#0H\<"!S='EL93TS1"=415A4+4%, M24=..B!C96YT97([($U!4D=)3CH@,&EN(#!I;B`P<'0[)R!A;&EG;CTS1&-E M;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/C0O,S`O,C`Q,3PO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$ M15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/@T*/'`@6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/C(P,3$\+V9O;G0^/"]B/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P M/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P M=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$Q-"PQ,CD\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ,S6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$T,"PV.#0\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN M.R<@=F%L:6=N/3-$=&]P('=I9'1H/3-$,SDE/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4W+#0T-SPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXV M,RPR,#8\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(S-"PR,CD\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXW+#DX M-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXW+#@Q M-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ,"PP M.#$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C,V M+#,U.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$ M24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP M.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I9'1H/3-$,SDE/@T* M/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T* M/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C M8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$ M)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE. M.B`P:6X@,&EN(#!P="`R,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXP+C(X/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C`N,S8\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ M+C,P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D1I;'5T M960\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXP+C(X M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C`N,S8\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ+C(Y/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O M;'-P86X],T0R/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$ M24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C(W+#@X-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y' M+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#DR,#PO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P M:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#DT,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z M("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C(W+#DT.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y' M+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#DW,3PO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4.B`P M:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@ M,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,SDE/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)U!! M1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E M(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(X+#$R,CPO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5)) M1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(X+#$T,CPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM' M4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/ M54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C(X+#$T-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(X+#$S.#PO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5)) M1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(X+#(P-SPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM' M4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R M/CPO=&%B;&4^#0H\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SX\8CX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R<@F4],T0R/E-#2$5$54Q%($E)("T@5D%,54%4 M24].($%.1"!154%,249924Y'($%#0T]53E13($9/4B!42$4@645!4E,@14Y$ M140@3T-43T)%4B`S,2P@,C`Q,RP@,C`Q,B!!3D0@,C`Q,3PO9F]N=#X\+V(^ M/"]P/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1) M3D6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1) M3D6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/BAC*3PO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU,1494 M.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`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`[ M=&\F(S$V,#M686QU871I;VX\8G(@+SX-"D%L;&]W86YC928C,38P.T%C8V]U M;G1S/"]F;VYT/CPO8CX\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N,C8E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U14 M3TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO M;F4[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$T+C4E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!" M3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D#L@ M4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%L;&]W86YC92!F;W(@1&]U8G1F=6P@06-C;W5N M=',\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4Q+#(W-#PO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N,C8E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$T+C4E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(Q+C6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@X,2PQ-S0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C@Y+#(V,3PO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#`N.24[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@ M,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`R,'!T.R<^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(V-RPY,C$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C(L-S0X M+#4Q,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N,C8E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(Q+C6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@R+#8W-"PQ,S0\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,T,BPR.3<\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@#L@ M4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N,C8E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$T+C4E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N,C8E.R!0041$24Y'+5)) M1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R+C8X)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3(E/@T*/'`@6QE/3-$)U!!1$1)3DF4],T0R/E1O M=&%L($%L;&]W86YC93PO9F]N=#X\+W4^/"]I/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI M9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$T+C4E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z M(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(L.#8W+#8W,3PO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[ M($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P M="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(Q+C6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXH,BPW-34L,S`X/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXI/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0S,2PU-3@\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@#L@4$%$1$E.1RU4 M3U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(Q+C6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N,C8E.R!0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I M=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R+C8X)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@ M0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)3X-"CQP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#`N.24[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$ M1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^ M/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N,C8E.R!0041$24Y'+5))1TA4 M.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(Q+C6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU,1494.B`P<'@[ M(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%L;&]W86YC M92!F;W(@1&]U8G1F=6P@06-C;W5N=',\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C0U+#(R,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$T+C4E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXI/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$T+C4E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z M("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$T+C4E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXI/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I M;F#L@ M4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!! M1$1)3D6QE M/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#(Q+C6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU,1494 M.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4U193$4Z(&ET M86QI8SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T.R<@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`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`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU2 M24=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T M.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#(N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52 M+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$T+C4E.R!0041$24Y'+5))1TA4.B`P M:6X[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,30E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE M9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D M:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$T+C4E.R!0041$24Y'+5))1TA4.B`P M:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#`N.24[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$ M24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P M=#L@34%21TE..B`P:6X@,&EN(#!P="`R,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$T+C4E.R!0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXW-2PP-SD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXH-C0L-S8S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXT-2PR,C`\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@#L@ M4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D-O;G1R86-T=6%L($-R961I=',O1&ES8V]U;G1S/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXQ.#8L,S6QE M/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ+#DR-BPQ-C0\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXH,2PX-S8L-C$T/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR,S4L.3(R/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$T+C4E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#`N.24[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X M.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P M=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&D^/'4^/&9O;G0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52 M+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$T+C4E.R!0041$24Y'+5))1TA4.B`P M:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU;2!N M;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@ M,&EN.R<@8F=C;VQO6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(R,2PR-S8\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXR+#`P,2PR-#,\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(X,2PQ-#(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPOF4Z,3`N,'!T.V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/&9O;G0@2!A;F0@:71S('=H;VQL>2UO=VYE9"!S=6)S M:61I87)I97,N)B,Q-C`[($%L;"!S:6=N:69I8V%N="!I;G1E6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0M2!A;F0@17%U:7!M96YT/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z M,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@F5D(&]V97(@=&AE(&QI9F4@ M;V8@=&AE(&QE87-E(&]R(&EM<')O=F5M96YT+"!W:&EC:"!I7!I8V%L M;'D@9FEV92!Y96%R'!E;G-E(')E;&%T960@=&\@<')O<&5R='D@86YD(&5Q=6EP;65N="!O9B`D M,3@L-S0U+"`D,38L,#@R(&%N9"`D,3,L-C@T(&9O65A6QE/3-$)U1%6%0M24Y$14Y4 M.B`P+C5I;CL@34%21TE..B`P:6X@,&EN(#!P=#LG/B8C,38P.SPO<#X-"CQP M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P:6X@,&EN M(#!P=#LG/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D]N('-A;&4@;W(@ M2!R96QA=&5D(&=A:6X@;W(@ M;&]S'0^)SQD:78@3I4:6UE6QE/3-$)U1%6%0M24Y$ M14Y4.B`P+C5I;CL@34%21TE..B`P:6X@,&EN(#!P=#LG/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D=O;V1W:6QL("T@169F96-T:79E($YO=F5M8F5R M)B,Q-C`[,2P@,C`Q,2P@=&AE($-O;7!A;GD@861O<'1E9"!R979I2!T:&%N(&YO="8C.#(R M,3L@=&AR97-H;VQD(&ES('=H96X@=&AEF%T:6]N(&]F("0R+#0P,2!A2X\+V9O;G0^/"]P/@T*/"]D:78^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^)SQD:78@3I4:6UE6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D]T:&5R($EN=&%N9VEB;&4@07-S971S("T@26YT86YG M:6)L92!A2XF(S$V,#L@ M5&AE(&)A;&%N8V4@F%T:6]N(&]F("0X+#@T-BP@86YD("0W+#@U,B!A65A2!I;G1A;F=I8FQE(&%SF4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T* M/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE=R!!8V-O=6YT:6YG('!R;VYO=6YC96UE;G1S M/"]F;VYT/CPO<#X-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T M.R<^/&9O;G0@2!A9&]P=&5D($%C8V]U;G1I;F<@4W1A;F1A6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS M1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^/&9O;G0@28C.#(Q-SMS(&9I;F%N8VEA M;"!S=&%T96UE;G1S(&%S(&$@=VAO;&4L(&ET(')E<75I2X@07,@ M=&AE(')E'0^)SQD:78@3I4:6UE6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CY!8V-O M=6YT:6YG(&9O6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=- M05)'24XZ(#!I;B`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`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.#@E.R!0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,B4^#0H\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT M97([($U!4D=)3CH@,&EN(#!I;B`P<'0[)R!A;&EG;CTS1&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C(P,3(\+V9O;G0^/"]B M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU M;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$ M<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C`V)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@ M,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$ M15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L,#4R+#0S,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#(N.#@E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]5 M3D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXR+#0X,BPS-#D\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,30E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN M9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C`V)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C0E.R!0041$24Y'+5))1TA4 M.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(N.#@E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C M8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$P+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/DUE9&EC87)E+TUE9&EC86ED(%!O6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,U-"PV,S@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXS,C`L-CDW/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C`V)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T M97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P M+C0E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[ M($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(L,SDS+#@W,CPO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.#@E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W M:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$P+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4 M.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C M0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR+#`W M,"PP-S,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1O=&%L($-O;G1R86-T=6%L($%D:G5S=&UE;G1S(&%N M9"!$:7-C;W5N=',\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXR+#6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$L.3(S+#6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#4Y+C`V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O M=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W M:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$P+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4 M.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C M0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXV-C$L M-C8Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C4U."PV-#(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@ M34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]2 M1$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C0E.R!0041$24Y'+5))1TA4 M.B`P:6X[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C8P+#(T-#PO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(N.#@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT M(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C,X M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXT-RPT,#8\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE="!2979E;G5E6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P M="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU" M3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q,"XT)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$ M15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N M93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXW,34L,S4T/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E M>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$P+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-% M149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXV,30L,C4U M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$P+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/ M54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52 M+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L M;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXU,C(L,#@Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C0E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXE/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXE/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXE/"]F;VYT/CPO<#X\+W1D/CPO='(^ M/"]T86)L93X-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^ M/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S M='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^/&9O;G0@2!R961U M8VEN9R!G'!E;G-E(&ES('!R M97-E;G1E9"!A'!E;G-E2!H879E(&)E96X@861J=7-T960@;W9E2!A8W1I;VXL(&EF(&%N>2P@=VAI8V@@:7,@=&%K96X@86YD('1H92!C;VYT M96YT(&]F(&QE9VES;&%T:6]N+"!I9B!A;GDL('=H:6-H(&ES(&%D;W!T960L M('1H92!#;VUP86YY(&-O=6QD(&5X<&5R:65N8V4@82!S:6=N:69I8V%N="!D M96-R96%S92!I;B!R979E;G5E2!I'0^)SQD:78@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`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`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(N.24[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C(P,3,\+V9O M;G0^/"]B/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/C(P,3(\+V9O;G0^/"]B/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^ M)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$P+C0T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I M=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU4 M3U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(N.24[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D-O;G1R86-T=6%L M($-R961I=',O1&ES8V]U;G1S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS-#(L,CDW/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXR-C6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1O=6)T9G5L($%C8V]U;G1S/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1O=&%L($%L;&]W86YC93PO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.24[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O M=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$P+C0T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4 M.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C M0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`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`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)' M24XZ(#!I;B`P:6X@,'!T.R<^/&9O;G0@&%M:6YA=&EO;B!B>2!T M87AI;F<@875T:&]R:71I97,N)B,Q-C`[($9O65AF4Z,3`N,'!T.V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/&9O;G0@2!P&5R8VES92!O9B!S=6-H(&1I;'5T:79E('-E8W5R:71I97,@=V]U;&0@ M8F4@=7-E9"!T;R!P=7)C:&%S92!C;VUM;VX@2!T:&4@;G5M8F5R(&]F('-H87)E2!D:6QU=&4@96%R M;FEN9W,@:6X@=&AE(&9U='5R92!AF4Z M,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/&9O;G0@ M'!E;G-E'0^)SQD:78@3I4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E)E8V]V97)A8FEL:71Y(&%N9"!);7!A M:7)M96YT(&]F($EN=&%N9VEB;&4@07-S971S(&%N9"!/=&AE28C.#(Q M-SMS(&%B:6QI='D@=&\@"!C87-H(&9L;W=S("AU;F1I6EN9R!A;6]U M;G0@;V8@6EN9R!A;6]U;G0@;V8@=&AE(&%S'0^)SQD:78@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%D=F5R=&ES M:6YG($-O6QE/3-$)V9O;G0M2!R96-E:79E9"!A(')E9G5N9"!O9B`D,2PP-C(@ M9F]R(&ETF4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/&9O M;G0@3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\W-&%D.3(T85\S,C$S7S0U,3-?.&0P95]C M.6$S8S0R-C9A.#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S1A M9#DR-&%?,S(Q,U\T-3$S7SAD,&5?8SEA,V,T,C8V83@W+U=O'0O:'1M;#L@8VAAF4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;CLG/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^#0H\=&%B;&4@6QE/3-$<&%D9&EN M9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C`V)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-3DE/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B@D*3PO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C`V)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-3DE/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/EEE87(F(S$V,#M%;F1E9#PO9F]N=#X\+V(^/"]P/CPO M=&0^#0H\=&0@6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#4Y+C`V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3DE/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!! M1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,B4^#0H\<"!S='EL93TS1"=415A4+4%,24=. M.B!C96YT97([($U!4D=)3CH@,&EN(#!I;B`P<'0[)R!A;&EG;CTS1&-E;G1E M6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C(P,3$\+V9O M;G0^/"]B/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$P+C0E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]5 M3D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C,L-3(T+#$P.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N M.#@E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N M;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$P+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$ M.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5)) M1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(] M,T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS M+#`U,BPT,S$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#(N.#@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3`E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T M.R<^/&9O;G0@6QE/3-$)U!! M1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,30E.R!0041$24Y'+5))1TA4 M.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#4Y+C`V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3DE/@T*/'`@ M6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXS-30L-C,X/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$ M)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C,X M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(Y,RPX-S0\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`Q,'!T.R<^/&9O;G0@6]R6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXR+#,Y,RPX-S(\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E M>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1) M3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$L-C(Y+#@S,SPO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,30E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#4Y+C`V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3DE M/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(L,SDP+#6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD M;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$P+C,X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I M=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU4 M3U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ M+#DR,RPW,#<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@ M34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI M9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C0E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z M(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT M(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C,X M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!" M3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@ M;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXU-3@L-C0R/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/E!A=&EE M;G0@4V5R=FEC92!2979E;G5E(%!R;W9I6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXV,"PR-#0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E M>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1) M3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C,V+#4V M,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,30E.R!0041$ M24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C`V)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B M;&4[($)/4D1%4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ M(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q,"XS."4[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N M,C5P="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E. M1RU"3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q,"XS M."4[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#4Y+C`V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3DE/@T* M/'`@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$P+C0E.R!0041$24Y'+5))1TA4.B`P:6X[($)/ M4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N M;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3`E/@T*/'`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`N,'!T.V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CLG/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^#0H\=&%B;&4@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.24[(%!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B@D*3PO9F]N M=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$<&%D9&EN9SHP.SX-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/D]C=&]B97(F(S$V,#LS,2P\+V9O;G0^/"]B/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/ M4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$<&%D9&EN9SHP.SX- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%2 M1TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C0T)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C,T,BPR.3<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$P+C0V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(V-RPY,C$\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52 M+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C0T)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXX.2PR-C$\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P M="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C0V)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@ M0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXU,2PR-S0\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)U!! M1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0S,2PU-3@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[ M($)/4D1%4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I M;CL@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q,"XT-B4[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/CPO=&%B;&4^#0H\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!A M;F0@17%U:7!M96YT/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$F4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CM&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)SX-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@ M,'!T.R<^)B,Q-C`[/"]P/@T*/'1A8FQE('-T>6QE/3-$)W1E>'0M86QI9VXZ M;&5F=#M415A4+4%,24=..B!L969T.R!724142#H@-#`X<'@[($)/4D1%4BU# M3TQ,05!313H@8V]L;&%P#L@4$%$1$E.1RU,1494 M.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N-"4[(%!!1$1)3D6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#,N-"4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O M=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E M(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)W!A9&1I;F#L@4$%$ M1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D#L@4$%$ M1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%2 M1TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXV-2PW-C(\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXU,"PS,S@\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)U1%6%0M24Y$ M14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@ M6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ.2PW M-C@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@#L@4$%$1$E.1RU,1494.B`P M<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q M,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR,2PV,C$\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$V+#4P,SPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$N,S@E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0 M041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W M:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$V+C,V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E. M1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$V)2!C;VQS M<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXQ."PR-#(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI M9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52 M+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$V)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ-BPP M.3(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@#L@4$%$1$E.1RU,1494.B`P M<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$V+C,V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4 M.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C M0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$V)2!C;VQS<&%N/3-$ M,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#,N-"4[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-U8B!4;W1A;',\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,38E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$S,RPU.3D\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,38E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$P,BPW,#$\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@#L@4$%$1$E.1RU,1494.B`P<'@[ M(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T M.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$V)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXV-RPY-3`\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S M;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@ M4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$V)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXU,BPR-C$\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1) M3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q M,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N M;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$V+C,V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0 M.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$V)2!C M;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N-"4[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU M;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/E1O=&%L6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[($)/4D1%4BU,1494.B!M M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$1$E.1RU,1494 M.B`P:6X[(%=)1%1(.B`Q+C,E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM' M4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$ M15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4P+#0T,#PO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,S@E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&%D.3(T85\S,C$S7S0U M,3-?.&0P95]C.6$S8S0R-C9A.#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-S1A9#DR-&%?,S(Q,U\T-3$S7SAD,&5?8SEA,V,T,C8V83@W+U=O M'0O:'1M M;#L@8VAA'0^ M)SQD:78@3I4 M:6UE6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SX\=3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CY/8W1O M8F5R)B,Q-C`[,S$L(#(P,3,\+V9O;G0^/"]U/CPO<#X-"CQP('-T>6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\=&%B;&4@#L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93LG(&)O6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0 M041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N M,3(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SX\8CX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#AP=#L@1D].5"U714E' M2%0Z(&)O;&0[)R!S:7IE/3-$,3Y);G1A;F=I8FQE)B,Q-C`[07-S970\+V9O M;G0^/"]B/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ M('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO M;F4[(%!!1$1)3DF%T:6]N/"]F;VYT/CPO8CX\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N M,3(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU" M3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D M:75M(&YO;F4[(%!!1$1)3DF%T:6]N/"]F;VYT/CPO8CX\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P M/CPO=&0^#0H\=&0@#L@4$%$1$E.1RU, M1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P M>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D-U6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXX+#6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR+#@W.3PO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXU M+#@V,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,C8E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I M;F#L@ M4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`Q,'!T.R<^/&9O;G0@6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXV+#4W,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N M,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@ M,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`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`X/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L.#@Y/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W+C0X M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3#L@4$%$1$E.1RU,1494 M.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1O=&%L6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W+C0X)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C(U+#$V-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N M,3(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[($)/4D1%4BU, M1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$1$E. M1RU,1494.B`P:6X[(%=)1%1(.B`Q+C,E.R!0041$24Y'+5))1TA4.B`P:6X[ M($)!0TM'4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE M.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C$V M+#,R,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,C8E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/CPO=&%B;&4^#0H\<"!S='EL93TS M1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^)B,Q-C`[/"]P/@T*/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D]C=&]B97(F(S$V,#LS,2P@,C`Q,CPO9F]N=#X\+W4^/"]P M/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/E=E:6=H=&5D+4%V97)A9V4\+V9O;G0^ M/"]B/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/D%C8W5M=6QA=&5D/"]F;VYT/CPO8CX\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D#L@4$%$1$E. M1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ('=I M;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[ M(%!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/DEN=&%N9VEB;&4F M(S$V,#M!6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/D%M;W)T:7IA M=&EO;B8C,38P.U!E6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/D-O6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D#L@4$%$ M1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N M;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$W+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0 M.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$W)3X- M"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]2 M1$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$S+C6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0 M041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@ M34%21TE..B`P:6X@,&EN(#!P="`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`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXT+#,P-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$S+C6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0L,C4W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D#L@4$%$ M1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E!A=&5N=',@86YD($QI8V5N6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$S+C6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXU+#(Y-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z M("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]2 M1$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ+#`U.#PO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P M:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT M(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXT M+#(S.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,C8E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I M;F#L@ M4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`Q,'!T.R<^)B,Q-C`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`P<'0[)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52 M+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R+C0V)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@ M;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z M(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$R)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXQ-"PQ-S4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O M=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$R+C0V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!" M04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@ M0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG M(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R M)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXV+#,R,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/CPO=&%B;&4^/"]D M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$F%T:6]N(&5X<&5N M6QE/3-$)V9O M;G0M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^#0H\=&%B;&4@#L@0D]21$52+4-/3$Q!4%-%.B!C;VQL M87!S93L@34%21TE.+4Q%1E0Z(#(N,C5I;CLG(&)O6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/ M4#H@,'!X.R<^#0H\=&0@#L@4$%$1$E.1RU,1494.B`P<'@[ M(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C$L.3$W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D#L@4$%$1$E.1RU,1494.B`P M<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C(P,34\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C$L.#4R M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU,1494.B`P<'@[ M(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,38\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$L-30P/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D#L@4$%$1$E. M1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,3<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$L,#8S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D#L@4$%$1$E.1RU4 M3U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C(P,3@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDT-CPO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N,R4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O M=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/ M4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE. M.B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N,R4[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT M(#(N,C5P="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU"3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`S M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/@T*/'`@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE M/3-$)U!!1$1)3D7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879AF4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;CM&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)SX-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^ M)B,Q-C`[/"]P/@T*/'1A8FQE('-T>6QE/3-$)W1E>'0M86QI9VXZ;&5F=#M4 M15A4+4%,24=..B!L969T.R!724142#H@,C8Q<'@[($)/4D1%4BU#3TQ,05!3 M13H@8V]L;&%P#L@4$%$1$E.1RU,1494.B`P<'@[ M(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)U!!1$1)3D6QE/3-$ M)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^ M#0H\=&0@#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D M:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXT.3,\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X M.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@ M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(W+C6QE/3-$)U!!1$1)3D#L@ M4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,38\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C4U,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N,R4[(%!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXU.#4\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$ M1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T M.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(W+C6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T* M/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y' M+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P M=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S M;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(W+C6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C M.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^ M#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#,E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z M("-C8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE' M2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXT+#$V,SPO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#(N,R4[(%!!1$1)3D3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W M-&%D.3(T85\S,C$S7S0U,3-?.&0P95]C.6$S8S0R-C9A.#<-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S1A9#DR-&%?,S(Q,U\T-3$S7SAD,&5? M8SEA,V,T,C8V83@W+U=O'0O:'1M;#L@8VAA"!R871E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG M/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^#0H\=&%B;&4@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4 M.B`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`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`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$Q+C(V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$ M.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,U/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS-3PO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXE/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#4S+C6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ,2XR,#PO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXE/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXE/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXE/"]F;VYT/CPO<#X\+W1D/CPO='(^#0H\='(@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/E!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BDE/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@P+C0T/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXI)3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52 M+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q+C(V)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@ M;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z M(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$Q)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXH,"XY-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,"XS-S5P=#L@4$%$1$E.1RU,1494.B`P M:6X[(%=)1%1(.B`S+C$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/ M54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@ M34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\ M=&0@6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`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`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P M:6X@,'!T.R<^)B,Q-C`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`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`@6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Q+C6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q M+C6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@ M0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q+C6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N M,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$Q+C6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C(E.R!0041$24Y'+5)) M1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP M.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Q+C6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q+C6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C(E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Q+C6QE/3-$)U!! M1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,X+#(Y-3PO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,S8E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXR-2PW.30\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(T+#4W,SPO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C(E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN M9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Q+C6QE M/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$Q+C6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE. M.B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)U!! M1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#,N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C M8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$Q+C6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D9E9&5R86P\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXH,3`L.#`S/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXH,BPQ.#,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B@T+#(R M,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C(E.R!0041$ M24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXI/"]F;VYT/CPO M<#X\+W1D/CPO='(^#0H\='(@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-T871E(&%N9"!,;V-A;#PO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W M:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$Q+C6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXH-BPR,S@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE M/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D M:75M(&YO;F4[(%!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@Q+#8X.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XS-S5P=#L@4$%$1$E.1RU,1494 M.B`P:6X[(%=)1%1(.B`S+C(R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$ M<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Q+C6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q+C6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#,N,C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$Q+C6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$Q+C6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,N,C(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#4Q+C6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[($)/4D1% M4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$ M1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q+C,V)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@ M;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z M(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@ M,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N M,S8E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[ M($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXS,BPS-C`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+C0R)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0 M.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR."PT.#<\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@F4Z,3`N,'!T.V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\=&%B;&4@6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#8P+C@X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C`E/@T*/'`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`@6QE/3-$<&%D9&EN9SHP M.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8P+C@X)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-C`E/@T*/'`@6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52 M+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C8T)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$U)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C8E.R!0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N M;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$U+C8T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0 M.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2!C M;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,S(E.R!0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#8P+C@X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N M,S(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8P+C@X)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I M9'1H/3-$-C`E/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(R+#4V,#PO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,S(E.R!0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#8P+C@X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/ M54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$U+C8T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C$L M.#$U/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`R,'!T.R<^/&9O;G0@'!E;G-E6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C8T)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I M=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$U)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS+#$T,3PO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD M;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$U+C8T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I M=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU4 M3U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2!C;VQS<&%N M/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXR+#8V-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$N,S(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T* M/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8P+C@X M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C8T)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0 M.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$U)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C8E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$U+C8T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4 M.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C M0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2!C;VQS<&%N/3-$ M,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$N,S(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM' M4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8P M+C@X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@ M=F%L:6=N/3-$=&]P('=I9'1H/3-$-C`E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0T+#(S,3PO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,C8E.R!0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD M;W=T97AT(#(N,C5P="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I=6T@;F]N M93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[(%=) M1%1(.B`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`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O M;G0@6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1% M4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C8T)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$U)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXT-"PR,S$\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C(W M+#$Y,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,S(E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN M9SHP.SX-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!"3U)$15(M5$]0.B!M961I M=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93LG('=I9'1H/3-$ M,S0Y/CPO=&0^#0H\=&0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[ M($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU M;2!N;VYE.R<@=VED=&@],T0X,CX\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO M;F4[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE M9&EU;2!N;VYE.R<@=VED=&@],T0X/CPO=&0^/"]T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W M-&%D.3(T85\S,C$S7S0U,3-?.&0P95]C.6$S8S0R-C9A.#<-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S1A9#DR-&%?,S(Q,U\T-3$S7SAD,&5? M8SEA,V,T,C8V83@W+U=O'0O:'1M;#L@8VAAF4Z,3`N,'!T.V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!C;VUP M=71A=&EO;B!O9B!B87-I8R!A;F0@9&EL=71E9"!N970@96%R;FEN9W,@<&5R M(&-O;6UO;B!S:&%R92!I6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Q+C@V)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-3$E/@T*/'`@6QE/3-$)U!!1$1) M3D6QE/3-$<&%D9&EN9SHP M.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Q+C@V)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-3$E/@T*/'`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`P<'0[)R!A;&EG;CTS1&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/C(P,3$\+V9O;G0^/"]B/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%2 M1TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$R+C4E.R!0041$24Y'+5))1TA4.B`P:6X[($)/4D1%4BU4 M3U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E M(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE M9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN8V]M92!!=F%I;&%B;&4@=&\@0V]M;6]N M(%-T;V-K:&]L9&5R6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0U+#@R-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z M("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0R+#$U-CPO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM' M4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS-BPS-3D\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T M.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR-RPV.3$\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R+C4T)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3(E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#DW,3PO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,C0E.R!0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#4Q+C@V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R+C4E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1) M3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@ M34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/'4^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R+C4E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R M+C4E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[ M(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ-SD\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXR,S8\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P M/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$R+C4T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E(&-O;'-P M86X],T0R/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E=E:6=H=&5D($%V97)A M9V4@1&EL=71E9"!#;VUM;VX@4VAA6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD M;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$R+C4E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C(W+#@U,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N M,3(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$R+C4E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!" M3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#DR,3PO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM' M4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI M9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R+C4T)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0 M.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$R)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR."PR,#<\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,3(E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$R+C4E.R!0041$24Y'+5))1TA4.B`P:6X[($)/4D1%4BU43U`Z(&UE9&EU M;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E(&-O;'-P86X] M,T0R/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE="!);F-O;64@4&5R(%-H87)E("T@0F%S:6,\+V9O M;G0^/"]U/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!! M1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C$N-3(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Q+C@V)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P M('=I9'1H/3-$-3$E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C$N M-3$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X\+W1R/CPO=&%B;&4^#0H\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SQS<&%N/CPO2!O9B!O=71S M=&%N9&EN9R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z,3`N,'!T.V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\=&%B;&4@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P M=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^ M#0H\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/E=E:6=H=&5D)B,Q-C`[079E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/D5X97)C:7-A8FQE/"]F M;VYT/CPO8CX\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,30E.R!0041$ M24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,V+C,X)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,S8E(&-O;'-P86X],T0W/@T*/'`@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,B4^#0H\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([ M($U!4D=)3CH@,&EN(#!I;B`P<'0[)R!A;&EG;CTS1&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/E)E;6%I;FEN9SPO9F]N=#X\+V(^/"]P/CPO=&0^ M#0H\=&0@&5R8VES93PO9F]N=#X\ M+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/E-H87)E&5R8VES93PO9F]N=#X\+V(^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE. M.B`P:6X@,&EN(#!P="`Q,'!T.R<^/&(^/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1% M4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/E!R:6-E/"]F;VYT/CPO8CX\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,30E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`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`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#0N-#(E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z M('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N M;VYE.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N M;VYE.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B0V+C$Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D M:75M(&YO;F4[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I M=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q+C$V)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$ M15(M5$]0.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+5))1TA4.B!M M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-% M149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)3X-"CQP('-T>6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CY097(@4VAA6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I M=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149& M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXP+C6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU M;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C8N,3$\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/ M54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52 M+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L M;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQP M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXV+C$Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#0N-#(E.R!0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/G1O/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0W+C8W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ+C`Y/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3`E/@T*/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C8R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!! M1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN M9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@ M+3$P<'0[($U!4D=)3CH@,&EN(#!I;B`P<'0@,3!P=#LG(&%L:6=N/3-$6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8N M-3@E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[ M(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD.2XQ,SPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N,C(E.R!0041$24Y'+5))1TA4.B`P:6X[ M($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$Q+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E!E6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$P+C`T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C$T M-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-#@E.R!0041$ M24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$N,#`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXY+C$S/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@+3$P<'0[($U!4D=) M3CH@,&EN(#!I;B`P<'0@,3!P=#LG(&%L:6=N/3-$6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$W+C4P/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I M;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[ M(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C,P M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(N-3(E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P M="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU" M3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q,"XP-"4[ M(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-#@E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[($)/4D1%4BU,1494 M.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$1$E.1RU, M1494.B`P:6X[(%=)1%1(.B`Q,"4[(%!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1) M3D'0^)SQD:78@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^#0H\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@ M,&EN(#!I;B`P<'0[)R!A;&EG;CTS1&-E;G1E6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N M-C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU" M3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D M:75M(&YO;F4[(%!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-C8E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U14 M3TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4^#0H\ M<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@,&EN(#!I M;B`P<'0[)R!A;&EG;CTS1&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/E=E:6=H=&5D)B,Q-C`[079E6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@ M0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W+C$V)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E. M1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$W)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXS,S4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#4Y+C(X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-3DE/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C M.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#4Y+C(X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO'!I6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W M+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C.#(Q M,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P M:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1) M3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@T,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XS-S5P=#L@4$%$1$E.1RU,1494 M.B`P:6X[(%=)1%1(.B`R+C8V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4^#0H\ M<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXX+C8W/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52 M+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W+C$V)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@ M;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z M(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$W)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXR.34\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#4Y+C(X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@ M,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3DE/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N M;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$W+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0 M.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$W)3X- M"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#(N-C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]2 M1$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W+C$V)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4 M.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$W)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,#@E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C(X)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!! M1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W+C$V)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^ M/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W+C$V)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,36QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#(N-C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C(X)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO&5R8VES960\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C@N-3(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C(U.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N M-C8E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52 M+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,S@E.R!0041$24Y'+5))1TA4.B`P M:6X[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T M.R<^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`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`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4Y+C(X)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO'!I6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C@N-C0\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`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`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(N-C8E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E M9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$W+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$W)2!C;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ,"XP,CPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$N,#@E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4 M.B!M961I=6T@;F]N93LG('=I9'1H/3-$-#$T/CPO=&0^#0H\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!" M3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R<@=VED=&@],T0Q.3X\+W1D/@T* M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$ M15(M3$5&5#H@;65D:75M(&YO;F4[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE M.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R<@=VED=&@],T0Q,#X\+W1D M/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[($)/4D1%4BU43U`Z(&UE9&EU;2!N M;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R<@=VED=&@],T0Q,3`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!"3U)$15(M5$]0.B!M961I M=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93LG('=I9'1H/3-$ M.#X\+W1D/CPO='(^/"]T86)L93X-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=415A4+4E.1$5. M5#H@.7!T.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<^/&9O;G0@&5R8VES92!A="!/8W1O8F5R M)B,Q-C`[,S$L(#(P,3`@=V5R92`S,3`@870@82!W96EG:'1E9"!A=F5R86=E M(&5X97)C:7-E('!R:6-E('!E&5R8VES92!A="!/8W1O8F5R)B,Q-C`[,S$L(#(P,3$@=V5R92`R M-S4@870@82!W96EG:'1E9"!A=F5R86=E(&5X97)C:7-E('!R:6-E('!E&5R8VES92!A="!/8W1O M8F5R)B,Q-C`[,S$L(#(P,3(@=V5R92`R-#0@870@82!W96EG:'1E9"!A=F5R M86=E(&5X97)C:7-E('!R:6-E('!E&5R8VES92!A="!/8W1O8F5R)B,Q-C`[,S$L(#(P,3,@=V5R M92`R,SD@870@82!W96EG:'1E9"!A=F5R86=E(&5X97)C:7-E('!R:6-E('!E M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!O9B!E;7!L M;WEE92!I;F-E;G1I=F4@F4Z,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;CLG/@T*/'`@6QE/3-$)U1%6%0M24Y$ M14Y4.B`Y<'0[($U!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\ M=&%B;&4@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N M-S@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU" M3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D M:75M(&YO;F4[(%!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-S@E M.R!0041$24Y'+5))1TA4.B`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`@6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D&5R8VES92!A="!/8W1O8F5R M)B,Q-C`[,S$L(#(P,3`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0N-C0\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^ M/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD M;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$U+C4V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I M=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU4 M3U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)3X-"CQP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXF M(S@R,3([/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q M,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I M=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C4V)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$ M15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N M93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$U)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N M;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXS+C@R/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D&5R M8VES92!A="!/8W1O8F5R)B,Q-C`[,S$L(#(P,3$\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#8R+C(V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C(E M/@T*/'`@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C4V)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I M=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$U)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-S@E.R!0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I M=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C4V)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@ M0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2!C;VQS<&%N/3-$,CX-"CQP M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$N,#@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8R M+C(V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C4V)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C4V M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D5X97)C M:7-E9#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-S@E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$U+C4V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/ M54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52 M+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L M;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)3X-"CQP M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXH.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,"XS-S5P=#L@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`R+C6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXS+C,Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D&5R8VES92!A="!/8W1O8F5R)B,Q M-C`[,S$L(#(P,3(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXU+C0W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D=R86YT960\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$U+C4V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]2 M1$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G M8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2!C M;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D5X<&ER960\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXH,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(N-S@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8R+C(V)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO&5R8VES960\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXI/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ('=I M;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[ M(%!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C4N,C4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C4V)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I M=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$U)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-S@E.R!0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I M=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U+C4V)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@ M0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2!C;VQS<&%N/3-$,CX-"CQP M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$N,#@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8R M+C(V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T M97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$U M+C4V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I M=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149& M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)3X-"CQP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXV/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E M>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1) M3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU M;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[($)/4D1%4BU43U`Z M(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R<@=VED M=&@],T0Q.3X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE M9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[($)/4D1%4BU4 M3U`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`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU M;2!N;VYE.R<@=VED=&@],T0Y-CX\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO M;F4[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE M9&EU;2!N;VYE.R<@=VED=&@],T0W/CPO=&0^/"]T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W M-&%D.3(T85\S,C$S7S0U,3-?.&0P95]C.6$S8S0R-C9A.#<-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S1A9#DR-&%?,S(Q,U\T-3$S7SAD,&5? M8SEA,V,T,C8V83@W+U=O'0O:'1M;#L@8VAA6UE;G0@0V]N=')A M8W1S(&%N9"!#;VYS=6QT:6YG($%G'0^)SQS<&%N M/CPO'0^)SQD:78@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^#0H\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=) M3CH@,&EN(#!I;B`P<'0[)R!A;&EG;CTS1&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$ M<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I M=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8X+CDX)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$ M15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N M93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG M;CTS1'1O<"!W:61T:#TS1#8X)3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(N-C(E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!" M3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO'0@,7!T M('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4L,38Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,34\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXS+#@W,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T* M/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#8X+CDX M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE M/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P M:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(T+C`R M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,C0E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C(L M.3$X/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C(P M,3@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ+#(T,SPO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[ M($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#8X+CDX)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@ M,&EN.R<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-C@E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I M;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[ M(%!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P M/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P M:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T M(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(Q+C0E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!" M3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C$E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$V+#@V,#PO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X\+W1R/CPO=&%B;&4^#0H\+V1I=CX\'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'!I'0^ M)SQD:78@3I4 M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/D]C=&]B97(F(S$V,#LS M,3PO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$)W!A9&1I;F#L@4$%$ M1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,N-"4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@ M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@ M,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E(&-O;'-P M86X],T0R/@T*/'`@6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU2 M24=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@ M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@ M;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@ M4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$V)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ-2PP,3,\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@ M0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$R+#`W.#PO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,S8E.R!0041$24Y'+5))1TA4.B`P M:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@ M,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@ M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C,V)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,38E/@T*/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$P+#4X,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#,N-"4[(%!!1$1)3D6QE/3-$)U!!1$1)3D#L@ M4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#,N-"4[(%!!1$1)3D6QE M/3-$)U!!1$1)3D#L@4$%$1$E.1RU4 M3U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E1O=&%L6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR M,"PW.#D\+V9O;G0^/"]P/CPO=&0^#0H\=&0@#L@4$%$1$E.1RU,1494 M.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DQE6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$S+#$R-3PO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#,N-"4[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C8L-S6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[ M(%!!1$1)3D6QE M/3-$)U!!1$1)3D#L@4$%$1$E.1RU,1494.B`P M<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE=#PO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N-"4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3DF4Z M,3`N,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CM&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)SX-"CQP('-T M>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S M='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^)B,Q-C`[/"]P/@T*/'1A M8FQE('-T>6QE/3-$)W1E>'0M86QI9VXZ;&5F=#M415A4+4%,24=..B!L969T M.R!724142#H@,S4W<'@[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/D]C=&]B97(F(S$V,#LS,2P\+V9O;G0^/"]B/CPO<#X\+W1D/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU4 M3U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU M;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXU+#8R,CPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$N-C8E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0 M041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#(P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C`E(&-O;'-P M86X],T0R/@T*/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0L-C,P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1) M3D#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,3<\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR+#$Y,CPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N-C8E.R!0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=( M5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#(P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$ M.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C8V,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N-C8E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A M9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\ M=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(P M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,C`E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C$U M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(P)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#(P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0 M.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(P)2!C M;VQS<&%N/3-$,CX-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXQ-BPX-#8\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M#L@ M4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(P)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,C`E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/CDT.3PO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N-C8E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I M;F#L@ M4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@ M6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q M,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N-C8E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I M;F#L@ M4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`Q,'!T.R<^/&9O;G0@6UE;G1S/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E M>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(N,38E.R!0041$24Y'+5))1TA4.B`P:6X[($)/4D1%4BU43U`Z(&UE9&EU M;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4^#0H\<"!S='EL M93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D'1087)T7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@3I4:6UE6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=-05)' M24XZ(#!I;B`P:6X@,'!T.R<^)B,Q-C`[/"]P/@T*/'1A8FQE('-T>6QE/3-$ M)W1E>'0M86QI9VXZ;&5F=#M724142#H@-3`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`R)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1'1O<"!W:61T:#TS1#0P M)3X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P M:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U!!1$1) M3D6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXS-#0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1) M3D6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR,C,\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXX M-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N.3@E.R!0041$ M24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#0P+C`R)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,3<\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXU-3@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#(T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C0E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C4U M.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(T)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,C0E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#0P+C`R)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N M/3-$=&]P('=I9'1H/3-$-#`E/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(T)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,C0E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O M;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P M="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU" M3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`R-"4[(%!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR M-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(T)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$ M15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N M93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#(T)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXV-30\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@F4Z,3`N,'!T.V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/@T*/'`@6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@ M0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4W)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4 M.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#4W)3X-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SX\8CX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#AP=#L@1D].5"U714E'2%0Z(&)O;&0[ M)R!S:7IE/3-$,3Y/8W1O8F5R)B,Q-C`[,S$\+V9O;G0^/"]B/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C(P,30\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#,V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,S8E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C$Q M+#DS.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$ M24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4W)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,38\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXQ,"PX-30\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D M9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#4W)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,V M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1O=&%L6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C0U+#4U-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/CPO=&%B;&4^#0H\ M+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO6QE/3-$)V9O;G0M6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^#0H\=&%B;&4@6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/ M4#H@,'!X.R<^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N."4[(%!!1$1)3D6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1% M4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D'0@ M,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4^#0H\<"!S M='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@,&EN(#!I;B`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`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ+#`P.#PO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(N.#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!" M04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C(S,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.#(E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$L,C0P/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ.#4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M#L@ M4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/DUE9&EC86P@17%U:7!M96YT/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR,C4\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXS/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3,E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(Q/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E/@T* M/'`@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C(Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXU,SPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.#(E.R!0041$24Y'+5))1TA4.B`P:6X[ M($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXU,SPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,#@E.R!0041$24Y'+5))1TA4.B`P:6X[ M($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X M.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`R,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E/@T*/'`@ M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@#L@4$%$1$E.1RU,1494.B`P M<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYO;BU#;VUP971E($%G M6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXW.3`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M#L@4$%$1$E. M1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D1E<&]S:71S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXF M(S@R,3([/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3,E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M#L@ M4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D-U6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L,C,U/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU, M1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P M>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/D=O M;V1W:6QL/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ+#DP-3PO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N.#(E.R!0041$24Y'+5)) M1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3,E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C8W,SPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(N.#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3,E/@T*/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(L-36QE M/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXM,3$X/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=( M5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`R,'!T.R<^/&9O;G0@ M6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXM,C`P/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3,E/@T*/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BTR,#`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@#L@4$%$1$E. M1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/E-H;W)T(%1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/BTQ+#(U,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N M,#@E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^ M#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E/@T*/'`@6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$N,#@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$ M24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE. M.B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$S+C0X)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$S)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXV+#`Q-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(N.#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C M8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[($)/ M4D1%4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@ M4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q,RXT."4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C6QE/3-$)U!!1$1)3D'0^)SQD:78@6QE/3-$)W1E M>'0M86QI9VXZ;&5F=#M415A4+4%,24=..B!L969T.R!724142#H@-#(P<'@[ M($)/4D1%4BU#3TQ,05!313H@8V]L;&%P#L@4$%$1$E.1RU4 M3U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=( M5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#,N,S@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U14 M3TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/E1O=&%L6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%C8V]U;G1S(%)E8V5I=F%B;&4\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C(T)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N M93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I M;CLG(&)G8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$V)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXQ+#6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@ M,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE. M.B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@'!E;G-E6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E/@T* M/'`@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C0R,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C

6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS-CD\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXF(S@R,3([/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,38E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C8R/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$V+C(T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E/@T*/'`@ M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C8R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D'1U6QE/3-$)U!! M1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C(T M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W,3PO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$N,C@E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0 M041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,38E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXW,30\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXW,30\+V9O;G0^/"]P/CPO=&0^#0H\=&0@#L@4$%$1$E.1RU,1494 M.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DUE9&EC86P@ M17%U:7!M96YT/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D#L@ M4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D-O;7!U=&5R($5Q=6EP;65N=#PO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E.R!0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,38E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,W-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#,N,S@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E M/@T*/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C4W-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N M,S@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$V+C(T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@ M,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/CDU,#PO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,C@E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I M;F#L@ M4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@ M6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T M.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXY,C8\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR+#$X,3PO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$N,C@E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0 M041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L.#4R/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$V+C(T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E M/@T*/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C,L.#4U/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C@L-36QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D#L@ M4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%C8V]U;G1S(%!A>6%B;&4\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXH,2PS.#@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXH,2PS.#@\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$ M24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%2 M1TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXI/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$V+C(T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@S.3,\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)W!A9&1I;F#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y' M+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@ M34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E M/@T*/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXH M-36QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXH-36QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O;G0^/"]P/CPO=&0^/"]T#L@4$%$1$E.1RU,1494 M.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D-A<&ET86P@ M3&5A6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/B@Q.3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B@Q.3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)W!A9&1I;F#L@4$%$1$E. M1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X.R<^#0H\=&0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T M.R<^/&9O;G0@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B@S M+#`P,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E.R!0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXI/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O;G0^/"]P/CPO M=&0^/"]T#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E9F5R6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C$V)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXH,3`X/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXH,3`X/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O;G0^/"]P/CPO=&0^/"]T M#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$ M1$E.1RU43U`Z(#!P>#LG/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,N,S@E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V+C(T)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,38E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@ M,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$V M+C$V)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I M=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G8V]L;W(],T0C0T-%149& M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$V)3X-"CQP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ,BPS,C8\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C(L M,3(W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE M9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$V+C(T)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]2 M1$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;CLG(&)G M8V]L;W(],T0C0T-%149&('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$V)3X- M"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXQ-"PT-3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0M6QE M/3-$)U!!1$1)3D6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,SDE/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/D9I6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1% M4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,B4^#0H\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U! M4D=)3CH@,&EN(#!I;B`P<'0[)R!A;&EG;CTS1&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/C0O,S`O,C`Q,SPO9F]N=#X\+V(^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO M;F4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED M.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/C(P,3,\+V9O;G0^/"]B/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P M:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O M;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$W-BPT-3(\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ.#4L M-#(W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q M,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y' M+51/4#H@,&EN.R<@8F=C;VQO6QE M/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXQ,2PS,S@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ-"PW,#$\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ,2PQ,C`\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXT-2PX,C4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@ M34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3`E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E/@T* M/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P M=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^ M#0H\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@ M86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D)A6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C`N M-#$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXP+C4S/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$N-C4\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`R M,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C`N,S$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXP+C0Q/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN M.R<@8F=C;VQO6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C`N-#`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ+C8U/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3`E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C(W+#6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#8Y.#PO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C(W M+#8W,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$ M24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#8W-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z M("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#8Y,3PO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4 M.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/ M4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,SDE/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3`E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O M;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@ M,&EN.R<@8F=C;VQO6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#DQ,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C M8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#@W.3PO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P M:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C(W+#@T,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#@T-#PO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM' M4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/ M54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C(W+#@U M,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X\+W1R/CPO=&%B;&4^#0H\<"!S='EL93TS1"=-05)' M24XZ(#!I;B`P:6X@,'!T.R<^)B,Q-C`[/"]P/@T*/'1A8FQE('-T>6QE/3-$ M)W1E>'0M86QI9VXZ;&5F=#M724142#H@,3`P)3L@0D]21$52+4-/3$Q!4%-% M.B!C;VQL87!S93LG(&)O6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/D9I6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1% M4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N M;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,B4^#0H\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=) M3CH@,&EN(#!I;B`P<'0[)R!A;&EG;CTS1&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C0O,S`O,C`Q,CPO9F]N M=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U14 M3TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N M;VYE.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3`E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/C(P,3(\+V9O;G0^/"]B/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P M:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/C$S."PW.3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[ M(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXQ-C`L-3,R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C$V,RPT.#<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$=&]P('=I M9'1H/3-$,SDE/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C8W+#4S-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXW-"PR-SD\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W-BPV,3$\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXW+#,V-3PO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM' M4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXY+#,P-CPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM' M4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ,BPU.38\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0R+#$U-CPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4.B`P:6X[($)! M0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@ M=F%L:6=N/3-$=&]P('=I9'1H/3-$,SDE/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P M86X],T0R/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN M9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C M;VQO6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y' M+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@ M,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`R,'!T M.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N M,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B0\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXP+C,T/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C`N-#4\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ+C4R/"]F;VYT/CPO<#X\+W1D M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1I;'5T960\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXP+C,S/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C`N-#4\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE M/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[)R!S:7IE/3-$,CXQ+C4Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$ M)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#@X.#PO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[ M($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!" M04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO M6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#8X-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C M8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C(W M+#8Y-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$ M24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/ M4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!" M04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO M6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,SDE/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3`E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E M.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/@T*/'`@ M6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(X+#`T,3PO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]5 M3D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$ M.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C(W+#@W.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$ M24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#@X.#PO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4 M.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@ M8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+#DP-CPO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]5 M3D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$ M.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4] M,T0R/C(W+#DR,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E M.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X\+W1R/CPO=&%B;&4^#0H\<"!S='EL M93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T.R<^)B,Q-C`[/"]P/@T*/'1A8FQE M('-T>6QE/3-$)W1E>'0M86QI9VXZ;&5F=#M724142#H@,3`P)3L@0D]21$52 M+4-/3$Q!4%-%.B!C;VQL87!S93LG(&)O6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$ M24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U!!1$1)3D6QE M/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,SDE/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C$O,S$O,C`Q,3PO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)T)/4D1% M4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO M;F4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED M.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/@T* M/'`@'0@,7!T('-O M;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@ M,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4^#0H\<"!S='EL93TS M1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@,&EN(#!I;B`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`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M)R!S:7IE/3-$,CXQ,30L,3(Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$R.2PT-C4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXD M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R M/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXQ-#`L-C@T/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4R,BPP.#$\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C0Y M+#(W-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$ M24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[ M(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXU-RPT-#<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C8T+#,P,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR,S0L,C(Y/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE="!);F-O;64\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$P+#0W-CPO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4 M.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXS-BPS-3D\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q M,'!T.R<^/&9O;G0@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@ M,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R M/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V M,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%2 M1TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q-C`[/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C M8V5E9F8[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E M969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$ M)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX] M,T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0 M041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y' M+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D)A6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C`N,CD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$ M,CXP+C,V/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C`N,S<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF M(S$V,#L\+W`^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN.R<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C`N,C@\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXP+C,V/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C`N,S<\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SX\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$<&%D9&EN9SHP.SX-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#,Y)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,SDE/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)U!!1$1) M3D6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$ M24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O M;'-P86X],T0R/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q M,'!T.R<^/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR-RPX.#0\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR-RPY,C`\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S M:7IE/3-$,CXR-RPY-#$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR-RPY-#D\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR-RPY-S$\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)U1%6%0M M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T.R<^)B,Q M-C`[/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R M:6=H=#XF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$ M24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0[)SXF(S$V,#L\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN.R<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)U!! M1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#XF(S$V,#L\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[)SXF(S$V,#L\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0 M041$24Y'+51/4#H@,&EN.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E M(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E=E:6=H=&5D($%V97)A9V4@ M0V]M;6]N(%-H87)E6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR."PQ,C(\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[)R!S:7IE/3-$,CXR."PQ-#(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M.R<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR M."PQ-#<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T.R<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[)R!S:7IE/3-$,CXR."PQ,S@\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S4@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S(@>65A'0^)SQS<&%N/CPO&EM=6T\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S$U('EE87)S/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&%D M.3(T85\S,C$S7S0U,3-?.&0P95]C.6$S8S0R-C9A.#<-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-S1A9#DR-&%?,S(Q,U\T-3$S7SAD,&5?8SEA M,V,T,C8V83@W+U=O'0O:'1M;#L@8VAA2!O9B!3:6=N:69I M8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A:6QS(#(I("A54T0@)"D\ M8G(^26X@5&AO=7-A;F1S+"!U;FQE'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR M+#0P,3QS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`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`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!I;G-P96-T:6]N(&9E93PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&%D.3(T85\S,C$S7S0U M,3-?.&0P95]C.6$S8S0R-C9A.#<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-S1A9#DR-&%?,S(Q,U\T-3$S7SAD,&5?8SEA,V,T,C8V83@W+U=O M'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'1U'0^)SQS<&%N/CPO2!A;F0@97%U:7!M M96YT/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO2!A;F0@97%U:7!M96YT/"]S=')O;F<^ M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-BPS,C`\'0^)SQS<&%N/CPO65A65A'!E;G-E(')E;&%T960@=&\@:6YT M86YG:6)L92!A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO MF%T:6]N(%!E'0^)S,@>65A'0^)SQS<&%N M/CPO65A65A'!E;G-E M(')E;&%T960@=&\@:6YT86YG:6)L92!A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)V)A'0^)T5U'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!O9B!P3QS<&%N/CPO'0^)SQS<&%N/CPO M6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO2!I;G-T86QL;65N="!I;F-L=61I;F<@<')I;F-I<&%L M(&%N9"!I;G1E'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A"!R871E/"]S M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#@Q M-3QS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO"!! M'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO"!B96YE9FET/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XQ-RPP-#$\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&%D.3(T85\S M,C$S7S0U,3-?.&0P95]C.6$S8S0R-C9A.#<-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-S1A9#DR-&%?,S(Q,U\T-3$S7SAD,&5?8SEA,V,T,C8V M83@W+U=O'0O:'1M;#L@8VAA&-E<'0@4VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D/"]T9#X-"B`@("`@("`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`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES960@8GD@=&AE(&]P M=&EO;F5E(&%F=&5R('1E'0^)SQS<&%N/CPO2!T:&4@;W!T:6]N964@869T97(@=&5R;6EN M871I;VX@;V8@96UP;&]Y;65N="!D=64@=&\@9&ES86)I;&ET>2!O'0^)S$@>65A'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO65E(&EN8V5N=&EV92!S=&]C:R!O<'1I M;VX@<&QA;BP@861D:71I;VYA;"!D:7-C;&]S=7)E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS M<&%N/CPO'0^)SQS<&%N M/CPO65A'0^)SQS<&%N/CPO&5R8VES86)L92!F;W(@=&AE(&9I'0^)SQS<&%N/CPO&5R8VES92!P2!T;R!L96YD(&UO;F5Y(&]R(&=U87)A;G1Y(&%N>2!O8FQI9V%T M:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,"XP,"4\'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO65E(&EN8V5N=&EV92!S=&]C M:R!O<'1I;VYS/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO&5R8VES92!P'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65E(&EN8V5N=&EV92!S=&]C:R!O<'1I;VYS/"]S=')O;F<^/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'!I'0^ M)SQS<&%N/CPO&5R8VES960@*&EN(&1O;&QA'0^)SQS M<&%N/CPO&EM=6T\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO65E(&EN8V5N=&EV92!S=&]C:R!O M<'1I;VYS/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO&5R8VES92!P'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO&5R8VES86)L92P@4VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!P'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!0'0^)SQS<&%N/CPO&5R8VES M86)L92P@17AE'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S$@>65A&5R8VES92!0'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO65E($EN8V5N=&EV92!3=&]C:R!/<'1I;VYS/"]S M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`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`@("`@ M("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XD(#$P+#4V.#QS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)S4@>65A M'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!I;G-U&-E&-E2!L:6UI=',\+W1D/@T*("`@("`@ M("`\=&0@8VQA&-E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&%D M.3(T85\S,C$S7S0U,3-?.&0P95]C.6$S8S0R-C9A.#<-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-S1A9#DR-&%?,S(Q,U\T-3$S7SAD,&5?8SEA M,V,T,C8V83@W+U=O'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@("`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`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7)O;&P@0F5N969I=',\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7)O M;&P@861J=7-T;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO7)O;&P@861J=7-T;65N=#PO=&0^#0H@("`@("`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`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO'!E;G-E65A'0^)SQS<&%N/CPO2!T:&4@=&AI2!E>&-E'0^)SQS<&%N/CPO&EM=6T@86UO=6YT(&EN('1H92!A9V=R96=A=&4L(&-O=F5R M960@8GD@=&AE('1H:7)D('!A'0^)SQS<&%N/CPO65E(&-O;G1R:6)U=&EO;G,@9F]R(&QI;6ET960@:&5A;'1H(&EN'1087)T7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N M/CPO2=S(&-O;G1R:6)U=&EO;B!U;F1E7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA2!&:6YA M;F-I86P@1&%T82`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htm IDEA: XBRL DOCUMENT v2.4.0.8
Selected Quarterly Financial Data (Tables)
 12 Months Ended
Oct. 31, 2013
Selected Quarterly Financial Data  
Schedule of quarterly financial data

 

 

 

 

 

 

 

 

 

 

 

 

Audited

 

 

 

Three Month Ended

 

Fiscal Year

 

 

 

1/31/2013

 

4/30/2013

 

7/31/2013

 

10/31/2013

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Revenues

 

161,256

 

176,452

 

185,427

 

192,219

 

715,355

 

Gross Profit

 

70,922

 

80,676

 

85,660

 

85,282

 

322,539

 

Net Income

 

8,665

 

11,338

 

14,701

 

11,120

 

45,825

 

Net Income Per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

0.31

 

0.41

 

0.53

 

0.40

 

1.65

 

Diluted

 

0.31

 

0.41

 

0.53

 

0.40

 

1.65

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding — Basic [in thousands]

 

27,716

 

27,698

 

27,672

 

27,677

 

27,691

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding - Diluted [in thousands]

 

27,912

 

27,879

 

27,842

 

27,844

 

27,851

 

 

 

 

 

 

 

 

 

 

 

 

Audited

 

 

 

Three Month Ended

 

Fiscal Year

 

 

 

1/31/2012

 

4/30/2012

 

7/31/2012

 

10/31/2012

 

2012

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Revenues

 

$

138,793

 

$

151,443

 

$

160,532

 

$

163,487

 

$

614,255

 

Gross Profit

 

$

60,118

 

$

67,534

 

$

74,279

 

$

74,681

 

$

276,611

 

Net Income

 

$

7,365

 

$

9,306

 

$

12,596

 

$

12,889

 

$

42,156

 

Net Income Per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.26

 

$

0.34

 

$

0.45

 

$

0.47

 

$

1.52

 

Diluted

 

$

0.26

 

$

0.33

 

$

0.45

 

$

0.46

 

$

1.51

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding — Basic [in thousands]

 

27,888

 

27,685

 

27,695

 

27,705

 

27,742

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding - Diluted [in thousands]

 

28,041

 

27,878

 

27,888

 

27,906

 

27,921

 

 

 

 

 

 

Audited

 

 

 

Three Month Ended

 

Fiscal Year

 

 

 

1/31/2011

 

4/30/2011

 

7/31/2011

 

10/31/2011

 

2011

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Revenues

 

$

114,129

 

$

129,465

 

$

137,802

 

$

140,684

 

$

522,081

 

Gross Profit

 

$

49,276

 

$

57,447

 

$

63,206

 

$

64,300

 

$

234,229

 

Net Income

 

$

7,985

 

$

7,817

 

$

10,081

 

$

10,476

 

$

36,359

 

Net Income Per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.29

 

$

0.28

 

$

0.36

 

$

0.37

 

$

1.30

 

Diluted

 

$

0.28

 

$

0.28

 

$

0.36

 

$

0.37

 

$

1.29

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding — Basic [in thousands]

 

27,884

 

27,920

 

27,941

 

27,949

 

27,971

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding - Diluted [in thousands]

 

28,122

 

28,142

 

28,147

 

28,138

 

28,207

 

XML 38 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Selected Quarterly Financial Data
 12 Months Ended
Oct. 31, 2013
Selected Quarterly Financial Data  
Selected Quarterly Financial Data

[23] Selected Quarterly Financial Data [Unaudited]

 

 

 

 

 

 

 

 

 

 

 

Audited

 

 

 

Three Month Ended

 

Fiscal Year

 

 

 

1/31/2013

 

4/30/2013

 

7/31/2013

 

10/31/2013

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Revenues

 

161,256

 

176,452

 

185,427

 

192,219

 

715,355

 

Gross Profit

 

70,922

 

80,676

 

85,660

 

85,282

 

322,539

 

Net Income

 

8,665

 

11,338

 

14,701

 

11,120

 

45,825

 

Net Income Per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

0.31

 

0.41

 

0.53

 

0.40

 

1.65

 

Diluted

 

0.31

 

0.41

 

0.53

 

0.40

 

1.65

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding — Basic [in thousands]

 

27,716

 

27,698

 

27,672

 

27,677

 

27,691

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding - Diluted [in thousands]

 

27,912

 

27,879

 

27,842

 

27,844

 

27,851

 

 

 

 

 

 

 

 

 

 

 

 

Audited

 

 

 

Three Month Ended

 

Fiscal Year

 

 

 

1/31/2012

 

4/30/2012

 

7/31/2012

 

10/31/2012

 

2012

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Revenues

 

$

138,793

 

$

151,443

 

$

160,532

 

$

163,487

 

$

614,255

 

Gross Profit

 

$

60,118

 

$

67,534

 

$

74,279

 

$

74,681

 

$

276,611

 

Net Income

 

$

7,365

 

$

9,306

 

$

12,596

 

$

12,889

 

$

42,156

 

Net Income Per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.26

 

$

0.34

 

$

0.45

 

$

0.47

 

$

1.52

 

Diluted

 

$

0.26

 

$

0.33

 

$

0.45

 

$

0.46

 

$

1.51

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding — Basic [in thousands]

 

27,888

 

27,685

 

27,695

 

27,705

 

27,742

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding - Diluted [in thousands]

 

28,041

 

27,878

 

27,888

 

27,906

 

27,921

 

 

 

 

 

 

Audited

 

 

 

Three Month Ended

 

Fiscal Year

 

 

 

1/31/2011

 

4/30/2011

 

7/31/2011

 

10/31/2011

 

2011

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Revenues

 

$

114,129

 

$

129,465

 

$

137,802

 

$

140,684

 

$

522,081

 

Gross Profit

 

$

49,276

 

$

57,447

 

$

63,206

 

$

64,300

 

$

234,229

 

Net Income

 

$

7,985

 

$

7,817

 

$

10,081

 

$

10,476

 

$

36,359

 

Net Income Per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.29

 

$

0.28

 

$

0.36

 

$

0.37

 

$

1.30

 

Diluted

 

$

0.28

 

$

0.28

 

$

0.36

 

$

0.37

 

$

1.29

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding — Basic [in thousands]

 

27,884

 

27,920

 

27,941

 

27,949

 

27,971

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding - Diluted [in thousands]

 

28,122

 

28,142

 

28,147

 

28,138

 

28,207

 
XML 39 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
New Authoritative Accounting Pronouncements
 12 Months Ended
Oct. 31, 2013
New Authoritative Accounting Pronouncements  
New Authoritative Accounting Pronouncements

[22] New Authoritative Accounting Pronouncements

 

The Company adopted Accounting Standard Update (“ASU”) No. 2011-7: Health Care Entities (Topic 954) — Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities commencing with the current fiscal year, the first year such standard is required for the Company. The adoption of this update did not have a material impact on the Company’s financial statements.

 

Although this update does not have a material impact on the Company’s financial statements as a whole, it requires that we adjust our presentation of our statement of operations along with prior periods presented in this report to maintain comparability. As the result of this change in presentation, our “Net Revenues”, “Gross Profit on Revenues” and our “General and Administrative Expenses” would change while our “Operating Income”, “Net Income” and “Earnings per Share” will remain the same. The presentation is adjusted for a portion of our “Bad Debt Expense” that is now reported in our Net Revenues as required under ASU No. 2011-7.
XML 40 R56.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Options and Warrants (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
Oct. 31, 2010
2003 Plan
        
Employee incentive stock options        
Maximum aggregate shares of common stock authorized under the plan 1,600,000      
Minimum specified percentage of outstanding common stock for the holder of which the exercise price must be at least 110% of fair market value 10.00%      
Period within which options must be exercised by the optionee after termination of his employment due to retirement 3 months      
Period within which options must be exercised by the optionee after termination of employment due to disability or death 1 year      
Shares Under Options        
Outstanding at the beginning of the period (in shares) 259,000 295,000 335,000  
Granted (in shares) 0 0 0  
Expired (in shares) (6,000) (13,000) 0  
Exercised (in shares) (4,000) (23,000) (40,000)  
Outstanding at the end of the period (in shares) 249,000 259,000 295,000  
Weighted Average        
Outstanding at the beginning of the period (in dollars per share) $ 9.95 $ 9.80 $ 9.66  
Expired (in dollars per share) $ 8.64 $ 9.13    
Exercised (in dollars per share) $ 7.25 $ 8.52 $ 8.67  
Outstanding at the end of the period (in dollars per share) $ 10.02 $ 9.95 $ 9.80  
Employee incentive stock option plan, additional disclosures        
Outstanding options, eligible for exercise (in shares) 239,000 244,000 275,000 310,000
Outstanding options, eligible for exercise, weighted average exercise price (in dollars per share) $ 9.97 $ 9.95 $ 9.80 $ 9.66
2003 Plan | Maximum
        
Employee incentive stock options        
Option term 10 years      
Aggregate fair market value of the common stock with respect to which options are exercisable for the first time by the grantee (in dollars) $ 100      
Percentage of exercise price of option for which the Board (or a Stock Option Committee) in its sole discretion, cause the company to lend money or guaranty any obligation 50.00%      
2003 Plan | Holder of 10% or more of the outstanding common stock
        
Employee incentive stock options        
Exercise price as a percentage of fair value of common stock 110.00%      
Option term 5 years      
2000 Plan
        
Employee incentive stock options        
Maximum aggregate shares of common stock authorized under the plan 1,600,000      
Exercise price as a percentage of fair value of common stock 100.00%      
Minimum specified percentage of outstanding common stock for the holder of which the exercise price must be at least 110% of fair market value 10.00%      
Shares Under Options        
Outstanding at the beginning of the period (in shares) 52,000 60,000 100,000  
Granted (in shares) 0 0 0  
Expired (in shares) (2,000) 0 0  
Exercised (in shares) (44,000) (8,000) (40,000)  
Outstanding at the end of the period (in shares) 6,000 52,000 60,000  
Weighted Average        
Outstanding at the beginning of the period (in dollars per share) $ 5.47 $ 5.19 $ 4.64  
Expired (in dollars per share) $ 3.60      
Exercised (in dollars per share) $ 5.25 $ 3.39 $ 3.82  
Outstanding at the end of the period (in dollars per share) $ 7.67 $ 5.47 $ 5.19  
2000 Plan | Maximum
        
Employee incentive stock options        
Option term 10 years      
2000 Plan | Holder of 10% or more of the outstanding common stock
        
Employee incentive stock options        
Exercise price as a percentage of fair value of common stock 110.00%      
XML 41 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
Organization and Business (Details)
 12 Months Ended
Oct. 31, 2013
item
Organization and Business  
Number of Reportable Segments 1
Laboratory testing business | Minimum
  
Organization and Business  
Percentage of assets to consolidated assets 98.00%
Percentage of net revenue to consolidated net revenues 98.00%
Percentage of net income to consolidated net income 98.00%
XML 42 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
 12 Months Ended
Oct. 31, 2013
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS  
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

BIO-REFERENCE LABORATORIES, INC. AND SUBSIDIARIES

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS FOR THE YEARS ENDED OCTOBER 31, 2013, 2012 AND 2011

[In Thousands]

 

 

 

(b)

 

(c)

 

(d)

 

(e)

 

(a)
Description

 

Balance at the
Beginning of a Period

 

Charged to Cost and
Expenses

 

Deductions Charged to Valuation
Allowance Accounts

 

Balance at the End
of a Period

 

Year Ended October 31, 2013

 

 

 

 

 

 

 

 

 

Allowance for Doubtful Accounts

 

51,274

 

119,161

 

(81,174

)

89,261

 

Contractual Credits/Discounts

 

267,921

 

2,748,510

 

(2,674,134

)

342,297

 

 

 

 

 

 

 

 

 

 

 

Total Allowance

 

319,195

 

2,867,671

 

(2,755,308

)

431,558

 

 

 

 

 

 

 

 

 

 

 

Year Ended October 31, 2012

 

 

 

 

 

 

 

 

 

Allowance for Doubtful Accounts

 

45,220

 

89,396

 

(83,342

)

51,274

 

Contractual Credits/Discounts

 

235,922

 

2,390,770

 

(2,358,771

)

267,921

 

 

 

 

 

 

 

 

 

 

 

Total Allowance

 

281,142

 

2,480,166

 

(2,442,113

)

319,195

 

 

 

 

 

 

 

 

 

 

 

Year Ended October 31, 2011

 

 

 

 

 

 

 

 

 

Allowance for Doubtful Accounts

 

34,904

 

75,079

 

(64,763

)

45,220

 

Contractual Credits/Discounts

 

186,372

 

1,926,164

 

(1,876,614

)

235,922

 

 

 

 

 

 

 

 

 

 

 

Total Allowance

 

221,276

 

2,001,243

 

(1,941,377

)

281,142

 
XML 43 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Oct. 31, 2013
Summary of Significant Accounting Policies  
Principles of Consolidation
Principles of Consolidation - The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  All significant intercompany accounts and transactions have been eliminated.
Cash and Cash Equivalents
Cash and Cash Equivalents - Cash equivalents are comprised of certain highly liquid investments with a maturity of three months or less when purchased.  The Company had $17,952 and $25,143 in cash and cash equivalents at October 31, 2013 and 2012, respectively.
Inventory
Inventory - Inventory is stated at the lower of cost [determined on a first-in, first-out basis] or market.  Inventory consists of purchased laboratory supplies, which is used in our various testing laboratories.
Property and Equipment

Property and Equipment - Property and equipment are carried at cost.  Depreciation is computed by the straight-line method over the estimated useful lives of the respective assets, which generally range from 2 to 15 years.  Leasehold improvements are amortized over the life of the lease or improvement, which is typically five years.

 

The statements of operations reflect depreciation expense related to property and equipment of $18,745, $16,082 and $13,684 for the years ended October 31, 2013, 2012 and 2011, respectively.

 

On sale or retirement, the asset cost and related accumulated depreciation or amortization are removed from the accounts, and any related gain or loss is reflected in general and administrative expenses.  Repairs and maintenance are charged to expense when incurred.
Goodwill

Goodwill - Effective November 1, 2011, the Company adopted revised Financial Accounting Standards Board (“FASB”)  rules promulgated under Accounting Standards Update (“ASU”) No. 2011-08 issued on September 15, 2011, Intangibles—Goodwill and Other (Topic 350) Testing Goodwill for Impairment. Under these simplified goodwill impairment testing rules the Company assessed qualitative factors to determine whether events and circumstances lead to the conclusion that it is necessary to perform the two-step goodwill impairment test have occurred and determined that no such events had occurred.  Under ASU No. 2011-08, entities are not required to calculate the fair value of a reporting unit unless they conclude that it is more likely than not that the unit’s carrying value is greater than its fair value based on an assessment of events and circumstances. The “more likely than not” threshold is when there is a likelihood of more than 50% that a reporting unit’s carrying value is greater than its fair value.  No impairment loss was recognized in the years ended October 31, 2013, 2012 and 2011.

 

The balance sheet reflects prior Goodwill accumulated amortization of $2,401 as of October 31, 2013 and 2012, respectively.
Other Intangible Assets
Other Intangible Assets - Intangible assets are amortized using the straight-line method.  The estimated useful life of costs capitalized is evaluated for each specific project when completed, at which time such costs begin to be amortized. The statements of operations reflect amortization expense related to intangible assets of $994, $581, and $1,322 for the years ended October 31, 2013, 2012 and 2011, respectively.  The balance sheet reflects accumulated amortization of $8,846, and $7,852 as of October 31, 2013, and 2012, respectively. During the 2013 and 2012 fiscal years, the Company did not write off any intangible assets.
New Accounting pronouncements

New Accounting pronouncements

 

Certain prior year amounts have been reclassified to conform to the current year presentation. The Company adopted Accounting Standard Update (“ASU”) No. 2011-7: Health Care Entities (Topic 954) — Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities commencing with the current fiscal year, the first year such standard is required for the Company. The adoption of this update did not have a material impact on the Company’s financial statements.

 

Although this update does not have a material impact on the Company’s financial statements as a whole, it requires that we adjust our presentation of our statement of operations along with prior periods presented in this report to maintain comparability. As the result of this change in presentation, our “Net Revenues”, “Gross Profit on Revenues” and our “General and Administrative Expenses” would change while our “Operating Income”, “Net Income” and “Earnings per Share” will remain the same. The presentation is adjusted for a portion of our “Bad Debt Expense” that is now reported in our Net Revenues as required under ASU No. 2011-7.
Accounting for Revenue

Accounting for Revenue

 

Service revenues are principally generated from laboratory testing services including chemical diagnostic tests such as blood analysis, urine analysis and genetic testing among others. Service revenues are recognized at the time the testing services are performed and are reported at their estimated net realizable amounts.

 

Service revenues before provision for bad debts are determined utilizing gross service revenues net of contractual adjustments and discounts. Even though it is the responsibility of the patient to pay for laboratory service bills, most individuals in the United States have an agreement with a third party payor such as Medicare, Medicaid or a commercial insurance provider to pay all or a portion of their healthcare expenses.  The majority of services provided by Bio-Reference Laboratories, Inc. (“BRLI”) are to patients covered under a third party payor contract. In certain cases, the individual has no insurance or does not provide insurance information and in other cases tests are performed under contract to a professional organization (such as physicians, hospitals, and clinics) which reimburses BRLI directly.  In the remainder of the cases, BRLI is provided the third party billing information and seeks payment from the third party under the terms and conditions of the third party payor for health service providers like BRLI. Each of these third party payors may differ not only with regard to rates, but also with regard to terms and conditions of payment and providing coverage (reimbursement) for specific tests. Estimated revenues are established based on a series of highly complex procedures and judgments that require industry specific healthcare experience and an understanding of payor methods and trends. We review our calculations on a monthly basis in order to make certain that we are properly allowing for the uncollectable portion of our gross billings due to the contractual adjustments and discounts and that our estimates remain sensitive to variances and changes within our payor groups. The contractual allowance calculation is made on the basis of historical allowance rates for the various specific payor groups on a monthly basis with a greater weight being given to the most recent trends This process is adjusted based on recent changes in underlying contract provisions and shifts in the testing being performed. This calculation is routinely analyzed by BRLI on the basis of actual allowances issued by payors and the actual payments made to determine what adjustments, if any, are needed. The table below shows the adjustments made to gross service revenues to arrive at net revenues, the amount reported on our statement of operations.

 

 

 

($)

 

 

 

Year Ended

 

 

 

October 31,

 

 

 

2013

 

2012

 

2011

 

Gross Service Revenues

 

3,524,108

 

3,052,431

 

2,482,349

 

 

 

 

 

 

 

 

 

Contractual Adjustments and Discounts:

 

 

 

 

 

 

 

Medicare/Medicaid Portion

 

354,638

 

320,697

 

293,874

 

All Other Third Party Payors*

 

2,393,872

 

2,070,073

 

1,629,833

 

Total Contractual Adjustments and Discounts

 

2,748,510

 

2,390,770

 

1,923,707

 

Service Revenues Net of Contractual Adjustments and Discounts

 

775,598

 

661,661

 

558,642

 

Patient Service Revenue Provision for Bad Debts**

 

60,244

 

47,406

 

36,561

 

Net Revenues

 

715,354

 

614,255

 

522,081

 

 

 

 

 

 

 

 

 

Percent of Contractual Allowances, Discounts and Patient Service Provision for Bad Debts to Gross Revenue.

 

79.7

%

79.9

%

79.0

%

 

* All Other Third Party and Direct Payors consists of almost eight hundred distinct payors, including commercial health insurers and administrators as well as professionally billed accounts such as physicians, hospitals, clinics and other direct billed accounts.

** Represents the amount of Bad Debt Expense that is now required to be presented as a deduction from patient service revenue (net of contractual allowances and discounts) pursuant to ASU No. 2011-7.

 

When new business is received by BRLI, service revenues net of contractual adjustments and discounts are calculated by reducing gross service revenues by the estimated contractual allowance. The Patient Service Revenue Provision for Bad Debts represents the amount of bad debt expense expected to occur on patient service revenue based upon our experience. The remaining bad debt expense is presented as part of operating expenses. The bad debt expense presented as part of operating expense represents the bad debt expense related to receivables from service revenues determined after taking into account our ability to collect on such revenue.  BRLI recognized the amounts in subsequent periods for actual allowances/discounts to gross service revenue; bad debt may have been adjusted over the same periods of time to maintain an accurate balance between net revenues and actual revenues. Management has reviewed the allowances/discounts recognized in subsequent periods and believes the amounts to be immaterial. A number of proposals for legislation or regulation continue to be under discussion which could have the effect of substantially reducing Medicare reimbursements for clinical laboratories or introducing cost sharing to beneficiaries. Depending upon the nature of regulatory action, if any, which is taken and the content of legislation, if any, which is adopted, the Company could experience a significant decrease in revenues from Medicare and Medicaid, which could have a material adverse effect on the Company. The Company is unable to predict, however, the extent to which such actions will be taken.
Accounting for Contractual Credits and Doubtful Accounts

Accounting for Contractual Credits and Doubtful Accounts

 

It is typically the responsibility of the patient to pay for laboratory service bills. Most individuals in the United States have an agreement with a third party payor such as Medicare, Medicaid or commercial insurance to pay all or a portion of their healthcare expenses; this represents the major portion of payment for all services provided by BRLI. In certain cases, the individual has no insurance or does not provide insurance information; in the remainder of the cases, BRLI is provided the third party billing information, usually by the referring physician, and seeks payment from the third party under the terms and conditions of the third party payor for health service providers like BRLI. Each of these third party payors may differ not only with regard to rates, but also with regard to terms and conditions of payment and coverage of specific tests. BRLI routinely reviews the reimbursement policies and subsequent payments and collection rates from these different types of payors. Contractual adjustments and discounts are recorded as reductions to gross service revenues and are collectively referred to as the contractual allowance. BRLI has not been required to record an adjustment in a subsequent period related to revenue recorded in a prior period which was material in nature. Aging of accounts receivable is monitored by billing personnel and follow-up activities including collection efforts are conducted as necessary. BRLI writes off receivables against the allowance for doubtful accounts when they are deemed uncollectible. For client billing, accounts are written off when all reasonable collection efforts prove to be unsuccessful. Patient accounts, where the patient is directly responsible for all or a remainder portion of the account after partial payment or denial by a third party payor, are written off after the normal dunning cycle has occurred, although these may be subsequently transferred to a third party collection agency after being written off. Third party payor accounts are written off when they exceed the payer’s timely filing limits. Accounts Receivable on the balance sheet is net of the following amounts for contractual credits and doubtful accounts:

 

 

 

($)

 

 

 

October 31,

 

October 31,

 

 

 

2013

 

2012

 

 

 

 

 

 

 

Contractual Credits/Discounts

 

342,297

 

267,921

 

Doubtful Accounts

 

89,261

 

51,274

 

Total Allowance

 

431,558

 

319,195

 
Current Income Taxes
Current Income Taxes — The Company recognizes interest and penalties on settlement of tax liabilities in its income from operations.  For the fiscal years 2011 through 2013, no material amounts for interest and penalties have been recorded.
Deferred Income Taxes

Deferred Income Taxes - Deferred income tax assets and liabilities are computed annually for differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.

 

The Company adopted GAAP guidance with respect to uncertain tax positions when it became effective.  Under these rules the Company may recognize the tax benefit from an uncertain tax position only if it meets the more-likely-than-not criteria (over 50% likelihood) of being realized on an examination by taxing authorities.  For the years ended October 31, 2011 through October 31, 2013 the Company had no material uncertain tax positions to report.
Earnings Per Share
Earnings Per Share - Basic earnings per share [“EPS”] reflects the amount of income attributable to each share of common stock based on average common shares outstanding during the period.  Diluted EPS reflects Basic EPS while giving effect to all potential dilutive common shares that were outstanding during the period, such as common shares that could result from the exercise or conversion of securities into common stock.  The computation of Diluted EPS is calculated by using the treasury stock method, which assumes that any proceeds obtained from the exercise of such dilutive securities would be used to purchase common stock at the average market price of the common stock during the period.  This reduces the gross number of dilutive shares by the number of shares purchasable from the proceeds of the securities assumed to be exercised.  Securities whose conversion would have an anti-dilutive effect on EPS are not assumed converted.  Securities that could potentially dilute earnings in the future are disclosed in Note 10.
Use of Estimates
Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
Recoverability and Impairment of Intangible Assets and Other Long-Lived Assets
Recoverability and Impairment of Intangible Assets and Other Long-Lived Assets — The Company evaluates the possible impairment of its long-lived assets under the provisions of FASB codification 350-30-35 and 360-10-35.  The Company reviews the recoverability of its long-lived assets on an annual basis.  Evaluation of possible impairment is based on the Company’s ability to recover the asset from the expected future pretax cash flows (undiscounted and without interest charges) of the related operations. If the expected undiscounted pretax cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.  No impairment loss was recognized in the fiscal years ended October 31, 2013, 2012 and 2011.
Advertising Costs
Advertising Costs -Advertising costs are expensed when incurred.  Advertising costs amounted to approximately $3,200, $2,366 and $2,026 for the years ended October 31, 2013, 2012 and 2011, respectively.
Other Income
Other Income — During the year the Company recorded a loss of $450on its investment in IncellDx.  The loss represents the Company’s share of IncellDX undistributed net loss under the equity method of accounting.  During the year ended October 31, 2013 the Company received a refund of $1,062 for its New York State clinical laboratory inspection fee that was included in other income.
Subsequent Events
Subsequent Events — The management considered subsequent events through the date the financial statements are issued as defined in FASB Codification 855-10-50.
XML 44 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies
 12 Months Ended
Oct. 31, 2013
Summary of Significant Accounting Policies  
Summary of Significant Accounting Policies

[2] Summary of Significant Accounting Policies

 

Principles of Consolidation - The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  All significant intercompany accounts and transactions have been eliminated.

 

Cash and Cash Equivalents - Cash equivalents are comprised of certain highly liquid investments with a maturity of three months or less when purchased.  The Company had $17,952 and $25,143 in cash and cash equivalents at October 31, 2013 and 2012, respectively.

 

Inventory - Inventory is stated at the lower of cost [determined on a first-in, first-out basis] or market.  Inventory consists of purchased laboratory supplies, which is used in our various testing laboratories.

 

Property and Equipment - Property and equipment are carried at cost.  Depreciation is computed by the straight-line method over the estimated useful lives of the respective assets, which generally range from 2 to 15 years.  Leasehold improvements are amortized over the life of the lease or improvement, which is typically five years.

 

The statements of operations reflect depreciation expense related to property and equipment of $18,745, $16,082 and $13,684 for the years ended October 31, 2013, 2012 and 2011, respectively.

 

On sale or retirement, the asset cost and related accumulated depreciation or amortization are removed from the accounts, and any related gain or loss is reflected in general and administrative expenses.  Repairs and maintenance are charged to expense when incurred.

 

Goodwill - Effective November 1, 2011, the Company adopted revised Financial Accounting Standards Board (“FASB”)  rules promulgated under Accounting Standards Update (“ASU”) No. 2011-08 issued on September 15, 2011, Intangibles—Goodwill and Other (Topic 350) Testing Goodwill for Impairment. Under these simplified goodwill impairment testing rules the Company assessed qualitative factors to determine whether events and circumstances lead to the conclusion that it is necessary to perform the two-step goodwill impairment test have occurred and determined that no such events had occurred.  Under ASU No. 2011-08, entities are not required to calculate the fair value of a reporting unit unless they conclude that it is more likely than not that the unit’s carrying value is greater than its fair value based on an assessment of events and circumstances. The “more likely than not” threshold is when there is a likelihood of more than 50% that a reporting unit’s carrying value is greater than its fair value.  No impairment loss was recognized in the years ended October 31, 2013, 2012 and 2011.

 

The balance sheet reflects prior Goodwill accumulated amortization of $2,401 as of October 31, 2013 and 2012, respectively.

 

Other Intangible Assets - Intangible assets are amortized using the straight-line method.  The estimated useful life of costs capitalized is evaluated for each specific project when completed, at which time such costs begin to be amortized. The statements of operations reflect amortization expense related to intangible assets of $994, $581, and $1,322 for the years ended October 31, 2013, 2012 and 2011, respectively.  The balance sheet reflects accumulated amortization of $8,846, and $7,852 as of October 31, 2013, and 2012, respectively. During the 2013 and 2012 fiscal years, the Company did not write off any intangible assets.

 

New Accounting pronouncements

 

Certain prior year amounts have been reclassified to conform to the current year presentation. The Company adopted Accounting Standard Update (“ASU”) No. 2011-7: Health Care Entities (Topic 954) — Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities commencing with the current fiscal year, the first year such standard is required for the Company. The adoption of this update did not have a material impact on the Company’s financial statements.

 

Although this update does not have a material impact on the Company’s financial statements as a whole, it requires that we adjust our presentation of our statement of operations along with prior periods presented in this report to maintain comparability. As the result of this change in presentation, our “Net Revenues”, “Gross Profit on Revenues” and our “General and Administrative Expenses” would change while our “Operating Income”, “Net Income” and “Earnings per Share” will remain the same. The presentation is adjusted for a portion of our “Bad Debt Expense” that is now reported in our Net Revenues as required under ASU No. 2011-7.

 

Accounting for Revenue

 

Service revenues are principally generated from laboratory testing services including chemical diagnostic tests such as blood analysis, urine analysis and genetic testing among others. Service revenues are recognized at the time the testing services are performed and are reported at their estimated net realizable amounts.

 

Service revenues before provision for bad debts are determined utilizing gross service revenues net of contractual adjustments and discounts. Even though it is the responsibility of the patient to pay for laboratory service bills, most individuals in the United States have an agreement with a third party payor such as Medicare, Medicaid or a commercial insurance provider to pay all or a portion of their healthcare expenses.  The majority of services provided by Bio-Reference Laboratories, Inc. (“BRLI”) are to patients covered under a third party payor contract. In certain cases, the individual has no insurance or does not provide insurance information and in other cases tests are performed under contract to a professional organization (such as physicians, hospitals, and clinics) which reimburses BRLI directly.  In the remainder of the cases, BRLI is provided the third party billing information and seeks payment from the third party under the terms and conditions of the third party payor for health service providers like BRLI. Each of these third party payors may differ not only with regard to rates, but also with regard to terms and conditions of payment and providing coverage (reimbursement) for specific tests. Estimated revenues are established based on a series of highly complex procedures and judgments that require industry specific healthcare experience and an understanding of payor methods and trends. We review our calculations on a monthly basis in order to make certain that we are properly allowing for the uncollectable portion of our gross billings due to the contractual adjustments and discounts and that our estimates remain sensitive to variances and changes within our payor groups. The contractual allowance calculation is made on the basis of historical allowance rates for the various specific payor groups on a monthly basis with a greater weight being given to the most recent trends This process is adjusted based on recent changes in underlying contract provisions and shifts in the testing being performed. This calculation is routinely analyzed by BRLI on the basis of actual allowances issued by payors and the actual payments made to determine what adjustments, if any, are needed. The table below shows the adjustments made to gross service revenues to arrive at net revenues, the amount reported on our statement of operations.

 

 

 

($)

 

 

 

Year Ended

 

 

 

October 31,

 

 

 

2013

 

2012

 

2011

 

Gross Service Revenues

 

3,524,108

 

3,052,431

 

2,482,349

 

 

 

 

 

 

 

 

 

Contractual Adjustments and Discounts:

 

 

 

 

 

 

 

Medicare/Medicaid Portion

 

354,638

 

320,697

 

293,874

 

All Other Third Party Payors*

 

2,393,872

 

2,070,073

 

1,629,833

 

Total Contractual Adjustments and Discounts

 

2,748,510

 

2,390,770

 

1,923,707

 

Service Revenues Net of Contractual Adjustments and Discounts

 

775,598

 

661,661

 

558,642

 

Patient Service Revenue Provision for Bad Debts**

 

60,244

 

47,406

 

36,561

 

Net Revenues

 

715,354

 

614,255

 

522,081

 

 

 

 

 

 

 

 

 

Percent of Contractual Allowances, Discounts and Patient Service Provision for Bad Debts to Gross Revenue.

 

79.7

%

79.9

%

79.0

%

 

* All Other Third Party and Direct Payors consists of almost eight hundred distinct payors, including commercial health insurers and administrators as well as professionally billed accounts such as physicians, hospitals, clinics and other direct billed accounts.

** Represents the amount of Bad Debt Expense that is now required to be presented as a deduction from patient service revenue (net of contractual allowances and discounts) pursuant to ASU No. 2011-7.

 

When new business is received by BRLI, service revenues net of contractual adjustments and discounts are calculated by reducing gross service revenues by the estimated contractual allowance. The Patient Service Revenue Provision for Bad Debts represents the amount of bad debt expense expected to occur on patient service revenue based upon our experience. The remaining bad debt expense is presented as part of operating expenses. The bad debt expense presented as part of operating expense represents the bad debt expense related to receivables from service revenues determined after taking into account our ability to collect on such revenue.  BRLI recognized the amounts in subsequent periods for actual allowances/discounts to gross service revenue; bad debt may have been adjusted over the same periods of time to maintain an accurate balance between net revenues and actual revenues. Management has reviewed the allowances/discounts recognized in subsequent periods and believes the amounts to be immaterial. A number of proposals for legislation or regulation continue to be under discussion which could have the effect of substantially reducing Medicare reimbursements for clinical laboratories or introducing cost sharing to beneficiaries. Depending upon the nature of regulatory action, if any, which is taken and the content of legislation, if any, which is adopted, the Company could experience a significant decrease in revenues from Medicare and Medicaid, which could have a material adverse effect on the Company. The Company is unable to predict, however, the extent to which such actions will be taken.

 

Accounting for Contractual Credits and Doubtful Accounts

 

It is typically the responsibility of the patient to pay for laboratory service bills. Most individuals in the United States have an agreement with a third party payor such as Medicare, Medicaid or commercial insurance to pay all or a portion of their healthcare expenses; this represents the major portion of payment for all services provided by BRLI. In certain cases, the individual has no insurance or does not provide insurance information; in the remainder of the cases, BRLI is provided the third party billing information, usually by the referring physician, and seeks payment from the third party under the terms and conditions of the third party payor for health service providers like BRLI. Each of these third party payors may differ not only with regard to rates, but also with regard to terms and conditions of payment and coverage of specific tests. BRLI routinely reviews the reimbursement policies and subsequent payments and collection rates from these different types of payors. Contractual adjustments and discounts are recorded as reductions to gross service revenues and are collectively referred to as the contractual allowance. BRLI has not been required to record an adjustment in a subsequent period related to revenue recorded in a prior period which was material in nature. Aging of accounts receivable is monitored by billing personnel and follow-up activities including collection efforts are conducted as necessary. BRLI writes off receivables against the allowance for doubtful accounts when they are deemed uncollectible. For client billing, accounts are written off when all reasonable collection efforts prove to be unsuccessful. Patient accounts, where the patient is directly responsible for all or a remainder portion of the account after partial payment or denial by a third party payor, are written off after the normal dunning cycle has occurred, although these may be subsequently transferred to a third party collection agency after being written off. Third party payor accounts are written off when they exceed the payer’s timely filing limits. Accounts Receivable on the balance sheet is net of the following amounts for contractual credits and doubtful accounts:

 

 

 

($)

 

 

 

October 31,

 

October 31,

 

 

 

2013

 

2012

 

 

 

 

 

 

 

Contractual Credits/Discounts

 

342,297

 

267,921

 

Doubtful Accounts

 

89,261

 

51,274

 

Total Allowance

 

431,558

 

319,195

 

 

Current Income Taxes — The Company recognizes interest and penalties on settlement of tax liabilities in its income from operations.  For the fiscal years 2011 through 2013, no material amounts for interest and penalties have been recorded.

 

Deferred Income Taxes - Deferred income tax assets and liabilities are computed annually for differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.

 

The Company adopted GAAP guidance with respect to uncertain tax positions when it became effective.  Under these rules the Company may recognize the tax benefit from an uncertain tax position only if it meets the more-likely-than-not criteria (over 50% likelihood) of being realized on an examination by taxing authorities.  For the years ended October 31, 2011 through October 31, 2013 the Company had no material uncertain tax positions to report.

 

Earnings Per Share - Basic earnings per share [“EPS”] reflects the amount of income attributable to each share of common stock based on average common shares outstanding during the period.  Diluted EPS reflects Basic EPS while giving effect to all potential dilutive common shares that were outstanding during the period, such as common shares that could result from the exercise or conversion of securities into common stock.  The computation of Diluted EPS is calculated by using the treasury stock method, which assumes that any proceeds obtained from the exercise of such dilutive securities would be used to purchase common stock at the average market price of the common stock during the period.  This reduces the gross number of dilutive shares by the number of shares purchasable from the proceeds of the securities assumed to be exercised.  Securities whose conversion would have an anti-dilutive effect on EPS are not assumed converted.  Securities that could potentially dilute earnings in the future are disclosed in Note 10.

 

Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

 

Recoverability and Impairment of Intangible Assets and Other Long-Lived Assets — The Company evaluates the possible impairment of its long-lived assets under the provisions of FASB codification 350-30-35 and 360-10-35.  The Company reviews the recoverability of its long-lived assets on an annual basis.  Evaluation of possible impairment is based on the Company’s ability to recover the asset from the expected future pretax cash flows (undiscounted and without interest charges) of the related operations. If the expected undiscounted pretax cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.  No impairment loss was recognized in the fiscal years ended October 31, 2013, 2012 and 2011.

 

Advertising Costs -Advertising costs are expensed when incurred.  Advertising costs amounted to approximately $3,200, $2,366 and $2,026 for the years ended October 31, 2013, 2012 and 2011, respectively.

 

Other Income — During the year the Company recorded a loss of $450on its investment in IncellDx.  The loss represents the Company’s share of IncellDX undistributed net loss under the equity method of accounting.  During the year ended October 31, 2013 the Company received a refund of $1,062 for its New York State clinical laboratory inspection fee that was included in other income.

 

Subsequent Events — The management considered subsequent events through the date the financial statements are issued as defined in FASB Codification 855-10-50.
XML 45 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Oct. 31, 2013
Summary of Significant Accounting Policies  
Schedule of adjustments made to gross service revenues to arrive at net revenues

 

 

 

 

($)

 

 

 

Year Ended

 

 

 

October 31,

 

 

 

2013

 

2012

 

2011

 

Gross Service Revenues

 

3,524,108

 

3,052,431

 

2,482,349

 

 

 

 

 

 

 

 

 

Contractual Adjustments and Discounts:

 

 

 

 

 

 

 

Medicare/Medicaid Portion

 

354,638

 

320,697

 

293,874

 

All Other Third Party Payors*

 

2,393,872

 

2,070,073

 

1,629,833

 

Total Contractual Adjustments and Discounts

 

2,748,510

 

2,390,770

 

1,923,707

 

Service Revenues Net of Contractual Adjustments and Discounts

 

775,598

 

661,661

 

558,642

 

Patient Service Revenue Provision for Bad Debts**

 

60,244

 

47,406

 

36,561

 

Net Revenues

 

715,354

 

614,255

 

522,081

 

 

 

 

 

 

 

 

 

Percent of Contractual Allowances, Discounts and Patient Service Provision for Bad Debts to Gross Revenue.

 

79.7

%

79.9

%

79.0

%

 

* All Other Third Party and Direct Payors consists of almost eight hundred distinct payors, including commercial health insurers and administrators as well as professionally billed accounts such as physicians, hospitals, clinics and other direct billed accounts.

** Represents the amount of Bad Debt Expense that is now required to be presented as a deduction from patient service revenue (net of contractual allowances and discounts) pursuant to ASU No. 2011-7.
Schedule of amounts for contractual credits and doubtful accounts

 

 

 

 

($)

 

 

 

October 31,

 

October 31,

 

 

 

2013

 

2012

 

 

 

 

 

 

 

Contractual Credits/Discounts

 

342,297

 

267,921

 

Doubtful Accounts

 

89,261

 

51,274

 

Total Allowance

 

431,558

 

319,195

 
XML 46 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Capitalized Lease Obligations (Tables)
 12 Months Ended
Oct. 31, 2013
Capitalized Lease Obligations  
Schedule of assets under capital leases expiring in fiscal 2018

 

 

 

 

October 31

 

 

 

2013

 

2012

 

Medical Equipment

 

15,013

 

$

12,078

 

Automobiles

 

10,581

 

8,711

 

 

 

 

 

 

 

Totals

 

25,594

 

20,789

 

Less: Accumulated Depreciation

 

13,125

 

6,776

 

 

 

 

 

 

 

Net

 

12,469

 

$

14,013

 
Schedule of aggregate future minimum rentals under capital leases

 

 

October 31,

 

 

 

2014

 

$

5,622

 

2015

 

4,630

 

2016

 

3,727

 

2017

 

2,192

 

2018

 

660

 

Thereafter

 

15

 

 

 

 

 

Total

 

16,846

 

 

 

 

 

Less Interest:

 

949

 

 

 

 

 

Present Value of Minimum Lease Payments

 

$

15,897

 
XML 47 R53.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
Reconciliation of income tax from continuing operations computed at the U.S. federal statutory tax rate to the company's effective income tax rate      
U.S. Federal Statutory Rate (as a percent) 35.00% 35.00% 35.00%
State and Local Taxes, Net of U.S. Federal Tax Benefit (as a percent) 11.20% 8.87% 9.87%
Permanent differences and Other (as a percent) (2.78%) (0.44%) (0.94%)
Actual Rate (as a percent) 43.42% 43.43% 43.93%
Current:      
Federal $ 38,295 $ 25,794 $ 24,573
State & Local 14,018 10,203 9,825
Deferred:      
Federal (10,803) (2,183) (4,223)
State and Local (6,238) (1,454) (1,688)
Provision for Income Taxes 35,272 32,360 28,487
Net operating loss carry-forwards 0 0 0
Deferred Tax Asset:      
Bad Debt Allowance 39,275 22,560  
Depreciation and amortization 1,815 1,963  
Accrued Expenses 3,141 2,667  
Deferred Tax Asset - Net 44,231 27,190  
Current Deferred Tax Asset - Net 42,154 24,912  
Long Term Deferred Tax Asset - Net 2,077 2,278  
Deferred Tax Asset - Net 44,231 27,190  
Net deferred tax benefit      
Net deferred tax benefit 17,041 3,638 5,911
Net benefit in allowance for bad debts 16,715    
Benefit from depreciation and amortization 281    
Benefit in certain accrued expenses $ 607    
XML 48 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Oct. 31, 2013
Oct. 31, 2012
CURRENT ASSETS:    
Cash and Cash Equivalents $ 17,952 $ 25,143
Accounts Receivable - Net 206,261 153,247
Inventory 19,095 14,902
Other Current Assets 9,416 5,373
Deferred Tax Assets 42,154 24,912
TOTAL CURRENT ASSETS 294,878 223,577
PROPERTY AND EQUIPMENT - AT COST 133,599 102,701
LESS: Accumulated Depreciation (67,950) (52,261)
PROPERTY AND EQUIPMENT - NET 65,649 50,440
OTHER ASSETS:    
Investments 5,237 4,977
Deposits 1,017 956
Goodwill - Net 35,185 23,408
Intangible Assets - Net 16,320 6,323
Other Assets 1,165 866
Deferred Tax Assets 2,077 2,278
TOTAL OTHER ASSETS 61,001 38,808
TOTAL ASSETS 421,528 312,825
CURRENT LIABILITIES:    
Accounts Payable 61,614 41,288
Accrued Salaries and Commissions Payable 19,601 16,490
Accrued Taxes and Expenses 18,292 9,753
Other Short Term Acquisition Payable 2,438  
Revolving Note Payable - Bank 26,139 0
Current Maturities of Long-Term Debt 493 464
Capital Lease Obligations - Short-Term Portion 5,185 3,957
TOTAL CURRENT LIABILITIES 133,762 71,952
LONG-TERM LIABILITIES:    
Capital Lease Obligations - Long-Term Portion 10,712 9,463
Long Term Debt - Net of Current Portion 3,670 4,163
Other Long Term Acquisition Payable 1,789  
TOTAL LONG-TERM LIABILITIES 16,171 13,626
SHAREHOLDERS' EQUITY:    
Preferred Stock $.10 Par Value; Authorized 1,666,667 shares, including 3,000 shares of Series A Junior Preferred Stock None Issued      
Common Stock, $.01 Par Value; Authorized 35,000,000 shares: Issued and Outstanding 27,683,213 and 27,707,382 at October 31, 2013 and at October 31, 2012, respectively 277 277
Additional Paid-In Capital 39,430 40,907
Retained Earnings 231,888 186,063
TOTAL SHAREHOLDERS' EQUITY 271,595 227,247
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 421,528 $ 312,825
XML 49 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
Oct. 31, 2010
Cash and Cash Equivalents        
Cash and Cash Equivalents $ 17,952 $ 25,143 $ 22,013 $ 17,779
Property and equipment        
Depreciation expense $ 18,745 $ 16,082 $ 13,684  
Leasehold improvements
        
Property and equipment        
Estimated useful lives 5 years      
Minimum
        
Property and equipment        
Estimated useful lives 2 years      
Maximum
        
Property and equipment        
Estimated useful lives 15 years      
XML 50 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
OPERATING ACTIVITIES:      
Net Income $ 45,825 $ 42,156 $ 36,359
Adjustments to Reconcile Net Income to Cash Provided by Operating Activities:      
Depreciation and Amortization 19,739 16,663 15,005
Deferred Income Taxes (Benefit) (17,041) (3,638) (5,911)
Stock - Based Compensation Expense 290 290 40
Loss on Disposal of Property and Equipment 1,408 537 1,680
Undistributed Equity Method (Income) Loss 450 323  
(Increase) Decrease in:      
Accounts Receivable (91,002) (11,240) (29,254)
Provision for Doubtful Accounts 37,988 6,053 10,316
Inventory (4,193) (5,211) (3,498)
Other Current Assets (4,043) (916) (1,637)
Other Assets (299) (141) 798
Deposits (61) (74) 507
Increase (Decrease) in:      
Accounts Payable and Accrued Liabilities 28,601 8,296 6,541
NET CASH - OPERATING ACTIVITIES 17,662 53,098 30,946
INVESTING ACTIVITIES:      
Business Acquisitions Related Costs (19,013) (5,675) (1,425)
Acquisition of Equipment and Leasehold Improvements (25,100) (15,715) (14,117)
NET CASH - INVESTING ACTIVITIES (44,113) (21,390) (15,542)
FINANCING ACTIVITIES:      
Payments of Long-Term Debt (464) (1,270) (1,178)
Payments of Capital Lease Obligations (4,648) (3,710) (2,968)
Increase (Decrease) in Revolving Note Payable 26,139 (18,632) (7,522)
Proceeds from Exercise of Options 263 227 498
Common Stock Repurchased (2,030) (5,193)  
NET CASH - FINANCING ACTIVITIES 19,260 (28,578) (11,170)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (7,191) 3,130 4,234
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIODS 25,143 22,013 17,779
CASH AND CASH EQUIVALENTS AT END OF PERIODS 17,952 25,143 22,013
Cash paid during the period for:      
Interest 1,503 1,547 1,754
Income Taxes 44,312 36,697 32,773
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:      
Write-off of property and equipment 4,464 2,508 5,944
Equipment with an initial cost     4,558
Purchase of new equipment     5,408
Capital Leases $ 7,125 $ 7,777 $ 5,444
XML 51 R59.htm IDEA: XBRL DOCUMENT v2.4.0.8
Capitalized Lease Obligations (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
Assets under capital leases      
Totals $ 25,594 $ 20,789  
Less: Accumulated Depreciation 13,125 6,776  
Net 12,469 14,013  
Depreciation expense on assets under capital leases 6,494 3,792 1,418
Future minimum rentals under capital leases      
2014 5,622    
2015 4,630    
2016 3,727    
2017 2,192    
2018 660    
Thereafter 15    
Total 16,846    
Less Interest 949    
Total 15,897    
Minimum
      
Assets under capital leases      
Interest rate under capital leases 2.00%    
Maximum
      
Assets under capital leases      
Interest rate under capital leases 8.00%    
Medical Equipment
      
Assets under capital leases      
Totals 15,013 12,078  
Automobiles
      
Assets under capital leases      
Totals $ 10,581 $ 8,711  
XML 52 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt - Bank (Tables)
 12 Months Ended
Oct. 31, 2013
Long-Term Debt - Bank  
Schedule of principal repayment for each of the five succeeding fiscal years and thereafter

 

 

Year Ended

 

 

 

October 31,

 

 

 

2014

 

493

 

2015

 

518

 

2016

 

551

 

2017

 

585

 

2018

 

2,016

 

Thereafter

 

—

 

Totals

 

$

4,163

 
XML 53 R65.htm IDEA: XBRL DOCUMENT v2.4.0.8
Employee Benefit Plan (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
Employee Benefit Plan      
Age requirement for employees to participate in the Plan 18 years    
Requisite service period 1 year    
Contribution by participants (as a percent) 10.00%    
Entity's contribution under the Plan $ 1,358 $ 1,106 $ 993
XML 54 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Insurance
 12 Months Ended
Oct. 31, 2013
Insurance  
Insurance

[16] Insurance

 

The Company maintains professional liability insurance of $3,000 in the aggregate, with a per occurrence limit of $1,000.  In addition, the Company maintains excess commercial insurance of $5,000 per occurrence and $5,000 in aggregate over the primary limits.  In addition, the Company also maintains excess umbrella coverage of $15,000.
XML 55 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Tables)
 12 Months Ended
Oct. 31, 2013
Income Taxes  
Schedule of reconciliation of income tax from continuing operations computed at the U.S. federal statutory tax rate to the Company's effective income tax rate

 

 

 

 

October 31

 

 

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

U.S. Federal Statutory Rate

 

35

%

35

%

35

%

State and Local Taxes, Net of U.S. Federal Tax Benefit

 

11.20

%

8.87

%

9.87

%

Permanent differences and Other

 

(2.78

)%

(0.44

)%

(0.94

)%

 

 

 

 

 

 

 

 

Actual Rate

 

43.42

%

43.43

%

43.93

%
Schedule of provision for income taxes

 

 

 

 

October 31

 

 

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

Current:

 

 

 

 

 

 

 

Federal

 

$

38,295

 

$

25,794

 

$

24,573

 

State & Local

 

14,018

 

10,203

 

9,825

 

 

 

 

 

 

 

 

 

Deferred:

 

 

 

 

 

 

 

Federal

 

(10,803

)

(2,183

)

(4,223

)

State and Local

 

(6,238

)

(1,454

)

(1,688

)

 

 

 

 

 

 

 

 

Total Provision for Income Taxes

 

$

35,272

 

$

32,360

 

$

28,487

 
Schedule of net deferred tax asset [liability]

 

 

 

 

October 31,

 

 

 

2013

 

2012

 

 

 

 

 

 

 

Deferred Tax Asset:

 

 

 

 

 

Bad Debt Allowance

 

$

39,275

 

$

22,560

 

Depreciation and amortization

 

1,815

 

1,963

 

Accrued Expenses

 

3,141

 

2,667

 

 

 

 

 

 

 

Deferred Tax Asset - Net

 

44,231

 

27,190

 

 

 

 

 

 

 

Current Deferred Tax Asset - Net

 

42,154

 

24,912

 

Long Term Deferred Tax Asset - Net

 

2,077

 

2,278

 

 

 

 

 

 

 

Deferred Tax Asset — Net

 

44,231

 

$

27,190

 
XML 56 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions
 12 Months Ended
Oct. 31, 2013
Acquisitions  
Acquisitions

[18] Acquisitions

 

On April 27, 2012, the Company entered into an agreement pursuant to which the Company purchased preferred shares of IncellDx, Inc. (“IncellDx”), a Delaware corporation.  Information about IncellDx and the agreement may be found in the Current Report on Form 8-K the Company filed on May 1, 2012.

 

As of October 31, 2013 the Company invested a total $6,000.

 

On December 21, 2012, the Company entered into an agreement with Meridian Clinical Laboratory Corporation, a Florida corporation having its place of business in Miami, Florida (“Meridian”), pursuant to which the Company purchased all issued and outstanding common stock of Meridian for approximately $1,848 of which $250 is deferred for one year.

 

On December 31, 2012, Bio-Reference Laboratories, Inc. (the “Company”) entered into an agreement with Florida Clinical Laboratory, Inc., a Florida corporation having its place of business in Melbourne, Florida (“FCL”), pursuant to which the Company purchased all issued and outstanding shares of capital stock of FCL for approximately $7,016, of which $1,000 is deferred for eighteen months assuming certain conditions, described, in the are met.

 

The following table sets forth these final purchase allocations.

 

 

 

($)

 

 

 

FCL

 

MCL

 

Totals:

 

 

 

 

 

 

 

 

 

Accounts Receivable

 

1,008

 

232

 

1,240

 

Autos

 

137

 

48

 

185

 

Medical Equipment

 

225

 

3

 

228

 

Computer Equipment

 

21

 

—

 

21

 

Leasehold Improvements

 

53

 

—

 

53

 

Other Non-Current Assets

 

3

 

—

 

3

 

Non-Compete Agreement

 

747

 

43

 

790

 

Deposits

 

—

 

2

 

2

 

Customer Relationships in Place

 

3,235

 

930

 

4,165

 

Goodwill

 

1,905

 

673

 

2,578

 

Accounts Payable

 

-118

 

-83

 

-201

 

Long Term Debt (Auto-Loans)

 

-200

 

—

 

-200

 

Short Term Acquisition Payable

 

-1,000

 

-250

 

-1,250

 

 

 

 

 

 

 

 

 

Totals:

 

6,016

 

1,598

 

7,614

 

 

On August 7, 2013 the Company purchased substantially all of the operating assets and certain of the operating liabilities of Hunter Laboratories, Inc., (“Hunter”) a California corporation having its principal place of business in Campbell, California.  The gross purchase price was $15,215 plus payroll adjustment of $111 totaling $15,326.  Of that amount $3,000 was deferred to cover anticipated pre closing liabilities.

 

On August 20, 2013 the Company through its subsidiary GeneDx, Inc.,  purchased the entire membership interest in Edge BioServ, LLC, (“Edge Bio”) a Delaware limited liability company having its place of business in Gaithersburg, Maryland.  The gross purchase price was approximately $2,502.  Of that $375 was deferred to cover anticipated pre closing liabilities.

 

The following table sets forth these final purchase allocations.

 

 

 

$

 

 

 

Hunter

 

Edge Bio

 

Totals:

 

Accounts Receivable

 

1,700

 

—

 

1,700

 

Prepaid Expenses

 

421

 

70

 

491

 

Inventory

 

369

 

—

 

369

 

Autos

 

62

 

—

 

62

 

Furniture and Fixtures

 

265

 

6

 

271

 

Leasehold Improvements

 

—

 

714

 

714

 

Medical Equipment

 

234

 

906

 

1,140

 

Computer Equipment

 

376

 

574

 

950

 

Non-Compete Agreement

 

1,255

 

926

 

2,181

 

Customer Relationships in Place

 

3,852

 

3

 

3,855

 

Goodwill

 

8,573

 

182

 

8,755

 

Accounts Payable

 

(1,388

)

—

 

(1,388

)

Accrued Payroll Benefits

 

(393

)

—

 

(393

)

Notes Payable

 

—

 

(578

)

(578

)

Capital Leases

 

—

 

(193

)

(193

)

Deferred Acquisition Payable

 

(3,000

)

(375

)

(3,375

)

Deferred Rent Payable

 

—

 

(108

)

(108

)

 

 

 

 

 

 

 

 

Totals:

 

12,326

 

2,127

 

14,453

 
XML 57 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 58 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Organization and Business
 12 Months Ended
Oct. 31, 2013
Organization and Business  
Organization and Business

[1] Organization and Business

 

Bio-Reference Laboratories, Inc. [“Bio-Reference”, “BRLI”, or the “Company”] was incorporated on December 24, 1981.  Bio-Reference is principally engaged in providing laboratory testing services, primarily to customers in the greater New York metropolitan area as well as to customers in a number of other states.  Bio-Reference offers a comprehensive list of chemical diagnostic tests including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology (including drug screening), pap smears, tissue pathology (biopsies) and other tissue analysis.  We perform cancer cytogenetic testing at our leased facilities in at our main processing facility in Elmwood Park, Smithtown, NY, Clarksburg, MD and Milford, MA and genetic testing at our GeneDx leased facility in Gaithersburg, MD, as well as at our Elmwood Park facility.  We perform cytology testing in Frederick, MD, Milford, MA, Columbus, OH, Houston, TX and at our Elmwood Park facility.  Bio-Reference markets its laboratory testing services directly to physicians, geneticists, hospitals, clinics, correctional and other health facilities.

 

The Company’s laboratory testing business currently represents its one reportable business segment. The laboratory testing business accounts for over 98% of consolidated assets, net revenues and net income in each of the three years ended October 31, 2013.  All other operating segments include the Company’s non-clinical laboratory testing businesses and consist of our clinical knowledge management service through our PSIMedica business unit and a web-based connectivity portal solution for laboratories and physicians through its Care Evolve subsidiary.
XML 59 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
Oct. 31, 2013
Oct. 31, 2012
Preferred Stock, Par Value (in dollars per share) $ 0.10 $ 0.10
Preferred Stock, Authorized shares, including Series A Junior Preferred Stock 1,666,667 1,666,667
Preferred Stock, Issued shares 0 0
Common Stock, Par Value (in dollars per share) $ 0.01 $ 0.01
Common Stock, Authorized shares 35,000,000 35,000,000
Common Stock, Issued shares 27,683,213 27,707,382
Common Stock, Outstanding shares 27,683,213 27,707,382
Series A Junior Preferred Stock
    
Preferred Stock, Authorized shares 3,000 3,000
XML 60 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Options and Warrants
 12 Months Ended
Oct. 31, 2013
Stock Options and Warrants  
Stock Options and Warrants

[11] Stock Options and Warrants

 

Employee Incentive Stock Options - In June 2003, the Board of Directors adopted, and in July 2003, the stockholders approved, the 2003 Employee Incentive Stock Option Plan [the “2003 Plan”].  The 2003 Plan authorizes the grant of stock options, which may be designated as  incentive stock options, to purchase up to a maximum aggregate 1,600,000 shares of Company common stock.  The 2003 Plan provides that the exercise price of an option granted there under shall not be less than the fair market value of the Common Stock on the date the option is granted.  However, in the event an option is granted under the 2003 Plan to a holder of 10% or more of the Company’s outstanding Common Stock, the exercise price must be at least 110% of such fair market value.  Under the 2003 Plan, options must be granted before the June 2, 2013 Termination Date.  No option may have a term longer than ten years (limited to five years in the case of an option granted to a 10% or greater stockholder of the Company).  The aggregate fair market value of the Company’s Common Stock with respect to which options are exercisable for the first time by a grantee under all of the Company’s Stock Option Plans during any calendar year cannot exceed $100.  Options granted under the 2003 Plan are non-transferable and must be exercised by an optionee, if at all, while employed by the Company or a subsidiary or within three months after termination of such optionee’s employment due to retirement, or within one year of such termination if due to disability or death.  The Board (or a Stock Option Committee, if designated), may, in its sole discretion, cause the Company to lend money to or guaranty any obligation of an employee for the purpose of enabling such employee to exercise an option granted under the 2003 Plan provided that such loan or obligation cannot exceed fifty percent (50%) of the exercise price of such option. In fiscal year ended October 31, 2013, 2012 and 2011, -0-, -0- and -0- options were granted under the Plan, respectively. A total of 4,000, 23,500 and 40,000 incentive stock options issued under the 2003 Plan were exercised in fiscal years ended in October 31, 2013, 2012 and 2011, respectively.  A total of 6,000, 13,000 and -0- options were cancelled in fiscal years ended October 31, 2013, 2012 and 2011.

 

In August 2000, the Company adopted, and on December 15, 2000, the stockholders approved, the 2000 Employee Incentive Stock Option Plan [“2000 Plan”]. The 2000 Plan provided for the granting of stock options, which may have been designated as incentive stock options, to purchase an aggregate of 1,600,000 shares of the Company’s common stock at a price not less than 100% of the fair market value per share of the common stock at the date of grant.  However, in the event an option was granted under the 2000 Plan to a holder of 10% or more of the Company’s outstanding common stock, the exercise price must have been at least 110% of fair market value at the date of grant.  Employees of the Company or its subsidiary, as determined, were eligible for the 2000 Plan.  The term of the options could not exceed ten years from the date of grant.  In fiscal years ended October 31, 2013, 2012 and 2011, no options were granted under the Plan. A total of 44,000, 8,000 and 39,600 incentive stock options issued under the 2000 Plan were exercised in fiscal years ended in October 31, 2013, 2012 and 2011, respectively. A total of 2,000, -0-, and -0- options were cancelled in fiscal years ended October 31, 2013, 2012 and 2011, respectively.  Options issued under the 2000 Plan must have been granted before the August 2010 termination date.

 

The following is a summary of Employee Incentive Stock Option Plan transactions:

 

 

 

2003 Plan

 

 

 

Shares Under Options
[In Thousands]

 

Weighted Average
Exercise Price Per Share

 

Outstanding at October 31, 2010*

 

335

 

9.66

 

Granted

 

—

 

—

 

Expired

 

—

 

—

 

Exercised

 

(40

)

8.67

 

Outstanding at October 31, 2011*

 

295

 

9.80

 

 

 

 

 

 

 

Granted

 

—

 

—

 

Expired

 

(13

)

9.13

 

Exercised

 

(23

)

8.52

 

Outstanding at October 31, 2012*

 

259

 

$

9.95

 

 

 

 

 

 

 

Granted

 

—

 

—

 

Expired

 

(6

)

8.64

 

Exercised

 

(4

)

7.25

 

Outstanding at October 31, 2013*

 

249

 

10.02

 

 

*Eligible for exercise at October 31, 2010 were 310 at a weighted average exercise price per share of $9.66

*Eligible for exercise at October 31, 2011 were 275 at a weighted average exercise price per share of $9.80

*Eligible for exercise at October 31, 2012 were 244 at a weighted average exercise price per share of $9.95

*Eligible for exercise at October 31, 2013 were 239 at a weighted average exercise price per share of $9.97

 

 

 

2000 Plan

 

 

 

Shares Under
Options
 [In Thousands]

 

Weighted
Average
Exercise Price
Per Share

 

Outstanding and Eligible for Exercise at October 31, 2010

 

100

 

4.64

 

Granted

 

—

 

—

 

Expired

 

—

 

—

 

Exercised

 

(40

)

3.82

 

Outstanding and Eligible for Exercise at October 31, 2011

 

60

 

5.19

 

 

 

 

 

 

 

Granted

 

—

 

—

 

Expired

 

—

 

—

 

Exercised

 

(8

)

3.39

 

Outstanding and Eligible for Exercise at October 31, 2012

 

52

 

$

5.47

 

Granted

 

—

 

—

 

Expired

 

(2

)

3.60

 

Exercised

 

(44

)

5.25

 

Outstanding and Eligible for Exercise at October 31, 2013

 

 

 

 

 

 

 

6

 

7.67

 

 

Summary of outstanding options:

 

 

 

Weighted Average

 

Exercisable

 

 

 

Shares

 

Remaining

 

Exercise

 

Shares

 

Exercise

 

Exercise Price Range

 

Outstanding

 

Life

 

Price

 

Outstanding

 

Price

 

$6.11

 

to

 

$6.11

 

Per Share

 

6

 

0.75

 

6.11

 

6

 

6.11

 

$7.41

 

to

 

$7.67

 

Per Share

 

62

 

1.09

 

7.48

 

62

 

7.48

 

$9.13

 

to

 

$9.13

 

Per Share

 

147

 

1.00

 

9.13

 

147

 

9.13

 

$17.50

 

to

 

$17.50

 

Per Share

 

40

 

4.08

 

17.50

 

30

 

17.50

 

 

 

 

 

 

 

 

 

255

 

 

 

 

 

245

 

 

 

 

Compensation cost recognized for the years ended October 31, 2013, October 31, 2012 and October 31, 2011 was $40 for each one of the years, with a related tax benefit of $-0- with respect to these options.
XML 61 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information (USD $)
 12 Months Ended
Oct. 31, 2013
Jan. 09, 2014
Apr. 30, 2013
Document and Entity Information      
Entity Registrant Name BIO REFERENCE LABORATORIES INC    
Entity Central Index Key 0000792641    
Document Type 10-K    
Document Period End Date Oct. 31, 2013    
Amendment Flag false    
Current Fiscal Year End Date --10-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Accelerated Filer    
Entity Public Float     $ 623,072,381
Entity Common Stock, Shares Outstanding   27,695,213  
Document Fiscal Year Focus 2013    
Document Fiscal Period Focus FY    
XML 62 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Employment Contracts and Consulting Agreements
 12 Months Ended
Oct. 31, 2013
Employment Contracts and Consulting Agreements  
Employment Contracts and Consulting Agreements

[12] Employment Contracts and Consulting Agreements

 

The Company has multiple employment contracts with its key executives with expiration dates ranging from October 31, 2015 through October 31, 2018.  At October 31, 2013, the approximate aggregate minimum commitment under these employment contracts and agreements, excluding commissions or consumer price index increases, is as follows:

 

October 31

 

Employees and
Consultants

 

2014

 

$

5,169

 

2015

 

3,873

 

2016

 

3,657

 

2017

 

2,918

 

2018

 

1,243

 

Thereafter

 

—

 

 

 

 

 

Total

 

$

16,860

 

 

Some of these agreements provide bonuses and commissions based on a percentage of collected revenues ranging from 1% to 10% on accounts referred by or serviced by the employee or consultant.

 

In addition to the above, in fiscal 2013 the Company has entered into seventy at — will employment and consulting agreements which together with prior at — will agreements provide for annual aggregate minimum commitments of approximately $33,555 which have no termination dates.
XML 63 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
CONSOLIDATED STATEMENTS OF OPERATIONS      
NET REVENUES: $ 715,354 $ 614,255 $ 522,081
COST OF SERVICES:      
Depreciation and Amortization 15,598 13,101 11,036
Employee Related Expenses 173,137 146,292 126,354
Reagents and Lab Supplies 135,486 121,446 100,569
Other Cost of Services 68,594 56,805 49,894
TOTAL COST OF SERVICES 392,815 337,644 287,853
GROSS PROFIT ON REVENUES 322,539 276,611 234,228
General and Administrative Expenses:      
Depreciation and Amortization 4,141 3,562 3,969
Other General and Administrative Expenses 177,508 154,928 131,967
Bad Debt Expense 58,917 41,990 38,518
TOTAL GENERAL AND ADMIN. EXPENSES 240,566 200,480 174,454
OPERATING INCOME 81,973 76,131 59,774
OTHER (INCOME) EXPENSES:      
Interest Expense 1,606 1,455 1,747
Other (Income) Expense (612) 323 (6,656)
Interest Income (118) (163) (163)
TOTAL OTHER EXPENSES - NET 876 1,615 (5,072)
INCOME BEFORE INCOME TAXES 81,097 74,516 64,846
Provision for Income Taxes 35,272 32,360 28,487
NET INCOME $ 45,825 $ 42,156 $ 36,359
NET INCOME PER SHARE - BASIC: (in dollars per share) $ 1.65 $ 1.52 $ 1.30
WEIGHTED AVERAGE NUMBER OF SHARES - BASIC: (in shares) 27,690,677 27,742,257 27,971,100
NET INCOME PER SHARE - DILUTED: (in dollars per share) $ 1.65 $ 1.51 $ 1.29
WEIGHTED AVERAGE NUMBER OF SHARES - DILUTED: (in shares) 27,851,720 27,920,920 28,207,358
XML 64 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt - Bank
 12 Months Ended
Oct. 31, 2013
Long-Term Debt - Bank  
Long-Term Debt - Bank

[6] Long-Term Debt - Bank

 

Effective as of October 31, 2007, we executed a fifth amendment to the Loan Agreement formalizing the repayment terms of the $5 million term loan from PNC Bank used by our wholly-owned GeneDX (formerly, BRLI No. 2 Acquisition Corp.) subsidiary to fund the $5 million acquisition cash payment in connection with its purchase of the operating assets of GeneDx, Inc. The term loan is evidenced by a secured promissory note payable over a six year term in equal monthly principal payments of approximately $69, plus interest at an annual rate of 6.85%. The note was paid off on October 31, 2012.

 

In December 2010, the Company issued a seven year term note for $5,408 at the rate of interest of 6.12% per annum for the financing of new equipment.  The note is payable in eighty-four equal monthly installments commencing on January 29, 2011 of $61 including principal and interest followed by a balloon payment of the principal and interest outstanding on the loan repayment date of December 29, 2017.  The balance on this note as of October 31, 2013 is approximately $4,163.

 

Principal repayment for each of the five succeeding fiscal years and thereafter as of October 31, 2013 is as follows:

 

Year Ended

 

 

 

October 31,

 

 

 

2014

 

493

 

2015

 

518

 

2016

 

551

 

2017

 

585

 

2018

 

2,016

 

Thereafter

 

—

 

Totals

 

$

4,163

 
XML 65 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Revolving Note Payable - Bank
 12 Months Ended
Oct. 31, 2013
Revolving Note Payable - Bank  
Revolving Note Payable - Bank

[5] Revolving Note Payable - Bank

 

In October 2011, the Company entered into an amended revolving note payable loan agreement with PNC Bank, N.A.  The maximum amount of the credit line available to the Company pursuant to the loan agreement is the lesser of (i) $45,000 or (ii) 50% of the Company’s qualified accounts receivable [as defined in the agreement].  The amendment to the Loan and Security Agreement provides for an interest rate on advances to be subject, at the election of the Company, to either the bank’s base rate or the Eurodollar rate of interest plus, in certain instances, an additional interest percentage.  The additional interest percentage charge on bank’s base rate borrowings and on Eurodollar rate borrowings ranges from 1% to 4% and is determined based upon certain financial ratios achieved by the Company.  At October 31, 2013, the Company had elected to have all of the total advances outstanding to be subject to the bank’s base rate of interest of 3.50%.  The credit line is collateralized by substantially all of the Company’s assets. The line of credit is available through October 2016 and may be extended for annual periods by mutual consent, thereafter.  The terms of this agreement contain, among other provisions, requirements for maintaining defined levels of capital expenditures, fixed charge coverage, and the prohibition of the payment by the Company of cash dividends. As of October 31, 2013 and October 31, 2012, the Company utilized $26,139 and $0 of the credit line, respectively.
XML 66 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Risks and Uncertainties
 12 Months Ended
Oct. 31, 2013
Significant Risks and Uncertainties  
Significant Risks and Uncertainties

[17] Significant Risks and Uncertainties

 

[A] Concentrations of Credit Risk - Cash - At October 31, 2013 and 2012, the Company had approximately $14,720 and $21,260, respectively, in cash and certificate of deposit balances at financial institutions which were in excess of the federally insured limits.

 

[B] Concentration of Credit Risk - Accounts Receivable - Credit risk with respect to accounts receivable is generally diversified due to the large number of patients comprising the client base.  The Company does have significant receivable balances with government payors and various insurance carriers.  Generally, the Company does not require collateral or other security to support customer receivables.  However, the Company continually monitors and evaluates its client acceptance and collection procedures to minimize potential credit risks associated with its accounts receivable and establishes an allowance for uncollectible accounts and as a consequence, believes that its accounts receivable credit risk exposure beyond such allowance is not material to the financial statements.

 

A number of proposals for legislation continue to be under discussion which could substantially reduce Medicare and Medicaid (CMS) reimbursements to clinical laboratories.  Depending upon the nature of regulatory action, and the content of legislation, the Company could experience a significant decrease in revenues from Medicare and Medicaid (CMS), which could have a material adverse effect on the Company.  The Company is unable to predict, however, the extent to which such actions will be taken.
XML 67 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Capitalized Lease Obligations
 12 Months Ended
Oct. 31, 2013
Capitalized Lease Obligations  
Capitalized Lease Obligations

[13] Capitalized Lease Obligations

 

The Company leases various assets under capital leases expiring in fiscal 2018 with interest rates ranging between 2% to 8% as follows:

 

 

 

October 31

 

 

 

2013

 

2012

 

Medical Equipment

 

15,013

 

$

12,078

 

Automobiles

 

10,581

 

8,711

 

 

 

 

 

 

 

Totals

 

25,594

 

20,789

 

Less: Accumulated Depreciation

 

13,125

 

6,776

 

 

 

 

 

 

 

Net

 

12,469

 

$

14,013

 

 

Depreciation expense on assets under capital leases was approximately $6,494, $3,792, and $1,418 for the years ended October 31, 2013, 2012 and 2011, respectively.

 

Aggregate future minimum rentals under capital leases are:

 

October 31,

 

 

 

2014

 

$

5,622

 

2015

 

4,630

 

2016

 

3,727

 

2017

 

2,192

 

2018

 

660

 

Thereafter

 

15

 

 

 

 

 

Total

 

16,846

 

 

 

 

 

Less Interest:

 

949

 

 

 

 

 

Present Value of Minimum Lease Payments

 

$

15,897

 
XML 68 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Capital Transactions
 12 Months Ended
Oct. 31, 2013
Capital Transactions  
Capital Transactions

[9] Capital Transactions

 

[A] Preferred Stock and Common Stock - The Company is authorized to issue an aggregate of 1,666,667 shares of preferred stock, $.10 par value.  None was outstanding as of October 31, 2013 and October 31, 2012.

 

Holders of the Company’s Common Stock are entitled to one vote per share on matters submitted for shareholder vote.  Holders are also entitled to receive dividends ratably, if declared.  In the event of dissolution or liquidation, holders are entitled to share ratably in all assets remaining after payment of liabilities.

 

On November 11, 2011, the Company announced that its board of directors has approved a Stock Repurchase Program authorizing the repurchase of up to 1,000,000 shares of its Common Stock in the over-the-counter market at prevailing market prices over the period ending October 31, 2012.  During the year ended October 31, 2012 the Company repurchased 285,450 shares at a cost of $5,193.  On December 6, 2012, the Company announced that its board of directors has approved a new Stock Repurchase Program authorizing the buyback of up to 714,550 shares of its Common Stock in the over-the-counter market at prevailing market prices through October 31, 2013.  As of October 31, 2013, the Company repurchased 81,600 shares at a cost of $2,030.  Subsequent to our year end, on December 19, 2013 the Company announced that its board of directors has approved a new Stock Repurchase Program authorizing the buyback of up to 2,000,000 shares of its Common Stock in the over-the-counter market at prevailing market prices through October 31, 2015.

 

[B] Equity Transactions for Services — For the fiscal years ended in 2013, 2012 and 2011, the Company issued 11,431, 11,432 and 11,432 shares of the Company’s common stock for employment or consulting services [See Note 11 for common stock options issued for employee and consulting services].
XML 69 R60.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
Operating Leases      
Total rental expenses for property and equipment $ 10,568 $ 8,787 $ 8,010
Contingent rental amounts 0    
Minimum purchase commitments      
2014 12,505    
2015 11,938    
2016 10,854    
2017 6,559    
2018 3,700    
Totals 45,556    
Regent supplies expenses 7,873 13,338 8,379
Property
      
Aggregate future minimum rental payments      
2014 8,671    
2015 2,333    
2016 1,422    
2017 558    
2018 558    
Thereafter 651    
Totals 14,193    
Medical Equipment
      
Aggregate future minimum rental payments      
2014 344    
2015 223    
2016 87    
Totals $ 654    
Minimum
      
Operating Leases      
Period of renewal options 1 year    
Maximum
      
Operating Leases      
Period of renewal options 5 years    
XML 70 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related Party Transactions
 12 Months Ended
Oct. 31, 2013
Related Party Transactions  
Related Party Transactions

[7] Related Party Transactions [Not in Thousands]

 

There were no material related party transactions during fiscal 2013 and fiscal 2012.
XML 71 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
 12 Months Ended
Oct. 31, 2013
Income Taxes  
Income Taxes

[8] Income Taxes

 

The reconciliation of income tax from continuing operations computed at the U.S. federal statutory tax rate to the Company’s effective income tax rate is as follows:

 

 

 

October 31

 

 

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

U.S. Federal Statutory Rate

 

35

%

35

%

35

%

State and Local Taxes, Net of U.S. Federal Tax Benefit

 

11.20

%

8.87

%

9.87

%

Permanent differences and Other

 

(2.78

)%

(0.44

)%

(0.94

)%

 

 

 

 

 

 

 

 

Actual Rate

 

43.42

%

43.43

%

43.93

%

 

The provision for income taxes shown in the consolidated statements of operations consists of the following:

 

 

 

October 31

 

 

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

Current:

 

 

 

 

 

 

 

Federal

 

$

38,295

 

$

25,794

 

$

24,573

 

State & Local

 

14,018

 

10,203

 

9,825

 

 

 

 

 

 

 

 

 

Deferred:

 

 

 

 

 

 

 

Federal

 

(10,803

)

(2,183

)

(4,223

)

State and Local

 

(6,238

)

(1,454

)

(1,688

)

 

 

 

 

 

 

 

 

Total Provision for Income Taxes

 

$

35,272

 

$

32,360

 

$

28,487

 

 

At October 31, 2013 and 2012, the Company had a net deferred tax asset of approximately $44,231 and $27,190, respectively.  The deferred taxes primarily relate to timing differences associated with the deductibility of depreciation and amortization, bad debts and certain accrued expenses and deferred costs.  For fiscal years ended October 31 2011 through October 31, 2013, the Company had no material net operating loss carry-forwards available to reduce current year taxable income.

 

 

 

October 31,

 

 

 

2013

 

2012

 

 

 

 

 

 

 

Deferred Tax Asset:

 

 

 

 

 

Bad Debt Allowance

 

$

39,275

 

$

22,560

 

Depreciation and amortization

 

1,815

 

1,963

 

Accrued Expenses

 

3,141

 

2,667

 

 

 

 

 

 

 

Deferred Tax Asset - Net

 

44,231

 

27,190

 

 

 

 

 

 

 

Current Deferred Tax Asset - Net

 

42,154

 

24,912

 

Long Term Deferred Tax Asset - Net

 

2,077

 

2,278

 

 

 

 

 

 

 

Deferred Tax Asset — Net

 

44,231

 

$

27,190

 

 

During fiscal year ended October 31, 2013 the Company recorded a net deferred tax benefit of $17,041.  This reflects a net benefit of approximately $16,715 in allowance for bad debts, a liability of approximately $281 from depreciation and amortization timing differences, and a benefit of approximately $607 in certain accrued expenses. Although realization is not assured and dependent upon things such as generating sufficient taxable income in future periods, management, through sufficient positive evidence,  believes it is more likely than not that all of the deferred tax asset will be realized. The amount of the deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income or changes in the accrued expenses during the future periods are reduced.

 

At October 31, 2013, fiscal 2010 through 2013 are subject to examination by US federal and state tax authorities.  Through the issuance of these financial statements the outcome of all of these examinations has not been determined.
XML 72 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings Per Share
 12 Months Ended
Oct. 31, 2013
Earnings Per Share  
Earnings Per Share

[10] Earnings Per Share

 

The computation of basic and diluted net earnings per common share is as follows [in thousands, except per share data rounded]:

 

 

 

For Years Ended October 31,

 

 

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

Income Available to Common Stockholders

 

$

45,825

 

$

42,156

 

$

36,359

 

Weighted Average Common Shares Outstanding

 

27,691

 

27,742

 

27,971

 

 

 

 

 

 

 

 

 

Effect of Dilutive Securities:

 

 

 

 

 

 

 

Warrants/Options

 

161

 

179

 

236

 

 

 

 

 

 

 

 

 

Weighted Average Diluted Common Shares Outstanding

 

27,852

 

27,921

 

28,207

 

 

 

 

 

 

 

 

 

Net Income Per Share - Basic

 

$

1.65

 

$

1.52

 

$

1.30

 

Net Income Per Share - Diluted

 

$

1.65

 

$

1.51

 

$

1.29

 
XML 73 R64.htm IDEA: XBRL DOCUMENT v2.4.0.8
Health Insurance Plan (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
Health Insurance Plan      
Initial amount the entity pays for covered medical expenses per person each year $ 150    
Maximum amount per person, covered by the third party insurance carrier for any excess 2,000    
Maximum amount in the aggregate, covered by the third party insurance carrier for any excess 20,504    
Health insurance premium expenses 6,797 5,792 4,426
Uninsured employee medical expenses 32,016 25,994 19,408
Employee contributions for limited health insurance plan $ 4,713 $ 4,124 $ 3,593
XML 74 R66.htm IDEA: XBRL DOCUMENT v2.4.0.8
Selected Quarterly Financial Data (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended 12 Months Ended
Oct. 31, 2013
Jul. 31, 2013
Apr. 30, 2013
Jan. 31, 2013
Oct. 31, 2012
Jul. 31, 2012
Apr. 30, 2012
Jan. 31, 2012
Oct. 31, 2011
Jul. 31, 2011
Apr. 30, 2011
Jan. 31, 2011
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
Selected Quarterly Financial Data                              
Net Revenues $ 192,219 $ 185,427 $ 176,452 $ 161,256 $ 163,487 $ 160,532 $ 151,443 $ 138,793 $ 140,684 $ 137,802 $ 129,465 $ 114,129 $ 715,354 $ 614,255 $ 522,081
Gross Profit 85,282 85,660 80,676 70,922 74,681 74,279 67,534 60,118 64,300 63,206 57,447 49,276 322,539 276,611 234,228
Net Income $ 11,120 $ 14,701 $ 11,338 $ 8,665 $ 12,889 $ 12,596 $ 9,306 $ 7,365 $ 10,476 $ 10,081 $ 7,817 $ 7,985 $ 45,825 $ 42,156 $ 36,359
Net Income Per Common Share:                              
Basic (in dollars per share) $ 0.40 $ 0.53 $ 0.41 $ 0.31 $ 0.47 $ 0.45 $ 0.34 $ 0.26 $ 0.37 $ 0.36 $ 0.28 $ 0.29 $ 1.65 $ 1.52 $ 1.30
Diluted (in dollars per share) $ 0.40 $ 0.53 $ 0.41 $ 0.31 $ 0.46 $ 0.45 $ 0.33 $ 0.26 $ 0.37 $ 0.36 $ 0.28 $ 0.28 $ 1.65 $ 1.51 $ 1.29
Weighted Average Common Shares Outstanding - Basic (in shares) 27,677,000 27,672,000 27,698,000 27,716,000 27,705,000 27,695,000 27,685,000 27,888,000 27,949,000 27,941,000 27,920,000 27,884,000 27,690,677 27,742,257 27,971,100
Weighted Average Common Shares Outstanding - Diluted (in shares) 27,844,000 27,842,000 27,879,000 27,912,000 27,906,000 27,888,000 27,878,000 28,041,000 28,138,000 28,147,000 28,142,000 28,122,000 27,851,720 27,920,920 28,207,358
XML 75 R63.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions (Details) (USD $)
In Thousands, unless otherwise specified
 0 Months Ended 0 Months Ended
Oct. 31, 2013
FCL and MCL
Oct. 31, 2013
FCL and MCL
Non-Compete Agreement
Oct. 31, 2013
FCL and MCL
Customer Relationships in Place
Oct. 31, 2013
FCL and MCL
Autos
Oct. 31, 2013
FCL and MCL
Medical Equipment
Oct. 31, 2013
FCL and MCL
Computer Equipment
Oct. 31, 2013
FCL and MCL
Leasehold Improvements
Dec. 31, 2012
FCL
Dec. 31, 2012
FCL
Non-Compete Agreement
Dec. 31, 2012
FCL
Customer Relationships in Place
Dec. 31, 2012
FCL
Autos
Dec. 31, 2012
FCL
Medical Equipment
Dec. 31, 2012
FCL
Computer Equipment
Dec. 31, 2012
FCL
Leasehold Improvements
Dec. 21, 2012
MCL
Dec. 21, 2012
MCL
Non-Compete Agreement
Dec. 21, 2012
MCL
Customer Relationships in Place
Dec. 21, 2012
MCL
Autos
Dec. 21, 2012
MCL
Medical Equipment
Oct. 31, 2013
Hunter and Edge Bio
Oct. 31, 2013
Hunter and Edge Bio
Non-Compete Agreement
Oct. 31, 2013
Hunter and Edge Bio
Customer Relationships in Place
Oct. 31, 2013
Hunter and Edge Bio
Autos
Oct. 31, 2013
Hunter and Edge Bio
Furniture and Fixtures
Oct. 31, 2013
Hunter and Edge Bio
Medical Equipment
Oct. 31, 2013
Hunter and Edge Bio
Computer Equipment
Oct. 31, 2013
Hunter and Edge Bio
Leasehold Improvements
Aug. 07, 2013
Hunter
Aug. 07, 2013
Hunter
Non-Compete Agreement
Aug. 07, 2013
Hunter
Customer Relationships in Place
Aug. 07, 2013
Hunter
Autos
Aug. 07, 2013
Hunter
Furniture and Fixtures
Aug. 07, 2013
Hunter
Medical Equipment
Aug. 07, 2013
Hunter
Computer Equipment
Aug. 20, 2013
Edge Bio
Aug. 20, 2013
Edge Bio
Non-Compete Agreement
Aug. 20, 2013
Edge Bio
Customer Relationships in Place
Aug. 20, 2013
Edge Bio
Furniture and Fixtures
Aug. 20, 2013
Edge Bio
Medical Equipment
Aug. 20, 2013
Edge Bio
Computer Equipment
Aug. 20, 2013
Edge Bio
Leasehold Improvements
Oct. 31, 2013
IncellDx
Acquisitions                                                                                    
Investment                                                                                   $ 6,000
Purchase price of issued and outstanding common stock               7,016             1,848                                                      
Deferral period               18 months             1 year                                                      
Final purchase allocations                                                                                    
Accounts Receivable 1,240             1,008             232         1,700               1,700                            
Prepaid Expenses                                       491               421             70              
Inventory                                       369               369                            
Property, plant and equipment       185 228 21 53       137 225 21 53       48 3       62 271 1,140 950 714       62 265 234 376       6 906 574 714  
Other Non-Current Assets 3             3                                                                    
Intangible assets   790 4,165           747 3,235           43 930       2,181 3,855             1,255 3,852           926 3          
Deposits 2                           2                                                      
Goodwill 2,578             1,905             673         8,755               8,573             182              
Accounts Payable (201)             (118)             (83)         (1,388)               (1,388)                            
Accrued Payroll Benefits                                       (393)               (393)                            
Note payable and Long Term Debt (Auto-Loans) (200)             (200)                       (578)                             (578)              
Capital Leases                                       (193)                             (193)              
Short Term / Deferred Acquisition Payable (1,250)             (1,000)             (250)         (3,375)               (3,000)             (375)              
Deferred Rent Payable                                       (108)                             (108)              
Totals: 7,614             6,016             1,598         14,453               12,326             2,127              
Additional information                                                                                    
Gross purchase price before payroll adjustment                                                       15,215                            
Payroll adjustment                                                       111                            
Gross purchase price                                                       $ 15,326             $ 2,502              
XML 76 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets (Tables)
 12 Months Ended
Oct. 31, 2013
Intangible Assets  
Schedule of information on intangible assets

 

 

October 31, 2013

 

 

 

Weighted-Average

 

 

 

Accumulated

 

Net of
Accumulated

 

Intangible Asset

 

Amortization Period

 

Cost

 

Amortization

 

Amortization

 

 

 

 

 

 

 

 

 

 

 

Customer Lists

 

20

 

$

8,739

 

$

2,879

 

$

5,860

 

Covenants Not-to-Compete

 

3

 

11,131

 

4,560

 

6,571

 

Patents and Licenses

 

17

 

5,297

 

1,408

 

3,889

 

 

 

 

 

 

 

 

 

 

 

Totals

 

 

 

$

25,166

 

$

8,847

 

$

16,320

 

 

October 31, 2012

 

 

 

Weighted-Average

 

 

 

Accumulated

 

Net of
Accumulated

 

Intangible Asset

 

Amortization Period

 

Cost

 

Amortization

 

Amortization

 

 

 

 

 

 

 

 

 

 

 

Customer Lists

 

20

 

$

4,573

 

$

2,537

 

$

2,036

 

Covenants Not-to-Compete

 

5

 

4,305

 

4,257

 

48

 

Patents and Licenses

 

17

 

5,297

 

1,058

 

4,239

 

 

 

 

 

 

 

 

 

 

 

Totals

 

 

 

$

14,175

 

$

7,852

 

$

6,323

 
Schedule of estimated amortization expense related to remaining intangible assets

 

 

October 31,

 

 

 

2014

 

$

1,917

 

2015

 

1,852

 

2016

 

1,540

 

2017

 

1,063

 

2018

 

946

 

Thereafter

 

9,002

 

 

 

 

 

Total

 

$

16,320

 
XML 77 R51.htm IDEA: XBRL DOCUMENT v2.4.0.8
Revolving Note Payable - Bank (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2013
Revolving note payable - bank
Oct. 31, 2013
Revolving note payable - bank
Bank's base rate
Oct. 31, 2013
Revolving note payable - bank
Bank's base rate
Minimum
Oct. 31, 2013
Revolving note payable - bank
Bank's base rate
Maximum
Oct. 31, 2013
Revolving note payable - bank
Eurodollar rate
Oct. 31, 2013
Revolving note payable - bank
Eurodollar rate
Minimum
Oct. 31, 2013
Revolving note payable - bank
Eurodollar rate
Maximum
Revolving note payable - Bank                  
Maximum amount of the credit line available pursuant to the loan agreement     $ 45,000            
Maximum credit line available as percentage of accounts receivable     50.00%            
Variable rate basis       base rate     Eurodollar rate    
Percentage of additional interest         1.00% 4.00%   1.00% 4.00%
Variable rate of interest (as a percent)       3.50%          
Amount of credit utilized $ 26,139 $ 0              
XML 78 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Litigation
 12 Months Ended
Oct. 31, 2013
Litigation  
Litigation

[15] Litigation

 

In the normal course of business, the Company is exposed to a number of asserted and unasserted potential claims.  In the opinion of management, the resolution of these matters will not have a material adverse effect on the Company’s financial position or results of operations.
XML 79 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Health Insurance Plan
 12 Months Ended
Oct. 31, 2013
Health Insurance Plan  
Health Insurance Plan

[20] Health Insurance Plan

 

The Company has a limited self-funded health insurance plan for its employees under which the Company pays the initial $150 of covered medical expenses per person each year.  The Company has a contract with an insurance carrier for any excess up to a maximum of $2,000 per person and $20,504 in the aggregate.  Health insurance premium expense for the years ended October 31, 2013, 2012 and 2011 amounted to approximately $6,797, $5,792 and $4,426, respectively.  Uninsured employee medical expenses incurred by the Company amounted to approximately $32,016, $25,994 and $19,408 for the years ended October 31, 2013, 2012 and 2011, respectively.  During fiscal years ended October 31, 2013, 2012 and 2011, employee contributions of $4,713, $4,124 and $3,593 offset the above health plan costs.
XML 80 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
Property and Equipment (Details) (USD $)
In Thousands, unless otherwise specified
Oct. 31, 2013
Oct. 31, 2012
Property and equipment    
PROPERTY AND EQUIPMENT - AT COST $ 133,599 $ 102,701
Less Accumulated Depreciation 67,950 52,261
PROPERTY AND EQUIPMENT - NET 65,649 50,440
Medical Equipment
    
Property and equipment    
PROPERTY AND EQUIPMENT - AT COST 65,762 50,338
Leasehold improvements
    
Property and equipment    
PROPERTY AND EQUIPMENT - AT COST 27,974 19,768
Furniture, Fixtures and Office & Computer Equipment
    
Property and equipment    
PROPERTY AND EQUIPMENT - AT COST 21,621 16,503
Automobiles and Aircraft
    
Property and equipment    
PROPERTY AND EQUIPMENT - AT COST $ 18,242 $ 16,092
XML 81 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Tables)
 12 Months Ended
Oct. 31, 2013
Commitments and Contingencies  
Schedule of aggregate future minimum rental payments on non cancelable operating leases (exclusive of several month to month leases)

 

 

October 31,

 

Property($)

 

Equipment($)

 

 

 

 

 

 

 

2014

 

8,671

 

344

 

2015

 

2,333

 

223

 

2016

 

1,422

 

87

 

2017

 

558

 

—

 

2018

 

558

 

—

 

Thereafter

 

651

 

—

 

 

 

 

 

 

 

Totals:

 

14,193

 

654

 
Schedule of minimum purchase commitments

 

 

October 31

 

Reagents ($)

 

2014

 

12,505

 

2015

 

11,938

 

2016

 

10,854

 

2017

 

6,559

 

2018

 

3,700

 

Thereafter

 

—

 

 

 

 

 

Totals:

 

45,556

 
XML 82 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (USD $)
In Thousands, except Share data, unless otherwise specified
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Balance at Oct. 31, 2010 $ 152,388 $ 278 $ 44,562 $ 107,548
Increase (Decrease) in Stockholders' Equity        
Exercise of Options - Employees 498 1 497  
Exercise of Options - Employees (in shares)   79,600    
Stock Based Compensation 40   40  
Stock Issued for Acquisition 482   482  
Stock Issued for Acquisition (in shares)   23,096    
Net Income 36,359     36,359
Balance at Oct. 31, 2011 189,767 279 45,581 143,907
Balance (in shares) at Oct. 31, 2011   27,949,900    
Increase (Decrease) in Stockholders' Equity        
Exercise of Options - Employees 227 1 226  
Exercise of Options - Employees (in shares)   31,500    
Stock Based Compensation 290   290  
Stock Based Compensation (in shares)   11,432    
Net Income 42,156     42,156
Common Stock Repurchased and Canceled (5,193) (3) (5,190)  
Common Stock Repurchased and Canceled (in shares) (285,450) (285,450)    
Balance at Oct. 31, 2012 227,247 277 40,907 186,063
Balance (in shares) at Oct. 31, 2012   27,707,382    
Increase (Decrease) in Stockholders' Equity        
Exercise of Options - Employees 263   263  
Exercise of Options - Employees (in shares)   46,000    
Stock Based Compensation 290   290  
Stock Based Compensation (in shares)   11,431    
Net Income 45,825     45,825
Common Stock Repurchased and Canceled (2,030)   (2,030)  
Common Stock Repurchased and Canceled (in shares) (81,600) (81,600)    
Balance at Oct. 31, 2013 $ 271,595 $ 277 $ 39,430 $ 231,888
Balance (in shares) at Oct. 31, 2013   27,683,213    
XML 83 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets
 12 Months Ended
Oct. 31, 2013
Intangible Assets  
Intangible Assets

[4] Intangible Assets

 

Intangible assets are summarized as follows:

 

October 31, 2013

 

 

 

Weighted-Average

 

 

 

Accumulated

 

Net of
Accumulated

 

Intangible Asset

 

Amortization Period

 

Cost

 

Amortization

 

Amortization

 

 

 

 

 

 

 

 

 

 

 

Customer Lists

 

20

 

$

8,739

 

$

2,879

 

$

5,860

 

Covenants Not-to-Compete

 

3

 

11,131

 

4,560

 

6,571

 

Patents and Licenses

 

17

 

5,297

 

1,408

 

3,889

 

 

 

 

 

 

 

 

 

 

 

Totals

 

 

 

$

25,166

 

$

8,847

 

$

16,320

 

 

October 31, 2012

 

 

 

Weighted-Average

 

 

 

Accumulated

 

Net of
Accumulated

 

Intangible Asset

 

Amortization Period

 

Cost

 

Amortization

 

Amortization

 

 

 

 

 

 

 

 

 

 

 

Customer Lists

 

20

 

$

4,573

 

$

2,537

 

$

2,036

 

Covenants Not-to-Compete

 

5

 

4,305

 

4,257

 

48

 

Patents and Licenses

 

17

 

5,297

 

1,058

 

4,239

 

 

 

 

 

 

 

 

 

 

 

Totals

 

 

 

$

14,175

 

$

7,852

 

$

6,323

 

 

The estimated amortization expense related to intangible assets for each of the five succeeding fiscal years and thereafter as of October 31, 2013 is as follows:

 

October 31,

 

 

 

2014

 

$

1,917

 

2015

 

1,852

 

2016

 

1,540

 

2017

 

1,063

 

2018

 

946

 

Thereafter

 

9,002

 

 

 

 

 

Total

 

$

16,320

 
XML 84 R58.htm IDEA: XBRL DOCUMENT v2.4.0.8
Employment Contracts and Consulting Agreements (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
item
Aggregate minimum commitment under these employment contracts and agreements, excluding commissions or consumer price index increases  
2014 $ 5,169
2015 3,873
2016 3,657
2017 2,918
2018 1,243
Total 16,860
Number of additional at-will employment and consulting agreements 70
Annual aggregate commitments under agreement $ 33,555
Minimum
  
Aggregate minimum commitment under these employment contracts and agreements, excluding commissions or consumer price index increases  
Bonuses and commissions based on percentage of collected revenues (as a percent) 1.00%
Maximum
  
Aggregate minimum commitment under these employment contracts and agreements, excluding commissions or consumer price index increases  
Bonuses and commissions based on percentage of collected revenues (as a percent) 10.00%
XML 85 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Employee Benefit Plan
 12 Months Ended
Oct. 31, 2013
Employee Benefit Plan  
Employee Benefit Plan

[21] Employee Benefit Plan

 

The Company sponsors a 401(k) Profit-Sharing Plan [the “Plan”].  Employees become eligible for participation after attaining the age of eighteen and completing one year of service.  Participants may elect to contribute up to ten percent of their compensation, as defined in the Plan, to a maximum allowed by the Internal Revenue Service.  The Company may choose to make a matching contribution to the plan for each participant who has elected to make tax-deferred contributions for the plan year, at a percentage determined each year by the Company. The Company elected to make a matching contribution which amounted to $1,358 for 2013, $1,106 for 2012, and $993 for 2011.  These amounts were charged to the Statement of Operations. The Employer contribution will be fully vested after the third year of service.
XML 86 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 177 354 1 false 41 0 false 5 false false R1.htm 0000 - Document - Document and Entity Information Sheet http://www.bioreference.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0010 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.bioreference.com/role/BalanceSheet CONSOLIDATED BALANCE SHEETS false false R3.htm 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.bioreference.com/role/BalanceSheetParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.bioreference.com/role/StatementOfIncome CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 0030 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Sheet http://www.bioreference.com/role/StatementOfStockholdersEquity CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY false false R6.htm 0040 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.bioreference.com/role/CashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R7.htm 1010 - Disclosure - Organization and Business Sheet http://www.bioreference.com/role/DisclosureOrganizationAndBusiness Organization and Business false false R8.htm 1020 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.bioreference.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R9.htm 1030 - Disclosure - Property and Equipment Sheet http://www.bioreference.com/role/DisclosurePropertyAndEquipment Property and Equipment false false R10.htm 1040 - Disclosure - Intangible Assets Sheet http://www.bioreference.com/role/DisclosureIntangibleAssets Intangible Assets false false R11.htm 1050 - Disclosure - Revolving Note Payable - Bank Sheet http://www.bioreference.com/role/DisclosureRevolvingNotePayableBank Revolving Note Payable - Bank false false R12.htm 1060 - Disclosure - Long-Term Debt - Bank Sheet http://www.bioreference.com/role/DisclosureLongTermDebtBank Long-Term Debt - Bank false false R13.htm 1070 - Disclosure - Related Party Transactions Sheet http://www.bioreference.com/role/DisclosureRelatedPartyTransactions Related Party Transactions false false R14.htm 1080 - Disclosure - Income Taxes Sheet http://www.bioreference.com/role/DisclosureIncomeTaxes Income Taxes false false R15.htm 1090 - Disclosure - Capital Transactions Sheet http://www.bioreference.com/role/DisclosureCapitalTransactions Capital Transactions false false R16.htm 1100 - Disclosure - Earnings Per Share Sheet http://www.bioreference.com/role/DisclosureEarningsPerShare Earnings Per Share false false R17.htm 1110 - Disclosure - Stock Options and Warrants Sheet http://www.bioreference.com/role/DisclosureStockOptionsAndWarrants Stock Options and Warrants false false R18.htm 1120 - Disclosure - Employment Contracts and Consulting Agreements Sheet http://www.bioreference.com/role/DisclosureEmploymentContractsAndConsultingAgreements Employment Contracts and Consulting Agreements false false R19.htm 1130 - Disclosure - Capitalized Lease Obligations Sheet http://www.bioreference.com/role/DisclosureCapitalizedLeaseObligations Capitalized Lease Obligations false false R20.htm 1140 - Disclosure - Commitments and Contingencies Sheet http://www.bioreference.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies false false R21.htm 1150 - Disclosure - Litigation Sheet http://www.bioreference.com/role/DisclosureLitigation Litigation false false R22.htm 1160 - Disclosure - Insurance Sheet http://www.bioreference.com/role/DisclosureInsurance Insurance false false R23.htm 1170 - Disclosure - Significant Risks and Uncertainties Sheet http://www.bioreference.com/role/DisclosureSignificantRisksAndUncertainties Significant Risks and Uncertainties false false R24.htm 1180 - Disclosure - Acquisitions Sheet http://www.bioreference.com/role/DisclosureAcquisitions Acquisitions false false R25.htm 1190 - Disclosure - Fair Value of Financial Instruments Sheet http://www.bioreference.com/role/DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments false false R26.htm 1200 - Disclosure - Health Insurance Plan Sheet http://www.bioreference.com/role/DisclosureHealthInsurancePlan Health Insurance Plan false false R27.htm 1210 - Disclosure - Employee Benefit Plan Sheet http://www.bioreference.com/role/DisclosureEmployeeBenefitPlan Employee Benefit Plan false false R28.htm 1220 - Disclosure - New Authoritative Accounting Pronouncements Sheet http://www.bioreference.com/role/DisclosureNewAuthoritativeAccountingPronouncements New Authoritative Accounting Pronouncements false false R29.htm 1230 - Disclosure - Selected Quarterly Financial Data Sheet http://www.bioreference.com/role/DisclosureSelectedQuarterlyFinancialData Selected Quarterly Financial Data false false R30.htm 1240 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS Sheet http://www.bioreference.com/role/DisclosureValuationAndQualifyingAccounts SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS false false R31.htm 2020 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.bioreference.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R32.htm 3020 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.bioreference.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) false false R33.htm 3030 - Disclosure - Property and Equipment (Tables) Sheet http://www.bioreference.com/role/DisclosurePropertyAndEquipmentTables Property and Equipment (Tables) false false R34.htm 3040 - Disclosure - Intangible Assets (Tables) Sheet http://www.bioreference.com/role/DisclosureIntangibleAssetsTables Intangible Assets (Tables) false false R35.htm 3060 - Disclosure - Long-Term Debt - Bank (Tables) Sheet http://www.bioreference.com/role/DisclosureLongTermDebtBankTables Long-Term Debt - Bank (Tables) false false R36.htm 3080 - Disclosure - Income Taxes (Tables) Sheet http://www.bioreference.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) false false R37.htm 3100 - Disclosure - Earnings Per Share (Tables) Sheet http://www.bioreference.com/role/DisclosureEarningsPerShareTables Earnings Per Share (Tables) false false R38.htm 3110 - Disclosure - Stock Options and Warrants (Tables) Sheet http://www.bioreference.com/role/DisclosureStockOptionsAndWarrantsTables Stock Options and Warrants (Tables) false false R39.htm 3120 - Disclosure - Employment Contracts and Consulting Agreements (Tables) Sheet http://www.bioreference.com/role/DisclosureEmploymentContractsAndConsultingAgreementsTables Employment Contracts and Consulting Agreements (Tables) false false R40.htm 3130 - Disclosure - Capitalized Lease Obligations (Tables) Sheet http://www.bioreference.com/role/DisclosureCapitalizedLeaseObligationsTables Capitalized Lease Obligations (Tables) false false R41.htm 3140 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.bioreference.com/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) false false R42.htm 3180 - Disclosure - Acquisitions (Tables) Sheet http://www.bioreference.com/role/DisclosureAcquisitionsTables Acquisitions (Tables) false false R43.htm 3230 - Disclosure - Selected Quarterly Financial Data (Tables) Sheet http://www.bioreference.com/role/DisclosureSelectedQuarterlyFinancialDataTables Selected Quarterly Financial Data (Tables) false false R44.htm 4010 - Disclosure - Organization and Business (Details) Sheet http://www.bioreference.com/role/DisclosureOrganizationAndBusinessDetails Organization and Business (Details) false false R45.htm 4020 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.bioreference.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) false false R46.htm 4021 - Disclosure - Summary of Significant Accounting Policies (Details 2) Sheet http://www.bioreference.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails2 Summary of Significant Accounting Policies (Details 2) false false R47.htm 4022 - Disclosure - Summary of Significant Accounting Policies (Details 3) Sheet http://www.bioreference.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails3 Summary of Significant Accounting Policies (Details 3) false false R48.htm 4023 - Disclosure - Summary of Significant Accounting Policies (Details 4) Sheet http://www.bioreference.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails4 Summary of Significant Accounting Policies (Details 4) false false R49.htm 4030 - Disclosure - Property and Equipment (Details) Sheet http://www.bioreference.com/role/DisclosurePropertyAndEquipmentDetails Property and Equipment (Details) false false R50.htm 4040 - Disclosure - Intangible Assets (Details) Sheet http://www.bioreference.com/role/DisclosureIntangibleAssetsDetails Intangible Assets (Details) false false R51.htm 4050 - Disclosure - Revolving Note Payable - Bank (Details) Sheet http://www.bioreference.com/role/DisclosureRevolvingNotePayableBankDetails Revolving Note Payable - Bank (Details) false false R52.htm 4060 - Disclosure - Long-Term Debt - Bank (Details) Sheet http://www.bioreference.com/role/DisclosureLongTermDebtBankDetails Long-Term Debt - Bank (Details) false false R53.htm 4080 - Disclosure - Income Taxes (Details) Sheet http://www.bioreference.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) false false R54.htm 4090 - Disclosure - Capital Transactions (Details) Sheet http://www.bioreference.com/role/DisclosureCapitalTransactionsDetails Capital Transactions (Details) false false R55.htm 4100 - Disclosure - Earnings Per Share (Details) Sheet http://www.bioreference.com/role/DisclosureEarningsPerShareDetails Earnings Per Share (Details) false false R56.htm 4110 - Disclosure - Stock Options and Warrants (Details) Sheet http://www.bioreference.com/role/DisclosureStockOptionsAndWarrantsDetails Stock Options and Warrants (Details) false false R57.htm 4111 - Disclosure - Stock Options and Warrants (Details 2) Sheet http://www.bioreference.com/role/DisclosureStockOptionsAndWarrantsDetails2 Stock Options and Warrants (Details 2) false false R58.htm 4120 - Disclosure - Employment Contracts and Consulting Agreements (Details) Sheet http://www.bioreference.com/role/DisclosureEmploymentContractsAndConsultingAgreementsDetails Employment Contracts and Consulting Agreements (Details) false false R59.htm 4130 - Disclosure - Capitalized Lease Obligations (Details) Sheet http://www.bioreference.com/role/DisclosureCapitalizedLeaseObligationsDetails Capitalized Lease Obligations (Details) false false R60.htm 4140 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.bioreference.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false R61.htm 4160 - Disclosure - Insurance (Details) Sheet http://www.bioreference.com/role/DisclosureInsuranceDetails Insurance (Details) false false R62.htm 4170 - Disclosure - Significant Risks and Uncertainties (Details) Sheet http://www.bioreference.com/role/DisclosureSignificantRisksAndUncertaintiesDetails Significant Risks and Uncertainties (Details) false false R63.htm 4180 - Disclosure - Acquisitions (Details) Sheet http://www.bioreference.com/role/DisclosureAcquisitionsDetails Acquisitions (Details) false false R64.htm 4200 - Disclosure - Health Insurance Plan (Details) Sheet http://www.bioreference.com/role/DisclosureHealthInsurancePlanDetails Health Insurance Plan (Details) false false R65.htm 4210 - Disclosure - Employee Benefit Plan (Details) Sheet http://www.bioreference.com/role/DisclosureEmployeeBenefitPlanDetails Employee Benefit Plan (Details) false false R66.htm 4230 - Disclosure - Selected Quarterly Financial Data (Details) Sheet http://www.bioreference.com/role/DisclosureSelectedQuarterlyFinancialDataDetails Selected Quarterly Financial Data (Details) false false R67.htm 4240 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) Sheet http://www.bioreference.com/role/DisclosureValuationAndQualifyingAccountsDetails SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) false false All Reports Book All Reports Element us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised had a mix of decimals attribute values: -3 0. Element us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding had a mix of decimals attribute values: -3 0. Element us-gaap_WeightedAverageNumberOfSharesOutstandingBasic had a mix of decimals attribute values: -3 0. 'Monetary' elements on report '4060 - Disclosure - Long-Term Debt - Bank (Details)' had a mix of different decimal attribute values. Process Flow-Through: 0010 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Oct. 31, 2011' Process Flow-Through: Removing column 'Oct. 31, 2010' Process Flow-Through: 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: Removing column '3 Months Ended Oct. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Jul. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Apr. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jan. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Oct. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Jul. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Apr. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jan. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Oct. 31, 2011' Process Flow-Through: Removing column '3 Months Ended Jul. 31, 2011' Process Flow-Through: Removing column '3 Months Ended Apr. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Jan. 31, 2011' Process Flow-Through: 0040 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS brli-20131031.xml brli-20131031.xsd brli-20131031_cal.xml brli-20131031_def.xml brli-20131031_lab.xml brli-20131031_pre.xml true true XML 87 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Options and Warrants (Tables)
 12 Months Ended
Oct. 31, 2013
Employee incentive stock options  
Summary of outstanding options

 

 

 

 

Weighted Average

 

Exercisable

 

 

 

Shares

 

Remaining

 

Exercise

 

Shares

 

Exercise

 

Exercise Price Range

 

Outstanding

 

Life

 

Price

 

Outstanding

 

Price

 

$6.11

 

to

 

$6.11

 

Per Share

 

6

 

0.75

 

6.11

 

6

 

6.11

 

$7.41

 

to

 

$7.67

 

Per Share

 

62

 

1.09

 

7.48

 

62

 

7.48

 

$9.13

 

to

 

$9.13

 

Per Share

 

147

 

1.00

 

9.13

 

147

 

9.13

 

$17.50

 

to

 

$17.50

 

Per Share

 

40

 

4.08

 

17.50

 

30

 

17.50

 

 

 

 

 

 

 

 

 

255

 

 

 

 

 

245

 

 

 
2003 Plan
  
Employee incentive stock options  
Summary of employee incentive stock option plan transactions

 

 

 

 

2003 Plan

 

 

 

Shares Under Options
[In Thousands]

 

Weighted Average
Exercise Price Per Share

 

Outstanding at October 31, 2010*

 

335

 

9.66

 

Granted

 

—

 

—

 

Expired

 

—

 

—

 

Exercised

 

(40

)

8.67

 

Outstanding at October 31, 2011*

 

295

 

9.80

 

 

 

 

 

 

 

Granted

 

—

 

—

 

Expired

 

(13

)

9.13

 

Exercised

 

(23

)

8.52

 

Outstanding at October 31, 2012*

 

259

 

$

9.95

 

 

 

 

 

 

 

Granted

 

—

 

—

 

Expired

 

(6

)

8.64

 

Exercised

 

(4

)

7.25

 

Outstanding at October 31, 2013*

 

249

 

10.02

 

 

*Eligible for exercise at October 31, 2010 were 310 at a weighted average exercise price per share of $9.66

*Eligible for exercise at October 31, 2011 were 275 at a weighted average exercise price per share of $9.80

*Eligible for exercise at October 31, 2012 were 244 at a weighted average exercise price per share of $9.95

*Eligible for exercise at October 31, 2013 were 239 at a weighted average exercise price per share of $9.97
2000 Plan
  
Employee incentive stock options  
Summary of employee incentive stock option plan transactions

 

 

 

 

2000 Plan

 

 

 

Shares Under
Options
 [In Thousands]

 

Weighted
Average
Exercise Price
Per Share

 

Outstanding and Eligible for Exercise at October 31, 2010

 

100

 

4.64

 

Granted

 

—

 

—

 

Expired

 

—

 

—

 

Exercised

 

(40

)

3.82

 

Outstanding and Eligible for Exercise at October 31, 2011

 

60

 

5.19

 

 

 

 

 

 

 

Granted

 

—

 

—

 

Expired

 

—

 

—

 

Exercised

 

(8

)

3.39

 

Outstanding and Eligible for Exercise at October 31, 2012

 

52

 

$

5.47

 

Granted

 

—

 

—

 

Expired

 

(2

)

3.60

 

Exercised

 

(44

)

5.25

 

Outstanding and Eligible for Exercise at October 31, 2013

 

 

 

 

 

 

 

6

 

7.67

 
XML 88 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies
 12 Months Ended
Oct. 31, 2013
Commitments and Contingencies  
Commitments and Contingencies

[14] Commitments and Contingencies

 

The Company leases various office and laboratory facilities and equipment under operating leases expiring from 2014 to 2019.  Several of these leases contain renewal options for one to five year periods.

 

Total expense for property and equipment rental for the years ended October 31, 2013, 2012 and 2011 was $10,568, $8,787 and $8,010, respectively.  There were no contingent rental amounts due through October 31, 2013.

 

Aggregate future minimum rental payments on non cancelable operating leases [exclusive of several month to month leases] are as follows:

 

October 31,

 

Property($)

 

Equipment($)

 

 

 

 

 

 

 

2014

 

8,671

 

344

 

2015

 

2,333

 

223

 

2016

 

1,422

 

87

 

2017

 

558

 

—

 

2018

 

558

 

—

 

Thereafter

 

651

 

—

 

 

 

 

 

 

 

Totals:

 

14,193

 

654

 

 

The Company has entered into several purchase agreements for reagent supplies through October, 2018.  Minimum purchase commitments as of October 31, 2013 are as follows:

 

October 31

 

Reagents ($)

 

2014

 

12,505

 

2015

 

11,938

 

2016

 

10,854

 

2017

 

6,559

 

2018

 

3,700

 

Thereafter

 

—

 

 

 

 

 

Totals:

 

45,556

 

 

Reagent supplies expensed under purchase agreements amount to $7,873, $13,338, and $8,379 for the years ended October 31, 2013, 2012 and 2011, respectively.

`_[8>S(NDDO>NI[M#>X4>BMRE`+#=I&C)%:F M.WS:JT\3N<--F3&QC&(9#W(9!YGSZG?2HJ2=2"=U`+$>_AA\/.M)BVZBG M=P_G%P_+>7]W/7V/@G?P8'PEF_W+<-_SS+S\OPO&+;<\_?IV\0FO!,"S<0#OS MP^CN.?X@@,Z%%[G1.^Z7&KU?>1$,8!B%5V&X@,Z)Y]PMHC"R/1P)G/FSF>]] MC=#X(]=!FF:_F(IV-)J@!4:$'^#SYZ,K60+*7\&W&R#+Z/_#P'5.=P'_AP&T?O]U$:C>LZR MI?12$*K41A#?E@,V$8PL:YQRJ9Q'CX(!K01SLD".UW]RT>(UTAG%V"'1R*U$ MDS4X9],=L$/R45K))W[_^>I/G:O9//#?XLZGC91(4X8BH[OH%0:WOC:=_,O.#R/TW-MW(==O>BXM^(H50#3N;*`EF-6F/N^R.VTA' M#)77T*R95*]RTML9F[2A7*F?7"-%DA5>;]6#I+(6,&CH1='2](A7@27Q"J#, M;4L0=^W:R(VB+\(P*X^>7C_-Q6#V)X8Q`"W17/4$>"43%W5*QT#F^MKW7AYA M,#N'3P75Z!'ACF5)XI3)&M:YHI=5&5_[MK>B(5HKF%NG(5(JCDYYKU4.6KQ8 MHI3/OA6673][/0MKVW#:6YRG54/5+I,[LB+O3,2G5:-3-I&PQC@JKQW=`H37 MJB$JHY"8HIS!`/@FR$SK*G'*#6957GG5(C3FK-7<1U\HR*8:M79J=WC<3L9L MK[I1#4P9=8,;P%L*+T;9''[7JH%KEVJB&[P;9=-(7JM&K5T*9&SR"J0AIN\' MQ>K5*+93Z<1YV@'C6;T:SW9Z9*=9M9!E>]!6IT';M7`>`8/N9".KO.9U\Y!7 MIT'>#D7%G.TW=^@@1*=!X2Z%QWB&M$-1A$Y#R%V*;N^/4G0:CNY2@GM_V*+3 MD/C&W,3.',?H-"3>I:)Q']A8O84Q;8-A`[2A%P2C@M.'EB?-/Y(U*F-V@YK[5;S>2*1G??EO@RZS+":.%:7H? M`0`>15CAD_TR<6GD4_CL!W#-[*F9[_:SUV2@,5\?;L)Y2WE\73S]$TZB1_\, M!36VZ^4#%Q`1-]TPN!WM^OPDGQ]*!KL/X-QVG8L?<^B%N0LQJ>GLUB)0 M92Z#N8;C3I3@RGM#/R-7E\^?>DFC]?P5W>I"`Y;\]I?E,JE7,AH(@#7QK/-> M4]E"ZL^D7L%H(I3+18!DL`@P3+YT?^"?&DE'YHZ.MR$>ZNV+)N)A2Q8KM?AR M0#+A19Y\B73%J+WY-J3[.B8O,N7.7:+@;4#YID8RXD6J+2Z:FQJO5=Y<4LZL M1JIM7+2I[/`:Q^X.M8L91N M,C]T_OM,FEG](-JQ,O2;YA8ODJUS)%FDO_$\5Y,`SJJ&JAQQO-%FB;L,V^H! MEU4-0JD3YX;F@P%:#612#4+I,N&^@F#4YWX'))9J]$D7"Q,4MZ1=TI!JD$D7 M!5=THAF#T8XFR-MBS(5R!R56O2<95$QB2=7(LT)=N$.1X0B&'H=84C76Y/"T MP.2-O+J)/AJ<5UM2-93DF/&8_WI#[?DS1P"3=+R.'>#=T]1]2;0)PW5[FDN@ M&E/R2`!8W'?_U[';8SAA29WBR[%BK#]);!%$M!XRZS.$VPRMB($1;=8^VUU? MD*L-S]V%5`C9='I(".3:`A!;>]-@2=3+JM2P$>.2?.[7UV=[=BIH2=0;J=W) M0K5VXWC0DJC73+L3Q,Z<$Z(%:RN)/3XPM`#UXBB3=+A/#HW=>5-A`>J]428Y M'43*P@+4JZ),@F**V`'@?E.W#>E0+X8R28R`#JLK\A^@9X!L&MQ"V/"!K`5ZQL>[?S)K@9Z1 M\V:.:/O)J\FML?3^9=KDU@AZ_W)O'=C4=)[>&Q_N1H)-;`^&:L$!5 MZQ^;-\G9_?+SCUB4^/^C?_X_4$L#!!0````(``\P+40D4CC]K!L``)G'`0`5 M`!P`8G)L:2TR,#$S,3`S,5]C86PN>&UL550)``--Q]-23S^0DV:V=DY)O4ZZRQRK;.4F>4C0% M6=BE"`4D[?'^^@`4*9$B;@V"`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`D9>*Z8?_?:@Q]SU$Z0[.Z.:YL[W*V;+MN/2%QJ\6$#S0(;=M7-5A6WO,H M>RK+;S8D>HZB%2O#3S^=H"3/ZM]P3WPZ_GA:C2S^4/WZ7V=%QL8Y6=;0Z9QD MS$/E+RB:7;*TE[]-"QHO6#Z?4AQO_)Q$3R@IAV&]1;$_<"?:B3@)R'DMU29) M4@T1SPO*X)"O@^0>Q0B_1"QH,G-76@J6.Q8LL.WF1H1,:-OC$8WKYMF/G?!H MCQ4KBI.,CV2XM&/,@K3FGU.R=(0P,J![&\[XZ:B/MDKGRJT9\#Y]*)?O+08.BCPS^%5H9 M:@A;>.9R;X/W_&62<:<4K2(\N_R^0FFV6QVY%]RO2]^5.?Y>?3`/.^W576I9 M1<6GT*+"MJ>!B@-'P.\]B;V7O?8!XK7Z0O[F=`WM\/$CMA^/4I# MW/@[DX%<&](`L:%C%32?1QXT4TI6+*V\31.^_)G.^(S>2M#_#"`9WA7));[' MZ#%UL.<`4JA9Q=`?1QY#=_D"T6\DC9NIHG?\**6"8T,1,4J M7OYWY/$R61*:X]_X/.ON(ECOJ#&0#8X=I\QBJ`.#V.:2Z5N%6L_;F/M.(R"2:@[+="LFNL^0RF:]RZHH*VX"21A M`^./I_WX/H!52`.5ZX7ZCZX#:]^]V#>2HSI=3-)9\TQ*[_[+0#8XX)0RQQ]C M0SK9%%1,&=PE-W]HMFC$74[3^%\^F?)V/I':V:H09 MNT`JQ_.&6<#7)HZ=UMT!JY>\22<]E!CH\(.;$>!#E*#L'KV@M$`/B+ZPS)A] M0[(Y$@UUY6@IE;NHE#11'4"AY`7SJX:N"#V+9GPD+LP\UD+4=JKX_1<#ND]( M'#E'V*-+A&ZBS*+1T4775THRV=XB+;T">16=Y_QN#QL"=T,WHX.;;\Y-*)J% MHVQKQ!SYW[CQ[N&00<>R>I78(*+<'OFXP'0VC?C.XNB-4,LZ5R?-N/B3 M"SK$ZL_0;0.7?W(M]GO,3Q1D;"0HB$L12.',K2E[0+4F%IKR%5/N.JH_<>Y[O,16]N%P2UIK1GGVE:"'HG6&X"8WNL3VO(E M<15IY4,Q25#&59\+8.,.A\+4#:7_,%%^+&)CL#`^1.S-X%"*#SHP+N=S%.>L M2]ZD@/LH1^M'%0J79+.,<`&5HR&,@;GG'L6$E30)7H.]3HK\'ON" M7^#5(@;YS4JRTJ%`B?Y#V@)09$BW"A."N9+--.%$N:#3297TRA<=RK-3,;B& M,^-M5W(Z'O^HAM=S(#_TK.IT;04]>2OJ?+?76P$JH"Z3H@AJ$ON'5Y\Z2&JV MLU*HV4+04#))T*U8:4P/].CG=2(!';QX'DU+<9W194[H43[BUS)!$!<+6ZL,!_"FPYP[DBMH)?2ZBZK*KQA M\ZPPYIV"0L?D'\R`NM7*$[:%JVECHP">N(,`P0\B8@>$9JRCA**%5_H"TJQ) M\\7:T):_UD](^HZ8]S&/SWZH?U^4.O5X1>D.(I MGQ=)?;V:J6N<-21SK(,&_"<@ZT&V:_>Z&9@[T"KHNB,"#%?]4P]ASBE9QMWZ/K_&'19N<[E4?+\,+A`[8H"[<>4^L[5`%_,1 MD-]2\S*B*4Z?LRFB#XN((M_;K?Y>>@O-)B]L@/F,OA7+)T3OYA_TG)%AC$C;^$ M20FH4S-?`74)NG!D@UZ*>&41)>=DN23IVHI)GE/\5.3\]JA'PL;!R5VI*T_` M?X\HC>0#+@<2MQLV[24=!.K=^=)U#/32S+R&]=Q-+U<)*;=VUT?HN1WLYZQ( M^&UDDV>*2B=XWR_=..*_O6Y4MO=$1=N]IJ%)XV^OC4B?BP(9'Q"&"U!Y0L+H M/^>HORUQX`]A(A%*:^V]`307='\I-^2!+Q'.^*D/,`2[K%KP-5D.`G92'[@& M7+.AH"=3Y":4U[18(:W#J05:@^,@<";S@&N8-=H)>EU6;@$_:IDOKE=7B MK,ER$$"3^L`UTIH-!7TP5F$"GMLB;9=3#[0MQV'@3.(!YS#;MC.6`ZW5*PSX M-S3;>8G!_X"M\4!$=A8E?-GQ88%0]43QV=MM]`NAYTF4*9;][834$0)D]IPE.*,O;O_T=)@>[F+''M_-T:R*:"C>&M%QBPFZ_3G-5C67Z=QDG!:K?K MM+>#]2*-7:L2-89,8HPU4)HQ=K!EVM%I#FJ/?6Q3!_B4=)C?9)A4U2VF@\A)I5IA+R8T;;A! M;&R&U$.[21P72^Y8-+M`*XIBY9*R6^FB7-5':F#QTGM$[\[%`TX`]%)RJ,,O^#F`L\=5^8;Q5PGSQ,E08/RX0 M1=$\[]Q2TE,*!,1-[D/'L-13>X1P4X<*P7\*?OF=+)=X\]C8^M:59T:,_=\O M75W\DCY;+?H!N2NT&'-YRSZ&&JJ7_NR$P'P4T/(?%`O$D:>$N<=08C/[0)4( M>AEP6M!XT=KH(P&IG+!^$E!`$)!9D*,/0&ZI`X(]]*#XF*2O&X1AUA75C"CC MAH(.)<.\H%VNLI8#ZQ'"6K(:OE.`+5L-UR_T6[KRGT.UIW:,^=1Y,ZSS.KTR M)NRDCE6N',T9'?,HT:T%])`$SI1!K0?L)5>"U@0&S99C61>01*;NZ)DIFSI; M!G7HK%>R!!TWL\J58SEH9APBNJ4F>T'01!G4R5*V'%)JTPYFH.2YF&B6XE54*6-0=-E2-9 MVI0%I>;HKRF;)E&&=.BW7YZ$'/>U2Y,V!WW#S9+:U7)K.;`<&=:*^?`I$K9J M/ER&',_*^7F4+:X2\NIO69P_YR23^=X$I.BLRG/(31?S, MT=V<6U7]929QI(V(>A0)8@TVBT`Q0YPX#Y)"##5LC5I!FH5](ESBE2N<1FGL M.($`A:H3B+$P;ZZ]1ZL**'?S&Y(^/R*ZO$!/LEVK.O+*'7*R8),`]+L3L%,@ M`6^H33/@Y5J$'=SK`ZWK%T/9SPDJT9#.)DM"<_Q;:^*O\]"-.>OF$1L3EF!1 MVJ/@M7#6P%6NF4;CN.EAF,&X736[A\&XL6)!;TOKU$C,S%E1/FN\/H-O6C++ M^&1U5D#YII&@J.BDG,&"V7&1 M9^8Z#W6?5+&P`5Z_9F?WWC7LB>N`7[4>HO:#N&CPLD^C3-#[,V]PBN[FYTQ_ MG%]%,7]3\:U\Y8F%V@5:_WN7+Q"5WT=M(Z+Z-##68*'<(P_W<-[`B1BF61?D MVDPL>0X.R=+7@FHIOS4Q)7#943!@K%' M:6?DD($K.ID.0NX6X_)=]ZMWX$AC+GZ"J9,APA3*X<- M#%M3G;K;>T,:--?36E>$WJ-5O5=YWM@JHIG%U#/N3&.J&(+%;I_^'NJHH3M\ M`WW"QNQVMW7U=??A;'/>[1/9)CS!@K='XK5QU\!Y MUU"E[B[TP"#<&ME?IY,X)@73_![%"+_P#7MR!!NS-M]XU[(<*'ZASAH>O@8: M5>C]8OEQ5/#=NL,"P!)F-80[3.\(Q&J'^8%Q M1Z<:R(%N%NZ:<5YD.1M-T@NT(AD&@%C&*`5PE^%]@%?CJ+T#MZM/#=HP=YG* MQXO3Z(T/%OF6YSBF!9K=X.B)[QN`U+L08=K9!+60]X%W"X=ZFW%0ZUC'A<$N M!1\7.33?//-VEX.R]!'VU.+29>\JJY\7$-*T#`CH<8`=-Q,S,X1!MV9H!L^. M".%):8\/V60+_N@'^X?/@[]$2?D,"$LS:,U1CRA0&+W MPY-^UBL04[74?G#&J(6P`-5:PV;:;Y:QY=M135BV$[L*TO",_DI)IIC/-F#2 M&5X1^P\8HZ](+,T7WYJF:'%G1EK94E@!M$X'WT@:&_2O7;)6%]O\LS>#8*OK M9@O$`:^@2S\,@1JIZ"VVXIM`UZUDAWD[2V/$P(*S>;?,VAX)4$S9-@<7=.0A M.$!=4\L)NT8&5%T;?RD",%48'+J6VJB%=N;#"!9.[GLX26H]W(1.%VN#T-S?4N'!5/SFD M)*YGAR1$02%%G;&-[+2;#Y&)#@L5C1.YRHT<$K)ZOJSS9_\8,,L/&L,L9@BZ M$L/ZXO61EC?Y=@L1R69?9O-/_K^R=KBOL`4VO&\+$EZN%(H[Y-O4;&K2[DXU M03I3.6*?-Z80,GO%22(!]NZ?ZUM/-K\.Y0NJ>RV)&>!QQ59.T'>%5?N&-Y%Z)4\676KJ.K9D5/YA8@8,,S,MZD.IX+!`40]?;DB4UKL>-(-%$>G. M4+%-XA\+X(&BPL9^P\2VX*#[X_)8ILD)#SEA_>"N@,`_*+1C"JU=L)&%2)SP M7D*/8\8\2I\Q/\:U+B=1?OD]3HH93I\U)3>$=3/&-&$)!2?JO&%A/KB,-VLC MZ)LNRQ!HID"#Q*(@;Z87(9E_\)C5]X:&6I3WY1%.T>PRHBF#=]9: M89WC6/H$@SGCYCD1/8-_&)D5LV#C+>I:DS;"ZM7J5Q[8X':3.-5YQX!CYPT/ M(:5_V&A+''-+8;6.4F[W1E"?\&B49=KU,B5MM]@-:[7,I(XQ,1!D5,*=F*,+XMHS;-)(B*A0CR$=IA)C04S M)O4QIM$A!&2T!5AT\KL7)6]PX^-2HH><#:KXMN"[^7IUSMO-1"S?;F]*G[Q$ M..$S"8^DL0>F&B^>11F.)9BVE+)]UQ[&'&\1ZU;,QXB;<.";'GET902^6O&`HIZ M(UWS+_ZAJ<(&,;%'"!V!U-:FNJ:TL#XM?T,LNTPAKH^ M^RZC\O_Y1=^50.T30J`AN;752R8Q+!BXC8S[$'$N?3S]62.*_ M^=?M]!$)BO@E,0N3_D^O++R,#@;663";\QH@`1^ZVQ1=D/`]H([#@@A6R M0*YZI@=6P8ZFGNN!)ZN:S@);09RU\SWK"RD5@YH`UB@>WET!:R/6:M:62XM: M-7GC#@$QF7]BJ3SEBZDR\L:*A;2\D"*O_H<;;L MJ_/!,$NT@E8#*VUV9A`Q17%^R^I;BJ/$;"9;PB.>U]VE]8\P\%RNTMQ^\[>[ MH@RP3J=W.D[@S*+AG&(` MZ+`O3`R-[EF8R%OI(B:D9WK73V2;K(0J*)NX4:^)AME7Z$T#]A!"@>8'2GWL MIKW`69R0K.!#O?8YZ@M^HI%U;+X@>L72"8YX2]!JQE1]71VQM^A4 M**9Z,,^436]^,(_F&7Y/8NT$882K6VU&O+ZUH)\64ZC?.,!LL`QN+T@/1JF` M`X.GF:.&`ZRT??$H>#Q=V#EK\]/O_5A0IC<15M7,W]CW?WQ%R0NZ)6F^L.CE M`$(-THZ)L$-+06`'#IB.3'09;>_:->Z?***/K\0)ZG=D68%](^/P,2YVUUZA MO5$AZ`4-"YM8\[)YJ9[2[%&]EO).<"UPV?Z1O58BZ'L=X59=D8(Z@W93F#6R MUT+>![`%#ML[KM8ZH4VP+)5H!?$?2X:-R*X]3*<5Z2GB&*^_R^F_#Z9 M"[3^5Q)S4';IB],R-K_/:U]G68%F%P7%Z?-:P_)-I/)O=R6FLLOOB,8XV\)! MY"$;.4U7P?C]9R`P+':?M.CA,,.[7\4*=5Z^@"D2]&R6Q)Z'1411!H]Z.TEJ M5*LEA.DY!\G`0)")W\).!Y9XT6<&<^_)4P-,.8,LH51JO&FB_.\9<\'LG"QY M#:9:4^XAR0CN$@GO!.\F_ML_X"5:!3TIKNSH'0#>0)!)L1H]OI!W&6Y M=T"P7@?J)&9NR?LYP!&*Q&T*N,I;[W:%70>,'KG/+J MC1Q341^B2KA`$O\0Y_>SYUV=R)252C4'<`___-U M&;UY(4D:TOCGMQ^^.WG[AL13.@OC^<]O\_1=D$[#\.U__M___;_^^7_>O7MS MEI`@([,W3^LW-R1)PBAZ1B338D5^?IN&RU5$JM\6"7F6PER!P1?@!T[Z_RA&>]\= M*O8WB3G[OIO191#&%D%L#VT#WF*H=TNR?"*)36#WQ[4`Z8(!E4SS)_)N2PB+ M\`I'M\L/Y#G(HZP?AJC&KD-<@=N$E0_\%%(V%TF8="7?3>GR?0'L>9A.(YKF M"9E,_\S#-.3B+CTG61!&J1YP+B88=!\^?3C9"+3_T`QH"]H+!@M=,V)D9S3. MDF":I9-XQOY.&5&8[IC,$T+X9SNX&$QG"],SNER&63'V9DH^'VL<$CNH0<:W MAF&[Z#/-R%VPYL.?!O$?5AA$.[@UN1JLPBR(PK_([)HP MV_KV*0KG@3WU!QG?%BYW"66V3+9F.^J"K?N*2W,K2"@'=J(5OA]0+7QO#\>K MF/E+\Y`Q\R1-B25A*AW4R\[P+F,I^9'.DS%&U9M!H![_:2..D(\HA-MUW7; M(N?JAN-#QG87-Q'8?%Q>+&@T(TG*S>YL;8*(9L!NT)X&$5W!PJ03PWA!,K9:@&2!&K#&8'4H9^0YC`LFOV;_W)N'O&8DGI%9-1.'L7,D MMIBZFCRBT[T9(YZFHLD^:O4P]7.0/A5!Y3Q]-P^"U7N&\L?W),K2ZA=.A(_O M3CZ4>:G_*'_^4@69:C`QA,D5XZRM:(N")Q(54'S!=,O"C!-&W?2]*\1Y#FV6 M1^3V60!@>KJN_:NP113$,!VJ)!"^^S[1=JPZ22KRE;D*5,KM.:%+@U6F5HEQ MOD7FS4]OH+"\R>@;*S`43,=(\_9-GK*_:&'2<=%`$R9:?W[[@;4L,C8_\:U, M9C^_S9*<['ZD<<:DPT54B&4FDCL*GXA:9%E:_]*R.=@233[SL:P+85B,I0SPLK`TFY?6,>2.+K&3C:NE<6G M':@BW=I=(&ON?R!$/F_^2TXED3O/NFL/HL>S[3>$J7 M*Y*178WPS1Y#"#:&OE.Y/JJ&PS.RJ5%'#;$W,4Q%@#19$P!`/RS73D?Q7[Y< M1C0)9\$9:\DS4=?!$S_O1)/U53QE:OF&L*]A$+>_UXY&27FNIQDJ%\OBP,,0 MU)Q0:`(,OU/[6FS:A42M;6P9RFI[8Z'S6:U,\HPNZ5/(U*!6FTC;EO07?!]> M=V!\#8K##^\2[>9LJ@;Y7(-J!,:L)(K.7[7R2MJPI(W@^_!K#PS\4@1>TC57 MS[4G*N1SH-?:D1LA29]!I74GS8_*!N[!"9;7AO`-NE-%V,YFX6;*S7'T:%?Z MDRH"$#:&4R2H0:/T2I"V+:()K-_YYL< M$X)67:>0T\]\Y(&MOZX<1`>AL-@F-(1]3Z#T`?.P^D!Q+%Z5.D;6.DGKMCK7 M'P"2R3!8Y75='6#TV>H_8XQ'ER0I2O$Y31;A2F__`WJ5*Z-L.=IX$AS_O@)* M$`AT?/?1J](;OITF\WE"YD%&N/Q$U=](>TN+<`0]O+"PKW7UKGCDK92X8J;U MF?,N\X31@A?%Q[/+\)7_I1=X^DY5<$[1<%0A$##&-F,A@$G[82V)2V$A#F[N M[G:(9(\]X&LQ1M!GY+>/4(%5_OU7'FH\ MFF-ZP:-I#J4PM7*B;WF>_V%"J\E!`S$U>^U69K:&[Z>K:<&-4TST1T[]ZS#:DNFWSR7$@ MLXAJ:&-(DI:U`.7>UU%%B]2XV0P1R6;JAT>ZI9HW(=,K[JR1E#%VFN9DQM"\ MS3-^V3F_D9[?E4OCXC:5CDEGL\EPZ6?L'%[(66E`?3#J=HJ_#P#EH'M'&+PP M"$'!(TX'$6`:/)XT`OFZ9TT\Y$__)M/LD9XQC<(PW#E`H@-#?4[3H:1'.?IA MN=@6*>U7:0\$;O1N&I\KCC]]W)M;C@'%9U\#$02286S%2]>.C@\HRD?T0FOW M[JM#2>J%NZX'5K>+OG=9\D:7JYS9.W#/7=.C*G63M1J5)P_#U:9'KYNQ'U[J MG*`YYQ=N,A/BCB0AG2%,3-1X:$G:',8+\8EVP4UHU(N7C0-D4%:M9?N)VG^6 MMZR"CX(&7C`.P%O6(F?)25;,@U[V\5GSYA>(]6;5FX`T[$KU6`3<^98OQ"Y/C;V53C?EMR&@X6;V0U!!P=?OI;YZL+=HY-[@>H!??'`4'>C6&BB*M M*&N`25$"1S*('%4#>,&6_5:Q2ZCEOF2]!9B.:%B)1#JML,_1K$=RH+7ZS!X"B/6D"FL\G7-\H%JF]74 M^EE,"ZM5(W\;^PA+8B^V%AQHW6[[T>FAP7T$DIP_)5H^TPS4@F-23RK/RYK18,!QD?O..688]QD M?9+5"WT%`5>[H<;Q7,19L`JS("KBM;=/43C?D)`+D]WKL]V,0L@,>#6F'O7; MV%88TGJQL6``:[>6VZLC:DKWF@:QPH/J97P+%M_^L&/<*WU2UD?K3@BN=I_T M?48&#/ZF?(W,[MG//6X7Q306=HUP]&]R\^CI[.,>4D&MW4HN"\A-#@7A3#?P M]O"S'^^;ZQM(SFA<$"%EKAG[.\VC+(SG MNW>.SDD6A%'ZUE[A,WCJ5FJ[51EM/E15.FTR@CTKH'9!-1B01Y6^[SQ@^TEP M[#@6Y5(016UIU'GE:0_T$I]A-8!R3S]WAPYP>3FG_BS[B0L&,OOY;9;D9/BC=!+\ M>FV;NA0*O%1G;\=LJF+16#Y?R'_#\%OF2^T""]M5-P?O?QO>SA,1G<+A5Z_R M_D6\ZO%\7NE*#N=!M(N]73(#*XC^'PF2FR#+$V8D`AX0-AQI>VX5V=LOBIWG MY"K^S'3,XU<2O9`;UF:ADNWX051TDG0].!E/8*FKH4Z"%2_[X24[O#PN8OP;O;6R^Y=CT,4W1)Z.)#< M+4CZN?^DN^".8P9]F=XJ;*;-7=)7\33*^8W^O\8,O-T.W/7\3+/M7=3\O$08 M%^A;D/9]@817$?8A.7R]TO/J.5=&O>'G\PU)0DF'U5D0+75H>LFE)@)SEMGM M-/W:1I/GC"1=S"/Q`!H+J=GIL)A11Y6A[20),-I+.$Y.S,XO=[:6N-CN;N#4 M1T';))O.!V]&"&CD6O/O@83A49>%]#4+98,6QXDU+D[(F%;.VY'\MRO"W["/ MY\4!T=GF?KL6_P@D/JQCR36ZQLX4WZY@1@BBK(S>I'NK:%[5I>_Z>.0JTLYH M2[6:&H*F$D/-?*QKKRW`L:[]6-?>\_(BWN`2+#O^,3%0#_^HT;Y`&D,-P?73 M&FK4>SC9-)B5A;XP)R4#_DKM'13@1^4$L_N\,8\'3OP_<")QBRL65+_^(V[5 M$`RCNDM?CY:-N_-5L_B\H?>-W_0RSYB767+K7;#>G,G.">!%(0K\.T-MW MBI576'0G6&,@'+VVG8??JJ;\0"U2">@K:H%KBG-#H#P\:V3D#IN>+,),=CQ' M=#Q'!%UIEV7_\(=AU8^DCOLAV.$>@#5]^-6,1R2V]#5A@HIPF<53"DG"&;H0 M^@W%<$]B\C6(5'FF#D-MG[LR&,&U/:`+$%NB3<=@<6O M*[9PY#-!^,?B?F+YT6SK6E9`TZ$8E"WE06%3^GR8"BZWV*S$GB9KC8;69;41 M7'/H`-I,1B_W^JP-V4'P.S]O9HW=6X-AN;TVP.$SNXQ:SGF]#9C/)ZWDRFE; M^I;Q'X,(P>.04;1FA:"G:Z[N;F3HR-&[R2$'`,VEHZ$_,E'6SQJ`@?#Y5`M< M"(8O]NS`UF!HQ;@;P#4+#Z`8)=1RKQA;@!T`JS\N2$("?BRC.Z>WQ\(Q>KW_ MH?.YE%:.V5P`E\^'R8!8=>=M,XX^?#[VBWO!/+M]Y=SE49V'?+D,DO7M\T,X MC\/G<,JCN)N7W6"1YZ6!I_B@0W1 M.LFCZS;4:1[$RDI/]*!(@"\1D+HV:`B.IWMJ"W$\W7,\W7,\W>,#-8ZG>XZG M>X9EQ>/I'O]/]]A9Z<+16M!H=K5<)?1E4\^F77=`KVU-HJ+EJ"I;X3C;K'*% MS#J*TP1`$]S>B0+UA,=3!<=3!="5=EDS)^7B7U/RG$?7X;,J#('HK3,*ZST\ MDMO:,`2>!!8C$)C)1U$[:R;%>ZF?QKA$Q#W3V-HF9;TM8_C6DK M*Y&RMF>%LX#+`%TF&FZ3>1"'?Q60,U2KY\1=9Q8>-F'0>[*B"<]X7,7/-%D& M)0VTN05,]RJ,#NKB07Y!`>CINOP(3S6@1VME'1`C#)6`0"V_-`5A2AJY'@*` M)<]'X,$YIB:.J8EC:F)`&9T%6;%7*BU:[LI4P[*@?I7<5;=UA_L&#&W*0=AN M7P4[32/`UJ*I,Q1(R;6!:J:6&A#.X/-F.*8#_$\'R"XH")YHPENO'TG*38V* M0]6W?P&[54%^7>OA5UN\R:@QBCI#4'`)&'2"483O\19K4ZXB%",@^@.&IR5] M07#X+(U5ZGGOVY0[R*+.@E]78N-3&5B^1N:N]8KEA:,ZX M)6#EO0#TD69!M/F'3&B;CE.%_M'=G8EU5#3`!FVLQ`&Z`3**_$!G-=$AX6NL M$O"YW^&V?_F8;9S4>"B`#)`(-@,QI0H0\*%LI^=P,CK]X[8`C;^9\WO`;W#+W*?' M%D%"3OE)[3.ZY(??-_F[W?5R3'EMFY2'H"9?@V368BI1B,[:X)4+86%`'Q)O M.C12&1Z(=)R=.=I)NJ[C#I:ZL\=\\L2>52++16EG5!3)0$LH'%R*D-=L?`Z6 MVG,@@F:5V;#WR3DB^D,S1`1NUGNI<)"7JE3&[E5O24>T>\R>Y]Q23J0JY_1`5FZ2)8-7T*N8AZ6"%_J+CPW"3Z>G'Q2Y['Q(^P]W`SKZ*"&6FP/M9]D M-L!<:Z`)4MT&DPW*2,4VX:?H2,+YO*S+>%B1:?@ZS;$3*?;;SC*<$A3PDZ+0DQ#4]5X?#9+-R@LPN7 MIX"G_@:9MVOD&3;7:-?NXI6)J##EH<#/N6:G]S:7I342C.\@CS<(4S>_DW"^R,AL\D(29I.4]"!W23@E]S2* MGFG"._8H`LR!L20C3``X]*5WO]YN%GF,ZJ'#!K*L,\R6MC=-@B>,;?6")<@W MHG0XQ2^'5"R"">W+E;U)#F&9>K?^I7/97YSQ6O\:-NY/A`]K]HO1[%$@=[7W MG53#6ZKLD=17&);)=P-*5IHQFN-3W5*JR-ZM0TL&_=T:0;5Z MM@20F#OIG$$],AM'K329XM:!+^17H)9.CFZBHCY../2!I<:\]V]$S^ M(<]X](;*J/>JU,'<"JY5F&S,Z*OXCB0AG?5E!/0$"G2G6Y]^1()@^'1(OXL] MYKQ(7Y09M9C2T.27XO1P18Y?$IKV4-"KW/VM7^`$XVHJTHM4&& M7Y4!C)`AD1I^T]K)YSV29*G9<>`/."_!!J"%CHY]K=!Y1@PYKKQ8B;/&4FX M4`[C8IQS_E;%/D&R0HZH3$?_P0D34K\C M/F^(P"R@PCRZID%\F_R2![RF<'T3K$]9._H2SH3A=7^`ZBHT[,!RE!X]K*GW M8L0JSCIY\N-A<-F@-Q*-X3@9#!_MI1TG1_:P>A/B.%D'BZN6K2Q?<3)VML+< MB3PB#H*AI646ER<$RHR@_CYU4;OJ/O7];W[>IZZ`W^@^=>%X6N?FY*2E<(8N M$=J\"Y!>_)DS[^PSS3:WLCRLF+-V1F,F`'G]USW?";KZ(/Q(]>(@3.^#DJ6= M2#>D=#0$U/=-T#6'NW]\T-61"3P4MFH4,#./:./Z=UC">(D/^:2$`5$P`LGE M8]Z3*9.R:3%X]8+W1W=/>&^KJC>R_X9D"SJ[8B(_S8IU:BDZY+[6R^+0#58SEA`JRIN0`0N3S M%=*MPT['M[V/;WO;8$]):IY?"AQ%YZ_L_^K+FJ4-2]P%WX?W.H$"@"+PDJZI M>JZ]%*U\#I]%T?&-3Z=O?+HX2PPRN)%N`\*N-''K4`V[*OD0C@G2YJS M_T;%2&1V29-=QFO72B:X;8PI-6TQ0SD(0AK[Q+8I9]%-M@?:*"[9,Q%)'>XN MP,@7_,4$=A_@$/.`8,7YR9(PR^2UD!V&4HL&]0B'(A$0=!I($(`@ZN<:C<[< MVIU)C7GSH%G2&TX$,^#WOJ6#"C60.DL&G>8I(WV:UD!J,8?`08-T*YE"W=2# MD+@`P/1T7?L7/-F#&ZH5^H9V'RH!!%IEJ>]F1`RI"%'!(O?2D#`<7.)'@+\F M$JSI(=_4CJ/$(HCXGPG1)V/`?178-]H[B3/KUHYV0QNS-T61:?A\@T9(+B.: MA+/@C+4,IT%T'3S1A'=>7\7323R[(>QK&,3M[VG'M&:P_PC2+0BU2U`%ED%&V!@0$13\"S"DS(ABF5'"@<"F&M=1F'NR0N- M7L)XS@\_W`5KCLII$/]1%N@Z"\GPU;A]/DO(+,PN@VEQUP(D)@/J5W*'IJTS MD2*"2Q=^T?91X#QP0`6V1-0,/^F.5\[:W/+ZV0XN2'(LD#L6R'E<-+6_%S5\ M*F]DZC<8JEH&B\I&S>GJ7)[\K1!W5LS\E3=A6G3!UP MB?];D(1ND[#(68E*_1?4'(.6%Z["K1KA1H;`?@_'L. M.6I>GS7$\:J'(:]Z<'J6H_)9]X6ZWOB#]*O,077;X3E#J<":AB("4:!.W0_E MX2;R2+WR_ZMCQMC^(&U4[S8$!TCQ]>_FU+U\^R'W[+Y:O+MO9A.0YR*-,H]J;YI\*ZF&<>I>Y$X#G M*VKRY2/`W_UBM\H>L=!JEQ>$D"M'UVH=O8$_".GRY9.!(_C%[I.2`&XP\`4- ML??-"71ZW]_Q;.6`9RL'$A<7>4)G-(J"Q-1TEXV@E2#MCN,WW[7$Z-F`E\[O MLV`1&=;EICFE24*_D^F)'R1%>-H>!:-`/ M[;GHZ)N8W>1*?]"A3Y5Z*'1TA23=XUKC>M1^7QZ>DW2:A`5\M\\-X:BL=S`9 M1FCZZKIZ+AJLT,.&56$$0#_O4??!J`7<#ZN$!+/;N(X0F$>U(PC94]%KE)P) MIX)]IM3//>BKS?O`W5><@T:UL_4"F:R?EW#MN>IIA>I9 MGB3BNR\@S6OV=;N)YXR#P,^>*RV=:-"G4S'V]UT2TN213ABOSU2WI-@8T\!= M:P_E.=O9)M;`[I@4&L^?_1#AN+FVK/:H`3(P*>VOX&-!'\\9M@L%^HM!RF<& M,.*VQL'ER3*VH\(LB,*_R.R:!"FY?8K">7%>+G5]N*P$K0!K-DE3`GON`=*M MJDA0-O7@L&H30`XA_(H?;>_6H51%CZ'.G8&63WK\%(JRO'1#,;W\R*E^VH,[ MB7:7T!5)F"J.@CCC1\/_S,-5X;*N']G%U\>CX@>CXCZR9[;;:5=8DG+VK6F>U^' M=V`P$D/P>HP<-[Q8V\TH>A5&-)///'(\).;TD)B+*[GT%C346)!:D(`;N:10 M@(T%P>P^[[1)GM$E?0HCDFIWF[1M25_!]U')9!U^-J6R?*Y!*ZKJ_)Y>\3N_ M2)JILGG:#H+(2J.=@T.9B)`""LM.403@3#Z7VQ[K^)W6\8]"3W=XC02LC8=Z MBJ2WN/8O"4V1,>V]+O)X=MG,;Z&+1--*\%8[E\\5B7MJXYHPZ,EIP*R/*7E8 M$))MT#E=WP3_ILE9%/`;%*?Y,H_XNTCG9)60S96(0(ZS,(/(+.@RZOCXV1X1 MK;._#=!\+HOB*D(R&TC$^X#.(V1Q+$GL/O\S.^GC6=G=+G*F>6OCXQV'JNZB]]HB%$X\[9(9,/9[PX+IIS) M915)190Z/5R7CT@7JB73,!G9MD#4)&2OO2HHD7,ON*H$-D3[OG--MZ'J2Q`K M*[_D'$,"O"21JCHT!,>JDV/5"9X:QZJ38]7),:W_C:3U7021@=IKB(RO&I1# M3?L6SO*"1K.KY2JA+X5ZUR>``;VJ,P>JEJ/:T7"<;>YNR*P^ISBD*.L2';". M.G/$6=+#W+E`(6[1I0#..VA5PC%:=HR6]1$MU83W:$EIYW!,Q+4INZQ#ZO'T>DR!.5PR;`A>X MLPGJ5ZZ-IJU'W*LW6S%XVS1<8?/ZG"R6(JU.#4.ZZ]^[T/:["%?+H-D??O\$,[CD%DY'*'-W7)A/+^C43@-274.^WMGF;1=M(23 MFC\*8M1E$FD*"#M%)(^HX>9-@D0,+S:Y`!H*09.+=FL,;2 M'!N"#(`PGPX>>:8-!,?!Y=ET^+=_)>1SL-0EX&P,"^1]]5!.\R0BL+39.EC' M6A9%U=A)CL[*X@L2+F"J&,L)%62BQ`P`HGZR`Y*`VA6S/Z+H_)7]7QTMDS8L M*2CX/KR]"J0P1>`EY0SU7'NA*_DV?KU%$3@U'T^[S=TT12A&K`"A6][C1X!^!4ZH!`[7@J,S[O],^6.THID9#)/"+"B6M^I7`!5P]&* M`##V?4D"```^!USDV/^:DN<\N@Z?50X2IKO60JIW\8HAM>Z1`1FL.D:H^0>M MP[X+,KXC)O'L.IPR]:2X(Q#4OJI_DC;SBG$@D@R#MFTA!IO;YZ).!>*Z/:4#'`S#PD@T%`OK MH/&Y=%F!EKIX&=91SZR."IA[8DQ$$;-E)NS_GBI;AYK^S,.$S.2HW),TG.5! M]%L0Y2I?Q'"D[1$E9.]Q\6@WXEAE6E-0QG*1%:HB_P=W&>,@3`H"ETJ+F__! M$W^2+N0>0,!1F=W&]V2:)PD#G#7X3..D^F?QJG"+[42*H8]Y*CUB=VQW6M<" M'KI2&1+D>/&J"Y_32=W).EY)(B0MX&59^7-QFG22187S=SJRZ2-`77T M$D4)DE14H$#Q.2]WD6;ADKGSM\];-+9_[.P^_:UE!L-4Y=2HK@Y<$Z,U;Q[$ M,:>/GH4A@+4*JDT`\IF1M]!?Q:N9XS;FH@#=R5.:)<%4>1D-M&\5PM&W=_A^0+IX8+8P#RU( M64!5VH7IOWTM`-1G^'T)7]C62P%X*DBWI1:*]BL!F-D]+@.S[\S)A";&D^G5 ML177C^'`''9%L997G[$,K"1V$Z.`0^EU199`XW\PLM$^@&VT#X=GHXF1'\Q& M:TZ/25YXPG2?C)CN$YCI/AT>TXF1'XSIFM,#F.Z##QDSH9/N_$3E,3]VS(\= M\V/'_-@Q/W;,CQWS8\?\V,CR8\=PTJ&%DT8BE%!]6SJ&#F&@L<6"NZ-[9"Q8.ML-]9@,.KX MQ"=GX6%.[J!\(^>_\R`*G]=<36T`37?H0$+`QF.53&70WYEX@<*J"]<:C8.D MU\!A5W,VH/9H(Q50:.B:0LH,JH,+@^[($$7T:\"D(+=^[TE*DA>2`EX@QPW0 M8GEU)T_)HHU^8KJ#2.(TUHE<8NGV!],"L.M5D,BW.@""09\QV`)T29,S)ANX M-\ADT1GS-L/"#>5RJ!!(ZGMJ3,>I(@CH[L-;QJA%I/9H8\B+@IMMC`'Q.-AN MID51$@+[$CH*))RH&-6+Z'5V.Z?Y4_:<1Q45M`XTO+-`A,@ZC$-H&)/`BJ0P MF-WGJ*$:]=,@XC\9&U*-_B!+:MO')3=:\ZC@5!G"DX)`,XKW%#0T<5P+>`SV M'(,]QV#/,=AS#/8<@SW'8(]_P9ZC_W;TWRSZ;RZ9\(:^%-KK*E83X9Y&$;Y?%[]/_-8"K7P_X&,X]AG.M&*F0+JW27F@G M-X7.>.O4B`@^VZ16'\0X)B"/"U MQ`\9G?YQ6X#&D?\]2)*`H5)L0G>.\<,B2,AIP"SS,[KD4;/-,G'8YH5-?KK> M-;D+UORG"8]I0#QE>X.7#&9C0&?BZ&&Z(+,\(K?/6C12&1XZ/]OZ'!7A[8T[ ME']ND?GH,$26BL_NJ#2%JWT4#JY(^BX*XL_!4N?NBYJ5Z[G_R3DB6B==W+"! MC%/'6TALBL!"NL7J(S/?6@-*MM%'X^$J1?O^ MQU9M6_NSFU(^F4S7@#^D)+=::@<0$">=)?F)J20_&;LD%V/>DR1O3N9SH8E. M:N[%)Z8,WS!;%U+RD=GEIPRP/SKXG?#!@0XG9,#A6=B=SXDFL$?.)@+V46\P M_FLZR;,%3<*_R.Q7_F!C0Z8P>^7BE9EG84KNDG!*[CG1K6Q`:Y-#-ZB%";^I M#6Q[@7S:X/9P&T4EG"347Q;!??0LV`]:G?;:F"<`;$VH3`ITG^0`%4G'[(&= MB7M7(#[D&:SQ^&!JI'M"HBO.PZF5P\Y<6*:6)@'2XVS=!;Q\AC&N3AL7;4ZG MQ]GZ4+].LTM]^+'W(;AF6+<'=(W;#9MU:T-S&1!.IHK&JEKZX MOG86C1H1:!CS0Q3Y!8`XXJ2=);O)GD@#V@'&"<%N"%N4;EI$?4XV]F^X]#!# M*V_8TQQNW:J?8S2FW)==7BK536EVD=DJMY;=DI\@(Y)&=T@;1 MZXR9U3`2_4J2,J"T#%4/JPXQ;2^QZ>94(]]\^F#G<`OE.M0Y!*:N51)KCW:> M!9WD:JG>=N1[`Z>8I$3R234)@`1G<\>NG'Y=K5PH)\FT?2BGUE0CWX##*B?U M0AV2O(]^>PB@N\?(>DPP!(>R]!GBS1 MHDV#WTDX7V1D-GDA23`G]X3O`?:Y=MW+(TF6'W42QA\(ZQ+(!ZB^"0GE`Z&] MDV`>$44GX7[X9B3<7I=3,@]C3KCRN8\/WH@Y&)A.9)T.M*/`<\8(WY34`U)& M)_K^YEKTV39TRR^\&L:1>RB'H$_W4#3K-R&+!E\^'\3,@$CK),C?74L06R*W M30.5R!W,6#($JP_C"`W*-R&`_%AH'Z22:TKH1-4_>D[,A"_HHH%V'WEBIM9T MY!L+EYB1D\6(;1``K M]GP6Z8&\D!C-C.U.O'+]3I0$KI;-*O!/H%U+1M(W]^#^"=DRG:[WOH"OE3`8KW5;!&J,H2Z! M`"^^]#H'<])(19(.*/E]"R;`C/_I)QC6FNL0\(.H!8*PHQ;B\:TC[#(FI8T;7\>WDA5+$+S?6DU M,B`&$3^5(AUY%(?4392-8O>AA"[@2#D"/-4&!8+E\\;5"O]V@]9Q7W$3-Z>G MS:0^`$F_9+W58UU5;NM?X7P1K;>N+ID]D)CY?#M)5-V>++*5.HY44MED`+?Z M`>(9V*%-9Y^@*Q@^'SN6T*!\-3Z]9&M8WYR_A]FBW@5O_&-'5GL$\-'\Y_9^ M"&?-([8%UCANK"`Q.%V7*I@D;>8NYK8/DC:D MIF@N1G+H6U%U*]$,A.D1DMOJDKE:\2W5'`=W"^A]\T8?D;Z2W+15^]TM_-H( M@:!5'8<^X@+PJ)+H3B48\'(-)KO+2#26*"3K;#U/\Y1MS#2=3/_,PW1#?35W M:GJ4I)*V\@I3_F="]/>U@OLJL&^T=\+[NK6CW="6[@_)O,W=`I_/YX!,4Z$U M'N<&V`WBE\6EK7S"5'_UL:Z/'%NWUQ!KUDAC.87\T68;]].6:S(/H(F:8R])UBE8EO5I?!X)],Z64NV5-JB*> MO4^#\J^*I!0$?(M%!4-6;"D=RF>!?1.\ALM\"`269BO5 M)8=?;=INNK037*+Q+)FWDDCWOW+FT277P1-->)^0I%?Q5%UM!^A2$D'9/!HRH<_;OZ%"M6)`V5YLO3BLUM3:!VK#!5EN*9M-8[8, MPBT2B?(+B-W3NA;SE/7U,GTEHR&LZA;@XQ/ MK`%:V%&`YUR0I+)X->8$)D`BF$9G2XRF$`ED=8H;M4ITY,WVK`G]Q&U\%+@8U0]$+F\)G/MD7CY?!E$R6 M-!?F4:!=A/&=>K/A&:93N$>!HLQF2NF M[R$4__L-O64=+(IF+`*=I9\<;2]V0U+DH*?KV^=-O4XXE==CF`XAMBL4W;QE ML\X4L&IWZ*?5,:++%U7WD6E@<)>$,2_\BL!LJ!M`R(3R3B-C03#V-AE0.ZF. M_5R^:KF/RA4OKB!I=A]DY"$KZ@V92?O&<GK+8YV)8,WSA$VKS8*9/6XX@`M@:OEC#'Z/&SA+;5./+NN- M:^&[ZM[I3\Z*C04QQ=;"PP+#;7Z11H%K33UX^$T`8'JZKOT+_N8;;JCJI@YT M]Z%*FD&K+'WES8@8F$HDJ;0PA@%0F3&N*NF[A*Y(DJWYVYO9))XQE1RN.$RG M:T#1-*)WN7R@'OY1`U1?C>BMHX;SRFO,RM*N9)#N:0`4S:V-F=WG.JM+3A%R M';Z0V56_,?C&L?C&L?C&E89;9)G=$F? MP@A0F"IM6U)4\'WX8`S&T*$X_/#VF+Q,53Z7S]SRF<93_L)?1B9SQN=%8%++ M-OI.)7U5#8=G)%,%2@VQ-S$"1(`T.0T`P*#GC"XCFH2SX(RU#*=!M+VI>ZT] M8@;O69F?@`YC.8B&1M[2V33$O!Z?<#*.;%F^]@X)ANWJ:I>Z`Q]$`O1H'3(" M]G%SD`H9/3+!W]>8DZEBPC>!,0"\/CZ$P%PR5=;J:YUY"0MJWNAFU]'Y?NK<;/I^%JT[+1S8@^3SV^78^O_.IMMV-`Z>>D MNZ4S5/S$Q8)&LZOE*J$OP*03H%=UPDK5OQ>B]7#F^?7NW MHIDQ+.7R4,M#OEP&R?KV^2&`BBM;?@NBG!3?;HL%3B]> MF<\=ID1%,^.QMD('W7_X(*8I8[2T7S=:2?C=WC1P)A=)KCM[B>=&H(V/GS39M M;GX4DZN'D+*^K)MO*FVSRF9T,AM-K=;4(_BP"S78P30:@E"(+2P>#ZC,0"#Y MO_\E6KI>M&-HK(F&`-AH^]U\(\YFU;M11SX&9*^KZ#/8#L"X_]>E_G7'(]3CB#1%PD`_A&NLWJVZ(=9#2(KH=1S[76U^")T?\@DAE9`N*143:!!K@Q2HP2 M,3LA6L!@(*;W)4AK'L5$L7R7."T:1!S#CS=4RW;HDFZ"UI#C5>*VNX-5S>_# M,Z,BF=8^0:5$1\I,[2D$1Z4D0^.98<#J37$N7U9)H$EJZ_.BPII+_?`#DQ`L M!*&E&-V2G1UJ-4PGUAX2=4+P(5*#G:RL/G.#W2RL]H(-J'%VKROQUWBOXK-@ M%69!I+^>%-*ONJI4W=9GK81!LX.&@DWSS>Y\D_AJC_O=*,KZR>4NO^='FF(R MNPB2F+^?IMW>Z@XE[66-?-[0(,0Z[&3-^%YSR6?"']VC2W)-TW3R$H01-PD? M:X]6Z'6C4U^RSQ0J[<'ST>LGHQ13KRH*"9%N MB7X8_1*I:M=Z70GQQ#J"_^VP"-ZMUL7Z,G2L<_F[F3:67,?VP(`AZ>2!Q"%- M[HKC1FROJH-]N(Y5G%K?WD<3S0A7`U,-.4]O]V7(V*3I>3PN2#V\?9D$TPT( M90SFT<#>XJ[4(TL4DGO'_<0OK)8BX333)SH(D63,[2E=SC.I?U63`^KCB M'-G"-4LU###7,%1CYE8%!VI&O_AL@R!_&`XI=.1=]N2.J)G3]RVR]0W)%CSL M\D+DCBFP1^V]"V$K5UM%L3B"QR[T"&KV1WLZT4L7JFF\KGN[#H.G,&+H,_\T MGK6=7\">P0Y174@,[N8#<>!VB[Y3FP`>6##H56S>R@Q%6[K?H!"T;F;6S^R9 M7MI!6ONLY1`J[22LD.EDR2-G+(2T*X!(0AA'(TUHYG'+S:IH86R84#] MVC+(*VNF+,,J+EV_?8K"^>9=GQV,2O<`V'?K&FC;.]U#<(,'BSED1^GM'_BL M7EM"1K8/V-KQTK[9S[[IW&Y%Z^VKM((6/MPIH=LX>M00MT3(]HEJ$K\TCQ=W M_!W/>TC/>XSD@(B?-G8UYP*"DG#Y`IP#K_8YIRL M:!HRI!IA3`7#Z+ILJ2AKYG],&(QBQZ"P=AZOM=7%:T#:F>.M`49DJ;M^S!&%!/2(&4A("2=P2\A MPG/:,7_HG'E*"B80-=M>3%__Y+DKJL"CF^LI'+BUU$[/H3+O.%_FA37!#-B$ M3,,BEL_^CDBQ1/%LLJ1)%OY5_"[UB]01#:M3[*(?EH;UU='MB7"F]8:VH?%K M(_Q"Z>QKN*M\%C!RLTE)S]W/_CO#$A0Z.[^M0YR@^P8U#1*@ M-JH7.U-\_Y%J7ZI[J&^>&H?K!T/1@@>HF\@O7JFB&=)XF`:`H26N4[%TI_#::AB'7AGR5VQH@YC<,K1 MB%OPSQ%S^L5BNO@5S`=3=@4>XQUC_!!)@CY+C=3S^\5TU5U7C\'K5J?K=2&@ M5^.&,6%+SSTZ%)8=7#O(/"VN<7/W+.;.'/-R/\BU.9AZOC:MW`1&0/$T9?MV M>&1I)\)G`,-!O^=8/!)8E6A`AEA^^>B$V_PU/!4#^U`K`;Y:T% MYX7&935J4;-A-"HF\8LO$(ZGQBT;H[O9MZ=I[&0:OI72ZT5=>K$!ZZB^HFM4 MP@2%L`6Y`IRO)6*[XO")]+ZGIOS0H:8_;=* MB%[[#WN-YTDO/(H=GEZ%3.(Y`_&SV.'FXFY^W3V-LS">DWC*\%*)&WVOVAEX M:YIS.%U=7SM\E4#\PO1NWT)[C@-+SS*';@+ M,YG7I9`U1!"Z#M"KS5;CTG)P%.VPD;%^U41`J]PT/61L,P:U!D/-)KL@ M%9K;.IDF\+=YEF9!S/T$#+\(NLF89J_IJ#A'CJ1-]A'-HN.A'[4YR?)W_I^G M("7LE_\/4$L#!!0````(``\P+420X9O!]@T!`&A%$@`5`!P`8G)L:2TR,#$S M,3`S,5]L86(N>&UL550)``--Q]-23ZI_O>&X]%2LIJS:.4-)*J>MK2UL:H"$CB M%(.,(AG*5/_Z!?_H!PO$K68?SX?_ZPR]X%V2H,__!_+_[?_Z___?]Y]PZ=I#C(\1K= MOZ#/.$W#*$(G2;I-TB`G!M"[=V7#GW&,TZKE^\GS[UQ]__/KUZP_?[M/H MAR1]_/'XIY\^_%CW$K:@?[VKFKVC'[U[?_SNP_L?OF7K/R#R]>.,^=9P4C4G M$79:?_U0M7W_XW]^OKAEP;\+XRP/XE73:^"E[/?^+W_YRX_L:MV4N`\E`=6F MR:^'4/'[I4F$;_`#HO_]Y>91\0M,Y&_;/'_^4,6 M;K81KCY[2O$#WU:4IAU3]+?]"_UMW_^)_K;_H^OAQ\FAWA&48OOQMMT`!)WD M0>0@Z):;=M`1_>B"_*OC''_+<;S&Z\H]=2!!&_//X,DLU[:35<=J1-F:I-WO M1(%,8G[_X?U/!>7^!_WDOTZ";4@CQH15V7F= M[_Z0)AOMNYN8W8CV[_I7)&R.\@3IF=UEQ%RRI9DHB*QBZ;_>FZ`I'PJB$TB1 M*!O<],;\]7:Y(N_3X MHC`/+NA2?_`5@TW0TW]^U^?Y&\K%8/$":3RB.)$%E@JAX1=`$,^7]&&5ANMQ-"!R@ M>!GG7:%;8XPNS*0(>29%4^"70.&A*RPC#/4$9%0HX/7`B"C@\[XO/&'/"QJF M1$GVZM$O2JRO&?\V'D]X0X'A(XW@\3%E#^]1L$EV10;Y2A]9O%LG7^.,/;4( M:T\92DEE]!B'_R099+U+JX<<6YR&R;IHW*2?H![X)BS[1+00CECV89)2X4O!?V M7+2N(';)KXDEY8U-C&Y"ES&BUCU:B(V")Q^1*_@*"QY+M%8:H.EP("2J>RR# M:(J`1E'RE:ZU_)2D)TG,W.V"Z"3%ZY`)^FF8K6C^SC[CS3U.N<(ZTD8EN,;= M`3@T,F0P9IG[5S'.U.*BU0J5S7ZL&_G`R;&P2D!N=8_!AE;ZS#8.`CYM&(9@ MEDXT!RSSX[Z8=>\.52H3"&=YWU$,1K9J\KW^0E"QO)U'\8"3J)@@^^Z(_I2=/5B,#`3'00#;L_H8*U2G%PF M3JD1G1>($ZK#2?P')O^@)%3S?@\Y#T%X@!IQ"M'G3GJ32L/IXR&[L*<5X7Z/ MA2P@?%QY=T@8M_&\9E:8CCF/5]%NC=?G\6T0X>PN^':#'W;Q^B0*PLT-H5GTW+Q$:?S[G"Y\"%L\29CO,D);]*" M-RO&F_2--QR`O#&G^\-8J4A](@^G0JW34%BQRH!.7E2JL_-)5+GZRJS7 M(%UG=\EU&B;IU=>89(_S^"3(GKC5JJIQ59&*VP$H@2H(B,I2XD/%8V'717&) M`H)=1,55RDIZW0?F*>]O8G8K>OP1->]S1&P6/J^(?%FHNBR`BLW$T5]P&X3K M/K(."5'"&F>O,&6E'K$!*U)7W#V%&<(1VT>%U`>=(F/5AMR602XIQ(S4'71/ MO]-O*'@@I$#!ZBG$SW3AV@JG>4"T+@_21T\6',.A4U0QV$;GA,S_,5B?XOO\ M[-L6QQEWFS5^B_(;]B].IPW?'93Z#JPKN-%KOR!_(_H!*C_Q`+Z"^Y-H_*I= MF';;]+#9-P`NEUT'9GE74<=-N^DTN1[&;1=E3Z]NO(WD.!$`BC38C+7O"4S6 M%":X_"GI:@#:A/1(4K8#6?%BC@]I;PR`!`D.$$`ZJ:S\ZNQK9WCUPV/R_.,: MA^3KOS^F_Z!I[OC=3^_+W7S_!_F(C+AQO*9W[Q1GJS3E7K@G2GH(,DT)RA4_Q`T[)I4])NB175^&6 M/K&^3O%)E-`W)B["8E>%$',W(W#DLJHG;7L#R%=N?A"(NL=ZI*H\:CF`1>4` MM3RP=Z-H-JZE4$>*-"0(T;J9=^VW^+;>C'E<9`R)IJ4>4TR9GW:Z%,4/,KF MB]K7^Q-%Q36X&:*V+\"IH=*LYIP0:]V:#*)_>S0+U+D?_.D?SBWKS_O0)H() MGZ*WRYF>:R:XGRJ]+4E2,JQHK)\@R0RU#$,T-NHK!2,+G\`>W, M)#GZ!N9EE9/`^#-/A6M4^T8G33G4;L>JJ:\T@(.79M-IQL:^@KF&U[?9)J,#OW)JI[**J.9OE> MMZX.9P4-9^W:,BL36`UA]70"\!4JJ_Z$X9NR6IK*:4=)MS,H#K0_V9%HX[P5 MUD42Q-EU\!+<1_S%V<"V)9,MX\S:25!3OJ*EZ9"1(8U('*,\"28LNK,/C354 MFFM/-B!F$)46/57S2>!7RS,`MR1J.\:ZAGR."]I)I3DF-#?C<;_Y3$?,MT]) MFJ,[G&ZZG'[CYU@\O3$4Z!=U-;CSG*2R?1G:@ZQJJ4:`[JLLO4HV]V%L7_6"B"60X M=Y\<8M[^T,G;/S8/_-Y2.`BX#HJN3B8=3O$V(0VTEW[H63&>2&@,N-2L?MA. M)P=:SL'DI[9I.N"O.NZ5Z`Q0-U9>!/`UEI'*SFC!:`*9,9-70>ZNMUQDJ,,;X.47(E>V"[7$:G8_=C: M8$9"31XX.B/4A.J2;DIT'81KV;&AHC;E[S*\/)WO(I=0V8MC7T'308_6/FW< MXWK_Z@%]A'F@$/`OT78#N+30=$O7F??1#OPZ('0D$45$! M#(4I^I5L-DE\FR>KWRYW])2`JX=?DQQGUSB]?0I2[J-VW3Z5OBF;`R!;,R0( MG*M=J7"OLK`H6B#6Y`@5C6A=PIK1Q?6(-?2!&+I82$;=KQYM%+WZ-%(Z@5=8 MA4OX<:1].%)9;B#XS"!(TC3*V$].U[P])=&ZW.QR52`WH]8.%YY"7=]_@-H8 M]CG`Z/`!8]R#+'OR%Y6K-'&P>BH!W`.M#Z,V6Z@5C,@EBY6#_B'2H'OO?!Q$[G"Q[PCA':V+C MB'P>Y"@LIFW*(-#]"VO^"9,T%D35$P!T3B\S`R=)NDV*+^*'0!@CN2\5(ZE0 M2X9N_X%XZ#NVD/QTG<..C&?A5'DH9=,:T49'Y>&4[`]4=RG/\GA=T!97<0<. M;J,:3V\0,@O"C\OY(BK_=#O]\"&DT_-4_6HV:NI&)4=0"BO&19,%E,[4W-;9:-SD'*K$2.Y3PS`E. MAW-AC$2=<[F#'FS7[=MS3]]I7N]6=,A-X53N*Y'A]#ED1WT_XWB'/1D(6T.X MN/YQC7"K]8YTY8)Q;^WZ!W2U@W&83NHA@R?A^K;TZB//GIZ;P\B4K8JE%]K] MC;EK<[F&MG,;CQ7G0'+@]RA>GRU91W7=G-3%%V1^B6]>PK3]760 MYB_7P4N2CARCJZSIYRZA(2>D5WP--[E-',1T-1#9ULQ]I#]B!A"S@)@)5-C8 M#]U0`=581_20KZ\J`GOF*B,,;(YL*@C&++N"C07GH!A-P(/=\W5&C2F.JH7Q MQ;/9#-V'452]J4UIN"5NV`[ZC)KY4Q"C#5Z'*[K"@!HK_@C71RA)B>44DZQ5 MV-B/D:8SUDZH!EX7;VT\Y_*1M/1]EK><9XR*O6./U5K[(8)LN)R+1FE5UU1U5_5!K8"[E1`=14;?0`KRTU M`G/&2B,,:X8T+8AECKDK]ZRBA75UZ<3,]"&=YK;Y/$H M=]BY'X-,5RP<723/S,(I)7*Q0]%YO$HV^"[X=IU$X>KE#G_+/Q(SOW$+8;TN M5;FK:@V@*'H!092N2D\J35`86%0;[Q8M$&F"OA2-$&V%6#,O'F]JHB`97&^+V/5K(#(-+MM@9?)E@!UML13C]%=D+1_<^O#X'B"51 M*;!W:+*1^RT!BK-TN\07_3?%&'MWK>CI0XZ'Q)L@LSO`&U@^KS9$./M]%T3% M:4WAZCIX8=,;Z@2OU9V;\14]H?FE%2AX3:#R:L0[N;%^U=#:A(EU0%4/5'7Q MCHQZ8)*QTP2.7+)*#4C9JW!M.7U(O=NN3MRAO+NS$V:XWB1Q_E2\^IP'4?0J MH:U7^1PFN.T72P[Q+=L5JH#[MI+Q;77CJI-CRCUAL#<'QKBE@%8Q-A,%P,JU M&WKF""8_^TV0<[>ZU&C.+<=Z+:$IS`T$O-SJ>S$B9K?S#E"P]TY;S0\>;[6('#F.TF/DU2$,FWFFY#4P8DY!PEJ/O@@P% M5.WI%B3?'QK<]`J6_0"<_0($$'-TY;5BMSE20CP\X%4>/M,WYRO18P"E#V]H M@^<^;/=BLF62]N/4$OP,T$65A@5<7 M`F=&9.3:&-8:=5I@(*(-T1?:U(?%(P;`D%%+`U%K;,(#5DQ3:EF^"%;L9"?EVV;G$51*M=Q(2PG37J(F>O MT@JBZV>=P-S7J*J=U-8G!I12_-%(W] M3S0]D)CPCXLO+?X5/8T86#ESG'`*MS.D'$C(TK1SOJ83FFR?U+`X+YLFB]ZX MI-HB^U7DG?YQC4/RL[X_IO^@N>GXW4_O MWY79B7Q4+9G[%&8$#O_`07H6KT^'TZ8Z3;OKX3G-)M%9)X)IJ4;A04Q5:<=Z MG7%Q"=%KZ(R^:@=4,/N/*K;W&K/U'(DY@.UR-<=]# ML6K$L=<##3@&:#TY<F80DO46UEJ#3O:I+LH3/LIBN-Y M--L'MA;-)_[G*"%4=#FJP)J2H_W^VBP=.G:8J?K.'4^1V<0O9R_$'J`/-EV! MD\&\:#L0.AB5;J.'SE9I<*P<0+=HL1E/03]EU4UU#[HA=\4M[@/G\T$5&S1=1^ MP`ZQ80MB+W(&>DBH'331&H:+)[^$&@Q8XCICSZ!E9\K'"L2&TSIA_)"DFP)G MP7VRRTGU6V)PU<9@D*;$)2[>%ODNVZV>Z-G-[!AVN@?X+@YS5/S>Q?9NY8'M MY97@:Y"NL^^+I]7T`OY]%^8O[^ALTKIYGX>=&1W&Z_`Y7-,W?O!F&R4OV(\M M4B"A+ZQ!K$,?H,:H=V(Y^T:=XX\XQ@]AOERMTAU>7Y#R)XQ"NGV\K/0P-M*K M2`SZPY'?.&@I]/Y2*$*,'TFMN-:L8$Q"T-0)?9.+\A(]AY<>XDM7101%,X2+ MSGZ\@#H68WP"C\5JC]7:9@1D-PC#6OK3CL'2Y-+\).!,-16[EA8[RY2Y,P^^ M58Q`W]T7MKY'09ZGX?TN9\-QRLE0?\.FX-@UK[B9;]4)6"RIZHU?55DT)14GI#"HL% M:!0E7^E;?9^2]#39W>N9B*C3P!-L9$8-)0=:6C.L[(D<Z&'0L.!?3V!Y% M.$?WS2@QZ-#J/EBSAZMO=!*BY(U0JI_*YG2K=XP:3MAR!IO-9M*\,6<:9G03 M:C:4U!MP,C<=XJZK?%CN:KT7`U"W#!Y9?WO!8'LU^2D%[RID]%O&Z^6&'@WR MSPX;#4IR#6MZ%;G4D'5YT_@:]NMQ>1#3)$UF6ZL:;QM@CY/:)OR7'AV<&BF/ M/O#U9$=BSTQUI(&Y+ALDP@$4(&/>NJS39,M3O.7([0EWRP_8M2ERR:V_JQ)]H>XXZIO'X@+67MK'(.G MVT=41ULX"$\W)!LUL?$Y4$H+W/K6S\/PM+&@H*G6<7BJ7BK"V3^73.72QOO( MMN'8653JV:%XEN"G7<3M'P"=E%WP&-0\&X]337FZT@4(J+I%BUV@3BM`PIBN M0HV+"IS:NWN2?),"MNUH!@Q[M\4)@9=0;AI'"I,P6+B5LU4 M?6N+LC5J-T>T_1$B/=CQ.E4?5';R@ZSFF!H0=RPL&PIK6QC2V<"YC1RD[=Y* M0303W&FA1%&=TB%VRMYS8$FI?@6!WJ9M0(9UJW!+7Z2D&\(]8<:'UX=Z28WU M&G!OJ0Z;"_J<*:Y"WSO@O\<(1^%C6,YB<;BP+A/&JITPZ.R5)T6<4X:(BSL? M&`)?]'T.OH6;W689Q[L@:E_,KG%:A7=='.IA4`N.,2LO$)REDI[!U1:>'C]2U,;L)>%_3O.R6,F&E;6;USD_(0.RW/_Z#@LYC=E MMBPI6-;VCVF2L1,TBY?RV>%75=:D9YG413RK]H.]+.X]H;394,!O2L,/'&[H MC$L6YO@6I\_A"A0&Y(,!45]K0B8/UKY@"?V/DR:!N;X$X2P/-W1) M77F(+Z*C5/3U*:3;B,2-\(19-0''!K_;-'D.UQAEA?'#G8500%A+DK1H()<> MO@D]D1&Y=U4A\/U#[_LT&Z7*!_FB$7'="96]4-'M-4+>L(0^0-`;%<`3!J-N MD,\JV@K>52K8OEYXFY63[N$]J41LUE'>8+I+[_HN6689SK-?XC5.3X)MF`?1 M!0XRP1GPYOWK`M&D*P2CS4.%H[.1;R6;#:PM.J_V5(NEZ9L)K`/:T1YH571! M$>WCQUJU$<#JDWPT-FN&ZUL8$-S$N87TI>_>TLY1+2QHO3'00G]:=&7S M*T+T^S%J<8I^<0'W*O`/NZ/3;+@_[FG]38/V91OM92?$>KU"L`O+.2_`;NN( MRM-2MXN24GP^I;1=5;KQVTP^F5+J>QHY9>;E9U+R>RVJC\MQOT>'4X*7TMXR),Q+MRWFSM_+R/LO38,5?^6+0KX=X>1>`O&40 M&D2VTG.GRE(Z5AK"T//S2M:SGVZTG%FCW=G#`U[E MX3.N7X"@9V_<8/KSAE&1!8D$;(*8Q'C:O&9+PKW*G_@'9$#9+'_;Z>:F4QGJ M*T'-00#$H]"!R1X6]=7.Z]E4,%@#_Y:V@.$VL8*=KM1,M=J3H>E!@@_[IH9D M92K$?^+1*9.[)XRV]"UZ,G*LCF6K6Z)[G'_%N'C>BRMO[5T8V'%NE*AK\DF6 MAROT@,G(APPS,_+[[$AN>1DV[^W3L!6R/V'P"];_OBH)HCF>-U%0_G*0\T-[(`;'?UC4-MI[*K#C[+IV4).P3WD)^XV. M:E#M-1VG#"/*-4@D,N*;A'A+SS:ZVE;/0LE=_DE\HIYY[VIH8-`10'N,PX30 M&!.G*C71M[6H7P*I&R/6&A7-V;-&N%;S\O3!K5QA=@'IX78!_-"#"A; M?0#D>V6+YJH/>Y2K^B`QYB@?9?H,_3"6H1_FS%0?QA19<)G*`G)[Y_TI,]6' M0\I44"R84+'M-P]`Y^KFP?^Q_DCZPYZ-I,'@/;X0LPWOR848%6;V7D"PRND\ M'/EWMHOHWHW+QQ07!X(OU^NP\'^YHT%=/337Q$4:E.5.`3?=*)0^0'T]\`P* M$)B6NDSVTW^+-&9-V`:B=;5:U$Q34EHZ*!X7%(I^G(*/_Q,5.HWGB M3RH&(P1/QX#9UE&XJ;:YZC<]8$N)?VI@H.^D[A>E:3'=6$*U*4;=QAAJ0:,Q MARYK_C?7W\AK!KDW^D[^+<'?KMTS#I,!P24O$P?YNZ]AI)>1WVAK!K6#H:V; M\0C;Z>9S&--M;TZ2S28LEFF1X52T6Y.F[#68YFLT/2^3_'9W_]]XE=\E=SC= MA+'PK$(/PC$?^'_4H.UL@].J-8EAOS)`0=T/C,!?_3S%FE0G\;BX]MWC21\V,/MEWOB^2F M<-<6RZ-RV[2GX!FC.$%YBQ9KTHJ>WTF9S7J[9.YHP^)C&)HKA*OE*6D5BR979= M;YI]]7"21!&F+_C=X&<<[[@[T#EQ:#SO,\J7RYPWX<=PFM/&Q0F6M<:X-\U* MI8^R1>T%!1FZ[NP@7WM"I:N]2CI3Z#.BNQ,5)Y?18BO)P\OL7E*35-N3LS\[1.>1:.;D: MD'JKW!:D*ZYP3L;0IV&VBI)LEV+9?H<0]HQ' MP#Q3+I.`^*LX';]RPP`3;HYUP]'G7FF?!)YCI4V)>&/=&EH<+4N\X+Q2G3O\ M+?](G/P&)3L#@Q-TIV5K'N$9?)F9E*<=AP7I:2Z?U@\TZ:S,`S M>L1&D[,>$N.I!G3']E6M3="#?ZM#-]G1FIB])5#W8*;HBK-J3];ZRG[-6KBB M\.19AYDI;.OTCS.V2/`TV01A_]T*T>6J\NYE;E!WIT&B^* MO]"7XN^9:T_AO4A4OV$/[ZT6W3,ZNGT]&$Q>A#$^S_%FXKX%`S/&`\>6!9=Y M=1"XTT%BVSM8YFR,F@X(O]"NB/7=KU'@$'YCLYH(R,:9K#8T.G^U0IFQ\*RC MF'-,9YB4`'76/YSX&H,?&IC=&<+P*8,1O2`.9,A#;`SXZ?*>-GN M=>)\>HH[`*3/.\-H!>S#A5/5_-XA+UN"H\7D*3[KM)A2[_V^"_.7SSA_2M;G M\3,NCKMJ7NUI/N/6>L:]JSK/H".`!AB'"5'?F3A5,5[?UJ)HBXK&J+G2?L.P M^=0'3IN#*)EX>WM,UN[?9[&!8_C$INW<0ODV"[9IV;;_Y1,]2[W;.GH*T7#;\-4C3P)/)#G>D$-9]ATX+ M*[7>/,P8UGA!092"&JUE[,73)\H'MH1>FQ->5'\.22&J^N8GA9-JKWCKFP!G M6MDW,&-<_[4LN!2'0>!.*\*V=S"1:(P*:\0C?I&(ZJY[)0)#\(U5`Q&,C46A M-C1:'5JAS)@[ZRCFK"WMLJ1;;;Z28M("9::7EX='FGDK3\N\$=:BJ_H^OJYB MU`:I)I>G#DD%7[`R/"TC9@FO/R6I;`R@4;D:V9.7L)JFK.F.T5>QG+-U8QDG M0GK6JQP>5`V9W`0Q?_[(7UTQ@ZB6P(Q!O5QGM"SJ"8YF<*[2N58X=G;7]99; MO/UM^V0;9GH1]>CV4W3/.M+Z/B`AKTB]_81QSO:\]3CAST5,P[KZM5,3=(=4 M?REY+)W<*=BY[*3"/7LL.!O=S"INW^@VI0;_ML)91JM]G*Y"ZC3;I52?FSA. MDF>"33`$H$L!7`:O!I\6B$J4IUA=% M;S8!4'0G>;_L3SXLNB'ZWV(>H.B,(M;;!RF"0&P"CIR>$$VPV!>B2<'!Y_T) MX=@IR;VE6JW MJT6!D81J4T[X;L?*!\^:5"QJA2`]4-7%9VF0(4I3"M2@5!&?8T&7Z%SG[M(H MQ[V%51>S@9V]BZPS/MS2\XA7JUV:8O+YZP.\<65Y6)"WLF9B/M0?]P=JF^!; M>1)@"^^R<=@J"L)-M9E3_:1E_\9IEMAB6AFZ9].U:?7$4H:3,($J_@TG6J)@9:M*OU5C=L#P^(`N;KD8QV\(;,1 MBGA4'@'##HUU^G-)K.?84L+3<6ZKPG,-[E9UMZO@766XUX5C>?EVP$BV5[@Y M!_.@:"O/BNHK89<2N(]H`?2F:>+'' MG\XM[[-*&R4UB\0]!KR1&;>0.,3N;!0]MM!&"YO_^>@OR/VG@>?X?WG(E5T0H$3.E[J%F2LNX"X6N MW3G)_T!H8_G__9]_^->?6`'`_G5XZ#*H`/8!7XXJ`"B(Z50`I+6G%<`DW.E7 M`#9P!UH!7,5&$P"#YL+\WVII@S>#0.R)[.T*-L.JGIO.7)5.(D]'89-0)M^ZOO' MF"SM[GRRL!9^TX5WXU6$$8-%2)A6%R5E.N8=*'/+GXLQ/QSJ]F;4/Q%D^LE_ M7V#F9N@/B+3A-EK5P2#FZVDB0`>8HI4'=0$:4R[D.C*FY,Z``1EK`;X MRP_OCUD)0/[QX=!`99#]O8>5H[P/@RR-"?\L_.9IMI^`-_U,#X\WT"Q_1]H; MS?9S.@@S?:>M#=9P@K&2[;M^C/G2[L[/^*R%WSF?=^-5A!B85A\YAM3;,^^[:*=FN\_D1^K!O\L(O7-WB%PV?!46KC3-35 M@&%O"(*-"AB$E30T,[@H.U3[:%==4-4'48*@HA>JNGE!UG$@ZQ-X"E1K M2AL9&=#<,`0+^<4H`ANES+PLZ!Z+ADM&A!45PI@>XY3M0G8Y+:C`=BIZK3P0 M5U"OBPEV)E]F)H/PK+.&&YF('+1UFR!^#$CG8(BP_/.((=/+Q*SM_#:(<'87 M?"N".*'W_X90+I*7B:8FNF6B?F\P=3`-&*Y,-/"LIPG:!JLR,>O5A:P/(IVJ M"I%U0U4_?]AOC#(N^T=BM' M,#A=7."^EE;BI3T5B1EV>](#$2AXUIX> ME)6WO/>#7;3XO:,Y_O$QQ8_D$X2S/-RP>Q^T.M?SI_0@SFRW6F&\#N-']!!F MJR!"+SA(,W8MK.-``0N$M+[_;[QBFV!V+'Y]"E=/Z"EXQN@>X[AU%"]M&0\L MH<NGDXO#AIZPCCL4\-F8.W6$O^X,J40JCZA6_G!4CG2^!AD*5K_O MPK1UWD),OL6+%V,:BU@6%3WNL3RE:-FEI*0BE=.G\!O]3[:,UU)'>C=QG5[H MV:M)'+W0^\.6<";,1\&RC-0Y]"']4Y`7<^YQ0@UM@KCH&L=XQ:P3D[0RS?)T MMV()+GE``;K?A1&;\$]2M,O#*,Q#G/V`SG,41%E"%X[29]&R..LY1?)Q1H%# M#Q^C39IX@RIDE.$\I_UHY%$2/[Z+V,SDFOX@JS!H/5U@7R@@859&:/"K%+,0 MCM"&!)#CN#C"C!ACL9_/^^$<RFD+F1:R`XEZ+UD?SDDY]WQ+MG[I+F4&S MA@\22Y`)5NC&K-X4C\V`8<%>VVD^]&30!($041WG,T:,BBS%F`0:*,<%4`Y` M.T0)UP8R)DR!_8QCO/XF?4@G:%)^K<'5Z4,'@4.`Z::A9469W^^P*#[P[8&9 MZ!8E.K]K%Y^]1KU:;V`"?-S8\V!E'==4&/1.Y1`/D&B_T_\LGAGL*TQ$*C`6%>Q\7/)^>>X%=V_X8X5M_M%IHYC3FHYIJT(F\<3];R(21!VDZPS]LET'.?9DVF<4HH930A.`64T6F9C@3"29 M16!E^M$D!/#IZWFASJ:]&["7/=@S2]8'M3JA+[0;8OU\F1>?@0;"^72/B#!E MJ)HDZZ]A%"WOLSP-5CEWC"IH4PU.!YRRJ3]"7ZC,O MZCO1?4JT?MM>/==KU2_D!D;@1P$]%_!+UZ9#@0IJ]=G^(D`X+H3%P`29^AL. MHOSI/,YV*5UEX47``TJ?K3T$"/3.+ MHAFJVR':T`.2F$$B&7_'NF32ZMICF*:[>6@G&@:/Z*E#/*A1[XCP;%-/K^(W ML<,G'VJ:>E3=C\&+`2L5`UJ]OB:\M#1^-7`,7RFYA2^MJO8R>\``552.'214 M;2RP=XS6XS\L6L(:QG1/NBW=C"9Y0%&X">G&"1F.'M[1;=/(OY\*:(;H&\I7LFQ(_E:YO%?C?TX)[--DI>,/9B[;@+%@@>-,S(@BF5U(X^\+BH M7B8-<29=%J#1O*J99"T!6*P.!*(ZDGI1L532>5%<1.VKOCV6T[G7B>E-Z7%& MW*%/%)EI^!PA]F:AAK$$,E:M#&'&E@X<&KR$I`LQ*Y6$+8[HOZHF`Z$71 M`(I$47FPATC\8()$Y1M4=H'XH1*[@P/4AQD!->4XC?4C_A@FMSA]EAVU+FQ5 M'8K!:0"PV;G0+4#5R#6NVJA\V&=!/T/5ASY5AI*;EFC^S+T]P0?M^MM^7XE)7]Q3`EKB5:DJ1?@EM[5/L(U(%"#G-=V@'2^00NZR7,$]4Z( M!>@4R;2`"KU$9=&G/2X!<"/.LWN`'#MI%Q1!W03\F"99UCZ;L?YA@ZS*N?0U MN>K?&8D6L^OD@X>0;HE(L;A-LI!^"S\2\W0,"E.T-0Q.2-;U`XF7\YBM2R(> MEO2D[P><8O);?<(XTUM,/\U2^5N--3*=E-/"!Q#[T0$HJ#S2[J+IAYJ.[&W` MNBMZP'/OFP@!O000"%W.C[/5TX2Q`7FB&=(W`2::&J4:H.\*3/P"SG7#8('K M6,-:RD$[>_S&P51<3I$4Q3L)(XU-$A6;2\%'1@(_8>D;D>AX[6"3L"7*B`:` M;Z2Q]T*%=[PY+@X4IM.])+.LFR1#WY:(&D:%74:E'4;Y,!KU@U*"\:S7E`*I M;N_H0=3QX\=RN87X<:YFET&U*F@-*0_2@$"K3Y$G;9+S#;138-D"54U\6HZG MBP$1)W60,V`>MY.080(7%I,3UZ/-RLT."'N56%["L%J'=:CH4Q=3^XD_NT60 M)0AVI][I='HD1N01"LIW1=E!11E^K*;=_7H.;@>VRH+%`6RG%"#$"<87."#^ M'I=I2G<`H[,1.L5'^^D(%.?=&; M559Z$3/QQXS\HT@B06.FXLH1?7WDC]?Q/^+/\>E=_#?RG]L_HN*-E2,V98:_ M!9MMA(](J_?_^-?/[S^<_I%6E^U:M"@V\1H]!,76)DF,T0L.4F(A?,9HD\3Y M$RU+XS5I'Y*F.$;KX,6/:;99*2JJ5GVDZ)2JEA3/5P\G*5Z'N>[#8;TN5;6J M:@T@-WH!052A2D\J\5`86-`&E*A%$Y\?Q6JB(!ESJWJ>4YB9YI M)(HX/7BKJ7UJ>%:._=M?UM,REZY(VG98_/LNB,*'$*]14/$Y;6'G*MX)E#S1"ITQ_4XG1 MOR[X& MZ9D0MN/U2\&$$6K5MSA!G8;!S5IO],.Q.Q_N%^/H$*-7/Y2E0S&]L*VX%;QQ M2XV7-W9I_%JVY_H](]AP`6ZS\X5D.#XDGGB$SG;T278Y(L3)PC5[2I^PPU^" M^`6M=FE:/)[(\C0LS^$EEUNAL$D#4B-&:W2/RVCP&B5IJU%6&8I>$/&5T3.M M:<1-5/LZ8>!"(@"&"S-*Q*3A0!X^,CQJ;@>BT;XNYV5-(51.'0I(.2YUH]0F M2>]%<]4+3FKXI<&1W0O?R&CGM/I,R)0J'K;S+6"82;&%I]/+CQ@VAB,)%-O7I>'!@9Z MM#1R#5[:&GBW\K1J+N@62ZKJ.K7JB:JNK=>@CA#M_<,1^OH4KI[05_J8:?7[ M+B2E![I_\>Q5,:=4$(T$7P,9C(9UBI)H-A+0IRD2Y*-6#Y]>(G<+EJC M^-0#7HCO5J+W`W<1/FC6PS''#+@D#WS`SU9#0(*6$Q04S5Q7NO>@$&5W/V%A M8YH5!!G#"=&8`Q04/-`S)]=XO5L5)U=_V^(XP_18)#81R8XOVN[2;!?FS3G7 MK.LJ"L*-#\7G>*@)GZ.DCSEV6\/B6CA*HI-[]"&:WR\71[`.2$^E)@"@\0D(KWDUTL M"A.4V^O2"-JR2U0"F!DJ`4$4H81:8B^(KDF3E*Y])M0HK/D@`V"@3NS@JB#G*G:"\8>MW-I90:5=_R\15%B"C%;B!E#U[U<6O9YHZ8.NO:N+L+8[#)/TF$6T:DRBC-E$F]HHPI55_[8CG(!4OOJ,AGQ/;/3M M"-3%)!!KF5X_"-!3U/S@$)M(K9E2]$.MCJCHB9JNJ.[[NJFA*I)?'3G`7YOS MA"&=\M8LE[QRABAJ58\8,J$:964P*8R3#;Y.HG#U(MT\3-VZ_*UD#:?36QT& M0(:3.E'P5-)W40PABXOH2W$9^;4[F,9M3@QO2)=#XO8]KL@,@V<-L3/XQ\AV MT$7KH3:^#@M+HIIE[]!DX^FS)4"1\J&UBV'S@CQ]Z+PMM(ON9MI,7X>%L*5X ME3S&X3_[JQY1G.1%RZ]AAA$]G:;8KB,LWKDIN]>GVOHP@H6$L*"H<`!AF"+A MAN[;G^^HC^O@A>U\6KPXC[DKPLQZ#HL':2=0CFJ$!UM4R!WJ,U9FIUMLM%JB MJBFJVOK%,QVP"#FGC[0A^R1]Q4R4.K296"2.K98L#K!+2YERT>0V"%D6^9S^ M0-]@(G'E!,$T[82;;9IL"<*W%9PWP9IM#?(4;JK$0T>[0?SR.@"N42,=#L0M MUU$N4"Y[`3IMZ74-\+2Z5=VRBI1/!'UQ>?(B?>69G5;4&`@>4US.[\2$[:SB M(G>;M63O)R?IAA#IUW"%T37I&*YI6V(V"R(_#FYTP1YU>>::/1/*MFM20Q-/ MRWA]0>XJ71XJ?G%2U;;\/<3-II->%0)`^25QH:"SL.>BO,(6`E37?'K]17EG M$Z.[T"6&J'6/"F*CX*E#Y`J^'H('$SMVAP.GPT&1J#S9(QS9*#HL0&E86.!O MJVB7T8-C(OP81"@-'Y]R])@&<=Z4$X_),T[C:@<-^DGR-2X>'M$_MLP=O82_ M;:.$;H@4DR+AF58A=%.5E%0=I"1?T7-D'XJ_ZF.D\G#3GO`A#J/@*\-Y$&5) MM1HR*^+*RJU3Z!:M['NU3]GQH1J!(H2@XK!,")VJHOR)V,_S$&3W[#?:9>\> M@V!+?JOWQS_B*,^J3VC]W5[:W?2F_K`V=OBO-EEEN$\NTONDCR(BC^X]?Q(&U6=;]P= M(...#!EB7&#N6I6732TNNJ<1-'U0V0D5#2E&6;_R;Q]2X5BL)2#WOYO+1?YVQE21_QU'T_\3) MU_@6!UD2X_5YENT&:P:TVY>_I*+M)`'0CF5:#:CC1DQG=>]%<1G1Z^]^HPU0 MU0(53>9EIOXM3XSO3)=OTBX-N32LSS/ZNL'/.-Y5I"[_,AY_2:WHC,`$!BPG M6VG83FI/401308Y5@?".CF6:\U6#K_IS5%SP9<@ENH&&6+VFO*'5P)J](16YB.G6U;=Y MLOKM]BD@^%KN\J7%" MZ)#EX[@P5!ERC-7%W1.N#X)L]D2+DY@8PGC#DN6VLHPR9A5]EZ3M#ZD_U&I/ M1F4X>D%!7JQOWE;G0;+WS]G,P?=TV?(FS//BI9[[\G.V:#F(RW>N_IBA%?%' M-V*GBYCO7Z+@:[%N/ZR^#"J^#5JBXON@^D=`[%?PHLJ=PI<$#+^]3#["4C^7 MCPH&OM8=$0;H3FW^L)D-"+L$.$)%5]3T/4+G(OJ\L44X+GS=?`'?O,TCTAQS M2--T*E/>D7[.>2.1-&@X*] MX(;=Z963XDSW8B:(AD9&3COQ+(N\>6>R1=04:,Y%'@G4U(O0B\X,C*!S-1%3 M7D;U=50T\&5"1G&O.?,R6NCH3,_P>_!F:42V_7L)].2)OL1+7U@]2],D/4G2 MM-BS1/^U4'T3@Q=%=;H"OSJJ'RWTRZ1:GDU>+]4PN&B]64I`&*^#=)VA7[;T M(;AO;Y@:X$CRSJDQ&DN*FUB0O9>JX]_FG&U6S2>6V]W0?838W\VVD0)F3[#0 MS-,:=08IK$>$"S.+8^9874.;V%NTVZ-J5\&ZAQ]U\Q@@#2KF\6AL*F4#&\,: MV2B`.:MC]D3HA`C[8Y*^"(MB;JM.+=QK`50"<_U"5;Y]XSH%;[=/5>>R3U'U ML2_5+?^F<8I:V=WMU+*=AKP2MF=IEI0EW?O>J*-&@@+=$=\H.,!)4BVG$U)1 M:]_\O*',)WF/Y@73KSBD`VS;,R=_5WO\-TNM#YZOYNW(;9D^6/%B&O?@) MTSRPMSL2N-[=1^'J4Y0$_3&^M$UG%-"Y#C0&X/B$&@%T3>O4_^T>5?5??(;8 MA[[4_KP;Q:G\Q?>S4_>WFO&J_HX5BS4_W20^?Y%L?\QM45?QW8L0*87G#JXN M[UE7YH=.^T7UMQ=*S;TO?4F6W+Q:>=MM!A+;-6"AA&@[L//.SZ2;SCFW/DKB MQW<1W:+\"&V?7K)P56\L1'\@MC!RFR;KW8KN&INLBZ6/&4Z?PQ5=D,*VFV4+ M4O#ONW#KS;ZMYH@2%[$>80KT!9EI6#IN),2KC=!'W'EA'0=VY^U69C?X,:1S MQ7%^&0SV@%(UZ]1G_29`)1K?,U25-K"N4ZCU.E6U6O,QHI_[4JX);AVG8I/> MY$[1UFW)J]OZMFR6;L]A1LQ^2M*/P?H4W^?9U<,M/9.D?`/KMLPX@K+.L'=3 M\FEW!)%RPS!A1%[?J3H!Z-I:U&W9!O&D-6+-V1;5M$/]SF/5Q8_488JC05H9 M!\0FX6CV'R8C;<DECYL@-N9 M'YX%X[(SR]B!>^7:S?+H#_QMRP[PH"_+/=(MFQ^#,,Y(:W*=?4$R6&0OXCT\ MD,$E^OH4KIY0F*%''),&4?12G41"_IU\#0B4&8'N"8'6+'/0O]CA)+MTFV3E M3A-D7$K'GL4<-#UJB[[ZY\>6N`[9)AZ_S,TVRRNW"?Y2NJ':&G_[?[!X=8J@ M77>M=K\-U")MOF^PU=D#\UK+LGN]ZO78Q>>(74#DBB_C']$=Y*W`EM[LS@BH MUY2[YKIOS=X8B(#I*=%]4_47#U"]74?,HG&G4Y,;TDO4X@[]%.#S#1\Y27V9F$L80EBQ:S[(ZV5 MLMUV&]'7-LMJZ>#@)2S\]Q!@5FIY6QB3GS`<<-%'*NM=6I7/91E?G<>WK50Q MJ9UY456#@E54-[L`ZX1*X0:OHB#+V#%O;+W(PS6Y=^D_<)`69ZEGS2)RZ6+7 M28;*WVRDC>G4G10\0$4RUK^"Y./,+OK=*.]91T1[HK(K:OKZMDAQ&A83.&AT MM6"4J9Y*C`P'/-F-B@.^SO*).$5MID.=-XJ(U_F^D<1&K>@53XS6#:<<1FT9 MHUXHHXK*U(M9VODI):A!O:74I+KU@0PO;M@\/2;_C>B>Z7?)">E)EYV1M)&D MU-C+>4P/$*O(`)3:,LKNHNB'JHZH[$GQ M7/5%36?4]$:DNQWI M'T:NM")7VI#K$G]%_TC2W]BV.QBM*JY%#=?"AFL/V(L-^ST@F[@0?J,;_#:- MGG&-E,)+*^1ZXU87/WO#+?B:F!3FVUV.KYYQRHMI2;L\X!23NTGBXSX@AK4L MKYF-C5H3IY%?SUY-;1[0.-4R]2.KN4M;*"'&!'5WP+J6!FD5[L<$&2CDM=1L M&I_DVF9H6T_KC`-V55<8!F9C8GJ?&$QK?D4=PI[M)M4$74-I?@42L/X5I1_> M*&T,Q#=23_XM[4RD[Q6OY4LYNC2G3.D/-$[Q-DAS-DM/>OP-!U'^U-&#CA90 M^QGM]\=,6Q<\G@7P2AC,1C+[(`R6UW,GFTT2MS8.O]KE&=U?E@!7O+A;HU-W MI;>T`]2R;XVHP-:`RWUI+0B7F:A7A[-&O2-=6@V]62RN@PC>RG%]))5,5O?C MKBF7^K$^U3!4!I8W=.3AYS3)I),-4+9[TPW3S<(5.%!?$7#*`2`DS=)FLJ=F MVH$_VU"4,+IS#H@9]:@:`<,_OQX!IE>O'IEJ75"13`_:VF!E:FCVYB#VA]+% ML\=QPY(C=(\?DA37[T,T"H* MPHU/4QR^ZX9BFF-/=6/>D=8EYAZD`FL9;I3%C'HAO*VOY\<(JPC(OM12/\"C M*V+R,&2PC7EP$1P2"DX`B6UX^6,!^U@TD<"\'%$YI#`=3=&;/KI`>EWC(MO$ MMC@F>GW4]G0TY)+=,XR$CE",F7WM`5`9R"&-@ZSKA+TQT%PZ,>_XI^Q\5N+5 MTEA(X`5N7#1PX(48"[ZV1Q77,$+[^MSWN3A3B&5;)]NR_5:;2Z6!P1OND+[_>& M//+D0'3E&'JBMS)SYL^VA/LL$?8&@[Y)Q*1!(MM)^@:ODLNAG%8?"`$T"`YNP*7G5*E4.F86U4D'K79,4TZ2F)U7OPLBM%S_]RYCBWW\ MT!(3Q/3EP1QM-=\UN@XHK.7.0N+6\&NIUG<'7EJ1FVQC50`];6SZ43Q;1K.X MQ#TT/,/6E@YQ?,R7X::I?]M[V@:ML.B:";2@I=$U)F@G4OJ(KQY:>;:59DDA M1X-DV[K=)6R%4VE&,'ENQ86PW)IHW88@@'QAJXEP:H3&4C/-87^R:UM;H]ET MU2H/@\8@*QW7E4E*Q$>VZ*],OIY,5]DABTKF("DIE,-)3I3".?$K.*@+)D5H M5A$;5Q#[)0#%?/>P*KGNZ(!@F,ATX+2M`\7BW\KXFPQ,1>B;$-C\F2WL>K?G M:D`/""\,#&A?'?&7';4H3P6@?ZJFZ!C9OCR\50F3<7O`\C!A*,8[]/`2YQ_9 MVT6\(;_^)CB1_I\K9H@'!ZC MQ%Z`S:K3-5-,3U4J'O'31G&2;H@,$BRGQ4&F][LLC'&6'0U?6]MV%+`^#M4' MP1L/ZP0&:5W),C;3$Z4188!7)<8Q@`Y`?*`;'43P3XBGKR-5_/#WE.W92"$J M]%\G+_]ZSPU24O?.FR]8H3NL?M7\$%2ZWO%C:K5Z%WPK%H(4NX,* MWB16-&U7GKQ60)P6!P`UC!:[T6$GIV/O];R,Y:H\^%:NV/2%8I);RR&2$@AM ML@P;\RC!,VDG,0P]P5=%@`AJ*AQRK5P45IXRY\D;UR``DM8C>P`A&V\K@D-) M]CYA7YF.Z%+S:+>N-D,)8Z*?.,MIMQ234OI^E^_]NX(PT)65"K:@"Y;V3^B] MN"&XCY[Q6IWZN(/?9,(6QII:H='Q^IV@PT297MVP'SBS7T,`0LVDEB@Q M2$H`,MK-'G91]%(#$GT-\R>V^^._4^:\H-.PG*LCAHCOXDC8^Q?F`K,=D?VK M'*:"6*N"L`1B.Y4$*6&*6L:PI!CT4]<6K2Y6^3D(S6ZUT78WGJ>-%57]P:8& MB[9^\VL($6VBB="EYEO=4Y]X+6 M?R%IQJUVP`ZED#@&KV4T=XWF=1I6*KXDZ94*?F'-?MZ?`#?P!R?X6]7D`)Z;F*)3*]\#H1,LFY^7 MMU%W5H/?GIO?^TVA"<8/Q1K/!NZ,"-?K+>9=S2M"J3X'_>.(``XRLD@1Q.5, MMX>4/'WCEC6^Z\[B@@M(\'&77E1-?)TJFPPTO>)A;Z`&_J:51;R1,N-I/]MS#+"8HQ6!:I]G_FS$(4)1KU+8)S#:GX0`QJ-L8F(XL]!9 M14%A2R`3E_M\LGDQ/G;]&TU!@%>K]+`(WBG%Q^H)KW<1OGHXVVRCY(6BL'JC MA[[Y3/Z=[2+Z0NCR,<5L[SH2YGW4YP6,L:IH&6\'@-93OP1$L3,A!I4(C#:] MJ+I216@ZUR^`9=5FG&5_U!A`7Y@)'_:#FX[1!!8N/W)CQL6KCHL7#4L#&I7 MK<<)1\4[%TF.HG`3%M:.6AL,/.QR&L`FC,/-;D/,;4@KYF='=Q0H>/1 MBW3O"^&%-:[OE`6)+O^Q"Z+PX866F*MRPSR#(F^, MI4'!9V8$4B#&A&]%*@P#T98-([LB`8E?4%#MPED>$D>E@_R[M..7/(S"I$@J M)@!\(!HFMH0"8A:0Q>1J$HC-4M,'Z@Q*T$VQ32W=<*Z]E_TJQ>NPVL<^V=WG M#[NH9M$;B?1JT5=,(\@S:#QCT'&7075?QI6F-ZJZ^SYI,1^!E,6K=P2:4M3B MZ.$3G>!>_PT'4?YT'I.RA18JUP2CQ:0JQFQ*-;S?M:NQ3CT[UDA5RIKW!Y"0 ML4%#:,<(WRK9,#:YH%U0T0<5G5#="]%N1ZCJB-H]?=")T8A+8$#0TP93,WU9 M,`\#/J6:QF"A*/6`%FR16H7Z5>M"48U6SPZ?"KZ$-5^VQ-YK)H:P[GR5U+`R M,>H#.X1+YFJJ%"OE@KA\6(YY6_8W3]0K/F4DDGAFO M[^JAB4@#'3'"N(Z>R`V:*(LJ-+<)7!Z-G05YGA*I.%50L")^F)9['#O(M.Z: MF*/JZ%=*3=#I7%\I>:PU43/\N"2G3V_S><6S,26U+SS3*;/+V\5N5897/SPF MSS^N<4ANV?MC^@]:@A^_^^G]N[(()Q_]UVF9OCZ%V2J(_H&#]!/YI%]?:[0L M?U-AJTFZH>%_FB#('8BY+NNWJ"Z@X@JBEQ"[-B\U=>YF8O#3=^DD:-Q016IQ MGL'F.3TF,XBN`[:>_%.2GB3/]$C!SW@=DO@JDE[CE/Q?-N*1R%@'.@-2<]N6 M<_C8+VL[IX^(:TJ6-W:GD_5+HZBTRF:H2[NH-%P7`/1H<%38]KT6&,T/@^I@ M(@=UJ@53%R;U@WGX;BMWT_@SL_L/,'9;XS?_B`+>P+00"@!@E MA(R99]@G"7$S%W'-'ASKS49PVG+G(SKM@&&8J[IS!=7P=I_E)_S%@Y8+$I,O97O&03.6*>6&E@N=F05F"#%+K6N5+50;\[TD,`*U01DP M@BPZB5_'K$FRUPO3[1A!)R;'TP&>,),.^S\'W]C^,V6U'\;%4_BJR5%=YI?; MT>6,J%M&U*9<7]'WD$E]3\<%Q?G"]#"'-[+J(.Z-KN8_GO-AO"^,'0[7-RH" M?WT*R2`\S,R83/>;##*,P@?6F&TMF3%>XW5O(6YA]1`'^+,*Q)B!O(\",<.@ M9/RC4A.C$PL?J(E0+1?]ZJ>9N7RM=<^DNJ=MW+'G2Y`CX=>ES(X6YGLBR+HK5)6S"KN MSPJE69D)/!"9C9F3!B(D263+6QR'27I-6F)Z1,-MGJQ^^XPW]SCE#S0T.]4# M"65["*W1#`IN(*!VJ)0+E8E%T00M4=$(U:T0:^8%OW71T.>O&8IJ=BJZ#=BG M=&,A[RE\6JIX[0.2[3;_1&I0'+%=P%':E*]9!=6L@.JVAFI&#:`-L^!'L6@) MLN)B[Q!`"UN,.0#KL5(_T9>BJ1=[=EE#I;#0<8S**87*4Y#BCV0@NSY)-G1E M5;'G5THJID>F1!]?FB;EFJSEUR!=7[%@LK-O.%V%&2X6G2P?2(:_P^DFC)F= MTQV^2T[#++@/HS!_N4I/<9`_<6N?&>.HRJE90@`0F!E_.@C%FB=\E0C.$=6" MF43,)FK[12W'='JJW:YZMX9Y/T*E?U0%4*V7"V@(J!4#(D%0(6K"0$3'62`^ MB/:<>I#,#P5^8IDADGZNFN7'@"_*9O@:%M8,O4EG\]LN2J&C1UV&<3FKGY1J MN-EE1#@QPJ7M>I*_:(!QJ8]Y2Q_I(9O->5KK0BW7';54^ MZZ6515MODMG\O/V'I%LC!6V>:!;S4"'1J#BGI\O0AY=:@LI14R_FL5ZYG(KF M-=[D=/]F7VYP'J;,UDS3+L,`W,VWM'WO11(<_EC[E?LZ\<^?]%KA3,MUG='" MJ,S''NX,AA-I'>`KR7L<-7">\(2*Y"[/-2&X3W#MK[^/`X4F?K,9E?GGH;U5 M1W:^U0QSSTT$;^HW)WW>]&\_]<]HAL23&65_1?#8RARRJO![4[XYB?.F?-[, M:9#`Z3`J>,17#_672<,5^;/XBI^2].^4D1=)$%^E/^\"8C)_^1R\?"3MDN=P MC=>@I610B)*BL"O/S^#.^@/@^ M'JU@>04R7*YI::EH-?)`VTI%D[Z*TO'(QX1$@+ZCKYB7J[%+L25?8A/F.<;? MT]=7Z4'E&;E1]"GLBHY'V%OL`8%L\48K^<;T%77*)QROT88,<=ACVL=*H.G5 MY#X*']FO\J;/_NDS^`S/FT)[KM!>K9EY#2+-744CU6Q:YMJ3;5SLNMQ5;?*7 M6+C+F.KC4&E4['OLTFV2%5\B#DCS^!%E.Q)LW9*8K;\>?>Y)?U3T2'THEP?M M]>/.@TT7T--BKRU=V)PVRT1?K-Y8ZU,0II^#]#><_QI$._*]J'`D,=.2OX?Y MTPW.MGB5WR7L:Y;3ALL4E[\&H3@FO\'=$_X4IEE^%V[X>_3Z'*CN--L\,3HH M+N;\\5U,R\WT_::6(+.$K36-ERGF\9IM`&F$J`@1L1AI95!$6=8K]+$9*@.E MLEW4-M6J`.JB%6U=9["`$8UX'VJ"6=7-L%;P0(EU*X@Y0C6M+.;Y.=T/4.?X MGC-,+;ZE$I.[LV@2P0--!)LB$3Q7B:"<,J3)(&N20=I/!DDK&6!.,GA@R2"G M["Q75Q3C28R^(V/?=1)%09I]_Y8H]C]1C)Z;?$L5KSQ5S#+'^98M3&Y0?TXT MF#EY%).10115WNHYS,)?.2%+9R:SN@F;2=V+B\5$@3""')$:(: MWN0AM*8)<$?22E1L,$[)'N2M1X`9=?CNGLW#E2FI>*B&J3.<[7Q."J1A]DP*; M/[/[-]-\UP,R*"[7\^1O_`4`U@'S=^KHZ5Z]/.:^'^CG,*8'Y-R2@6#X$++N MU1"Q63DC'$Q9]]@>6UET!B2DUG\.J`++9J`Z^FK//\0[3*4G5+OJ+G=HO/FB MYO9IR!%W5]QO*[TUGSSAM_@%[=1QU@*V])3^8%6('9A=BDA6BTAW@7BRR[,\ MB-=T>77G&4CU5.,IB>C#"]*TF2CJK2JOMB8(7%FU9YHU76'A,?KEQQ3@MWJ5Y*;^PA;U_2O)D4/S!-DXVT7X>F31V'%]BG M3UC[X;1?1E&="CC)4GO[:/4KEKD,1YG=M[[] M.U!K&B(Y(C85WFUI,K;%DYP1`=DICXP#L31$\X9`=$CUM[JF8,,<4@XD:5T? MB"J2-^)(3U)\HX[A08PF(P9_V-.M\,.8E.F;8EJ45-IY0*P0VI"[VBW=#6CF MZ>K)F5DGJZ7]9-V4VI=Z.<^R'5Z?[E("D+NG0,.MIU;C#?8E:TIH\-7" M^&A@E[QYRDBVE(WE]J+_$2HL'#&Z%4:.BER6':'&4/D1:IEZ(YH(/V]44_U4 M\$O*?.4;*=+[+&J3B+T*6Z0_+]Z$]8I0HDI['PBE4W.7MXO=J@RO?GA,GG]< MXY#\]@OV`2H^05_H9S-/NVNTZJ[]S`^KV!0O%AV?7F"/@;Q;SX,7T>@0E3[>H4+ MHZ)3,;Z;B(?C4@?81OD>/0X<<^L%51K@K;=52YV6W+\C9CF%%.]R^1V[ER:7 M4#Q/T^NGGE5Y\=1IO*C^0O3/^6LF[IU(5+]@%X_M%MU2J=O77IV4Y$'T,XYQ M&D3+>+UGG\\L?T-E_7I]=WI[='CY,A27N80$5M$AVAU%: M4#,U_KFEQMVFJ&S["J`J*LGG@>J$FNF7.(RS78K79^4>7Y_Q.EP%4>F9N\9` MMT_YVZB;3V>>;DB`-9*&2P7OE!8&[Q<4USM5SRY-F\-5BW5$[>?[I*"B!1#Y MJWS23U\UV%6.ZYW=O'BJKXVK9-2][U)5U:M'4[43\&RB<@GZ.-T^FFF54[=! M52-4MJIRAP\/O2WA4%3?'``2P9\V.X#C<1N.]0Z7?8D]8#@*:AC'<)Q0N_P] M#7-\]?!P]?!IE\9A3J(@%=39[[MP2_,WKW31[%+^(LK6TZFE&1"`PJL]*1BE M,K!@#1!I09<0UFW80*%NY0&?=#&0C+E172XI.O6HI'0!+NP*C_"OQ]@&(2TR M6)-W20'#APX,\:'#4%1C[#L0;;QL8AV+Q_+)[7I#;P%&T=>4'F1(CQRD;XG0 MO4\Q:?.PBZ*79I8;KWT8NMD!LZ!"<0IFD/KDG(`Q?@SO([S,,LQ_E"5 M#!M",E$4!F@MPG&BS;I!WVX%TEQ&Q76O>"*\R2***%`QX$:_O9`60\,6Y;WO MS,I:(COP8H]I=/0\;(`7%#^]3,G+)Y2^Z?AD?*I+D3U!*/CDAB5X'O=*WP/7 M/W5U8`U?ILNE'H+LGOU6N^S=8Q!LBS53.,JSZI/^XJGRX_]:KE;)C@C,#5[A M\)F>+7&)\Q,ZYS^8WS#I4OYB\J:32&42#0"O--V)R:5E8%%=1HIR9.$,>.$AQB[HA"[@B5C0X5>Z("PAWZ M0,9^UVE"=XMXD8_Y^JT&8[VF`62QTW<+7^*T/&B7-G6?;D&S+3_VJHX9W#A1 M_2*XPX.JI6HGK%8:0Q:KX,H)Z$-F&%34<[S50/_Z('"A'B]YA@R[<[*3$*([ M\UHJ2HCE0W1O)UO-0:8<-(&!##1YZC_7E?40)E5[3W5EX=A+MF.?8W#[\Y.P MQ\_3I!!0,<3DH2ZOCY(WSIZD\1Q:3N>0N!.F>8\7%(`A3[\8V"/LN2D80#$X MW..[7SN\',)#6SC<:M<7UG`[H>[XN,O"&&?9Y;*+&)V46F84J\T[=G68[:8DKB`9U?]@)WTY!+\ M*X#7!<`1PB]+W'_BG)"LX7>S>2=[^V=5TCT*@_LP"NGLQQO=IR+Q MC?`V?V8;(X>]Y_QP;++M2D"YN7A0%0*X*`1:RE!)0:,0/HQ+]E,*!".?-RF` M_9D_&.5^C7T>]EX'/OQA\7.:D%%`E_YO1)Z*L`,FLOU)DE/\@.FKZ>4Y8Q/F M0@26S*8\!D:<*9L@?'<3&,,`8`2J;]=L.J+J71TCO3]R)<+C*%62@]M,>GJV MQBG,(*"Y*H)>(+,-^AW1AP[A:TYLRSM(A^O/01HFNPP%I-K M*,GHOAY[.8RWR:&)@_+#9M&,(VE71!J.B]=]7M%)L<*&9\=O^4"?:0/9.>@S MH9K]%"5IN`Y.2$NZ:P5)&4E*.[^^)(F3@X'4&7'#P%?Q^4IQ6^I].+@HBGUR\47,=:^0YP5T9VM'_'',+G%Z?/%Q8EXT#*F?_G[FW6=KG]C0@48 M6ABZ52B7D;5%T1JUF]?#`MH#D2Z(]D&DDT_U_RA8)9-O=U<93"STN&_F'#S5 MF[B'K[3G0SRMEDO,MR'^^@`MJGQ?":1MU*F:(()JT!."V%]R05^1R4DI2D+&69X5Q^Z2:*]V>983((7QXTFRV20Q.Y5W MPHJ,<8[,%FR8^G#V1&W($?<_[D`2'#B>, MUJD5YE%M'YTW.M-R@0H?B#EY$PY(!+])AUOI`-_O]*#TXWCPIAW=\5==>[QI M`B0T7XDFP(X9.R\/+"-FC7Q<++8*HFMV0)SFL-#(EGCDIVG&BE0:?04[991N M".9*IV>97PKU=@IH>J.J.RKZ^ZEI9M!4RM88I(MU25^9J&#:N>:4V7DM%:=<;Q7XJ4#];%*ID\C8U&3F!ZM<-)P M9ZPC)''-67?/SUNV+5:7>YZ^(^L7^:87ZV_T*W[(>6MZ#QAX7#[AW]!#6.A4 M>;N:7Y7/W`+N\W<4%!XPJTFW)8^K@]GW:P@P%Y$G#PX\([++8<-%L['"Q`PH-!S.HI?;7GF.HH1,"D0Y6&!;_RVB+@W MACMAN!?#)C])#C:@"DJIV)92<5]!D+]M\%Z.MSR2$*B1F/\2,M,8K=HSZH9\ M?%T\)H0>H$E<`(S.N-;GE6?)%YYY7,:/S*(<\QQ"C,CJ/1^I851:WG.ME?$$ M3FC5;`306(X30('E?@6O"C1.A'Z-OWP0@L[>K6\\AH38&Y-M_LR^C;.\(#/8 M"*O>=I8E_7+IVH$.K^:3"@L#*^^D`G9(M5ROP\+1SV1(EP;1:9C1W<1W1("6 M]UF>!BO=\QI,3(F'2'I6K,BGR1>P,^31C,!V:T?K;<]>,'DP'_G(X[5X3E+(^/V:BO18"0"/ M?O9."9RLYA@[YC$U9[Q*P]68QO2+.%U]`:-_VL9-5U7LRWC$&*QCGYN,'V_H M&AS]-&2F0D0WFCF7-KAE&7LU=D_&`/,19_HZA-=#G7G7$CAF#]QKK7M>E<_( MS@NR>W:]=]NXQ"+;DOKT__A%'>59]0NOOXW<_O7]7 M5N#EQ_^U7*TH1K-RI4&Y'*$G`7J-R]]9U&B2_.A%`)"5E8[$JJ'HNJ@^]V/U MG^8]3QBR:G@ MTI=FSF.2\_%=\`UG2LV5MV]D5]0.BC?R.,"((W2CQ1U![_K5U^(:8A?](Y#B M5O,XI(6.AD3\YEP>B2Q;DF6^.]`QMV64M5^Q9I\7YW-YL;64#9!)M-HZS)PJ M]FZSB^B0[)3N3+H*RPTMMQ%F2XGB]7*3I'GXSZ+83Y,M3O.7:X*BG!X&1D8' M6\ZDM2WS33X`,@O%;]!O*27$7PHQB/$C]:R@DAPOL(LVTV;W`6KG=!]"L]4U4X3AEEI1Z.&/8&$KA1 M,4.5*J;.=73*S.:B7K-?]'@7T2ZHZ5/L07^$JFZ(]?-%I<8ACB-&4Z!;*XZ1 M$9ZP&$9A)^4;!6%I]FUV8M"*_"S+PPU+T&D%_N<)*Q=T= MLD\+#A7'^(TY7!)9M9(R^,[LI`9X4/5>OJ;7WIT?**R$XFT96+.+\6>\N<>I MF21W^\B%N6IKDU#=>.R3JO8WFEJEA0&]]D2U>P#0)1D7-W*B%5VTZ59Y<*CF MA4OPV7J[R.-)>X,]]*5H-?,N-#9!:*CW5F#H4ONK];/9)?F]@^SI/,>;["ZY MP?3W#R-\B?-B)<%%DI'/3TB3ZS1Y#M=X_?'EEXR..*ZV.`WR,'YVX M)=C4RK7;.@/9=@>D(VY^%2@ALAZMCI99#F+1\G"$2A^(.3FBK*_](.*H6@GW M'?7U/;U,W:'*'[I_0=]1EV0,]CVJO:+&K3?[?#DG*D>DG4I$K?)VO?(2A>WO M::?DL1NUI9'P*U"LHH"K?0@UBB=./$GZZYL0N8+Z:YL2\MA`R"%%7F&*M\X]G7D:]!MT?K,CP.W->X>A^:*.UW3LM^.1Z2A+3M9 MN._'4MX$@DJ1FQJPT!U4?%G#/PDJ8@VW`999=)+=J^LD"E0P7EMX:FBBPF.ZP1>#2B$-?&'K!)B@`9M32@,V09KY.4@ZUJ"PGJE%^\-B.Y64#/H>X_"?>(V^ M"V.T3J(H2+/O/>&P&7B&5!X#OHK/6GTYM-;T:27Y:/D&ST&N<S"0#N?O$*UVEKU.^2BT5OO8X M"SP=5CZM-RNO'GKOAV2BJD>K4U7Q*!K#,%,K(J`4HO*E042YB47[.MU_M/_Z MH"^4U,/!D(XF^*F(*.W#(:'"AY7\(/5IY^F;;3"R.J8-1^S7[EI6("@L5IR" M<*XL4!V(>T(&[X]8+PD(^G!SP*"M!?()XK'&O*$_4^+U+0R20'VB?7LJQ4<6 MBK"@(*$<0EP&]KJH"#CP8#\)]%R"#V?M@G`@_AT8%FT.%X%Z6<`N!AWF`):3 MRLT@56]HR-I6FL]O`\,QF7\@9@E<:#"*VW-1?%SO@.O?8G[I/1TR1P,"%5]X M33D\X5NTHM$\5W;J7FYNSR#BUO;\_N;GU9@0V`'J'>6L2/:WW5 M$E:IHEJ14IL:.@+U?=7T5"QU<:XCCRINZF&YUJ@O#YC.?\,VY90*$"V]N!^%- M*Q'&VW;L:5WCQ5#MDCR(=-5N(C:HXMU=W2TOT-7=W\YND'_J-P8=<@6$Q,=, M@V>=0;-LL&QCD&-Q<&P^FAD,AGV"M/IT#LE]Y(U8%",5!R-T]=*\FG($S9/K.G8;:*DFR78JVY,(U^'?V1M@?$M49K*GO!*W%B?XK`.5 M30.R1EX]^K"#1+GVN\7B?'.*6HE"W%PPQV@E+8BCL#/G.();G,Z<.4A/!5]R MEY433SKR/FRMGH9R(>9#;Q8U'!A>5+';$YA>Z38$H'1G-.$AY4Z3/^ZR,,99 MQDZ5R-CNM=<$NT]!AJ_3<(7+5S[)Q^54QD48W(=1L<57]XAP@8Q;\%#>#E#+ M(*2V\%T!50`V.K5P0/I;U&_7E9_X(38VP#W0)WL,*@4-T,%0`T&CMY&)`0.$ M7@>\QXREU4%E#K7L':'*(F(F46.S6439,GN$WI@/"\W#Y+Z7)5.Q__\%)I>N M[J/PD7U*OEBZ$YY[!6S=O%226W6MN#K?<9X221$9J-A*?2VJ:D'# M>(HT&O#$7!1EQB<)HCSJF0LA67`S%D&^<')<\=.F,6ILHM+H&[''H?"PJ#UK MG;/\%HK6CBA:B^N0HI4M`6O'8$V.2B>CY(7UY8H%^D*O>3)-K[J].C3FX$%, M2MI8BV2%58])0[=SO7JHCNT]B\E7?V&'*`3A6I],.E;$))/WMD4^G9BMD5+A M?!19I38%&9_VH2]8UR?(%]V.RI-82$]O&:Z%.1WF&X!7K`@R(UI*(8_"444M M"\*L9LP#O#LQ&^0%^_;Y!GD?9YU_3I+U MUS"*"KV=/,W,-V<\K]PWXWC&BO\M7$]0#:*`G)'J&3>?@*H,H,*"MPID!M0) M$TQ2Z!O/)W6M39E`ZLS\'*-5;?7)&UM$.'CCB_1WL"6 M8WIRU+J8VR1W\[%*-^3WW45LM$?!C(+&[ANI1 -U+-^]BBJ.WQ:;()PMC@ M`0:WG^111J^]M8<:W+CL/=[HNQOWH*-K15">5JW0EZ*=QX\_^.#0>A`BPY7D MD4BGF][#D9XGCTDJD!G%2T+C#1F/8(%?+!H?^2R%@M$K(R/,+CZ%!)+-+'!0 M-_%W]E<7:1/RO_SE)G,[4S*^W1>BS..8;Z&193*,6#[DW7M]\])E^NC3)6'< MY]V39'-/]);)JV:&E77IY5)^4U"5D$4#JP8"3_J\YQI8M-#C68*3WF@A-S7@ MT>,@KX>8;7S[OO%*K0G51L;LN?9Y_$S^G:0OTU\&D)H=^\+DP-P\+UP)OM6< MKT8.0[+P=E7?R:+^IU^*,1F>TU]\D@/?./OSK0*\X#2(TXLW&GM1S?X:XQSL MFO3"8K71QAM!C2&V[Q3UL3:2TXO)D*L4]ZT"F M4UKVW@AK`K9#H.RL)`\QQN#8F/015Q&M)K:TJE!--;TI^UIE+(T!@3[ M(-`&B+7P=W'#\.[K$%R$&3%QZQY:E&S9=Y0?:X]6-C*V"C_VDK*WC^7AL&:0 M)BRAS;O].#JI2U_RM4V9[A?B/Z)Z-_HN^4N3]Y=)$&^MADU`\H1G$_I$ M,7XX(3$]Y?F$-.)YGRI*0IOOP:(7E!SU>)'9JXZ104&\1M3DN[SB]1N5S='W M1F:(G]/9<-AK3I,!,[U,M\#L,/0M\X+AZW#HZN,(Y"I_PFGKN$^8-RZD5HU' M'0)KCL50^IUF&6F((H(4/[Z/!?N8'M+\KKL`:M\$3@[4"=*FPP!C2>,:G2)F M@BCGK3JX0)B-9:,&##4Q5V^\'`&N_6:FCP7&=4J/1LA?K@E9_;&W'&0.PSNSKJ+ MW&F8K:(DVZ7X#G_+/Q+GORE*$KW.XIWEN)UL[3$GB=#:;G-\GZ/VG>.9:C2G MU1`U+=$7VA:QQIZ]=J$)'9V]ZM30ZZF"O*_6_G5Y<3793FXO.J>G9$2KZH+(3JGHATHV>.DDZ(M;3#WT8 MB[F!4$P#;ZD7AD:&PF$R.T8#U;'.4P>HXC*L#/3>8=T;UM+J@;W?^D8W$Z@<`N%F*D,^ M!@34*WS[A'&YMNWCR^?@OY/T)`JRC'P-G9)#VPBOO-#H#*]-VA%;*!MT?!N* MC=KDH!PHNR#6YZA"A%^GB3RXXI;GD"H[2A$!.-&*QG M:F4,]K/R'*2@V?:5`UPKA\X.<9^&Z*<[T29_1GU-YK)=3M+-,&L--P]G-#_M M(>V5H!DW+3=A)F[D]-N,L\PS#2!!<;QWP\#I&)TT7VP)I3.EG0M,+%E%!560V;60R$#(()_:6E!>__U MC:K`N#HLLLY4^]#G]C'Y,F$0W>8D9%:J73W0[YFD^B\*@=CDU3GFMN!%<.SW ML25\(^(QE#MC#U41$_Z3B!NS@:[NH_`Q\.C]#AB,RG5M(O1Y6F9J4J%@YA%: M+S),0X)^_]ASK&=%SE.K0^J+8%RF,(.&X(ZR<0%".=)".MB3,S.Z]+(!+SFG!30 M;0;.-EX4\*+?\V)&K$[G+I_6]3&\[*I_[.+>9"FM)+#@L*G=6DZCKEW;(M[V M9EV]P=!5/P\]."3I*+,=+'FVIN8\OB,^(5X;'=HQW&:AU=_I2^6#N-UNM=!V M#_=&>6/5>+L%VG4/7Q[EX&_TF^@B*)LLCFB;&?\N>BN2.3=>J,.8=>L%RU0I MWR']TQOLIV[!X!+XGB74)<"[)YSBX(%@>TH.'%HQ28/MWNXT8!BSPV38<0XD`2V; M1J/(IM\>J08'<>.$0PA=$^5HC(P4CW84LV7%)HCY$J-=8K`ITC>X]^ZQWX#W M*6&JMB]8WF=Y&JS&CR=-'8#M1-08]F2+D_XW]65GHE9<+O8ZJ=T![U1$^H?9 MBIBCLS;HQXTH3NY];'57QS522 M>"H'M)`I!6!3,IL./H,H0[MX3;+RJE2+R-.%._Z3V=[&23[0V;\W5S"&?W-% M:M/PS16!+:!_H\13,U.7ZUO"#" M.=]&/'>%:0&X_9HEAH&?P^I`E\,W^CK_^.F=Q)_D;_O;6,HLC MLOI^_]@EFAP3XK?[CU#9QC_N28"@^V:U]D+C81_MMZJ=+28>^G3Y8C\<&@?S M>YW=)MZAVZ;0E3)R=ETT^9GVY/#!-*X=9E# MH%&JRB072?RX/XD$!*^&Z<0J8GUZ/',>$^CB+#^/5]%NC=?G<75E]*,:M4GM MQS8R4XZFJ=7?QM7C'&DD$//6$@?ZBUPK(ZBR0I_Z5)?]TYG1$!XQ'ZY-#.V9 M<;'%,;/DLOCF>48DCFBFYT4S437\F@G06JXMI0)G0*Y&+`* MH/QZ<"O.7(>)W&,3Y&YQ&B;KVSQ(<__P>TSPN[S]&UI>GB+VC[/_^.7\U^7% MV>7=+5K>H8]G/Y]?7IY?_HRN/J'KLYOSJ]/;5X3KX]>%ZP_FN#Z+U_ZA^H," MU6?D\U>)YP_^X7GN,<-U$H6K%_7[809]I6.&01^+_!;$9[W>&OH=R^R^I?VL MMD0XT62Q'&92#O>ZZG)XX-%=3NJYAG]7RBE@I0.$(U2T1E_*_WKXHI-].)L- M'MP`>NZDU,NAREU@1M@PF=@"W\ME1+RN)PD,]V$PL;B?24R%IW$EJ6JG$P,3 M(PM4V_N5&(3@)MDY`[HB^0TF>CW<+,@]$2;-I3FB@MOT>,M6IZQQRF+\%(3% M/YKWBR5I4;MO*QUJ]`&3!NWXX`1!QZ6>$*@M%?2OVQ4T/T*T:4GYIK$_E-<' M#9?JIIAK$5S9E4]L#8^V\;I?:);PSE$,G#0[C" MZ1\S%(4/]&5QTH8>#(ZV=-`1X@Q]%Z!5LMDF,5V71WIO!_>R MU#87\MVFLD]1\I6NMR3_/(^?<9:3S$NRH-N3OYV= M_G)Q1I]'7EY=OF./*\\O?SV[O:-/W>D3S$_GE\O+$_;7R=WYK^=WYV>W?WTC MJ"[$]IVB#BN4*,BRJX?;/%G]=IIL@C`6U1S"AE45P6D`HSQ"ST"9GF=?0Q:& MW1;L,UKMLT_1E^)S7S*K^`X.J:BZVQ6U!NTX9.'8\@;^R683YL6FM_'Z)(DI MBW&\ZK!6N5!@E)&*-H:=82@U*F+(Q&T:@`8?S4PN6NV+R>IV#T\8.PY80S9/ M`6C%=",;'!4PC,%*#6L4`_B3F;DQSR:T9*CW?`?66=@@+"J]XH-G&5,U?S7& MADF^A)Z9&A.O0]$P&\X:63R8-*DQ_)R`2A-1D`PKS2+8`TDP%P!]NMLGMS,J M3R6N@J8_>,_34:PTYJ`1XYR7H'9F2.V!CI635Y\_G]]]+EZRH&]>7%W2.L@!&W8B"$!1W;G4]B=F\S6>\N1>?[BMJU]+PWG4P+G']`O.G[T./ M-=U>B^*C8F+0'V+P;QN7#K([W*)`IQD?^#U+MF2VX\;&8!X`%]60O$(&^E)\ M[M&0>RQ$9#H)#9)9-/'V*2!8O-KE64XJ+J+?:GD4=ADJ):K56^UN#7U^T. M\%#&FA\J_C2$W3("9Y'[SLO88HGOOK,]D/5?(3<-$G@%EV^#=_7[G7HL*1># MGV?9#J^](XCJ?7OY71[20/0._<".9<']U7SO'?U%V1`P&XNSS39*7C!&'W&,'\(<71/KWA#7&#P\(H]$8$-K70-]'C)Z[NH+J#ZBC\$E-U:+MG46&@1 MB].83R*N54L5&L^9A?5LT#@J"[(>DOQ;X08"*4D19A54+E68_)@Q20TTDILP M^\WD!6G]KK4^ZW0!8IA^=*#*K>56AWX:AA:WX6,$_F%=$WS M((QSC][F,@`+AY[&4*N9JN[)HZV./SN)0>T9/DLXQ&R1/UKM&&Y]?T?9-GC% MB68N^#I-05D2A6L6K>8A'AI=FI0C:0K%664TL"E&YDZ+IF(#B^LTC%?A-L)L MRYM.6V_8J+[Y/!;J0J;AGK`'EW,2^Y92A="CA11A#W-E2FBN[\%Q&N`8E&0` M1RATJOAL,FH71,WQ]:<[?![?8O+CK_^!`_$\D'[7)@-H=(&BI'9TL!E!QZT6 M2]6&%N2N_JLW--1'`X^.IEAJ2*GLR26GAC]+J4+IV4+*<`?*,H54[5#3\`B1 MIBB,4=$8T=:O!;R2G#(3?'W(,9_"A_QI5(H9]%1FF%8/RT0>Q.8DO[2]3F%R M8X=FEW_SG:!#(!CP4X0B)3GKCB;<;'ESFUEJQ^X2"S@:-=(*:[L7604&M.8Y MQ2YL9\XHG\)L%40TT,]!ODO#_.5V]837NPC?!?>1SC.4Z39E64C?ECTY,/T^ MMC.703PC543;PZ+ZG,ZU!8^/*28&,-J$<;C9;>A9,^6&0FC'CJK!;!T-^V!5 M.BX>^02D*UORD1TA_&T5[=BKDJQ_EI&(,KKRGW3)=AMB9IN&*ZI>:_R-_.\J MQ4'FT8,B`$;H*=M(HLD43]>DIA;J1^@LN>N&Y"3M^T-E6:E0V&!%`JJLH)KY M7Y@A+^]&`,3\H\=!`^ZJD?!K2ZV1QV#Z-R,@]MN)PT]&D-T M)/QGCZ5`A`:3484(2^I!1=W3:%31\N=X-%Q[=C@ESH"8-=Z/$3$0>$>, MB2W#UX<<0>CO,I9!^8HWGH M7WRGLA`K!H16X$U)ZGY_$VH/?;O-3WW_[K*49?AJ9"S:!15]4-'I-:+=/(FY MQ+L/">WN*4S'K4T9]%2FL%8/R\P?Q.8D:;6]3J%[8X>FJ3_Y3MPA$`P8*T*1 MDJAU1Q.&MKRY346U8WN1N%W M5N25?B>K3.9'Z""[#!R/IW3/U.+N":$6+&8VS1Y0?ZGZ[=?S:)W-6J9@U^R)LVS3%L,H9ESA405A;;?YV;E!,^92 MO?XJ?\(9?EN%98UK$]=W.&/;S.G:)"GKI%Z;:N(@C8X7!%%*])B%AEPSX),F M:QQF(L/=*I,\B$9FF_$0HIGCCGH^',P8J3`0:EPJ:I9?/=SB])FDW^P4;U.\ M"EF,RWB]W"1I'OY3KK*&_6OEU>X'Q"C#.$&GYO1]Z_!.U]JB?9&59.W+OC#4 M%#\X\;FM[MI,E--W#3^'-`NAB(B_+Z>LA5?,C]`9RP;WV#^:S MI;601)R380U.PR`2K[W3Z,-/7_VV-NC-C\<*H0>NC$G,E6` M`14[I=#A\[';1Z904RQ0D(G2[VVXCCW:& MA,>?9D:PBL"YE%]+ZJ7:;H5,-M5[!$^&^NPC&W3AKX-V%;Q=**JE^9R)6&`S M.%=WRPMTAHX%15SJ9SR\;2L,5?UP!\VRR*P MH8*&C\>X70>JZ.%38.F=59!"]4R7UU9%$=M/:'F^'-2B`'!BLQ<]2?WK(<%( M3V.A@>10!T7 MQ:>H^AA]*2[X(K*RFSGDAOK65[S@M.2P@FO/3TXLOX7"$9>P(9F.,[96;'+>'U! M/$5WP;>S;_0`,ER>[B8BA$G?BB-Z?6!H8Q(?$),T76J02\O2HFQ6'`)>S`C2 MEH@T165;]%W9VI=#E8U@,V3F"-159-7IRN&OGDK9(,'<=+E1V&\"^/'JRTNSL!13A=--MA- M5Z,,00K`A&\"FMC&Q:&M$6/,URFPZ,S/?$>HL8$:(_[-ADT'KDB`II.AJTDC M[`F%:E1L%O/MB'AL)F'_6,=F`HO>ODP`>L4<13[WG#N^9/Y1V=TH@SN1#>?" M`$#^)JWF))]NT^0YS/Q9C*@'`$,^CV&L*2OGR%K@2V=M8Z^57*1%W2&#<5P" M@8:C\T3P":])LC*=@53UZJ8"<6M(,JIB`N6BQ)DV&84V:BZ6+?:`C$I`B-BH MB:0N&46=A&P4>[&8'41.;0Y<;.*29HGRVF%C3Y$*G*'/93+('./A;MIB5O6HL]I`<0KH6]0)O&\Z+!GV&]1?8C8I[[01GP+.511W>^:'(.& M/$)PK-F1X($C^*H<#"=%_=U&"OI27/%FEG0:9,2*:@]-G#J]_PY_.5;I/Z'44K+!?/)+=>R&?U(#IL8K3 M0RD7"WY[;3D2F_9P@)-.KYM2&[EP)071;_. MH?$-.WH"G)4'2WLIOMV[JV`+#PIKEZN':YR& MR3I<70=LIVDMTJB[IKE*/;-(Q7X3:(T+:X M[N7@1`,\"J)JPX_+7G%O%:5E?NT756+OT!/"LV"9EF"#&:8.O*L.J.SQVL"M M5\3-`>^YTAB;!KC=ICA87\7M^0&M+*;LS4UBDEX62*^,T5H*DWDV9;W8UH(@ M;45:!(^LR@S6Z[#`&`IC$C;.O&2Y&CD*DNM"C\MP86<5P25>[:\.GMBOC$K/I7)`R;":+`_:YC^3CW&-5H2A"!;\LK%LKR\"670>CFMJ;Y5$, M#*3XHQ1R&2T/$EJ:8PX+X)I+F\?,AYE,@KF8^7(]W35]7F`PL?4YB?.GZ(6) M=Q!%3+W#N#KJKIGIHEL+^3Q4&#D+,&)>RW"T/\,,EM-I*W!,GIJYK*,H4P-UXM/O""0'II%"B8&!7QTQT#:WJ-JR#>J*UK3`+=H?(=:# M/<>J^_BB!<:@XFC!2>J#;GZ<$^K[M9#Y=_Y;F&V="?)'^FJ/L&;:#UF'V MKQ'>XE3G`\#=I[J39$,W^6-X6*8IP1ZF@?X]S)_.XW7X'*YW073[%*3T76^2 MMU2[;_.]<;8DI@'KNYS$=Q1?``6>UEKOL/X`+X+;'ZS=3#8%/M-)CR$`_D@X"O4(K`C M^288%&N6-X?R30C(:C+VD'W%EW9.#^7QCD"K%^\XA;XJ!<0G?+*F[41"G MR1E"`C23[%X(P&B2CZ*Q,55G26ESI"T(7+;33PN9.'LMF!R97/8$E<=:J/Q+ M@>P'(+VI6J9-5XR;FG`[#3'+ ME`/D`,=P*F'?Y@PFCVXFS06,'K/,.L:?=70$6\,*O:.P M.A3\:"^A!$/0O&*K.220=9&(KZ7B7Q:-/3$>50MQ#8C%V==R7GK_M8BE5[CS M>NC1S$V)SO/H9F$])`#Y0N[9,S,XR)EHNAW0S:OQ)SORB?YK7<,>$H6O6UJC M62\6>_K>.!K'KJJ_:>E]A,J>_O*OCPV4&/>K5U5W)?.G2F]D!P MY&N]-_NWP&+-1.GW`VUZCYU*M#WC]#Z9&V_']#3NXJ?=O\'B)/`I'C?9!I_[ M(H.][+Z,UQ?$UZ/FWF9UT(K!:',U"`5H^];#_6N&M*J[F!_B,PVSR MC^JS,N8;G.'T&6?D.RU7JW071%D]Y/N4I*?)[CY_V$7D&CVI0/5V.;PCT:`> MP(&=JACLFUN:0H"(;T3I/=TM?\*"_KN^4%H^0I5M)H>5]:-F,@,])"FJ/*#* MA5^2:8%+ZG$"-&]%@XO)?C3&)`#?QG*<;B9[]E4X:&WT,5@7AW7[OI)@ MK[BN/8]U$&SWOFRC_\7KBS"X#Z,P#S%PL28T/ZU$XYB=4V:%WW+6'##M)EHBT&UM[7CJ,R-Y"D8ZO<0]+6R;,EXLT MG3T5$3Y"M)ZE"I$E>9C:]-%[GMKVX>IY?N/3V0(24)CNW3*2Z0`T64RR9Q!T MMZH$%H3'?UA<)/$CNL/I9@]7EP!@TF"-B3U,.JU8PIAN?QKG:7B_H_'0?:=/ MDBR_P:OD,0[_B=?BPD6_;U._Z/2!XJA^?+"Y0LNO%ELU+"W.8A+'RQ\SM&HU M1+MXC5.4/V%V.($WI#6`#(^[QHAK"*SNRN6QCD=+*4;M&OZX':?8+:L>VA"U M6S+(TFW\Z%$[=>O7@V%):30;BETFI6V2A7E69D[U`%K>O$X]HF9`=)5'`<5/ MH1<=2@HZ+ZHKS?#8NR&PXAYS>*:%BII8_-8\+HGLVDD"?&^6!KD6P%4>),.N M'1J6Q#)M&TU.Q;@^!(A.P[:.`!+KL:I'(\GBEE#\4<4")LP21UKT$?;O',1T M1-$5X?I,IG9+IMO;-%GO5CX=T:2&`X]QFAAJ*"?JP&6=V+HE&1'!8+"HDTB]$]S-(_BUU)@KOZHK)P6(NX"34!4=?%*0>#3CH]"0=IKP MCZ%*L$BIJ@DU#F-%/>74%?NSG3M$GJTG$>OHW<.T8@>T.HG&+6SG23T:*4:2 M2BQPSS+#C)G4XPLN5LSX1Q,].JA!+P>W?>V%GVJ?(?J M%6:K*,EV*;YZ:)\G>8,CNEDYG6W/AD=(WN%O^4<2U6\BP8.Q6FGD5&LPM(+Y M3D`\G!R,!G4G^E@T!NBJM;8)5-I@#\NR(\3,O+NG=E!E"'VAIA"SY MGM)-F/_WC'`>5AGW[2^BVH86Q*AIC2$PYE;+I-_(<84AB@50PO@N#D>_Y``= M+U\ZP#?5+J[-"=(EB-$7Y3H+TCB,'[-KG+)P3\-HEPM7ERI:ES^YL!6(B"AB M@%$'L1,U[45]%]4%1*X40X(C5%[T@]"JVSM@JAX>2@H*&@^Y);1JH[X6.+-2 M-UM`%3M7YNP.G5^>7'T^0]=G-^CV;\N;,_0.G9Y?_')W=OI7]%T8HW4214&: MH2V!7D;[>[)A'13D1#7K?H'.SBLJ-F!7GJ]7[HA8"QJ%7?D+OPK4"=Y,V2_4 M?3!!'5L:%S[/!+L/=-;M%>'KPSSXFJ_^)"/]<-5#L59;0>U9MK'"GXY_.W5G MY<*<,45/;LW)+OE)E.XM5=*$AP`!15A3-4%*BR[DE[ER4F=.1)&DQORXO#T_ MV:\*/,LUJTE>4.:HCI\+L`]W`\57@2;-Z MA,33?)6C:LV&LKV@@H1>9Z&,PV(A8/8(5MR;4U;Z21N-AZ6ZN!"01_)X4V+9 MA2B/7`-@/D@!0A4M,X>X\G"9#"3(="M+&S";3ZNODRAC3G7-_&WNBY"`)*PLFQ(R!=KY.:>@,O+G2^Y]2VVEO`'U_YCU#1 M#'TI_^M](H!"IVY2L(W/^1*$8FF4JKD@)0`O9U)%88=_1DN0A)WW1O'5RX4T MP2#@D'B)C]BN"U6W>M"V%4RQ:>+N_-U)LMDD<0$O3T[:AL.7KDK#(\RA+C\\ MX!6=IJL/)[L)J7Z4%9A M>`W['8%R"EA0&G(!Y&M1&VJ?PTD['*'&&FK,'=4-4-9#O2'9\8592J@8$:+09[1;$=(M67"M+ MRR%M^B8/X[!\6`+A8[DUN:(:730YU\^Y2A]@^3,O8/9-?2`$9JJ"3!&)N0L% MPUH@R8,(LA8`QGMQ_E.^(SF8U>#?!1D*Z#J+%8YS7U99.,7V]/QH$]US9[E> M;LX_%07<;56_=1H;I;]1EJ5YT="B11T9]=UL9E+3@,9*CID?<>[MS0T!FO+T@84=U.>((VA$F#5".KV,%*D&Q=0LM=PIZ$F2BN+JLF[M-SCL]7H")WX=$"7/C2& MK#=$545L53<.>]6>K&1*E5L[Z=`-2HNY]U6Z(_"\#:(@)9=8CJ,+\L(L8W/) MU\%+F:[:K(SFPK&@^D=O1OG)6 M;%VO2#HPQGN9::I14'V`^886)&1R8/HZ,]'5HOTA6B59?H2JY$E7VMQ7-77S M/K8O%34LS(72!4JCGKI-LRV6P*DQVTSJTV(#?X-JWQC+WL;85U2FVKM_I[Y]_*/QT2=5(AX1E6'Y&O)/>VHI#W48<1O2M6$E% M72?@B64Z')CH5Q^A+\6'OFCW2$0(=148$VXU+W_YC/.G9'T>/^,L9P>>-#JM MW.S)V$!+*74[@E'&+%(X+FG[U:.9IKE%T185C5&K-7NH].])2)CY*_F;%5BM M8Q$]W+O-'&9<,H^":HOE>OWY`J#KVU:^T/-OY_GI7!R@6:AI@<*8+L+#473Z M[37B6I:_YD?V[%G/+,7IY3.[_'5'U2F\;%/0EX6OBGNJ2S(C/FF3QVD.L#%V M``90-9;@UC*'!2A#B0:#U-SB6T\1T2,8C828VU,JRKT>%LG%C]CN5= MUTY+Q'VF'!\.FO2384E*Q$Y'75+VO+G3_(YC-_IO!9.RO-!^CG#BS^,]RY@U M2Q_V43MG6L'X,MC@TV03A+%V1N%U$B:3;F-+A.5%9(NI/5]C2-HQP64GQD>( MMD%?BE;>3C%QL:#!2@F&A'1L]]%A8M>'OR0LSL^.UVRRL9IK5*W7&6=%/A`7 M][8YN%+%;'7()7$^>B@FM+F/TVQ*1.F.VC2A*1_+B8QHC_'$47BC#UD>;DCI MOF).&R+6\JCU[\Y3 M5+_6/#@G@'`LZ@T%W"6^.L2/+_4__Q;BE-S`IY<+_$QP\"T4/8`RZUS^V+J= M0%3!+$(8-=#VJ=8!35.+-N?KZ^@+O>@)RPVA,N#W**B5O-;K.V2TKD_ON/P9 M!U1K:.U=G-"D=SZ>,IHC1TQP M0_#U.:[J+J&YVK.-PE7;/735.A.4:;W*![/_!_2YQ+FH2O4!Z3/DM&6683:3 MU-HCH_P:ZZOX!J]V:1K&CZ3!91*GU9_TC/'LCFY+HLIY4/;[.7&Z75B5@?J> MP!H$$):!1DWV)DK'1ZCNS)8RM[NC+ZRO;U(&!GRQU`%SJR^$4\U+A')ZY-X) MZ=5#^:56O^]"\C54PBAJWQ>Z83M8X1+%8:.XY_@R4)=![\4U^9I/0<;FYV+\ M%6&_7D13WVLQMQ7PZ'.UWUS"O:%EJ^5WWYVU.V-AF6NQXV(Q18[<[C=DK)%[];D MKE=KE,8!36MPK(M7R?!8:$)OB"R)P#NQ*-3,I$35GA4&,,T?'(\T:6-#0\SE%'MLK*H[*$DE@V'&;FRD&QQU-]$+!7#8TA2,4?%8^RK!P0 MCXS7:OT^(3(KKQ;O%8_9R06K)[S>16P,\4!9_&U6`P-\XXO'7T^X?\TRF M,30`).&>SK0#WX/5ZI7GTMH#>SL0[!6*G2W%_9T-!P2ALJ9S`,,9DL!YO-WE M&7M]Y(/TA6*-'OT$P&L)2SQQ+,"DXSHRH!RG?V>JIKA^A%@+],&SER)U[KV8 M;4K`])DV["#A&<^Z5;$?.K0[\0`//?9X)7R,PX=P%<0Y^B5.[C.JX7^_1X(??_>:_&,#Q@) MR]Z;L.R]:Z%_[UCH@:!'A?X_=@D]B?0Z#5>DE@]CM&2'R://0?H;?3KTD*3H M?$T&F.Q,DF)F\/ M)W*RZM\IO:[R)P*H*U'Y=>POZ?I`T"(='ST2RAV;4.[8=5HXMK.!CT7T=:=Y M^N7(\1Z4(U-P9R+V-I#G4.S#.,SQ!4GTZ_,X)W`)B;BPY/Y+AA]VT47X('P' MV:!K)?]:76!H:!`=9$+0HW3,/'E32H3M`RY:HZUBK(:/3G`;/(RY!RS(+:_>.-41-RV)4 M<82*QHBV?BW@%6:#K0P[*/@?_G:0G49!ERKW'1UI19B9!;\MDE\9LF_4B MYU,$@&]3K@2DWF2]$.OFXR;G8T%GH!$ZZ%6*!=>(B6X(HM@#"6E71&??Z!G* M^!\X2#^1MN9*HF%,+2A2([9U1>,;."F'%8%,DAJ9Z05!T+]Y+QXZ.#/1$'W< MJJ5$8LM(4:0QN2VM9;&X*[9GHH2R("=IN#.L+/L?(6H!41-O?.+A99\8Y46J M_CE-,N&[;YK=U.FW;&Y;4CI1N4FIED$4OH]"(U7*A>C3;HJDX1%]`O,AM$9YVL M%V9O&>H84E#6QY>#3?!B0EX1VM3TO9"\T*?ESW&2N;#[/JU+`-.LTT)MP*Z^ M%J".R#3["]5C$Z@^X_0^\0^LQW]8%,N!PE<+V6/?(.M%D208_]\1]W!SW1UK MHR>[2RLSS>MUOL.LT]U5)#8F]PK;=,+[3]X+@Q;8`&;H>.@=/4''C$',T)51 M^3'IS8*9?];;.C,FSGLS&V^\XH-FOYCE1?+^M*.'#'.^AFJ+$P"3ZC2N87KT]A1E_A82KV.2">PIR>NEB:]G^"1A_6 M)L)F2A:UMBDM&@F<1GR.ZP=E1*XGAN;G9?M4XS4*VO3#14N4XHA=)/=^_\;O M,U%O1&'A&?F\*#$^OC2K^&3G(YM;4!<0PYZVY4D4J_7R@.-XDNH,[*D>M]R_ M=-;->G6@\@ALF4B)`J!JW>@;,)*)H?<]4(7E:K7;[%A2:@OLS(?+('@,%+P7"A7.C*8SM#"K,8_!MV,VA2&*Q?6\ M(#\.EU."3JF@-1'X1A8-8.P#7?S(N9R1Q`-)(:!OIG`MCGIBU[,TPX,)[G>9 M[@8G/KDH1?=_,_U.@'- M^VS/*7?&/^-C=-OO-USL$P_F@=]\U/.U%KC$W_*[KSAZQI^3.'\:,5%G8'14 M13`T-H.JB;[1;'4!)R!H>1NXH.M[_F4?Y4F(QXD*I<#Y*(GJVYRJ4L,8YZ\1 M^C'-6R;,0*7QQ0*UA`I3J+#U1D@=8.TS)7VM'5CM0[0!;,%OV]CXS2V8D;E> MXV]]@WDWMR@"L?(F/S5-:X$_[Z/T#'`&\3+^$+>CUR-26R"OXK.8YL_U52SS M+_.U3(FIFUL0$V]\XN%EGQCE;!TW\L[UUP$*P M\LX!L3SI?8.OR;XJ41N7$.\:#&`^6H6(*9"W#&A$?F1U$HKK9;=S4(GF=:+! M__I&B>%=WQ]2>)&8+_&(5VM:G=2IEC6VK0>MB+1HG^1!-(GVA<-)_*8F%N1_ MZ%FF>[O"I@T%$RH/(:1F+/VM3*C)?#A.3,2GPV$E#`IUAHFDV2%C<43^L(!& MAQEAEY)`Z5L=\?I3^(W^*Y.?"?NOJBOH2!> MH^JJ)R13W^TAP7014E%+V)Y#*XEM*P(O]`L/:H[^$%80_0,R#L*?26- M]?H.*:WKTT8RT?.MF5C^4J`YQH]TK*@N8)R#FN8=VHKB^33,MDD61!U,TU3T M*A$M2DWS8MIARL(Q3H.()-7E>D/&2?3=<7K(;CEK)LI5>KVJ)*5J#<-HO9B` MTI+2F09U%38690-&SFZ3ZD&,)TS51,.0HD8PJI@I[\2AI,J+E?PB=VKE@8@# M4-)$4NSTJ0:G)\-F6^@49@['^/0F5RAV!3/LK9<[@/?Z,HS122XQVBE(UY9& M;O%N_RU3`)D26KZKEF9G8WK;W2M+T_D?`/7_ODZB>U'F5Y?&EO?\_NJROM_/=B'# MC]--&3_P/:EVZ5GS5#KUH6)29$C1IBXMNMV-2HJ^9\=U>->]P_K;)G9UZNWJ M^EZ7V>#('U%6.\.^^[1VOMD&84K7#UR(3R67-^XEK'XC4'KS(["0B@:.]+G; MZ[IH_D:1-THA:2+`T.2 M2I7M8,F+8<1IF*V(,-!ER(JGW6-LJ(<3O+ZV:S)QO-:K,J[K2949Q^)B4([Y M158S")D46THDJLNMH0FCDHL7@6\R4,@47K=>!QU1B6GTYQ9GTGX6TJU&G#;R MK]RM:4J661OD:+SN;J:_!YE;!TR*9*Z/1VYVEW17)7RI9_OUI,2]U?EDQSCO M3CJTX!UX]R:[2VSKU:[SH-MA:DM).-=I\A`*Z]=ABRH]M:_`\'/H"RC%=`QK MD*O5?L'^0,5?GO"$N`KI30,.EMN]K6AQX\!0;?5V!YEPRYEBWES= MWJ+KFZM/YW?HZA+=G/UZ=OG+V>U^`D`H=MY`X-A&PIT`@>-#X'WSJ]JY[>[R M5),_KQ[Z0\=B5X^([NHAR&&&OS1M=6>6D\>>(_` MRMUN6',_B&<*H`$IQR&PI*MFYR&5M;W:4'=-YU:&6C/@FA8-)\$V),5)^$]R M,U9)EF?H:QKF.8X)T!]>%Y)%%H%4&^KO;T2/`*(VT"\SOX@:ODF>BG" M`>D$K8?:LI!V]IL9R`!]T:0TOX^OG.R[?FB4:P>E(`[+P'B5;/!M'N28?D/% M:A%%ZZH<$[6"T4EY#$!*)W2BH5:"OHN3J\O;JXOST^7=V2FZO2/_^7QV>7>+ MKCZAJ^NSF^7=.6G@B6`H;O20]%K(J&C+;\RAGLBJ7_2Y"[XU"T24PR&-+ATB MB9H"LDD>#22EA)YT>24PL"BN(G(9-=?1%_]2L<[M%]!+"S0=CO%[B(@FLF^E MW)5XM#/I9A-_K)RL$>C+EE+P6!,68L[0-JNV:Y5'TAYB9;=2)DECL:;K(\HE M?O_]X)1N=:0###&?5%62P+I?;*++BSZ1W_,DB?,PWI'QTM46IVR-5_81/R0I MKK\,SCZ'<9*&^0L94F&"^9RMRVU;H?N4YB^?(H,-V M1YX!U4>,2W3.?J#"$"DNH9>H(M87W M")U](VJ2I.LP#M(7=$Y&8_14%R*6Q#JY,5$Y+<;"]4FFW9)=(/MS*$XGC3@) M0)26''U[>T,4)U_`RAK#5ZR%;#QV>7+U^0Q]//MT=7.&RK_NEO_IRRK)UR91 M\K'CFTC-58M/J:+'U+\N*]E"LERD/!\=Z;U=T M]?C.9-;?'::/_["X?0I2=A+7KJ//_NS3X@3"@G<[YH3P#(\.RIW&/^(8/X0Y MK[S4?:1@;JG_J,'$`NPC"//8;3SW,XK"X+F%@=W%=9H\AQGY#)%!!0J+[)=[ M^'1C!-S$3SU&8[?_-$3?D.0IB4DT5I]\ZP=BI]+S@A/=)^?UH2[?E5V_/Q), M8?MVZLO,.[,G8[.$JY=4[2J$$PV8PG,YD[WFJ3$7C=BFS2BG&9H%"ZSC5P0LZ8#<'K!FR/,XNPY" MX68+_%;]O%Y=A:5)UR=P'J^-&_"A[--99X?H1YZ!OW>SQ*#GWM4^U(M&$HA7 M5JQJ9N'$;A(>CPG/5S0;`D*95H$@X53M4AQD^!07_SV/3W993F)-3_$VR4+9 M`US-CHTF*CM`,4,S,C#E5/O3(H[*S*)J@[ZK6GV/PAA5#5'5TAN6Z4*$1SPS M>#5,5/3CDE/IRY*$*_S:4G4W>*7:_YH0*-A3 MA\0\?VY2R]"S9G(9L7[-'81IBGG-:-5/.:[P.F?:6:Y6R2[.LQN\PN%S*\$F9/&PIPZ+ M>?[<9)VA9V=9QR*":=9YQ6#53SJNX.I#TKD.7FBHRYB>B)#N"&C#8O/`$.N/ M?DR,*1.3W(AEQNM\`]O)2Q'#%#&0FE8FN+(WVS&R[(]:!GP7$BUT&DB+`=J5 M4B.S92(^\IC<9D]9+(ZF"&>F5"?COK%G!#KVB3^S3ET62Q#CQW*;<_7">D,# MXFE,84=;4T**2*U-:8K]CIH5$ID33F]6'5#9P\=5P*:HTID^TD.F>`I)T%]K M(DGHV]'TI\"_H_3I"/+L>(8G8@VS=`>2S/ZJK`Q_S ML$[06?ZX;M#)YF,/0816']D-?8Y^XM$W)7]LUV2W/7@4(L*.[L,0.?;D#T-Z M?;4?APQ\.GR`U_/M]A&>/4@WC_%>'V8-'^$Y0NV<*8F^BQT3;R83IYP^P@34 M:6N)K9QX;*6;KJLQE&Q;$"675AM?V`'0]NLD7+I;,D M`0K$8N%X\>?+X2).7_WM8Y(,]*PMOJO: M?H^JUGO!?P%R3*@O!9^:\]WN1G3O>W:S&-`>4QJWIR1:$\$N=F2\2:+H4Y)^#5+)[@MCK`CSFZ*W)5W0BMF6 M-JB?DD"11'CU>-Q_T,^F\C'"<5>GFQ4%TDFPV2;%M-%V(>9>< M!%%TM2UV5XS7?P_2-)">SS#58CO;CK4$IS'3O@NTVHR.1E-Y1MI?G#T\8%)I M)@_H-(QV>?B,T2U>[=)BY1BJ&OY8]D7?$8'*F'U_]F6W:5._K*F0&JCC@8T?4O=Z4B&Q,"BONH+KS5N-8>XV@"I M>2GNP2.>S+Z=E";V")^S+"*LR#KE==0T0%]H$\3:>#/=`HT]<59PA;X9=%WY MD%#0KJ_@X`_]!'Z!263XT*/?RUM!UGDR(;^S??#+GC,,+/D#\YS M>)A4,=H]:RIH]``BAW9L4'31<:A#(+6=1=.H>B[H>1[2!PJ'A*8HJVFI[,@C MJH8W._61TK&EJ7MGN"TJIQYR7P="Q773/!B=+[U< M8GBMFFS2O0I%/YY/L!S1,Z[%IDZ?1?5!=72<-WSAWBL>-20WM>%`NQ$7[ETK MEJ2X[<26ZDZ%1*FE!P0*B32"PL*]X$F/W!HVZ4D=Z&%;0V^P(F=PI%*K0X-D MG\[7XMP9(89E)VLU+<38M7FF5N/!JIB-NO5M&=O7^ZX2KNEWWJ5DE6^G7R=1 MN'I1SS?+F]=2)FH&!'%Y%*!@%[K2`;Z@LW^;`BAN*X1[@W\:;@%%G*V>1;[U:TLIPN)CUG1\56):]$P&3-6V+&;P:&<5D4<"(G\*('>F[G M17.E/+[W"/DVNE+<8RXY-%#1H@FO-9\R?+NVE)/GS=H^9A;@U6QH^5UQX7O? M)AZAL"438;OHN/R11(U`""2/`$:4 MA3[4G!%T7=#/W]$+B%XY0O0:^E)<]60@IKBW`])H8:$D#+_MD"XBF[Z29?DM M%+UD*FLJ($K1Q`I-VM[MD*3T8$X1UE%`$'K-4WIT[J>2')R[+Z`&;:DF1F'/ M&UH$]TFZC-=`^/\\TV39[9&[O99[RYQZE(?M4]*@V6M82AD#H6(#66.M)@ MD:3_HKZ(VE?1E^*Z+^6+QFT?ZJB`-[@+ M6]%[(.2XB,KTS0:5MVX7#L`T< MI43^`8L%C@M-]@QZ+LH/PG_2LWS9+GA7]U'X&+"-4SPBC_"V\FFC0$&;+OVF M`J(,+?I#D<<@^ASD-/.3XFD%8?($H9Q`=:'NGY MU>&=CJ7%19B7K/.%=";`X)#0'%$U(8:=044 M5J@>WUW=+2_0R2\W-V>7=^CB?/GQ_.+\[OSL]A`@(Y15*Z"913"76;;;X/5[ MM6+V6PXELVD!38>^;\@JF^O%B`YUOT6=*7,4E=<]66$KNY$R)@CN^I`(54,I M$QIKEO6S<@1>\<*AA56SK<,/R\\/`RX:R@D*F%FT\Y+\CKKUYK#M4#_;;:`) M,?0/3HB."R-*M'IVR\_F@G>TX-Q0&3&$]W](C*:IE!IMBY;5M'%ENR"%P%!3 MEEY<7?[\[N[LYK/7A>EH)&F(+#B6YAS5JQZ]*#L(1_G0#V&4D=@:]9L]CA%W MY\X">'>$G\8=UQCE*9[/"-OKC/GL'C'(@*BS*].<4 M;.!LYCI97\'%?61ULST=%\=CL8X>2R^.!5%=[;.F2S"@5R!I*_NPBV:YY$S? MARYM2[P-&+(Y#UY1[I_4@X'/J$JW!+]YII;C]?`(1?T,H-6=,PDM[P8^T:@3 M)?SJ.MHB2(4?"88O::DR]B,`)['&$8C>!:(O0M\.3"Q+^=%*>WW$B,+2TN,'/2?1,J1TG.1F3;8,7EOR2IE&9 M+/VEO!@X6EQ7X4Y"\4%7/6YS/+I*:@/7+K*9101+\U?1&K6:OQX0FV0J5S"> M-S>=QZ3.#S)\BHO_LDU>Q1O-CS$AR53BKM:XKHK6'N$EGL?Q7FA03/ZJ"_JN MZO3]$6+]/-HR?Q3(M`1!$ZH251!9T!,'L7]7J4X4@:7-J&?E07$HP`#P*(Q1 M4^%=D@H/71<%WFN%OTE:G(<`\R9)^MEYCC?"?7]U^DC28*NM->(/XK&7Z-JN MQC&ZL2!*9>@+N\`:>;-:0P<%6D05@4?"R[J+'A%;'EREGMJEI6475H%(%7B'/@;Q;X>+09/L8`N%\^K_';W/!MK?:2_1_;*=-<9UXK"G]Y6;<10K M>HMUGEWW6.*[-UN+6CQ\2$C%FNL1JK3L$YFR*D;5/C;BIBT*#9N`L4?D'8XX M'`]ZG!ET[-'%NTUM)/>2RQ#%G6^1H]^2SXNA/5M53M^3M>(&##S=4J8]_O6N ME)D&(EGAXCV,+.T5#`JDXS\LEO6:D561N'=YR'8]/1@0B;8$M@8BET<;!7%& M!2"[2X,U7L9K-A]S@U3K%5'XXTR@;0Z4D3XH>4 M^I%QZ!S"-,;R8KE:48IGJ&F(EE&4?`T(^WS9RG@2^#@G.4W'#CUJX>4$E8N'E, M)K<'$MZ5Y\*I7CV5-&T=2#AL`G8@H<@[E`QP/>@=2#CH6!Q(>%<=2.C7:$AV M)[E'$2KN>TVI84O^481#>SX20H,($@)8`+Z5$K%CW@SM?U@P;"?>+?_BW2$I ML-6`E@/95GG4>("O>B;<^*)&:9^XNJ\W7EP>>'3KC>9O=%__FW3_C_^PN*-^ MO!FS&=]WT50,V'V?)V=]?/DVWH(4D1#E9/U.PCYRA/!^VM7KHTV;BMH+:87(_0I\* M3/Z#8!)5[?W;XL8*+G4J!/O(G">;J"?J)6TYN0-^HEWBWU*F,)T"Y/7Q(L[0%**(W8+,BSW*L^WV1V%K>K)[S>16S%U":,V?O[V[(# M6M4]/!L9ZX!%2$M]I/4H*NDH)JS4F\TL('%L*R48&($O`PT M_P:6QAE&@9C5D@:F%P1!?_)+#D;B3%ITCL8MIR;5MR4O6DUBLCTXTH_%YNC) M"TKPIL>:WD>HZ4\KQ&8".(R+Z3-FY(U1/,3L$Z=\3M9?$[!4W9@:G:BIB9D$ MJ8E^UB3-PK"A1\0P3=#_NJ]RTD(7@)@,L#I:2+XF$#)"X_$C,7]-YD_+%DDP M.25_3=X8U,?)OG#(XT3\B7`9*A.W;8U-Q86->32H'?^ZKOAS1KRG?/H0DE`#6%"ENH,/9&136J]I>,GM8* MK-0)G\&>?;=MC1[&,QLSC5M:\<\ZC"_BL#%TH99I[O^W/12<`<0`!A]#Q(X> M>M`W70"&'BRBV7-[%U*S8XE'Y]D%W.K9:21@@-#FN:MG+BM&W:EN#&EW45!L%758JC6G71 M.WK4$MN\N?QQKY.4_EZ'!"X=48:'EWMI9GO)E=LG*X29U[0GR]TFH-SA>;?` MFYX;?=9T.BZ*31,;WBQ7O^_"+*2WW;/#FF0W5\@5"11Z/&FW%+.D:\^F!+<] MV9I$`<%0O25GA1>Z-6>E(X>"'97*PJ/'RRG_Y0-1*;A9?ZXY\XG_GAG7DYW< M;S'/]'\_%-!9SZ[QQ9W'&R^-PMV4.4P9DLTG,3O6)LUC]N*:^;%`)YH9GPRX MH\G8YP.,5WO\B,`RPP`>%,S$,7=I_7,0;>GF6>$*G\?9+J6G""SC>!=$)\DS M3H-'?!%N0M$DEV'O\C9H]P)1'L,8`5.ROF>UM.C:6ERGR0/.,H8K%(7!?7%N M6UAU0JNRO1]J88J@@3B,@V"I!)J=A\37]FHCEVHZATZ=,\"9)L964U2W/4)% M:U0U1ZS]Z\*T*+_-C>IYL]?GX!O=4*J*^!JGYR0#K\5/:L89D>0R66=K`J". MV')FDP8P3A$D)O7S'-J2&CE9%5--*X_3G@;FM)1"&[L2N1#;T%,-60RN4J(X M!A>9T2D=)'FR[-0D2M(-5?U>,QE,LN=\='"92V,2&AVV?L:;>RQZZUK4K,Z' M_HI2-?H4_"$T_S%%Y8);AR'1]);7/.D MVXK'A+X=.]+?]0(O[@"X*`2Z^@Q]*3[U9)/(\<@0:R@T-ESJ(--JA0ARVM0* MV+D&A'&./U#MZ]K7`7B[QZ+\TQ<\\^X.!\SBFUCCN-6$!^*.!3OJUG(!+VV3 M;GLA:D5YZ9NBF2-`K&5P&'"H8G@=[C;TV00[65.N9K*VE:KQV\!@7.8?4N4$ M?C1@S^VYN,7/I`L]90BQ)W@)`:2W=$@$#014=.`UY="";]&*1/)<@4LE M+':8=+(+Q3-?=LDW$07`D%!4+:+(H<@69Q?(Q977IA+5[C48-O#\08IHS[X& M`3H]%N6?GF"<>W>&V);E2=]>*9R(Q`@ M5#5`##A4L>29#<3/XU^#:!?0>)91E'RE$Y?9,E[?X`RGSSB[2:+H4Y)^#=*U M2.O&6ZH4<8P%&/:,CQU274=%H4'&$787=5-VA.;ONR`*'U[HBUC!:I7LO#F? M9PKJACR?#.%*"\P-<11C3#16K+4Y9Z*+]%<4-RY^4UP!$$,2>`;,A MUXF:T9QNBZOT,8C#?S;I[.,N"V.<>9+#)#=R0#7E32]Y-&PWI`G/EHW\,?0# MG1[`L$+%O?B4+K9O_7C^'1$Z#34B_;6#&X?JB?.3('NZ3I/G<(W7'U]^R?#Z M//X4QD3\2?FZ7.7A,UNH?Y+$>1COR&?-]^B?==U77%#CE4H#&86A*N@WA,P& M4(%IJ`*,J\6G\\OEY7)W_NOYW?G9[5\]T0Y8(`_UQ@91*H4"L]1;1$U)H]08[13$U1V M?:D(]H+5PLICKWD]>X53AJSZ/F:5C:%1>46C;O%8Y4ZCJJMLX"L@U3=.FMI9IQ^BP M-M&,R5%-X@_+-&J0VI*Z!GFCI`ZT]IF4^U)8C)LZ&6DO9Z]PIL^3C)\4<3\#,G6Z8[2X00^X!',8IDWRN8`^R]!G=^C\\N3F;'E[AKX[/2O^]3WYK)C76UZ>%O\X^X]? MSG]=7IQ=WOD]JV<-_(:IU#G\9T^*Y_$SSJ"?)Q@:E:=.;6,VE<7P&]F7&OV` M1JN/KHOV\X3SRU_/;O?I>8(I5'7%:!P%Y.JD:5-;L+1C=)C"-6-R-%#WAV4: M`_/:TIX_3YB9DH8E@Z>D=%I8G,>K9(,ODBQ;/@=A1`\UN$M.DLTFB6_S9/7; M4Q*M<9I]#+)P):XDQEAI2@>SWE`2-B9F,,4R=*XE448VF2(5/=!WM,_WJ.Y% M`5_T0^V.1XAU]4:`1H&.IS@3T-L(C(D1KJ*816$IKYL$86MX/C4_-&B2"@"OPBBXW75Z!?6_'Q-32_7C]SP#+8U\W>*`DV->LI*6\9J.P^;Y^:URPKGZ[+8J)($2KY5 M3/ZY8IO"9==)%*Y>BO^ENSJQ39V$MT[?3Q18]&0HRC/)/`6BN,F16>EIC&8:<:,(L"/N][P(`BEWZ$OY7__VN9N-'^(<[!M#O,BKRWA]\D3@B[/SN-TFC%?A-L+J:0,PR^KL MJV_1MA:9?C?KXF00T"2]TO93"-@N?TK2,"?UYC,6RYGWDF4,91,5&\D3M:SI M&C92.OUH#T#\)@PTC$U/ES^'`Q+C;^=FD&(2EE49[`]F7HD.3BOGQE)FNA*. M*_H,XG4\5-*.S.'PR3]N*H=9;-?YTA8]-*+3L#+GXR;CWC-XQ"#-GC+"J=Y0$JM@/5]HS8$Y`Z9W&[+KF2SQ3E>/J:XJ!ZEQPBK M.[3*(5%#,"V31P*L2D)G>@HCZ+XX29YQ'-"!V662O\N3=R=%2W]D0G&_N937 MPDB+O/SV?"**;-O*F'Q_X+,,MB#V7V6A6EQ%S67/3D"&A9HL4^PAV(S>R-5_ M0=$:YHX9YBHM:T!WD%`3O4KK!&H.BX4=C>?JX09O$U+0WD?X%C^R2$7%@K)# M52Q(&L(P2QD)D(C+_&@02MQ]45RCPXGF*JHN>T(K]?T>TDH7(Q6IA.TYI)+8 M]HU4U3FPN!XX*$@E[M`C%:\A**G$D4!6X#)G^LSB=&\QZ[Z^BH+RLE_,DMQT M(;.40.DQ:]A>S"R>;2N5D=`?>!EN"V>L#*^1UERO)X(/$6G"*MP)UMRI>+T/ M_04.2("?=O18XL]A'&YVF^O@A>6\(I#AYRX?3*:#OESSNB/P@_1\<- MF"'&Q*`FM+G51?-O/R@]'E0#ID_%9TE_8S-#51@1B8W$9!P&=+[R!/4TNS6G MKA2]CE#1#Y4=4=7S")&^Z(TF/%3X3Q3OLJIB-?](*V89%7B5_LB8W6=3HR7X MIC87R\?'%#\&.48/A9)L2B5)2=,@0MNRTUX)B'I=_33$FDF'>+V\<10SYE=; M;\Q[P`*CS$H3*[D89BO"CG_@($6?`](PS%^\>_E]+K9,3+7.^#)'FDVR["1( MTY>')/T:I&O1O+ZZPR!Y#AL"RX,H$BLID>/,A/>#[FR3BZ0F>40:H!5M\:YJ MXAMGA3=>0D\%6`8\[+>746YHVVXVZONSEWB`L=9+)Q1IG>N'"#2UY-N$VFSC MI1N2<J,C?A_^6*C?UD;!QX_'WCAGX,^XGNM96-S1C5JK`0LN M+F2(@(=N`4*ZDM*,OI&#?]^%6W]62.C!0E6+2='$K[NZ79155M^#@S%(UZ7E M$0.K!S1`X@:)KO79S=+ MMKVH3P?N3`6,4D^!(>/=TX?S^(YXQ72R33U?8FS)["E$UX++"5A>[.Z?1O2B M`)N+[=A=$+S\R3/RC@#6V'E4"4K-9E+;AD;/IG:CF?$)1#N0F9Y"N$#_B.?\ M88Q8?_8\PKOYI7F(,_$AA'/J^)AUOR8P.;=GQSCCUOT=RTTO[EFR;1,#I-I4 M5FFF_==]$XP^G";(!1^9QE)1FIDB%'4D\V;8,HSY\JM5O(_,K5^3_1S##W;00#6XHU9FCS_O%<2 MPSD(M4*8R<-0IY3Q M87EB<9#;(_G@AJV3TTRN.A:42Q M?*&E6]S[.+8,GV'6$0T,&8\M&P..*^Q^Y+.,+5M!0!;9M5DZMOPW+V7!!%,3 M2F4!/HT+YL645QWQC2\NP'SFVI*=+[>78T@9AIH\M75)FKAR[ M+K9@OPAC?)[CC5X^%77BYLYA8PMJ(8K(6D[D.#05@H&)`>5]I+'PWBLHJ\`, MEYS]/BHB#GW8SU-]GW9SD@78<7+-NCIYYPMMA5@S+_?"@`*C7JZP#4?OQEG3 M!E?C1E1NBTFC/&'X+I32,UCE6+XZ[66^4,-C;*TWJ;P;7=/-.O:9:<`#B57C M]2BO"]031RW68.TP-Z6/01S^,Z"!G"1QED3AFOVQC-?7A$QTSI+^>?7P*8R# M>!4&T2WYI#S/4['!(:3M*J_!V(21$1M;#(];5NE!SS4=E%CB/3Q@W1IY8.5835,(9>9X M`19I[O>P,@H#CM+*L;\'H1)T%/@QR,*,"D#;P!O!H2!WZ!3?NY*,M+X-'^/P M(5P%<;YA"/S(POR;V5B'.')5LQF'`EG0&[GW2=.-?S3_%-_D*SC*"?E"+ MV]UF$Z0O-&.TNJ"F#ZHZ'502,>>KK20S5CE@4Y!V%-92E,'OX'&5JOTMP!\Z MO,E940!##Y1I'X4R'NY@>@]ETG*M?D!"Z;#6SY]P6JS;4&SS(6Q8UR([XOLW%`;5O:Z(.VC'H1;'EI4J8>#' MSFP4%%A80F1PJ7ZZXO(AH$4H]%;PXE@LBPV)B=27KQ$?03\DOCPD6OZ!%.SRAZ5+)ZX MR?5BQIP]H8L11[2)H<4&NZ=5#AV!SS/`H:0I3LJ#++P[(G(B9*05B@70S#*@ MNR2_H^Z8;MAV.*QKMX&NV8?^P0=W'1=&)7NK9V^(UUSQB!?".RHKW84`&-;N M35-I^=ZV:'G$U[BR/>B#`%&CKIX.^49#1V/@!PX>Q])ZDF3YU<,M3I_#%1:^ M/BINV9;5?@LX6O!]`TKJP($F%WK]JBD0\BE[SEE^[A$C!'>1SP?I+6]SH=M0 MP(2^-6LBVG5D3T)A0-.:.3M(V$A%U`)PYIH_8W^5$Q`&"[G'V.#.KBG[6IAL MTXS7QMR;VK7I5)S*8G<(29_6%A^473Q?\SP*9XHI/3.X]$D)Z]SR<+VI2H=><1)V2WFTT\-BC;/.*T%E.+:M98B.-[L90-H;%&- M/X])!)@,2KR3>1!(2<7;*J@<2_)%$L39=?`2W$>JTX\4S=N2S&T&QQY)%-#< MX;O2Y`ZO:0G.\67F,"0VPI@!G%RM$^;A&#P1:4J6V"JX9B^KB2(8@48'4Z:-1)O5\.*G` M.SXU5?XO!1)C_!CD>'VGN8.<;512];^[NEM>H*N[OYW=H+/_O#Z[O#V[1>_0 MY=G=(<-1NV*W"DA?0,\Y5F:E,Z.<3/%6GZX#'D ML<921V5?4U8[6!"I].UF^L[\XO3ZX^GWU?IZ"_OB;TCLM&MO'K M+CM5^T]^2M(;O"44>0HR?/5PDFPV27R;BQ]ZZW*[(. MV#WH52EP?MC/F!;/XYP`,;R/SO4%\5EE^T#5.U+ZX%#S6($K$77[W33X.O3D)#?UW=H::%G&9F>8U:J\7B%$ MM?.+`Y#.F$FNTV2]6^7ALV$F$?4399)A>SM$%<5EB:8<=R-H.K#")6G3RF^2 M"J&A)JD"52**]KMI4'3HR4D>Z;MU-;"Q@U.:3GK%SAGY:TM[L7>DV+E53TFT M1N>;;9H\%YL,'CYNM9.+`^0Z3"XXSHI])MG#K&LR?$UQ3D*F7^`CCO%#:'+, MS51S52H:;09&`B9^"\!GQ1-"T1"+L<879YMME+Q@C,I6Z)JX\D0CID)P*!TP MH*[T9*0UCLR,CLM*WAP9#?BPS$?&L$%\4ESP]C\H=?PHSM/<,< MYG<"Z,M@@T^331#&HJS-;53EXMY%&+'@>@02@+YM#5IWNRSHWXA^@+X4'_G" M/?Z-&C)*=D,KEG3:<+#?L^$;HI??0N',!Z=)#\W%)5`LM[W!(KFTK(]CUJ&- M8OJ!9QCNW!PA@CFWL(=?VD*,WJ*_-]@EMG":XC5;P_%K$.U$[PE)6E9(YK6` M`;38-Q"NN0XTX,WIMZ@_+)8:'2'V^1$ZS[*=-^L/)'=S"'WEK:\8,&S((0+/ MFI7Z?^C(K+1_QNE]HC4FAH,/J\N[`$+_\X?W/Z'K("V`]+_0`+-$_[Z+PR1% M?3>728P/"J3"2[5MVBQM4:"FXJ!-7S(>-+3!4%)$-B>?X,J7KP,10 M^(LF+;[ZR"LA$!044P"(R[5^'Q7MAC[L)XJ^3RMOW%A'(R>/'+431Y$6#AF/ M>NIO&Y'SYH0BFQOD@VX'22ZH&EHC8#<2>SF@]C..<65WH?;[6T]Q;[@6Q[@@ MD;"K:*_'K,JV*YTO_#G3>!"T<;6]_)%]U_7Q>#/1TM@?;S&[1[-]HG:,\[LK[: MY5D>Q'2BW6!XS>DE&6-W6EL;`7%BLCP(ZGH<-Q)JVUBT_F@][]AV.>TC8\6H MT!H8B>$D&1NU?RRM`5+'BZMQ>KG^[UV6TU5YBCWVM/K424+:%HB,&O%`$5'N2H>&,@N+&[R*@BP+ M'T)RR\MW2U@7]`],ZKOE)MGY\R:)%@XX'-2'3\T_21<>^Z0>/.1>_[8W89_B M;)6&+%@U'8W,#!FJV1V:M$91@Q9ZQB$8\5O/Z(#R_K';#%8RPH\!Z%`#M*Q( M94$S#CNEHUD4\+6D!ZBGU6:_X1&Z3J)P]8*^E/_U[[6-V2@A+DQ](X7+])FL M,%YGG\@]8F7V%8LI._N&TU682181:/:K$Z2R/9`P:,8%I0-J=SK$5UE95$T0 M)5.Y<+-LA>IFOA!<%QH<1INAJB:PHAN/L4I/=O*6PJVEIT9.4%K,?K1Q6EVB M`["R]>%C5)QFW*/4:2+9XC1_H>^[Y,MX7>_E\$N&'W;11?@@7KN@W;-))NH> M4'S5C0V6KQI>M1BKM+,XR_)PPQ8G[-BG*`J?_5E)I`\-'E$-<=405=612U6U M-TLI1>48?O3C#)]E3F'-CMBK=L7F,'73(U0T1K3UZT"M),',@EL/DLP=\2Q_ MLUR_IRK)M'O89?`P-LO\[3BLY-G4=F9C!2\5+VZ$SIR7M. M%M/'RFW6#+NK&#KH9I>H@BA=#.6&KB=PMV]L/RDLPHP^D^6H4Q&ZU]N`UP._ M3@=Z/>_.1GLV(:PQ[O/_09(1\/'47K'7%O%'TL< M-U?79S=W_T#+RU-T]A^_G%]_/KN\\^F0:WCL&><`G MW5&E^ZT.=DDXB,S%X*3M=`(=&S/=`0G>DP')$!7ZE!0A2D7+NI\!.5N^G":( MVJ^S(0_C"A"X&N<1JX#U(*?\G":9<3[I=%+EDK*Q7:YV M(K+,TLK7!(86)E1C"=;*0@"-'?<>O!QN]ML@O2E M>`^<-^0@3`URM$HRWPV3D3^CU5":?=PRZ!A[%9YF_'X00"M^SHK6[SZ=`+ M`Z3H4U<(,Q5SFXX&U&U[\YZ[!D<6CC"A8K/%HPE'1.NBI!Q]H)J)P?U<7V-V M%MIX-*I(KW?BF9%_IY6GB[,#YX2WNB[U^UQ`Y_@W+EB=,\!I(GP.Z5F%GY+T M--G=YP^[:+E:L1UWQ(E/V:5)=)*F4+171@-&P/HI MR/#5?10^LMU.3G?X/+XD6>GN*XZ>\>;P5M>KE1RBYQQ\K.(>J2R_E$U1T_8( MD=8HC!%MCXH.J.CQNE`M3$(SXWK.U*2=A90)QQI=C=*(YEIKGI,Q//S#XHYZ M])9()IS1)8<.#UQ)N7W5'@D,@18?`D[T910"*;/7[;>8_*)KND6R6<4^[">O MU=OM;18^P[CLU^<=GZ/KG9856I/_JZ]D$MU^W;I%B!QYO=)TTZY4VIX$Y%S^W6)*$2.G(9--VT:MCTYS!:-6T?9`AI_JFQ1M/0_ M6X"`U#!;6(7IG-GB4YBM@HA&^3G(=VF8OZCV^QIA0IA#9%TM<5D=K=7,(G4_ MAN02@XO/81QN=ANTK5B_2C:;D.UW[^U4D0::--BNC4DA[<46=!1`YM]-SA)' M8#]].02Y,*D578HSI:I.Z$O5S9?54,[AKY_WYB+`[&.GNZ^\]ER%`#.*B8JJE_X\1>/'Y6Q:Y=759!HH\)13:;2A M_[D!`)RF\VCVX.DN-_S'+DB)#$8OG\(XB%=A$)W'#TFZ84&K7B0TZUS^J+J= M0!AK%B%@SM!VK":PIJG%+8[PBAZO5'=`=0]T&N2!'_PU!,V`Q:-`5S)9K^^0 MS[H^;20=/=_0J<#8/(BL)@&7F2(H4:HC#$,CA@K!B\(7J;@A\)-M8#.X M7OYPK<]!B#OP`T/)MEDUV9K6"_9/KS:(&=Z)`1=$-ZM$>7UYB-]63Z^0^1EO M[K%HPHW3HHW.Z@H.8ZT,`UI]^B?@^[N8J6491\)3G6 MEZ.097=SB'OEK:_P/VS(X0'/FC]\B.CAU=>D,'JY2X,X(]&1F#+]?;=&6*CY M8]`3B%?&L0+.GIEYUR&COKU%V1BQUJC=W!>"FL.(0]RQ6*P)K6V`1W0#[S8F MU0P"@)Y9FQ';=(Y-C&Z_-]MRC7K1G)LON)\]\5THCD#2[29/<1?`QQ_I1F4_ MF5T8G3"C-%(3>\N(G>]+VAKB09>U(B3)B7HA/D5&[<=A*KJP=>21$SA*,XV' M1QW9`Z=A'K$(SWDR1C&7HY$CN@TY6:%J`,ZZKF=XEM7VS7A5=NOQR+/),?$- ME#*%>[,YS"C:R;E0V?(1_2V>GGW;XCC#V2?R`[9KO[^'^5.[BUDY96I57FWI M6[.9^DR_D_U:S2"BT;E3V\=B&1*"!@\Y2G'LSTY)4`#5S;`CD2]/O[I&M;.S M?I0.:TO=H!R5GCZQ2UJX'J'*#*+8[\Z>?"664*?K&R_UP+7?S)R]L%`_GM/K MIGC6`/[@3B\JNY.NAH_T%$;V]M&!SH,^(Q`I)DMECP!5?GQGX\>7]A794B1C M`PJ&\CI:Y:HX4KNLY?H=SU^.N?Z@VZ=U4^:PT6:S$GH*7@_[ZS.17Z)-B&=.]RW'D34UR.&5N0Z+BPIS4.*F*UI_9B MQ^,(*K(GS`EE!\1ZM%YA]F;090XL+6[KH5-"=H$!/?X+O;M*.H(`'.8A1\CO M9ZLWO`MNN)^(=YD$\R",\?HL2.,P?LR6J]5NLV.#JE/\$*Y"\8!%MV.=\M0= M@(BO&QE4@M/PI\-NI9E%U095C=!WK6:H;/>]+Z361@B'RX;HJ@FLZL?CK=J7 MG02E\FOE<$5G<"V>B_4`^QJ@*0^XWB';_`J>8Q#&H[RR;ZJ0RV]XH9`W%%%`L4>B1\=!@F[+\IKJ'41!?$: MG20Q:[$C(^[E^K]WF4][SFL@@$,N3=34]!*UYU%,;-N.9HO\62JW+<&/BGCY M=GX(($F5G(74)M3T:^3*%R]J-\4U^PGU/=!>TMT$\1EE7-#GV.H MU[L+11-U?&` M$53J2HN<$@N+^C(JKJ.J@7?C;AT,\%BH#9V&?^(N7.[)/%A*$V*7MD8+-F%8 MYH<2B'&28[0-7MB>4N_0?1#_=K@8E&0!9RATJ/YA]ENVC->_D-\ZI5-8>:C> MDTVG3Z7^\K8P[-.)!TC]%:XT:">UL+@-2;WP$*Z".$>L*9LGZC3VA'I:(!A2 MSP`[%?%D73C$DWOPA7BW3T&*[X,,KT^2#7U;C"WX6*8IW:^1S@)^?&F:E"MT MEE^#=%V=_W"=ABM\]4!Z;Y+X-B73_@MKM2A>(^3BJ3TY!S`U;N\8<(>:)7"]\^:&6 M#L@WD%IGA"]UVIZ_H=;I\ MQ(]A3-=%?`PBNAWU>Z,:==X0I57M7*%93$KS_MK6D]AL7V]LVILIX$75')7M MZ08U9>(L*N[OPABMDR@*THSF3Y310#U94N[53VF84[V0.VD.GB="W:P]U^_G M;MPPSS>$?M3MTW?;.WVF`QG1),I10=L,-4&A'8VJF!I!A3_$`ANH.@ON"+7" M*]N3IOV4T.O[)OW[*?UF`[`W\3<7_ST=Y)6?T,>^&K^*DT'=R)!L#.*,0_&O M(ACY:_HZ2#/_.HZ3OFF`BU:'USO^&LMYNTEWFA+92+&&$5E.J<:_C_?C)\-O MY/5XZ="DTO9XJ!7.:QX/'804.QGO'+08[^EX1CG*N\'TN`^Z:+-Y,9/NSG/L MQ?,J972S/*J21.5?"I_^&_LZ]IGTS7R;^Q3'RGDL53=&%^'#(29=`&&8>?Y1 M5[EFF7@4!C?WG*/D5_-^K#3^RWD];'H=*NO'PZ5&U]O;9-``WS1^GS3>C\=+ MAZ?R#@=AJR>\WD4X>?A$(LWQ1?B,U^!MG>;AA M>YX&K8X(%SU16A[%0C0@K=--6#M&`?/L2;ZQ09%ATK!'Q$KW`3UPQ!LT?BMU M-F"$X,7R/C.?E:TM[A<6WS&3J+&)"J-'J#"+VG:K0QC1%V;:O_U/]D\$A.7? MPB5K!B)T\!B#5$CK1$"!!WP6[ M@,HK9-1;7CM"Y*HG6J"XOT-::P&BXB>_,8=J(JM6DB??F9VW(.%A15/4Y=D= MNCG[]>SRE[/;OQX6DH1:OU=8,GO6D]!C.V;!TC$1J>+/2J8R*D[%J_#G#/&": MMY3\.4TRT1%VRO:2QDQJ3FB4N7\$P[:8V"9Q M<7K<>;Q*-O@N^%;.6WS$,7X(^^G0J<`6#CS.9T5O6G.$0;%LYJCHK/Y+&-$ M0':F;/SE7__IQ#9-GL.,/G.@)P*$!0/SX)LW=:!G]%(]1_"=8'/4"FS-RL?! M2I9FT4JV7.7A,*:21N@3/N-BZSQ4,`-M23@H3P-B?<5L^B9WD[$M43T@W@RD;ZQ= MF0*.C]5NI3$V+EMK);RG9[_RD"SM;2WAS8Y096X/A@`^DE9=L>P3;>>H7ZK3 M-*]Q6GVM<+6,UZ=AM,OQVK!H&65M4*D86@$6OU'?`5KO3(,P$3DSVQU=JP^H MO:9O(]#.1XAU+Q][,@-[H&7C<"H1L"G`'VB6D3&94!E&9;>H,`K&\M2%-_3J M%PYD%+S=Y<5"2?+G?])4>V=35V\T,RL._"3:'&7`YR#? MI2$]Q^7JX2*)'^GK,:?XWO0YAYF90>+7[0ZL3&916Q$D[1!,E$C3:&_.-(Q7 MX3:(4(JWY7$@=/84!ZLG>CU_PNB!S3CL5BN,V0N&#V&V(AU>,-TGBXH5?0R* M@X?A8P$JD:)14!\HD)X5F?3HQF$WN>M%86]^8$;^]%-XTXO^1?N](T38 M(-IS#TICUPQ19VE?.#)'7B[>G_@Y>[Q!8"F:^LVLY/<)09DHUF@W'04+'A]3_!CD)-,7[V]M"H.D)(B) M@:SZ&FZR>U30P7 M3&ITA5ZHI1VMG759.NZ-%F*I#7;K!]:"6R70;2'"M-@"HIHW(`#Z-]^4R`!P MLA58IK`=+KA26I"NL-+P;WG-HC(">_E\!A[T0-&8S=8'H+PRAD3X=,'\R/-CE\.C_"%/2CQ-'?QL[3 MQ#'A&#U2-'?0D:&TTY)^TBR&1E0#$+F>A_&.)N9DBU/6+BN?1M*=G7(V\?_+ M#[<_H`=,TCK1M"P/\AWAP@NSDM+I`L)$VHRNB@GBES^2;%\%WG9(F_HF>!/X M(7M<.95UPR>6QA:ECRU'Q&=YD8!Q1/;J!P]IW:\O:@OM]XNH$=2UL@.MRP9[VMIPY7Q;@P?IR^WF"<;?F2`U.;-A]G MCOM^]A<>&,3Y0=H6SWC)..:F/S_BAX0'#$F)I67ZG'#=_C;*MIE M=(1$+&?XF4U=;)(X?Z*T+?Y1M/7E7$]0RN@^$)W$2/D343/3V@]%32-VN)K! M+#1'"QI\Y;YB64-AK+NNH;:WIRL;O.*RX?J&O6#S',73-5&+IZ`\EV09,9_F MSVF,K`P*(LW>P-IG%+.5(D2-9TVX,T[987ZM3K!S/F2*?_ ML0M2D@>BET]$5.-5&$3G,:G]-F.2Z@A;@]1J9`-864;$;R7-FL5A(C0FECMB M\WO5D25?UA.M@SSP35C&0%`B+^,1/9`8`U,RH3&*R&XB-@C%7CKV@BO]U%QW M175?U.J\!PEZ/AZID[5_3)HC<9_B!YRF=,^#;\53I&6\O@B#^S!B+V`:INY1 MU@;)V]`*L!Z-^@Y6$KAI)":R9&:[(TMT3Y-UV9VM$&0O$*`O4=G]Q3L9&@=+ MB1!-P?E`B(R,R:3(,"J[:=TH&'N)W1L.]9-[U9FM`2P?X-/-.%H&]B#!S\LL M=9+WDUL^+ODS6!M@:LEX$:#%Y_ZFL;M>%CCZD9ZV7?.%@CX+D#D8)RP>U'^B MKFMHRG)"=T_+=0.QO`W@[-SIY_"P-1@G_^?Y,>ESD47CD;57=)DC.W_<96&, MLVRY^GT79B%["OGQI?67WII<,S.#O*S;'5A?S**&SLC:WDTD1=-H1TVJ/JC= MZ0C=O[0_\'61KR'R)+HR"L,#2=&S(M,3W3C\$Y/N8IRUR7L]ZJX#T9!U`18* M=730XB#U:"(($D,=$>@MEO-];;\&7B14UT;;@-[BGC)*R_SY1^,SHC3YRV>< M/R6DHGG&Y9'5>D36Z3S<*T#:"?K=88T(P=\1EOLT>AM89JK[UB]KB8JFJ-76 M5U)K84?V%J\^]@;$EO65OI-#>B2O-71#=$'D3HB M>]LO`.$;<[JDIST0Z[(OS!^"RIS](F#J*D#=?X0*M'Q;W@]#X=_V.1EN$4^G MPTJ<;PJCDG-3"@WY40P=+Z- MFVRIB&2ZFD@=+'A9%.,C1%N@+[3-GJ10+7P:2X\!ZC6E2&;17)SD\?DG5X*3 M`NFGV7)'OD4:_A.O?Z$;I;:.#[PF%,@^OIQ]P^DJ+-?NWQ!6&#Q2M^U8]W1A M`(=NSC8%^V5=2-IU:KW*M/`>S^8OXGG=&/'>S$H+S;'/P M*4;W6:$#/;">6%3/)NU\1P\3"GZDLSXW>)ND=)5%ZT7(CR_E1;7M=N6TN(+J?NUWF)E.5BU\E49C,,KT;B2RAR*F:TBJ M3/K1>"@W7%E=IBD52?9LC'R'NDVY6=GR:Y"NIY2JQO8UJU(#NTX*4./OZ:;6 M-`EK>EFI[TVK@D1M>TSY6@U+FX@9]58+@3AA7!&.I9UF\:=MWKS.,XC[#[5D5W:`WI-2*$GP?2I57HPTHY<:Z^TZ6;8_8A%G.]KZHV_LJ M%)I(DNTT:8+%@1S(>TMWEE3X]8_TOP;1KBB@XO5_[((H?'@A(]3E:I7L2"5U M&F:K*,EVJ<$JF]$6!](PPA*P6HS^+E86O(R)QD18S.TO;D_^=G;ZR\49.C]' M[]"ORXM?EG?G5Y=H>7F*_N.7Y<7YIW^<7_Z,EBG((K>7/2M+4\`R>'5TBE>4[V9-,']_KM`Y>89J: M#;[.$\]IL@G"6)YANFVZJ:2Z!DG#KC]0MM6FM6E5]JC9\Z7XP"^.].Z0B`S< M&]G%?-%$".[*@C\H3D.<+:_3EA#7XHVWD@T+.C$18L;V#D4=^Z"!)&N2QM7DBYH!,,L:01` ME!+YT&`3O^M"M-K'$_;(;^N0.#HPJ!C#;$*Z$66T76W`K<6A(F6A%6O`.0735O5_\=AX]/.5XOZ:'H MC[C[7D`2162L3#L:J;N+0*29PVX`%@7%Q2]G,^-9CG^L`EH-2YBIV^MRI_OM`PT*7R-TS!9_YPF MF7`=@SU/0,4[UX,764;RW?THO_D!VD\0/+^@!73A`(4Q*ES03Q)OUGU8I!1X MSE#S%R@EO4JV#>;N0R[^/^W=RW-;>-(^*^@]K*S5 M5"7+\D15BN6QY$EMY43;M,U:6?20E)WLKU\^)8K$HP&AP2;E2QX2@&Z*_7W= M:#0`O5+"X\4<'V11+$6T9^CVJ%0$HF-YF9#=L:_^W@7/25$Q[&1+6>HJ06"1]3^'4C&[YI/03.('P)9YEGKK,O0P_G>,AE:8#\X M+NM5B%\\5\%4W);!+T8FM-?3W8FOTE')=EA?RC[%H-X$]QB. MT)Q_[#E!#1U07*#6;T`TF-=X!JJA?+_)L0CCBP\&'\CWD+T0@_@!\1>A`![V MV-G!^1B1NUWIEG9P@:62V)JA^1O1V.D%5QI_[P94%ZL[PFI"AQ*-6\:R]6TD M9F1B:6,)4+C]S2;@IR95:JVG/*UZ[/Y27!9CO!75L_*?L6E(7$2D9!FE68^21X5`.1^@:]7@A'TW<]R>4&S\\!,5#[.\9 MB\=W<1)Y]PE24`>2:2F\4\@BP=>@WX-0'D&E+SY_RS50[05GKZEZ9\S;#<(> M]J,,@_!A$+-._3K(MN0"I"+M.P/%$U(,!Z4J6[\T9=C7T_0(8P'6'%I'TBI/[$J;4QV\Y!BO&P[#%I6X`+S6A4Q#BW1,U\6ZN4H!\]$,6;CZTHM]4>.`FPG M^^J1X,#OI.N05AS/QN MR5[UW!VSO$0]1((72K7![.7\+WQD9:RX'[_GC*[$D#TR!\+U6!87B;%(X.(G M(144BM2DE+MC6N; M3QZ39S^O.?D@!7LV.GQ:Z#JD:^J;)T*6F847D>IU:M'QP0Z7F^RGJ!ZWEL0L M(UNM0`]-NC3\0Y"*2/9HOQ&Z`\#0W-0MV-=E=+"R6\:&M7D=93^`ASN@=\`& MOM1C6!<.]2,(3^TNZ+2NO)O4Y*!)2):\/&O/5\M(-9=89BQ9+O.LP>D%Q:=#<;T(H,]_M1]Y_#-`")95DHX/C,42NG8^JF?OW,U( M%$1U*4*Y(Q[MLQ_9=Z27J^Q`P2:5`W%W/&F+!%DE:/'3#(",VX\V-[I#VI8P MC%S%W,E=T[9^`:J9B+F%*VZ/%KW?Z#C;;72L1_!#C,/;&,$-NT68Q(BQY[K7 MY1[_3.23!'.S*ZX=YP0HT`'NC+\WU]KWC5>YQ\^.T&ZWRGHF.M+N:@T7\@8(L4W((7+[US\8E![(0B9UZNGH4WJ M1D6V'1PBKRG=_D:E'APBK_D;D=O"T/D)RU!=L+8XG,@A\KI8QMP%X?X0>:!P MU%T2_3M$'JB\7L;C-3^9<+IQ<&QG#VFNN1/?2_*J7'_SD)4PY`6ZQ?&10SXA MOB]B6CT@U;RC$F*.+J/F#/[$-C-( MP.>FUE>)?LQ*W[9P1Y6^O*CLC3D)="[4<2N2)1:VJ8H>GY)\&M0C8S;ZKHNIVLHL-\'4=P@ M&A4>8QV^5\GC_),>9F`LPPNY7$X*:I22N4.)V(5SS>QX M-A=7%G3E`C]X"-OJ3Y6)NHY+C=+9J%>(".78K^,B=86(\+G)U68YO!*@+16O MWFI(5XB(082YO(=YA4A+#.J"'>4K1%IJFA0ZN2\=Z)(U!.5+LG*`?`(ZE(M$ MNJ0#!]5('X30^,D-:HE<5SYV2@?\ZB!^->,'$5BWRN$30=?3.L/)Z^WKJ^OE M!H%(C.6&EBAZ64'!KT%UN:&MKN/$8%,!P7+#<_#T?*+K#2)\X>;YY*C&R/(U M)")G^5K/1WZ]H:$QZ?4&:K2"O=Z0BQOX>@,)'G*RWD":B1P'IO$LCK?R.XH: M3>J!W^XK>W3:D(:3,-L+`?)6U6%T[J7-[ZE>9=M\57SL\E]H'6EE"P$R=OW1 M?&HI`7>#J*D19,YF0&8@I5PJAJ"5+P,&0\;O_W-U=^H9*S[I[:N7)7RLO'J7 MWBR,DI4?O9R'412^!YNG>'P7)Y%W+\Z2*'OL?)VDI25C5^IBR_)E@B!`$/A8F?+>KFA^9_8N?>YK]40*)^Z1S,0"UE!R!A!QZ>)*.3@5?B M)7DB=I6]4A&BN(TJ$#6^M(,;KD1+4&F.#4#'89?1[O_L1_X)E5/'^.^I;?>R M]UF9^D$;CG4WQB!GT'/5"=C"ADW#GML^>5HHV;*!S_5.=VUWJQOZG-PQJN(7 M*+9XTF2UO6DB?KJD^'8"+"&12*D71`D8O'/,WU M'*X?4EN9_KT-DE^JX%JG;Y-(Y7WL@@:BGV6Z58C4P)1TI-%D<;5K)5M&T/8`,GI/Q\BN[ MG"^^+\F!4FP!,BRJ[*8-P58/*?(XXY,#W/DV3GU\'"_]I^R_L>P6-$B?)N3X M;>UB3J:/9=`)1&F@CCO"J/J451_3NO0+].;%4`,83!-KO"X2L/$ED$/;XO$R MV'B;^\!;7X=QD)<3@MVC^?CJ\DT MC5.GTQ4])ZBV#YDSA%I7VRD*>TJ=HT0>.=A.UEX;HNRF+RU=KBW[/-?>1[L7_A%W\+P64\T@YV!B-8`J2Q[K:@:J(`!,3Z MXXX*5)<+^44W5K2MJB+/RO^SJC/[K>I.I:+E"&OD,,2QIKWC#NV!>*QBH`W. M$H*V(IIK#&'BK2%K#&3`DZU2K#*M/U!P^+K[@0,B?K?X_#*,EG[T%MS[XGC6 M9!"(M^5TQJ<,H<96UR,U%3B2)MI#CO;':A8UH-F_[L.7EW##XMSS!H7G?0PC MYN=7&>=+Y.G_4L3'VW62^>.X'*X'/",V1#V*41DTA%M:8VC2"D<'YYZUI8/U M33]=8Z18ZU<'H;,]4)8?>)!4%%!"A&,?>^._IG![SK;EC#/\9>W MWDKGM'HCU+TKM*<]SM#3U2)=@`4#N0(X7DD3M=;,VSRPLGV3-_(^A!A"T[+X M]&!DGG5F@`T@H`6H=#0O"5,`J;:M,\///.0DC!-)%!GM!SI-DY>ZPY,P>MC^ MI]\+H]_X3U[B0[;!=6CVGS.SSXV<3_R3;'_=^F0M7K0SBXC%=Q;Z74?A4^2] M5/<,-/=DK\)SO_:$L�$Q^>*@[%@:3F#T/2@BIK8HVR6A*:(69K!R@?DE* M^\"(%$MW?IVC2-*2H2&KB.HH?/")2V]()97I:NC`G>NIY"*JI8;%+/)59E"] M)@:I!\,D,`@,F$FCD,@*SOC^[VU0E$T9+=[P^D/6;0[[X>>B>7JZ6JUIR#XR M"7TPVF'V.'R'MBGI99HEU@A),=>[:V:7#R4[7VJIBW>ZRH)GV]"U ME7J?T[-RHZ441W;>N8O+Y_JU(\QVQY=)9\XFX\A=GJP_)C>H]<9W@5(=C.E" M,NK^"-;L/M#R6LA/;)H7*/C$%UX!E@;E"K#1RAE#/`R8.62:./248C4<>4S7 M4%!YT+SGV<$YH?'NA%!*T\^.<*+I6SM%"@U?:SZ;%'8'>%9W:3`JO MJ;CR\R+`RS!Z](-D&Y'*Q'2():D[)H@F:F7Q15[ZJ+KXPR&T"N.KK@Y+)@^U M=5D:OY-LJU:R'%"O.+[H1(@\=.W+L'*2:Z7\R@?I"*:5DY7\[HJ%"PTZ+)%' M`@"H5(AZ99`#VS^N4'X@UM]EK3R6_4.KY8E6M+@%P5&U\RY`T/E:1*%F_F?K MFC.3(C?Y2)!R-]$(^)5!FH40)Q-#P],J&0%8, M*1_B#Z192"32QGGI'%\1IT5T;M$!+:SK:2JG0RP9%>-UB*;.'?4^#76DGP8, M!"G1Z\!+`S1W5:1GG85DPPI=-&DJ@=B97N'1\4Y9,HYFX5'W+EFBA],B/9=0 M@);I#<4=.\*04?5>9RCJW!47<<25_YY_9;07K-49,C.N=<*/]5L:.@CNZS*/ MC.?W0X$"^+1YT8(V'XB,1R\B%QD?)`3?]=6,NFLRG4];=[+QED-<6G3N!(O< M9&G4Z:NX3AM&;/&^297N6>;&FCD;S2G1#9J(NQ*4RAMD>&4#@1*\_`$B-(0LASW;;0>+60JJ0OH'IK2W MAIT*JA!K$TB`Z_/>^5"M1>@.$K*Z!'*0I0#TAQ;Y%6:6([P#SF MTFAA]Q'O.NA_$\*L]B700`.I(Q!\W;-X;#0GPY6'$J)AV-BW"^L2+$H?,DTWKSKUU5F,^"$.13<3H&LH7?4.9;J#9`RMF\F589O+% MI9ET&9A=A8FO/>?F=1(&;(>-D1#"TPC++3=DF<#E8(C1Q'L-TGB2K2)O$Z>? M$#MX1?WJ`8B2F(P06_4^$)P=RJ"-N?S3Y>LZ2";AYBW]*E7S)EN)T`*A;:+T+>F5F`X2^VO*DD.=TAX*= M*]F=>^.(Q\^>.K%C8:XU:\_V'=B/K`O+^Y!=VL(SF*CUL3I\DL@`P%/8>[;]BQ7=$$*A\ MQVW(`H\KE*TZPH3DPLVIB0QQU867=,K5K0 M5307\+3M15R%%CA8TENX%77N"ST#5FIAMB"`C61U5C@N4="L4GD7X8L7"$]7 M4K7GPZ;>#@,W;3U0@',@1ALYM=XMZ+#L2_:C^)JF"^*\:Q60A.;!1]*^N1)* M]9&)8FD>;/Q9XK\(3TI1-.B#:-]YS:*?F1?LOQ;FB!J MOV45AD1VP8?0KK420;5Q']=,:*5NQ'^3?Y;!.&&4.S4"X-N=.)]OAG`)P; M-%N+)]E%*ZPI=ET'M`EV*<1H>IWW%4VNLR]IXJWU?B$3:XY!B*?566/0I+H8 ME2IJLDV;0,C4FPKP4C1!`4M=.@Y22@GZ,,D[A@NE"(0IX>'&LXO/"?_2B^HTFM1B8$#.6M&I%+@GU]7>=G('KK MB1<_7Z[#]]GF,8Q>\D,2E>O*6KUW)`SL90E:6CK:@AI4*`1\L+%&]88L:\FR MIJS6EMYI2YH&Q(&LB07N(`SJS`,U4"J.KP`)1UI\<&[7N9NYO;Z>3[]-K[(C MD2YFR\E\L;R]F2[9XI)-QLNO['*^^,YF5Y>+FV_CU6QQ1>4\.T?F+?91W1JX M.S^VRIY[\3C;/`1OP8?L^/-]%_:>]F'U3IF-%]V(59Z8VER+*XXSWI(Q M-`=I,X>V%F08)/(>_/'F89$\^]'X_C[#]ZRG$B1;!?QAD[?BBU@ M?>QPA(Y^%L,%J%P`*8!&&I7?9/?_I,XJ.V4C]U,9(TPB_R%(XOP&[8MP>Y<\ M;M>L&HD(%6B949L`#*RP@CVD*P?L,(D843!(M.T,BF-[SC=C90USH\V;[BR6 M[1O37W)U8=BB&+A+TW;JO3;Q:Q@EN9_-MIN]OJ@2YJ`^>V\E:VL+TFI]['HG MJ3P0BB4CC,;;)'P)[X*U7[B=<9!"QGLD<@`K[/7SP`BVFCT$Q5VXT)-)0/(F M8I$(7@33[DJO46O`=BV(Y>OXW3R=8T3H(7+Q'>4\IO5/X\ MS2^MX(DOT2)WMP2H0=/H,KHM[DS;?4(#$H)WU<*`])V6)G_8IFWCS3$PF/50 MAFTJ/=H,,K)L&@+]>-K,2$3,:-=,W'%?=L%TD8[>//R93O&#QU_IQ+^*U6L' M`TDJJ8S&*'\^S;Y6X&2DKQVLZ8I60U%OQ-&N>1Y,[SOLY\0'QV\1*O$RL[(6 MG(\QUA+K6D.TJ4!3`WI,L5Z'[]F9]7'Z`#=^[$=O?BQ=$M+IVN(%61?+=*#6 MSC8+2"7J@%\R4`WS^V8Y_*N&Q%9SM,Q%`G"PL;5P+>XI@[-,7C]0/'GVHB?_ M815.PCA)/Y_^S*YZ5?M]@[%`.!>.X0#X"OTMSL-,]3B6'T0CC\HO,EO/OLJY MHOR2R`SO.-/3Y`R8)8-(1#"4+JL(-<*8?1JI8GN22@PCV917Z5;/F`1('SAJ MFTI_D$3%89>W1QDYZ$9?D$/>]7'`+`W]7/#(7N2QO%&-!&$)4E>`Z=F,)@/P M30Z$][*K+KYW$MU[QE(T2@VQ8S/>G6B[-^+3L58S_]1?>\6[7].UU>YOX61> MPI)GGYW[3\%FD^4[PT?FE6>.GY`I"R[R'*HI8]T`ZMJ0O[0,.57S1$U8<,EH MER9,939PX3]LBSN!S!+QK>ZP9'RMFXN$?$M+J0'_7H![XS]YB7\TM`^$'YV? MWP\VVO^[GC3@3!Z(E5MK6Y1NOEYDD["<_?Y7U52A3%)GJ]SJ#:$\M;Z/4T=%%MHK71&#C4:#GY.KVXG4_9 M;,8^L;_&\]M\+S$;7UVP/V_'\]GE?V97?[#Q9+*XO5HMJ0$=9#V:-27R_?.P MOKI5)/0V%T.K7N:*4["-Q]$L.)M;/C?;6&^WA6=SK:.0]4?5+$";4SN>V]S\ MC"O11)8,(A#.,.85:7/<(\"UU4!.K7>*E,.8.$3G@.XQH8Z<3P\5 M6@G\-S^Z"_N$B\__&.WG-!\`4*?TZ0"`2IY4<9BR7F=0CM3R4E\]>:GZ+;1(G MJ?-+0[!S+P[N!;QG-$;Y\VGVM8(9(WWM`$I7M!IO>B..JN:L;,^*#EEA1]&% MU?ID=:)I+QIX-;.R%IR/,=82ZUI#M*E`4P,,KZ&E`DK*JV,@9'[I^W3VQ]?5 M](*-_YK>C/^8LJO;;^?3F^QPVN77<79,[2=V/E[.)O]FOP4;%N<#_>MTP2!R M?:<&!YQ<5]>`^,SQ#9/PY26=";<=0X:,_&U^`./`(DX;&'JEKV$<),%;#Y#Q M10L9'X@X,`6ZB.A\CG41K+?IIRWM]699JE'D\RQQ;TS^4.F,'V=*-#"F#^&8 MH$CS8C:_39OT)]94&AZ40H`6+*<0T2!@$A%KX="QBI2PG=>_BO]L/HH_>/.B_WTD_\#4$L#!!0````(``\P+40[ M^J&=1GX``*@!"0`5`!P`8G)L:2TR,#$S,3`S,5]P&UL550)``--Q]-2 M3R_**66>' M+BV/UE:W-)(\WO/DH*I0)8Y9A,R+6O*OWP"+K.(%"20N)$!*$1/3[2X@D4A^ MF4@D$HF__:^77?+5,\GRF*;__8=O__CA#U^1=$77<;K][S^4^==1OHKC/_RO M_____7_^]O]]_?579QF)"K+^ZN'UJT\DR^(D^>J,9D\TBPI&X*NOOZX;_DA2 MDC4M+V\O[[[Z/Z>W5U_5_\R;?DRW<4KV'9(X_?6_^/\]1#GYZB6/_RM?/9)= M=$575>/__L-C43S]US???/GRY8\O#UGR1YIMO_GNPX?OOSGT`EOP__JZ:?8U M_Z>OO_WNZ^^__>-+OO[#5VSZ:5Z-C1BD:'TB__V'/-X]):3YM\>,;,2TDBSKD.*R M_8'+]MN_<-G^1W>$;ZQ9O:=%E(S/;WL8!TPSU2(3,-T:!LOT0TS9L"1C^D[^ MN**[_3CG<;Y*:%YFY&3U6QGG,5?`_#YZ2$BNG@+'+6/QV^^__;#7L/^0TQN# MUW-21''BD-D#P1&Y_N?,C);R5)BX_/[/_<2!@DZHKKL^@I9JH< M_\YL$&'6^_HAB;>1.XA@Z+N:RT?&&GW=,3F=T;3(HE61GZ1K]O>\3`JV5I]L M,T)VSKZ-P7#NL+;;1=GK]>8NWJ;Q)EY%:7&R6M$RY0/?T"1>Q<21UNB.Y66. MWT\XQ^_=S?&2>9$[0%-&;7KMV4SH;A<7E9#V MLN."8XT9E)W,1$U^!#UQP;F`G"M.;S+Z'/-]X@7-7&NWBK9C#;C/HC1GBN?: M%Q#2G7;5:/Z<8M4XCC7M'%THBMY(KN9W1=,MVZOMSLE#<1JEO[J8"433[>I( MR"E)R28N;I(H=>ADBNFZLZ[L_WFDQ)$/TJ?FQ2/\TX0>X9\#R@V9E& MR^@Z]$*>F&A>F9`^_E;&3]Q)A&G[./&47(>%9&3E1@U@JOY7!>/I'8QG6!>1,^9MQ`]\),5 MFKTRG7HBE5_)\'G;]-D01Q9(:R!7L[LESR0MV1\KRNQ?/62S)2ZCY&3][S(O MW`6U3,:;8+_J9O^!H._%5YG057%H([)ME,:_1S5&3LL\3DGN9DHJVLZ^4D%7 MOUX_55M1-L[/4<;69%>A>P7M:=8>-U/!#>'0YM'DF6'W,RW(3?3*%S>^9W-E MX.3$Q]K%NEF#(*)C>HZN@EFQO'5'(02`J)?5 M^<\3+L]_=C?'BRC._ADE)?E$(O[?[GQ$.657_/,1&@>`+3Q)O'GEYSY[R;F9 M"'((=]9I3Y@YUR1^YHIXDB3T"X\"N,K'0`PPC>]D>^BL(N[.UTAX:M`- MG1]X*(F/%35T$WJ&B-IQ?5,%TR$B6K<[3G\)/=?X^RA^36-9KN+'7<0]113T^='YN. M&_5R'^X:+^KB-MPR56QZS*#T-+OV\;;KHY_3C')`XX[KTRB/\^O-349RICG5 M.'8<"PF.'`L9)08R_CG+.`L1VRL.YFV$9@^M1%O7#B)>(YC/1MO[XSN'M@2Z>QJ ME(SN")F-SE(:I\MEO"#6]R!0([C;5Q^][5I@=BL3DK+CO1];L9E93]=1MLY_ M>EHS`^]DXRY2J(\KX)3U3=E.S76 MY5\DRDYV#CQB#/WV7)Y:^+IB_]`9G+P4)%V3=3,\GXMMU8AJ[&;TA*XZ`R:\ MQ@O-NM.MQZNJ8&RB_*$JA5'F7V^CZ.D;)H;OOB%)D3?_P@7SW=^)LV+SZS+A.WQ;LIL M]1CES)[$JRK\LH=']5'NV7<^9?_R*R`'0RJU:+1[=Z75!NA)UI5X^0`[$U&=YK?G;J23]O"?_5?7V&8^*J@7QD/7N9L M4%J%6[@+2K,UR?[[#]_^X:NG2I6SNDB/1)*5&(M!D1F/2MWVI$X>\NI$3:'4 MLBX]I18W#4"I!1C)3U];_U5]>Z56ZY$9J#6V>S!Z+?WT0KTVDI!"L45,D'.ZB^(4O_**^\'+;[^]@0R&?A;_EU\N$IK%Z^B,M>2[ M^/9.8\6V&)\(^S6.TN'OK>)XG\CN@62]V8]$O9:12\+!J+(:('1LN>+7[RZ' M7->=<[;$Q;TMP9=8PUEOMY88BJJ5=T0;+S945P8`8'49:*]5X,#()2D0"]*6 ME4*LLM5(PR*P$55R[(WD@PWO0X3WH$%[0X3B'_=6H3Z1XI.OCL<[P7PGY'.V(9'/A M@N0`PB:DO,/9Q0KJ4)HCK+!VW$W@GK_'GR82IIF0M"?O?3P`\BV#Q^YGE='@'K*!().MUO&=V M_X)=<@Q30G%`%Z0D2$=1&54F9S0OKC^5:O2`5). MMN1AV9E3]KM=LP43'5W8HDV<(=<'L^.4VS#LSGNNQ/O9?5"X`=*(D2=<^H1@ MM"D)S$!L9V7&T;PO.'$L@*"AF8:$M<4*$PQ1W['@DIL".]GB;86"6X49T>9R MX2O;U>+O[8A/GDZVVZQZX9?[/.A@$M@3C"@)>H1H`H;?E-K(P?(>#FK`T173 MZXFPQ6FN],M)PJ'*\U]]GN0?M`[=19S&!;F*G\FZ7^[J]/53]&^:G?'[ MH9+-@0&%YI!3IV>($CKRJ`S:&U)12TKH.M:AE#4,&H11%U$`0^I@3L=#&G6QH1X[!,\D>J'^? M'3P4/GWEQ\*2Q4>CIRK1H-W#.W)UYD7M\B[TCNF/X[>ABAIW@E0WRUPV\P.R M>=R&'#MQR]D!XU@97`[.&1U>:'F_^9+/FVV7\XO\[PD M:S;CZ[+(>16H.-WREQYH6M5]M3@`-AM([RA8=XP0M4,8)YM,T(9AM3'YFYN6 M8>+_3,Q/4;S^^/)$TKQ_^\H]8;O3I3[-$+5&XX!I-/$Z/6!RR>5"-,@T'4F7 MG+:VO*5T(T-A3I1>A.?N_;[\O(N2?.@= MGH:7J="3=W.K2C;<^[(D7I9,3AJ<+U$H)L1?\/O1HX^:P49\;#$8[7842IPP M$/DKGSX-UD5]_1L_TZ?X-U-VULBB"$L;HI(J2]V^^90Z*'< M&)%R[$CS"EI4QU6^0A_G%;-1@#F&G8ACBY.F=*3\Y=GLS8T#6+G+>(A>B>DQW*P.2:TAW,EH\+DG!#IL4 MZ?X?:-6Z=-#YU3N:#7?Z\FFZV=X/Q@@#38`/TLIL(/`6$F[5($30P#M(]#>, MRGE:[Q-%(X@!\B>7V\,PI"_TQYS=2;6\$F0ROJ,O%\1"H7&2<8)ST!2MF]-#J)5WK!LZ;+AINW'< MP+%&1]U,#V7,[QZ.<#BCQ0SX1;U_%]LHED&-*L=!+!P'XB_PYS>O4QK5$`)Y MK\+A-PO2VZW><>:W`=O!(FM/5TI5V\L%J'G7B*D]7(Q4/7NW`(M+TJTKPJ;] M2)/UY>XIH\^("\^('O77D[;TCG=#+Q<_?3>>KG0\1T@,Y'*SAEKO:%;$O_,E ML>]`6EM[!&W]PFHRFMXU86K+CY>P9_LO952L>W\)XZA`Y\#ZB;(&V$P@)!6# M%(6&P,S5P8W@?-Y/.K(DAOA?9^GHX.?_(Z7K+W&2,.TO'<3)Q>2T%:1/9N9J MXEB.GA>*/F]BQ?G/Q?ME=9+&51P]Q`EK2%B?%1=)?A.]2AXO'&$$TVP@&>4W MIW.ZT@XC1TC&KE@S?YB;UR:<:5:2=7U]\I2D9&/MU>F.XD;GA`/,7/6F$7P` MM]H1+`/5K3XLW*W\3`O2V*&3='U%T^T]R7;GY,'>QT30UM9-**"L'5*,=3U%TG@CI2 M]NV(RED%U'!V55Z&:_X5C5)@KS<*;0<>9Y?LS+5J3"&'Y5UV&04T*N1KN^B9 MGM<3N&7_/))J289PH&%"ZF]=T=0B#TO?A/P":C?/)%^!=)07FO&N(YJ4Q3WY MV6N50_E-Y0$B^`*T1#]A:'"S_6_?#+[S%?N'_6_"GSH8("\%2=?D\"D'*'B( M:<4A25?DCRNZV_-Q3!)M9RN>DR**D_R[/_C27]73-/F]Y`1"KW.-,6PG;R;- MQ0M"FH)"/4J$$Y^0BU("5_U4;5V+,""` MM0JMC@XO!PO'VA](UXL:65_0[)CR?VPEVDZXH"=_!P])*GP]'P*!NA>BJ:(? MF#M>:[9B:DDO8.(>Q%.^`REY14_5V)W^7S(7+4G.7Z3EY M%#E%0(_DHQQT1T#]_>7)]Y<@ M;-,\&M7]S;M^B.1-<5,!T-VBV`9KC]*2%M]JQI*-YN#W-J(#V0(.>:08I91A MH&^N.E3"LTU-1.R,[A[BM)K1X.XR$!R5=>D%0<5-O7]^U$PT]OW"(),BD"D: M6V=?WXPYP9N#P,9#L,W@CPK%17&,3")VIA@R\@VIG()WM+G?AVJ(;/3MIYR7 M9==:UXT?0DNCLV!@:P#DDQZSDI]Q:&^R:&N;@[!K$J*UV$. MP%Z/"%7?!YUWY4-.?BMYF(%7GFT.._V==7;Y49YE*)HW)Q=@,[\/Y)SPH MS7Y=Q4\\1,T@?L:^3IQN6VDJR,RH,8:T2-S0&LV_/5.AR>91`W/!0R8/X-;J M(0,M+M^C-I*HS?SCJ&\@[A1`H.D]A.PFA#QKZR,PU1);I&@-K]>>[92((V$M M=,1\Q374X9GWVGM7$]4W5#R'*IN^1GWXGFU$C#1&_/3]+3GDTP!AOR4W3]/; MWP$K#GE4S<4[3O!PQ]]$I4G#DJ;B"0H3@OUOX>2G5NI9XK9>XO,I(?4`',X^ M8[VG2Q50$#]T"K8*#1!PZ!PU3QP>AE%QB'B8<)`Z8\KV,"2"<;Y4'UN."ZWD M+O%("G`X<;9&@8=TFRIM*X9%,,Z8^CO#H-#QP,!Q))`(:(N;D]4?M_3YFS6) M]QAB?^E#A_W3+U=D&R7[^*)@<9&T.)18[OTZ$=_[(84&$/JY.;GK_.0-SS+1 M4N4D>J`5$.,P'1(98U?(7VY8R].^@2;U9`:_>OTH0JE3U$0$7Z5-[;!G&U#Q M9#`T:@54K\E>T"2A7^)T6Q\RU"<4^R;7SR3[^3%>/8Y\Z5STN;A0SD\@9N&^]'3RJQ2:]Z?^VQGPGAY[G,9B8;(O3WNO,1P;P\2AS(* M)T@R:6S%3?0*9:C94=)+"1D0"0TY6NN/OIA&3N`8##YZ8J7_+^8LA5BAW2UR M1S$&+PSU_EI3'$*"`;U8:!CE'>J]RS!OB[JGI[0D.VOF0>9GA)_Q*7?8DJ:M MG;:PE7=@Z/MCN!E;.V7@,,`3"Q\^.*@C[3O;N"X?&O_.9M`M(>H]\;A=V32_ M*`O&[:)^Q@(O\+L2-NVW[,< MM@F@Q%7[&Z]/\NJ%.ERU.V7/05$K20_O&B__BL(;@%@!`#HK'%%\TT\R4GCW M^L%72D]?%9DP&CT/HD7T\(XM'KP%U0 M23@Z`,+@3C8.T*IU*;GS:[C8D>?MR*>IBQ-Q[LY@ MC"5YGGT+3=3E1C%=!-NP85-W\:_.SN&2QU](7MQ&A?#Y`65CT1ZRV\Z[NJ"^ M`=6<,&*SUQ_K$/V2C+$D=5E`@;O]CEI^.U'4IKF=V/W-NR:H;B=*IJ)Y.[%+ M:7&H?B]P-_,"=P([_6-&P>%6$]Q?E":X87ZVZPN27=.RH+NZ$.NLR2DV,_]]/53]&^: MG241SR1J59(?( MQB0N0@P#.II!AE;_H+3"7Y@!DFB0@886LTN\;(-.-QLMJ=DT*\TE0XNUC_+E M@HD$8QS11$26$='9NQ)8.0NZTG'I$R#&%D-;_WG[P8:X[+=X=:5`P:T-DMG'SRY6!*J>9>K)H_3+PN`EEJ%V66QGQ: M%_$+_R,_2=?7FTV\(NPO9W3W5#*3(+^W:$VG_K!F)+RKCV;:I"MIV:556G"Q MY)I('W=/":WT]HRFE3'(*U&D>9D4<;H]V6:$[#U>WR62:O[**#D6;KI@$XD2 M'M3Y%+$/RHO#*>H@F5%I5C_=WOX\"A&G513L,\/,_1>2/)-/K,TCZ#EH$Y#) M".CHW929PH$Z$!2TK.NQU%F[-5@)XTH@5*,9;Y4.E@Q0?&?TFFH$5J3!'<%%/^W< M;F"M3'3OV'A_FGH1-\;?:T$LJ1:$M>-W!13^L26C[>9=036"PO5AAI-6[6?0 M.V0[G^5*F%VHRY`CA%M?DQU[)W]'5C1=KMHN[:NMN&^1H]7>^6S+G*PS=MW;73FG*9K+_=;>+\YS- M)S_);TBVXH+>\KNZ-$G(JB#K6_),TD':U70#:KN`1F/-VEF<_&,X]"NGX#T, MK1W;`;U_C#,S_W/04^E^MGIX7_-']3XAT4SI?+9X".,:HO7Z<[)>Q_LY?"ZY M`W6].?YFM]!@*&NO*'*B;VGIT!"OOS5"SF08*C3V8L"OIQ6/1JO!L*MR.6AW M6?9Z``IGR@6AS408EP_M5X0T9?.L@^.5:U?4.<<\UY@UK6J>'37[V/,S+>[* MAW\SC^^>WI-L%Z>BJCBAL*._]KCGY$TM6"-_2(^KG/N9A6%+1E\:XXWIRMCO MJ5X8CST6OBX"HIET63SRL*@;Q:()ZV`7@]8%X],/(MW=S`WB/B*@="?\$K*I M015W5MC4?J?%PE8EH.DL:Y^-,6]@3+OKX-Z/W4:A34';M]]W?DONN$!<_CSH M/3-+OD]T5^YV4?9ZO;F+MVF\B5?\4M9J11 M,.D&]\WL+G=/49QQFW0%/[HD;]R#4;^1WS4&A`?5G)YHK>@3;WLT$-$E@>B8 M"7,1IW%!KN)G7IJAB-)M_)"0$XUWTK$$!O>+U!V]B4?"6JV^``^I"2LIG`U3LM#5>BPV7URH`U^"Z>"19GQ.9GX#J4$M.T=;?*U4[ MFA7Q[]47O=[T&81\.E2GQJ]3-/:[WN&^(36<=*,=+H*V/8CJR. M]IE[M8I1EI2NUO7`R+KU_H2!UXOH+W2$I?WFYAOCA6#G+DO'61)&)3Y#2P)M MRZGO*2H(J1U&D,#,ECIK&5DM?R:C+PGJ1S4>+OY[V21<-@"^-7O7'PS=:V9( M-I.&%7S10RXIR5&BLZV7+*)=K]@9WC;+J*@-L[BW=Z?79#^.,],(<0&NL09/ M2*,MYD5VI./]P^!V(];!.:/=B&&'83,&QYAX0S'HJK8.5P'4(Q@]P`?) M9:K(WI7J@J;)::ZHX,"LSG._?S_/G6:Z]3W#6[*B[*M4"BV?KKI#4_5(TM"[ M.=%;R-!SMEJX9*.$<>@'G!-PCIG%B1[BA&=GI6N)J\_+Y/(=PQ5-MY4]5)\J MC$#^`%&'E-W)4[93`M@0R`RS4F4!%&VB''!^"]$:#&U>I"='O/#C4\>R$^D]GJV#6ENP$X9R.\H:BA*2U][2'XQ7)?\S@ M\6\YY])C6)VN*%@&<^"JB2DT&G4.6'$\X$$H/U!U MFBA]&/^"9JT]VAE;V^+^_@QZ!,Z41G.XH-T]<-`!K[]9BLD(>[VGW_19>..) MR<;1-_,L99TAP\B1,X][)DD5SZTJ+=Y$_/W"Z)5FPB,!>VKXN"A(:,'10*3T M)@L'POR$`7I'1_8M@WQ.RX=B4R:-#RNM#H_O*%AEH0[>+;/NNFHL#6/N$ON!PN+!:OL(^^5G/(41AE.P+B(3BP_D^*4;&A&;C+Z'/,G&9@; MEJMY:9VGNC4F[H]&I7C.:H1:_TX)IB5 MWD]BZCZTI)+%/:V2F6HR0DLZTA#@!0I+ZG-$_01R=F2XG3,IUJ^_AN%*-Z_3 M,/;9YF)5[./*^_K]_)+;,/)E(2QRP!5R3 MG'_%6R8%NB/WTO?^)^9KJ*DS@270;I M2<:Q`%=4P[$N$O30L<6I,BE#WMJFPQE/2[(C8J'T9EY<$#;%*+ECHB\9 M(Z^=QEH:9419JDV:%+UKDFO54&J=C<@!C7,T![5V:O*^),VL/9UZQ@-71^X+ MJWIU'5ZXM7=M<>".#IU;I'2@-YB,61(XLC`K2\+R>HYE((8<5QH29'EWMPC\Y&M^)1*M):DIXM$JAI:$],9#$MMCK5V,#HG>E@;7U3O\1XJJ&@ANFM@JCK$E MJL,A^G.342:JXO4FX0]1I.N/OY7Q$T]@Q081E02@X*"D8S"*8!STPTK%=3!/ M,FX8,`82Z561#7RTVQ4Y9&AN'L%KC8"58_G91[+L&;)%/B+$98-]S';RAF2[ M*&6"/(\W=>[\X0D#D0*XHJD1P)"3\ZX*(P0QQI#T^%$,1UPOZ7U*PS,Q_B>; M9KRO&1&#D437Y.V.6P5DO2OG1(>L*HGZ.5H5<+4DY=+;;..VA^%NH1UMG:UV MR9:[8\V-\+RK%FE&KLW.]^VBU>@QP[`:9CN\<\*87,5-&3;1Z_$:&SP$-=S^ M3DK(.WA'VM[AI3?-[D[*CRWH76WNW"R6M65.MU@>QHU40+8YR%4S9\&!7AIKZEJ95:(2.@?=4K13.ND(HTUKM=#LM0=6BX9 MJV)Q3`?5P_BAE+(<#ZN?F=.J#==A)PEBVXV7#%I0*-/AMLV"HRJ1@;V?,>+W M\_;5W%4N'#CEOBL7?MP])?259ULU)2'Y.1_[>UXF/"QTLLT(J8I#5B^)F-0U MA%)(T",K2XDYH]>$;*Q(^?H4RYUW0'#[=8D++;T%7)_"BXPA65.'5AM]._KT=GZ-= ML_9M.,^BIY@9\_AW-@,2Y>0H''-+Z<8,5.SD-7^*N]_2MC6Z@#;^WANHH7:] MJ7FJ&.3OV>SS5Q!6S81$\S*!5E?O[IC\`U,G(@$<,>'0G?<)M(9<4L&&X\PO M2F8_R:\ M+[UTMXL/%>OW&[LM:QP3WTNOA#-T/60C&@'[F)U@;0+- M:,NMH"Y-[X;0#%MJ`VDE7.CZL`ZO"-NIR^.2_`W^Z.,]R78W9;9Z9),]RE:E M31H]F^T"IL?\-4%?,*YQCN)@.:M^JR")YU4>D7^]L#<.CB853=%FNG\#@5GE^-OQ\B2EM=6((/NGBB_?YCS!YB%!U&Z`2I3BL-XE3ZE M^>J&K=A[9N?0=&:O)W=4`VUN(/D^RQ* MTF0,W*XJV#&@*/]:"")Q%T9W$39=585#ES_,TI*XPB).`2G(+A@J[K MP4]*>+ESQGKSJOT_V41SP"YJ]6F=Q,N;SPAD)@*P6\/5@RVI.$$USUOR5!_D MW61TFT6[9N)]#^:>GI)CX[7,';>EV?;6S6G-".EC2,_:V%HRLZ3+G#U1K$_2 M]2TI8C:'\S)C"P^S#S%=[T6"4PP4";$>*+K.'_8ZLG&-D.!2U(UST7BVB19"8"=#VTH\N@X>#Y,L]+D>KN__V"9GXY7\3<,]E74G769/K,YTNP5!TY5\T.V!]1L9A!$SM<*=?`8843079WJ`$\\X8"G MV_WP8;#=9@9,8WE8`!4_YI(B\S]2NOX2)PF;\"637+J-'Q*R3U]L?MK/'T"N M=O_Z4VGTFQEV325B!5Z-09<4+9=,N__?IBB6TU&C&>J_'%2C)#06NJ'!EQ0^ M_TR^M.24T93]=;4O;;2?+L[),"53?T'][C.#N*5\K!"N/_:2XNFWA.T1RNH^ MW3:-\2$M=+_Z$R':SPRSNA*P`BEBL-'"X!Y0>9]%:]*\K=@\7,HF3^)G?I5' MZE!H]:V_#;+/S!!J(@DKE"('%"/UAT#R]WJ70^3F4*<+<'%GKG;08.I&X,*- M`P3Y/X0!JL$3!PA48?M`#U?,&E>:DS<'EGH@`%GS/#_Z&&4I$\!<58*Z.N%$M[/Z/,T.6=&Y6 M0.I3!G`SSQ.?R]U3%&=\AWZ=GJ#*6#S5$43]OXY8MND;MT\`"QI.!,LZ4W8?),D&P+` MSCR/>^[*AYS\5C(I?7S6/>/1ZMODDN/ZS`2.-I*P,G#(`0&HSO/@YH+Y)-7] MCD\DXLGBQW09'%RU^]3+/]U8Y; MLDJB/*^N.%3P6/^[S*MJP^C:7>8#-PK$FY&=2U'?$ZL-S>1U0P]Z#NI_JCC,Q('8",=]L MZ`P9QM4>)13Y`K__P.GZ'V64Q)M7_DI>?4"N`TL32@.(ZA&9)UPM!.4"NGK# M+^G>S\&AW8<_:[=V?9TR#Z#,^'5>)I+/-,V:_SR-\AA7HMDEZ?YNQHKD3%1D M1#FZV0-9\3/F]LBWZ]@\QW).'HK3*/W5]RN@+794CX!*FO8>]>DV":"L?/W^ M+$/M_KBG85*SGKP>F<%JC>WNW0A)/[6P=+R19`!3(QI=7"P>.^IBGQ?>/]], MFH+7_-:=[ZK0_"D+DN:-R[2O95-%!S2>-M2E<"RGB._I-"Q^BE[X M(YXG:1YFHY[LKRLF*0U$FY"5XUR/XA+1;R'3\75"C[DEU>``!,*S MC>HK:[^#Q82U^LKUH]]GKAI@(QHW,-?D8+2R'+ZW2IA[@W1@1/EP M%M#N4$!I\+LWJ_$I2IXX"\Q].+)5&T_F"D=;R-'O7\T?W\FX[X"]) M;84`V(C!B&U+@!XIC-W+>`BM5_EFUC=59F2\'OJ&=D0D>)5UGB]LT2)QA5[9 M@$%O8SZ^K$B>\VBJ(HDC-&;+ZLG('8=38853ODT+ZI]U# M1I(DTG!(#7MWX(KK.!MP&LC!$(JXD48KO.=[?XK+*:TWKW_RMGMM72!2[%\E M+8?WML8XEKLEFY+'1WC1&L+^3/BSB/?TC/5DTDW8UZ<9)_;*$/=$JC=U+XCP M53<[2H>Z669$O)L*V8>D+B4$&`[!^`?383KNDK:VQWR(_6L\9/0^ M+3]GQHI<%F0'/J*B36"0VJ+NZ+%\.4?.%S)H1KHET5$,V"KZ#WM%3\FVLBRST/=PI6),-_ M)>1SQ-:3E]C4*&)((L4G)Q6^H>A"1I@?:"U#4]M1\2;.'C3A"30G_NJ``?R> MTUT40UD7]W[WC!OF=*7**`!+DHQQV,@+J2]JDS/TV:K_R#L`]JBU0 M!PEB.]A;2#J3-;^*!P^P*/TXSO+C"\_O@1QXN.$05H<&W@"%@XBXF)9X>CT@ M20<`2F<="(\.H`"=(7-O'0P#3>:;MSEP?Y`?K)VUVKO;E6-"CGC\&#,3J?J0 MPDI^0O)!IP.T.+YE'SDN]IFBT6OUN9M`N\CKT>LY/`*2=O(.*\PAB)$$#`X] ML.,$4V8**JL1);P0R,O^$.?'C.;"C!))LR;`)FHQ"\BHYV:`#R'1,>LQN0?# M9@@ MQ,Z@[0S!(Y^O-7H&Y$'X!.+Q=-G?@_XS0=B<05,A9%JM9@@6:([6,&D1!@$2 M2#IA!]?WE!>.+XLJ*?*."8"(UEULM<%(3GHV[BFW"^OUV5&<=JN:`P_R!7#UNW5$T&..UW9< M,1R>QTG)<:M7:\^(VC#A3H^*=ZNDQ('X.,A"5E#6"L`(<#JDQ\!BZ_&U[N[< MQOFO.1/!3ZQI5D1Q6ARO[WBS2D*F%*8)U:?Q#N1M';[M3%->>R>KOB,?]8R! M)JZ$_A-#8E5U%HX=Z_<^%!C$=_1N2W`?CMK*!#`@TM&/KT%KC+I8J_%W$B7% MX^'>HUT53T!A1&.H"G+J=ZPA@>SC,(9+DLU%R3^"8.C+-"[B**G/1R]H5I=G M_,20MHJ29JO(UB[VOWSP/,UX`S3>BEO:?G.]].!")Q"O*&$,Q>4Q&&J/#E&,QN#H+4Y+#,0XLF;@.`JZ/H_I_$ZVVZRZ M,>A2&P9$+;6A1>\M:0,D1G_:T.(HZ-Q`Z?SZ_Y2175SNI&D8]N0P&J"BM#CL M:XEN9-2K>`FZCM!A!]I4_.WY=")08_O4XEPC&C4>-+L M&T`&P467A-\2GSV@36F0.:!!P;M],D.),)7`5'"`\=+B3)Q;H,'1 MK"L`-#.FLAE?E`47V(YF1?Q[)>QZBZ.E'RZ'Z"F.&]++T:@11#V6JKEAU5T` MW[<[P?9I9%40_NIWQKA+7IEXV#8MCI+SJ(@\.Q=#IB[3#37 M$%]!E4T;<9=B.!YP([4W3EAI.?L?32XIU]Q-TX24%:&FPI@9C;G! MT(6H[`!JR$%8.33-[#Z^[)GGY;HU06M(XO`NBV;ON0'53CQV$-4>.["4%IC5 MSP1=?4;>3[U$M[K,#7L&@AAMT6X-N)QW:U67.S?$YEH1H!:8&Z6XZP-VE&K$ MF!(9_2VAUDU<#(\B`;FE+']K2)NHWP0/2^PHWB:RD[`H#<2,7]5;1MI\AK5S MJ0WYWC`S\UYR?MK>0G?:$O=/ET37_T9% M0`4;U6(5_+X(L*GF/0*!&SJ]2"Z0:E6Z(*\J/$M?>M#O?;Q(CN[H?4N( M^&345B#0+7)PZ/85\XQX>90\]]/7>S:VQ&II]%1ENK=[A"<) MSIOT+4&-GLJ<_U8/[_JE\X51:?^P./3R_H_CXS+_6^-.\%I@PP?\5*"X10\; MP9A9G>])<3/4^]S'<0XN;Y_^DDRRS)/%IC4:T3CLS+3Z!I#2>,VP$'$NKTB4 MDW4K-5Z9P:CN.DA8E'7QKJQF'UZ8G8@6#:#/6JR(4Q%E+"`MN8=OH"7"_B;$ MY.5G>)C![B341YR%4[CJ/[?7SW%$=6IR'!6-W3D`5X31)GP8-MI)EG&Y5VK0 M92&_)2GY$B7W)-L)#X[-R32GQB84O*L/\JM29V*"TC&D?!Q<$:/QE^2O].:Y MOR=3;YF;)]G.2Y7'8DA%J-R(WJ%+ZXR?#@XRK^R(Z,GJT#DP@X"'!G4D,)1] M4++5>153DYTEF8N;,EL]LEE?/R3QMI+I!?,&H^1?),H^14P0GU!D4#]/)N$(R^/[66#Q"VT&"F M$Z[",K$DY?\4O:B/($1MFB.([F_>D:@Z@I!,1?,(HDLIC)JACAX*:>)\4E0` MK9H4M_ZOWI&A&37%3=,N<@J.,3J:9A2$,3G600T,?JE0]C-LEUO4B8[# M1[FT^HAW*_VVWG&&CU:8S-XX-($<;$GK"')3=9G>?Z'<.<-%%37HZ.VOV_T# M0_&86VQ0;-YVV6V.EK@26A\)V6RW'1\-Z;&R).L&;!?OR(JF:SY]O5C`L)\\ M"M!N[QW1(^W_89E,LO-O#[]$.V3JD6N=\CERQE5CAO%*P=@>_,$P%_P?HP3I M,6$H*+U[04_O"';IZZLD,Z+G+QAZP7B6N'UL5.)F)S"@I+T7:%$(#.JZ5WS!EOPW6EX&C+K1YV=)1Y7_H,7#S-Q"77;IYZ^#`>G)K8 MU;N@9>;$TQL0TG7T6@0"`_NX?AXD.(]N7HNE)2D%X![PV1:/^F[>L)_'KMX9>$7+SFQL]N-NX#0MKF_$C`.]@G->>`X'R:\R-+8;QU M.*XYCS=&UKS?36',C\V]PWLL6PY)9!I3?AQ]2:!%*NW](\E(M"G`K#]C.GIV MO-W?.\ZG,^.@V+Q9\39'HSWY&8011YMMI:$.`++N3?/4QM@=W&@1);[AAM0V M.Z-K9FH#0.MT!C84LPJA^Z_VZ/9=]^VNW.VB[/5Z\?$ MPFX]Q)P[R7@=+_P6RP!YP9WE?/V2)/U MY>XIH\_[\B%2&XWH<:@!(VD9+K[DMR3QTW=S8U(ZWI+6@J'GK"C%H.[0/)DG M:>BOU%Z4/_)L&/8'1\!SE%3Y,<59E&6OC-5_1HFR<(T1C:;4GEY?[^J*^-K4 MC60`O849:*NKYL!+4F#4U&V0;(+@`)!KAD5=,"-3\71XT<;US`%\O*D#K]&H MRIZX[H/JGJINWI&L/4,7%2;E0\VFRB0XC2M%I4E\1]7V[LJJXN3(8O@I)YLR MN8HWD'II]%0)HMW#NU)I?%_,-EJ4:91RXFK1@6_ M)3%T#ZQV(_@QD=5]9N9TC%!1">^.S+2JTCEA'WD5RS)%1$UJ^75_\@X>L\55 M,C\GJVB7_A)-XRA*"SN\X^OLU00%&'SG,UQGVRB-?]_C)%V?ECF;=/Z>P/"> MP/">P/">P&"Q%5AN`D/;9)[1-&>^^+JQGVTA76\NXC1*V9J?W+%_V9_BJ9XE M<$F[R91T0].;O#^7'$/\V>DGFA5\];XCVXHY0(CJ#LWSX)*&WE75+12H@7B@ M_%$7C+5MA8RA\):$HXM9<[EGF^W*+],-S7;5W$]?ZQ]QAP?:E`;G"!H4_$FN M04'C93:?6>+HH?HTTI"W]:[1-M^;FHE$N4U"<](),^0S?2[AO%2-@U6670O$Q7=-<@<_\?VN9( M0@-CC(3=_0/9N2E"B&EL0R1D8;''[7<%7?UZ74V,U\7].>(/>!?OQ^WOQ^WO MQ^WOF;?8KVJ8>3O/&%PK5VES1G?\29%**+\FPA$2Q9$HIU('+)+=!(#`E"WCX2UM/+OT<[23UC<1-&EDW_G).VC= M0XSBQ*#<4-NQTTD+[K`1+J#DA6*$C7J@"N986_CE!6W_< M/27TE1"VRV6,QL_MW2!GATL+/L'6[]T\5J_1,1@(``?;QD)0H*-WR*TSS*)\ M[9ICP'C^'!>/E^DZ?H[7990,["BSK?=;8R/)[2>,,XNT3#?CA M4ZA\+1Y3>HR?[NE'!MGB5;HN&%*IA:K=V[M9&1EKU)5D(1][%/;;RZ$VVQ.L ME]5$>!DLDG%NZBL%=T]D%6]B-KM66+FRS_#::4>IV74:$O$.?E-(4I?2`Y"M MR=MAA3;E:4FKM7*S`^UU!J=%_;B-,\)MU;$D.#\Q-_<:JE_SD[)XI%G\^_'T MR)745>/8?@28OG?3YA"I=+HO`84QK"?3B::YG\2[\63BJ4]OK\LB+R*V;*7; M6YHD%S3C/[I6;=1@MOJM&&0)GVB/Z?&_3G<<]Q^FH3]?PXM#M`MCC/PZKHVQ M=().##0\,4<&^HED,5W?%5%6+,A,_TSB[6-!UB?/)&,;@X\O;(\0Y^0FBU>$ M?Z+-5"9<#+VOQT-6E<186C:\\_G*#%,E(2Y%<%.\+ M5%]T)^MUO!?',9%"E;TTR9B.K))BK-E^MQK8/&M@U,T%.(ZC[R.@/_OU`8=O MATN!ZB.-9/2E\W1IWP7S"R,69)YI\<$JT^*#::;%AV!.A>PS+<1"<)YI\4%^ M=K.8RVGN,^DFR;"8,B=OK`F%5Y'7H<7VL`'6'-V]*[/P#;!/!\?_7M>'VV.R MK76X,LW(\OQ8W6B\3&^J/?J/&'=E-GJ,:IE4EURW-&TBE/4::8RTS7J@&TC-=)`\S5'ZA2_*;[-=+E^ M(\UF<2;`:D,XL)^C15#`D9Q%2P0CS%?;)]_;J+_0;/1/S=O*:DNY"YLM+D]R';8[5#NW=7/>\P#9APM[_4&MR_PBUE=VG^S9>Z MM]222-#U*8W]Z?X]Q*%#S20!WE`=?43;_2)RL/D:&>&> MKMXM8I.[S/.2K,_+C#^_O$\_Y?+)VQ4]&Q,';@J-"1U>.-(G,%]EU-_2V'].W$2YRZ+5.'V=RP;PCU(RX)W1S^'I/LAVX"70_A/M4ACUU_]HX MTC9OM$\PT;[.)?]AZ&1P/J;PSI=S^K]\-W8IB5^">,)K]!WB^%]FMH=]Z#(2 M?W;KO?E9BT^VVZS:\%Y$ M-8XN=W_8Q[A_)!=QEA?WL?B1HJ`9M?8+1N5QOE9I#.]B.CB$[*.,*@5'5L_3 M[@-Y.K>/*YYL&)?4;\?`%8 M%+>S$UN*O[P92W'.+6B#6LS]JGRS*QJEU]F/9<3OT[U^BEY/63OZ'*\'I^CA M,&1K7MSP\FYGQOV\`1L<-[,56Y[_G'<]%:>8G+1^<]A5P14S$6/IAWI9`2;(/[R!T#D*="I*SP)MB0@"TYOGT09W"*W]E6]2F>66[^YMW M%:FN.$E>V99,1?.5[2XEP'_Z\,&AQ9DZS7G_I%+^\;>2[5$_TV)?C^_NB6U9 MSVC*+'#.9GO+Y27+<=:GTDYPUNGM'7PCV6_"7_J8)Z\%"1M M!:\&J'^(:<4A25?DCRNZV_-Q]'+O2$)6;.;_**.,<9>\7L1IE*YBY@E'171. MBBA.\C_XLK(?HRQE`,G95ZJ^IJ(ROJIY4Z@9;.9M.>FSQ&`;KY"S[+0%IEBW M\6Y,E5^(ZLT3,$[0,&T3`I!W]48%S6->T-JWGS+4Z\N4V=/=_E#J8`84BF5( MI?Y(VKW]>7510O);\DS2DEG&[)F9__PS`2M\R5LWWA+4RKLRFGY5JBL"0$LU MQ^^L_]"XCM27^0$/U/\NHV^CSN.D+,`+QHK6P-)P:.4=CS:+@WBN#I>'PP". M*J*%LD!4M6MO,KJ)(3,G:%&+M_.+=_@X,&?P5-V;L,Y82RJSQ^SP9,+M/6TEZ=:!(YF7:TBE_ES:O9>`7CN1N4>X-C^CEPV9YW=%;FO= M?T!XX"7="^P%?[H/H+?"5#)K942C_FZ:?9>`:!MQN8>Y)C>.;HH$LL4`)E^[ MNP,9Z.%?146N`7#O!>L`4F23:0',CZ-[$"(]\!T5OR7/-'GF=V)I06ZB5^ZW MG$;IK[[CX8.2LCTUA$K.MO[=FZ$1Y&F(N!AXP#24MO,V;K M#K][S+Y27%Q$J^IB3Z>\4V^^RO;U;"7MO&L*YIM1_2F#20;@:&VMDHP2GNWL MLBE9S.&&M=!$#;P#1/W%J<84`5R`@[11(2(>W/?OOK\L14#OJ681!IHFWE$@ M^;#@YQ?.#P#`D#[\Y1NZ`7S[P[ZBRZ'<*\;T:?QD>=O`8#%\>]QDSBB$'-\= M1PX1UHOVY^2AN$S9PE?R/+9_1EG,C=UM5%3Y;8(U1+-7+4I,AZDF)32,VOU0 M$_-N-76_%C671$];D",?[JSB1K2RM$9HX7\*K:A17Q1JVMU"1L[0RMK(1!\_ M1].K.>ZL=\,B#_6J?^<#L3\<])'L$5MM@YKWI^B%!ST.>[BSZ(G]4KQJB$%% M0B(5N*MW=PCWP17;::1H-'925Z(+/WI#AQ'8`I82G:FK%2W3(K\E M*Q(_"T(]H]$W`+B:]'P48&RYFFK'"'PM*16LEH+\G$#4ICDGZ/[F':^JT$M,W$6M3ZK$&YOSJZ#?;N[BHX+!'?M(T?HZ;>,#I?/*WD)UE_0*$CL: MFHX5B%LEEXPZ>KIW(-\(U&^=T)R-SBO&">M-K"Y\;IN$2H'>8YL+%;W7,DC@ MP$$+_*RM8A#28<)XV\!=@#EOY'%69OQK20+)4--6/&W89#X0TYBJBP#P<(@1 MD\"G#O7>9#'-[ND)4Z#U;H@J9_0,0KE#4O.!J&NY31:J'?*QL!IF(F&<['A` M6GWA1ZNO!/&"/O.!MHTPQCB/$XP)0M;!69SO6SI7--WRY&#N^X1P.^>TS/D: MF9^L?BOCO"HH6_TU(^)L)NU^-700[=VMH#^2E*Q?+M,5''\&FC1%(OJ_>M=O MO+PI:H:`*BN'.:Q*`_)A')\[6F68EA:UEMZSP:2J(&_@YU:%/YX` M8U[D#M/LDEX;L9OU17'62-6VA>M@DD`"O[%J3 MI*4PGA/*52;I-P%CLQJWET0#P.'78"\L]35<P6I29SN+<4FE1F)$CJ.]!!.XI"I_NIGPW\8X8=;Q'9Y;:D1\% M\25FLR/WCSA39+:%!&E;9:R/9K#/:%[P&S"5S5A_3-G<7\^B_/$FBJ$"YX94 M8`,O[QT8J*2[#SO1F&]*M,ZZM;"B&6W86#H$'H->K/5]PZ4]$>_,!3TDL1&!VM$6A$S7I;V1+Q#=XJ% M22`O#TO3GHLEJ4'O>"(COY4D7;VRJ5=/;,:K^A5.W%F1LKOX[$C2S3NXS<^2 ML,)P=K8D&7#63WUHZ^D%+:'XH!4M4T.]I^$=RA/8:8&TIC?3>R:6]-B-O@CB M9V>^2IN6L094--Z$!@REY4$#*B:6=(&PN]3UUK?#[%%>BJJST$>!.WD'M;&' M@A2$*_\$'FY)0&WK*L("2PQK`-"RLY=CFD%G=U@+6D2);]!T%>4R94@F><&O M@=\Q>9'UL?H8 MQ6I\5_ZXR>@3R9C$TC5;B^(G+@K?U3\:GFZ2*"W:C)V^*F[-:O0\P`K1PYOY M`KE3EG_0Z*F2!%P8PH/]T?G"U$X<0GN#&+]M=%#CAG>[X\"F]%X'T*H6X.#7 M<+$CO]@AGZ8N3L3W.P9C+.F.V=WJD:S+A/`5%I**I"J&;O?FI6-T-^_`U)XA MQK))ECSQ"\%()E#FK3UX>.8-9'NP.\.NJL-MG6)1;74(3PP_9C37%D&GDVKZ M=6/OFJ?Q03$Z)Y:!W@(AW+.K1ISU^@!.3E&K`-U/A4:H8D%(@)1ML0U72%UD MBG;5^*'#6P:N>.S_D2;KR]U31I])%0:0>KR('DV(1]8R7)3)/6'\]-UXQ=+Q MEG@=:11'$/9-QO<#6V,OZ>[DR6I5[LJ$9Q"<$\;_*JZDR/Z>D`HNZ?ID1[,B M_KWZ=U`\@)EQ3;[^X.[(>E<4,[]M)+DZ\?#<\1:&H@''V!=EEL9%F9&+^(7_ MD3/>KS>;>$787\[H[JEDX\K#3]9TZL]F1B)[1>7[,+I5^B:O#Z&_?S^%?C^%?C^%GN`4.H"` MW$E9T!U]B!-%04&P7;/1'?X>+F3DBX]JJFX6',$H2SJ`;DJKL3W&0YQ6LLH5 M9PN8+KUJ>.*F`9RZ"RK+Y:>OK?_"G;[KD1F]=4U*<7GKX824A1.%;$ MA?@`!CMZ>`7%4_U64`51IU'J@*XA&Y]\+7Z)&L8`2%H!.:Q>OH MC+6,5U54AF:\\ZOT:3Y\KR:\C.@0)"[D#_AIR\'Z33_,B$OR5B_8/`MR%3^3 M]2636[J-F0T^R7-2Y/R&P[]I=I9$3'#P"FE`H0&M3L\0)73D\7.TD]MY0RIJ M28E[>]=U$U105^("K(`&3^V50YN7`-R1SS1=T=T3*/-7_D()&_C$V$^6!RE0R_LC&9/ M_*^,;=A[-NA^>!A&HZ=WO.G[T^:2L7:LM89>=KJE>23&W-<>(3JCQ4P`C]F< ME7E!=R2[)`SJU93[V`L*.0!J_\DC_%*E;0E;E1_@?Z/WA%H M:`ZEDW1C`?M#+`Q+S<[B*LX5*Z^D96\+V&GA'5H.MW[PU,?;\G7&7!CXFK*< MC?4F>?/X*G1&H^S0G-%(&GI'I&[&&WK6EKEMLG&67)3OKJ"K7Z^?]G))US]' M6<:6AKQR,OR5Y3OR=[WANW"2YM7\JQ@06?/'BO.[1P:V!^:BKYMBMHH\6S=$ MFU*PEL0"R-6MV#OE[+4G<,(!L-UO=DY?CVWJ*9Q\B;(U+HG7$?U!=J\U7>]& MT!$2A8G!;J4.E?ZUFH`XI]B:\?#20KF;S3T-<`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`Z'0)[AN1Q[)I>J./"KQ[A.:C4(X^7C$8P]^O5CAX:]_0*R M?E&]$%Y`UM?`"UI"87`[8L8F?$\D9$Q/9,$%T@S.@.]YG'4A2H-)L[;N=*9% MS%QG*B+O.B.29G@Z4_%8Z\R?WX#.G&P8TTX51TC12'MZE-ZX"LGD&I0>]1BM ME>DOLS[2F?#3N_"N77W=BA?QHC!..(>"0M<<:LPZ*A(6QGFVJHL&AN21ZORRCY9Y24D&MA2*7^Y-J]0U8A M:33&3DZ.PC/:3"RK,&ZYVT79Z_7F+MZF\29>\8KIJQ4MTR).MSHA2XJT7W6'@[;!#?WM=J(XJ]!6NZ/\I#-ZB).XB/EA9\2_W/HZO26K M,LL8ZZS!9YIFS7^>1GDLO6KCG'[C$+BCZ]VH(1!$QY`C+!\>HFQN)G'HFY0"MS-;[5W"-^B=PC?+GJ'();#!#N$;^4[ MA-D^R"J:J_AI)HT>$GB&\_[2&/#4>I'))3P5;S0Q>#KP'WT?3@OC4]XK?;^? MS?HW7N]G?N]G?N]G?N]G?DL_\PL)H.]1Y?>H\GM4^3VJ[-,&'2>J2@#%=.E; M"&'3<,`NFXF_5$09>WZ3$6=JF-Z#QWKS>(\6SS):;)T/91TN-DY_DH[\'B"> M:X!X%$1J18B=(O+[(2(7$!/FL]R#(EW_HXR2>//*EXC]?0COP6$%=X=9R`+` M1C1J7&GV]69DCGPF"?T2L6_-W8!;!ISLF>3W;'A)(%>O\T`R\D[>K9#9YZ>6 MX@$,DA8S;8.$92*\@*R<#L,L'^OBQ4:+<,*6JAE&:3A72\F6:9Q M(O2Q;(.&7;'1;);W=Z&$H""\H'[-C-BJ..?POEA#_64 M;'D)V+#!+MZ/H?K\\JW)3NR7$++0+/%M)IX`=V':SX/L=V$?TW50*0^-DW=+ M5B1^YH[A41CO"0_O"0_O"0\S2G@(/H3YGN&PN`P'*\P9!16M(XHVX<0W$4OT M'4@C:Z4Z792TK&4O;.$=@C*^QSTD%(QL<2(8P/KYGI[U1M.SM,.! MLM)F`6[2!F<9H25HS7MW\M8/DD3:X#NV(_D.V]Q ME2.'UYLSNN.G%)4$;DG"HZ[\^"*_>V3H?8ARLKZ)7JNK0@K?Q0W1&I>VQ+Q9 MP[O5(UF7"6.[8N^4L]>>0/6O^4E9/-(L_IVL?^)5,%LXN4FB-#]]_?A"LE6< MDYLL7I';*-U*8US3#%I_FK$'\VZ4'0&9>OH^@$FWFU7;QH\]F_#2\AS/4Q*, M'7&D1GW'&,&[SDZD873*+P4H\KA3[2CZ&%-;G48^`48#CX=2I^\`G;O'G<2=9RSFA7PI!JR\H] M9"$F#V<#4N:6=!/)J1!5\;5Q!QMC_0$C=;/]1/0+R>JI[6(HD#+%D*-\KOY0 MR[*D0\B/Y3K(O]D4!OE*='%TW#DNR:Y_W#TE])60.Y(]LPF+!7>RW695EBN^ M[*0SNHT?9$_/ZSGIBD>NQ%S++VGH=6Z=EV(Z>3=[[F!"+44&O55ARV#_Q!7# M6!@&!KW5N?]"=;8Z@^;@5J?5TCM2_6QU(%D%L=5I,;?$JY.S"M3B]SUSCM5* M9[FDJVM.9?33T]/4>SE@R#'V>[EY-]L&7NYP1R7N'"YSPIPO9L; M_>#?`<-+6DY0XKB/7DY)2C9Q<<'@A-^ANB6NL]]'$/6NC*/L<$<1^10[8%>, MAZ&<^!TR:Z]U'"CH`.^2VVV]X]W3/AF45Q@[Y39[MG4'0EI8G(KQ<\D%=+VY M+HN\B-)UG&[KC.0IMBSJT107_)9>QI9-,-P]:@U\D+6F8Z MR^2P/;A*MILN2['0BR0HK2#6R#9WCLJ8A+-$/CB2XE#'?R;Q]I%MCD^>219M MR2WA8F8_MVXJWY-L]YUL"0V'N_82&P)7R[(4ZB4X!)D'M$2'((YW6V@JU$Z7 M4[*-T[1Z-K&JE?5M$`81QZ(7JZAB[=TTAH")-V(?53(1&\D_S]=(NMXIP_9PH+C5=%DJB`\40](*(U#< MXDX,6P]OSJ.1>Q>_Z`!WT!S$;:OE&X4M)*L@4-MB#@1ML#<\[L@S2;5@.^P` M`[?=]JU"%Y17&.!MLP?"UT'ZE>\R>'6FZ4V4%:_W&1-6M'\MQ/?S`A!?RB*] MN&Z'BKVJY@$4JX.8/'WM_(*J06=`:U!:3HN&=_.&1H2P)IRYO,":R')VQ,7< MM-@(KXH3CGU)Z35]`@H%%W7T#E4[V%$'XE)>E=-@K(UD'8;"AJ^TAAC<4`#' M8"IX&:`%P)I.72W\J!"0QJAVY08PGZ(TVE:/7TFKPD/-:L$-?PX**G!]=\6\ M$(`8UFX?T@RC9L"H"^0@A(Q;%H>19^EB>&55R@G84C?G27^/MX_)ZV'+1M9W M)&5;DN/G;"[(].=H2:6>L@F!H+1,^EFI*S'IV>A.--^8@='U=X$>'*39$_MM M5\NL00#,MKZ#E_.[>6W9_1P7C^TN>D9:EZK=<1'>LVC@PMK)TSAD;3 M&]\!Q8]1QC/5\AN25<%9WX'$/C^J,FZ*YDU0'VSFS7I])L5ERCX(N:)Y?O+, MA,ZM.7_P?+>C:143?Z0)@UE^&N7Q"IB_(97&W=+M[=T:*;\W=24;Z+8YP$#; MVF@/;.I,!?)L52]UH_$N]X<]K=19&9"-:-2?2K/OK$!L(Q<+"&L.ZVAY?*)Y M7,3/W@'-M#>K]C]14NOL_MRR*++XH2QJ;8Z2I,Y=:CU(!<#;`<7ZHUI1FA7T MW145N:&'>\\*[W:R<6_LX8&-[_A1 MID:^@=R7B,PKD;8%]A9S]#(P\[0`&$#>]!94(&[O8.N\UQ[/Y$L MINN/Z=JWD:\F?TN>RFSUR+-9JQ?+BYC-X[S,F`FZJ1CE;S6#V7SZ%-JJ@NT9 MN(3V,+$249>$EHR:KF'HJ"88J!-!R90;QU!'Z[48L;8*/^RM0EJ5\/1N$ZJ8 M`)OU.=G_>9D.3>0M39(+FGV),FAA,:32#@/I]/8.?=/Y]N$O!= M[[6QT5=X*YFA?5HQM8$IT&4&MA4>(5WO,*5W4(2-#D#L_NA_*F=)E.?UCEGV M)KRJ?7^"PW8!Z)/PRU#]68*ZT1Z@JP$@X0!QWF92>@\`;E@+2M0@'!R`7YEJ M3%&%A?X@;5B(B`>(A\-BY#OM M(5WYUT&0[6C;MU\/MQZ!N.0IG3DSJ.L?V@RVWM:#H2&((1QN5%B\^5Q M&T$%ZWIC1"?SO'680[O@`%-OQYH(2RZ8F!,I(8P]`0B$)K8:-P[DAJ&$,BDH MR85F4^331AL5C/1,K(J0+MZL`&R]&;MRLF(N&D_,E!1EU>R.L"'=;J$)ILX" M-)8,W!]C)62R"(M0@2^1C8@38UM/9W65B8SDLR313W;K3Z]G?-\CX! MP%EG;J*XFT:!&=1@PAB+U97H6/<5%E$B-+ZI/+7%%6^^@PAEEG1D;&6C%`(O4Y[&-M45,8"QK MK14/^'Z>%N66EP%(R;I)M)>:$GGC0R4,<2/O",89#]0"U=X`OXH]2PL\*_-#_`(VKM%,[XA,I)1P_("O#0UU[Q^ MY26W88-?!D\R"9O,&:6(2?M,N_^KX[ME\_HXL+QLLJ.=?CB]S.C_-`M<`V5- M[]C8)#_9E[6\:5`"1Z;U.C4JKV[O'6+R38[1M+4V.]@10G\O:>#SWS^2]G'A M1;8O(1@E]?'A^M]E7O#8H[!@K@-RT'FQ#B7O\+2P@([EZ,XBVC,6NC*E)N*!+(HE4P?[ MHV)FJ?E1!TN$3XL"NPRSH01-?49W.3OL\S['S&*?OOZ4$[9YNV8?.RHZ,#FC M*?N'DOU;_:/ZN3>WQ(^Q8"=$O9L.%'CHR-)4IZD->.O%A)WPM"A#\GYB8J(. MCN$]]D&*&W9'.%^9J=*T=L*-V\(SM^[I+5FQ_XX3TI$/+\*+DKYBB9IJV$-F MU=C#>?N`YX2A;A57^&9_3TAE.]+UR8YF1?R[[)*53M=#T`#3Q;M1FPQ>U$J: M@(T;F_NV]<-QO2B3-PPR'F15IQ(JC)<^`;":&-PQ1/&BO9?Q=%#G&#<%S,B:J`+.P)U2HKV?<_,HX6F0XQ4'0X(B$;#!E@I$;#0'[Z%D3`G=R*X+A: ME$D!]J3'^.\(P3Q#XO)@GC91;R)GZ*K\XWM:I0!GY+3,XY2PA2MG<]M'S^I? MH*(U)B0:-=+JZMWX.(80=2-#K?B.)J]M$Z7'X\)J*`/B%!Q'N3--AL3EIDF; MJ,<[/4\UXJXW5S3=WI-L=TX>("&JFA_N]4#-0C4OIC"@VK+1,R6:?'7O$$'\ M+,QLW)5/3TGS'EM]$'69;FBVVP-+<3RKU[LYJ<7VPLY6>3'=)0";7<&-4X*M#9/ MBUK&!F<=3#SKDDN"['H+DG7=(NHQ8Z\IE MQ+@U@I5%5??5>_$*]:A5J.]6^8@MK M\[0H`WL5I\Q9/F,\Q\5%M.*G5*_]U>:Z>"09DQY@3DU(U%]4KZMW+1@OTFDA MP\E"G7H\6FM)<+'.G@?&%X24C:9S,570!\RM[+3U#GW'296P(,;-INR,NS"( M`L<.3`AE!D>UD+T.EQ(4K;T#=8P(EYZ,)HAS*1E:VH,UHJ7,?L=GOKT+="_G MR$TWWXY9^N(Z.RH#,(,[J@G!_&,4ISSP=YW>10DYUF&]2:*T@'+ES3K7GPK; MR3MZ?81ZC20:0.@7R[>U[H3EX]B%5O56!TVB3JK9!J"%HY;M="?G*:MX6G&] MJ-6+26%%R#J_8)"1OL,]3.K`]3MF=JC:AZHH#J)!^M*:*`2$8&Q1.P]!U($' MN,[X+BLMI(G/.EWA\FV"+MYQ[S@4I!3+N!$AT?`+-!"-'K5D9].SF=RC[>@>QCOV$BSP"V&TBVK1^(#4MQFEL/%S0[OJAZO6G5 M;U?<>E%W[%U[D77PKB\C.CS:\IK,XT%PMC#45V7KTC7_@ROZ(/M[AKQM<-9&%95@5.:2K=[R?]@\A%E%6^`8MX-CU M7$(]7QWH+/?6!YV\XW8,?UTNF@D\]@$#"S/"=BN97J!3DZB3WE7&*P#9"8'GZZ//DCWKL_'U/M" M,5P?S\J\8)OU[)P\T3S6<'J@CJ##,^S@':..G1V%2,9U=(:#.S.Q(5WLT=U7 MF14!MC0OZ$'%G^BO@;SX?L(?M\_OZ0VS7MGUEY0-PG#&YM,S$KC&S1MX<#OO MX')>HA$KE+&K-$KX@!Z2__"V[(2S3^_,/['C9HK/.N7[H*UW`*\W3>V[L\2JP-&7,`^)$K?_^ESNR_A9P5\<9I#F4=$Q\41HVR1>8X/:K:_XA M+9YITCI>%=5?\^TH11#(UH*G?KY6$/"LDB8OV>S(^KS,F'!N]EEDO)9=_IE\ MJ7Z"8AUZG9O:ALA.B\2UD<0F@#J6+PC]+@\]IT;_CUF4%MUY5^D)U>0?L&4] MS2FU]4*7PG*5Q$J64VF,+I.0^K@XD/[;-P,,7+%_V/\F_*F##_)2D'1]O,PX M0,A#3"L.2;HB?US1W9Z/HY`^[IX26@5->8R5BROG&4`TS`BG]G,^B_,^)MX\D9R8&2R?VMIZQML_D4MPFB MP%I^2(R.DD,*"'\#AN0Y(6K#YI2FH#B;`2WOGIT<$T`]-ENA`8Z;D!>H!)L! M#XMZAAPK"YJY5PPI34W%`&@M3S$P0AM;,0`>QDSJ\;YHT]TNWN=.[;T8[L*P MQKP:J3?=A7E2[F"L:#2ZJ=?7GXW#\*DT:D9$="05DMDR@P5U)"XH(J/#5,>N M:3*SW+U'ZZS-G]TZ+?,X9)O&FW@5I47]PB@_ MTJ))['4_-&1%81S4'9H+29*&WDS#=;:-TOJ*#0^K,\[6>^U,UVU\7V\$&_D6 MP-.U]'.JS(TO-NI/,_WPWLTB`K8TF.\#W44#Y]`VM-/SOESC?4N>25H2?M>/ MB:(68G,T5T9)ZW:@-PLNX%%NP=4=:AC*&KH[/Q^.@CPGU^H(3BE,+P[QC:B% M&``#`X]Z.*%&CK9A>G.$3K`$0W22L,6DEZO!^R0;0DY)2C9QP9^0\7D< M=9*[%+2GBK/+$=`ZC="D<#UCP/?V5"6`L[AFL"F'>4,;1@=/Z$VH<2=F2 M:W3-F(QWDV,"&.I>@.!Q%9:Y3C$!8Z:6:^8N4_;_;']'/$:>:PZ4\6:@W2'B M.OC=8VRYYD4GMJSNTI]IF*8#_E#4:+I@1+DW3#>.+"._7'7^&&5IG&[S&Y)5 MEQ^\:76?$85RJYHWB>I@,V^JWF=)I>?*]L!40])PY=>B^O,%M!P:JJWLDB&6 MJ^FML.MMG/_*TV]^8DVS(HK3PN=9D9`;5;`1TZ<)SLG;>LR%8PSQF"__WIQ) MG0PX?-?#M@S3Q;NEP'U8:B4**$PI&[J;PX89=(DX>G](]OMC=YDCA0*#['9_25;7W^9RPF#>-^*4!"95DPK(T^A^>.A*/ MT-E0LM%[,%AC^.5:GD%U0U\:]R.EZR]QDK!OT><)?<)B1*,&E69?CV%-B#EU M=!/=\Q#D1/3P;G[,OCJU$0Q@@;0XZ89*$1PLUPC=D82L"K+^1QEEC+OD]9#O M=AX5D3>3-&2G];`*VB@94JF1IMW;FV&2N.4A\5+0PF-Z693F MGVE!\OLL6I,F;Z#%)-X!LJ)U2$\SHN'=!,F^.W4K(C!E=:*IC<;8W5;06&5G-)V<74F`,OW.>)EW:\WZL>3P89-[7%!`^\&R>TG MIQKB`.R3$X8ZU<`%C"S77)U&>9SS]UJ.@[R;JC=BJAQ=9)OH+N;(=RU#\OI& M,[(C?XJI3+3[:2S7P%=5GJ^KF?&4CI^CC%=\]N>/MCSE33L9_98D_`6Y,YH7 M^;'X=/.(G<*ZNR%:H]B6F#=[CF;\M,VXRGP[HJHK7(B:=^/L"&MT+`D#1MB. M[;;UM69WN<;VECS3Y#E.MSPBPF;.`R!>[[#>/=*LX)9"W=)8JQK\2!QD`1(](X=+H1596Z8[K46)$W]>;UB-A2^32H/I)IAV0< M4%^0FLT=,`^R(=N>@F*HY1H(/NEF0_J/,DKBS6OU,,_^#-*;?9"SI;`4>IUK M`&$[^7L_:_5(UF7"++F<57RXRP'%QL&RH>3=+FGBA8XA0/OIK[>9Q';"*[V)R;^,BK$#"G3*W#=#KD6JN;>[!G$&MY^&5!0B"5, M^X3^YM2%;,#L"CD3;1ND-?AR;8C/)-6Y<2,INRO*^,W^AQE M`#`&`9YX<UB'9 M39<@I*,*'+"Y#B;0R1=QPOCB[#5=5<$P?D>+S;IX;24PM:Z^M0]%1%-YXQ0W%EAX>`%7=2+)P17H8AN62J^O*_R2L(!J!=!PV# M-G.%@WRR;O`P&$,,B.^F`T0SAWM&5H`#T<\]&[?_:7Y?73(UVX_=)2W^QM]/ M_XWW+[9_3-?G;&LH^=C"=KVOWFLSW\\OFZPK'/3&$`/B3],!XH0QM>:,7231 M5@`$X>_-0R+=W^;WX663L_W@/=KB#_UG#Q_ZG.2K+*XXD7UO0;/^9^\TF?'7 MAZ?J#`2=(<18^,MT6#@K,R[-BSA?12)/\[I5_2.Q+E-"7KRSPO228`":I]9ZL`MIT?7'0F[V;K`(X% MO5D],7#^29.233)[O8@3DO7OL2G;=8`R:#-7@,@GZP88@S'$@/AA\B##WM3= MDB>:\4@FOU11PKB0-^^&'("F`Z(T`X&#R".5-^9#$JXN$1OV0O+1-!P.=W^>*`'B2;KY_ MAS[P]2<,1]96BNYV-*TNHU5W0_+KLLB+*%TSBP4O((A.W65$VF&N@-$0@Z,E M13H@`"D/T<_CGNN"_8O($5&T[$5`!ZWFAQCC`-B8,!#:96T?IL6A M0]!6B(].N[DC!)ZT6XQTQ@%0.LX5^%($U?%'=/^<(--UM1? M$3"RC9)/4<%S4NIG?=D"PF2.>,!;JV\C!EP?ORJ+^JS43A`BU96-VRGHA1MO M:?E*A_H0UYO+E/VKST?=^/`'?I1/NTE;%TU%8*"5OWLW44+R^JWC.Y(]QRN2 M?R;@I61YZ^:^#-3*>\ZDZBM1W:D"J8W`.)V;+!#]\33:RXM".=/D9G[*%UYE MC9N3,:!1(%,\)^PKK>+F9M+)C@<#]Q5R4+-&]!<*0MK/N]XIOBRUEP:@B.*! MNT\GH0>[_BKH7OYJ]6CK M*QZ38>ND[A>E)B*`*OWCQNY4NY&-N:@ULRK<^YFF=%_X,MWNO0FU#R-?5R(^J)P MI?`IS/Q:/7\V`,A9>'5ZHG#GV2G'711,+]-GMJ+R%6"_(#1K+.C3R)L?G!NH MF7=$VG@YJ+D[='>@\:P1^,,>@2G9<@/L&X.]F$?,-E;%)\98%D<)]$P"JH\X M--5OZQV2QN$HZ:Q=A:#Z@\"7W&9H_G[,:)[?9'03@Y&F88MF]6W_XAU$&ML& M>$KF>X4.36<0H464F$,$.'$_C=;GY`'8O$M:U#+J_^C]RQOX6.I9VOM3PC$6 M93P&2[K MH;%')"0-W^U^&\%'LR,X"P\#.][X'\;&^[CG/HU><$B[7RUK7!?OF#/U7PPD MXLBKP8WL#(=V7O`4IX!&IW]:IWX!X-2A]R.3PW@^4&]4:WQVHTCW(<`4Y0M) MG809>T#C.#\XO^?/,S5K7=VXHCGH0,,M&P,F:N$=/AH>G7J*YMZ;D/;X4`I< MX";9,1;?`#D<7,!FAEOD(]XNV&?:WULHV=R/[_B>D@W-R+[=??1"\D]QRLM( MOS8'+LS%ZU+Y^%O)?OY$BD>Z/I[20);#`P>=_/Z)1IZ3XOG[).;:.RG/<(VB M&2[R!XG4ENZ4[=S@`Q]%ZXYJ"5K-3PU44[6%K(`^7,EHABO,9U(KD.8H3 M_K[C/6U=EW^D"9MASE]57P&P,Z12-$7D-7O/":9VHC&'K_:X<#VF&5K-CU&6 M\A<>;TC6/-L*@E?:MBG%(6XS)R!BIFD.-X"ZI#(WESR3>/A9D??+,O)8M M^5SN'DAVO1G4$Y&AS8A&_7DT^\X)G39B,4>MYJB2LE,S1'-?9<_CI"R.E\P5 M5K+7&K"3AU9SPB)NJNYLY8&^I+#5#/$%*%<]6U7%+$LJ0L`:W'C-6IN-$;8[07@QP@XBR)\IPY M=7S+>_(20Y%N9?L^3H;MPH%,]].+P*&8I0HGU0!"1`P)APP.MB*02_97)2H& M#?MP:#7P-JV3/">%JC2,N%$]G?Z/X4!Z^`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`%T MH/]S4\G_\,^!8!"W/`.SL=C"'RDNS;)F)5FW*B,I(]_R]D?;![7S#B3M[![4 MC&T3?*!!QH?;S'9^MI$BDVV??L1HIO:@V7):1Q+1#B0ATM&3OZ`(Z"8+JK$CY`BI$9I'YJA4JVD#TG,=*9VZI+))=W& MS(VLPQND^/BR2DI>-$D1"]+I>HC#8[H$@C[<@FD@!8OX$FZT1=G!RM"W]SN( M]532O+VJ"IMY1Y]>X`DY7ZNX$SS&O*%U2XHH3LFZ*8;8.178Q"NPQ#F^8RU^ M3`?OP-/;BVK+P&I;BAEM469/%7]4;U:EW9`7W`-`I:/T'XPTQLD``D9>E!MY M7G-\'[T<'!/Y.HWH<<@?EK3T#D_T3A@_8=,ML70$9T]%A71`A*VM99K[IRJO MA4_NFORA4H9UDI2,8I"-LF__@=*:N=5=2ODXBWJB=3]# MJ942FJ=@L*,V2&[V:PNS/>V;/PHO&FXIN'05SK*EZ4,K9VGG0HO(+]"0*)9WYOO[\;;VV%W]3)\)!JK>R2T3KI.\..%<[976W*U,EVHD9S@,P8JA"Q@H M[^LOH$3!N#4)\$4(#-ZF#L*FM5X2.J>[*$XA.P8V;&R7H(%W+*F?8J(:4U05 M7>D/TK%0`N(0DCYX?;:)9/Q0MUN4\A/A[P]"X49UCR;N*&OI'2R2[T]-9@O` M93A,)_(H(R\#S`P7,EZQ,MX_Y\!?3J%I$:=;DJZ8`"`KI.[1*A4*MO0.-9ND M#[P,'.9[2`<=$Y;^'Q^]J;[F(RGB%9N=]]?TWE\B?7^)]/TETO>72-]?(GW? MY,QWD^/76+QO<6:VQ9GMNR&+?`*Y^^68?WR=5?RMJW<';DAV]\B0"$Q5K[/P M%1&XDW<%PQ7]-96!?LE?[$CCJUW8#A*D=^:>T55P#T4P@C%7Z>^__5`K-/^7 M'D0J/.0G9?%(L_CWJAC3_OIE;;7_ITQCVE\FK>D(U1Q+(AR<"97>H7#P^F\Q M:"!H'6.IZHL`M41!G5"8#1Z=IG.V78J&(RRJ`(]HLI=Y7FIAKMM!@K>FX8RQ M!LW5#M_[LC7"(&F91%U1:,T:NM(@>0P#. M=HW%S]86<-C5=:9YG(.92I=616L(8#-;5'&S=`,L^7(ZT[2ZP2RORR(OHI1O MD;#($G2!X-5I.E>,P?-U`[0.?6>)=X$D&9S'^2JA>9F1N_(A)[^5;("/_/6* MW%^608\156:!HGD3O`:;^8O,]UBZ9]_PE(WW*W*F@_;`5%OM_.NXZFM1_?E" M:@X,U8F4PD.,%XWVK>EUHOI]%J4YDP=/4O>84M3/_/I,"Z+]LKVH$WC/O-LX MH*OTG+'C9U*:`]W^4H$(^_DW%[@O+;V3CY,*^JI^FP'Y=7UPX.6:EM,RYS4P MG>8/@R%)+I-41,UE'A;Y-UY.CL,4JWU8W=CUE&LS/*Y+S"1%1,2!S? MK]7HZO/Y7B6;JNV8$0T-,85@I*P00=W("BHOI<%2[\E@'5:6;+PNTV>25U?T M+U.V>25)$_?_Z9/WO>`(FE;=YLSM8R182,K0H?7 MP8QH>+`L``00E#@``!#D!``#M7>MSVSB2_WY5]S_P_.7F/CCR(]G;I":S M)U)I3M*$,!"+".CV/"3]C#+*&\?KB>6_^\>+BQXL>< M],I;$P]'#,^^\\&W-WB++.SB+?:"*67;2[Q"H1M\//HS1"Y9$>P<62@(&%F& M`2X0A%Z.)$!LC8,[M,7^#MGXX]$F"'8?1J.GIZ<-9SHY/3H\S)I=X7PN?>88/)\4Z'_'72^3CA-P+MVIJ)V`C_HT1 M4&!&[)2!>@UXJ'=+:!ZO7QB.MYG%2M?]G(?0.E2TBX(35&$'8&%CMT1!56ZV`A7ADR$JY:-E6*6#![E#UV3'<5A]@\:%__P9U MC\M9@"(6__'EX5K?4XO"75([Y*//V'.NO(`$+]?04-E6%/;((M!_:2G2`B1% MR&KD+R?P/^O82OCS/Y'G6)$P*R?MYU%91%EZZ&-GYOTB?I?-&G/')#K.4E_0 MG+'8W-1\\=,$BOX(72"7=^'S#<9!A$CAB1Z!4X[`'(R$8P@FL[OY[.;ZPF#.M"UFOH!_;J_N`)39U)K=7SV,%]=`8""I@60> M4/OKAKH.S+NN_@RAYY?@49#HH3IO`=7\\_CAZO/LYO+J8?[?UM6O7ZX7?QC0 M5*!-D+^9NO3)CP#*_M2#\;8%&)/Q_+,UO9G];MJ-VBDCONU2/V1XQM;((W^) M@H,#=A'ZQ,-^#$T]F0ZRT\@YR(3`'WDYPDE+)!F<]#C-P^T6L1?HQ,C:(RL8 MIL%AMFT:@I/KK>^I2VQPW32HW@FH1B+M>C*R@FV,LE6(MK`JH?U/IIU MO?"Y#XQ(.]ZUE4%4TN@A.Y<@2X1$,Z-$C(%'#\\U:.NMR=+%8]_'@=2^I/=Z M6-Y*L&0"K$B"042/R`-^I.XC=#%W-,#WZ`6!Z2Z0][6,3"6='J%W$D*I((M+ MLF)1\()+,VCIT;JAWGJ!^:K",E"A)+W7H_,W"1TNX)A+L+@(@TK#-N3R)0&8 M\P@B2685I'"VBN$/-@9/;O,9MO$,-E M7*3W6E!.3R10$@$62+"$"`-)S3R5Q]AF.U%]8<+R.V)0GV7'N8I,#Y`<3Q!R MK%B0F-LDH@Q0-6UGNW/I"Y\$3J@7,.AQ.!#PVP]=/H4?KQD6D38)NQ:<>CCE MP$(FVDIE"U0SZ58FWD#<:.0B?V'G!B,?SY8N62/="*8DU8,HAQIRLBPAS,I) M,YC58$:W6Q*(ZATU*E[G@5@1W-.1ZC&3XQ`Y64E[RZ09S&IFN?#I=3ZA0?5& MCX@<=\A8C?GKYDCP_U$26GF&E+S0&U\.*Z2$7T!4A8@ MX@6J!8DZ>CU2980R!?U4I%63J9!4(_@ M9XS<8)..'/1SD.D8BS4GFY@8U+-.CI MT>/^0)+Q]:O8#/;"PWM18Y#:8PVU'CTY(C&??+ZZ_')S95U?PU^_C6^^B$18 M:WQW:?WZ97QS/?WC^NZ3-9Y,9E_N3&[Y?O+'^N61-I[ M07S!LUDZXAWSZM`^[XEV]`F#=8M3:Y/&85K;WA)Z*]M>67X]QW^0>@WO_+!\UT/4, M>F1;9OP8(/NG_E0`6*OWBND%F+^L1%8Y.$QXM M>EW6)@RD_3:P7^(`$;?I/O:$6@?CVS;;V:V?8I$&O[V$J2O@;,>L1[=?H-K` M_0IPG_7"^ZP.\-,]`&Z=&LA;'F(C6F"77,!*M"K(M.CUC@;P*#5.AV@ MZ/[Y4Z;]]DZ@TKLY.@X]N*U3J`R6O7.HJK"LY]!CV3J+RF#9 M\ER?RME[Z;T>)\TI/P:3?9WW4^6U-F33(]CI]!^#;9>TQ0H<521ZS.H2%PTX MG4^7J<+2<+D/(!I%V*._V7GH$`ZA[>:4`^9'`+-Y6BF MHJQ(ED&K+C\STW@6;#"3[^%N1JO'3)6AF0FSA#1S)7>+[4V1^;/KAM6O]*#( M7DB"`V-WU_K/*9$P]N1Y&.>QJBIQM@6K'DPY[-RT\S1`-^]&;1?YOEA_$9[BZIX!RQ\8L?%6>41L`PX] MK'*:8%DDW]4EA%IJ)[,D'O`N9O4&^-,=6$^GA4B1W"2EQIF8FQR#4`2%-&EDF]A&E)3I"Z03WP^3E-F73@UJYY[%N$X#9N-J\A6(OY&$GNHZ*$:?X M\[TS(7+'SK_#R'M0-=?&K%J8%6F5L6PK)SS=)Q"+MW+R#MZKCL6@X]A'*(1P^AZ8#W@&7E'J)Z%CV:&HU7<&\O:K]5*(0DFCAZ_A5LT?.^[P\^C9=SZ@W8YX*RJ>Q4\\CT8J M1`_Y,[+=4198'MIB?X=L7`#Q>7O-\R&9E M<1DK<'4JR`KY2R$M](_7".V@,"#AY/3X_+2R%*($2L81=@,_>7*'B'; MQ_:;-7T<.9@T+D^9A__H5(*\8AQJ?T\F$;(ZE:A<6Q^"'\(0$(2_@)T;#W<V1% MOW?0EJG#N[^/1T[(XO4EC[@N=[X^'@4L!%&!>`]=!J>W^8(MB.!,&G7B]-OB M,<3CN)`YE6KH,K6BHNQ=JX@#/@+.2`.U>`SG$3.T)"X1!YA?;W>(,$XQ6Y74 M@+=".WZ,ZPUYQ$ZE$?8J=6@FT^CB5RB3,TTG[GTVANC=$KF\"X$7>$D"O66V MU`-/B;TTL,W8`=@#<+&\]83ZRKI13:)#HT;AMG%;V+ZK M/9[XIM0%%4GHLR*^JY-:%\CAAY!?/>^PY^=]DO*+ MP2H01YERG\Y6X@$@?N5!P5[NXUP_@(8?+`:S<'@%37,,;VVR$QO!&)[` M%)GP02<:L@G.#UFO_J5>)I;&QLZ-(?*K@W8VOQ<"II3W>GQ(B]2+;1.1S&#` M^WU#[,WK8/%M2I#'**F=^\:H?PLHZ,='HFA",PE!3R_(*71#D>?'248UYNTF M\J#KM%KE2[R#>A'45<MMXP?/RZ1\11^+#RJZ'YKKGT\;N0>UJS MU6\TP.G!Z'EE:DGSRA%P:]8PP_V^31\<2SYOC^CX08F1>\E_??$(/]X-)D_" M$2LHVISI8"JI,K,C/\$H&J"6>*CN3GW95>VT!=/P6G!MV5U7A`L6&\*BW?PP M^E#6#O%J(8=;$VZA6=O0>LDAF"[M4RABL62*')-V,)Q8B7Q;X.;B` M,?AK7ODZRL*?^(N"D,&D@]\FE5--1]3+@WT%%9+! M]NI/J(61$T]L:'RY]%V%3C5;_ M2C',YBP'I.U5R*A#X1.LA;XRTP`UCL(8,(_A(3M!KM"PFFBP&J4C=!R,C$]` M'MLVR';4`:(.O,.8Z^S!+KF5ATL:+H-5Z":)E"TLI)7RH]CJ$N\8MDER'#!, M>\&]_0N5W.0^0@[74M6>`$7+S+WG(*U'L/G(]Z\W13EIWW_:;FN@!1_%< M/,?LD=@XFFC4&Z.*;Y"5(^N\XA,,%S1*N/CB.9CE7)RMY-GA#*%Y-VR(/>"[)*IZ5 MIGDY.0/T%S6TGB#IJJY%D!PTR]WKR)OVV16MV$:G)O=H/#G730^'[C& M3>YT'#N.6,U#;A)PRMY)UN@O<'@K3"TT$R/_+?&X&Y"[*B]*_`%2,2YD^F>< M=S28A\M_0T>RH#Q&&>\5ZF;?_9?B8):PFUOI@GJACZ.W8"*?!]C\L1^[9XA[ MMA/J1M?4Q-N<.Z'1Z3O#'!$:W0";;=.1?85^8@;G0W301C65["FGYSSS&YOB M!N8*O&S=AHX<]^'6AM)"55O&`4Z@KF"J%[SS8NFR$R9[E]6[!--25 MUN8Z1.-P4(BJ=.)^35/T&GG5RH@DFCCW*\HO[%0K&HHY'#_EV8YVF&]A?"=< MB?@>RDPO$4[C_@'\<\\(WVQ\0[;%I+M^8@XF)%&I9J+AQTCU03&DBV:,1V0)3BP<8+I`_+6>`K3<'FBKB4;WM1<+BX- MY95:/=D!:#7SFD"5HSH`G>9\!M=`JP+=(>A%GIMHE5$=@$Z+#3C6#;0JT!V" M7D^TB589U0!U$FO+D=<'(S3/4G1@!!.[YZ:,;J-]<]&)2$67NBWG8&<6D2)^ MONS-=AVVYARJ":;\G!,L=C^7MT=/PX"'AG)9!K'6"QH@-YTGY*RR#V'?Q5#U MLKZ=R)?7!6^(0][#RK0)7>#++L`;']">9[H:MT4%(,3Q=*G2<0 MI`APRZ^&%J;\C)$;;-+Y'U^GU(;L&](?E)JJ('Q3AB%$VS^'O(FD73?A!^;( M#4I+-;A&=>6L\06A/%E(X9,K7@Y.@^2&%A46BG<#+#\)"(\%\?W\Z6A84$)- M<##AHB8W%VL[PZX"AM8[MM-#U5UVEM"S_WR=]:M,FP7V^9I;LIE=:LBUE(-K MUC=0.(QY$B)?2V2,S_W%:N(,!"&N0G3FV@/X7T_(+2U.=N(>X`HE7SB>K:)= MWC4UNXYRF#4X5^HILL5A:W$Z\@5E+#H.!.W@3?!23#Z1SZRN,$9_L=VS6O:Q MFZ^-+N+TH@4=`[M3&@7[B3F8!?9_T@B9ZQ+FB4,]@V+&#Z&R"[$@U^?0" ML8>?X80TKW=_67D[?9?=U8D.G\EZX[ZDFQFQ,\<>]#JWR$/14)WNSU$8H`US M'XU?9]"+#UCE6??5&[5T1(,:&)W!<4-L ML98A]T0/F9S%SD7.\%HE-8@5B0:.EAO()L>U9N[M8KU.9M1K$ M&V8B#:(_FBJO9#THY>-<[U@%.<.\"_/@#,#B7;)B9XPX0LP?A\&&,GX/9+H? M88YY='+\?R$?>_(FZ,1><#H%SS>=9N2OF8U[YG0_G-:5;LLX-.=:5W[5P-R0 M?@@!]WM&@8.GI9:'H=*+X0T^C#X2ON5D2EE\G*T_6XET@+C7B+?G^D6M&C,- M-7D@.7LRNV4V>5+05$=U,/X2N'@N\GUQ!9%H32L1>/@#(Q9-[VJ"N1WYA]`R MB^D\Z2YL57I#$J:>8ES0O9N`@01RNIL((.5Y#SPMO$DPO]YDK04.-M20*"@K M-H?A"C?1#DKLJVS67^0!]4J]5;[#P7YM*`0>7M/MH7',G"0%[M>XUKCON=$%%3Q.+\;5&Z"GY-1>$&EA*Y=%"#W&!81Z" M54YPSA8=>`<[WA6S@R.7K]CU5E(<3E_:+'GZ,"]FT90Z7>)IIF2._$"T+7M: MRK>'6DV3FX-J("R3':JZUX.=T$V/S6NT[;^4E-%#1H>8H1-\ MV+SPX3E<=),`X7;"1B$\MA=3:'Q8D>1:YVL,^=/$^Q:6#XD32Z.(&-U$7)BWPG]^\@K67^V/8,TM_D4Y. M&*]A:%D73_+?@ZP?WFZMZUXS60=D-[%6&Z49%==WI<6U!K2#6V\3B]3\9H#" M\?*YQ.F+EXPD[E#$E9G1L9%^ND];?':\`K\^=Q#?)5_ROR1^?)ORC%UB%.1O MW_P^G\_7OH'D>W\#0SS@@#!>_UR$07SH:Z# M&6^"92WR?6V%$]A1P/`\0UZZ:]\/L7,9\L@;=#31*!\E-D[Y%PD_L2].=,S6 MT/+FZ"/E53,C&YB`-W\^:$H@EU\,#CR19LM/J&#(Y=?;.."1$?X=?NR[?'%\ M,_*AILZE-^`F@;52G".G:#WIP0R@OS/XYFRUFJW2XV+XE1:*??"UE$,%-BMX M^0@DI78RT?`52Q)RE0IE+P]'D=HZJ"8)7\7$];O+VBH9W(_6>Q#MC>4)&"@]M`=:`9MHMN6WWT*+3LD M-9;2-:NR%;5^4KOC@WCWD9VR4"7;X+1N6.VC\\>3A`H_7%A MP&LBWV^4FWJU;U9MY4LN4&M#IDU(W>;4UJUJYFW,6^AJXV,4>1!3="S)C=5Z M"S84T=](=;6M*EJQ!WO$=[!'/M8]PSM$''E*L2=Y/UYUBM7-76,;7VP+`Q>C MKAM?4%KC*O06_GJ&37(+!F#9Q"=X@,=@@5)>TMXE'[)-LPL8XCA`EB_N*S9_ M=I;PZN.L.EELKPY^G#0=-:G,!^_IW%=*_?'ZP):F:RYE@*;Z><0MY=L;O$7P MY_\#4$L!`AX#%`````@`#S`M1/:Y5BG<4@$`H^4<`!$`&````````0```*2! M`````&)R;&DM,C`Q,S$P,S$N>&UL550%``--Q]-2=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`#S`M1"12./VL&P``F<`Q0````(``\P+418R9V\>D```'^W!``5`!@```````$```"D@2)O M`0!B`L``00E#@``!#D! M``!02P$"'@,4````"``/,"U$D.&;P?8-`0!H11(`%0`8```````!````I('K MKP$`8G)L:2TR,#$S,3`S,5]L86(N>&UL550%``--Q]-2=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`#S`M1#OZH9U&?@``J`$)`!4`&````````0```*2! M,+X"`&)R;&DM,C`Q,S$P,S%?<')E+GAM;%54!0`#3`Q0````(``\P+41 XML 25 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Options and Warrants (Details 2) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2011
Employee Incentive Stock Options      
Weighted Average, Shares Outstanding 255    
Exercisable, Shares Outstanding 245    
Compensation cost      
Compensation cost recognized (in dollars) $ 40 $ 40 $ 40
Compensation cost, related tax benefit (in dollars) $ 0 $ 0 $ 0
$6.11 to $6.11
      
Employee Incentive Stock Options      
Exercise price range, low end of range (in dollars per share) $ 6.11    
Exercise price range, high end of range (in dollars per share) $ 6.11    
Weighted Average, Shares Outstanding 6    
Weighted Average, Remaining Life 9 months    
Weighted Average, Exercise Price (in dollars per share) $ 6.11    
Exercisable, Shares Outstanding 6    
Exercisable, Exercise Price (in dollars per share) $ 6.11    
$7.41 to $7.67
      
Employee Incentive Stock Options      
Exercise price range, low end of range (in dollars per share) $ 7.41    
Exercise price range, high end of range (in dollars per share) $ 7.67    
Weighted Average, Shares Outstanding 62    
Weighted Average, Remaining Life 1 year 1 month 2 days    
Weighted Average, Exercise Price (in dollars per share) $ 7.48    
Exercisable, Shares Outstanding 62    
Exercisable, Exercise Price (in dollars per share) $ 7.48    
$9.13 to $9.13
      
Employee Incentive Stock Options      
Exercise price range, low end of range (in dollars per share) $ 9.13    
Exercise price range, high end of range (in dollars per share) $ 9.13    
Weighted Average, Shares Outstanding 147    
Weighted Average, Remaining Life 1 year    
Weighted Average, Exercise Price (in dollars per share) $ 9.13    
Exercisable, Shares Outstanding 147    
Exercisable, Exercise Price (in dollars per share) $ 9.13    
$17.50 to $17.50
      
Employee Incentive Stock Options      
Exercise price range, low end of range (in dollars per share) $ 17.50    
Exercise price range, high end of range (in dollars per share) $ 17.50    
Weighted Average, Shares Outstanding 40    
Weighted Average, Remaining Life 4 years 29 days    
Weighted Average, Exercise Price (in dollars per share) $ 17.50    
Exercisable, Shares Outstanding 30    
Exercisable, Exercise Price (in dollars per share) $ 17.50